Citrus Sinensis ID: 040698

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------31
Protein Sequence
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLLGESST
Secondary Structure (PSIPRED)
cHHHHHHcccccccccccccccEEEEEEEccccEEEEEcccccccccHHHHHHHHHHHHHHccccccccEEcEEccccEEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHcccccccHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEEcccHHHEEEccccccHHcHHcHHHEcccccccEccEEEEEEcccccHHHHHccHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
selvkatknydkrhllgeggfgfvykgvlpdntlvavkkpkmvDKILINEVFQHKMRIISQINHKNVVKILGVCLetkvpllvyefvpngtlfqHVRYQSSQVLKTWKTCLRIAAETASALDYlhslgsppiihgdvksanillddnytakVADFASSVLisshdqtatttkeietvgwldpeylfwteksdvYSFGVVLVELLtgkhprsyVALASNEmtrmvpyfpypiennSLRQILNFQVADENEMEEIEIVAKLASKCLrtsgterptmrQVSEQLDSLRRLHENFWAQKNSEETEQLLGESST
Flexible Loop (DISEMBL)
selvkatknydkrhllgegGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVlisshdqtatttkeietvgwLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLrtsgterptmrqvSEQLDSLRRLHENfwaqknseeteqllgesst
Low Complexity Region (SEG)
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLLGESST
Disordered region (IsUnstruct)
*********YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCL*********************************************
Disordered Region (DISOPRED)
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAV***************QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRS*********TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS*******************L******
Disordered Region (DISEMBL)
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS************
Disordered Region (DISPRO)
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS**************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLLGESST
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	309	2.2.26 [Sep-21-2011]
Q9LMN8	741	Wall-associated receptor	yes	no	0.961	0.400	0.488	1e-74
Q8VYA3	769	Wall-associated receptor	no	no	0.967	0.388	0.469	5e-72
Q9C9L5	792	Wall-associated receptor	no	no	0.961	0.375	0.478	1e-71
Q9LMN7	733	Wall-associated receptor	no	no	0.961	0.405	0.478	1e-70
Q39191	735	Wall-associated receptor	no	no	0.961	0.404	0.472	2e-70
Q9LMN6	738	Wall-associated receptor	no	no	0.961	0.402	0.469	5e-70
Q7X8C5	748	Wall-associated receptor	no	no	0.915	0.378	0.482	4e-68
Q9S9M2	761	Wall-associated receptor	no	no	0.909	0.369	0.472	4e-68
Q9LMP1	732	Wall-associated receptor	no	no	0.961	0.405	0.465	5e-68
Q9S9M5	730	Wall-associated receptor	no	no	0.961	0.406	0.463	6e-68

>sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2

 Score =  280 bits (715), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 149/305 (48%), Positives = 208/305 (68%), Gaps = 8/305 (2%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +AT  YD+  +LG+GG G VYKG+LPDNT+VA+KK ++ D   +++ F H++ ++SQINH
Sbjct: 410 EATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQ-FIHEVLVLSQINH 468

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +NVVKILG CLET+VPLLVYEF+ NGTLF H+         TW+  LRIA E A  L YL
Sbjct: 469 RNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYL 528

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS  S PIIH D+K+ANILLD+N TAKVADF +S LI   D+   TT    T+G+LDPEY
Sbjct: 529 HSSASIPIIHRDIKTANILLDENLTAKVADFGASKLI-PMDKEQLTTMVQGTLGYLDPEY 587

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                  EKSDVYSFGVVL+ELL+G+    +    +++   +V YF    E N L +I++
Sbjct: 588 YTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASK--HLVSYFVSATEENRLHEIID 645

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
            QV +E+ ++EI+  A++A++C R  G ERP M++V+ +L++LR    ++ W+ +  EE 
Sbjct: 646 DQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKHKWSDQYPEEN 705

Query: 301 EQLLG 305
           E L+G
Sbjct: 706 EHLIG 710

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  271 bits (692), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 146/311 (46%), Positives = 205/311 (65%), Gaps = 12/311 (3%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           EL KAT+N+    +LGEGG G VYKG+L D  +VAVKK K+VD+  + E F +++ I+SQ
Sbjct: 425 ELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEE-FINEVVILSQ 483

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ-VLKTWKTCLRIAAETASA 120
           INH+N+VK+LG CLET VP+LVYEF+PNG LF+H+   S    + TW+  LRIA + A A
Sbjct: 484 INHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGA 543

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLHS  S PI H D+KS NI+LD+ + AKV+DF +S  ++  D T  TT    TVG++
Sbjct: 544 LSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTV-DHTHLTTVVSGTVGYM 602

Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEY     +T+KSDVYSFGVVL EL+TG+   S+  L S E   +  YF   ++ N L 
Sbjct: 603 DPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSF--LRSQEYRTLATYFTLAMKENRLS 660

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF----WA 293
            I++ ++ D  ++ ++   AK+A KCL   G +RP+MRQVS +L+ +R   E+     +A
Sbjct: 661 DIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYA 720

Query: 294 QKNSEETEQLL 304
            +N EE ++ L
Sbjct: 721 SENEEEKKETL 731

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  270 bits (689), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 146/305 (47%), Positives = 202/305 (66%), Gaps = 8/305 (2%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           EL KAT+N+    +LG+GG G VYKG+L D  +VAVKK K+VD+  + E F +++ I+SQ
Sbjct: 439 ELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEE-FINEVVILSQ 497

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASA 120
           INH+N+VK+LG CLETKVP+LVYEF+PNG LF+H+  +    ++ TW   LRIA + A A
Sbjct: 498 INHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGA 557

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLHS  S PI H DVKS NI+LD+ Y AKV+DF +S  ++  D T  TT    TVG++
Sbjct: 558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV-DHTHLTTVVSGTVGYM 616

Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEY     +T+KSDVYSFGVVLVEL+TG+   S+  L S E   +  YF   ++ N L 
Sbjct: 617 DPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISF--LRSQENRTLATYFILAMKENKLF 674

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
            I++ ++ D   + ++   AK+A KCL   G +RP+MR+VS +LDS+R    +   Q+  
Sbjct: 675 DIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECV 734

Query: 298 EETEQ 302
            E E+
Sbjct: 735 SENEE 739

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  266 bits (681), Expect = 1e-70,   Method: Compositional matrix adjust.
 Identities = 146/305 (47%), Positives = 206/305 (67%), Gaps = 8/305 (2%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +AT  Y++  +LG+GG G VYKG+L DN++VA+KK ++ D+  + E F +++ ++SQINH
Sbjct: 403 EATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQV-EQFINEVLVLSQINH 461

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +NVVK+LG CLET+VPLLVYEF+ +GTLF H+         TW+  LRIA E A  L YL
Sbjct: 462 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLAYL 521

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS  S PIIH DVK+ANILLD+N TAKVADF +S LI   DQ   TT    T+G+LDPEY
Sbjct: 522 HSYASIPIIHRDVKTANILLDENLTAKVADFGASRLI-PMDQEQLTTMVQGTLGYLDPEY 580

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                  EKSDVYSFGVVL+ELL+G+    +    S++   +V YF   ++ N L +I++
Sbjct: 581 YNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSK--HLVSYFVSAMKENRLHEIID 638

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
            QV +E    EI+  A++A +C R  G ERP+M++V+ +L++LR +  ++ W+ +  +E 
Sbjct: 639 GQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRVKTTKHQWSDQYPKEV 698

Query: 301 EQLLG 305
           E LLG
Sbjct: 699 EHLLG 703

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2

 Score =  266 bits (679), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 144/305 (47%), Positives = 203/305 (66%), Gaps = 8/305 (2%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           KAT  Y +  +LG+GG G VYKG+LPDN++VA+KK ++ D   + E F +++ ++SQINH
Sbjct: 404 KATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQV-EQFINEVLVLSQINH 462

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +NVVK+LG CLET+VPLLVYEF+ NGTLF H+         TW+  L+IA E A  L YL
Sbjct: 463 RNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYL 522

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS  S PIIH D+K+ANILLD N TAKVADF +S LI   D+    T    T+G+LDPEY
Sbjct: 523 HSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLI-PMDKEELETMVQGTLGYLDPEY 581

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                  EKSDVYSFGVVL+ELL+G+    +    S++   +V YF    + N L +I+ 
Sbjct: 582 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSK--HLVSYFATATKENRLDEIIG 639

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
            +V +E+ ++EI+  A++A++C R  G ERP M++V+ +L++LR    ++ W+ +  EE 
Sbjct: 640 GEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKHKWSDQYPEEN 699

Query: 301 EQLLG 305
           E L+G
Sbjct: 700 EHLIG 704

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  264 bits (675), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 144/307 (46%), Positives = 205/307 (66%), Gaps = 10/307 (3%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +AT  YD+  +LG+GG G VYKG+LPDN++VA+KK ++ D   + E F +++ ++SQINH
Sbjct: 405 EATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQV-EQFINEVLVLSQINH 463

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +NVVK+LG CLET+VPLLVYEF+ +GTLF H+         TW+  LR+A E A  L YL
Sbjct: 464 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYL 523

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS  S PIIH D+K+ANILLD+N TAKVADF +S LI   D+    T    T+G+LDPEY
Sbjct: 524 HSSASIPIIHRDIKTANILLDENLTAKVADFGASRLI-PMDKEDLATMVQGTLGYLDPEY 582

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                  EKSDVYSFGVVL+ELL+G+    +    +++   +V YF    + N L +I++
Sbjct: 583 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSK--HIVSYFASATKENRLHEIID 640

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH-ENFWAQK--NSE 298
            QV +EN   EI+  A++A +C R +G ERP M++V+ +L++LR    ++ W+ +    E
Sbjct: 641 GQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTKHKWSDEYPEQE 700

Query: 299 ETEQLLG 305
           +TE L+G
Sbjct: 701 DTEHLVG 707

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  258 bits (659), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 140/290 (48%), Positives = 194/290 (66%), Gaps = 7/290 (2%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           EL KAT N++K  +LG+GG G VYKG+L D  +VAVK+ K VD+  + E F +++ +++Q
Sbjct: 408 ELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEE-FINEVVVLAQ 466

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           INH+N+VK+LG CLET+VP+LVYEFVPNG L + +  +S     TW+  L IA E A AL
Sbjct: 467 INHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGAL 526

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLHS  S PI H D+K+ NILLD+   AKV+DF +S  ++  DQT  TT+   T G++D
Sbjct: 527 SYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTI-DQTHLTTQVAGTFGYVD 585

Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           PEY     +TEKSDVYSFGVVLVELLTG+ P S V   S E   +  +F   ++ N +  
Sbjct: 586 PEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRV--RSEENRGLAAHFVEAVKENRVLD 643

Query: 239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
           I++ ++ DE  M+++  VA LA +CL   G +RP MR+VS +L+ +R  H
Sbjct: 644 IVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  258 bits (659), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 136/288 (47%), Positives = 194/288 (67%), Gaps = 7/288 (2%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT N++   +LG+GG G VYKG+L D  +VAVK+ K +D+  + E F +++ +++
Sbjct: 415 NELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEE-FINEVVVLA 473

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           QINH+N+VK+LG CLET+VP+LVYEFVPNG L + +R +    + TW+  L IA E A A
Sbjct: 474 QINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGA 533

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLHS  S PI H D+K+ NILLD+ Y  KV+DF +S  ++  DQT  TT+   T G++
Sbjct: 534 LSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTI-DQTHLTTQVAGTFGYV 592

Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEY     +T+KSDVYSFGVVLVEL+TGK+P S V   S E      +F   ++ N   
Sbjct: 593 DPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRV--QSEENRGFAAHFVAAVKENRFL 650

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
            I++ ++ DE  ++++  VAKLA +CL   G +RP MR+VS +L+ +R
Sbjct: 651 DIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIR 698

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  258 bits (658), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 143/307 (46%), Positives = 201/307 (65%), Gaps = 10/307 (3%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +AT  Y +  +LG+GG G VYKG+LPDN++VA+KK ++ ++  + E F +++ ++SQINH
Sbjct: 399 EATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQV-EQFINEVLVLSQINH 457

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +NVVK+LG CLET+VPLLVYEF+ +GTLF H+         TW+  LRIA E A +L YL
Sbjct: 458 RNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAYL 517

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS  S PIIH D+K+ANILLD N TAKVADF +S LI   D+   TT    T+G+LDPEY
Sbjct: 518 HSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLI-PMDKEQLTTIVQGTLGYLDPEY 576

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                  EKSDVYSFGVVL+ELL+G+    +      +   +V  F    +NN   +I++
Sbjct: 577 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPK--NLVSCFASATKNNRFHEIID 634

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF-WAQKNSE-- 298
            QV +E+   EI+  A++A++C R  G ERP M++V+ +L++LR     + W+ +  E  
Sbjct: 635 GQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALRVKTTKYKWSDQYRETG 694

Query: 299 ETEQLLG 305
           E E LLG
Sbjct: 695 EIEHLLG 701

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  257 bits (657), Expect = 6e-68,   Method: Compositional matrix adjust.
 Identities = 141/304 (46%), Positives = 204/304 (67%), Gaps = 7/304 (2%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           EL KAT N+    +LG+GG G VYKG+L D ++VAVK+ K+VD+  + E F +++ ++SQ
Sbjct: 421 ELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEE-FINEIVLLSQ 479

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           INH+N+VK+LG CLET+VP+LVYE++PNG LF+ +  +S     TW+  LRIA E A AL
Sbjct: 480 INHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGAL 539

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            Y+HS  S PI H D+K+ NILLD+ Y AKV+DF +S  + + DQT  TT    T G++D
Sbjct: 540 TYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSV-TLDQTHLTTLVAGTFGYMD 598

Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           PEY     +T KSDVYSFGVVLVEL+TG+ P S V   S E   +  +F   ++ N +  
Sbjct: 599 PEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENRVID 656

Query: 239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSE 298
           I++ ++ DE+++E++  VAKLA KCL   G  RP M++VS +L+ +R   E+   +  +E
Sbjct: 657 IIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVRTENE 716

Query: 299 ETEQ 302
           + E+
Sbjct: 717 DEEE 720

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	309
224102957	615	predicted protein [Populus trichocarpa]	0.990	0.497	0.620	1e-105
255573255	739	kinase, putative [Ricinus communis] gi|2	0.980	0.410	0.610	1e-102
255573259	771	serine-threonine protein kinase, plant-t	0.990	0.396	0.605	1e-100
255565901	457	BRASSINOSTEROID INSENSITIVE 1-associated	0.983	0.665	0.588	1e-98
224132144	646	predicted protein [Populus trichocarpa]	0.983	0.470	0.593	2e-98
224145581	584	predicted protein [Populus trichocarpa]	0.990	0.523	0.588	5e-97
224102953	633	predicted protein [Populus trichocarpa]	0.915	0.447	0.625	1e-96
224132202	721	predicted protein [Populus trichocarpa]	0.990	0.424	0.578	5e-95
224132168	321	predicted protein [Populus trichocarpa]	0.944	0.909	0.595	1e-93
224132160	667	predicted protein [Populus trichocarpa]	0.919	0.425	0.613	1e-92

>gi|224102957|ref|XP_002312869.1| predicted protein [Populus trichocarpa] gi|222849277|gb|EEE86824.1| predicted protein [Populus trichocarpa]

 Score =  386 bits (992), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 193/311 (62%), Positives = 231/311 (74%), Gaps = 5/311 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT NYD    +GEGGFG VYKG+L DNT+VAVKK K VDK  +NE FQH++ ++S
Sbjct: 278 AELTKATNNYDDDKKIGEGGFGSVYKGILADNTVVAVKKSKGVDKAQMNEDFQHEICVVS 337

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTLF+H+  + SQVL +W   LRIA+E A A
Sbjct: 338 QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKRSQVLASWSNRLRIASEAALA 397

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLDDNYTAKVADF +SVLIS        TK   T G+L
Sbjct: 398 LDYLHSLADPPVIHGDVKSVNILLDDNYTAKVADFGASVLISPGQTNILATKIQGTFGYL 457

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     TEKSDVYSFGVVLVELLTG+ P S     S      + YF   +ENN L 
Sbjct: 458 DPEYLLTGNLTEKSDVYSFGVVLVELLTGEKPNSNA--KSGNKRNFIQYFNSALENNDLF 515

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
            IL+FQ ADE EM+EIE VA+LA +CL + G  RP+M++VSE+L  L+ L++  WAQ+NS
Sbjct: 516 GILDFQAADEAEMDEIEAVAELAKRCLNSIGVNRPSMKEVSEELAKLKALNQKSWAQQNS 575

Query: 298 EETEQLLGESS 308
           +ETE LLGE S
Sbjct: 576 DETEHLLGEPS 586

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573255|ref|XP_002527556.1| kinase, putative [Ricinus communis] gi|223533048|gb|EEF34808.1| kinase, putative [Ricinus communis]

 Score =  379 bits (972), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 191/313 (61%), Positives = 236/313 (75%), Gaps = 10/313 (3%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KATKNYD   LLGEGGFG+VYKGVL DNT +AVKKPK +DK  I + +QH++ I+S
Sbjct: 404 AELAKATKNYDPSQLLGEGGFGYVYKGVLADNTQIAVKKPKDIDKAQIKQEYQHEIGIVS 463

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVKILG+CLETKVPLLVYEF+ NGTLF H+ ++ SQ+L  WK  LRIAAETA A
Sbjct: 464 QVNHKNVVKILGLCLETKVPLLVYEFISNGTLFHHIHHKRSQILANWKNRLRIAAETALA 523

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
            DYLHSL  PPIIHGDVKS NILLDD YTAKV+DF +SVLISS  ++    K   T G+L
Sbjct: 524 FDYLHSLADPPIIHGDVKSLNILLDDTYTAKVSDFGASVLISS-GESDIGAKLQGTFGYL 582

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     TEKSDVYSFGVVLVELLTG+ P S    ++     ++ YF   +E+++L 
Sbjct: 583 DPEYLMTGILTEKSDVYSFGVVLVELLTGEKPNS----SARSGEHIIQYFLSSLESHNLS 638

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKN- 296
           QIL F V +ENEMEEI + A+LA +CLR+ G +RPTM++ +E+L  L++L+EN W   + 
Sbjct: 639 QILCFNVTNENEMEEIVVFAELAKQCLRSCGVKRPTMKEAAEELGRLKKLNENSWNHDDH 698

Query: 297 -SEETEQLLGESS 308
             EET+ LLGESS
Sbjct: 699 SGEETQYLLGESS 711

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573259|ref|XP_002527558.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533050|gb|EEF34810.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  370 bits (950), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 189/312 (60%), Positives = 233/312 (74%), Gaps = 6/312 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT  Y   + LGEGGFG VYKGVL D T VAVK+PK ++K+ +N+ FQ ++ I+S
Sbjct: 434 AELAKATNYYTTSNFLGEGGFGCVYKGVLADGTQVAVKRPKDIEKMKMNQEFQKEIGIVS 493

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NH NVVK+LG+CLET VPLLVYEFV NG L+QH+  + SQ+L  WK  LRIAAETA A
Sbjct: 494 QVNHINVVKVLGLCLETNVPLLVYEFVSNGNLYQHIHQKRSQLLTAWKNILRIAAETALA 553

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL +PPIIHGDVKSANILLD+NYTAKV+DF +SVLISS +QT   TK   T G+L
Sbjct: 554 LDYLHSLANPPIIHGDVKSANILLDENYTAKVSDFGASVLISS-NQTDMATKIQGTFGYL 612

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     TEKSDVYSFGVVLVELLTG+ P S     S E   ++ YF   +EN  L 
Sbjct: 613 DPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNS--NPKSGEKNNIIQYFLSSLENGDLN 670

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
           QI  F++  + EMEEIE+ A+LA +CLR+SG +RPTM +V+ +L  LR+LHE+ W+Q NS
Sbjct: 671 QIPCFEITSKEEMEEIEVFAELAKQCLRSSGIKRPTMNEVAHELVRLRKLHESSWSQHNS 730

Query: 298 EETEQLLGESST 309
            ETE LL + S+
Sbjct: 731 NETEHLLQDDSS 742

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565901|ref|XP_002523939.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223536786|gb|EEF38426.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  365 bits (937), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 183/311 (58%), Positives = 238/311 (76%), Gaps = 7/311 (2%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT+NY+    LGEGGFG VYKG+L D T VAVKKPK +D+  IN+ FQ ++ I+S
Sbjct: 119 AELTKATRNYETSQFLGEGGFGSVYKGILADGTQVAVKKPKDLDRTQINQEFQKELAIVS 178

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NH NVVKILG+CLETKVPLLVYEF+ NG+L+QH+  + SQ+L +WK  LRIA ETA A
Sbjct: 179 QVNHINVVKILGLCLETKVPLLVYEFISNGSLYQHIHQKRSQILTSWKNRLRIATETALA 238

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           +DYLHSL +PPIIHGDVKSANILLDDNYTAKV+DF +SVLIS    T   TK   T G+L
Sbjct: 239 IDYLHSLANPPIIHGDVKSANILLDDNYTAKVSDFGASVLISP-GYTDMATKIQGTFGYL 297

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     TEKSDVYSFGVVLVE+LTG+ P S     S   + ++ YF   +E+ ++ 
Sbjct: 298 DPEYLMTGKLTEKSDVYSFGVVLVEILTGEKPNSNA--RSGVKSNIIQYFLSSLESKNIS 355

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
             L F V +E+E+EEI++ ++LA +CL ++G +RPTM++V+E+L  LR+L+E+ WAQ+NS
Sbjct: 356 GTLCFMV-NEDELEEIKVFSELAKRCLSSTGIKRPTMKEVAEELGRLRKLNESLWAQENS 414

Query: 298 EETEQLLGESS 308
           +ETE LLG++S
Sbjct: 415 KETEHLLGDAS 425

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132144|ref|XP_002328196.1| predicted protein [Populus trichocarpa] gi|222837711|gb|EEE76076.1| predicted protein [Populus trichocarpa]

 Score =  364 bits (935), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 184/310 (59%), Positives = 233/310 (75%), Gaps = 6/310 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT NY     LGEGGFG+VYKGVL DNTLVAVKK K VDK  +NE FQ ++ I+S
Sbjct: 340 AELEKATNNYVDDQKLGEGGFGYVYKGVLADNTLVAVKKFKGVDKDQLNEEFQKEIGIVS 399

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NH+NVVK+LG+CLETKVPLLVYEF+ NGTL++H+  + SQ+L +W   LRIA+E A A
Sbjct: 400 QVNHRNVVKLLGLCLETKVPLLVYEFISNGTLYKHIHDKRSQILASWSNRLRIASEIALA 459

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLD+NYTAKVADF +SVLISS  Q+   TK   T G+L
Sbjct: 460 LDYLHSLADPPVIHGDVKSVNILLDNNYTAKVADFGASVLISS-GQSFIATKIQGTFGYL 518

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     T KSDV+SFGVVL+ELL G+ P S+    S E   ++ YF   +ENN+L 
Sbjct: 519 DPEYLMTGNLTPKSDVFSFGVVLLELLIGQKPNSHA--KSGETRNIIEYFISALENNNLF 576

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
            IL+FQ ADE EM+EIE+VA++A +C+ + G  RPTM++VS++L   + LHE+ WAQ  +
Sbjct: 577 GILDFQAADEGEMDEIEVVAEIAKRCVNSMGINRPTMKEVSDELAKQKALHESSWAQHKN 636

Query: 298 EETEQLLGES 307
           ++T+ LL ES
Sbjct: 637 DDTKHLLSES 646

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224145581|ref|XP_002325694.1| predicted protein [Populus trichocarpa] gi|222862569|gb|EEF00076.1| predicted protein [Populus trichocarpa]

 Score =  360 bits (924), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 183/311 (58%), Positives = 230/311 (73%), Gaps = 5/311 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +ELVKAT NY     LGEG FG VYKGVL DNT+VAVKK K VDK  +N  FQ +M I+S
Sbjct: 247 AELVKATNNYADDRKLGEGSFGSVYKGVLTDNTVVAVKKSKGVDKAQMNAEFQKEMSIVS 306

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTL +H+  + S++L +W   LR+A+E A A
Sbjct: 307 QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGSRILVSWTNRLRVASEAALA 366

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLD+N+TAKVADF +SVL+S      + TK   T+G+L
Sbjct: 367 LDYLHSLADPPVIHGDVKSVNILLDNNHTAKVADFGASVLMSPGQTDISATKIQGTLGYL 426

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     T +SDVYSFGVVLVELLTG+ P S     S E   ++ +F   +ENN L 
Sbjct: 427 DPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFISALENNHLF 484

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
           +IL+FQ ADE++M+EIE VA+LA +CL + G  RP M++VS++L  L+ LH+   AQ+NS
Sbjct: 485 KILDFQTADEDDMDEIEAVAELAKRCLNSMGVNRPAMKEVSDELAKLKALHQKSLAQQNS 544

Query: 298 EETEQLLGESS 308
           EET+ LL ESS
Sbjct: 545 EETDYLLDESS 555

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224102953|ref|XP_002312868.1| predicted protein [Populus trichocarpa] gi|222849276|gb|EEE86823.1| predicted protein [Populus trichocarpa]

 Score =  359 bits (921), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 180/288 (62%), Positives = 215/288 (74%), Gaps = 5/288 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KAT NYD    LGEGGFG VYKGVL DNT+VAVKK K VDK  +NE FQH++ ++S
Sbjct: 348 AELTKATNNYDDDKKLGEGGFGSVYKGVLADNTVVAVKKSKGVDKAQMNEDFQHEICVVS 407

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTLF+H+  + SQVL +W   LRIA+E A A
Sbjct: 408 QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKRSQVLASWSNRLRIASEAALA 467

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLDDNYTAKVADF +SVLIS        TK   T G+L
Sbjct: 468 LDYLHSLADPPVIHGDVKSVNILLDDNYTAKVADFGASVLISPGQTNILATKIQGTFGYL 527

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     TEKSDVYSFGVVLVELLTG+ P S     S +    + YF   +ENN + 
Sbjct: 528 DPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNSNA--KSGKKRNFIQYFNSALENNDVF 585

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
            IL+FQ ADE EM+EIE VA+LA +CL ++G  RP+M++VSE+L  L+
Sbjct: 586 GILDFQAADEAEMDEIEAVAELAKRCLNSTGVNRPSMKEVSEELAKLK 633

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132202|ref|XP_002328210.1| predicted protein [Populus trichocarpa] gi|222837725|gb|EEE76090.1| predicted protein [Populus trichocarpa]

 Score =  353 bits (906), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 180/311 (57%), Positives = 225/311 (72%), Gaps = 5/311 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +ELVKAT NY     +GEGGFG VY GVL DNT+VAVKK K VDK  +N  FQ +M I+S
Sbjct: 384 AELVKATNNYADDRKIGEGGFGSVYSGVLTDNTMVAVKKSKGVDKAQMNAEFQKEMSIVS 443

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTL +H+  + S++L +W   LR+A+E A A
Sbjct: 444 QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGSRILASWTNRLRVASEAALA 503

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLD+N+T KVADF +SVL+S        TK   T+G+L
Sbjct: 504 LDYLHSLADPPVIHGDVKSVNILLDNNHTTKVADFGASVLMSPGQTDILATKIQGTLGYL 563

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     T +SDVYSFGVVLVELLTG+ P S     S E   ++ +F   +ENN L 
Sbjct: 564 DPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFISALENNHLF 621

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
           +IL+FQ ADE +M+EIE VA+LA  CL + G  RP M++VS++L  L+ LH+   A + S
Sbjct: 622 KILDFQTADEGDMDEIEAVAELAKGCLNSMGVNRPAMKEVSDELAKLKALHQKSLAHEKS 681

Query: 298 EETEQLLGESS 308
           EET+ LLGESS
Sbjct: 682 EETDYLLGESS 692

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132168|ref|XP_002328202.1| predicted protein [Populus trichocarpa] gi|222837717|gb|EEE76082.1| predicted protein [Populus trichocarpa]

 Score =  349 bits (895), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 177/297 (59%), Positives = 215/297 (72%), Gaps = 5/297 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +ELVKAT NY     LGEGGFG VYKGVL DNT+VAVKK K VDK  +N  FQ +M I+S
Sbjct: 27  AELVKATNNYADDRKLGEGGFGSVYKGVLTDNTVVAVKKSKGVDKAQMNAEFQKEMSIVS 86

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTL +HV  + S++L +W   LR+A+E A A
Sbjct: 87  QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHVHDKGSRILASWTNRLRVASEAALA 146

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LDYLHSL  PP+IHGDVKS NILLD NYTAKVADF +SVL+S        TK   T+G+L
Sbjct: 147 LDYLHSLADPPVIHGDVKSVNILLDSNYTAKVADFGASVLMSPGKTDILATKIQGTLGYL 206

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     T +SDVYSFGVVLVELLTG+ P S     S E   ++ +F   +ENN L 
Sbjct: 207 DPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNSIS--KSGEKRNVIQHFISALENNHLF 264

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ 294
           +IL+FQ ADE EM+EIE VA+LA  CL + G  RPTM++VS++L  L+ LH+   A 
Sbjct: 265 KILDFQTADEGEMDEIEAVAELAKGCLNSMGVNRPTMKEVSDELAKLKALHQKSLAH 321

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132160|ref|XP_002328200.1| predicted protein [Populus trichocarpa] gi|222837715|gb|EEE76080.1| predicted protein [Populus trichocarpa]

 Score =  345 bits (886), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 178/290 (61%), Positives = 221/290 (76%), Gaps = 6/290 (2%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +EL KATKNYD    LGEGGFG VY+GVL DN  VAVKK K VDK  +NE FQ++M ++S
Sbjct: 381 AELEKATKNYDDDQKLGEGGFGSVYRGVLADNAQVAVKKFKGVDKAQMNEEFQNEMGVVS 440

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           Q+NHKNVVK+LG+CLETKVPLLVYEF+ NGTLF+H+  ++SQ+L +W + LRIA+E A A
Sbjct: 441 QVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKTSQLLASWSSRLRIASEIALA 500

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L+YLHSL  PPIIHGDVKS NILLD+N TAKVADF +SVLISS DQT   TK   T G+L
Sbjct: 501 LNYLHSLADPPIIHGDVKSVNILLDNNNTAKVADFGASVLISS-DQTIIATKIQGTFGYL 559

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           DPEYL     T +SDV+SFGVVLVELLTG+ P S  + +S E   ++ +F   +E N+L 
Sbjct: 560 DPEYLMTGILTARSDVFSFGVVLVELLTGEKPNS--SSSSGEKRNLIQHFISALETNNLF 617

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
           +IL+FQ ADE EM+EIE VA+LA  CL + G  RPTM++VS++L  L+ L
Sbjct: 618 RILDFQAADEGEMDEIEAVAELAKGCLNSMGLNRPTMKEVSDELAKLKDL 667

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	309
TAIR|locus:2014897	741	WAK3 "wall associated kinase 3	0.961	0.400	0.488	1.6e-70
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.967	0.388	0.469	2.1e-68
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.961	0.375	0.478	7.2e-68
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.961	0.406	0.463	3.1e-67
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.961	0.405	0.478	4e-67
TAIR|locus:2014902	735	WAK1 "cell wall-associated kin	0.961	0.404	0.472	2.2e-66
TAIR|locus:2014952	738	WAK4 "wall associated kinase 4	0.961	0.402	0.465	2.8e-66
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.967	0.399	0.464	1.5e-65
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.925	0.362	0.479	1.1e-64
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.961	0.395	0.453	1.1e-64

TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 1.6e-70, P = 1.6e-70
 Identities = 149/305 (48%), Positives = 208/305 (68%)

Query:     5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
             +AT  YD+  +LG+GG G VYKG+LPDNT+VA+KK ++ D   +++ F H++ ++SQINH
Sbjct:   410 EATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQ-FIHEVLVLSQINH 468

Query:    65 KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +NVVKILG CLET+VPLLVYEF+ NGTLF H+         TW+  LRIA E A  L YL
Sbjct:   469 RNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYL 528

Query:   125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
             HS  S PIIH D+K+ANILLD+N TAKVADF +S LI   D+   TT    T+G+LDPEY
Sbjct:   529 HSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPM-DKEQLTTMVQGTLGYLDPEY 587

Query:   185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                    EKSDVYSFGVVL+ELL+G+    +    +++   +V YF    E N L +I++
Sbjct:   588 YTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASK--HLVSYFVSATEENRLHEIID 645

Query:   242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
              QV +E+ ++EI+  A++A++C R  G ERP M++V+ +L++LR    ++ W+ +  EE 
Sbjct:   646 DQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKHKWSDQYPEEN 705

Query:   301 EQLLG 305
             E L+G
Sbjct:   706 EHLIG 710

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 694 (249.4 bits), Expect = 2.1e-68, P = 2.1e-68
 Identities = 146/311 (46%), Positives = 205/311 (65%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT+N+    +LGEGG G VYKG+L D  +VAVKK K+VD+  + E F +++ I+SQ
Sbjct:   425 ELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEE-FINEVVILSQ 483

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ-VLKTWKTCLRIAAETASA 120
             INH+N+VK+LG CLET VP+LVYEF+PNG LF+H+   S    + TW+  LRIA + A A
Sbjct:   484 INHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGA 543

Query:   121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
             L YLHS  S PI H D+KS NI+LD+ + AKV+DF +S  ++  D T  TT    TVG++
Sbjct:   544 LSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTV-DHTHLTTVVSGTVGYM 602

Query:   181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
             DPEY     +T+KSDVYSFGVVL EL+TG+   S+  L S E   +  YF   ++ N L 
Sbjct:   603 DPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSF--LRSQEYRTLATYFTLAMKENRLS 660

Query:   238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF----WA 293
              I++ ++ D  ++ ++   AK+A KCL   G +RP+MRQVS +L+ +R   E+     +A
Sbjct:   661 DIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYA 720

Query:   294 QKNSEETEQLL 304
              +N EE ++ L
Sbjct:   721 SENEEEKKETL 731

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
 Identities = 146/305 (47%), Positives = 203/305 (66%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT+N+    +LG+GG G VYKG+L D  +VAVKK K+VD+  + E F +++ I+SQ
Sbjct:   439 ELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEE-FINEVVILSQ 497

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ-VLKTWKTCLRIAAETASA 120
             INH+N+VK+LG CLETKVP+LVYEF+PNG LF+H+  +  + ++ TW   LRIA + A A
Sbjct:   498 INHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGA 557

Query:   121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
             L YLHS  S PI H DVKS NI+LD+ Y AKV+DF +S  ++  D T  TT    TVG++
Sbjct:   558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV-DHTHLTTVVSGTVGYM 616

Query:   181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
             DPEY     +T+KSDVYSFGVVLVEL+TG+   S+  L S E   +  YF   ++ N L 
Sbjct:   617 DPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISF--LRSQENRTLATYFILAMKENKLF 674

Query:   238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNS 297
              I++ ++ D   + ++   AK+A KCL   G +RP+MR+VS +LDS+R    +   Q+  
Sbjct:   675 DIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECV 734

Query:   298 EETEQ 302
              E E+
Sbjct:   735 SENEE 739

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 683 (245.5 bits), Expect = 3.1e-67, P = 3.1e-67
 Identities = 141/304 (46%), Positives = 204/304 (67%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT N+    +LG+GG G VYKG+L D ++VAVK+ K+VD+  + E F +++ ++SQ
Sbjct:   421 ELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEE-FINEIVLLSQ 479

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
             INH+N+VK+LG CLET+VP+LVYE++PNG LF+ +  +S     TW+  LRIA E A AL
Sbjct:   480 INHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGAL 539

Query:   122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
              Y+HS  S PI H D+K+ NILLD+ Y AKV+DF +S  ++  DQT  TT    T G++D
Sbjct:   540 TYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTL-DQTHLTTLVAGTFGYMD 598

Query:   182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
             PEY     +T KSDVYSFGVVLVEL+TG+ P S V   S E   +  +F   ++ N +  
Sbjct:   599 PEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVR--SEEGRGLATHFLEAMKENRVID 656

Query:   239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSE 298
             I++ ++ DE+++E++  VAKLA KCL   G  RP M++VS +L+ +R   E+   +  +E
Sbjct:   657 IIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVRTENE 716

Query:   299 ETEQ 302
             + E+
Sbjct:   717 DEEE 720

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 682 (245.1 bits), Expect = 4.0e-67, P = 4.0e-67
 Identities = 146/305 (47%), Positives = 206/305 (67%)

Query:     5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
             +AT  Y++  +LG+GG G VYKG+L DN++VA+KK ++ D+  + E F +++ ++SQINH
Sbjct:   403 EATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQV-EQFINEVLVLSQINH 461

Query:    65 KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +NVVK+LG CLET+VPLLVYEF+ +GTLF H+         TW+  LRIA E A  L YL
Sbjct:   462 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLAYL 521

Query:   125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
             HS  S PIIH DVK+ANILLD+N TAKVADF +S LI   DQ   TT    T+G+LDPEY
Sbjct:   522 HSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPM-DQEQLTTMVQGTLGYLDPEY 580

Query:   185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                    EKSDVYSFGVVL+ELL+G+    +    S++   +V YF   ++ N L +I++
Sbjct:   581 YNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSK--HLVSYFVSAMKENRLHEIID 638

Query:   242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
              QV +E    EI+  A++A +C R  G ERP+M++V+ +L++LR +  ++ W+ +  +E 
Sbjct:   639 GQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRVKTTKHQWSDQYPKEV 698

Query:   301 EQLLG 305
             E LLG
Sbjct:   699 EHLLG 703

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
 Identities = 144/305 (47%), Positives = 203/305 (66%)

Query:     5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
             KAT  Y +  +LG+GG G VYKG+LPDN++VA+KK ++ D   + E F +++ ++SQINH
Sbjct:   404 KATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQV-EQFINEVLVLSQINH 462

Query:    65 KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +NVVK+LG CLET+VPLLVYEF+ NGTLF H+         TW+  L+IA E A  L YL
Sbjct:   463 RNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYL 522

Query:   125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
             HS  S PIIH D+K+ANILLD N TAKVADF +S LI   D+    T    T+G+LDPEY
Sbjct:   523 HSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPM-DKEELETMVQGTLGYLDPEY 581

Query:   185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                    EKSDVYSFGVVL+ELL+G+    +    S++   +V YF    + N L +I+ 
Sbjct:   582 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSK--HLVSYFATATKENRLDEIIG 639

Query:   242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR-RLHENFWAQKNSEET 300
              +V +E+ ++EI+  A++A++C R  G ERP M++V+ +L++LR    ++ W+ +  EE 
Sbjct:   640 GEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRVEKTKHKWSDQYPEEN 699

Query:   301 EQLLG 305
             E L+G
Sbjct:   700 EHLIG 704

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0007166 "cell surface receptor signaling pathway" evidence=IPI

GO:0005773 "vacuole" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009615 "response to virus" evidence=IEP

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0009505 "plant-type cell wall" evidence=IDA

TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 674 (242.3 bits), Expect = 2.8e-66, P = 2.8e-66
 Identities = 143/307 (46%), Positives = 205/307 (66%)

Query:     5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
             +AT  YD+  +LG+GG G VYKG+LPDN++VA+KK ++ D   + E F +++ ++SQINH
Sbjct:   405 EATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQV-EQFINEVLVLSQINH 463

Query:    65 KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +NVVK+LG CLET+VPLLVYEF+ +GTLF H+         TW+  LR+A E A  L YL
Sbjct:   464 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYL 523

Query:   125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
             HS  S PIIH D+K+ANILLD+N TAKVADF +S LI    +   T  +  T+G+LDPEY
Sbjct:   524 HSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQ-GTLGYLDPEY 582

Query:   185 L---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                    EKSDVYSFGVVL+ELL+G+    +    +++   +V YF    + N L +I++
Sbjct:   583 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSK--HIVSYFASATKENRLHEIID 640

Query:   242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH-ENFWAQK--NSE 298
              QV +EN   EI+  A++A +C R +G ERP M++V+ +L++LR    ++ W+ +    E
Sbjct:   641 GQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVTKTKHKWSDEYPEQE 700

Query:   299 ETEQLLG 305
             +TE L+G
Sbjct:   701 DTEHLVG 707

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048527 "lateral root development" evidence=RCA;IMP

GO:0048589 "developmental growth" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 667 (239.9 bits), Expect = 1.5e-65, P = 1.5e-65
 Identities = 143/308 (46%), Positives = 201/308 (65%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT N++K  +LG+GG G VYKG+L D  +VAVK+ K VD+  + E F +++ +++Q
Sbjct:   408 ELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEE-FINEVVVLAQ 466

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
             INH+N+VK+LG CLET+VP+LVYEFVPNG L + +  +S     TW+  L IA E A AL
Sbjct:   467 INHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGAL 526

Query:   122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
              YLHS  S PI H D+K+ NILLD+   AKV+DF +S  ++  DQT  TT+   T G++D
Sbjct:   527 SYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTI-DQTHLTTQVAGTFGYVD 585

Query:   182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
             PEY     +TEKSDVYSFGVVLVELLTG+ P S V   S E   +  +F   ++ N +  
Sbjct:   586 PEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVR--SEENRGLAAHFVEAVKENRVLD 643

Query:   239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH--ENFWAQKN 296
             I++ ++ DE  M+++  VA LA +CL   G +RP MR+VS +L+ +R  H       + +
Sbjct:   644 IVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDD 703

Query:   297 SEETEQLL 304
              EE +Q +
Sbjct:   704 DEEDDQAM 711

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 140/292 (47%), Positives = 193/292 (66%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT N+ +  +LG+GG G VYKG+L D   VAVKK K+VD+  + E F +++ I+SQ
Sbjct:   443 ELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEE-FINEVVILSQ 501

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
             INH++VVK+LG CLET+VP LVYEF+PNG LFQH+  +S    KTW   LRIA + A AL
Sbjct:   502 INHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGAL 561

Query:   122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
              YLHS  S PI H D+KS NILLD+ Y  KV+DF +S  ++  D T  TT    TVG++D
Sbjct:   562 SYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTI-DHTHWTTVISGTVGYVD 620

Query:   182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
             PEY     +T+KSDVYSFGVVLVEL+TG+ P   V+  S E+  +  +F   ++ N   +
Sbjct:   621 PEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVS-NSQEIRGLADHFRVAMKENRFFE 679

Query:   239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
             I++ ++ D  + E++  VA LA +CL + G +RP MR+V   L+ +    E+
Sbjct:   680 IMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQED 731

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 138/304 (45%), Positives = 199/304 (65%)

Query:     2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
             EL KAT N++   +LG+GG G VYKG+L D  +VAVK+ K++D+  + E F +++ ++SQ
Sbjct:   413 ELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEE-FINEVGVLSQ 471

Query:    62 INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
             INH+N+VK++G CLET+VP+LVYE +PNG LF+ + + S     TW   LRI+ E A AL
Sbjct:   472 INHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGAL 531

Query:   122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
              YLHS  S P+ H DVK+ NILLD+ Y AKV+DF +S  I+  DQT  TT    T G+LD
Sbjct:   532 AYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINV-DQTHLTTLVAGTFGYLD 590

Query:   182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
             PEY     +T+KSDVYSFGVVLVEL+TG+ P S   +   E   +V +F   ++ N +  
Sbjct:   591 PEYFQTSQFTDKSDVYSFGVVLVELITGEKPFS--VMRPEENRGLVSHFNEAMKQNRVLD 648

Query:   239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSE 298
             I++ ++ +   +E++  VAKLA +CL   G +RP MR+VS +L+ +R   E+       E
Sbjct:   649 IVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLELHIEEE 708

Query:   299 ETEQ 302
             + E+
Sbjct:   709 DEEE 712

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IX.563.1 hypothetical protein (548 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	309
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (422), Expect = 5e-50
 Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 41/279 (14%)

Query: 16  LGEGGFGFVYKGVL---PDNT--LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LGEG FG VYKG L          VAVK  K        E F  + RI+ +++H NVVK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LGVC E +   +V E++  G L  ++R    ++  +    L  A + A  ++YL S    
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESK--- 121

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFW 187
             IH D+ + N L+ +N   K++DF  S  +   D       ++  + W+ PE      +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKF 180

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD 246
           T KSDV+SFGV+L E+ T G+                    PYP  +N   ++L + + +
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQ-------------------PYPGMSNE--EVLEY-LKN 218

Query: 247 ENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQL 281
              + +       +  L  +C      +RPT  ++ E L
Sbjct: 219 GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  165 bits (421), Expect = 8e-50
 Identities = 82/279 (29%), Positives = 128/279 (45%), Gaps = 40/279 (14%)

Query: 16  LGEGGFGFVYKGVLPDN-----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LGEG FG VYKG L          VAVK  K        E F  + RI+ +++H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LGVC E +  ++V E++P G L  ++R    + L +    L  A + A  ++YL S    
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLESK--- 122

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFW 187
             IH D+ + N L+ +N   K++DF  S  +   D       ++  + W+ PE      +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGKF 181

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD 246
           T KSDV+SFGV+L E+ T G+                    PYP    S  ++L + +  
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEE-------------------PYP--GMSNAEVLEY-LKK 219

Query: 247 ENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQL 281
              + +       + KL  +C      +RPT  ++ E L
Sbjct: 220 GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (416), Expect = 1e-49
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 13/194 (6%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           LGEGGFG VY          VA+K  K  D   + E    ++ I+ ++NH N+VK+ GV 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            +     LV E+   G+L   ++    ++  +    LRI  +    L+YLHS G   IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKL--SEDEILRILLQILEGLEYLHSNG---IIH 115

Query: 135 GDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTE 189
            D+K  NILLD DN   K+ADF  S L++S      T   + T  ++ PE L     ++E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173

Query: 190 KSDVYSFGVVLVEL 203
           KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (412), Expect = 2e-48
 Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 35/281 (12%)

Query: 16  LGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           LGEG FG VYKG L       T VAVK  K        + F  + R++ ++ H NVV++L
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC------LRIAAETASALDYLH 125
           GVC E +   LV E++  G L  ++R          K+       L  A + A  ++YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           S      +H D+ + N L+ ++   K++DF  S  +   D     T     + W+ PE L
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 186 F---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
               +T KSDV+SFGV+L E+ T G  P  Y  L++ E+   +       +   L +   
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYL------RKGYRLPK--- 228

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
                E   +E+    +L   C +    +RPT  ++ E+L+
Sbjct: 229 ----PEYCPDEL---YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (406), Expect = 1e-47
 Identities = 80/274 (29%), Positives = 119/274 (43%), Gaps = 38/274 (13%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIISQINHKNVV 68
           LG G FG VYK        +VAVK           D+    E+     RI+ +++H N+V
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREI-----RILRRLSHPNIV 61

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +++    +     LV E+   G LF ++         +     +IA +    L+YLHS G
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IIH D+K  NILLD+N   K+ADF  +  +     + TT   + T  ++ PE L   
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGG 173

Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
             +  K DV+S GV+L ELLTGK P      L   ++ R +   P   +           
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG---- 229

Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                  EE      L  KCL    ++RPT  ++
Sbjct: 230 ------SEE---AKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  157 bits (400), Expect = 8e-47
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 30/275 (10%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           Y+    LGEG FG VY         LVA+K  K        E    +++I+ ++ H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           ++  V  +     LV E+   G LF  ++ +                +  SAL+YLHS G
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG 117

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              I+H D+K  NILLD++   K+ADF  +  +   ++  T    + T  ++ PE L   
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGK 171

Query: 187 -WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA 245
            + +  D++S GV+L ELLTGK P        +++  +             ++I   +  
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLEL------------FKKIGKPKPP 215

Query: 246 DENEMEEIEIVAK-LASKCLRTSGTERPTMRQVSE 279
                 +I   AK L  K L     +R T  +  +
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (391), Expect = 2e-45
 Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 38/278 (13%)

Query: 16  LGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LGEG FG VYKG L        T VAVK  K        E F  +  I+ +++H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LGVC + +   +V E++P G L   +R    ++  T K  L++A + A  ++YL S    
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL--TLKDLLQMALQIAKGMEYLESKN-- 122

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---W 187
             +H D+ + N L+ +N   K++DF  S  I   D           + W+ PE L    +
Sbjct: 123 -FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 188 TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE 247
           T KSDV+SFGV+L E+ T                      PYP  +N   ++L   + D 
Sbjct: 182 TSKSDVWSFGVLLWEIFTL------------------GEQPYPGMSNE--EVLEL-LEDG 220

Query: 248 NEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQL 281
             +   E     + +L  +C      +RPT  ++ E L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (327), Expect = 7e-36
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKN 66
            + +  LLG G FG VY  +  D   L+AVK  ++        E  + ++RI+S + H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 67  VVKILGVCL--ETKVPLLVYEFVPNGTLFQH-----------VRYQSSQVLKTWKTCLRI 113
           +V+  G     E     +  E+V  G+L              +R  + Q+L         
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL--------- 111

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
                  L YLHS G   I+H D+K ANIL+D +   K+ADF  +  +   +    T   
Sbjct: 112 -----EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163

Query: 174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
             T  W+ PE +    +   +D++S G  ++E+ TGK P
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (323), Expect = 2e-35
 Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 39/220 (17%)

Query: 10  YDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMVDKI----LINEVFQHKMRIISQINH 64
           ++    +G+GGFG VYK         VA+K  K+  K     +INE+     +I+ +  H
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-----QILKKCKH 56

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR------IAAETA 118
            N+VK  G  L+     +V EF   G+L          +LK+    L       +  E  
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELL 108

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             L+YLHS G   IIH D+K+ANILL  +   K+ DF  S  +S       T      VG
Sbjct: 109 KGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARNTMVG 159

Query: 179 ---WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSY 212
              W+ PE +    +  K+D++S G+  +EL  GK P S 
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  122 bits (307), Expect = 3e-32
 Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 29/288 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINH-K 65
           +Y     LGEG FG VY     D  LVA+K    K+  K    E F  +++I++ +NH  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+VK+     +     LV E+V  G+L   ++    +   +    L I A+  SAL+YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYT-AKVADFASSVLISSHDQTAT----TTKEIETVGWL 180
           S G   IIH D+K  NILLD +    K+ DF  + L+     T++     +  + T G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 181 DPEYLFWTE------KSDVYSFGVVLVELLTGKHPR--SYVALASNEMTRMVPYFPYPIE 232
            PE L           SD++S G+ L ELLTG  P      + A+++  +++   P P  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233

Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
                  L   ++  N     +  + L  K L      R +       
Sbjct: 234 ------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 3e-30
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 18/215 (8%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
            +G+G FG VYKGVL  NT VAVK  +      +   F  +  I+ Q +H N+VK++GVC
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           ++ +   +V E VP G+L   +R + +++  T K  L+++ + A+ ++YL S      IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRL--TVKKLLQMSLDAAAGMEYLESKNC---IH 116

Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDPEYL---FWT 188
            D+ + N L+ +N   K++DF  S          T     K+I  + W  PE L    +T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYT 173

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
            +SDV+S+G++L E  + G  P  Y  + SN+ TR
Sbjct: 174 SESDVWSYGILLWETFSLGDTP--YPGM-SNQQTR 205

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  114 bits (287), Expect = 6e-30
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 49/229 (21%)

Query: 15  LLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILI------NEVFQHKMRIISQIN-HKN 66
           ++GEG F  V        N   A+K   ++DK  +        V   K  +++++N H  
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIK---ILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPG 63

Query: 67  VVKILGV-----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           ++K+         L       V E+ PNG L Q++R   S      K     AAE   AL
Sbjct: 64  IIKLYYTFQDEENL-----YFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLAL 115

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD---QTATTTKEIET-- 176
           +YLHS G   IIH D+K  NILLD +   K+ DF ++ ++  +            I++  
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 177 ----------VG---WLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
                     VG   ++ PE L      + SD+++ G ++ ++LTGK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (282), Expect = 2e-29
 Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 57/292 (19%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDKIL---INEVFQHKMRIISQ 61
            Y+    +G+G FG VY      D  L  +K+     M +K     +NEV     +I+ +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEV-----KILKK 55

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASA 120
           +NH N++K      E     +V E+   G L Q + + +        +  L    +   A
Sbjct: 56  LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLHS     I+H D+K  NI L  N   K+ DF  S ++SS    A T   + T  +L
Sbjct: 116 LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYL 170

Query: 181 DPE------YLFWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFPYPI 231
            PE      Y     KSD++S G VL EL T KHP    + + LA   +    P    PI
Sbjct: 171 SPELCQNKPY---NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----PI 223

Query: 232 EN---NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
            +   + LR +++                      L+    ERP++ Q+ + 
Sbjct: 224 PSQYSSELRNLVS--------------------SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 5e-28
 Identities = 82/289 (28%), Positives = 134/289 (46%), Gaps = 41/289 (14%)

Query: 15  LLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEV--FQHKMRIISQINHKNVV 68
           +LGEG FG V +G L   D +   VAVK  K +D    +E+  F  +   +   +H NV+
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 69  KILGVCLETK------VPLLVYEFVPNGTLFQHV---RYQSSQVLKTWKTCLRIAAETAS 119
           K++GVC E         P+++  F+ +G L   +   R          +T L+   + A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            ++YL +      IH D+ + N +L ++ T  VADF  S  I S D           V W
Sbjct: 125 GMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           +  E L    +T KSDV++FGV + E+ T G+ P  Y  + ++E+      + Y    N 
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEI------YDYLRHGNR 233

Query: 236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           L+Q        E+ ++E   +  L   C R    +RPT  ++ E L+++
Sbjct: 234 LKQ-------PEDCLDE---LYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  108 bits (272), Expect = 7e-28
 Identities = 70/225 (31%), Positives = 110/225 (48%), Gaps = 26/225 (11%)

Query: 16  LGEGGFGFVYKG----VLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+ G    + P+N   LVAVK  K        + F+ +  +++   H+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-----------TWKTCLRIAAETA 118
             GVC E   P++V+E++ +G L + +R                   T    L+IA + A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
           S + YL S      +H D+ + N L+  +   K+ DF  S  + + D        +  + 
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 179 WLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE 219
           W+ PE   Y  +T +SDV+SFGVVL E+ T GK P  +  L++ E
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--WYGLSNEE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 7e-28
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 32/236 (13%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKN 66
           NY    L+G G FG VYKG+ L     VA+K+  +        +    ++ ++  + H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKT-----CLRIAAETASA 120
           +VK +G  +ET   L ++ E+  NG+L         Q++K +             +    
Sbjct: 61  IVKYIG-SIETSDSLYIILEYAENGSL--------RQIIKKFGPFPESLVAVYVYQVLQG 111

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLH  G   +IH D+K+ANIL   +   K+ADF  +  ++   +   +   + T  W+
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV--VGTPYWM 166

Query: 181 DPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALAS-NEMTRMV----PYFP 228
            PE +     +  SD++S G  ++ELLTG  P  Y  L     + R+V    P  P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP--YYDLNPMAALFRIVQDDHPPLP 220

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (271), Expect = 9e-28
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQIN 63
           + + +G G FG VY  V L    L+AVK        PK + +I        +M+++  + 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI------ADEMKVLELLK 57

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALD 122
           H N+VK  GV +  +   +  E+   GTL + + +            +R+   +    L 
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH----VIRVYTLQLLEGLA 113

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---W 179
           YLHS G   I+H D+K ANI LD N   K+ DF  +V + ++  T     +    G   +
Sbjct: 114 YLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ-SLAGTPAY 169

Query: 180 LDPEYLFWTEKS------DVYSFGVVLVELLTGKHP 209
           + PE +   +        D++S G V++E+ TGK P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  108 bits (272), Expect = 1e-27
 Identities = 71/232 (30%), Positives = 119/232 (51%), Gaps = 28/232 (12%)

Query: 16  LGEGGFGFVYKG--VLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG VYKG    P+     T VA+K  K   +  + + F+ +  ++S + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQ-------HVRYQSSQVLKTWKTCL------RIAAE 116
           +LGVC + +   +++E++ +G L +       H    +    +T K+ L       IA +
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A+ ++Y   L S   +H D+ + N L+ +  T K++DF  S  I S D     +K +  
Sbjct: 133 IAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 177 VGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           V W+ PE   Y  +T +SD++SFGVVL E+ + G  P  Y   ++ E+  M+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--YYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (267), Expect = 5e-27
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 10  YDKRHL-----LGEGGFGFVYKG---VLPDNT--LVAVKKPK--MVDKILINEVFQHKMR 57
           ++KRHL     LGEG FG V       L DNT   VAVK       ++   +  F+ ++ 
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD--FEREIE 58

Query: 58  IISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           I+  ++H+N+VK  GVC +   +   L+ E++P+G+L  +++    Q+    K  L  ++
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSS 116

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEI 174
           +    +DYL S      IH D+ + NIL++     K++DF  + VL    D         
Sbjct: 117 QICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT 205
             + W  PE L    ++  SDV+SFGV L EL T
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 5e-27
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 54/293 (18%)

Query: 16  LGEGGFGFVYKG----VLPDN--TLVAVK----KPKMVDKI-LINEVFQHKMRIISQINH 64
           LG+G FG VY+G    V+     T VA+K       M ++I  +NE       ++ + N 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA-----SVMKEFNC 68

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------TWKTCLRIAAET 117
            +VV++LGV    +  L+V E +  G L  ++R +  +          T +  +++AAE 
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A  + YL +      +H D+ + N ++ ++ T K+ DF  +  I   D      K +  V
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN 234
            W+ PE L    +T KSDV+SFGVVL E+ T         LA           PY   +N
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQ---------PYQGLSN 227

Query: 235 SLRQILNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDS 283
              ++L F V D   ++  E     + +L   C + +   RPT  ++   L  
Sbjct: 228 E--EVLKF-VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 7e-26
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 58/293 (19%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQHKMRIISQIN 63
           K       +G+G FG V  G       VAVK  K         L        +R      
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQAFLAEASVMTTLR------ 58

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N+V++LGV L+     +V E++  G+L  ++R +   V+ T    L  A +    ++Y
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEY 117

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L        +H D+ + N+L+ ++  AKV+DF    L     Q   + K    V W  PE
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFG---LAKEASQGQDSGK--LPVKWTAPE 169

Query: 184 YL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            L    ++ KSDV+SFG++L E+ + G+                VPY   P++       
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR----------------VPYPRIPLK------- 206

Query: 240 LNFQVADENE----MEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
               V    E    ME  E     V K+   C      +RPT +Q+ EQL  +
Sbjct: 207 ---DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  102 bits (256), Expect = 8e-26
 Identities = 67/196 (34%), Positives = 108/196 (55%), Gaps = 13/196 (6%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LLG+G FG V+KG L D T VAVK  K  +  ++ I   F  + RI+ Q +H N+VK++G
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIG 59

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC + +   +V E VP G     +R +  + LKT K  ++ A + A+ + YL S      
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKT-KQLVKFALDAAAGMAYLESKNC--- 114

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTE 189
           IH D+ + N L+ +N   K++DF  S        +++  K+I  + W  PE   Y  ++ 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173

Query: 190 KSDVYSFGVVLVELLT 205
           +SDV+S+G++L E  +
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 8e-26
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 17/215 (7%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V+ G     T VAVK  KP  +      E F  + +I+ ++ H  +V++  V
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
           C E +   +V E++  G+L   ++    + L+     + +AA+ A  + YL S      I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLESRN---YI 125

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D+ + NIL+ +N   K+ADF  + LI   + TA    +   + W  PE   Y  +T K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-PIKWTAPEAANYGRFTIK 184

Query: 191 SDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           SDV+SFG++L E++T G+ P  Y  + + E+   V
Sbjct: 185 SDVWSFGILLTEIVTYGRVP--YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (251), Expect = 5e-25
 Identities = 73/275 (26%), Positives = 132/275 (48%), Gaps = 35/275 (12%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V++G+  +   VA+K  K  D +   + FQ +++ + ++ HK+++ +  VC 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLRHKHLISLFAVCS 72

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
             +   ++ E +  G+L   +R    QVL    + + +A + A  + YL        IH 
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEGQVLPV-ASLIDMACQVAEGMAYLEE---QNSIHR 128

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + NIL+ ++   KVADF  + LI   D   ++ K+I    W  PE   +  ++ KSD
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI-PYKWTAPEAASHGTFSTKSD 186

Query: 193 VYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN--SLRQIL-NFQVADEN 248
           V+SFG++L E+ T G+                    PYP  NN     QI   +++    
Sbjct: 187 VWSFGILLYEMFTYGQ-------------------VPYPGMNNHEVYDQITAGYRMPCPA 227

Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
           +    + + K+  +C      +RP+ + + E+LD+
Sbjct: 228 KCP--QEIYKIMLECWAAEPEDRPSFKALREELDN 260

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =   99 bits (249), Expect = 2e-24
 Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 34/238 (14%)

Query: 16  LGEGGFGFVYK----GVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G+G FG V++    G+LP    T+VAVK  K      +   FQ +  ++++ +H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR----YQSSQVLKTWKTC--------------- 110
           +LGVC   K   L++E++  G L + +R         +  +  +                
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           L IA + A+ + Y   L     +H D+ + N L+ +N   K+ADF  S  I S D    +
Sbjct: 133 LCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 171 TKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             +   + W+ PE +F+   T +SDV+++GVVL E+ + G  P  Y  +A  E+   V
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP--YYGMAHEEVIYYV 245

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 3e-24
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 16  LGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           LG+G FG V     K       L A+K   K K++ +  +      +  I+S+INH  +V
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIV 56

Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           K L    +T+  L LV E+ P G LF H+   S +   + +     AAE   AL+YLHSL
Sbjct: 57  K-LHYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
           G   II+ D+K  NILLD +   K+ DF  +  +SS      T     T  +L PE L  
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPEYLAPEVLLG 167

Query: 187 --WTEKSDVYSFGVVLVELLTGKHP 209
             + +  D +S GV+L E+LTGK P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.0 bits (244), Expect = 5e-24
 Identities = 78/277 (28%), Positives = 137/277 (49%), Gaps = 30/277 (10%)

Query: 13  RHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +H LG G +G VY+GV    +  VAVK  K  D + + E F  +  ++ +I H N+V++L
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEE-FLKEAAVMKEIKHPNLVQLL 68

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           GVC       ++ EF+  G L  ++R  + Q +      L +A + +SA++YL       
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN--- 124

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWT 188
            IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE   Y  ++
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 183

Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADE 247
            KSDV++FGV+L E            +A+  M+      PYP I+ + + ++L      E
Sbjct: 184 IKSDVWAFGVLLWE------------IATYGMS------PYPGIDLSQVYELLEKGYRME 225

Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                   V +L   C + + ++RP+  ++ +  +++
Sbjct: 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 6e-24
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 16  LGEGGFGFVYKGVL--PDNT--LVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG V +G L  P      VA+K  K    DK  ++  F  +  I+ Q +H N+++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDHPNIIR 69

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV  +++  +++ E++ NG+L + +R    +   T    + +    AS + YL  +  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEMNY 127

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+ + NIL++ N   KV+DF  S  +   + T TT      + W  PE   Y  
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           +T  SDV+SFG+V+ E+++ G+ P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 9e-24
 Identities = 64/216 (29%), Positives = 115/216 (53%), Gaps = 17/216 (7%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V++G+  + T VAVK  KP  +D     + F  + +I+ ++ H  ++++  V
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP----KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
           C   +   +V E +  G+L ++++  + + LK     + +AA+ AS + YL +      I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL-PQLIDMAAQVASGMAYLEAQN---YI 125

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D+ + N+L+ +N   KVADF  + +I      A    +   + W  PE   Y  ++ K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF-PIKWTAPEAALYNRFSIK 184

Query: 191 SDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP 225
           SDV+SFG++L E++T G+ P  Y  + + E+ + V 
Sbjct: 185 SDVWSFGILLTEIVTYGRMP--YPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.7 bits (240), Expect = 2e-23
 Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 40/267 (14%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG+G FG V+ G     T VA+K  KP  +      E F  + +++ ++ H+ +V++  V
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +
Sbjct: 70  VSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YV 124

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 191 SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           SDV+SFG++L EL T                      PYP   N  R++L+ QV     M
Sbjct: 184 SDVWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRM 222

Query: 251 ----EEIEIVAKLASKCLRTSGTERPT 273
               E  E +  L  +C R    ERPT
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 97.0 bits (241), Expect = 2e-23
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 26/216 (12%)

Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      +LP  D  LVAVK  K   +    + FQ +  +++ + H+++V+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTVLQHQHIVR 71

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQ--SSQVLK----------TWKTCLRIAAET 117
             GVC E +  L+V+E++ +G L + +R     +++L           T    L IA++ 
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           AS + YL SL     +H D+ + N L+      K+ DF  S  I S D      + +  +
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 178 GWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            W+ PE   Y  +T +SD++SFGVVL E+ T GK P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 85/295 (28%), Positives = 130/295 (44%), Gaps = 49/295 (16%)

Query: 14  HLLGEGGFGFVYKGVL-----PDNTL-VAVKKPKM--VDKILINEVFQ-HKMRIISQINH 64
             LGEG FG V K        P+ T  VAVK  K    +K L + V +   M++I +  H
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTCL 111
           KN++ +LGVC +     +V E+  +G L   +R +                   T K  +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
             A + A  +++L    S   IH D+ + N+L+ +++  K+ADF  +  I   D    TT
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYF 227
                V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+      F
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP--YPGIPVEEL------F 244

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
               E   + +  N       E+        L   C     ++RPT +Q+ E LD
Sbjct: 245 KLLKEGYRMEKPQNCT----QEL------YHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 94.6 bits (236), Expect = 1e-22
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 41/222 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM---VDKILINEVFQHKMRIISQI 62
            + Y     +GEG  G VYK         VA+KK ++     +++INE+      I+   
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEI-----LIMKDC 72

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTL-----FQHVRYQSSQVLKTWKTCLRIAAET 117
            H N+V      L      +V E++  G+L        VR    Q+         +  E 
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-------YVCREV 125

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L+YLHS     +IH D+KS NILL  + + K+ADF  +  ++       +      V
Sbjct: 126 LQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-----VV 177

Query: 178 G---WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHPR 210
           G   W+ PE      Y     K D++S G++ +E+  G+ P 
Sbjct: 178 GTPYWMAPEVIKRKDY---GPKVDIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 18/215 (8%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINH 64
            +Y+   ++G G    VY  + LP+N  VA+K+  + +K    ++E+ + +++ +SQ NH
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDEL-RKEVQAMSQCNH 58

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            NVVK     +      LV  ++  G+L   ++    +          +  E    L+YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTATTTKEIETVG---WL 180
           HS G    IH D+K+ NILL ++ + K+ADF  S+ L    D+T    K    VG   W+
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF--VGTPCWM 173

Query: 181 DPEYLF----WTEKSDVYSFGVVLVELLTGKHPRS 211
            PE +     +  K+D++SFG+  +EL TG  P S
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.5 bits (232), Expect = 2e-22
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)

Query: 16  LGEGGFGFVYKGVL-PDNTLVAVKK------PKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG V+ G L  DNT VAVK       P +  K      F  + RI+ Q +H N+V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK------FLQEARILKQYSHPNIV 56

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +++GVC + +   +V E V  G     +R +  + LK  K  +++    A+ ++YL    
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKV-KELIQMVENAAAGMEYLE--- 111

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YL 185
           S   IH D+ + N L+ +    K++DF  S         +T   +   V W  PE   Y 
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
            ++ +SDV+SFG++L E  + G  P  Y  L SN+ TR
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP--YANL-SNQQTR 206

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 16  LGEGGFGFVY------------KGVLPDN-----TLVAVKKPKM-VDKILINEVFQHKMR 57
           LGEG FG V+            K    ++      LVAVK  +         + F  +++
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED-FLKEVK 71

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTC 110
           I+S+++  N+ ++LGVC       ++ E++ NG L Q ++         +        + 
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 111 L-RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
           L  +A + AS + YL SL     +H D+ + N L+  NYT K+ADF  S  + S D    
Sbjct: 132 LLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
             +    + W+  E +    +T KSDV++FGV L E+LT    + Y  L   ++      
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV------ 242

Query: 227 FPYPIENNSLRQILNFQVADENEMEEI--------EIVAKLASKCLRTSGTERPTMRQV 277
               IEN             ++  +          + + +L  +C R    +RPT R++
Sbjct: 243 ----IENAG-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKN 66
           +++  + +G+G FG V+K V   +  V   K   + K+     E    + R++++++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVL---KTWKTCLRIAAETASALDY 123
           +++     L+     +V E+  NG L + ++ Q  + L   + W    R   +    L +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS     I+H D+KS N+ LD     K+ D   + L+S +   A T   + T  +L PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPE 171

Query: 184 YLF---WTEKSDVYSFGVVLVELLTGKHP 209
                 + EKSDV++ GVVL E  TGKHP
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-22
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL-------INEVFQHKMRIISQIN 63
           K  +LG G FG VYKGV +P+     VK P  +  +          E+      +++ ++
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGE--KVKIPVAIKVLREETSPKANKEILDE-AYVMASVD 67

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS----SQVLKTWKTCLRIAAETAS 119
           H +VV++LG+CL ++V  L+ + +P G L  +VR       SQ L  W  C++IA     
Sbjct: 68  HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW--CVQIA----K 120

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            + YL       ++H D+ + N+L+      K+ DF  + L+   ++          + W
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLT-GKHP 209
           +  E +    +T KSDV+S+GV + EL+T G  P
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 3e-22
 Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  + +++ +++H  +V++ GVC 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR--EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q  +  +  +T L +  +    + YL    S  +IH 
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ--ETLLGMCLDVCEGMAYLE---SSNVIHR 124

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 93.4 bits (232), Expect = 3e-22
 Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 15  LLGEGGFGFVYKGVLPD-------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
            LG G FG VY+G   D          VAVK  +        + F  +  ++S  NH N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQV----LKTWKTCLRIAAETASALDY 123
           VK+LGVCL  +   ++ E +  G L  ++R    +     L T K  L I  + A    Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 124 LHSLGSPPIIHGDVKSANILL-----DDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
           L  +     IH D+ + N L+     D +   K+ DF  +  I   D      + +  V 
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           W+ PE L    +T +SDV+SFGV++ E+LT                      PYP  NN 
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ------------------PYPALNN- 219

Query: 236 LRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQL 281
            +++L   V     +++ E     + +L + C     +ERPT  ++ E L
Sbjct: 220 -QEVLQH-VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.6 bits (227), Expect = 1e-21
 Identities = 70/215 (32%), Positives = 113/215 (52%), Gaps = 18/215 (8%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V+ G    NT VAVK  KP  +      E F  + +I+ ++ H  +V++  V
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             E  +  +V E++  G+L   ++    + LK     + +AA+ A+ + Y+  +     I
Sbjct: 70  VSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKL-PNLVDMAAQVAAGMAYIERMN---YI 124

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D++SANIL+ D    K+ADF  + LI  ++ TA    +   + W  PE   Y  +T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 191 SDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           SDV+SFG++L EL+T G+ P  Y  + + E+   V
Sbjct: 184 SDVWSFGILLTELVTKGRVP--YPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 31/281 (11%)

Query: 14  HLLGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +++  G  G  YKG    N +   VK+   V+ I  +E+       + ++ H N+VK++G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-----MGKLQHPNIVKLIG 750

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK--TWKTCLRIAAETASALDYLHSLGSP 130
           +C   K   L++E++    L        S+VL+  +W+   +IA   A AL +LH   SP
Sbjct: 751 LCRSEKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFW 187
            ++ G++    I++D      +        +S      T TK   +  ++ PE       
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDI 855

Query: 188 TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE 247
           TEKSD+Y FG++L+ELLTGK P +      +    +V +  Y   +  L   ++  +  +
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP-ADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIRGD 912

Query: 248 NEMEEIEIV--AKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             + + EIV    LA  C  T  T RP    V + L+S  R
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 11  DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           ++  +LG+G  G VYK    P   + A+KK  +       +    +++ +       VVK
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKT-----CLRIAAETASALDYL 124
             G   +     +V E++  G+L        + +LK            IA +    LDYL
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSL--------ADLLKKVGKIPEPVLAYIARQILKGLDYL 115

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTATTTKEIETVGWLDPE 183
           H+     IIH D+K +N+L++     K+ADF  S VL ++ DQ  T    + TV ++ PE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPE 170

Query: 184 ------YLFWTEKSDVYSFGVVLVELLTGKHP 209
                 Y +    +D++S G+ L+E   GK P
Sbjct: 171 RIQGESYSY---AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 50/280 (17%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G       VA+K   + +  +  + F  + +++ +++H N+V++ GVC 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           + +   +V E++ NG L  ++R +    L T +  L + ++   A++YL S G    IH 
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLR-ERKGKLGT-EWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 136 DVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE---K 190
           D+ + N L+ ++   KV+DF  A  VL    DQ  ++      V W  PE   ++    K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVL---DDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 191 SDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE 249
           SDV+SFGV++ E+ + GK                    PY   +NS       +V +   
Sbjct: 182 SDVWSFGVLMWEVFSEGK-------------------MPYERFSNS-------EVVESVS 215

Query: 250 MEEIEIVAKLAS--------KCLRTSGTERPTMRQVSEQL 281
                   KLA          C      +RP  +++  QL
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.3 bits (221), Expect = 9e-21
 Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 14/213 (6%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     ++ E F  + +I+ ++ H  +V +  V  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK--PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V EF+  G+L   ++    + LK     + +AA+ A  + Y+  +     IH 
Sbjct: 72  EEPI-YIVTEFMGKGSLLDFLKEGDGKYLKL-PQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ DN   K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 193 VYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           V+SFG++L EL+T G+ P  Y  + + E+   V
Sbjct: 186 VWSFGILLTELVTKGRVP--YPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 47/222 (21%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK-----IL-INEVFQHKMRIISQI 62
           Y+K   +GEG +G VYK        LVA+KK +M ++     I  I E+     +++ ++
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREI-----KLLQKL 55

Query: 63  NHKNVVKILGVCLETKVP--LLVYEFVP---NGTLFQ--------HVRYQSSQVLKTWKT 109
            H N+V++  +          +V+E++     G L           ++    Q+L+    
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE---- 111

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
                      L YLHS G   I+H D+K +NIL++++   K+ADF  +   +  +    
Sbjct: 112 ----------GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 170 TTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T + I T+ +  PE L     +  + D++S G +L EL  GK
Sbjct: 159 TNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 22/226 (9%)

Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R           Q   + K  +++A E A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  +++ ++ R V
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFV 234

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 88.7 bits (220), Expect = 1e-20
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G+G FG VY G L D+       AVK    +  +   E F  +  I+   +H NV+ +
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  ++YL    S
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYL---AS 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+++T KVADF  A  +    +      T     V W+  E L  
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 186 -FWTEKSDVYSFGVVLVELLT 205
             +T KSDV+SFGV+L EL+T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.4 bits (219), Expect = 2e-20
 Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 14/199 (7%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VA+K  K     +  E F  +  ++ Q+ H  +V++  V  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK--QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70

Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            T+ P+ ++ E++ NG+L   ++      L   K  + +AA+ A  + ++        IH
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMAFIERKNY---IH 125

Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKS 191
            D+++ANIL+ +    K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKS 184

Query: 192 DVYSFGVVLVELLT-GKHP 209
           DV+SFG++L E++T G+ P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 52/300 (17%)

Query: 16  LGEGGFGFVYKGV------LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V K            T VAVK  K             +  ++ Q+NH +V+K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR--------YQSSQVLK-------------TWK 108
           + G C +    LL+ E+   G+L   +R        Y  S   +             T  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA 168
             +  A + +  + YL  +    ++H D+ + N+L+ +    K++DF  S  +   D   
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
             +K    V W+  E LF   +T +SDV+SFGV+L E++T         L  N       
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGN------- 228

Query: 226 YFPYP-IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             PYP I    L  +L      E      E +  L   C +    +RPT   +S++L+ +
Sbjct: 229 --PYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.1 bits (216), Expect = 5e-20
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 15  LLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
            +GEG FG VY+GV      +   VAVK  K      + E F  +  I+ Q +H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 71  LGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +GV  E  V  +V E  P G L  +  V   S  +        ++    ++AL YL S  
Sbjct: 73  IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL----STALAYLESKR 127

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD-QTATTTKEIETVGWLDPE---Y 184
               +H D+ + N+L+      K+ DF  S  +       A+  K    + W+ PE   +
Sbjct: 128 ---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK--LPIKWMAPESINF 182

Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHP 209
             +T  SDV+ FGV + E+L  G  P
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 9e-20
 Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 42/224 (18%)

Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVK--------------KPKMVDKILINEVFQHKM 56
           K  L+G G FG VY G+      L+AVK              K  M+D +        ++
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDAL------AREI 57

Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGT----LFQHVRYQSSQVLKTWKTCLR 112
            ++ ++ H+N+V+ LG  L+     +  E+VP G+    L  +  ++ + V    +  +R
Sbjct: 58  ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVR 113

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
              +    L+YLH+ G   IIH D+K ANIL+D+    K++DF  S  + ++  +  T  
Sbjct: 114 ---QILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 173 EIET----VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
              +    V W+ PE +    +T K+D++S G ++VE+LTGKHP
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 27/215 (12%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           Y+    +G G +G VYK   +    LVA+K  K+        + Q ++ ++ +  H N+V
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIV 63

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA---AETASALDYLH 125
              G  L      +V E+   G+L Q + YQ   V +   + L+IA    ET   L YLH
Sbjct: 64  AYFGSYLRRDKLWIVMEYCGGGSL-QDI-YQ---VTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE---IETVGWLDP 182
             G    IH D+K ANILL ++   K+ADF  S  +     TAT  K    I T  W+ P
Sbjct: 119 ETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFIGTPYWMAP 170

Query: 183 EYLF------WTEKSDVYSFGVVLVELLTGKHPRS 211
           E         +  K D+++ G+  +EL   + P  
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 32/236 (13%)

Query: 13  RHLLGEGGFGFV----------YKGVLPDN-----TLVAVKKPKM-VDKILINEVFQHKM 56
           +  LGEG FG V          + G           LVAVK  +  V K   N+ F  ++
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND-FLKEI 68

Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLK-------TW 107
           +I+S++ + N++++LGVC+      ++ E++ NG L Q +  R   S           + 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
              L +A + AS + YL SL     +H D+ + N L+ ++YT K+ADF  S  + S D  
Sbjct: 129 ANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM 220
               + +  + W+  E +    +T  SDV++FGV L E+ T    + Y  L+  ++
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.9 bits (212), Expect = 2e-19
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 26/229 (11%)

Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      + P  D  LVAVK  K        + F  +  +++ + H+++VK
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-FHREAELLTNLQHEHIVK 71

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAETAS 119
             GVC+E    ++V+E++ +G L + +R      +           T    L IA + A+
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            + Y   L S   +H D+ + N L+ +N   K+ DF  S  + S D        +  + W
Sbjct: 132 GMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 180 LDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + PE   Y  +T +SDV+S GVVL E+ T GK P  +  L++NE+   +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECI 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 83/308 (26%), Positives = 141/308 (45%), Gaps = 61/308 (19%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   V+ +   +  +KP  V K+                LI+E+    M++I
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 80

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR----------YQSSQV---LKT 106
            +  HKN++ +LG C +     ++ E+   G L +++R          Y  +QV     +
Sbjct: 81  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
           +K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 139 FKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195

Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 253

Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +         N   E+ ++ +    C     ++RPT +Q+ E LD
Sbjct: 254 LLK------EGHRMDK-------PSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 297

Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 298 RILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 79/301 (26%), Positives = 138/301 (45%), Gaps = 54/301 (17%)

Query: 16  LGEGGFGFVY----KGVLP-------------DNTLVAVKKPKM-VDKILINEVFQHKMR 57
           LGEG FG V+    +G+                  LVAVK  +   +K   N+ F  +++
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND-FLKEIK 71

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL--------FQHVRYQSSQVLKTWKT 109
           I+S++   N++++L VC+ +    ++ E++ NG L         Q    ++  V  ++ T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
            + +A + AS + YL SL     +H D+ + N L+  NYT K+ADF  S  + S D    
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
             + +  + W+  E +    +T  SDV++FGV L E+LT    + Y  L+  ++      
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV------ 242

Query: 227 FPYPIEN------NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
               IEN      +  RQ+   + A   +      + KL   C R +  ERP+ +++   
Sbjct: 243 ----IENTGEFFRDQGRQVYLPKPALCPDS-----LYKLMLSCWRRNAKERPSFQEIHAT 293

Query: 281 L 281
           L
Sbjct: 294 L 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 24/227 (10%)

Query: 15  LLGEGGFGFVYKGVLPDNTL-----VAVKKPK-MVDKILINEVFQHKMRIISQINHKNVV 68
           LL EG FG ++ G+L D        V VK  K    +I +  + Q    +   ++H+N++
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNIL 71

Query: 69  KILGVCLE-TKVPLLVYEFVPNGTLFQ------HVRYQSSQVLKTWKTCLRIAAETASAL 121
            IL VC+E  + P ++Y ++  G L             + Q L T +  + +A + A  +
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL-VHMAIQIACGM 130

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH  G   +IH D+ + N ++D+    K+ D A S  +   D       E   V W+ 
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 182 PEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            E L    ++  SDV+SFGV+L EL+T G+ P  YV +   EM   +
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTP--YVEIDPFEMAAYL 232

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 31/241 (12%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDK---ILINEVFQHKMRIISQI 62
           Y+    +G+G FG V K     D  ++  K+     M +K    L++EV      I+ ++
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-----NILREL 56

Query: 63  NHKNVVKILG--VCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETAS 119
            H N+V+     +    +   +V E+   G L Q + + +  +     +   RI  +   
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 120 ALDYLH--SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           AL   H  S     ++H D+K ANI LD N   K+ DF  + ++      A T      V
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-----YV 171

Query: 178 G---WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFP 228
           G   ++ PE L    + EKSD++S G ++ EL     P   R+ + LAS          P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231

Query: 229 Y 229
           Y
Sbjct: 232 Y 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.4 bits (211), Expect = 4e-19
 Identities = 85/298 (28%), Positives = 132/298 (44%), Gaps = 52/298 (17%)

Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKI 70
           ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++  H N++ +
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       L  E+ P+G L   +R   S+VL+T                +  L  AA
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A  +DYL        IH D+ + NIL+ +NY AK+ADF    L    +     T    
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 185

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 237

Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
           +   L + LN    DE        V  L  +C R    ERP+  Q+   L SL R+ E
Sbjct: 238 QGYRLEKPLN--CDDE--------VYDLMRQCWREKPYERPSFAQI---LVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 85.1 bits (210), Expect = 4e-19
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 29/218 (13%)

Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKIL-INEVFQHKMRIISQINHKNVV 68
           LGEG FG V+      + P  D  LVAVK  K  D  L   + FQ +  +++ + H+++V
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLTNLQHEHIV 70

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQ--------SSQVLKT-----WKTCLRIAA 115
           K  GVC +    ++V+E++ +G L + +R            Q  +          L IA+
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + AS + Y   L S   +H D+ + N L+  N   K+ DF  S  + S D        + 
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            + W+ PE   Y  +T +SDV+SFGV+L E+ T GK P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.7 bits (209), Expect = 5e-19
 Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 44/287 (15%)

Query: 16  LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
           LGEG FG V +G L  D++++ V    M  KI I      E F  +   + + +H NV++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTM--KIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 70  ILGVCLETK------VPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETAS 119
           ++GVCL+T        P+++  F+ +G L   + Y       Q L T +  ++   + AS
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT-QMLVKFMTDIAS 123

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            ++YL    S   IH D+ + N +L++N    VADF  S  I + D           V W
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           +  E L    +T KSDV+SFGV + E+ T G+ P  Y  + ++E+      + Y  + N 
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSEI------YDYLRQGNR 232

Query: 236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L+Q            + ++ +  L S C   +  +RP+   +  +L+
Sbjct: 233 LKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.2 bits (209), Expect = 5e-19
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 28/208 (13%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQH---KMRIISQINHKNVVKI 70
            LGEG +G VYK +      +VA+K       + + E  Q    ++ I+ Q +   +VK 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKV------VPVEEDLQEIIKEISILKQCDSPYIVKY 63

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA---LDYLHSL 127
            G   +     +V E+   G++   ++  +  +     T   IAA        L+YLHS 
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-----TEEEIAAILYQTLKGLEYLHSN 118

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                IH D+K+ NILL++   AK+ADF  S  L  +  +  T    I T  W+ PE + 
Sbjct: 119 K---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV---IGTPFWMAPEVIQ 172

Query: 187 ---WTEKSDVYSFGVVLVELLTGKHPRS 211
              +  K+D++S G+  +E+  GK P S
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.9 bits (207), Expect = 8e-19
 Identities = 65/229 (28%), Positives = 121/229 (52%), Gaps = 30/229 (13%)

Query: 12  KRHLLGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHK 65
           K+ ++G G FG V++G+L         VA+K  KP   +K   +  F  +  I+ Q +H 
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQFSHH 66

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLKTWKTCLRIAAETASA 120
           N++++ GV  + K  +++ E++ NG L +++R     + S Q++   +         A+ 
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-------IAAG 119

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGW 179
           + YL  +     +H D+ + NIL++ N   KV+DF  S VL    + T TT+     + W
Sbjct: 120 MKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 180 LDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             PE   Y  +T  SDV+SFG+V+ E+++ G+ P  Y  ++++E+ + +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP--YWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 8e-19
 Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 31/217 (14%)

Query: 10  YDKRHL-----LGEGGFGFVY------KGVLPDNT--LVAVK--KPKMVDKILINEVFQH 54
           ++KR L     LGEG FG V       +G   DNT   VAVK  KP+     + +   + 
Sbjct: 1   FEKRFLKRIRDLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIAD--LKK 55

Query: 55  KMRIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
           ++ I+  + H+N+VK  G+C E       L+ EF+P+G+L +++    +++    K  L+
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI--NLKQQLK 113

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            A +    +DYL   GS   +H D+ + N+L++  +  K+ DF  +  I +  +  T   
Sbjct: 114 YAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170

Query: 173 EIET-VGWLDPEYLFWTE---KSDVYSFGVVLVELLT 205
           ++++ V W  PE L  ++    SDV+SFGV L ELLT
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 15  LLGEGGFGFVYK-GVLPDNTLVAVKKPK---MVDK---ILINEVFQHKMRIISQINHKNV 67
            LG+G +G VYK   L DN   A+K+     M  K     +NE+     RI++ +NH N+
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEI-----RILASVNHPNI 61

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQV-LKTWKTCLRIAAETASALDYLHS 126
           +      L+     +V E+ P G L + +  +  +  L   +   RI  +    L  LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                I+H D+KSANILL  N   K+ D   S ++    +    T +I T  ++ PE   
Sbjct: 122 QK---ILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKT-QIGTPHYMAPE--V 172

Query: 187 W-----TEKSDVYSFGVVLVELLTGKHP 209
           W     + KSD++S G +L E+ T   P
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.1 bits (205), Expect = 1e-18
 Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 52/284 (18%)

Query: 14  HLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +G+G FG V    Y+G       VAVK    +      + F  +  +++Q+ H N+V+
Sbjct: 12  QTIGKGEFGDVMLGDYRG-----NKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 70  ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +LGV +E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL    
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLE--- 119

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
           +   +H D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L   
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREK 174

Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
            ++ KSDV+SFG++L E+ + G+ P   + L       +VP                 +V
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVP-----------------RV 212

Query: 245 ADENEMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
               +M+       +V  +  +C       RP+  Q+ EQL+ +
Sbjct: 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 68/232 (29%), Positives = 115/232 (49%), Gaps = 28/232 (12%)

Query: 16  LGEGGFGFVYKG--VLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LGE  FG +YKG   LP      LVA+K  K ++       FQ +  ++++++H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQS--------SQVLKTWKTCL------RIAAE 116
           LGV  + +   +++E++  G L + +  +S        S    T K+ L       IA +
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A+ ++YL    S   +H D+ + NIL+ +    K++D   S  I S D      K +  
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 177 VGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + W+ PE   Y  ++  SD++SFGVVL E+ + G  P  Y   ++ E+  MV
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP--YYGFSNQEVIEMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 79/297 (26%), Positives = 136/297 (45%), Gaps = 51/297 (17%)

Query: 16  LGEGGFGFVYK----GVLPDN----TLVAVK--KPKMVDKILINEVFQHK-MRIISQINH 64
           LGEG FG V +    G+          VAVK  K    DK L + + + + M++I +  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRY-------------QSSQVLKTWKTCL 111
           KN++ +LGVC +     ++ E+   G L + +R              +  +   ++K  +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
             A + A  ++YL S      IH D+ + N+L+ ++   K+ADF  +  +   D    T+
Sbjct: 138 SCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYF 227
                V W+ PE LF   +T +SDV+SFG+++ E+ T G  P  Y  +   E+ +++   
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP--YPGIPVEELFKLLR-- 250

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
               E + + +  N     E  M        L  +C     T+RPT +Q+ E LD +
Sbjct: 251 ----EGHRMDKPSN--CTHELYM--------LMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 2e-18
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 48/221 (21%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIIS---QINHK 65
           Y+K   LGEG +G VYK        +VA+KK ++ ++     +    +R IS   ++ H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHP 58

Query: 66  NVVKILGVCLETKVPLLVYEFVP---------NGTLFQ--HVRYQSSQVLKTWKTCLRIA 114
           N+VK+L V    +   LV+E+                    ++    Q+L          
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLL---------- 108

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQTATT 170
                 L Y HS     I+H D+K  NIL++ +   K+ADF    A  + + ++      
Sbjct: 109 ----RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY------ 155

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T E+ T+ +  PE L     ++   D++S G +  E++TGK
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQINHK 65
           +     +G+G FG VYK +    N +VA+K     +  D+I   E  Q +++ +SQ    
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRSP 59

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
            + K  G  L+     ++ E+   G+    ++      L        I  E    L+YLH
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAF-ILREVLLGLEYLH 115

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDP 182
             G    IH D+K+ANILL +    K+ADF  S  ++S     T +K    VG   W+ P
Sbjct: 116 EEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS-----TMSKRNTFVGTPFWMAP 167

Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRS 211
           E +    + EK+D++S G+  +EL  G+ P S
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 32/210 (15%)

Query: 19  GGFGFVY---KGVLPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           G +G V+   K    D  + A+K   K  M+ K  +++V   +  I+SQ     VVK+  
Sbjct: 4   GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERD-ILSQAQSPYVVKLY- 59

Query: 73  VCLETKVPL-LVYEFVPNG---TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
              + K  L LV E++P G   +L ++V      V +         AE   AL+YLHS G
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI------YIAEIVLALEYLHSNG 113

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT---ATTTKEIETVGWLD---P 182
              IIH D+K  NIL+D N   K+ DF  S +     Q        ++   VG  D   P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           E +     ++  D +S G +L E L G  P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.3 bits (203), Expect = 3e-18
 Identities = 81/290 (27%), Positives = 136/290 (46%), Gaps = 41/290 (14%)

Query: 15  LLGEGGFGFVYKGVLP--DNTL--VAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +LG+G FG V +  L   D +   VAVK  K  +     I E F  +   + + +H NV+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE-FLREAACMKEFDHPNVI 64

Query: 69  KILGVCLETK------VPLLVYEFVPNGTLFQHV---RYQSSQVLKTWKTCLRIAAETAS 119
           K++GV L ++      +P+++  F+ +G L   +   R          +T +R   + AS
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            ++YL    S   IH D+ + N +L++N T  VADF  S  I S D           V W
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           L  E L    +T  SDV++FGV + E++T G+ P  Y  + ++E+      + Y I+ N 
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSEI------YNYLIKGNR 233

Query: 236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
           L+Q            + +E V +L  +C       RP+ + + +QL+ + 
Sbjct: 234 LKQPP----------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 76/298 (25%), Positives = 140/298 (46%), Gaps = 36/298 (12%)

Query: 10  YDKRHL-----LGEGGFGFVYK---GVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +      + + F+ ++ I+
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD-FEREIEIL 59

Query: 60  SQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC         LV E++P G+L  +++    ++    +  L  A++ 
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQI 117

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   GS   +H D+ + NIL++     K+ DF  + ++    +     +  E+ 
Sbjct: 118 CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNEM-TRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ Y 
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R             E    +  +  +C     ++RP+  +++ Q++++R
Sbjct: 235 LIELLKNNGR----LPAPPGCPAE----IYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 48/288 (16%)

Query: 16  LGEGGFGFVYKGVL----PDNT--LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G+      D     VAVK             F  +  I+S+ NH+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY------QSSQVLKTWKTCLRIAAETASALDY 123
           ++GV  E     ++ E +  G L   +R       + S +  T K  L  A + A    Y
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL--TMKDLLFCARDVAKGCKY 131

Query: 124 LHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L        IH D+ + N LL        AK+ADF  +  I          + +  + W+
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE      +T K+DV+SFGV+L E+ +                  + Y PYP   N  +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS------------------LGYMPYPGRTN--Q 228

Query: 238 QILNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQL 281
           +++ F V     ++  +     V ++ + C + +  +RP    + E++
Sbjct: 229 EVMEF-VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.4 bits (203), Expect = 4e-18
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 51/303 (16%)

Query: 16  LGEGGFGFVY--------KGVLPDNTLVAVK--KPKMVDKILINEVFQHKM-RIISQINH 64
           LGEG FG V         K    +   VAVK  K    +K L + V + +M ++I +  H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR----------YQSSQVLK---TWKTCL 111
           KN++ +LG C +     ++ E+   G L +++R          Y  ++V     T+K  +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
               + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  +++ D    TT
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYF 227
                V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++   
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK-- 253

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
               E + + +  N      NE+        +   C     + RPT +Q+ E LD +  L
Sbjct: 254 ----EGHRMDKPANCT----NEL------YMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299

Query: 288 HEN 290
             N
Sbjct: 300 TTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 79/296 (26%), Positives = 137/296 (46%), Gaps = 49/296 (16%)

Query: 16  LGEGGFGFVYK----GVLPDN----TLVAVK--KPKMVDKILINEVFQHKM-RIISQINH 64
           LGEG FG V      G+  D       VAVK  K    DK L + V + +M ++I +  H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTCL 111
           KN++ +LG C +     ++ E+   G L +++R +    +              T+K  +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
             A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  + + D    TT
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
                V W+ PE LF   +T +SDV+SFGV+L E+ T      Y  +   E+ +++    
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLK--- 250

Query: 229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
              E + + +         N   E+ ++ +   +C     ++RPT +Q+ E LD +
Sbjct: 251 ---EGHRMDK-------PANCTHELYMIMR---ECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 81.3 bits (201), Expect = 5e-18
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD-----KILINEVFQHKMRIISQINHK 65
           K  LLG G FG VY+G+ L D    AVK+  + D     +  + ++ Q ++ ++S++ H 
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ-EIALLSKLQHP 62

Query: 66  NVVKILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA---SAL 121
           N+V+ LG   E    L ++ E VP G+L      +             I   T      L
Sbjct: 63  NIVQYLGTEREED-NLYIFLELVPGGSL--AKLLKKYGSFPE----PVIRLYTRQILLGL 115

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWL 180
           +YLH       +H D+K ANIL+D N   K+ADF     ++      +  K  + +  W+
Sbjct: 116 EYLHDRN---TVHRDIKGANILVDTNGVVKLADFG----MAKQVVEFSFAKSFKGSPYWM 168

Query: 181 DPEYL----FWTEKSDVYSFGVVLVELLTGKHPRS 211
            PE +     +   +D++S G  ++E+ TGK P S
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.2 bits (200), Expect = 6e-18
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 44/274 (16%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +GEG FG V +G       VAVK  K     +  + F  +  ++++++HKN+V++LGV L
Sbjct: 14  IGEGEFGAVLQGEYTGQK-VAVKNIKC---DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
              +  +V E +  G L   +R +   ++   +  L+ + + A  ++YL S     ++H 
Sbjct: 70  HNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLES---KKLVHR 124

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSD 192
           D+ + NIL+ ++  AKV+DF    L          +K    V W  PE L    ++ KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFG---LARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKSD 179

Query: 193 VYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEME 251
           V+S+GV+L E+ + G+ P  Y  ++  E+                       V     ME
Sbjct: 180 VWSYGVLLWEVFSYGRAP--YPKMSLKEVKE--------------------CVEKGYRME 217

Query: 252 EIE----IVAKLASKCLRTSGTERPTMRQVSEQL 281
             E     V  L + C  T   +RP+  ++ E+L
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 81.6 bits (201), Expect = 9e-18
 Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 46/296 (15%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E+ +         LA             P +  S  Q+
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQ-----------PYQGLSNEQV 230

Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           L F V D   +++ +     V  L   C + +   RPT  ++   L     LH +F
Sbjct: 231 LKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 283

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 1e-17
 Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 45/281 (16%)

Query: 11  DKRHL-----LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           D + L     LG G FG V  G       VA+K  K  +  +  + F  + +++ +++H+
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHE 59

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLKTWKTCLRIAAETASA 120
            +V++ GVC + +   +V E++ NG L  ++R     +Q SQ+L+  K       +    
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK-------DVCEG 112

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + YL    S   IH D+ + N L+DD    KV+DF  S  +   + T++   +   V W 
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWS 168

Query: 181 DPEYLFW---TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
            PE L +   + KSDV++FGV++ E+ + GK P  Y    ++E    V         +  
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP--YERFNNSETVEKV---------SQG 217

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            ++    +A E        V  +   C      ERPT +Q+
Sbjct: 218 LRLYRPHLASEK-------VYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 29/221 (13%)

Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI-------LINEVFQHKMRIISQIN 63
           K  LLG G FG V+KG+ +P+    ++K P  +  I          E+  H M  +  ++
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDH-MLAMGSLD 67

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETAS 119
           H  +V++LG+C    + L V +  P G+L  HVR        Q L  W  C++IA     
Sbjct: 68  HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW--CVQIA----K 120

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            + YL       ++H ++ + NILL  +   ++ADF  + L+   D+    ++    + W
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALA 216
           +  E +    +T +SDV+S+GV + E+++ G  P + +   
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 36/229 (15%)

Query: 15  LLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
            LG G FG V+             TLV VK  +      +   F+ ++ +  +++HKNVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK------TWKTCLRIAAETASALD 122
           ++LG+C E +   ++ E+   G L Q +R   S+  K      + K  + +  + A  +D
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-------IE 175
           +L +      +H D+ + N L+      KV     S+L  S D       E       + 
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKV-----SLLSLSKD---VYNSEYYKLRNALI 180

Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            + WL PE +    ++ KSDV+SFGV++ E+ T G+ P  +  L+  E+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEV 227

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 49/290 (16%)

Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKI 70
           ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++ +H N++ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       L  E+ P+G L   +R   S+VL+T                +  L  AA
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A  +DYL        IH D+ + NIL+ +NY AK+ADF    L    +     T    
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 173

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 225

Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
           +   L + LN    DE        V  L  +C R    ERP+  Q+   L
Sbjct: 226 QGYRLEKPLN--CDDE--------VYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 79/309 (25%), Positives = 134/309 (43%), Gaps = 58/309 (18%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI---NEVFQHKMRIISQI-NHKNVVKI 70
           ++GEG FG V + ++  + L      KM+ +      +  F  ++ ++ ++ +H N++ +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       +  E+ P G L   +R   S+VL+T                +  L+ A+
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLR--KSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A+ + YL        IH D+ + N+L+ +N  +K+ADF    L    +     T    
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG---LSRGEEVYVKKTMGRL 180

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T KSDV+SFGV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 232

Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR----- 286
           +   + +  N    DE        V +L  +C R    ERP   Q+S QL  +       
Sbjct: 233 QGYRMEKPRN--CDDE--------VYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282

Query: 287 ----LHENF 291
               L ENF
Sbjct: 283 VNMALFENF 291

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 35/215 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPK------MVDKILINEVFQHKMRIISQ 61
            Y+   ++GEG +G V K        +VA+KK K       V K  + EV     +++ Q
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREV-----KVLRQ 56

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA------ 115
           + H+N+V +           LV+E+V    L         ++L+     L   A      
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLL---------ELLEASPGGLPPDAVRSYIW 107

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +   A+ Y HS     IIH D+K  NIL+ ++   K+ DF  +  + +   +  T   + 
Sbjct: 108 QLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-VA 163

Query: 176 TVGWLDPEYLF----WTEKSDVYSFGVVLVELLTG 206
           T  +  PE L     + +  DV++ G ++ ELL G
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.4 bits (196), Expect = 3e-17
 Identities = 81/296 (27%), Positives = 137/296 (46%), Gaps = 64/296 (21%)

Query: 16  LGEGGFGFVYKGVL---PDNTLVA-VKKPKMVDKIL-----INEVFQHKMRIISQINHKN 66
           LG+G F  +YKGVL    D  +V   ++  +V K+L      +  F     ++SQ++HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +VK+ GVC+  +  ++V E+V  G L   +  + + V   WK  L +A + ASAL YL  
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 127 LGSPPIIHGDVKSANILL-----DDNYT--AKVAD--FASSVLISSHDQTATTTKEIETV 177
                ++HG+V   NIL+     ++ Y    K++D     +VL        +  + +E +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--------SREERVERI 168

Query: 178 GWLDPEYL-----FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            W+ PE +       T  +D +SFG  L+E+ + G+ P S   L+S+E  R         
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS--TLSSSEKERF-------- 218

Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
                     +Q      M +   +A L ++C     T+RP+ R +      LR L
Sbjct: 219 ----------YQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI------LRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.2 bits (195), Expect = 3e-17
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 22/218 (10%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM-VDKILINE----VFQHKMRIISQINH 64
           + K  +LG+G +G VY G+     L+AVK+ ++    +L  E      Q ++ ++  + H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA--AETASALD 122
            N+V+ LG CL+     +  EFVP G++        S +L  +           T   LD
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSI--------SSILNRFGPLPEPVFCKYTKQILD 113

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS---VLISSHDQTATTTKEIE-TVG 178
            +  L +  ++H D+K  N++L  N   K+ DF  +     +  H   +   K +  T  
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 179 WLDPEYLFWT---EKSDVYSFGVVLVELLTGKHPRSYV 213
           W+ PE +  +    KSD++S G  + E+ TGK P + +
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.9 bits (194), Expect = 5e-17
 Identities = 69/274 (25%), Positives = 130/274 (47%), Gaps = 35/274 (12%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V+ G   ++T VAVK  KP  +      + F  +  ++  + H  +V++  V
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV----QAFLEEANLMKTLQHDKLVRLYAV 69

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             + +   ++ E++  G+L   ++      +   K  +  +A+ A  + Y+        I
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIERKN---YI 125

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D+++AN+L+ ++   K+ADF  + +I  ++ TA    +   + W  PE   +  +T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 184

Query: 191 SDVYSFGVVLVELLT-GKHPRSYVALASNE-MTRMVPYFPYPIENNSLRQILNFQVADEN 248
           SDV+SFG++L E++T GK P  Y  +++++ M+ +   +  P                EN
Sbjct: 185 SDVWSFGILLYEIVTYGKIP--YPGMSNSDVMSALQRGYRMP--------------RMEN 228

Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
             +E+  + K    C +    ERPT   +   LD
Sbjct: 229 CPDELYDIMKT---CWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 28/223 (12%)

Query: 16  LGEGGFGFVYKGV--LPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           LG G FG V KGV  +       VAVK  K        + F  +  +++Q++H  +V+++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVR-YQSSQV--LKTWKTCLRIAAETASALDYLHSLG 128
           GVC    + +LV E  P G L ++++  +   V  LK        A + A  + YL S  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLI---SSHDQTATTTKEIETVGWLDPE-- 183
               +H D+ + N+LL + + AK++DF  S  +   S + +  T  +    + W  PE  
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR--WPLKWYAPECI 170

Query: 184 -YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            Y  ++ KSDV+S+GV L E  + G  P  Y  +   E+  M+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 7e-17
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G       VA+K   + +  +  E F  + +++ +++H  +V++ GVC 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           + K   +V EF+ NG L  ++R +  ++ K     L +  +    ++YL        IH 
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+      KV+DF  +  +   D+  +++     V W  PE   +  ++ KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ T GK P
Sbjct: 184 VWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 8e-17
 Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 39/221 (17%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILIN------EV--FQHKMRIIS 60
           Y +  L+G G +G VY+G  +P   +VA+K        +IN      +V   Q ++ ++S
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALK--------IINLDTPDDDVSDIQREVALLS 54

Query: 61  QINH---KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           Q+      N+ K  G  L+     ++ E+   G++   ++   +  +      + I  E 
Sbjct: 55  QLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISV-IIREV 110

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL Y+H +G   +IH D+K+ANIL+ +    K+ DF  + L++       ++K    V
Sbjct: 111 LVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-----NSSKRSTFV 162

Query: 178 G---WLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRS 211
           G   W+ PE +    ++  K+D++S G+ + E+ TG  P S
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 18/204 (8%)

Query: 15  LLGEGGFGFVY---KGVLPD-NTLVAVKKPKMVDKILINEVFQHKMR-IISQINHKNVVK 69
           +LG+G FG V+   K   PD   L A+K  K     + + V     R I++++NH  +VK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 70  ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            L    +T+  L L+ +F+  G LF  +   S +V+ T +      AE A ALD+LHSLG
Sbjct: 63  -LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              II+ D+K  NILLD+    K+ DF  S    S D          TV ++ PE +   
Sbjct: 119 ---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 187 -WTEKSDVYSFGVVLVELLTGKHP 209
             T+ +D +SFGV++ E+LTG  P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 48/221 (21%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQI 62
           Y K   +GEG +G VYK        +VA+KK K+      + K  + E+     +++ ++
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREI-----KLLKEL 55

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQ------------HVRYQSSQVLKTWKTC 110
           NH N++K+L V        LV+EF+ +  L++             ++    Q+L+     
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQ----- 109

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     L + HS G   I+H D+K  N+L++     K+ADF  +    S       
Sbjct: 110 ---------GLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPY 155

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T  + T  +  PE L     ++   D++S G +  ELL+ +
Sbjct: 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ---HKMRIISQIN 63
           K +     +G G FG VY    +  N +VA+KK     K   NE +Q    ++R + Q+ 
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLR 73

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASA 120
           H N ++  G  L      LV E+             +S +L+  K  L+   IAA    A
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCLG---------SASDILEVHKKPLQEVEIAAICHGA 124

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L  L  L S   IH D+K+ NILL +  T K+ADF S+ L+S  +        + T  W+
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF------VGTPYWM 178

Query: 181 DPEYLF------WTEKSDVYSFGVVLVELLTGKHP 209
            PE +       +  K DV+S G+  +EL   K P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD------KILINEVFQHKMRI 58
           +Y    +LG+G FG   +  L     D++LV  K+  +        +  +NE+      I
Sbjct: 1   HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI-----VI 52

Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           +S + H N++      ++    L+  E+   GTL+  +  Q  Q+ +  +  L    +  
Sbjct: 53  LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-EMVLWYLFQIV 111

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
           SA+ Y+H  G   I+H D+K+ NI L      K+ DF  S ++ S    A T   + T  
Sbjct: 112 SAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV--VGTPY 166

Query: 179 WLDPEY---LFWTEKSDVYSFGVVLVELLTGK 207
           ++ PE    + +  KSD+++ G VL ELLT K
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 34/281 (12%)

Query: 16  LGEGGFGFVYKGVL-----PDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V +         D  + VAVK  K        E    +++I+S + NH+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            +LG C      L++ E+   G L   +R +    L      L  + + A  + +   L 
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAF---LA 158

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
           S   IH D+ + N+LL      K+ DF  +  I +             V W+ PE +F  
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218

Query: 187 -WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN-FQV 244
            +T +SDV+S+G++L E+ +         L SN      PY   P+++   + I   +++
Sbjct: 219 VYTFESDVWSYGILLWEIFS---------LGSN------PYPGMPVDSKFYKLIKEGYRM 263

Query: 245 AD-ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           A  E+   EI  + K    C      +RPT +Q+ + +   
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 41/230 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLV-AVK---KPKMVDKILINEVFQHKMRIISQINH 64
           +++   ++G+G FG V      D   + A+K   K K V+K  +  V   + RI+ ++NH
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER-RILQELNH 59

Query: 65  KNVVKILGVCLETKVPLLV---YEFVPNGTLFQHV--------RYQSSQVLKTWKTCLRI 113
                          P LV   Y F     ++  V        RY  SQ +K  +  ++ 
Sbjct: 60  ---------------PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF 104

Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
              E   AL+YLHS G   IIH D+K  NILLD+     + DF  +  +     T TT+ 
Sbjct: 105 WICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTST 159

Query: 173 EIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGKHPRSYVALASNE 219
              T G++ PE L     S   D +S GV   E L GK P    +    +
Sbjct: 160 S-GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 3e-16
 Identities = 57/228 (25%), Positives = 111/228 (48%), Gaps = 41/228 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKK---PKMV-----DKIL-INEVFQHKMRI 58
            + K  L+G+G +G VY  +      ++AVK+   P  +      +   + +  + ++  
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 59  ISQINHKNVVKILGVCLETKVPLLVY-EFVPNGT----LFQHVRYQSSQVLKTWKTCLRI 113
           +  ++H N+V+ LG    T+  L ++ E+VP G+    L  + R++  Q+++ +      
Sbjct: 62  LKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFTE---- 115

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH-----DQTA 168
             +    L YLHS G   I+H D+K+ N+L+D +   K++DF     IS       D   
Sbjct: 116 --QVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG----ISKKSDDIYDNDQ 166

Query: 169 TTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRS 211
             + +  +V W+ PE +      ++ K D++S G V++E+  G+ P S
Sbjct: 167 NMSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 28/206 (13%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL-------INEVFQHKMRIISQINHKN 66
           +LG G FG VYKG+ +P+     VK P  + KIL        N  F  +  I++ ++H +
Sbjct: 14  VLGSGAFGTVYKGIWVPEGE--TVKIPVAI-KILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS----SQVLKTWKTCLRIAAETASALD 122
           +V++LGVCL   +  LV + +P+G L  +V        SQ+L  W  C++I    A  + 
Sbjct: 71  LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW--CVQI----AKGMM 123

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL       ++H D+ + N+L+      K+ DF  + L+   ++          + W+  
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 183 E---YLFWTEKSDVYSFGVVLVELLT 205
           E   Y  +T +SDV+S+GV + EL+T
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 18/206 (8%)

Query: 15  LLGEGGFGFVYKG--VLPDNTL--VAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
            LG+G FG V +G        +  VAVK  K   +  I+  + F  +  I+  ++H+N++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENLI 59

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           ++ GV L   + ++V E  P G+L   +R  +        T    A + A+ + YL S  
Sbjct: 60  RLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHF-LISTLCDYAVQIANGMRYLES-- 115

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---Y 184
               IH D+ + NILL  +   K+ DF     L  + D             W  PE    
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHP 209
             ++  SDV+ FGV L E+ T G+ P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPK---MVDKILINEVFQHKMRIISQI 62
             N+     +G+G F  VYK + L D  +VA+KK +   M+D     +  + ++ ++ Q+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ-VLKTWKTCLRIAAETASAL 121
           +H NV+K L   +E     +V E    G L + +++   Q  L   +T  +   +  SAL
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
           +++H   S  I+H D+K AN+ +      K+ D       SS  +T      + T  ++ 
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMS 174

Query: 182 PE------YLFWTEKSDVYSFGVVLVELLTGKHP 209
           PE      Y F   KSD++S G +L E+   + P
Sbjct: 175 PERIHENGYNF---KSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 79/315 (25%), Positives = 130/315 (41%), Gaps = 92/315 (29%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKK------PKMVDKILINEVFQHKMRIISQI 62
           Y+   L+GEG +G V K    +   +VA+KK       KMV KI + E+     R++ Q+
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI-----RMLKQL 57

Query: 63  NHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTCL 111
            H+N+V ++ V    K   LV+EFV           PNG     VR    Q+L+      
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR------ 111

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
                    +++ HS     IIH D+K  NIL+  +   K+ DF  +  +++  +  T  
Sbjct: 112 --------GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160

Query: 172 KEIETVGWLDPEYLFWTEKS----DVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
             + T  +  PE L    K     D+++ G ++ E+LTG+                 P F
Sbjct: 161 --VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-----------------PLF 201

Query: 228 PYPIENNSLRQIL----NF-----------------QVADENEMEEIE--------IVAK 258
           P   + + L  I+    N                  ++ +  E+E +E        +V  
Sbjct: 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLD 261

Query: 259 LASKCLRTSGTERPT 273
           LA +CLR    +RP+
Sbjct: 262 LAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 4e-16
 Identities = 56/205 (27%), Positives = 108/205 (52%), Gaps = 13/205 (6%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINE--VFQHKMRIISQINHKN 66
            Y+K  ++G G FG V+      +  + + K   V+++  +E    Q++ +++  ++H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +++     LE K  ++V E+ P GTL ++++ + + +L    T L    +   AL ++H 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLALHHVH- 118

Query: 127 LGSPPIIHGDVKSANILLDDNYT-AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
             +  I+H D+K+ NILLD +    K+ DF  S ++SS  +  T    + T  ++ PE  
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV---VGTPCYISPELC 173

Query: 186 F---WTEKSDVYSFGVVLVELLTGK 207
               + +KSD+++ G VL EL + K
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 60/220 (27%), Positives = 113/220 (51%), Gaps = 24/220 (10%)

Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGV-LPD----NTLVAVKKPKMVDKILINEVFQHKMR 57
           ++K T+ + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS----SQVLKTWKTCLRI 113
           +++ +++ +V ++LG+CL + V L + + +P G L  +VR       SQ L  W  C++I
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI 118

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
           A      ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++       
Sbjct: 119 A----KGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHP 209
              + W+  E +    +T +SDV+S+GV + EL+T G  P
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 5e-16
 Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 34/286 (11%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           E+ + +   +K+  LG G FG V+      +T VAVK   M    +  E F  +  ++  
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKT 57

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           + H  +VK+  V   TK P+ ++ EF+  G+L   ++          K  +  +A+ A  
Sbjct: 58  LQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEG 114

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + ++        IH D+++ANIL+  +   K+ADF  + +I  ++ TA    +   + W 
Sbjct: 115 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWT 170

Query: 181 DPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
            PE   +  +T KSDV+SFG++L+E++T G+ P  Y  +++ E+ R            +L
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIR------------AL 216

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
            +       +    E   I+     +C +    ERPT   +   LD
Sbjct: 217 ERGYRMPRPENCPEELYNIMM----RCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 7e-16
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTL-VAVKKPKM--VDKILINEVFQHKMRI--ISQIN 63
           N+ +  LLG+G FG VY     D    +AVK+            EV   +  I  +  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 64  HKNVVKILGVCLETKVPLLVY-EFVPNGTLFQHVR-YQSSQVLKTWKTCLRIAAETASAL 121
           H+ +V+  G CL     L ++ E++P G++   ++ Y +     T K   +I       +
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTATTTKEIETVGWL 180
           +YLHS     I+H D+K ANIL D     K+ DF AS  L +             T  W+
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
            PE +    +  K+DV+S G  +VE+LT K P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 9e-16
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 10  YDKRHL-----LGEGGFGFV----YKGVLPDN----TLVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG V    Y    P N     +VAVK  K          ++ ++
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYD---PANDGTGEMVAVKTLKRECGQQNTSGWKKEI 57

Query: 57  RIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H+N+VK  G C E   K   L+ E+VP G+L  ++      + +     L  A
Sbjct: 58  NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL----LLFA 113

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    + YLHS      IH D+ + N+LLD++   K+ DF  +  +    +     ++ 
Sbjct: 114 QQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170

Query: 175 ET-VGWLDPEYLF---WTEKSDVYSFGVVLVELLT 205
           ++ V W   E L    ++  SDV+SFGV L ELLT
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM---VDKILINEVFQHKMRIISQIN 63
             ++K + +GEG +G VY+        +VA+KK +M    D I I+ +   ++ ++  + 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL--REITLLLNLR 64

Query: 64  HKNVVKILGVCLETKVP--LLVYEFVPN--GTLFQHVR--YQSSQVLKTWKTCLRIAAET 117
           H N+V++  V +   +    LV E+      +L  ++   +  SQV      CL +  + 
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQV-----KCLML--QL 117

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L YLH      IIH D+K +N+LL D    K+ADF  +       +  T    + T+
Sbjct: 118 LRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK--VVTL 172

Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE L     +T   D+++ G +L ELL  K
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K          F  +  I+ Q +H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R    Q   T    + +    AS + YL  +G  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF--TVIQLVGMLRGIASGMKYLSDMGY- 127

Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S VL    +   TT      + W  PE   Y  
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           +T  SDV+S+G+V+ E+++ G+ P
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 58/272 (21%), Positives = 119/272 (43%), Gaps = 51/272 (18%)

Query: 23  FVYKGVLPDNTLVAV---KKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV 79
            +YKG+  +N  V +   KK     K+LI ++ +++++ + +I+  N++KI G  ++   
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLI-DITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 80  PL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
            L    L+ E+   G L + +  +      ++KT L +A +    L  L+   + P  + 
Sbjct: 93  DLPRLSLILEYCTRGYLREVLDKEKDL---SFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147

Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEK 190
           ++ S + L+ +NY  K+       ++SS        K +  + +   + L      +T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSS-----PPFKNVNFMVYFSYKMLNDIFSEYTIK 202

Query: 191 SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
            D+YS GVVL E+ TGK                +P+     EN + ++I +  +   N  
Sbjct: 203 DDIYSLGVVLWEIFTGK----------------IPF-----ENLTTKEIYDLIINKNNS- 240

Query: 251 EEIEIVAKL-----ASKCLRTSGTERPTMRQV 277
            ++ +   L        C      +RP ++++
Sbjct: 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM----VDKILINEVFQHKMRIISQIN 63
            Y+K   LGEG +  VYK        +VA+KK K+      K  IN     +++++ ++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV------RYQSSQVLKTWKTCLRIAAET 117
           H N++ +L V        LV+EF+   T  + V          + + K++         T
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADI-KSY------MLMT 111

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L+YLHS     I+H D+K  N+L+  +   K+ADF  +    S ++  T   ++ T 
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVVTR 166

Query: 178 GWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
            +  PE LF         D++S G +  ELL   
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 56/214 (26%), Positives = 83/214 (38%), Gaps = 34/214 (15%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS-QINHKNVVKILGVC 74
             +     + K   P NTLVAVKK  +      +     +  I S Q+ H N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA---------SALDYLH 125
           +      +V   +  G+           +LKT         E A         +ALDY+H
Sbjct: 69  IVDSELYVVSPLMAYGS--------CEDLLKT--HFPEGLPELAIAFILKDVLNALDYIH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT----TKEIETV-GWL 180
           S G    IH  VK+++ILL  +    ++    SV +  H +         K       WL
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 181 DPEYLF-----WTEKSDVYSFGVVLVELLTGKHP 209
            PE L      + EKSD+YS G+   EL  G  P
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 32/220 (14%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV-----DKILINEVFQHKMRIISQI 62
            + K   LG G F   Y+   +   TL+AVK+   V     ++  + E  + ++R+++++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGT----LFQHVRYQSSQVLKTWKTCLRIAAETA 118
           NH +++++LG   E     L  E++  G+    L ++  ++ + ++   +  LR      
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR------ 114

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLISSHDQTATTTKEIE-- 175
             L YLH      IIH DVK AN+L+D      ++ADF ++  +++     T   E +  
Sbjct: 115 -GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA---KGTGAGEFQGQ 167

Query: 176 ---TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
              T+ ++ PE L    +    DV+S G V++E+ T K P
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 49/233 (21%)

Query: 13  RHLLGEGGFGFVYKGVL-----------PDNT------LVAVK--KPKMVDKILINEVFQ 53
           +  LGEG FG V+   +           P N       LVAVK  +P   +K   N+ F 
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARND-FL 67

Query: 54  HKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------- 105
            +++I+S++   N++++LGVC++     ++ E++ NG L Q   + SS  L         
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ---FLSSHHLDDKEENGND 124

Query: 106 -----------TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD 154
                      ++ + L +A + AS + YL SL     +H D+ + N L+ +N T K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIAD 181

Query: 155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELL 204
           F  S  + + D      + +  + W+  E +    +T  SDV++FGV L E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 73.3 bits (181), Expect = 6e-15
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNT-LVAVK---KPKMVDKILINEVFQHKMRIISQIN 63
            +++    LG G FG V       +    A+K   K K+V    +  V   K RI+  I 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK-RILQSIR 59

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ---SSQVLKTWKTCLRIAAETASA 120
           H  +V + G   +     LV E+VP G LF H+R        V + +      AA+   A
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY------AAQVVLA 113

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L+YLHSL    I++ D+K  N+LLD +   K+ DF  +  +     T   T E     +L
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YL 165

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
            PE +    + +  D ++ G+++ E+L G  P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.1 bits (179), Expect = 7e-15
 Identities = 58/232 (25%), Positives = 109/232 (46%), Gaps = 28/232 (12%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGE  FG VYKG L           VA+K  K   +  + E F+H+  + S++ H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQ-------HVRYQSSQVLKTWKTCLR------IAAE 116
           +LGV  + +   +++ +  +  L +       H    S+   KT K+ L       I  +
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A+ +++   L S  ++H D+ + N+L+ D    K++D      + + D        +  
Sbjct: 133 IAAGMEF---LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + W+ PE + + +    SD++S+GVVL E+ + G  P  Y   ++ ++  M+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 33/207 (15%)

Query: 16  LGEGGFGFVYK-GVLPDNTLVAVKK---PKMVDKI---LINEVFQHKMRIISQINHKNVV 68
           +GEG  G V+K         VA+KK    ++   I    + E+     + +    H  VV
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI-----KALQACQHPYVV 62

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLKTWKTCLRIAAETASALDY 123
           K+L V       +LV E++P   L + +R        +QV    K+ +R+  +    + Y
Sbjct: 63  KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV----KSYMRMLLK---GVAY 114

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +H+ G   I+H D+K AN+L+  +   K+ADF  + L S  ++    + ++ T  +  PE
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWYRAPE 170

Query: 184 YLF----WTEKSDVYSFGVVLVELLTG 206
            L+    +    D+++ G +  ELL G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.8 bits (178), Expect = 8e-15
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 37/236 (15%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVR------YQSSQVLKTWKTCLRIAAETASA 120
           V K  G  L+     ++ E++  G+    +R      +Q + +LK          E    
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----------EILKG 113

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG-- 178
           LDYLHS      IH D+K+AN+LL +    K+ADF  +  +     T T  K    VG  
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-----TDTQIKRNTFVGTP 165

Query: 179 -WLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP 230
            W+ PE +    +  K+D++S G+  +EL  G+ P S   +    +  ++P    P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS--DMHPMRVLFLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 35/217 (16%)

Query: 12  KRHLLGEGGFGFVYKGV-LPD----NTLVAVK------KPKMVDKILINEVFQHKMRIIS 60
           K  +LG G FG VYKG+ +PD       VA+K       PK  +K +++E +     +++
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAY-----VMA 64

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAE 116
            +    V ++LG+CL + V L V + +P G L  +VR       SQ L  W  C++IA  
Sbjct: 65  GVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW--CVQIA-- 119

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               + YL  +    ++H D+ + N+L+      K+ DF  + L+   +           
Sbjct: 120 --KGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHP 209
           + W+  E +    +T +SDV+S+GV + EL+T G  P
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 16/206 (7%)

Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V +G L         VA+K  K          F  +  I+ Q +H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  +++  +++ EF+ NG L   +R    Q   T    + +    A+ + YL  +   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLSEMN-- 126

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE---TVGWLDPE---Y 184
             +H D+ + NIL++ N   KV+DF  S  +       T T  +     + W  PE   Y
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHP 209
             +T  SDV+S+G+V+ E+++ G+ P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 35/189 (18%)

Query: 35  VAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG 90
           VAVKK  +  +    +L NEV      I+    H N+V++    L      +V EF+  G
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVV-----IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101

Query: 91  TL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN 147
            L     H R    Q+       L+       AL +LH+ G   +IH D+KS +ILL  +
Sbjct: 102 ALTDIVTHTRMNEEQIATVCLAVLK-------ALSFLHAQG---VIHRDIKSDSILLTSD 151

Query: 148 YTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYL----FWTEKSDVYSFGVVL 200
              K++DF     +S         +    VG   W+ PE +    + TE  D++S G+++
Sbjct: 152 GRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMV 205

Query: 201 VELLTGKHP 209
           +E++ G+ P
Sbjct: 206 IEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 5e-14
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 47/289 (16%)

Query: 16  LGEGGFGFVYKG---VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +G G FG V  G          V VK+ +         +F  +++   ++NH NV++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQV--LKTWKTCLRIAAETASALDYLHSLGSP 130
            C+E+   LLV EF P G L  ++R     V  +       R+A E AS L +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---- 186
             IH D+   N  L  + + K+ D+  ++     D   T       + WL PE +     
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 187 ------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
                  T+KS+++S GV + EL T          A           PYP  + S  Q+L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT---------AADQ---------PYP--DLSDEQVL 219

Query: 241 NFQVADEN-EMEEIEIVAKLASK-------CLRTSGTERPTMRQVSEQL 281
              V +++ ++ + ++  K + +       C     T RPT  +V E L
Sbjct: 220 KQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPET-RPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 55/229 (24%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK---------MRII 59
           Y+    +G G +G V   V       VA+KK        I+ VF            ++++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKK--------ISNVFDDLIDAKRILREIKLL 53

Query: 60  SQINHKNVVKILGVCLETKVP-----LLVYEFV----------PNGTLFQHVRYQSSQVL 104
             + H+N++ +L +             +V E +          P      H++Y   Q+L
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL 113

Query: 105 KTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISS 163
           +               L YLHS     +IH D+K +NIL++ N   K+ DF  +  +   
Sbjct: 114 R--------------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156

Query: 164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKH 208
            D+    T+ + T  +  PE L     +T+  D++S G +  ELLT K 
Sbjct: 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 6e-14
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG VYK    +  L A  K   ++     E F  ++ I+S+  H N+V +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 76  -ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWK--TCLRIAA---ETASALDYLHSLGS 129
            E K+ +L+ EF   G L        S +L+  +  T  +I     +   AL++LHS   
Sbjct: 73  YENKLWILI-EFCDGGAL-------DSIMLELERGLTEPQIRYVCRQMLEALNFLHS--- 121

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
             +IH D+K+ NILL  +   K+ADF  S    S  Q   T   I T  W+ PE +    
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEVVACET 179

Query: 187 -----WTEKSDVYSFGVVLVELLTGKHPRS 211
                +  K+D++S G+ L+EL   + P  
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 20/169 (11%)

Query: 52  FQHKMRIISQINHKNVVKIL--GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKT 109
           F+ +  + +++ H N+V +L  G      +   V+E+VP  TL +     +   L   +T
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVPGRTLRE--VLAADGALPAGET 81

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLIS-SHD 165
             R+  +   AL   H+ G   I+H D+K  NI++        AKV DF    L+    D
Sbjct: 82  -GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137

Query: 166 QTATT-TKEIETVG---WLDPEYLFW---TEKSDVYSFGVVLVELLTGK 207
               T T+  E +G   +  PE L     T  SD+Y++G++ +E LTG+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 9e-14
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-----PKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG+G FG VY         LVA+KK         + + + EV     + + ++N H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV-----KSLRKLNEHPNIV 61

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVL--KTWKTCLRIAAETASALDYLHS 126
           K+  V  E      V+E++  G L+Q ++ +  +       ++ +    +    L ++H 
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIY---QILQGLAHIHK 117

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL- 185
            G     H D+K  N+L+      K+ADF  +  I S       T  + T  +  PE L 
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILL 171

Query: 186 ---FWTEKSDVYSFGVVLVELLTGK 207
               ++   D+++ G ++ EL T +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 16  LGEGGFGFVYK-GVLPDNTLVA---VKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           LG GGFG V    V   N   A   VKK  +V+      +F  K  I+ + NH  +VK+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLY 59

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
               + K   ++ E+   G L+  +R    + L    T     A    A +YLH+ G   
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG--- 113

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WT 188
           II+ D+K  N+LLD N   K+ DF  +  + S  +T T      T  ++ PE +    + 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF---CGTPEYVAPEIILNKGYD 170

Query: 189 EKSDVYSFGVVLVELLTGKHP 209
              D +S G++L ELLTG+ P
Sbjct: 171 FSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKIL------INEVFQHKMRIISQINHKNVV 68
           LG+G F  ++KG+  +      + K +++ K+L       +E F     ++SQ++HK++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
              GVC+     ++V E+V  G+L  +++   + +  +WK  L +A + A AL +L   G
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT---KEI--ETVGWLDPE 183
              + HG+V + N+LL      K     +   I   D   + T   KEI  E + W+ PE
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKT---GNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 184 YL----FWTEKSDVYSFGVVLVELLTG 206
            +      +  +D +SFG  L E+ +G
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 71/281 (25%), Positives = 110/281 (39%), Gaps = 47/281 (16%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVD------KILINEVFQHKMRIISQINHKNVVK 69
           LGEG  G V K  L +  ++   K    D      K ++ E     + I        +VK
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE-----LEINKSCKSPYIVK 63

Query: 70  ILGVCLETKVPLL--VYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             G  L+     +    E+   G+L   ++ V+ +  ++ +  K   +IA      L YL
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE--KVLGKIAESVLKGLSYL 121

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
           HS     IIH D+K +NILL      K+ DF  S  L++S   T T T       ++ PE
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-----YMAPE 173

Query: 184 YLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
            +    ++  SDV+S G+ L+E+   + P         E    +     PIE   L  I+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP------FPPEGEPPLG----PIE--LLSYIV 221

Query: 241 NFQVADENEMEEIEIV-----AKLASKCLRTSGTERPTMRQ 276
           N    +  +     I           +CL    T RPT   
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 82/318 (25%), Positives = 135/318 (42%), Gaps = 84/318 (26%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD---NTLVAVKKPKMVDKILINEVFQHK---MRIISQ 61
           + Y+    LG+G +G V+K +  D     +VA+KK        I + F++     R   +
Sbjct: 7   RKYEILQKLGKGAYGIVWKAI--DRRTKEVVALKK--------IFDAFRNATDAQRTFRE 56

Query: 62  I-------NHKNVVKILGV--CLETKVPLLVYEF-------VPNGTLFQ--HVRYQSSQV 103
           I       +H N+VK+L V      K   LV+E+       V    + +  H RY   Q+
Sbjct: 57  IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQL 116

Query: 104 LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
           LK              AL Y+HS     +IH D+K +NILL+ +   K+ADF  +  +S 
Sbjct: 117 LK--------------ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 164 HDQTATT---TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALA 216
            ++       T  + T  +  PE L     +T+  D++S G +L E+L GK         
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--------- 210

Query: 217 SNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIE-IVAKLASKCLRTSGTERP-TM 274
                   P FP     N L +I+  +V      E+IE I +  A+  L +  +     +
Sbjct: 211 --------PLFPGTSTLNQLEKII--EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPL 260

Query: 275 RQV-----SEQLDSLRRL 287
            ++      + LD L++L
Sbjct: 261 DELLPKASDDALDLLKKL 278

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 14  HLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ---HKMRIISQINHKNVVK 69
           H +G G FG VY       N +VAVKK     K   NE +Q    +++ + Q+ H N ++
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASALDYLHS 126
             G  L+     LV E+             +S +L+  K  L+   IAA T  AL  L  
Sbjct: 86  YKGCYLKEHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAITHGALQGLAY 136

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S  +IH D+K+ NILL +    K+ADF S+   S  +    T        W+ PE + 
Sbjct: 137 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY------WMAPEVIL 190

Query: 187 ------WTEKSDVYSFGVVLVELLTGKHP 209
                 +  K DV+S G+  +EL   K P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 2e-13
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN---EVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    V   K++D        E  Q ++ ++SQ +   
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 67  VVKILGVCLETKVPLLVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+   L +      +Q+     T LR   E    LDY
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 116

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL ++   K+ADF  +  ++  D        + T  W+ PE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE 171

Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            +    +  K+D++S G+  +EL  G+ P S
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 12  KRHLLGEGGFGFVYKGVLPDNTL-VAVKKPKMVD----KILINEVFQHKMRIISQINHKN 66
           +R +LG+G +G VY        + +A+K+    D    + L  E+  H       + H+N
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS-----YLKHRN 66

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +V+ LG   E     +  E VP G+L   +R +   +    +T +    +    L YLH 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 127 LGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
                I+H D+K  N+L+ + Y+   K++DF +S  ++  +    T     T+ ++ PE 
Sbjct: 127 N---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTETFT--GTLQYMAPEV 180

Query: 185 L-----FWTEKSDVYSFGVVLVELLTGKHP 209
           +      +   +D++S G  +VE+ TGK P
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 24/221 (10%)

Query: 16  LGEGGFGFVYKGVL---PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG+         VAVK  K    D  L +E+ + +  ++ Q+++  +V++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L + ++ ++  V  T K    +  + +  + YL      
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQ-KNKHV--TEKNITELVHQVSMGMKYLEETN-- 115

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHD---QTATTTKEIETVGWLDPE---Y 184
             +H D+ + N+LL   + AK++DF  S  + + +   +  T  K    V W  PE   Y
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW--PVKWYAPECMNY 172

Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             ++ KSDV+SFGV++ E  + G+ P  Y  +  NE+T+M+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMI 211

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 39/221 (17%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
             Y     +GEG +G V      P    VA+KK    +     +    +++I+ +  H+N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 67  VVKILGV----CLET-KVPLLVYEFVPNGTLF----------QHVRYQSSQVLKTWKTCL 111
           ++ IL +      E+     +V E +    L+           H++Y   Q+L+      
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR------ 117

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATT 170
                    L Y+HS     ++H D+K +N+LL+ N   K+ DF  + +    HD T   
Sbjct: 118 --------GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T+ + T  +  PE +     +T+  D++S G +L E+L+ +
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 22/223 (9%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTL-VAVKK----PKMVDKILINEVFQHKMRIISQIN 63
           N+    LLG G FG VY     D    +AVK+    P   +        + +++++  + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 64  HKNVVKILGVCL----ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           H  +V+  G CL    E K+ + V E++P G++   ++   +    T     R   +   
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGAL---TENVTRRYTRQILQ 117

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVG 178
            + YLHS     I+H D+K ANIL D     K+ DF +S  I +   + T  K +  T  
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRS-YVALAS 217
           W+ PE +    +  K+DV+S    +VE+LT K P + Y A+A+
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 34/216 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQI 62
           K Y +   +G+G  G VY  + +     VA+K+  +  +    ++INE+      ++ + 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-----VMREN 73

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL---RIAA---E 116
            H N+V  L   L      +V E++  G+L   V           +TC+   +IAA   E
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRE 123

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
              AL++LHS     +IH D+KS NILL  + + K+ DF     I+      +T   + T
Sbjct: 124 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGT 178

Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
             W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDN-TLVAVKK------PKMVDKILINEVFQHKMRIISQI 62
           Y+K   +GEG +G V+K    +   +VA+KK        ++ KI + E+     R++ Q+
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREI-----RMLKQL 57

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPN---GTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
            H N+V ++ V    +   LV+E+  +     L ++ R     ++K      +I  +T  
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------KIIWQTLQ 111

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           A+++ H       IH DVK  NIL+      K+ DF  + +++        T  + T  +
Sbjct: 112 AVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWY 166

Query: 180 LDPEYLF----WTEKSDVYSFGVVLVELLTG 206
             PE L     +    DV++ G V  ELLTG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 52/282 (18%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G  G V K +  P   ++AVK     +++ +  ++ + ++ I+ + N   +V   G 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR-ELDILHKCNSPYIVGFYGA 67

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQ----VLKTWKTCLRIAAETASALDYLHSLGS 129
                   +  E++  G+L + ++    +    +L       +IA      L YLH    
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG------KIAVAVLKGLTYLHEKHK 121

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
             IIH DVK +NIL++     K+ DF  S  L++S  +T   T       ++ PE +   
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS-----YMAPERIQGN 174

Query: 186 FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF--Q 243
            ++ KSD++S G+ L+EL TG+                   FPYP EN+    I      
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR-------------------FPYPPENDPPDGIFELLQY 215

Query: 244 VADE------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
           + +E      +     +      + CL     ERP+ +++ E
Sbjct: 216 IVNEPPPRLPSGKFSPDFQ-DFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQH---KMRIISQINH 64
           + ++   +G G FG V+           A+K   + + I + +  QH   + R++ +++H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSH 60

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             ++++     + +   ++ E+VP G LF ++R        +  T L  A+E   AL+YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     I++ D+K  NILLD     K+ DF  +  +     T   T E     +L PE 
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-----YLAPEV 169

Query: 185 LFWT---EKSDVYSFGVVLVELLTGKHP 209
           +      +  D ++ G+++ E+L G  P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.3 bits (165), Expect = 9e-13
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 49/225 (21%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVF----QHKMRIISQINHKNVVKI 70
           LGEG FG VYK   +    +VA+KK  M ++    + F      +++I+ ++ H NVV +
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKILKKLKHPNVVPL 72

Query: 71  LGVCLE-----TKVPLLVYEFVP------NGTLF-QHVRYQSSQVLKTWKTCLRIAAETA 118
           + + +E      +    VY   P      +G L    V+   SQ+       L       
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL------- 125

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             ++YLH      I+H D+K+ANIL+D+    K+ADF    L   +D      K     G
Sbjct: 126 EGINYLHENH---ILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKGGGGGG 179

Query: 179 -----------WLDPEYLFWTEKS-----DVYSFGVVLVELLTGK 207
                      W  P  L   E+      D++  G V  E+ T +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.5 bits (162), Expect = 9e-13
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 12/207 (5%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRII--SQINHKN 66
            Y+    +GEG FG +Y      ++   V K   + K+ + E    K  +I  +++ H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +V       E     +V E+   G L + +  Q   VL +    L    + +  L ++H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD 119

Query: 127 LGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                I+H D+KS NI L  N   AK+ DF  +  ++   + A T   + T  +L PE  
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLSPEIC 174

Query: 186 F---WTEKSDVYSFGVVLVELLTGKHP 209
               +  K+D++S G VL EL T KHP
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 48/224 (21%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-------HKN 66
           ++GEG +G VYK        LVA+K        +++ +   +  I  + N       H N
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--------IMDIIEDEEEEIKEEYNILRKYSNHPN 64

Query: 67  VVKILGVCLETKVPL-------LVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIA-- 114
           +    G  ++ K P        LV E    G+   L + +R +  ++ + W     IA  
Sbjct: 65  IATFYGAFIK-KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYI 118

Query: 115 -AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
             ET   L YLH      +IH D+K  NILL  N   K+ DF  S  + S      T   
Sbjct: 119 LRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-- 173

Query: 174 IETVGWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
           I T  W+ PE +         +  +SDV+S G+  +EL  GK P
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 27/258 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI-------LINEVFQHKMRIIS 60
           N+     +G G F  VY+   L D   VA+KK ++ D +        I E+      ++ 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEI-----DLLK 57

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-YQSSQVLKTWKTCLRIAAETAS 119
           Q+NH NV+K     +E     +V E    G L + ++ ++  + L   KT  +   +  S
Sbjct: 58  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           AL+++H   S  ++H D+K AN+ +      K+ D       SS  +T      + T  +
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 172

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP---YFPYPIEN 233
           + PE +    +  KSD++S G +L E+   + P     +    + + +    Y P P ++
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232

Query: 234 NS--LRQILNFQVADENE 249
            S  LRQ++N  +  + E
Sbjct: 233 YSEELRQLVNMCINPDPE 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG VYKG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 6   FTKLERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW-KTCLRIAAETASALDYLH 125
           + +  G  L+     ++ E++  G+    ++     + +T+  T LR   E    LDYLH
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR---EILKGLDYLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           S      IH D+K+AN+LL +    K+ADF  +  ++  D        + T  W+ PE +
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173

Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHPRS 211
               +  K+D++S G+  +EL  G+ P S
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQ----HKMRIISQINH 64
           +D    +GEG +G VYK    D   LVA+KK ++ ++    E F      +++I+ Q+NH
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNH 65

Query: 65  KNVVKILGVCLETKVPL----------LVYEFVPN---GTLFQH-VRYQSSQVLKTWKTC 110
           +N+V +  +  + +  L          LV+E++ +   G L    V +    +    K  
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           L         L+Y H       +H D+K +NILL++    K+ADF  + L +S +    T
Sbjct: 126 L-------EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 171 TKEIETVGWLDPEYLFWTEKS----DVYSFGVVLVELLTGK 207
            K I T+ +  PE L   E+     DV+S G +L EL T K
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMR--------IISQINHKN 66
           +G G F  VY+   L D   VA+KK      + I E+   K R        ++ Q+NH N
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKK------VQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRY-QSSQVLKTWKTCLRIAAETASALDYLH 125
           V+K L   +E     +V E    G L Q ++Y +  + L   +T  +   +  SA++++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
              S  ++H D+K AN+ +      K+ D       SS  +T      + T  ++ PE +
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 186 F---WTEKSDVYSFGVVLVELLTGKHP 209
               +  KSD++S G +L E+   + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 64.7 bits (157), Expect = 5e-12
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 20/222 (9%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-----PKMVDKILINEVFQHKMRIISQIN 63
           N+ +  LLG+G FG VY     D       K     P+  +        + +++++  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 64  HKNVVKILGVCLE---TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           H+ +V+  G CL     K   +  E++P G++   ++   +    T     +   +    
Sbjct: 63  HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL---TESVTRKYTRQILEG 118

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGW 179
           + YLHS     I+H D+K ANIL D     K+ DF +S  + +   + T  + +  T  W
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP-RSYVALAS 217
           + PE +    +  K+DV+S G  +VE+LT K P   Y A+A+
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 7e-12
 Identities = 67/253 (26%), Positives = 104/253 (41%), Gaps = 71/253 (28%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMR-----IISQINHKNVV 68
            +G G FG V K +     T++AVK+ +      ++E  Q ++      ++   +   +V
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIR----STVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 69  KILG---------VCLE------TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           K  G         +C+E       K    VYE V    +         ++L       +I
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVI-------PEEILG------KI 112

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTK 172
           A  T  AL+YL       IIH DVK +NILLD N   K+ DF  S  L+ S  +    T+
Sbjct: 113 AVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TR 166

Query: 173 EIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
           +     ++ PE +       +  +SDV+S G+ L E+ TGK                   
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK------------------- 207

Query: 227 FPYPIENNSLRQI 239
           FPYP  N+   Q+
Sbjct: 208 FPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 29/207 (14%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ---HKMRIISQINHKNVVKIL 71
           +G G FG VY    + ++ +VA+KK     K   NE +Q    ++R + ++ H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASALDYLHSLG 128
           G  L      LV E+             +S +L+  K  L+   IAA T  AL  L  L 
Sbjct: 82  GCYLREHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
           S  +IH DVK+ NILL +    K+ DF S+ +++  +    T        W+ PE +   
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY------WMAPEVILAM 186

Query: 187 ----WTEKSDVYSFGVVLVELLTGKHP 209
               +  K DV+S G+  +EL   K P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 21/159 (13%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQI 62
           Y++   +GEG +G VYK   L     VA+KK ++      +    + E+    ++ +   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI--ALLKQLESF 58

Query: 63  NHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            H N+V++L VC       E K+  LV+E V +  L  ++       L        +  +
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKL-TLVFEHV-DQDLATYLSKCPKPGLPPETI-KDLMRQ 115

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF 155
               +D+LHS     I+H D+K  NIL+  +   K+ADF
Sbjct: 116 LLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADF 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)

Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 82

Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----KALSVLHAQ 135

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S       +   + T  W+ PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPELISR 190

Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ---HKMRIISQINHKNVVKIL 71
           +G G FG VY    +  N +VA+KK     K   NE +Q    +++ + +I H N ++  
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASALDYLHSLG 128
           G  L      LV E+             +S +L+  K  L+   IAA T  AL  L  L 
Sbjct: 92  GCYLREHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
           S  +IH D+K+ NILL +    K+ADF S+ + S  +    T        W+ PE +   
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY------WMAPEVILAM 196

Query: 187 ----WTEKSDVYSFGVVLVELLTGKHP 209
               +  K DV+S G+  +EL   K P
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 16/203 (7%)

Query: 16  LGEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V KGV         VA+K  K  ++  + +    +  I+ Q+++  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC E +  +LV E    G L + +  +  ++  T    + +  + +  + YL        
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEI--TVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQ--TATTTKEIETVGWLDPE---YLFW 187
           +H D+ + N+LL + + AK++DF  S  + + D    A +  +   + W  PE   +  +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW-PLKWYAPECINFRKF 175

Query: 188 TEKSDVYSFGVVLVELLT-GKHP 209
           + +SDV+S+G+ + E  + G+ P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 47/222 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
           N+ K   +GEG +G VYK        +VA+KK ++      V    I E+      ++ +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI-----SLLKE 55

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA-ETASA 120
           +NH N+VK+L V        LV+EF+              Q LK +     ++       
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-------------HQDLKKFMDASPLSGIPLPLI 102

Query: 121 LDYLHSL-------GSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQTAT 169
             YL  L        S  ++H D+K  N+L++     K+ADF    A  V + ++     
Sbjct: 103 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----- 157

Query: 170 TTKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T E+ T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 158 -THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 31/204 (15%)

Query: 19  GGFGFVY---KGVLPDN-TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           G FG VY   K    D   +  +KK  M+ K  +  V   +  ++ Q     V K L   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK-LYYS 65

Query: 75  LETKVPL-LVYEFVPNG---TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            ++K  L LV E++  G   +L + +        K +       AE    ++ LH  G  
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQRG-- 117

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASS--VLISSHDQTATTTKEIETVGWLDPEYLF-- 186
            IIH D+K  N+L+D     K+ DF  S   L +         K + T  +L PE +   
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK--------KFVGTPDYLAPETILGV 168

Query: 187 -WTEKSDVYSFGVVLVELLTGKHP 209
              + SD +S G V+ E L G  P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 43/210 (20%)

Query: 16  LGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VYK      G L    ++  K  + ++  ++      ++ I++  NH  +VK
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV------EIEILATCNHPYIVK 73

Query: 70  ILGVCL-ETKVPLLVYEFVPNG----TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +LG    + K+ +++ EF P G     + +  R  +   ++       I  +   AL YL
Sbjct: 74  LLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV------ICRQMLEALQYL 126

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLD 181
           HS+    IIH D+K+ N+LL  +   K+ADF  S          T  +    +G   W+ 
Sbjct: 127 HSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMA 178

Query: 182 PEYLF--------WTEKSDVYSFGVVLVEL 203
           PE +         +  K+D++S G+ L+E+
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 9   NYDKRHLLGEGGFG--FVYKGVLPDNTLV--AVKKPKMVDKILINEVFQHKMRIISQINH 64
            Y+   ++GEG FG   + + V  D       ++ PK    +   E  + +  +++++ H
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV---EDSRKEAVLLAKMKH 57

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N+V             +V E+   G L Q ++ Q  + L    T L+   +    + ++
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHI 116

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H      ++H D+KS NI L  N   K+ DF S+ L++S    A T   + T  ++ PE 
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEI 171

Query: 185 ---LFWTEKSDVYSFGVVLVELLTGKHP 209
              + +  KSD++S G +L EL T KHP
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 59/261 (22%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR------------ 57
           Y K   +GEG FG   K +L       VK  +   + +I E+   KM             
Sbjct: 2   YVKVKKIGEGSFG---KAIL-------VKSKEDGKQYVIKEINISKMSPKEREESRKEVA 51

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR------YQSSQVLKTW--KT 109
           ++S + H N+V+      E     +V ++   G L++ +       +   Q+L  W  + 
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL-DWFVQI 110

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
           CL        AL ++H      I+H D+KS NI L  + T K+ DF  + +++S  + A 
Sbjct: 111 CL--------ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159

Query: 170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV-- 224
           T   I T  +L PE      +  KSD+++ G VL E+ T KH     A  +  M  +V  
Sbjct: 160 TC--IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH-----AFEAGNMKNLVLK 212

Query: 225 ----PYFPYPIENNS-LRQIL 240
                Y P     +  LR ++
Sbjct: 213 IIRGSYPPVSSHYSYDLRNLV 233

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 27/208 (12%)

Query: 15  LLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILIN-----EVFQHKMRIISQINHK 65
           +LG+G FG V     KG    + L AVK  K   K +I      E    + R+++     
Sbjct: 2   VLGKGSFGKVLLAELKGT---DELYAVKVLK---KDVILQDDDVECTMTEKRVLALAGKH 55

Query: 66  NVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +  L  C +TK  L  V E+V  G L  H+  Q S      +     AAE    L +L
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARF-YAAEIVLGLQFL 112

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE- 183
           H  G   II+ D+K  N+LLD     K+ADF           T +T     T  ++ PE 
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--CGTPDYIAPEI 167

Query: 184 --YLFWTEKSDVYSFGVVLVELLTGKHP 209
             Y  +    D ++ GV+L E+L G+ P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 35/228 (15%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKIL------INEVFQHKMRIISQIN 63
           LG G    +Y G+L       D+     K+ K++ K+L      I+  F     ++ Q++
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           HK++V + GVC+     ++V EFV  G L   +  +S  +   WK   ++A + ASAL Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120

Query: 124 LHSLGSPPIIHGDVKSANILL-----DDNYTA--KVADFASSVLISSHDQTATTTKEIET 176
           L       ++HG+V + NILL     D       K++D    + + S  +       +E 
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VER 171

Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVEL-LTGKHPRSYVALASNE 219
           + W+ PE +      +  +D +SFG  L E+   G+ P     LA  E
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV---DKILINEVFQHKMRIISQINH 64
           +Y+    +G G +G VYK   L    L AVK  K+    D  LI    Q ++ ++ +  H
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI----QQEIFMVKECKH 65

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            N+V   G  L  +   +  E+   G+L    HV    S++   +     +  ET   L 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQGLA 120

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---W 179
           YLHS G    +H D+K ANILL DN   K+ADF  +  I     TAT  K    +G   W
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI-----TATIAKRKSFIGTPYW 172

Query: 180 LDPEYLF------WTEKSDVYSFGVVLVEL 203
           + PE         + +  D+++ G+  +EL
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.8 bits (152), Expect = 2e-11
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 28/213 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQI 62
           K Y +   +G+G  G VY  + +     VA+K+  +  +    ++INE+      ++ + 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL-----VMREN 73

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAETAS 119
            + N+V  L   L      +V E++  G+L   V        Q+    + CL+       
Sbjct: 74  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ------- 126

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           ALD+LHS     +IH D+KS NILL  + + K+ DF     I+      +T   + T  W
Sbjct: 127 ALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYW 181

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           + PE +    +  K D++S G++ +E++ G+ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 16  LGEGGFGFVYKGVLPDNT--LVAVKKPKMVDKILINEVFQHKM-----RIISQINHKNVV 68
           LG+GGFG V        T  + A KK   +DK  + +    +M     +I+ +++ + +V
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKK---LDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56

Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
             L    ETK  L LV   +  G L  H+ Y   +        +  AA+    L++LH  
Sbjct: 57  S-LAYAFETKDDLCLVMTLMNGGDLKYHI-YNVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               I++ D+K  N+LLDD+   +++D   +V +              T G++ PE L  
Sbjct: 115 R---IVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGK-KIKGRAGTPGYMAPEVLQG 168

Query: 187 --WTEKSDVYSFGVVLVELLTGKHP-RSYVALASN-EMTRMV 224
             +    D ++ G  L E++ G+ P R         E+ R  
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 19/210 (9%)

Query: 16  LGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +G G FG V  G +        V VK+ ++   +     F  + +    + H N+++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT--WKTCLRIAAETASALDYLHSLGSP 130
            C E    LLV EF P G L  ++R      L T    T  R+A E A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL----- 185
             IH D+   N LL  + T K+ D+  S      D   T  +    + W+ PE +     
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 186 -----FWTEKSDVYSFGVVLVELLT-GKHP 209
                  T++S+V+S GV + EL   G  P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 32/209 (15%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINE---VFQHKMRIISQINHKNVVKIL 71
           +G G +G VYK   +    L A+K    V K+   E   V Q ++ ++    H N+V   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIK----VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           G  L      +  EF   G+L    HV    S+    +     ++ ET   L YLHS G 
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQGLYYLHSKGK 127

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYLF 186
              +H D+K ANILL DN   K+ADF  S  I     TAT  K    +G   W+ PE   
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAA 179

Query: 187 ------WTEKSDVYSFGVVLVELLTGKHP 209
                 + +  D+++ G+  +EL   + P
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 67/203 (33%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+G FG V    L     L AVK  K  D IL ++  +  M   RI+S   +   +  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 71  LGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           L  C +T   L  V EFV  G L  H+  Q S+     +     AAE  SAL +LH  G 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEITSALMFLHDKG- 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---F 186
             II+ D+K  N+LLD     K+ADF   +         TT+    T  ++ PE L    
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFG--MCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +    D ++ GV+L E+L G  P
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 57/232 (24%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKM-------------VDKILINEVFQHKMRIISQ 61
           LGEG +G V K        +VA+KK K+             V    I+     +++I+++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 62  INHKNVVKILGVCLETKVPLLVYEF--------VPNGTLF--QHVRYQSSQVLKTWKTCL 111
           I H+N++ ++ V +E     LV +         V          V+    Q+L       
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNG----- 131

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF------ASSVLISSHD 165
                       L+ L     +H D+  ANI ++     K+ADF             +  
Sbjct: 132 ------------LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 166 QTATT------TKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
           +  T       T ++ T+ +  PE L   EK     D++S G +  ELLTGK
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 37/225 (16%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINEVFQ----HKMRIISQI 62
             Y+K   +G+G FG V+K        +VA+KK  M ++    E F      +++I+  +
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLL 68

Query: 63  NHKNVVKILGVCLETKVP--------LLVYEFVPN---GTL-FQHVRYQSSQVLKTWKTC 110
            H+NVV ++ +C     P         LV+EF  +   G L  ++V++  S++ K  K  
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTA 168
           L       + L Y+H      I+H D+K+ANIL+  +   K+ADF  A +  +S + +  
Sbjct: 129 L-------NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 169 TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP 209
             T  + T+ +  PE L     +    D++  G ++ E+ T + P
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 22/229 (9%)

Query: 16  LGEGGFGFV----YK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V    YK    P   +   +K K++ +  ++ VF  + +I++ INH   V +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNL 96

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            G   +     LV EFV  G  F  +R   ++       C   AA+     +YL SL   
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCF-YAAQIVLIFEYLQSLN-- 151

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT-- 188
            I++ D+K  N+LLD +   K+ DF  + ++ +   T   T E     ++ PE L     
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE-----YIAPEILLNVGH 205

Query: 189 -EKSDVYSFGVVLVELLTGKHP--RSYVALASNEMTRMVPYFPYPIENN 234
            + +D ++ G+ + E+L G  P   +   L   ++   + YFP  ++NN
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254

Length = 340

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTL-VAVKK----PKMVDKILINEVFQHKMRIISQIN 63
           N+    LLG+G FG VY     D    +AVK+    P+  +        + +++++  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 64  HKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           H+ +V+  G   +   +   +  E +P G++   ++   +    T     +   +    +
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL---TENVTRKYTRQILEGV 119

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWL 180
            YLHS     I+H D+K ANIL D     K+ DF +S  + +   + T  K +  T  W+
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
            PE +    +  K+D++S G  +VE+LT K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-----VK 69
           LG G +G V K   +P  T++AVK+ +      +N   Q ++ +   I+ ++V     V 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 70  ILG---------VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
             G         +C+E     L  +F     ++         +L       +IA     A
Sbjct: 65  FYGALFREGDVWICMEVMDTSL-DKFYKK--VYDKGLTIPEDILG------KIAVSIVKA 115

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH--DQTATTTKEIETVG 178
           L+YLHS  S  +IH DVK +N+L++ N   K+ DF     IS +  D  A T        
Sbjct: 116 LEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKTID-AGCKP 168

Query: 179 WLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
           ++ PE +        +  KSDV+S G+ ++EL TG+ P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 16  LGEGGFGFVYKGVLPDN-TLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V           VAVKK  +  +    +L NEV      I+   +H+NVV +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-----IMRDYHHENVVDM 84

Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+     + LR       AL YLH+ 
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR-------ALSYLHNQ 137

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISR 192

Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 48/226 (21%)

Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +G G +G V   +  D      VA+KK P   D   + +    +++I+    H N++ I 
Sbjct: 13  IGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 72  GVCLETKVPLLVYEFV--------------PNGTL-FQHVRYQSSQVLKTWKTCLRIAAE 116
            + L          +V               +  L  +H+RY   Q+L+           
Sbjct: 71  DI-LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR----------- 118

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEI 174
               L Y+HS     +IH D+K +N+L++++   ++ DF  A  +  S  +     T+ +
Sbjct: 119 ---GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 175 ETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKH--P-RSYV 213
            T  +  PE L     +T   D++S G +  E+L  +   P ++YV
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 18/108 (16%)

Query: 112 RIAAETASALDYL---HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISS--HD 165
           ++      AL YL   H      +IH DVK +NILLD +   K+ DF  S  L+ S    
Sbjct: 118 KMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172

Query: 166 QTATTTKEI--ETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHP 209
           ++A     +  E    +DP      +  ++DV+S G+ LVEL TG+ P
Sbjct: 173 RSAGCAAYMAPER---IDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 24/215 (11%)

Query: 8   KNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           ++YD   ++G G FG V    +K       +  + K +M+ K   +  F  +  I++  N
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFAN 101

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
              VV++     + K   +V E++P G L   +   +  V + W       AE   ALD 
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY--TAEVVLALDA 157

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETVGWLD 181
           +HS+G   +IH DVK  N+LLD +   K+ADF + + +   D+T        + T  ++ 
Sbjct: 158 IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMVRCDTAVGTPDYIS 211

Query: 182 PEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
           PE L       ++  + D +S GV L E+L G  P
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 58/296 (19%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN--TLVAVK---------------KPKMVDKILINEV 51
            Y     LG G FG VYK    +N   L+A+K               + K +  I ++E 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDI-VSE- 58

Query: 52  FQHKMRII-SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLK 105
               + II  Q+ H N+V+     LE     +V + +    L +H      + Q     +
Sbjct: 59  ----VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER 114

Query: 106 TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD 165
            W   +++      AL YLH      I+H D+   NI+L ++    + DF    L     
Sbjct: 115 IWNIFVQMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQ 165

Query: 166 QTATTTKEIETVGWLDPEY---LFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR 222
             +  T  + T+ +  PE      + EK+DV++FG +L ++ T + P       S  M  
Sbjct: 166 PESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-----FYSTNMLS 220

Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS 278
           +              +I+        E    E V  + + CL      RP + QVS
Sbjct: 221 LA------------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 44/269 (16%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL---VAVKK------PKMVDKILINEVFQHKMRI 58
           K Y +   +G+G  G V+  +  D      VA+K+      PK   +++INE+      +
Sbjct: 19  KKYTRYEKIGQGASGTVFTAI--DVATGQEVAIKQINLQKQPK--KELIINEIL-----V 69

Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAA 115
           + ++ + N+V  L   L      +V E++  G+L   V       +Q+    + CL+   
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ--- 126

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
               AL++LH+     +IH D+KS N+LL  + + K+ DF     I+      +T   + 
Sbjct: 127 ----ALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--VG 177

Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMV- 224
           T  W+ PE +    +  K D++S G++ +E++ G+ P       R+   +A+N    +  
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237

Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEI 253
           P    PI  + L + L   V      +E+
Sbjct: 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 34/216 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQI 62
           K Y +   +G+G  G VY  + +     VA+++  +  +    ++INE+      ++ + 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-----VMREN 74

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAETAS 119
            + N+V  L   L      +V E++  G+L   V        Q+    + CL+       
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ------- 127

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG- 178
           AL++LHS     +IH D+KS NILL  + + K+ DF     I     T   +K    VG 
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----TPEQSKRSTMVGT 179

Query: 179 --WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
             W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 29/230 (12%)

Query: 8   KNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQ 61
           +++D   ++G G FG V    +K       + A+K     + I  ++   F  +  I++ 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASA 120
            N + +V++     + K   +V E++P G L   V   S+  + + W       AE   A
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL---VNLMSNYDIPEKWARFY--TAEVVLA 154

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           LD +HS+G    IH DVK  N+LLD +   K+ADF + + + ++      T  + T  ++
Sbjct: 155 LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYI 210

Query: 181 DPEYL-------FWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEM 220
            PE L       ++  + D +S GV L E+L G  P    S V   S  M
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+G FG V+   L   N   A+K  K  D +L+++  +  M   R++S       +  
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 71  LGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           L    +TK  L  V E++  G L  H+  QS       +     AAE    L +LHS G 
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATF-YAAEIICGLQFLHSKG- 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
             I++ D+K  NILLD +   K+ADF   +   +    A T     T  ++ PE L    
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFG--MCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +    D +SFGV+L E+L G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 45/288 (15%)

Query: 8   KNYDKRHL--LGEGGFGFVYKGV-LPDNTLVAVK------KPKMVDKILINEVFQHKMRI 58
           +N D   +  LG G  G V K   +P  T++A K      K  +  +IL       +++I
Sbjct: 3   RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL------RELQI 56

Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-----TWKTCLRI 113
           + +     +V   G  L      +  EF+  G+L         ++ K       +   +I
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL--------DRIYKKGGPIPVEILGKI 108

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTK 172
           A      L YL+++    I+H D+K +NIL++     K+ DF  S  LI+S   T   T 
Sbjct: 109 AVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166

Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
                 ++ PE +    +T KSDV+S G+ ++EL  GK P ++  +  +     +     
Sbjct: 167 T-----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-- 219

Query: 230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
               + L+QI+          +  E +      CL    TERPT +Q+
Sbjct: 220 ----DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 25/201 (12%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNVVKILGV 73
           LG+G FG VYK    +  ++A  K  ++D     E+  +  ++ I++  +H N+VK+L  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAK--VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
                   ++ EF   G +   V  +  + L T      +  +T  AL+YLH      II
Sbjct: 71  FYYENNLWILIEFCAGGAV-DAVMLELERPL-TEPQIRVVCKQTLEALNYLHE---NKII 125

Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYLF---- 186
           H D+K+ NIL   +   K+ADF  S        T T  +    +G   W+ PE +     
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 187 ----WTEKSDVYSFGVVLVEL 203
               +  K+DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.6 bits (141), Expect = 7e-10
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 24/211 (11%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           L+G G +G VYKG       +A  K   V      E+ Q    +    +H+N+    G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 75  LETKVP------LLVYEFVPNGTLFQHVRYQSSQVLKT-WKTCLRIAAETASALDYLHSL 127
           ++   P       LV EF   G++   ++      LK  W     I  E    L +LH  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQ- 129

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-IETVGWLDPEYLF 186
               +IH D+K  N+LL +N   K+ DF  S  +   D+T       I T  W+ PE + 
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184

Query: 187 WTE--------KSDVYSFGVVLVELLTGKHP 209
             E        KSD++S G+  +E+  G  P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+G FG V    L   N   A+K  K  D +L ++  +  M   R+++       +  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 71  LGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           L    +TK  L  V E++  G L  H+  QSS      +     AAE    L +LH  G 
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARF-YAAEIICGLQFLHKKG- 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---F 186
             II+ D+K  N+LLD +   K+ADF       + +  A+T     T  ++ PE L    
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIAPEILKGQK 172

Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           + E  D +SFGV+L E+L G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 63/212 (29%), Positives = 87/212 (41%), Gaps = 36/212 (16%)

Query: 16  LGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQIN---HKN 66
           LG G FG V    YK       L A+K  K  D I  +EV     + RI    N   H  
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +V +   C +T+  +  V E+   G L  H+    + V    +     AA     L YLH
Sbjct: 64  LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVF-YAACVVLGLQYLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
                 I++ D+K  N+LLD     K+ADF             +T   T E     +L P
Sbjct: 119 ENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE-----FLAP 170

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E L  TE S     D +  GV++ E+L G+ P
Sbjct: 171 EVL--TETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 16  LGEGGFGFVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +G+G FG V +    D      L  ++K  +V +  +      +  +++Q+N   +V  L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVP-L 58

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               ++   L LV  F+  G LF H+  Q        +     A E   AL+ LH     
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTA-ELLCALENLHKFN-- 113

Query: 131 PIIHGDVKSANILLDDNYTAKVA--DFASSVL-ISSHDQTATTTKEIETVGWLDPEYLF- 186
            +I+ D+K  NILLD  Y   +A  DF    L +   D+T T     E   +L PE L  
Sbjct: 114 -VIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPE---YLAPELLLG 167

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
             +T+  D ++ GV+L E+LTG  P  +     NEM R +
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP--FYDENVNEMYRKI 205

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)

Query: 10  YDKRHLLGEGGFGFVYK-GVLPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKN 66
           + +  +LG+GGFG V    V     + A KK   K + K     +  ++ +I+ ++N + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           VV  L    ETK  L LV   +  G L  H+ Y   +        +  AAE    L+ LH
Sbjct: 62  VVS-LAYAYETKDALCLVLTLMNGGDLKFHI-YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                 I++ D+K  NILLDD+   +++D   +V +    +  T    + TVG++ PE +
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVV 173

Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHP 209
               +T   D ++ G +L E++ G+ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 16  LGEGGFGFVYKGVLPDNT--LVAVKKPKMVDKILINEVFQHKM-----RIISQINHKNVV 68
           LG+GGFG V   V   NT  + A KK   +DK  + +    KM      I+ ++N   +V
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIV 56

Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
             L    E+K  L LV   +  G L  H+ Y   +     +  +  +A+    + +LHS+
Sbjct: 57  N-LAYAFESKTHLCLVMSLMNGGDLKYHI-YNVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               I++ D+K  N+LLDD    +++D   +V +       T T+   T G++ PE L  
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKE 168

Query: 187 --WTEKSDVYSFGVVLVELLTGKHP 209
             ++   D ++ G  + E++ G+ P
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR 57
           +L    ++Y+   ++G G FG V    +K       +  + K +M+ K   +  F  +  
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERD 95

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           I++  N   VV++     + +   +V E++P G L   +   +  V + W       AE 
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEV 151

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             ALD +HS+G    IH DVK  N+LLD +   K+ADF + + ++        T  + T 
Sbjct: 152 VLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTP 207

Query: 178 GWLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
            ++ PE L       ++  + D +S GV L E+L G  P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 40/271 (14%)

Query: 13  RHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           + +LG G  G VYK   L    ++AVK   +   + + +    ++ I+ + +   ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 72  GVC-LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           G   +E ++ +   EF+  G+L  + R     VL       RIA      L YL SL   
Sbjct: 66  GAFFVENRISICT-EFMDGGSLDVY-RKIPEHVLG------RIAVAVVKGLTYLWSL--- 114

Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
            I+H DVK +N+L++     K+ DF  S+ L++S    A T   + T  ++ PE +   +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTY--VGTNAYMAPERISGEQ 169

Query: 190 ---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD 246
               SDV+S G+  +EL  G+ P  Y  +  N+ + M      P+      Q+L   V +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP--YPQIQKNQGSLM------PL------QLLQCIVDE 215

Query: 247 ENEM----EEIEIVAKLASKCLRTSGTERPT 273
           +  +    +  E      ++C+R    ERP 
Sbjct: 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 48/223 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
           +Y K   +GEG +G VYKG       +VA+KK ++      V    I E+      ++ +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-----SLLKE 55

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           + H N+V +  V ++     L++EF+             S  LK +   L       + L
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFL-------------SMDLKKYLDSLPKGQYMDAEL 102

Query: 122 --DYLHSL-------GSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQTA 168
              YL+ +        S  ++H D+K  N+L+D+    K+ADF    A  + +  +    
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY---- 158

Query: 169 TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
             T E+ T+ +  PE L     ++   D++S G +  E+ T K
Sbjct: 159 --THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 30/254 (11%)

Query: 9   NYDKRHLLGEGGFGFVY---KGVLPD-NTLVAVK---KPKMVDKILINEVFQHKMRIISQ 61
           N++   +LG G +G V+   K    D   L A+K   K  +V K    E  + +  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETAS 119
           +     +  L    +T+  L L+ ++V  G +F H+ YQ     +     +R  + E   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL-YQRDNFSED---EVRFYSGEIIL 116

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           AL++LH LG   I++ D+K  NILLD      + DF  S    S ++  T +    T+ +
Sbjct: 117 ALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEY 172

Query: 180 LDPEYLFWT----EKSDVYSFGVVLVELLTGKHP------RSYVALASNEMTRMVPYFPY 229
           + PE +       +  D +S G+++ ELLTG  P      R+  +  S  + +  P FP 
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232

Query: 230 ---PIENNSLRQIL 240
              P   + L ++L
Sbjct: 233 FIGPEAQDLLHKLL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 42/216 (19%)

Query: 10  YDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKM----VDKIL-INEVFQHKMRIISQIN 63
           Y     +GEG F  V K          A+K  K     ++++  + E+    +R +S   
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREI--QALRRLS--P 56

Query: 64  HKNVVKILGVCLETKVPLL----------VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           H N+++++ V  + K   L          +YE +         R    + +K++   L  
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQL-- 109

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
                 +LD++H  G   I H D+K  NIL+ D+   K+ADF S   I S       T+ 
Sbjct: 110 ----LKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSK---PPYTEY 158

Query: 174 IETVGWLDPEYL----FWTEKSDVYSFGVVLVELLT 205
           I T  +  PE L    ++  K D+++ G V  E+L+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)

Query: 9   NYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +++    LG G FG V    +KG      +  +KK +++    +  V Q K  I+ +++H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK-SILMELSH 77

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASAL 121
             +V ++    +      + EFV  G LF H+R      + V K +       AE   A 
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY------HAELVLAF 131

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
           +YLHS     II+ D+K  N+LLD+    KV DF  +  +     T   T E     +L 
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE-----YLA 183

Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           PE +      +  D ++ GV+L E + G  P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+G FG V    L       AVK  K  D +LI++  +  M   R+++       +  
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 71  LGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           L    +TK  L  V EF+  G L  H+  Q       ++     AAE    L +LHS G 
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATF-YAAEIVCGLQFLHSKG- 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
             II+ D+K  N++LD +   K+ADF         D  A+T     T  ++ PE L    
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF--CGTPDYIAPEILQGLK 172

Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +T   D +SFGV+L E+L G+ P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 30/182 (16%)

Query: 41  KMVD-------KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF 93
           KM+D       ++L NEV      I+    H+NVV++    L  +   ++ EF+  G L 
Sbjct: 52  KMMDLRKQQRRELLFNEVV-----IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106

Query: 94  QHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA 153
             V    SQ     +    +      AL YLHS G   +IH D+KS +ILL  +   K++
Sbjct: 107 DIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159

Query: 154 DFASSVLISSHDQTATTTKEIETVG---WLDPEYL---FWTEKSDVYSFGVVLVELLTGK 207
           DF     IS         K    VG   W+ PE +    +  + D++S G++++E++ G+
Sbjct: 160 DFGFCAQISK-----DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Query: 208 HP 209
            P
Sbjct: 215 PP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 37/212 (17%)

Query: 16  LGEGGFGFVYKGVLP-DNTLVAVKK-PKMVDKIL-INEVFQHKMRIISQINHKNVVKILG 72
           +G G FG V+    P D   VA+KK P +   ++    VF+ +++++    H NV+  L 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT--WKTCLRIAAETAS----------- 119
           + L+           P+   F+ + Y  ++++++   K  +     ++            
Sbjct: 67  I-LQP----------PHIDPFEEI-YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLHS G   I+H D+K  N+L++ N   K+ DF  + +    D++   T+E+ T  +
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYY 170

Query: 180 LDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
             PE L     +T   D++S G +  ELL  +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 63/247 (25%), Positives = 110/247 (44%), Gaps = 28/247 (11%)

Query: 9   NYDKRHLLGEGGFG--FVYKGVLPDNT-----LVAVKKPKMVDKILINEVFQHKMRIISQ 61
           N++   +LG G +G  F+ + V   ++     +  +KK  +V K    E  + + +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           I     +  L    +T   L L+ +++  G LF H+   S +     +     + E   A
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L++LH LG   II+ D+K  NILLD N    + DF  S      D+         T+ ++
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYM 173

Query: 181 DPEYLFWTEKS-----DVYSFGVVLVELLTGKHP------RSYVALASNEMTRMVPYFPY 229
            P+ +   +       D +S GV++ ELLTG  P      ++  A  S  + +  P  PY
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY 231

Query: 230 PIENNSL 236
           P E ++L
Sbjct: 232 PQEMSAL 238

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 5e-09
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 22/157 (14%)

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++SQ++H ++  + GVC+     ++V EFV +G L   +R +  +V   WK  + +A + 
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126

Query: 118 ASALDYLHSLGSPPIIHGDVKSANIL-----LDDNYTA--KVADFASSVLISSHDQTATT 170
           ASAL YL       ++HG+V + NIL     L +  +   K++D   S    S ++    
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE---- 179

Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVEL 203
              +E + W+ PE +      +  +D +SFG  L+E+
Sbjct: 180 --RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.6 bits (135), Expect = 6e-09
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 40/224 (17%)

Query: 1   SELVKATKNY--DKRHLLGEGGFGFVYKGVL---PDNTLVAVK--KPKMVDKILINEVFQ 53
           SELV+  KN    K+  L +G FG V   VL   P   L   K  K K  + I   E   
Sbjct: 7   SELVQFLKNCEIVKKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAI---EPMV 61

Query: 54  HK-MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
           H+ M+     ++ N +K+       K  +L+ +++ +G LF  ++ +    L       +
Sbjct: 62  HQLMK-----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSE-AEVKK 113

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLI---SSHDQTA 168
           I  +   AL+ LH      IIH D+K  N+L D       + D+    +I   S +D T 
Sbjct: 114 IIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT- 169

Query: 169 TTTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
                   + +  PE +    +    D ++ GV+  ELLTGKHP
Sbjct: 170 --------LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 27/225 (12%)

Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL-INEVFQHKMRIIS 60
           L   T  ++    +G+G +G VYK     D +L AVK   ++D I  ++E  + +  I+ 
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEIEAEYNILQ 73

Query: 61  QI-NHKNVVKILGVCLETKVPL-----LVYEFVPNGTLFQHVR--YQSSQVLKTWKTCLR 112
            + NH NVVK  G+  +    +     LV E    G++ + V+      Q L        
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE----AM 129

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
           I+     AL  L  L +  IIH DVK  NILL      K+ DF  S  ++S      T+ 
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 173 EIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHP 209
            + T  W+ PE +         +  + DV+S G+  +EL  G  P
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.3 bits (133), Expect = 7e-09
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 16/204 (7%)

Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           +LG G FG + +G L         VA+   +          F  +   + Q +H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV       ++V E++ NG L   +R    Q+       + +    AS + YL  +G  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL--VAGQLMGMLPGLASGMKYLSEMG-- 127

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG-WLDPE---YLF 186
             +H  + +  +L++ +   K++ F    L     +   TT   ++   W  PE   Y  
Sbjct: 128 -YVHKGLAAHKVLVNSDLVCKISGFRR--LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           ++  SDV+SFG+V+ E+++ G+ P
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 8e-09
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 46/223 (20%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINE-VFQHKMRIIS---QIN 63
            Y+K   +GEG +G V+K    +   +VA+K+ ++ D    +E V    +R I    ++ 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELK 57

Query: 64  HKNVVKILGVCLETKVPLLVYEFVP----------NGTLFQH-VRYQSSQVLKTWKTCLR 112
           HKN+V++  V    K   LV+E+            NG +    V+    Q+LK       
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK------- 110

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATT 170
                   L + HS     ++H D+K  N+L++ N   K+ADF  A +  I     +A  
Sbjct: 111 -------GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA-- 158

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP 209
             E+ T+ +  P+ LF    ++   D++S G +  EL     P
Sbjct: 159 --EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 10  YDKRHLLGEGGFGFVYK-GVLPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKN 66
           + +  +LG+GGFG V    V     + A K+   K + K     +  ++ +I+ ++N + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           VV  L    ETK  L LV   +  G L  H+ Y         +  L  AAE    L+ LH
Sbjct: 62  VVN-LAYAYETKDALCLVLTIMNGGDLKFHI-YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                  ++ D+K  NILLDD    +++D   +V I   +   +    + TVG++ PE L
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVL 173

Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHP 209
               +T   D +  G ++ E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 8e-09
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 25/207 (12%)

Query: 16  LGEGGFGFVYKGVLPDNTLVA---VKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +G G FG V    +  +T VA   VK+ K          F  +      + H N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLKTWKTCLRIAAETASALDYLHSL 127
            C+E    LLV+E+   G L  ++       ++SQ+L       R+A E A+ + ++H  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ----RMACEIAAGVTHMHKH 118

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
                +H D+   N  L  + T KV D+         D   T   +   + WL PE +  
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 187 ---------WTEKSDVYSFGVVLVELL 204
                     T+ S+V++ GV L EL 
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 51/223 (22%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQI 62
           Y K   +GEG +G VYK        +VA+KK ++      V    I E+      ++ ++
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI-----SLLKEL 55

Query: 63  NHKNVVKILGVCLETKVPLLVYEF-----------VPNGTL-FQHVRYQSSQVLKTWKTC 110
           NH N+V++L V        LV+EF            P   L    ++    Q+L+     
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ----- 110

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTA 168
                     + Y H   S  ++H D+K  N+L+D     K+ADF  A +  +       
Sbjct: 111 ---------GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP----VR 154

Query: 169 TTTKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T T E+ T+ +  PE L     ++   D++S G +  E++  +
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 45/217 (20%)

Query: 16  LGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKM-RIISQINHKNVVKI 70
           +G G +G VYK   P +     L +V+     D + ++ V +  + + +   +H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 71  LGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW-----------KTCLRI 113
           + VC       ETKV L+          F+HV     Q L+T+           +T   +
Sbjct: 68  MDVCATSRTDRETKVTLV----------FEHV----DQDLRTYLDKVPPPGLPAETIKDL 113

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
             +    LD+LH+     I+H D+K  NIL+      K+ADF  + + S        T  
Sbjct: 114 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPV 167

Query: 174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 30/233 (12%)

Query: 53  QHKMRIISQINHKNVVKILGVCL-ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL 111
           + + +++SQ+ H N+V        E  +  +V  F   G L+  ++ Q  ++L      +
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVV 105

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
               + A AL YLH      I+H D+K+ N+ L      KV D   + ++ +    A+T 
Sbjct: 106 EWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL 162

Query: 172 KEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
             I T  ++ PE LF    +  KSDV++ G  + E+ T KH     A  + +M  +V   
Sbjct: 163 --IGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKH-----AFNAKDMNSLV--- 211

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
            Y I    L  +       +   E  E++A + SK       +RP+++ +  Q
Sbjct: 212 -YRIIEGKLPPM-----PKDYSPELGELIATMLSK----RPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 57/226 (25%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQ---------HKMRII 59
           Y     +G G +G V           VA+KK        ++  FQ          ++R++
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK--------LSRPFQSAIHAKRTYRELRLL 68

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHV------------RYQSSQVLK 105
             ++H+NV+ +L V            F P  +L  FQ V                 Q L 
Sbjct: 69  KHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS 116

Query: 106 TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD 165
                  +  +    L Y+HS G   IIH D+K +NI ++++   K+ DF  +       
Sbjct: 117 DDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171

Query: 166 QTATTTKEIETVGWLDPEYLFW----TEKSDVYSFGVVLVELLTGK 207
                T  + T  +  PE +       +  D++S G ++ ELLTGK
Sbjct: 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 52/230 (22%), Positives = 100/230 (43%), Gaps = 33/230 (14%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           YD   L+G+GG G VY    P  +  VA+KK +  + +  L+ + F  + +I + + H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVR--YQSSQVLK------TWKTCLRIAAETA 118
           +V +  +C +         ++   TL   ++  +Q   + K      +    L I  +  
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI----------------S 162
           + ++Y+HS G   ++H D+K  NILL       + D+ +++                   
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 163 SHDQTATTTKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGKHP 209
            +       K + T  ++ PE L     +E +D+Y+ GV+L ++LT   P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 13  RH--LLGEGGFGFVYK-GVLPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKNV 67
           RH  +LG+GGFG V    V     + A KK   K + K     +  ++ RI+ ++N + V
Sbjct: 3   RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           V  L    ETK  L LV   +  G L  H+ Y         +  +  AAE    L+ L  
Sbjct: 63  VS-LAYAYETKDALCLVLTIMNGGDLKFHI-YNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL- 185
                I++ D+K  NILLDD    +++D   +V I    +  T    + TVG++ PE + 
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVIN 174

Query: 186 --FWTEKSDVYSFGVVLVELLTGKHP 209
              +T   D +  G ++ E++ G+ P
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           ++G G +G VYKG       +A  K   V +    E+      +    +H+N+    G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 75  LETKVP------LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR-IAAETASALDYLHSL 127
           ++   P       LV EF   G++   V+      LK  +  +  I  E    L +LH+ 
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREILRGLAHLHA- 139

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-IETVGWLDPEYLF 186
               +IH D+K  N+LL +N   K+ DF  S  +   D+T       I T  W+ PE + 
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 194

Query: 187 WTE--------KSDVYSFGVVLVELLTGKHP 209
             E        +SD++S G+  +E+  G  P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKIL-----INEVFQHKMRIISQINHKNVVK 69
           +G+GG+G V+     D   +VA+K+  M   +L     +  V   +  I++    + +VK
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKR--MKKSLLFKLNEVRHVLTER-DILTTTKSEWLVK 65

Query: 70  ILGVCLETKVPLLVYEFVPNG---TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +L    + +   L  E+VP G   TL  ++   S    + +       AE   A+D LH 
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY------MAEMFEAVDALHE 119

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPE 183
           LG    IH D+K  N L+D +   K+ DF  S            T     VG   ++ PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLS--------KGIVTYANSVVGSPDYMAPE 168

Query: 184 YLFWTEKS---DVYSFGVVLVELLTGKHPRS 211
            L         D +S G +L E L G  P S
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 66/299 (22%), Positives = 116/299 (38%), Gaps = 68/299 (22%)

Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI---- 70
           LG G  G V+  V  D    VAVKK  + D   +    + +++II +++H N+VK+    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 71  ----------LGVCLETKVPLLVYEFVP--------NGTLF-QHVRYQSSQVLKTWKTCL 111
                     +G   E     +V E++          G L  +H R    Q+L+      
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATT 170
                    L Y+HS     ++H D+K AN+ ++ ++   K+ DF  + ++  H      
Sbjct: 126 --------GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 171 TKEIETVGWL-DPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
             E     W   P  L     +T+  D+++ G +  E+LTGK                 P
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-----------------P 217

Query: 226 YFPYPIENNSLRQIL-NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
            F    E   ++ IL +  V  E   +  E++  + S      G  R  +R +   ++ 
Sbjct: 218 LFAGAHELEQMQLILESVPVVREE--DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 24/165 (14%)

Query: 55  KMRIISQINHKNVVKILG-------VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
           ++ I+  I+H+ ++ ++        VC+     +  Y+      LF +V       L+  
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCM----VMPKYKC----DLFTYVDRSGPLPLEQA 187

Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
            T  R   E   AL YLH  G   IIH DVK+ NI LD+   A + DF ++  + +H  T
Sbjct: 188 ITIQRRLLE---ALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
                   T+    PE L    +  K+D++S G+VL E+      
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 30/219 (13%)

Query: 9   NYDKRHLLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQ 61
           N++   +LG G +G V+     G      L A+K   K  +V K    E  + + +++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRI-AA 115
           +     +  L    +T   L L+ ++V  G LF H+     +  S+V        R+  A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV--------RVYIA 112

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           E   ALD+LH LG   II+ D+K  NILLD      + DF  S    + ++         
Sbjct: 113 EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-EEEERAYSFCG 168

Query: 176 TVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           T+ ++ PE +           D +S GV+  ELLTG  P
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 29/209 (13%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG V     KG    + L A+K  K  D I+ ++  +  M   R+++       
Sbjct: 7   VLGKGSFGKVMLAERKG---TDELYAIKILKK-DVIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--AAETASALDYL 124
           +  L  C +T   L  V E+V  G L  H+     Q +  +K    +  AAE A  L +L
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPE 183
           HS G   II+ D+K  N++LD     K+ADF    +   +     TT+    T  ++ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIAPE 171

Query: 184 ---YLFWTEKSDVYSFGVVLVELLTGKHP 209
              Y  + +  D ++FGV+L E+L G+ P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 11/120 (9%)

Query: 132 IIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL---FW 187
           I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE L    +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERLQGTHY 175

Query: 188 TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE 247
           T +SD++S G+ LVE+  G++P       + E+  M        E     + ++    D 
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYP--IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 52/187 (27%), Positives = 81/187 (43%), Gaps = 42/187 (22%)

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           LR +++ A  +D+L    S   IH DV + N+LL D   AK+ DF  +  I +       
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASN-------- 218
                 V W+ PE +F   +T +SDV+S+G++L E+ + GK P   + + S         
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331

Query: 219 -EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            +M+R  P F  P                     EI  + K+   C     TERPT  Q+
Sbjct: 332 YQMSR--PDFAPP---------------------EIYSIMKM---CWNLEPTERPTFSQI 365

Query: 278 SEQLDSL 284
           S+ +   
Sbjct: 366 SQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +H + S  +IH D+KSANILL  N   K+ DF  S + +     AT + ++       P 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-----ATVSDDVGRTFCGTPY 210

Query: 184 YL---FW-----TEKSDVYSFGVVLVELLTGKHP 209
           Y+    W     ++K+D++S GV+L ELLT K P
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 13  RH--LLGEGGFGFVYK-GVLPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKNV 67
           RH  +LG+GGFG V    V     + A KK   K + K     +  ++ +I+ ++N + V
Sbjct: 3   RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           V  L    ETK  L LV   +  G L  H+ Y         +  +  AAE    L+ LH 
Sbjct: 63  VS-LAYAYETKDALCLVLTLMNGGDLKFHI-YNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL- 185
                I++ D+K  NILLDD    +++D   +V I   +   T    + TVG++ PE + 
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK 174

Query: 186 --FWTEKSDVYSFGVVLVELLTGKHP 209
              +T   D +  G ++ E++ GK P
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 28/241 (11%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKM--RIISQINHKNVV 68
           LG+G FG VY  ++ D   VA ++ K++ +I +     NE  Q     +++S+++H  +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVR--YQSSQVLKTWKTCLRIAAETASALDYLHS 126
           K     LE     ++ E+     L   +     + + L   + C     +    + Y+H 
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC-EWFIQLLLGVHYMHQ 124

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL 185
                I+H D+K+ NI L +N   K+ DF  S +L+ S D   T T    T  ++ PE L
Sbjct: 125 ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFTG---TPYYMSPEAL 177

Query: 186 F---WTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFP--YPIENNSLR 237
               +  KSD++S G +L E+    H    ++++++    +    P  P  Y  + NS+ 
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237

Query: 238 Q 238
           Q
Sbjct: 238 Q 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 29/209 (13%)

Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G+G FG V       D +  AVK   K  ++ K   N +   +  ++  + H  +V  
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG- 60

Query: 71  LGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR------IAAETASALDY 123
           L    +T   L  V ++V  G LF H++ +          C         AAE ASA+ Y
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGY 111

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHSL    II+ D+K  NILLD      + DF   +     +   TT+    T  +L PE
Sbjct: 112 LHSLN---IIYRDLKPENILLDSQGHVVLTDFG--LCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 184 YLF---WTEKSDVYSFGVVLVELLTGKHP 209
            L    +    D +  G VL E+L G  P
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           ++G+G FG V       D    AVK   +  KI++N   Q  +     +  KNV     V
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 74  CLE-----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            L      T+    V +FV  G LF H++ + S      +     AAE ASAL YLHS+ 
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF---YAAEIASALGYLHSIN 116

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              I++ D+K  NILLD      + DF   +      Q+ TTT    T  +L PE +   
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFG--LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 187 -WTEKSDVYSFGVVLVELLTGKHP 209
            +    D +  G VL E+L G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG V     KG    + L A+K  K  D ++ ++  +  M   R+++       
Sbjct: 7   VLGKGSFGKVMLAERKGT---DELYAIKILKK-DVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKT-CLRIAAETASALDYLH 125
           +  L  C +T   L  V E+V  G L     YQ  QV +  +   +  AAE A  L +LH
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLM----YQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPE- 183
           S G   II+ D+K  N++LD     K+ADF    +   +     TTK    T  ++ PE 
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 184 --YLFWTEKSDVYSFGVVLVELLTGKHP 209
             Y  + +  D ++FGV+L E+L G+ P
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 36/211 (17%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---------RIISQINHK 65
           +G G +G V      + N  VA+KK        I   F +++         +++  ++H+
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKK--------IANAFDNRIDAKRTLREIKLLRHLDHE 64

Query: 66  NVVKILGVCLET-----KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           NV+ I  +             +VYE + +  L Q +R  SSQ L +   C     +    
Sbjct: 65  NVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIR--SSQTL-SDDHCQYFLYQLLRG 120

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L Y+HS     ++H D+K +N+LL+ N   K+ DF  +   S      T    + T  + 
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWYR 175

Query: 181 DPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            PE L     +T   DV+S G +  ELL  K
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 13/131 (9%)

Query: 83  VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANI 142
           V E+   G LF H+  +  +V    +      AE  SAL YLHS     +++ D+K  N+
Sbjct: 73  VMEYANGGELFFHLSRE--RVFSEDRARF-YGAEIVSALGYLHSCD---VVYRDLKLENL 126

Query: 143 LLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPEYLF---WTEKSDVYSFGV 198
           +LD +   K+ DF    L         T K    T  +L PE L    +    D +  GV
Sbjct: 127 MLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183

Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 184 VMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 45/238 (18%)

Query: 8   KNYDKRHLLGEGGFGFVY--KGVLPDNTLVAVKKPKMVDKILINEVFQHKMR---IISQI 62
            +++   ++G G FG V+  +       + A+K  +  D I  N++  H      I++  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQ-VYAMKVLRKSDMIKRNQI-AHVRAERDILADA 58

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQH-VRYQSSQVLKTWKTCLRIAAETASAL 121
           +   +VK+     + +   LV E++P G L    +R     V    +T     AE   AL
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VF-PEETARFYIAELVLAL 114

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV-LISSHDQTATTTKEIE----- 175
           D +H LG    IH D+K  NIL+D +   K+ADF     +  + D+              
Sbjct: 115 DSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 176 ---------------------TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
                                T  ++ PE L    +  + D +S GV+L E+L G  P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 23/205 (11%)

Query: 16  LGEGGFGFVYKGVLP-DNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +G+G FG V       D    AVK   K  ++ K     +   +  ++  + H  +V  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHV---RYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               +T   L  V ++V  G LF H+   R       + +      AAE ASAL YLHSL
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY------AAEIASALGYLHSL 115

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               II+ D+K  NILLD      + DF   +     + + TT+    T  +L PE L  
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFG--LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 187 --WTEKSDVYSFGVVLVELLTGKHP 209
             +    D +  G VL E+L G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 20/236 (8%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G+G FG V       +    AVK   K  ++ K     +   +  ++  + H  +V +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
                       V +++  G LF H++ +   +    +     AAE ASAL YLHSL   
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHSLN-- 116

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---W 187
            I++ D+K  NILLD      + DF   +   + +   TT+    T  +L PE L    +
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFG--LCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 188 TEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
               D +  G VL E+L G  P   R+   +  N + +  P    P   NS R +L
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLL 227

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 66/210 (31%), Positives = 90/210 (42%), Gaps = 32/210 (15%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKNVVK--- 69
           LLG+G FG V         LV  K        KIL  EV   K  +   +    V+K   
Sbjct: 2   LLGKGTFGKV--------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR 53

Query: 70  -----ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
                 L    +TK  L  V E+V  G LF H+  +  +V    +T     AE  SALDY
Sbjct: 54  HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRF-YGAEIVSALDY 110

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDP 182
           LHS     I++ D+K  N++LD +   K+ DF    L       A T K    T  +L P
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFG---LCKEGITDAATMKTFCGTPEYLAP 164

Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           E L    +    D +  GVV+ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +Y+K   LGEG +  VYKG    N  LVA+K  ++ ++         +  ++  + H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 68  VKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           V +  +    +   LV+E+V           P G   ++V+    Q+L+           
Sbjct: 66  VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR----------- 114

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEI 174
               L Y+H      I+H D+K  N+L+ D    K+ADF  A +  + SH    T + E+
Sbjct: 115 ---GLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH----TYSNEV 164

Query: 175 ETVGWLDPEYLFW-TEKS---DVYSFGVVLVELLTG 206
            T+ +  P+ L   TE S   D++  G + VE++ G
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG V     KG    + L A+K  K  D ++ ++  +  M   R+++  +    
Sbjct: 7   VLGKGSFGKVMLAERKGT---DELYAIKILKK-DVVIQDDDVECTMVEKRVLALQDKPPF 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWK-TCLRIAAETASALDYLH 125
           +  L  C +T   L  V E+V  G L  H++    QV K  +   +  AAE +  L +LH
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPE- 183
             G   II+ D+K  N++LD     K+ADF    +   H     TT+    T  ++ PE 
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTFCGTPDYIAPEI 172

Query: 184 --YLFWTEKSDVYSFGVVLVELLTGKHP 209
             Y  + +  D +++GV+L E+L G+ P
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 38/234 (16%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK----- 69
           +G+G FG VY+    D   + A+K        L  +    K  +   I  +N++      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV-------LSKKEIVAKKEVAHTIGERNILVRTLLD 53

Query: 70  ----ILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
               I+G+    +      LV +++  G LF H++ +        K  +   AE   AL+
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI---AELVLALE 110

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           +LH      I++ D+K  NILLD      + DF  S    + +   TT     T  +L P
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAP 165

Query: 183 EYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY----FP 228
           E L     +T+  D +S GV++ E+  G  P  + A  + +M R + +    FP
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP--FYAEDTQQMYRNIAFGKVRFP 217

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 23/165 (13%)

Query: 15  LLGEGGFGFVYK-----GVLPDNTLVA----VKKPKMVDKILINEVFQHKMRI-----IS 60
           L+G GGFG VY+         +N  VA    ++   +V + L+        +I     I 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR-IAAETAS 119
            I+H  + K  G C   K   + Y F+    L ++ +    ++    K  ++ I  +  +
Sbjct: 79  NIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLT 137

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH 164
            L+Y+H  G   I HGD+K  NI++D N    + D+     I+SH
Sbjct: 138 TLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYG----IASH 175

Length = 294

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 53/216 (24%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL------INEVFQHKMRIISQ 61
            Y+K + + EG +G VY+        +VA+KK KM  +        + E+      I+ +
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-----NILLK 60

Query: 62  INHKNVVKILGVCLETKVP--LLVYEFVPNG--TLFQHVR--YQSSQVLKTWKTCLRIAA 115
           + H N+V +  V + + +    +V E+V +   +L + ++  +  S+V    K  +    
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV----KCLML--- 113

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +  S + +LH      I+H D+K++N+LL++    K+ DF  +    S       T+ + 
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS--PLKPYTQLVV 168

Query: 176 TVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L     ++   D++S G +  ELLT K
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 17  GEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIIS---QINHKNVVKI 70
           G G +G VYK       D    A+KK K  DK     + Q   R I+   ++ H+NVV +
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 71  LGVCLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY----- 123
           + V LE   K   L++++  +  L+Q +++              I      +L +     
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRV------SIPPSMVKSLLWQILNG 120

Query: 124 LHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQT-ATTTKEIETVG 178
           +H L S  ++H D+K ANIL+     +    K+ D   + L ++  +  A     + T+ 
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 179 WLDPEYLF----WTEKSDVYSFGVVLVELLT 205
           +  PE L     +T+  D+++ G +  ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 12/116 (10%)

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
           AAE    L+++H+     +++ D+K ANILLD++   +++D   +   S     A+    
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 174 IETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMV 224
           + T G++ PE L     +   +D +S G +L +LL G  P R +     +E+ RM 
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQI 62
           Y+K   +GEG +G VYK      N  +A+KK ++      V    I E+      ++ ++
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI-----SLLKEM 58

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N+V++  V    K   LV+E++ +  L +H+   S    K  +       +    + 
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMD-SSPDFAKNPRLIKTYLYQILRGIA 116

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTA-KVADF--ASSVLISSHDQTATTTKEIETVGW 179
           Y H   S  ++H D+K  N+L+D    A K+ADF  A +  I       T T E+ T+ +
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP----VRTFTHEVVTLWY 169

Query: 180 LDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
             PE L     ++   D++S G +  E++  K
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 22/161 (13%)

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           I+  +NH NVVK   +        ++ EF+  G+L +       Q L        +A + 
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLAD------VARQI 177

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIET 176
            S + YLH      I+H D+K +N+L++     K+ADF  S +L  + D   ++   + T
Sbjct: 178 LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231

Query: 177 VGWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
           + ++ PE +        +     D++S GV ++E   G+ P
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 62/258 (24%), Positives = 128/258 (49%), Gaps = 34/258 (13%)

Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQIN 63
             K+Y   +++G G FG VY+ +  D +  VA+K      K+L +  ++++ + I+  +N
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK------KVLQDPQYKNRELLIMKNLN 117

Query: 64  HKNVVKILGV----CL---ETKVPL-LVYEFVPNGTLFQHVRYQS--SQVLKTWKTCLRI 113
           H N++ +       C    E  + L +V EF+P  T+ +++++ +  +  L  +   L  
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL-Y 175

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLISSHDQTATTTK 172
           + +   AL Y+H   S  I H D+K  N+L+D N +T K+ DF S+  + +  ++ +   
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-- 230

Query: 173 EIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
            I +  +  PE +     +T   D++S G ++ E++ G +P      + +++ R++    
Sbjct: 231 -ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVLG 288

Query: 229 YPIENNSLRQILNFQVAD 246
            P E+    + +N   AD
Sbjct: 289 TPTEDQ--LKEMNPNYAD 304

Length = 440

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 16/151 (10%)

Query: 74  CLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYLHSLGSPP 131
           C +T+  L  V EFV  G L  H++ Q     K  +   R  +AE + AL++LH  G   
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG--- 116

Query: 132 IIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
           II+ D+K  N+LLD     K+ D+      I   D T+T      T  ++ PE L   + 
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG---TPNYIAPEILRGEDY 173

Query: 190 --KSDVYSFGVVLVELLTGKHPRSYVALASN 218
               D ++ GV++ E++ G+ P   V ++ N
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 49/152 (32%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL-RIAAETASALDYL 124
           N+V +    +      LV +    G L+ H+    S+ L   + C+ R AAE   ALD L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDAL 101

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA--SSVLISSHDQTATTTKEIETVGWLDP 182
           H  G   I+  D+   NILLDD    ++  F+  S V  S   +          VG +  
Sbjct: 102 HREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISE 158

Query: 183 EYLFWTEKSDVYSFGVVLVELLTGK-----HP 209
           E    TE  D +S G +L ELLTGK     HP
Sbjct: 159 E----TEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 35/220 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
            Y+K   +GEG +G VYK        LVA+KK ++      +    + E+   +M  +S+
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQM--LSE 59

Query: 62  INHKNVVKILGV-CLETKVP----LLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAA 115
             +  +V++L V  +E K       LV+E++ +    F     +        KT      
Sbjct: 60  SIY--IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADF----ASSVLISSHDQTATT 170
           +    + + H  G   ++H D+K  N+L+D      K+AD     A S+ + S+      
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY------ 168

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTG 206
           T EI T+ +  PE L     ++   D++S G +  E+   
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 12/103 (11%)

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   A+D +H LG    +H D+K  N+LLD N   ++ADF S + + + D T  +   +
Sbjct: 109 AEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAV 164

Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 16  LGEGGFGFVYKGVL--PDNTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG+G +G VYK VL  P    +A+K+ ++ +D+   N++   ++ I+ +     +V   G
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDFYG 66

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
                    +  E++  G+L +      +          RI       L +L       I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 133 IHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE-------- 183
           IH DVK  N+L++ N   K+ DF  S  L++S  +T      I    ++ PE        
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-----NIGCQSYMAPERIKSGGPN 179

Query: 184 -YLFWTEKSDVYSFGVVLVELLTGKHP 209
               +T +SDV+S G+ ++E+  G++P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 19/188 (10%)

Query: 41  KMVDKILINE-----VFQHKMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQ 94
           K+V K L+N+       Q +  +  Q ++   +  L  C +T+  L  V E+V  G L  
Sbjct: 26  KVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 85

Query: 95  HVRYQSSQVLKTWKTCLRI-AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA 153
           H++ Q     K  +   R  +AE + AL+YLH  G   II+ D+K  N+LLD     K+ 
Sbjct: 86  HMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 138

Query: 154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPR 210
           D+   +         TT+    T  ++ PE L   +     D ++ GV++ E++ G+ P 
Sbjct: 139 DYG--MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Query: 211 SYVALASN 218
             V  + N
Sbjct: 197 DIVGSSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 3/82 (3%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +N   K+ DF  +  I               + W+ PE +F
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248

Query: 187 ---WTEKSDVYSFGVVLVELLT 205
              +T +SDV+SFGV+L E+ +
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 30/209 (14%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKM--VDKILINEVFQHKMRIISQINHKNVVK--- 69
           LLG+G FG V         LV  K        KIL  EV   K  +   +    V++   
Sbjct: 2   LLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 53

Query: 70  -----ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
                 L    +T   L  V E+   G LF H+   S + + T +      AE  SAL+Y
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEY 110

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS     +++ D+K  N++LD +   K+ DF   +        AT      T  +L PE
Sbjct: 111 LHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKTFCGTPEYLAPE 165

Query: 184 YLF---WTEKSDVYSFGVVLVELLTGKHP 209
            L    +    D +  GVV+ E++ G+ P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 119

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 172

Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 57/224 (25%)

Query: 10  YDKRHLLGEGGFGFVYKGV--LPDNTLVAVKKPKMVDK-----ILINEVFQHKMRIISQI 62
           Y K   LGEG +  VYKG   L    LVA+K+ ++  +       I E       ++  +
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAPFTAIREA-----SLLKDL 60

Query: 63  NHKNVVKILGVCLETKVPL-LVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
            H N+V  L   + TK  L LV+E++             G    +VR    Q+L+     
Sbjct: 61  KHANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR----- 114

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQ 166
                     L Y H      ++H D+K  N+L+ +    K+ADF    A SV       
Sbjct: 115 ---------GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV------P 156

Query: 167 TATTTKEIETVGWLDPEYLFW-TEKS---DVYSFGVVLVELLTG 206
           + T + E+ T+ +  P+ L   TE S   D++  G +  E+ TG
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 6/97 (6%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +N   K+ DF  +  I               + W+ PE +F
Sbjct: 190 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249

Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE 219
              +T +SDV+SFGV+L E+ + G  P  Y  +  NE
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASP--YPGVQINE 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKIL 71
           +LG+G FG V    L     V   K    D IL ++     M   RI++       +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 72  GVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYLHSLGS 129
             C +TK  L  V E+V  G L     +Q  +  K  +   R  AAE   AL +LH  G 
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLM----FQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +I+ D+K  NILLD     K+ADF   +         TTT    T  ++ PE L   E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFG--MCKEGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 190 ---KSDVYSFGVVLVELLTGKHP 209
                D ++ GV++ E++ G+ P
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 16  LGEGGFGFVYKGVL-PDNTLVAVKK--PKMVDKILINEVFQHKM---RIISQINHKNVVK 69
           LG+GGFG V    +     L A KK   K + K    + ++  M   RI+++++ + +V 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK---RKGYEGAMVEKRILAKVHSRFIVS 57

Query: 70  ILGVCLETKVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETASALDYLHS 126
            L    +TK  L LV   +  G L  H+    + +      + C    A+  S L++LH 
Sbjct: 58  -LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-YTAQIISGLEHLHQ 115

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                II+ D+K  N+LLD++   +++D   +V +   D  + T     T G++ PE L 
Sbjct: 116 ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGTPGFMAPELLQ 170

Query: 187 WTE---KSDVYSFGVVLVELLTGKHP 209
             E     D ++ GV L E++  + P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD---NTLVAVKKPKMVDKILINE----VFQHKMRIIS 60
           K++D + L+G G FG V   V+ +     + A+K   M   +L+ +     F+ +  I+S
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKV--MKKSVLLAQETVSFFEEERDILS 56

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETAS 119
             N   + ++     +     LV E+ P G L   + RY+        +  L   AE   
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL---AELVL 113

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           A+  +H +G    +H D+K  N+L+D     K+ADF S+  +++ ++   +   + T  +
Sbjct: 114 AIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDY 169

Query: 180 LDPEYL---------FWTEKSDVYSFGVVLVELLTGKHP 209
           + PE L          +  + D +S GV+  E++ G+ P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 19/159 (11%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL      K+ DF  +  I +             V W+ PE +F
Sbjct: 230 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289

Query: 187 ---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
              +T +SDV+S+G++L E+ +         L S+      PY   P+++   + I    
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS---------LGSS------PYPGMPVDSKFYKMIKEGY 334

Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
                E    E+   + S C      +RPT +Q+ + ++
Sbjct: 335 RMLSPECAPSEMYDIMKS-CWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 13/132 (9%)

Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
           L+ E++  G LF H+  +   +  T   C  ++ E + AL++LH  G   II+ D+K  N
Sbjct: 77  LILEYLSGGELFMHLEREGIFMEDT--ACFYLS-EISLALEHLHQQG---IIYRDLKPEN 130

Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPEYLFWT---EKSDVYSFG 197
           ILLD     K+ DF    L        T T     T+ ++ PE L  +   +  D +S G
Sbjct: 131 ILLDAQGHVKLTDFG---LCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLG 187

Query: 198 VVLVELLTGKHP 209
            ++ ++LTG  P
Sbjct: 188 ALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 4/87 (4%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +N   K+ DF  +  I               + W+ PE +F
Sbjct: 195 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 254

Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHP 209
              +T +SDV+SFGV+L E+ + G  P
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 46/221 (20%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQIN 63
           T  Y     +G G FG V           VA+KK        +L    ++ +++++  + 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPN--GTLF-----------QHVRYQSSQVLKTWKTC 110
           H+N++ +  + +    PL    FV    GT             Q ++Y   Q+L+     
Sbjct: 68  HENIISLSDIFIS---PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR----- 119

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     L Y+HS G   ++H D+K +NIL+++N   K+ DF  + +     Q    
Sbjct: 120 ---------GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162

Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           T  + T  +  PE +     +  + D++S G +  E+L GK
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 33/215 (15%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKIL-----INEVFQHKMRIISQI-NHKNVVK 69
           +G+G +G V+K       L      K   KIL     I+E  + +  I+  + +H NVVK
Sbjct: 26  IGKGTYGKVFK------VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79

Query: 70  ILGVCLETKVP-----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTC--LRIAAETASALD 122
             G+  +  V       LV E    G++   V+      LK  +      IA     AL 
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVK----GFLKRGERMEEPIIAYILHEALM 135

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            L  L     IH DVK  NILL      K+ DF  S  ++S      T+  + T  W+ P
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193

Query: 183 EYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
           E +         +  + DV+S G+  +EL  G  P
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 59/229 (25%)

Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQ---HKMR---- 57
           K Y     +G G  G V   Y  V   N  VA+KK        ++  FQ   H  R    
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQN--VAIKK--------LSRPFQNVTHAKRAYRE 65

Query: 58  --IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTC--- 110
             ++  +NHKN++ +L V            F P  +L  FQ V Y   + L     C   
Sbjct: 66  LVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDV-YLVME-LMDANLCQVI 111

Query: 111 -LRIAAETASALDY--------LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
            + +  E  S L Y        LHS G   IIH D+K +NI++  + T K+ DF    L 
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LA 165

Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +   +   T  + T  +  PE +    + E  D++S G ++ E++ G 
Sbjct: 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   A+D +H L     +H D+K  NIL+D N   ++ADF S + +   D T  ++  +
Sbjct: 109 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAV 164

Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.9 bits (111), Expect = 5e-06
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 50/220 (22%)

Query: 16  LGEGGFGFVYKGVLPDN--TLVAVKKPKMVDK------ILINEVFQHKMRIISQINHKNV 67
           +GEG +G V+K     N    VA+K+ ++           I EV    +R +    H NV
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--AVLRHLETFEHPNV 66

Query: 68  VKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW-----------KTC 110
           V++  VC       ETK+ L+          F+HV     Q L T+           +T 
Sbjct: 67  VRLFDVCTVSRTDRETKLTLV----------FEHV----DQDLTTYLDKVPEPGVPTETI 112

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
             +  +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + S        
Sbjct: 113 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 166

Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           T  + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 46/212 (21%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQI 62
           + Y     +G G +G V   +       VA+KK   + +   +E+F  +    + ++  +
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK---LSRPFQSEIFAKRAYRELTLLKHM 71

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI---AAETAS 119
            H+NV+ +L V           +F     +  +++    +++    +  ++     +   
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFY---LVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC 128

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L Y+HS G   IIH D+K  N+ ++++   K+ DF    L    D  A  T  + T  +
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG---LARHAD--AEMTGYVVTRWY 180

Query: 180 LDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
             PE    ++ + +  D++S G ++ E+LTGK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   A+  +H L     +H D+K  N+LLD N   ++ADF  S L  + D T  ++  +
Sbjct: 109 AEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAV 164

Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 16  LGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           LG G  G V K    P   ++A K   +  K  I      +++++ + N   +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL-----RIAAETASALDYLHSLGS 129
                  +  E +  G+L         QVLK  K        +++      L YL     
Sbjct: 73  YSDGEISICMEHMDGGSL--------DQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--K 122

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
             I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE L   
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERLQGT 177

Query: 186 FWTEKSDVYSFGVVLVELLTGKHP 209
            ++ +SD++S G+ LVEL  G++P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILG 72
           ++GEG +G V K    +   +VA+KK K  ++   + E    +++++  +  +N+V++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 73  VCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
                    LV+E+V           PNG   + VR    Q++K              A+
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK--------------AI 113

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            + H      I+H D+K  N+L+  N   K+ DF  +  +S     A  T+ + T  +  
Sbjct: 114 HWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRS 169

Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGK 207
           PE L    + +  D++S G +L EL  G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G +  V    L  N     +  VKK  + D   I+ V Q +  +  Q +    +  
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWV-QTEKHVFEQASSNPFLVG 60

Query: 71  LGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYLHSLG 128
           L  C +T   L LV E+V  G L  H++ Q     K  +   R  AAE   AL++LH  G
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG 116

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLFW 187
              II+ D+K  N+LLD +   K+ D+      +   D T+T      T  ++ PE L  
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG---TPNYIAPEILRG 170

Query: 188 TE---KSDVYSFGVVLVELLTGKHP 209
            E     D ++ GV++ E++ G+ P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 38/215 (17%)

Query: 16  LGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI------ 62
           LG+G +G V          + T VA+KK        I  VF  K+   R + ++      
Sbjct: 8   LGQGAYGIVCSARNAETSEEET-VAIKK--------ITNVFSKKILAKRALRELKLLRHF 58

Query: 63  -NHKNVVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
             HKN+  +  + +        L +YE +    L Q +R  S Q L        I  +  
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR--SGQPLTDAHFQSFIY-QIL 115

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-SHDQTATTTKEIETV 177
             L Y+HS     ++H D+K  N+L++ +   K+ DF  +   S +  + A    E    
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 178 GWLD-PEYLF----WTEKSDVYSFGVVLVELLTGK 207
            W   PE +     +T+  DV+S G +L ELL  K
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 31/225 (13%)

Query: 15  LLGEGGFGFVYKGVLPDN-TLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKN 66
           ++G GGFG VY     D   + A+K       K K  + + +NE       ++S ++  +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLSLVSTGD 55

Query: 67  VVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
              I+ +      P     + + +  G L  H+   S   + + K     A E    L++
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEH 112

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +H+     +++ D+K ANILLD++   +++D   +   S     A+    + T G++ PE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165

Query: 184 YL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRM 223
            L     +   +D +S G +L +LL G  P R +     +E+ RM
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LLG+G  G V+    KG      L A+K   K +M+ +  +  V   +  I++ ++H  +
Sbjct: 8   LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFL 63

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI------AAETASAL 121
             +           LV ++ P G LF+ ++ Q          CL        AAE   AL
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-------GKCLSEEVARFYAAEVLLAL 116

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
           +YLH LG   I++ D+K  NILL ++    ++DF  S     
Sbjct: 117 EYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 8   KNYDKRHLLGEGGFGFVYKG--VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + Y K   LGEG +  VYKG   L DN LVA+K+ ++  +         ++ ++  + H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQV-LKTWKTCLRIAAETASALDYL 124
           N+V +  +    K   LV+E++ +  L Q++    + + +   K  L    +    L+Y 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYC 120

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H      ++H D+K  N+L+++    K+ADF  +   S    T T + E+ T+ +  P+ 
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYSNEVVTLWYRPPDI 175

Query: 185 LF----WTEKSDVYSFGVVLVELLTGK 207
           L     ++ + D++  G +  E+ TG+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTL--VAVKKPKMVDKILINEVFQ--HKMRIISQINH 64
           +++   L+  G +G VY  V    T    A+KK    + IL N++ Q   +  I++   +
Sbjct: 2   DFETIKLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNG---TLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
             VV +     ETK  L +V E+V  G   TL +++      + + +       AET  A
Sbjct: 61  PFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY------FAETVLA 113

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV--LISSHDQTATTTKEIETVG 178
           L+YLH+ G   I+H D+K  N+L+      K+ DF  S   L+S          E +T  
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 179 WLD------PEYLF--------WTEKSDVYSFGVVLVELLTGKHP 209
           +LD      PEY+         + +  D ++ G++L E L G  P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 12/132 (9%)

Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 72  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 126

Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPEYLF---WTEKSDVYSFG 197
           ++LD +   K+ DF    L     +   T K    T  +L PE L    +    D +  G
Sbjct: 127 LMLDKDGHIKITDFG---LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183

Query: 198 VVLVELLTGKHP 209
           VV+ E++ G+ P
Sbjct: 184 VVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78

Query: 61  QINHKNVVKILGV-----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
            +NHKN++ +L V      LE    + +   + +  L Q ++ +      ++     +  
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLY 133

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +    + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVV 187

Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           T  +  PE +    + E  D++S G ++ E++ G 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 35/165 (21%), Positives = 78/165 (47%), Gaps = 22/165 (13%)

Query: 52  FQHKMRIISQINHKNVVKILGVC--------LETKVPLLVYEFVPNGTLFQHVRYQSSQV 103
            ++++  + ++NH+N++KI  +         +  K    +Y F+ +        ++   +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPL 265

Query: 104 LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
           L   +T   I  +   A++Y+H      +IH D+K  NI L+ +    + DF  + +   
Sbjct: 266 L--KQT-RAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFE 318

Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT 205
            ++ A     + TV    PE L    + E +D++S G++L+++L+
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 41/132 (31%), Positives = 65/132 (49%), Gaps = 18/132 (13%)

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           ALD +HS     ++H D+KSANI L      K+ DF  S   S        +    T  +
Sbjct: 181 ALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 180 LDPEYLFW-----TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-----FPY 229
           L PE   W     ++K+D++S GV+L ELLT   P  +   +  E+ + V Y     FP 
Sbjct: 238 LAPE--LWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQREIMQQVLYGKYDPFPC 293

Query: 230 PIENNSLRQILN 241
           P+ ++ ++ +L+
Sbjct: 294 PV-SSGMKALLD 304

Length = 478

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-----I 174
           ALDY+H +G    +H  VK+++IL+  +    ++   S++ + +H Q      +     +
Sbjct: 113 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSV 169

Query: 175 ETVGWLDPEYL-----FWTEKSDVYSFGVVLVELLTGKHP 209
           + + WL PE L      +  KSD+YS G+   EL  G  P
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 71

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 72  CVNHKNIISLLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 182

Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKG--VLPDNTLVAVKKPKMVDK-----ILINEVFQHKMRIIS 60
           + Y K   LGEG +  V+KG   L +N LVA+K+ ++  +       I EV      ++ 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREV-----SLLK 58

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
            + H N+V +  +    +   LV+E++ +  L Q++    +  L +         +    
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRG 115

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQTATTTKEIET 176
           L Y H      I+H D+K  N+L+++    K+ADF    A SV       T T + E+ T
Sbjct: 116 LSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV------PTKTYSNEVVT 166

Query: 177 VGWLDPEYLFW-TEKS---DVYSFGVVLVELLTGK 207
           + +  P+ L   TE S   D++  G +L E+ TG+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 60/231 (25%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQH---KMRIISQIN 63
           Y  + ++G+G +G V   +  D      VA+KK        IN+VF+H     RI+ +I 
Sbjct: 2   YKIQEVIGKGSYGVVCSAI--DTHTGEKVAIKK--------INDVFEHVSDATRILREIK 51

Query: 64  ------HKNVVKILGVCL-----ETKVPLLVYEFV---------PNGTLF-QHVRYQSSQ 102
                 H ++V+I  + L     E K   +V+E +          N  L  +H ++   Q
Sbjct: 52  LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ 111

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS 162
           +L+              AL Y+H+     + H D+K  NIL + +   K+ DF  + +  
Sbjct: 112 LLR--------------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154

Query: 163 SHDQTATT-TKEIETVGWLDPE-----YLFWTEKSDVYSFGVVLVELLTGK 207
           +   TA   T  + T  +  PE     +  +T   D++S G +  E+LTGK
Sbjct: 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 21/162 (12%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   +H D+ + N+LL      K+ DF  +  I       +       V W+ PE +F
Sbjct: 253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312

Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T  SDV+S+G++L E+ + G  P   + + S    ++   +     +++ +++ + 
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372

Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            V                 KC  +   +RP+   +S+ ++SL
Sbjct: 373 MV-----------------KCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 7e-05
 Identities = 33/147 (22%), Positives = 51/147 (34%), Gaps = 18/147 (12%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVA-VKKPKMVDKILINEVFQHKMRIISQINHKNVV--KIL 71
           LL  G    VY     D   V  +   +        EV      I+  +  K +   K+L
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREV-----AILQLLARKGLPVPKVL 59

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
                     L+ E++   TL +    +             IA + A  L  LH L    
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLV 109

Query: 132 IIHGDVKSANILLDDNYTAKVADFASS 158
           + HGD+   NIL+DD     + D+  +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.0 bits (101), Expect = 9e-05
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 37/209 (17%)

Query: 16  LGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           LGEG +  VYKG+   N  LVA+K   M  +  +      +  ++  + H N+V +L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 75  LETKVPL-LVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           + TK  L  V+E++           P G    +VR    Q+L+               L 
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR--------------GLA 117

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y+H      I+H D+K  N+L+      K+ADF  +   S   QT ++  E+ T+ +  P
Sbjct: 118 YIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS--EVVTLWYRPP 172

Query: 183 EYLF----WTEKSDVYSFGVVLVELLTGK 207
           + L     ++   D++  G + +E+L G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 56/241 (23%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVVKIL 71
           ++G G FG V      D   + A+KK +  + +   +V   +    I+++ ++  VVK+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK----TWKTCLRIAAETASALDYLHSL 127
               +     L+ E++P G +        + ++K    T +      AET  A+D +H L
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMM-------TLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADF---------------------ASSVLISSHDQ 166
           G    IH D+K  N+LLD     K++DF                       S  +    +
Sbjct: 121 G---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177

Query: 167 TATTTKEIE------------TVGWLD---PEYLF---WTEKSDVYSFGVVLVELLTGKH 208
             ++ ++ E            TVG  D   PE      + ++ D +S GV++ E+L G  
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237

Query: 209 P 209
           P
Sbjct: 238 P 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 16/152 (10%)

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVP--NGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           ++  +NH +V+++    +   +  +V   +P  +  L+ ++  +S  +       L I  
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPL--PIDQALIIEK 164

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +    L YLH+     IIH DVK+ NI ++D     + D  ++               +E
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221

Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELL 204
           T     PE L    +  K+D++S G+VL E+L
Sbjct: 222 TNA---PEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 57/290 (19%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           +++   ++G G FG V      D      +  ++K  M++K  +  + + +  I+ + + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI-RAERDILVEADG 60

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             VVK+     + +   L+ EF+P G +   +  + +  L    T   IA ET  A+D +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIA-ETVLAIDAI 117

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHD-----------------Q 166
           H LG    IH D+K  N+LLD     K++DF   + L  +H                  Q
Sbjct: 118 HQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 167 TATTTKEIE------------TVG---WLDPEYLFWT---EKSDVYSFGVVLVELLTGKH 208
              + ++ E            TVG   ++ PE    T   +  D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 209 PRSYVALASNEMTRMVP------YFP--YPIENNSLRQILNFQVADENEM 250
           P  + +    E  R V        FP   PI   +   IL F    EN +
Sbjct: 235 P--FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRI 282

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 37/210 (17%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQINHKNVVKI 70
           +G G +G V   +       VA+KK   + +   +E+F  +    +R++  + H+NV+ +
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 71  LGVCLETKVPL-------LVYEFVPN--GTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           L V     + L       LV  F+    G L +H +    ++       L+        L
Sbjct: 80  LDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK-------GL 131

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            Y+H+ G   IIH D+K  N+ ++++   K+ DF  +    S       T  + T  +  
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183

Query: 182 PE----YLFWTEKSDVYSFGVVLVELLTGK 207
           PE    ++ +T+  D++S G ++ E+LTGK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 6/98 (6%)

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   +H D+ + N+L+ +    K+ DF  +  I       +       + W+ PE +F
Sbjct: 255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314

Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
              +T  SDV+SFG++L E+ T G  P  Y  L  NE 
Sbjct: 315 NNLYTTLSDVWSFGILLWEIFTLGGTP--YPELPMNEQ 350

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 8   KNYDKRHLLGEGGFGFVYKG--VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + Y K   LGEG +  V+KG   L +N LVA+K+ ++  +         ++ ++  + H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V +  +    K   LV+E++ +  L Q++      ++      + +  +    L Y H
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLY-QILRGLAYCH 121

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHDQTATTTKEIETVGWLD 181
                 ++H D+K  N+L+++    K+ADF    A SV       T T + E+ T+ +  
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV------PTKTYSNEVVTLWYRP 172

Query: 182 PEYLF----WTEKSDVYSFGVVLVELLTGK 207
           P+ L     ++ + D++  G +  E+ +G+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 43/213 (20%)

Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 74  CLETK----------VPLLVYEFVPNGTLFQ-----HVRYQSSQVLKTWKTCLRIAAETA 118
               +          V  L+   + N    Q     HV++   Q+L+             
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR------------- 131

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             L Y+HS     IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  
Sbjct: 132 -GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRW 182

Query: 179 WLDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
           +  PE    ++ + +  D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           ++++   ++G G FG V      D      +  ++K  M++K  +  + + +  I+ + +
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHI-RAERDILVEAD 59

Query: 64  HKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
              VVK+     + K+ L L+ EF+P G +   +  + +  L   +T   IA ET  A+D
Sbjct: 60  SLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIA-ETVLAID 115

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
            +H LG    IH D+K  N+LLD     K++DF 
Sbjct: 116 SIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 57/227 (25%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y +   +G G  G V      D  L   VAVKK   + +   N+    +    + ++ 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKK---LSRPFQNQTHAKRAYRELVLLK 75

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTC----LRIA 114
            +NHKN++ +L V            F P  +L  FQ V Y   +++     C    + + 
Sbjct: 76  CVNHKNIISLLNV------------FTPQKSLEEFQDV-YLVMELMDA-NLCQVIHMELD 121

Query: 115 AETASALDY--------LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            E  S L Y        LHS G   IIH D+K +NI++  + T K+ DF  +       +
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-------R 171

Query: 167 TATT----TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
           TA T    T  + T  +  PE +    + E  D++S G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 27/226 (11%)

Query: 54  HKMRIISQINHKNVVKILGVCLETKVPLLVYEFVP--NGTLFQHVRYQSSQVLKTWKTCL 111
           H+ R++ +++H  V+ +L V +   +  LV   +P     L+ ++  +   +     T  
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTA- 264

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
            +A +  SA+DY+H  G   IIH D+K+ N+L++      + DF ++        T    
Sbjct: 265 -VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
               TV    PE L    +T   D++S G+V+ E     H  S  + AS    R      
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE--AAVHTASLFS-ASRGDER------ 371

Query: 229 YPIENNSLRQILNFQV-ADE-NEMEEIEIVAKLASKCLRTSGTERP 272
            P +   LR I   QV  DE  +     +V++      R +   RP
Sbjct: 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH---RAARNRRP 414

Length = 461

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 70/259 (27%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM-----VDKILINEVFQHKMRIISQI 62
           N+ +   LGEG +  VYKG       +VA+K+  +          I E+      ++ ++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI-----SLMKEL 55

Query: 63  NHKNVVKILGVC-LETKVPLLVYEF-------------VPNGTLFQHVRYQSSQVLKTWK 108
            H+N+V++  V   E K+ +LV+E+             V        V+  + Q+LK   
Sbjct: 56  KHENIVRLHDVIHTENKL-MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK--- 111

Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQ 166
                       + + H      ++H D+K  N+L++     K+ADF  A +  I     
Sbjct: 112 -----------GIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153

Query: 167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR 222
             T + E+ T+ +  P+ L     ++   D++S G ++ E++TG+               
Sbjct: 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR--------------- 198

Query: 223 MVPYFPYPIENNSLRQILN 241
             P FP     + L +I  
Sbjct: 199 --PLFPGTNNEDQLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G +G VYK    D         K ++   I+     ++ ++ ++ H NV+ +  V L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 76  ---ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSL 127
              + KV LL +++  +  L+  +++  +   K  K  +++      +L Y     +H L
Sbjct: 69  SHSDRKVWLL-FDYAEH-DLWHIIKFHRAS--KANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 128 GSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD-P 182
            +  ++H D+K ANIL+     +    K+AD   + L +S  +       +    W   P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 183 EYLF----WTEKSDVYSFGVVLVELLTGK 207
           E L     +T+  D+++ G +  ELLT +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 12/97 (12%)

Query: 82  LVYEFVPNGTLFQH-VRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK 138
           L+ EF+P G L    ++Y   S  V + +       AE   A++ +H LG    IH D+K
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRFY------MAECVLAIEAVHKLG---FIHRDIK 128

Query: 139 SANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
             NIL+D     K++DF  S        +A   K ++
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 43/213 (20%)

Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHK-MRIISQINHKNVVKIL 71
           +G G +G V      D  L   VAVKK     + LI+    ++ +R++  + H+NV+ +L
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQV---LKTWKTCLRIAAETAS------- 119
            V            F P  ++  F  V   ++ +   L     C +++ E          
Sbjct: 81  DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 120 -ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             L Y+HS G   IIH D+K +N+ ++++   ++ DF    L    D   T    + T  
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG---LARQADDEMTGY--VATRW 180

Query: 179 WLDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
           +  PE    ++ + +  D++S G ++ ELL GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 48/209 (22%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G +G VYK    D         K ++   I+     ++ ++ ++ H NV+ +  V L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 76  ---ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSL 127
              + KV LL +++  +  L+  +++  +   K  K  +++      +L Y     +H L
Sbjct: 69  SHADRKVWLL-FDYAEH-DLWHIIKFHRAS--KANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 128 GSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD-P 182
            +  ++H D+K ANIL+     +    K+AD   + L +S  +       +    W   P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 183 EYLF----WTEKSDVYSFGVVLVELLTGK 207
           E L     +T+  D+++ G +  ELLT +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 30/115 (26%), Positives = 50/115 (43%), Gaps = 26/115 (22%)

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA----------------KVADF 155
           +I  +T  ALDY H+     ++H D+K  NIL++ + T                 ++ D 
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 156 ASSVLISSHDQTATTTKEIETVGWLDPEY---LFWTEKSDVYSFGVVLVELLTGK 207
                    D+  + T  + T  +  PE    L W   +D++S G ++ EL TGK
Sbjct: 293 GGCC-----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 20/44 (45%), Positives = 26/44 (59%), Gaps = 3/44 (6%)

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS 158
           +E A ALDYLH  G   IIH D+K  N+L+ +    K+ DF  S
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 13/100 (13%)

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI----- 174
            L+YLH  G    IH ++K+++IL+  +    ++  +    +  + Q A    +      
Sbjct: 113 GLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 175 ETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHP 209
             + WL PE L      +  KSD+YS G+   EL TG+ P
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 19/148 (12%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVVKILG 72
           +G G FG V      D N L A+K  +  D ++ N+    K    I+++ +++ VVK L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK-LY 67

Query: 73  VCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA----AETASALDYLHSL 127
              + K  L  V +++P G +        S +++       +A    AE   A++ +H +
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMM-------SLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADF 155
           G    IH D+K  NIL+D +   K+ DF
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDF 145

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.0 bits (90), Expect = 0.003
 Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 34/185 (18%)

Query: 55  KMRIISQINHKNVVKILGVCLET---KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWK-TC 110
           ++ ++ ++ HKN+V+ +   L     K+ +L+ EF   G L ++++       K  +   
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 111 LRIAAETASALDYLHSLGSPP----IIHGDVKSANILLDDNY-----------------T 149
           + I  +   AL Y H+L   P    ++H D+K  NI L                      
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELL 204
           AK+ DF  S  I       +    + T  +  PE L      + +KSD+++ G ++ EL 
Sbjct: 181 AKIGDFGLSKNIGIESMAHSC---VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 205 TGKHP 209
           +GK P
Sbjct: 238 SGKTP 242

Length = 1021

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	309
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
smart00090	237	RIO RIO-like kinase.	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG3087	229	consensus Serine/threonine protein kinase [General	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.04
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.94
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.9
PRK09902	216	hypothetical protein; Provisional	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.65
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.04
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.01
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.01
PRK10593	297	hypothetical protein; Provisional	97.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.86
PRK05231	319	homoserine kinase; Provisional	97.82
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.77
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.76
KOG2270	520	consensus Serine/threonine protein kinase involved	97.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.37
PLN02236	344	choline kinase	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.2
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.1
PLN02756	418	S-methyl-5-thioribose kinase	97.06
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.04
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.92
PRK12396	409	5-methylribose kinase; Reviewed	96.85
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.72
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.65
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.59
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.48
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.44
PRK06148	1013	hypothetical protein; Provisional	96.26
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.16
PTZ00384	383	choline kinase; Provisional	96.09
PRK11768	325	serine/threonine protein kinase; Provisional	95.4
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.34
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.34
COG2334	331	Putative homoserine kinase type II (protein kinase	95.3
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.63

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-50  Score=338.29  Aligned_cols=251  Identities=25%  Similarity=0.302  Sum_probs=208.4

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhh------hHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL------INEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ..+.|.+.+.||.|+||.|-+|. .++|+.||+|.+.......      ......+|+++|+.++|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678999999999999999999 5679999999876653322      1223569999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN---YTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~---~~v~l~d~  155 (309)
                      ..||||||++||.|.+.+-.++.-   .+..-..+++|++.|+.|||+.|   |+||||||+|||++.+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l---~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYL---REDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcccc---ccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999998755543   55666789999999999999999   9999999999999755   77999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      |++....   ......+.+||+.|.|||++.      +..+.|+||+||++|-+++|.+||+.....             
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------------  387 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------------  387 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-------------
Confidence            9998763   345667789999999999997      556899999999999999999998765221             


Q ss_pred             cccccchhhhhcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          230 PIENNSLRQILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                         ....+++...++.+.  .+...++...+||.+||..||++|||+.++++|-
T Consensus       388 ---~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  388 ---PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             ---ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence               223344444444443  3556778899999999999999999999998753

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=331.00  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=212.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc-cEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV-PLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~iv~e   85 (309)
                      .+.+.++.||+|..|+||++.+ +++..+|+|.+........+.++.+|+++++..+||+||.+|+.|.++.. ..|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            4678889999999999999996 46899999999776667778899999999999999999999999999884 999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|||+.++...   +..++..+..++.++++||.|||+ .+   |+||||||+|+|++..|.|||||||.+..... 
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-  231 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-  231 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence            99999999999755   345889999999999999999996 77   99999999999999999999999999876622 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                         .......||..|||||.+.   |+.++||||||+.++|+..|+.||....            .+....-..+..+.+
T Consensus       232 ---S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~------------~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  232 ---SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN------------PPYLDIFELLCAIVD  296 (364)
T ss_pred             ---hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC------------CCCCCHHHHHHHHhc
Confidence               2556788999999999998   9999999999999999999999976540            011122222333333


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ..++......+++++++||..||++||.+|||+.|+++|--
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence            33333323357888999999999999999999999998753

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-49  Score=344.76  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+|+..+.||+|+|+.||.+++ .+|+.||+|++...  .+....+.+.+|+++.++++|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4599999999999999999997 78999999988664  34555778999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |+|+.++|..++++.   +.+++.+++.+.+||+.||.|||+++   |+|||||..|++++++.+|||+|||+|..... 
T Consensus        98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-  170 (592)
T ss_pred             EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC-
Confidence            999999999988733   45588999999999999999999999   99999999999999999999999999988632 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ......+.+||+.|.|||++.   .+..+||||+||++|.|+.|++||...+                 -......+..
T Consensus       171 -~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vkety~~Ik~  232 (592)
T KOG0575|consen  171 -DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VKETYNKIKL  232 (592)
T ss_pred             -cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HHHHHHHHHh
Confidence             235556789999999999997   7778999999999999999999976542                 2223333333


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..+..+.  ..+..+.+||.++|+.||.+|||+++++.+
T Consensus       233 ~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  233 NEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            3322222  444669999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=336.19  Aligned_cols=254  Identities=30%  Similarity=0.464  Sum_probs=211.9

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +.+.+.+.||+|.||.||.|.+....+|++|.+.....  ..+.|.+|+.+|+.++|++||++++++..+..++|||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            34567889999999999999998888999998877532  3467889999999999999999999999988999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      +.|+|.++++... ...+....++.++.|||+||+||++++   ++||||..+||||+++..+||+|||+++.... +..
T Consensus       284 ~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y  358 (468)
T KOG0197|consen  284 PKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEY  358 (468)
T ss_pred             ccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-Cce
Confidence            9999999998733 334577889999999999999999999   99999999999999999999999999985422 222


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......-...|.|||.+.   ++.++||||||+++|||++ |+.|++...+                  ...-..+...
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~ev~~~le~G  420 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------EEVLELLERG  420 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------HHHHHHHhcc
Confidence            2222233356699999998   8999999999999999999 8888664422                  2233344555


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ..-+.|..||+.+.++|..||+.+|++||||..+...|+++..
T Consensus       421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            5666677888999999999999999999999999888877654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-48  Score=311.83  Aligned_cols=257  Identities=26%  Similarity=0.324  Sum_probs=204.9

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeee-eecCC-ccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGV-CLETK-VPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~-~~~   81 (309)
                      ...+|+|.+.||+|+||.||++. ..+|..+|.|.+... .....++.+..|+.+|++++|||||+++++ |.+++ .++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            34679999999999999999998 578999999988754 335556789999999999999999999984 44444 488


Q ss_pred             EEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           82 LVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLG-SPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ||||+|.+|+|.+.++... ....++++.+|.++.|+++||.++|+.- .+.+.||||||.||+++..|.||++|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999997544 3456789999999999999999999921 0229999999999999999999999999998


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...+  ........+|||.||+||.+.   |+.++||||+||++|||+.-+.||-...-.+                 .-
T Consensus       177 ~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-----------------L~  237 (375)
T KOG0591|consen  177 FLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-----------------LC  237 (375)
T ss_pred             Hhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-----------------HH
Confidence            7633  344556789999999999997   9999999999999999999999976442111                 11


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..+.+...+..+...++.++..||..|++.||+.||+...++..+
T Consensus       238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            111111111122256778899999999999999999854444433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=325.42  Aligned_cols=260  Identities=33%  Similarity=0.467  Sum_probs=212.2

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-ccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETK-VPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv~e   85 (309)
                      .+..+.+.||.|+||.||+|.++....||+|.+..... ....+.|.+|+.+|.+++|||||+++|++.+.. .++||||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            44566677999999999999996555599998766432 222678999999999999999999999999887 7899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~~~~  164 (309)
                      |+++|+|..++... ....++...++.++.||++||.|||+++ + ++|||||+.|+|++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999865 3445688999999999999999999987 2 79999999999999997 9999999999765321


Q ss_pred             cccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  ...+...|+..|||||++.     ++.++||||||+++|||++|..||.....                 ......+
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------------~~~~~~v  258 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------------VQVASAV  258 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHH
Confidence            1  3444478899999999998     89999999999999999999999775532                 2222222


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      .........+..+++.+..+|.+||+.||..||++.+++..|+.+.....
T Consensus       259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            22223333333466779999999999999999999999999998876443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=309.54  Aligned_cols=266  Identities=21%  Similarity=0.307  Sum_probs=208.7

Q ss_pred             hcccccceeecccCceEEEEEEcCC-CcEEEEEeccc-chhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+.|+.+..+|+|+||+||+|++++ |+.||||+.-. .+.+...+...+|+++|++++|+|+|.++++|...+.+++||
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            3689999999999999999999765 99999997644 455777889999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||+.. +.+.+......  .+.+.+..+++|++.|+.|+|+++   ++||||||+||+|+.+|.+|+||||.++.... 
T Consensus        81 E~~dhT-vL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   81 EYCDHT-VLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             eecchH-HHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            999764 44455544433  367899999999999999999999   99999999999999999999999999987643 


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc---cc-------
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP---YP-------  230 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~-------  230 (309)
                       .....+.++.|-+|+|||.+.    |..+.|||++||++.||++|.+-|+..+.-.+-+......++   ..       
T Consensus       154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             445566778899999999987    899999999999999999999999876544433222221111   00       


Q ss_pred             --ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 --IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        +....+-...+.......-+..+..+.+|++.||+.||++|++-++++.|
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence              00111111111111111223444569999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=315.33  Aligned_cols=199  Identities=28%  Similarity=0.442  Sum_probs=177.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|.+.+.||.|+||+||+|++ +++..||||.+.... .....+.+..|+.+|+.++|||||++++++.+.+.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            357899999999999999999995 458999999887663 555678889999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC------CCeEEEeeec
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN------YTAKVADFAS  157 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~------~~v~l~d~g~  157 (309)
                      ||||+||+|.++++..+   .+++.++..++.|++.||++||+++   |+||||||.|||++..      ..+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999998665   4478999999999999999999999   9999999999999754      5689999999


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                      ++...   ........+|++.|||||++.   |+.|+|+||+|+++|++++|.+||...
T Consensus       162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98763   344455678999999999995   999999999999999999999998754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=311.73  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=202.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++++.||+|+||.|+.++.+ +++.+|+|++....-.  ...+....|..+|..++||+||.++..|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34678999999999999999999954 5999999987665322  22456789999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|+||++||.|...+++.+.   +++..+.-++..|+.||.|||+++   |+||||||+|||++.+|+|+|+|||++...
T Consensus       102 lVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999986554   477888999999999999999999   999999999999999999999999999764


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  ........+||+.|||||.+.   ++.++|+||||+++|+|++|.+||...+...                 ..+.
T Consensus       176 ~~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----------------~~~~  236 (357)
T KOG0598|consen  176 LK--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----------------MYDK  236 (357)
T ss_pred             cc--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----------------HHHH
Confidence            22  223444579999999999997   9999999999999999999999976543221                 1112


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCC----CHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERP----TMRQVSE  279 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp----s~~~ll~  279 (309)
                      +...+ ....+...+..++++++++|+.||++|.    ++.++.+
T Consensus       237 I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  237 ILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             HhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            22211 1112223446699999999999999995    5555443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=323.34  Aligned_cols=269  Identities=22%  Similarity=0.277  Sum_probs=216.3

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC-cc
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETK-VP   80 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~   80 (309)
                      ....++|.+++.||.|.||.||+|+. .+|+.||||.+...-..-..-.-.+|+..|++++ ||||+++++++.+.+ .+
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34678999999999999999999994 5699999997755433322334568899999998 999999999998877 99


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||++ .+|.++++.+  ...+++..+..|++||++||+|+|++|   ++|||+||+|||++....|||+|||+|+.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            99999995 7999999876  456789999999999999999999999   99999999999999888999999999987


Q ss_pred             cccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYPIEN  233 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  233 (309)
                      +   ....+.+.++.|-+|+|||++.    |+.+.|+|++||+++|+.+-++.|+......+-.-.+.   ......+..
T Consensus       160 v---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 V---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             c---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            6   4456677888899999999997    99999999999999999999999887655544432222   222222222


Q ss_pred             -cchhhhhcccccCcc-------chHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 -NSLRQILNFQVADEN-------EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 -~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ..+...++.+.+.-.       -..++.++.++|.+|+++||.+||||.+++++-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             223333333322211       123778899999999999999999999998864

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=320.72  Aligned_cols=280  Identities=43%  Similarity=0.689  Sum_probs=227.1

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-cc
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK-VP   80 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~   80 (309)
                      +|.+++++|.-...||+|+||.||+|...+|..||+|.+....... ...|..|+.++.+++|||+|+++|||.+.+ ..
T Consensus        69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            6899999999999999999999999999888999999877665432 345999999999999999999999999988 49


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++|+||+++|+|.+.+...... .++|..+..|+.++++||+|||....++++|||||++|||+|+++..||+|||++..
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            9999999999999999765544 669999999999999999999998777899999999999999999999999999965


Q ss_pred             ccccccccccccc-ccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKE-IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~-~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....  ....... .|+..|++||+..   .+.++||||||+++.|+++|+.|.+.......  .....|.........+
T Consensus       227 ~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~--~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  227 GPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE--LSLVEWAKPLLEEGKL  302 (361)
T ss_pred             CCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc--ccHHHHHHHHHHCcch
Confidence            4321  1222222 7899999999996   88999999999999999999988765431111  1122222222233366


Q ss_pred             hhhhccccc-Cccch-HHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          237 RQILNFQVA-DENEM-EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       237 ~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      ..+++++.. ..... .....+..+..+|++.+|..||++.++++.|+.+...
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            677777755 33333 5667799999999999999999999998888555443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=303.57  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=212.7

Q ss_pred             HHhhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +...+.|++...||.|..+.||+|+ .+.++.||||++........-+.+.+|+..|+.++||||+.++..|..++.+|+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            3456789999999999999999999 567899999998776554445778999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||.++.+||+.+.+...-..+ +++..|+.++.++++||.|||++|   .+|||+|+.||||+.+|.|+|+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999998665554 578999999999999999999999   9999999999999999999999999875553


Q ss_pred             cccccc--cccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          163 SHDQTA--TTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       163 ~~~~~~--~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  ......|++.|||||++.     |+.|+||||||++..|+.+|..||.....-.--+....+..+... ...
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~  256 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSG  256 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-ccc
Confidence            322111  114568999999999954     999999999999999999999998865333333333333332221 111


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .        ..+.....+..+.++|..||..||.+|||+++++++
T Consensus       257 ~--------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  257 L--------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             C--------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1        111112233469999999999999999999999874

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-45  Score=287.22  Aligned_cols=266  Identities=25%  Similarity=0.332  Sum_probs=214.1

Q ss_pred             HHHhhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC---
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK---   78 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   78 (309)
                      |...+++|+|.+.||+|+|+-||.+. ..+++.+|+|++......+ .+...+|++.-+.++||||++++++...+.   
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~-~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED-IEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH-HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            44568899999999999999999999 5679999999987776443 567799999999999999999999876543   


Q ss_pred             --ccEEEEEcCCCCCHHHHHHhhcccc-ccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           79 --VPLLVYEFVPNGTLFQHVRYQSSQV-LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        79 --~~~iv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                        ..||+++|+..|+|.+.++.....+ ..++..++.|+.++++|+.+||+.. ++++||||||.||++++.+.+++.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence              4899999999999999998766554 7789999999999999999999997 67999999999999999999999999


Q ss_pred             ecccccccccccc-------cccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh
Q 040698          156 ASSVLISSHDQTA-------TTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR  222 (309)
Q Consensus       156 g~~~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~  222 (309)
                      |.+....-.....       ......-+..|+|||.+.      .++++|||||||++|+|+.|..||.......     
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-----  248 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-----  248 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence            9987653211111       111234477899999996      7899999999999999999999987653211     


Q ss_pred             cccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                                .+..-.+.+.....+.....++.+.++|++||+.||.+||++.+++..+..+.
T Consensus       249 ----------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 ----------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      11111122333333333347788999999999999999999999999987653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=305.45  Aligned_cols=256  Identities=30%  Similarity=0.414  Sum_probs=205.2

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--ccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK--VPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv   83 (309)
                      ..+|...+.||+|+||.||++.+. +|+..|+|.+....... .+.+.+|+.+|.+++|||||+++|......  .++|.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            356899999999999999999954 49999999887764443 567899999999999999999999744433  68899


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeeecccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFASSVLIS  162 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~~~~  162 (309)
                      |||+++|+|.+++...+.  .+++..+..+..|+++||.|||+++   ++|+||||+||+++. ++.+||+|||++....
T Consensus        95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999999987665  4688999999999999999999999   999999999999999 7999999999887653


Q ss_pred             c-ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchh-hhcchhhhhcccCccccccccch
Q 040698          163 S-HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYV-ALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~-~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      . ...........|++.|||||++.    ...++|||||||++.+|++|..||... ....                 .+
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-----------------~~  232 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-----------------AL  232 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-----------------HH
Confidence            3 11223344578899999999998    223899999999999999999998863 1000                 00


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ..+.........+...+++.++|+.+|++.||++|||+.++++|.-..+
T Consensus       233 ~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  233 LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            0011111111334456678999999999999999999999999874433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-44  Score=312.79  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=200.4

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC-
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET-   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-   77 (309)
                      ..++|++.+.||.|+||.||+|.+      .++..||+|.+...........+..|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999973      235789999887554444456788999999999 899999999988764 


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhcc--------------------------------------------------------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSS--------------------------------------------------------  101 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~--------------------------------------------------------  101 (309)
                      +..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            467899999999999999875321                                                        


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccc
Q 040698          102 ---QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG  178 (309)
Q Consensus       102 ---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~  178 (309)
                         ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++................++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               123566788899999999999999999   99999999999999999999999999875432222222223344567


Q ss_pred             cCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHH
Q 040698          179 WLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIE  254 (309)
Q Consensus       179 ~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (309)
                      |+|||.+.   ++.++||||||+++|+|++ |..||..............                + ......+...++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----------------~-~~~~~~~~~~~~  304 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK----------------D-GTRMRAPENATP  304 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh----------------c-CCCCCCCCCCCH
Confidence            99999875   7889999999999999997 9999865422111111000                0 000011223346


Q ss_pred             HHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          255 IVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       255 ~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            69999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=287.80  Aligned_cols=236  Identities=27%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILI--NEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++++.||.|+||.|.+++.+ +|..+|+|++....-...  .+...+|..+|+.+.||+++++++.+.+.+.+++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            4578999999999999999999954 589999999877644332  3457788999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++||.|.++++..+..   ++..+.-++.+|+.|++|||+++   +++|||||+||++|++|.+||+|||.+... 
T Consensus       122 vmeyv~GGElFS~Lrk~~rF---~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v-  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGRF---SEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV-  194 (355)
T ss_pred             EEeccCCccHHHHHHhcCCC---CchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe-
Confidence            99999999999999866544   67888999999999999999999   999999999999999999999999999764 


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                          .......+|++.|+|||.++   ++.++|.|+||+++|||+.|.+||...+                 +....+.+
T Consensus       195 ----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-----------------~~~iY~KI  253 (355)
T KOG0616|consen  195 ----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-----------------PIQIYEKI  253 (355)
T ss_pred             ----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----------------hHHHHHHH
Confidence                34467789999999999998   8999999999999999999999976542                 22333334


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCC
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTER  271 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  271 (309)
                      ...+..+  |...+.++.+|+++.|+.|-.+|
T Consensus       254 ~~~~v~f--P~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGKVKF--PSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCcccC--CcccCHHHHHHHHHHHhhhhHhh
Confidence            4433333  33455679999999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-44  Score=329.48  Aligned_cols=259  Identities=28%  Similarity=0.458  Sum_probs=220.4

Q ss_pred             cccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .+-+..+.||+|.||.||+|..      .+...||||.++.......+++|++|+.++..++|||||+++|++..++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            4556778899999999999982      2357899999988877778999999999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccc-----------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQ-----------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      +||||+..|+|.+||......           ..++..+.++|+.||+.||.||-++.   ++||||..+|++|.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            999999999999999755432           22567889999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccC
Q 040698          151 KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      ||+|||+++...+.+.........-.++|||||.+.   ++.++||||+||++||+++ |..||...             
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-------------  709 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-------------  709 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-------------
Confidence            999999998765555444333344477899999998   8999999999999999999 88886544             


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                          .....++.+.+.+. .+-+..+|..+++||..||+.+|.+||+|++|-..|...-..
T Consensus       710 ----Sn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  710 ----SNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ----chHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                34455556655555 566778889999999999999999999999999998765443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=308.68  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=203.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      .-++|..++.||.|+|++|++|+. .++..+|+|++...-  +....+.+..|-.+|.+| .||.|++++..|+|+..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346899999999999999999994 569999999876542  222234567778888888 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|+||+++|.|.+++...+.   +++.-...++.+|+.|++|||++|   |+||||||+|||+++|++++|+|||.+..+
T Consensus       151 FvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999987654   367778899999999999999999   999999999999999999999999999776


Q ss_pred             cccccc-------ccc----cccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          162 SSHDQT-------ATT----TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       162 ~~~~~~-------~~~----~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ......       ...    ...+||..|.+||++.   .+..+|+|+|||++|+|+.|.+||......           
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----------  293 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----------  293 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----------
Confidence            432111       111    3478999999999998   677899999999999999999997644222           


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                            ...+.+....  .+.+.+.++++.+||++.|..||.+|+|+.+|.+|.
T Consensus       294 ------liFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  294 ------LIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------HHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                  1122222222  223334447799999999999999999999998763

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-45  Score=308.20  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=210.3

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ....|...+.||+|.||.||+|. ..+++.||+|++.........+.+++|+.+|.+++++||.++++.+..+..++++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            45678889999999999999999 46799999999988877777788999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||.||++.+.+.....   ..+..+.-++.+++.|+.|||..+   .+|+||++.||+++.+|.|+++|||++......
T Consensus        91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999999874443   256778888999999999999999   999999999999999999999999999776443


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ..  ...+.+|++.|||||++.   |+.++||||||++.++|.+|.+|+.....                 ...+.-+..
T Consensus       165 ~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------------mrvlflIpk  225 (467)
T KOG0201|consen  165 VK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------------MRVLFLIPK  225 (467)
T ss_pred             hh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------------ceEEEeccC
Confidence            22  226789999999999998   99999999999999999999999765421                 111111111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..++ .....+++.+++||..||+.||+.||||.++++|-
T Consensus       226 ~~PP-~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  226 SAPP-RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             CCCC-ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            1111 12225667799999999999999999999999863

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=308.04  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch---h-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD---K-ILINEVFQHKMRIISQIN-HKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~---~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.|+.+.+ .+|+.||+|.+....   . ....+.+.+|+.+++.++ ||||+++++++...+
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567999999999999999999984 568999999665531   1 134566778999999999 999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEeeec
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFAS  157 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~g~  157 (309)
                      ..++||||+.||.|.+++...+   .+.+..+..++.|++.|++|||+++   ++||||||+|++++.+ +.+||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999998633   3466899999999999999999999   9999999999999998 9999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----c-CCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----W-TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~-~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      +....  .........+|++.|+|||++.    | ..++|+||+|+++|.|++|..||.........             
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------------  232 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------------  232 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            97653  3445667789999999999997    2 46899999999999999999998863211111             


Q ss_pred             ccchhhhhcccccCccchHH-HHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEE-IEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          ..+......  .+... +.++..|+.+||..||.+|+|+.+++++
T Consensus       233 ----~ki~~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  233 ----RKIRKGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             ----HHHhcCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                111111111  11122 5679999999999999999999999854

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=307.62  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ...|...+.+|+|..|.||.+. ..+++.||+|.+....... ++.+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4578888999999999999998 4568899999887654433 6778999999999999999999999998899999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++||+|.+.+....    .++.+++.++..++.||+|||.++   |+|||||.+||+++.+|.|||+|||++..+....
T Consensus       351 ym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             ecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999998886443    578999999999999999999999   9999999999999999999999999998774332


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .  .-...+|++-|||||+..   |..+.||||||++++||+.|.+||=+.......+..                ..+.
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI----------------a~ng  485 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------------ATNG  485 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH----------------hhcC
Confidence            2  334578999999999998   899999999999999999999996542211111110                1112


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+....+...+..+++|+.+||+.|+++|+++.+||+|
T Consensus       486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            22233445566789999999999999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4e-43  Score=303.99  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILI--NEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++++.||+|+||.||+|+.+ +|+.+|+|++........  -+.+..|-++|...++|+||+++..|++.+.+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999954 599999999887654322  2347788899999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++||++.++|...+   .+++..+..++.+.+.|+..+|+.|   ++||||||+|+|||..|++||+|||++.-..
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999998554   4588899999999999999999999   9999999999999999999999999984321


Q ss_pred             c--------------------cccccc-------------------------ccccccccccCCCcccc---cCCCcchh
Q 040698          163 S--------------------HDQTAT-------------------------TTKEIETVGWLDPEYLF---WTEKSDVY  194 (309)
Q Consensus       163 ~--------------------~~~~~~-------------------------~~~~~~~~~~~~PE~~~---~~~~~Diw  194 (309)
                      .                    ......                         ....+|+|.|+|||++.   |+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            0                    000000                         11235899999999998   89999999


Q ss_pred             hHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCCCC
Q 040698          195 SFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTERP  272 (309)
Q Consensus       195 slG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  272 (309)
                      ||||++|||+.|.+||...                 .+......+++-+  ..++.....++.+.+||.+||. ||++|.
T Consensus       373 SLG~ImyEmLvGyPPF~s~-----------------tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSE-----------------TPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCC-----------------CHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999997643                 2222333333222  3333334455779999999999 999998


Q ss_pred             C---HHHHHHH
Q 040698          273 T---MRQVSEQ  280 (309)
Q Consensus       273 s---~~~ll~~  280 (309)
                      .   +.+|-+|
T Consensus       435 G~~G~~EIK~H  445 (550)
T KOG0605|consen  435 GSKGAEEIKKH  445 (550)
T ss_pred             CcccHHHHhcC
Confidence            5   5555543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-43  Score=295.03  Aligned_cols=249  Identities=23%  Similarity=0.276  Sum_probs=206.9

Q ss_pred             HhhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhh--hHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL--INEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      +...+|++.+.||.|.||.|-+++ .+.|+.||||.++...-.+  .--.+.+|+.+|..++||||++++.+|+..+..+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            345789999999999999999999 4789999999876653222  1234789999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      |||||..+|.|.+++...+.   +++.+..+++.||+.|+.|+|+++   ++|||||.+||++|.++.+||+|||++.++
T Consensus       130 ivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999987664   478999999999999999999999   999999999999999999999999999776


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                         .........+|++-|.+||...    -.+..|.||||+++|-++.|..||+..+-                 ...++
T Consensus       204 ---~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------------k~lvr  263 (668)
T KOG0611|consen  204 ---ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------------KRLVR  263 (668)
T ss_pred             ---ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------------HHHHH
Confidence               3445556778999999999987    46679999999999999999999876531                 11222


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ++....+..   ++-+.+..-||++||..||++|.|+.++.+|-.
T Consensus       264 QIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  264 QISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            222211111   112244889999999999999999999988754

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.8e-42  Score=300.07  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=202.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||++.++ +|..+++|.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            579999999999999999999954 6889999988765444456778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |+++++|.+++....   ..++..+..++.|++.|+.|||+. +   ++|+||+|+||+++.++.++|+|||++..... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  156 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  156 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence            999999999987543   347788999999999999999985 6   99999999999999999999999998865422 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-------------c
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-------------P  228 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-------------~  228 (309)
                         .......++..|+|||.+.   ++.++|+||||+++|+|++|..||.................             .
T Consensus       157 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         157 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence               1223346788999999986   78899999999999999999999865432111000000000             0


Q ss_pred             cc------------ccc----cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          229 YP------------IEN----NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       229 ~~------------~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..            ...    .....+.............++++.+||.+||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00            000    000011111111111223457799999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-42  Score=277.12  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=204.9

Q ss_pred             cccccceeecccCceEEEEEE-cCCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+|...+.||+|.||.||+|+ ..+|+.||||++..... ........+|++.|+.++|+||+.+.++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            579999999999999999999 56799999998866532 2334567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++ .+|...++...  ..+....+..++.++++|++|||+++   +.|||+||.|++++++|.+|++|||+++.+...+
T Consensus        82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 68888776443  34566889999999999999999999   9999999999999999999999999998875543


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-ccccccccchhhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-FPYPIENNSLRQIL  240 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  240 (309)
                      ....  ..+-+-.|+|||.+.    |+...|+||.||++.||+.|.+-|+..+.-++-....... -|.+.....+.++.
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            3322  225677899999886    9999999999999999999887776443222211111111 11122222222222


Q ss_pred             ccc--------ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          241 NFQ--------VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       241 ~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +..        ........++++..+|+.+||..||.+|+|+.|++++=
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence            111        11112345567789999999999999999999998863

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-43  Score=318.43  Aligned_cols=268  Identities=24%  Similarity=0.282  Sum_probs=220.3

Q ss_pred             HHhhcccccceeecccCceEEEEEEcCCC-cEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeee-eec---C
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGV-CLE---T   77 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~-~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~---~   77 (309)
                      .++..+++|.+.|.+|+|+.||++....+ ..+|+|++...+... -..+.+|+.+|+.|. |+|||.++|. ...   .
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~-L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEA-LNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHH-HHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            45677899999999999999999996554 999999877664443 567899999999997 9999999993 321   1


Q ss_pred             ---CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           78 ---KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        78 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                         -..+|.||||.||+|.++++...... +++.+++.|++|+|+|+++||... ++++|||||.+|||++.+|..||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence               24569999999999999998776655 688999999999999999999997 7799999999999999999999999


Q ss_pred             eeccccccccccc-------ccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh
Q 040698          155 FASSVLISSHDQT-------ATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT  221 (309)
Q Consensus       155 ~g~~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~  221 (309)
                      ||.++-.......       ........|+.|++||++.      +++|+|||+|||+||.++....||+...       
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------  262 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------  262 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence            9988543211100       1112345689999999996      7899999999999999999999977542       


Q ss_pred             hcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhhh
Q 040698          222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQK  295 (309)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~  295 (309)
                                    .-.+.+..+.++..+.++..|.+||..||+.||.+||++.|++..+..+..-..+....|
T Consensus       263 --------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  263 --------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             --------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                          223455566666667888999999999999999999999999999999987766666665

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.6e-42  Score=305.98  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=198.4

Q ss_pred             hcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (309)
                      .++|++.+.||+|+||.||+|.+      .++..||+|.+.........+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45899999999999999999863      235689999886544334456788999999999 89999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc----------------------------------------------------------
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS----------------------------------------------------------  101 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~----------------------------------------------------------  101 (309)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998864321                                                          


Q ss_pred             --------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698          102 --------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus       102 --------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                                    ...+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++++|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          113466788999999999999999999   999999999999999999999999998755332221


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......++..|+|||.+.   ++.++|+||||+++|+|++ |..||............                 ....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-----------------~~~~  333 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-----------------IKEG  333 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-----------------HHhC
Confidence            1122233456799999886   7889999999999999998 88887643211111100                 0000


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .....+...+..+.+|+.+||+.||++|||+.++++.|++
T Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            0111111224569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.2e-42  Score=306.07  Aligned_cols=258  Identities=28%  Similarity=0.418  Sum_probs=199.6

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (309)
                      .++|++.+.||+|+||.||++.+.      ++..||+|.+.........+.+..|+.+++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999998732      24579999887654444456788999999999 89999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc----------------------------------------------------------
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS----------------------------------------------------------  101 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~----------------------------------------------------------  101 (309)
                      .++||||+++++|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999999864321                                                          


Q ss_pred             ---------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698          102 ---------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus       102 ---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                               ...+++..++.++.|++.||.|||+++   ++||||+|+||++++++.++|+|||++..............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     113466788999999999999999999   99999999999999999999999999865432211111122


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCcc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN  248 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (309)
                      ..++..|+|||.+.   ++.++|+||||+++|+|++ |..||...........                 ..........
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-----------------~~~~~~~~~~  336 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-----------------MVKRGYQMSR  336 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-----------------HHHcccCccC
Confidence            23456799999875   8889999999999999997 9999865422111000                 0000001111


Q ss_pred             chHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       249 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      +...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            112246699999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=297.77  Aligned_cols=263  Identities=23%  Similarity=0.283  Sum_probs=209.9

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-------------hhhHHHHHHHHHHHhhcCCCccce
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-------------ILINEVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~   69 (309)
                      .+..++|++.+.||.|.||.|-++++ .+++.||+|++.....             -...+...+|+.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            35678999999999999999999994 5799999997654321             111256899999999999999999


Q ss_pred             eeeeeec--CCccEEEEEcCCCCCHHHHHHhhccccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 040698           70 ILGVCLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVL-KTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD  146 (309)
Q Consensus        70 ~~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~  146 (309)
                      ++++..+  .+.+|||+|||+.|.+..    ...... +.+.+++.++.+++.||.|||.++   |+||||||+|+|+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            9999876  578999999999887643    223333 678899999999999999999999   999999999999999


Q ss_pred             CCCeEEEeeecccccccc---cccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhc
Q 040698          147 NYTAKVADFASSVLISSH---DQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALA  216 (309)
Q Consensus       147 ~~~v~l~d~g~~~~~~~~---~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~  216 (309)
                      +|+|||+|||.+......   +.......-.||+.|+|||...       .+.+.|||++||+||.|+.|+.||-..   
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---  322 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---  322 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---
Confidence            999999999998655221   2222333468999999999886       466889999999999999999996533   


Q ss_pred             chhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          217 SNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                                    ......+.+++....++...+..+.+.+||++||++||++|.++.+|..|....+..-.+
T Consensus       323 --------------~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  323 --------------FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             --------------hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence                          222233445555555555555667899999999999999999999999988766654433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-43  Score=308.71  Aligned_cols=245  Identities=24%  Similarity=0.290  Sum_probs=207.8

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.|++++.||.|+.|.|-.|++ .+|+..|||.+....  .......+..|+.+|+.+.||||+++++++++...+|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            46799999999999999999996 579999999876652  222345688999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      .||++||-|++++..++.   +++.++++++.||+.|+.|+|..+   ++||||||+|++++..+.+||+|||+|.+-  
T Consensus        91 lEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--  162 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--  162 (786)
T ss_pred             EEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc--
Confidence            999999999999986654   477999999999999999999999   999999999999999889999999999753  


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                       .......+.+|+++|++||.+.    -..++||||.|++||.+++|..||+.-                     +++.+
T Consensus       163 -~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---------------------Nir~L  220 (786)
T KOG0588|consen  163 -VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---------------------NIRVL  220 (786)
T ss_pred             -cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---------------------cHHHH
Confidence             2334455678999999999997    577999999999999999999997722                     22222


Q ss_pred             hcc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          240 LNF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       240 ~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +..  +..++.|...+.++++||.+||..||++|.|..+|++|-
T Consensus       221 LlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  221 LLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            221  223334456668899999999999999999999999975

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-42  Score=297.26  Aligned_cols=268  Identities=24%  Similarity=0.293  Sum_probs=207.8

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~   81 (309)
                      -.+.|+.+++||+|.||.||+++ ..+|+.||+|+++... ....-....+|+.+|++++||||+++.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            35679999999999999999999 4679999999987764 344455678999999999999999999998876  6899


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++ .+|..++....  ..+++.++..++.|++.||.|+|.++   +.|||||.+||||+.+|.+||+|||++..+
T Consensus       195 lVFeYMd-hDL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEeccc-chhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            9999996 57877776443  34578999999999999999999999   999999999999999999999999999877


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh---hcccCcccccccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT---RMVPYFPYPIENN  234 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~  234 (309)
                      ... .....+.++-|.+|+|||.+.    |+.+.|+||.||++.||+.|++.|...+.-.+-..   .+...-...+...
T Consensus       269 ~~~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPS-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCC-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            443 344577788899999999997    99999999999999999999999876643332211   1111111111100


Q ss_pred             chhhhhcccc-------cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNFQV-------ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+-.....+.       ..+.....+....+|+..+|..||.+|.|+.+++..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1111011111       111223444668999999999999999999999864

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8e-42  Score=295.82  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             hcccccceeecccCceEEEEEEcCC-----------------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccce
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-----------------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   69 (309)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4789999999999999999997432                 34699998776544444567889999999999999999


Q ss_pred             eeeeeecCCccEEEEEcCCCCCHHHHHHhhcc----------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 040698           70 ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS----------------QVLKTWKTCLRIAAETASALDYLHSLGSPPII  133 (309)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~  133 (309)
                      +++++.+.+..++||||+++++|.+++.....                ...+++..++.++.|++.||.|||+.+   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999999999999999999999998865321                123466788999999999999999999   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh--CCC
Q 040698          134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT--GKH  208 (309)
Q Consensus       134 h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~--g~~  208 (309)
                      |+||+|+||+++.++.++|+|||++................++..|+|||.+.   ++.++|+||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999986542222111222233467799999875   7889999999999999987  455


Q ss_pred             CCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          209 PRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ||........ .......+..         . ........+..++..+.+|+.+||+.||.+|||+.++.+.|+
T Consensus       241 p~~~~~~~~~-~~~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQV-IENAGEFFRD---------Q-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHH-HHHHHHHhhh---------c-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6553321110 0000000000         0 000001112234466999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=295.72  Aligned_cols=244  Identities=23%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++..+ +|+.+|+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999964 689999998764322  223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence            9999999999987543   3477888899999999999999999   99999999999999999999999999865421 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                          ......|++.|+|||.+.   ++.++||||||+++|+|++|..||.........                 ..+..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-----------------~~i~~  212 (291)
T cd05612         154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-----------------EKILA  212 (291)
T ss_pred             ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHHh
Confidence                122345788999999887   788999999999999999999998643221110                 11111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~l  281 (309)
                      ...  ..+...+..+.+||++||+.||.+||+     +.+++++-
T Consensus       213 ~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         213 GKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             CCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            111  111122356899999999999999995     88988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-41  Score=290.88  Aligned_cols=256  Identities=29%  Similarity=0.452  Sum_probs=202.7

Q ss_pred             hcccccceeecccCceEEEEEEcCC------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|++.+.||+|+||.||+|....      ...+++|.+...........+.+|+..+..++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            4689999999999999999998532      2578999886655455566789999999999999999999999998999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccc-------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQ-------------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      +++|||+++++|.+++......             ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            9999999999999998754321             34577888999999999999999999   9999999999999999


Q ss_pred             CCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhc
Q 040698          148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRM  223 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~  223 (309)
                      +.++|+|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.......  .   
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~---  235 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V---  235 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H---
Confidence            999999999986543222222223344567799999875   7889999999999999998 998875432111  0   


Q ss_pred             ccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                                  ...+. .......+..++..+.+|+.+||+.||.+|||+.+++++|+.
T Consensus       236 ------------~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 ------------IEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ------------HHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                        01111 111112234456779999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.5e-42  Score=294.59  Aligned_cols=265  Identities=22%  Similarity=0.272  Sum_probs=196.8

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||.|+||.||+|.. .++..||+|.+...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46899999999999999999985 46899999987654333334567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++ +|.+++.....  ..+...+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++...... 
T Consensus        84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-  156 (288)
T cd07871          84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP-  156 (288)
T ss_pred             CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence            9975 88888764432  3467888999999999999999999   999999999999999999999999988653221 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC--------ccccccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY--------FPYPIEN  233 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  233 (309)
                       ........+++.|+|||.+.    ++.++|+||+|+++|+|++|..||...+..... ......        ++.....
T Consensus       157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccccc
Confidence             12223345688899999874    678899999999999999999998654322211 111000        0000000


Q ss_pred             cchhhhhcccc----cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQV----ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...........    ........+.++.+||++||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000000    000011234568999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-41  Score=296.82  Aligned_cols=266  Identities=21%  Similarity=0.262  Sum_probs=200.7

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|+||.||++.+. +|..+++|.+.........+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4689999999999999999999964 688899998766544445667899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+++++|.+++....   ..++..+..++.+++.|+.|||+. +   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999987543   347788889999999999999974 7   99999999999999999999999998865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--c-Cc----------
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--P-YF----------  227 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~-~~----------  227 (309)
                          .......++..|+|||.+.   ++.++|+|||||++|+|++|..||..............  . ..          
T Consensus       157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             ----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence                1122345788899999986   77889999999999999999999875432211100000  0 00          


Q ss_pred             ----------cccccccc----hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 ----------PYPIENNS----LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 ----------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                +...+...    ...+.............+..+.+||.+||+.||++|||+.+++.+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                      00000000    0001111111111112346689999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=323.31  Aligned_cols=258  Identities=29%  Similarity=0.467  Sum_probs=214.0

Q ss_pred             hcccccceeecccCceEEEEEEcC--CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP--DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~--~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ..+.++...||+|.||.||.|...  +|.    .|++|.+....+......|.+|..+|+.++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            456678889999999999999943  343    48999998887777788999999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS----QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      +|++||++||+|..+++....    ...+....++.++.||++|+.||++++   ++||||..+|+|++....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999986622    234577889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      +++.+...+.........-...|||||.+.   ++.++|||||||++||+++ |..||+...+.+               
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------------  912 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------------  912 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence            998553333333333333456799999998   9999999999999999999 999977664332               


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                        .+...+... ..+.|.+|++.+.++|..||+.+|++||+|..+++.+..+.
T Consensus       913 --v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  913 --VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             --HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence              111111222 44556788888999999999999999999999999776655

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=300.40  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=211.0

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc-cEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKV-PLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~iv   83 (309)
                      .++|+.++++|+|+||.++.++++ +++.+++|.+.... ....+....+|+.++++++|||||.+.+.++.++. ++|+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            478999999999999999999854 58899999876653 23334577899999999999999999999998887 8999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |+||+||++.+.+..++ ...++++.+..|+.|++.|+.|||+++   +.||||++.|||++.++.|+++|||++.....
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998777 445688999999999999999999999   99999999999999999999999999988744


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......|++.|++||.+.   |..++|||||||++|+|++-+++|...+...-.                 ..+ 
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li-----------------~ki-  218 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI-----------------LKI-  218 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH-----------------HHH-
Confidence            32  3556688999999999998   999999999999999999999997654322211                 111 


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......+.+..++.++..+|+.||..+|..||++.+++..
T Consensus       219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1111334455666789999999999999999999999987

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.4e-42  Score=295.24  Aligned_cols=267  Identities=21%  Similarity=0.297  Sum_probs=196.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|+||.||+|..+ +|+.+|+|.+...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999964 689999998765443333445678999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++ ++|.+++....  ...+...+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..... 
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-  155 (303)
T cd07869          83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-  155 (303)
T ss_pred             ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC-
Confidence            9995 57777776443  23467888999999999999999999   99999999999999999999999998864321 


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc--ccccchh-
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IENNSLR-  237 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-  237 (309)
                       .........++..|+|||.+.    ++.++|+||+|+++|+|++|..||...................+  ....... 
T Consensus       156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         156 -PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             -CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence             112223456688899999874    67789999999999999999999975432222211111000000  0000000 


Q ss_pred             --hhhccccc--Cc-------cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 --QILNFQVA--DE-------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 --~~~~~~~~--~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ........  ..       .....+..+.+|+.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence              00000000  00       001123568899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=302.25  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=208.3

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++..+...||+|.||+||+|.|..  .||||.+.... .....+.|+.|+.++++-+|.||+-..|++-.... .||+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            34667889999999999999999853  48999876543 23346789999999999999999999999998776 9999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      -||+|.+|..++.....  .+...+++.|+.|+++||.|||.++   |+|+|||..||++.++++|+|+|||++..-..-
T Consensus       467 qwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             hhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            99999999999865553  3477899999999999999999999   999999999999999999999999998765433


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-cccccccchh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-PYPIENNSLR  237 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (309)
                      ..........+...|||||++.      |+..+|||+||+++|||++|..||. .. ..+.+..++..+ ..+...    
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~-~~dqIifmVGrG~l~pd~s----  615 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQ-NRDQIIFMVGRGYLMPDLS----  615 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CC-ChhheEEEecccccCccch----
Confidence            3333444455677899999997      8999999999999999999999988 32 222222222222 111110    


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                               .....++.++.+|+..||+.++++||.+.+|+..|+.+...
T Consensus       616 ---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  616 ---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                     11234556799999999999999999999999988877764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-41  Score=301.66  Aligned_cols=261  Identities=23%  Similarity=0.371  Sum_probs=202.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLET   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   77 (309)
                      ...++|++++.||.|+||.||+|.+.      .+..||+|++.........+.+..|+.+++.+. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            34678899999999999999999842      235799998876555555677899999999996 99999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhcc--------------------------------------------------------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSS--------------------------------------------------------  101 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~--------------------------------------------------------  101 (309)
                      ...++||||+++++|.+++.....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999998864321                                                        


Q ss_pred             -------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 040698          102 -------------------------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL  144 (309)
Q Consensus       102 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv  144 (309)
                                                           ...+++..+..++.|++.|+.|||+++   ++|+||+|+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                 112466778899999999999999999   9999999999999


Q ss_pred             cCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhh
Q 040698          145 DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM  220 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~  220 (309)
                      ++++.++++|||++................++..|+|||.+.   ++.++||||||+++|+|++ |..||..........
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999986543222222222334567799999876   7889999999999999997 889976432111110


Q ss_pred             hhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ...                 ........+..++..+.+++.+||+.||++|||+.++.+.|+++.
T Consensus       351 ~~~-----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 NKI-----------------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHH-----------------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            000                 000111122234567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-41  Score=297.32  Aligned_cols=244  Identities=25%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||.|+||.||+|.++ +|+.||+|.+....  .....+.+..|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999964 58999999876542  122345678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+.+....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999887543   3467888889999999999999999   99999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                           ......|++.|+|||.+.   ++.++|+|||||++|+|++|..||.........                 ..+.
T Consensus       171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------------~~i~  228 (329)
T PTZ00263        171 -----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-----------------EKIL  228 (329)
T ss_pred             -----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-----------------HHHh
Confidence                 122346788999999986   788999999999999999999998643221110                 1111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      .....  .+...+..+.+||.+||+.||.+||+     +.++++|
T Consensus       229 ~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        229 AGRLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             cCCcC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  11123355899999999999999997     6888876

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-41  Score=287.97  Aligned_cols=244  Identities=22%  Similarity=0.336  Sum_probs=193.8

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCccEEEEEcC
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLE----TKVPLLVYEFV   87 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~iv~e~~   87 (309)
                      ..+++|++|.||+|.. +|+.||+|.+.....  ....+.+.+|+.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 689999998765432  2224567899999999999999999999876    35678999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++|+|.+++....   ..++.....++.+++.|+.|||+. +   ++||||+|+||+++.++.++++|||++.....   
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~---  175 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS---  175 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc---
Confidence            9999999987543   346788899999999999999985 7   88999999999999999999999999865422   


Q ss_pred             cccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          167 TATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        ......++..|+|||.+.     ++.++||||||+++|+|++|..||........                 ...+..
T Consensus       176 --~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----------------~~~i~~  236 (283)
T PHA02988        176 --PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------------YDLIIN  236 (283)
T ss_pred             --ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHh
Confidence              112345678899999984     78899999999999999999999875421111                 011111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .......+..+++.+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            111111222455679999999999999999999999999988764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.9e-41  Score=285.45  Aligned_cols=255  Identities=22%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             hhcccccceeecccCceEEEEEEc----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||+|.+    ..+..+++|.+...........+..|+..+..++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            357899999999999999999974    2367899998876544444567889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  .+++..++.++.|++.|++|||+++   ++|+||+|+||+++.++.++++|||.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999875432  3477889999999999999999999   999999999999999999999999976543


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .... ........++..|+|||.+.   ++.++|+||||+++|++++ |..||........                 ..
T Consensus       158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-----------------~~  219 (266)
T cd05064         158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-----------------IK  219 (266)
T ss_pred             cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HH
Confidence            1111 11111223356799999876   7889999999999999775 9999864322110                 00


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      .+.. ......+..++..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       220 ~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 AVED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0000 001112233456699999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.8e-41  Score=288.93  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .|++.+.||+|+||.||++.. .+|+.||+|.+.....  ......+..|+.++..++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            488899999999999999985 5799999998764322  2223457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|...+..... ...++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++.....  
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--  154 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE--  154 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--
Confidence            9999999887764432 23577888999999999999999999   99999999999999999999999999865421  


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       ........++..|+|||.+.   ++.++|+||||+++|+|++|..||........... ..            ....  
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~~------------~~~~--  218 (285)
T cd05631         155 -GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-VD------------RRVK--  218 (285)
T ss_pred             -CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-HH------------HHhh--
Confidence             11223446788999999986   78899999999999999999999875422110000 00            0000  


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      ......+...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0011112234466999999999999999997     7888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=297.15  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=198.0

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|+||.||+|.+. +|+.||+|.+.....  ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999964 589999998765422  223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999986443   3467888999999999999999999   99999999999999999999999999865422 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                          ......|++.|+|||.+.   ++.++|+|||||++|+|++|..||.......... .... +...         ..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~i~~-~~~~---------~~  218 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKY-WKET---------LQ  218 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-HHHh-cccc---------cc
Confidence                334456788999999986   7889999999999999999999986543211100 0000 0000         00


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...........++.+.+||.+||+.+|.+|||+.+++++
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000012334669999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-42  Score=288.75  Aligned_cols=249  Identities=33%  Similarity=0.482  Sum_probs=190.8

Q ss_pred             ccceeecccCceEEEEEEcC-----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698           11 DKRHLLGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++.+.||.|.||.||+|.+.     .+..|++|.+.........+.+..|+..+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            45789999999999999965     3678999988665555456788999999999999999999999998888999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...+...++.++.|++.||.|||+++   ++|++|+++||+++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999987622 23477899999999999999999999   9999999999999999999999999987653222


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .............|+|||.+.   ++.++||||||+++|++++ |..||.......                 ....+.+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----------------~~~~~~~  220 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----------------IIEKLKQ  220 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----------------HHHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccc
Confidence            223333445667899999986   7889999999999999999 678865442211                 1111111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ......+..++..+.++|.+||+.||.+|||+.++++.|
T Consensus       221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             111112223446699999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-41  Score=290.79  Aligned_cols=266  Identities=20%  Similarity=0.250  Sum_probs=195.2

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||+|+||.||++.++ +++.+++|.+.... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            57999999999999999999964 58899999875432 22334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++++++..+... .  ...++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9998776554432 2  23577889999999999999999999   9999999999999999999999999987652211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh--hhhcccCcccccc-----ccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE--MTRMVPYFPYPIE-----NNS  235 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-----~~~  235 (309)
                       ........++..|+|||.+.   ++.++|+||+|+++|+|++|..||.........  ........+....     ...
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence             11222346788899999885   788999999999999999999998653221110  0000001000000     000


Q ss_pred             hhhhhcccccC------ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVAD------ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...........      ......+..+.+||++||+.||++|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000      0011244679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-41  Score=298.54  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=194.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|+||.||++.+ .+|+.|++|.+...........+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            357899999999999999999995 4689999998765444444567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|...       ....+..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus       152 e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999998542       12355778889999999999999999   999999999999999999999999998664221


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                        ........|+..|+|||.+.        .+.++|||||||++|+|++|..||..........               .
T Consensus       222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---------------~  284 (353)
T PLN00034        222 --MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS---------------L  284 (353)
T ss_pred             --cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH---------------H
Confidence              11223456788999999874        2458999999999999999999987321111000               0


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ............+...+..+.+||.+||+.||++|||+.+++++-
T Consensus       285 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             HHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            000000011112233456699999999999999999999998863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=301.64  Aligned_cols=259  Identities=29%  Similarity=0.411  Sum_probs=207.2

Q ss_pred             cccccceeecccCceEEEEEEcC--CC--cE-EEEEeccc--chhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP--DN--TL-VAVKKPKM--VDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~--~~--~~-v~ik~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ++-.+.+.||+|+||.||+|..+  ++  .. ||+|....  .........+..|.++|++++|||||+++|++.+...+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            34556789999999999999943  22  23 89998764  23344467789999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +||||+|+||+|.++|+..+.  ..+..+...++++.++||+|||+++   ++||||-.+|+|++.++.+||+|||++..
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999987665  3477889999999999999999999   99999999999999999999999999865


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...  .........-...|+|||++.   ++.++||||||+++||+++ |..||......                 ...
T Consensus       312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----------------~v~  372 (474)
T KOG0194|consen  312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----------------EVK  372 (474)
T ss_pred             Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----------------HHH
Confidence            421  111111223457799999998   8999999999999999999 78886654322                 222


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      ..+......-..+...+..+..++.+||..||+.|||+.++.+.++.+..-..+
T Consensus       373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            222222233333445667799999999999999999999999999988876664

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.9e-41  Score=285.48  Aligned_cols=255  Identities=28%  Similarity=0.425  Sum_probs=201.3

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|.+.+.||+|+||.||+|...      ++..+++|.+.........+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            567999999999999999999853      24789999887655544467889999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc-----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS-----------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      +++|||+++++|.+++.....           ....++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            999999999999999975432           233567888999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||..........     
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~-----  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE-----  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----
Confidence            9999999886542222212222333467799999886   7888999999999999998 999975433221111     


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                                  .+... .....+...+..+.+++.+||+.||.+|||+.++++.|.
T Consensus       236 ------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 ------------CITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------------HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                        01100 011111234466999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=285.03  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=208.8

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecc-cchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-----C
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPK-MVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-----T   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   77 (309)
                      ...+.|..++.||.|+||.|..+.+ .+|+.||+|++. ........++..+|+++|+.++|+||+.+.+++.-     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3456777789999999999999984 579999999886 34455557788999999999999999999998854     4


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      +..|+|+|++ +.+|...++....   ++...+..+++|+++|+.|+|+.+   ++||||||.|++++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            6779999999 6788888874442   477888899999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ++...........+.++.|-.|+|||...    |+.+.||||.||++.||++|++-|+..+.-.+-...+. ....+ ..
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~-~lGtP-~~  249 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE-LLGTP-SE  249 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH-hcCCC-CH
Confidence            98875543445557788899999999987    89999999999999999999999887654332211111 11111 11


Q ss_pred             cchhhhh--------c---ccccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 NSLRQIL--------N---FQVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~--------~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..+..+.        .   ..+...   ..+...+.+.+|+++||..||.+|+|++++++|-
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            1111111        0   000111   1234457799999999999999999999998864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=299.09  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=206.3

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .++|.+.+.||+|+||.||+|+ ..+.+.||+|.+....+ ...-..+.+|+++++.++||||+.++++|+....+|+|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            3789999999999999999999 45689999998866543 333456899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+.| +|.+++.+.+.   ++++.+..++++++.||.|||+++   +.|+|++|.||+++.+|++|++|||+++.... 
T Consensus        81 e~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            99976 99999985553   488999999999999999999999   99999999999999999999999999987644 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       .....+...|++-|||||...   |+..+|+|||||++||++.|++||-...-..-                 .+.+..
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L-----------------v~~I~~  214 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL-----------------VKSILK  214 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH-----------------HHHHhc
Confidence             233445567999999999997   89999999999999999999999754422211                 111111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        .+..++...+..+.+|++..|.+||..|.|-.+++.|
T Consensus       215 --d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  215 --DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             --CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence              1222344667789999999999999999999999765

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.1e-41  Score=293.23  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=198.6

Q ss_pred             hhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec-C
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE-T   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~   77 (309)
                      ..++|++.+.||.|+||.||+|...      +++.|++|.+...........+..|+.++.++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3568999999999999999999632      35789999876543333345677899999999 79999999998764 4


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhcc--------------------------------------------------------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSS--------------------------------------------------------  101 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~--------------------------------------------------------  101 (309)
                      ...++++||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            677899999999999998864321                                                        


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccccccccccc
Q 040698          102 --QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW  179 (309)
Q Consensus       102 --~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~  179 (309)
                        ...+++..+..++.|++.|+.|||+++   ++||||+|+||++++++.++|+|||++................++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              124577889999999999999999999   999999999999999999999999998765332222222334456679


Q ss_pred             CCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHH
Q 040698          180 LDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEI  255 (309)
Q Consensus       180 ~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (309)
                      +|||++.   ++.++|||||||++|+|++ |..||........ ..                ...........+...++.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----------------~~~~~~~~~~~~~~~~~~  304 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----------------RRLKEGTRMRAPEYATPE  304 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----------------HHHhccCCCCCCccCCHH
Confidence            9999876   8889999999999999997 9999764321110 00                000000001111223456


Q ss_pred             HHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          256 VAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       256 l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      +.+++.+||+.+|++|||+.+++++|+.+.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-40  Score=284.81  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             HhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ..+++|++.+.||+|++|.||+|...      ++..+++|.+...........+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            36789999999999999999998742      356899998765443334556888999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS-------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      ..++||||+++++|.+++.....       ....++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999999865332       122356788899999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCc
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||................ 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-  238 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-  238 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence            99999886542222111122234466799999876   7889999999999999998 788875432211110000000 


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                                       ....+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 -----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                             00111223456999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=282.37  Aligned_cols=255  Identities=26%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             hcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.++.    ...+++|.............+..|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4689999999999999999998642    457899987665444445678889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      +|||+++++|.+++.....  .+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999875443  4577889999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ............++..|+|||.+.   ++.++|+||||+++|+|++ |..||......... ......            
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~------------  224 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG------------  224 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHHcC------------
Confidence            211111111223356799999886   7889999999999999998 99997543221110 000000            


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                           ...+.+..+++.+.+++.+||+.+|++||++.+++++|.++
T Consensus       225 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 -----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 00111123346699999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=290.22  Aligned_cols=259  Identities=23%  Similarity=0.410  Sum_probs=199.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..+|++.+.||+|+||.||+|.+. +|+    .|++|.+...........+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            467999999999999999999853 343    48999887654444566788999999999999999999998764 568


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ++++|+++|+|.+++.....  .++...+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999999875443  3467888999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ..............+..|++||.+.   ++.++|+||||+++|+|++ |..||.........                  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~------------------  221 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------------  221 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH------------------
Confidence            3322211122223356799999886   7889999999999999997 99997643221110                  


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ...........+..++..+.+++.+||+.||.+|||+.+++..+..+..-..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            0001111111112233558999999999999999999999999887765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8e-41  Score=291.89  Aligned_cols=240  Identities=23%  Similarity=0.217  Sum_probs=190.0

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||++.. .+|+.+|+|.+.....  ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 5689999998765321  222345678899999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccc
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT  170 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~  170 (309)
                      +|.+++....   .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.....  .....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~  152 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcc
Confidence            9988886543   3477888999999999999999999   99999999999999999999999998864311  11222


Q ss_pred             cccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc
Q 040698          171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE  247 (309)
Q Consensus       171 ~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
                      ....|++.|+|||.+.   ++.++|+|||||++|+|++|..||...+.......                 +....  ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-----------------~~~~~--~~  213 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----------------ILMEE--IR  213 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH-----------------HHcCC--CC
Confidence            3456889999999986   78899999999999999999999854322111000                 00000  01


Q ss_pred             cchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          248 NEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       248 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .+...+..+.+||.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1223346699999999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-40  Score=282.00  Aligned_cols=258  Identities=23%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|+||.||+|.. .++..+++|.+...  ........+..|+.+++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999995 46899999976542  22333456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+++++|.+++..... ....++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988864332 234577889999999999999999999   99999999999999999999999998865432


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......++..|+|||.+.   ++.++|+||+|+++|+|++|..||.............               +.
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~---------------~~  221 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK---------------IE  221 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH---------------Hh
Confidence            21  1122345677899999875   6778999999999999999999975332111111100               00


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ............+..+.+++.+||+.+|.+|||+.++++.++.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            001111112234466999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=286.91  Aligned_cols=262  Identities=29%  Similarity=0.407  Sum_probs=202.8

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeee
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCL   75 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   75 (309)
                      +....++|++.+.||+|+||.||++...      +...+++|.+...........+..|+.++..+ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3445689999999999999999999853      24688999876544333345688899999999 7999999999999


Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQS-------------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANI  142 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~ni  142 (309)
                      ..+..+++|||+++++|..++....             ....+++..+..++.|++.|+.|||+++   ++|+||+|+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            9999999999999999999986532             2234577889999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcch
Q 040698          143 LLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASN  218 (309)
Q Consensus       143 lv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~  218 (309)
                      ++++++.++++|||++................++..|+|||...   ++.++|+||||+++|++++ |..||........
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            99999999999999987653322212222233456799999875   7889999999999999997 8888764322111


Q ss_pred             hhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          219 EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ..                  ..........+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       244 ~~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FK------------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HH------------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            00                  00011111122233456999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-40  Score=279.95  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=200.0

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .++|++.+.||+|++|.||+|...++..+++|.+.....  ..+.+..|+.+++.++|+||+++++++.+.+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            578999999999999999999987888899998765332  246788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++..... ...++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++++|||++........
T Consensus        83 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999998875433 23467888999999999999999999   99999999999999999999999999876432111


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       .......++..|+|||...   ++.++|+||||+++|+|++ |..||............ ...                
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~----------------  220 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRG----------------  220 (261)
T ss_pred             -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcC----------------
Confidence             1111223456799999876   6778999999999999998 99998643222111110 000                


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                       ...+.....+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 -YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             00111122345699999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-40  Score=303.17  Aligned_cols=250  Identities=23%  Similarity=0.229  Sum_probs=196.9

Q ss_pred             ccccceeecccCceEEEEEEc-CC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .|.+.+.||+|++|.||++.. .+ +..|++|.+..... .....+..|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            499999999999999999984 33 67888887644332 3345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ++|++|.+++... .....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999888643 22334577889999999999999999999   9999999999999999999999999987653322


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .........|++.|+|||.+.   ++.++|||||||++|+|++|..||........                 ...+...
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-----------------~~~~~~~  286 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-----------------MQQVLYG  286 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHhC
Confidence            222233456889999999886   78899999999999999999999864321110                 0011000


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .. ...+...+..+.++|.+||+.||++|||+.+++.+
T Consensus       287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            00 01112334669999999999999999999999764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=299.30  Aligned_cols=241  Identities=27%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.++||+|+||.|+++.. .+++.+|||.+....-  .+.-+....|.+++... +||.++.++.+|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            467899999999999999999995 4589999998766532  12234566777777766 4999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+.||++..+.    ....+++..+.-++..++.||+|||+++   |++||||.+||++|.+|.+||+|||++...
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999843222    2234477888999999999999999999   999999999999999999999999999875


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  ......+.+||+.|+|||.+.   |+.++|+|+||||+|+|+.|..||...                 ......+.
T Consensus       519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-----------------dEee~Fds  579 (694)
T KOG0694|consen  519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-----------------DEEEVFDS  579 (694)
T ss_pred             CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-----------------CHHHHHHH
Confidence            32  334566789999999999998   999999999999999999999996633                 23333333


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM  274 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  274 (309)
                      +++...  ..|..++.+..++++++|..||++|...
T Consensus       580 I~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 IVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            433322  2345666779999999999999999944

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-40  Score=283.44  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=197.7

Q ss_pred             cccccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .+|++.+.||+|+||.||+|.+     .++..+++|.+...........+..|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5789999999999999999973     24678999988755444444678889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhcc--------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           83 VYEFVPNGTLFQHVRYQSS--------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                      +|||+++++|.+++.....              ....++..+..++.|++.|+.|||+++   ++|+||+|+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998854321              123467788899999999999999999   99999999999999999


Q ss_pred             CeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcc
Q 040698          149 TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV  224 (309)
Q Consensus       149 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~  224 (309)
                      .++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.......  ...  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VIE--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence            99999999986543222222222333456799999875   7889999999999999998 888875332111  000  


Q ss_pred             cCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                                    ..........+..+++.+.+++.+||+.||++||++.+++++|..
T Consensus       238 --------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                          000011111122234669999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-40  Score=282.58  Aligned_cols=254  Identities=25%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ....+|++.+.||.|+||.||+|.++++..+++|.+...... ....+..|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            456789999999999999999999878999999987655432 2456888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++..... ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          82 ELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             eecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999999999976443 34577889999999999999999999   999999999999999999999999988654221


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      .  .......++..|+|||.+.   ++.++|+||||+++|+|++ |..||........                 .....
T Consensus       158 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-----------------~~~~~  218 (261)
T cd05148         158 V--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-----------------YDQIT  218 (261)
T ss_pred             c--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-----------------HHHHH
Confidence            1  1111223456799999875   7788999999999999998 8999764321110                 00010


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                       .......+..+++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus       219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             011111223444669999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-40  Score=281.83  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             hcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|.+.+.||+|+||.||++..      .++..+++|.+...... ....+..|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN-ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            46899999999999999999973      23456888877654332 345688899999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS----------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      +++|||+++++|.+++.....          ...+++..+..++.|++.||.|||+++   ++||||+|+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            999999999999999875431          123578899999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccC
Q 040698          151 KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      +++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||..........      
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~------  233 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE------  233 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------
Confidence            999999986543222212222333466799999886   7889999999999999998 899876442211100      


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                                 .+.... ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       234 -----------~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~  284 (288)
T cd05093         234 -----------CITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP  284 (288)
T ss_pred             -----------HHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence                       000000 000111233569999999999999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=297.18  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=198.3

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|+||.||+|... +|+.||+|.+.....  ......+..|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            57999999999999999999964 689999998765422  123456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998755   34577889999999999999999999   999999999999999999999999998655332


Q ss_pred             c---------------------------ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhh
Q 040698          165 D---------------------------QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVA  214 (309)
Q Consensus       165 ~---------------------------~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~  214 (309)
                      .                           .........|++.|+|||.+.   ++.++|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           001223456788999999986   7889999999999999999999987543


Q ss_pred             hcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-HHHHHHH
Q 040698          215 LASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-MRQVSEQ  280 (309)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~  280 (309)
                      ..... .....+.              .....+.....++.+.+||.+||. ||.+||+ +.+++++
T Consensus       235 ~~~~~-~~i~~~~--------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETY-NKIINWK--------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH-HHHhccC--------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            21111 0000000              000011111134669999999997 9999999 9999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.1e-40  Score=278.09  Aligned_cols=248  Identities=24%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      ++|++.+.||+|+||.||++.++++..+++|.......  ..+.+..|+.+++.++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            57999999999999999999988888999998764332  2456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          82 ENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            99999998865432  3477889999999999999999999   99999999999999999999999998865422111 


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......++..|+|||.+.   ++.++|+||||+++|+|++ |..||................ .               
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~---------------  219 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-R---------------  219 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-C---------------
Confidence            1111223345699999986   6789999999999999999 899986543221111100000 0               


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                        ...+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus       220 --~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 --LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              000111235589999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-40  Score=282.10  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=204.3

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|.+.+.||+|+||.||++...      ++..+++|....... .....+.+|+..++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            467999999999999999999732      345688887765433 2245688999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      ++||||+++++|.+++.....             ...+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            999999999999999975432             123577889999999999999999999   9999999999999999


Q ss_pred             CCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhc
Q 040698          148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRM  223 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~  223 (309)
                      +.++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||...........  
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence            999999999986543322222223344567799999876   7788999999999999998 9999765432211100  


Q ss_pred             ccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                                     +.. ......+...+..+.+++.+||+.||.+|||+.++++.|.++....+.+
T Consensus       238 ---------------~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~  289 (291)
T cd05094         238 ---------------ITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY  289 (291)
T ss_pred             ---------------HhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcc
Confidence                           000 0001111223456999999999999999999999999999987655443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-40  Score=278.92  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=199.8

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|++|.||++...++..+++|.+.....  ..+.+..|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            4578999999999999999999977778899998765432  24567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.... ....++..+..++.|++.|+.+||+++   ++|+||+|+||++++++.++++|||++.......
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999987554 224578899999999999999999999   9999999999999999999999999987653211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      . ...........|+|||.+.   ++.++|+||||+++|+|++ |..||........ ........              
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~--------------  221 (261)
T cd05068         158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQVDQGY--------------  221 (261)
T ss_pred             c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCC--------------
Confidence            1 1111112235699999876   6789999999999999999 9999764321110 00000000              


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                         ....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               0111223346699999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-41  Score=267.26  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=206.8

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++++.||+|-||.||.++ .+++-.||+|++...  .......++.+|+++-..++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            5789999999999999999999 567899999987654  3445567899999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      +||.++|+|...+....... .++...+.+..|++.|+.|+|.++   ++|||++|+|++++..+.++++|||.+.... 
T Consensus       101 lEya~~gel~k~L~~~~~~~-f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKR-FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhccccc-ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999998555443 366788999999999999999999   9999999999999999999999999986542 


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                         ...-...+|+..|+|||+..   .+...|+|++|++.|+++.|.+||.....                 ......+.
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-----------------~etYkrI~  235 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-----------------SETYKRIR  235 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-----------------HHHHHHHH
Confidence               33344568899999999998   78899999999999999999999875431                 11222222


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ......  +...+..+.++|.+|+..+|.+|.+..+++.+-
T Consensus       236 k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  236 KVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             HccccC--CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            222211  234446699999999999999999999998874

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=292.28  Aligned_cols=244  Identities=25%  Similarity=0.281  Sum_probs=194.9

Q ss_pred             hcccccceeecccCceEEEEEEcCC--CcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD--NTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.++.  +..||+|.+....  .....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4689999999999999999998433  4689999775432  22234567889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999987543   3477888999999999999999999   9999999999999999999999999986542


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .     ......|++.|+|||++.   ++.++|+|||||++|+|++|..||...+......                 .+
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-----------------~i  240 (340)
T PTZ00426        183 T-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ-----------------KI  240 (340)
T ss_pred             C-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-----------------HH
Confidence            1     123456788999999986   7889999999999999999999986432211100                 01


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .....  ..+...++.+.++|++||+.||++|+     |+.+++++
T Consensus       241 ~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        241 LEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             hcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11000  01122335589999999999999995     89999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-41  Score=276.39  Aligned_cols=266  Identities=22%  Similarity=0.212  Sum_probs=202.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~   81 (309)
                      ..++|+++..|++|.||.||+|++ ++++.||+|+++... +...--...+|+.+|.+.+|||||.+..+.+.  -+..|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            357899999999999999999995 579999999887653 22222346789999999999999999998874  35789


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||||+ .+|.+++.... + .+...+..-+..|+++|++|||.++   |+|||||++|++++..|.+||+|||+|+.+
T Consensus       154 ~VMe~~E-hDLksl~d~m~-q-~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMK-Q-PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHH-hhHHHHHHhcc-C-CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            9999996 68888887665 2 3355788889999999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcccccccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYPIENN  234 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (309)
                      .+.  ....+..+-+..|+|||.+.    |+.+.|+||+||++.+|+.+.+-|+......+-.....   ..-...++..
T Consensus       228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            543  34455667789999999997    99999999999999999999998876543332211111   1100111111


Q ss_pred             chhhhhc---c--------cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILN---F--------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~---~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..-..++   .        +..+. ....++...+|+..+|..||++|.|+++.+++
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~-~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFG-ALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhcc-ccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1111110   0        00000 11144668999999999999999999999886

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-40  Score=291.58  Aligned_cols=250  Identities=23%  Similarity=0.290  Sum_probs=193.4

Q ss_pred             ccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCcc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVP   80 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   80 (309)
                      +|++.+.||+|+||.||++..    .+|..+|+|.+....   .....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            589999999999999999874    358899999875432   222345677889999999 589999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999886543   3477889999999999999999999   99999999999999999999999999865


Q ss_pred             cccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ..... ........|+..|+|||.+.    ++.++||||||+++|+|++|..||..........             ...
T Consensus       155 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------------~~~  220 (332)
T cd05614         155 FLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS-------------EVS  220 (332)
T ss_pred             ccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH-------------HHH
Confidence            42211 11223356889999999875    5778999999999999999999986432111000             000


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ..+....  ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       221 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         221 RRILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HHHhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0011100  111122345689999999999999999     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-40  Score=277.71  Aligned_cols=246  Identities=27%  Similarity=0.423  Sum_probs=190.9

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      +.||+|+||.||+|.. .+++.+++|.............+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4689999999999986 468999999876544444566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++....  ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++..............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99986443  23477889999999999999999999   99999999999999999999999998865322111111111


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCcc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN  248 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (309)
                      ...+..|+|||.+.   ++.++|+||||+++|+|++ |..||.......... ...                 .......
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~~-----------------~~~~~~~  217 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIE-----------------QGVRLPC  217 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HHH-----------------cCCCCCC
Confidence            12245699999876   6788999999999999997 888875432211100 000                 0011111


Q ss_pred             chHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       249 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      +...+..+.+++.+||+.||++|||+.++++.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2233456999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-40  Score=295.85  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||++.. .++..+|+|.+....  .....+.+..|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3467899999999999999999985 468999999876432  1222345778999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++...    .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999988643    2467788889999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ... .........|++.|+|||.+.       ++.++|+|||||++|+|++|..||.......                 
T Consensus       193 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----------------  254 (370)
T cd05596         193 DAN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----------------  254 (370)
T ss_pred             cCC-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----------------
Confidence            221 111223456889999999874       5778999999999999999999986432211                 


Q ss_pred             chhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHH
Q 040698          235 SLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~  280 (309)
                      ....+....  ...+.....+..+.+||++||+.+|.+  |+|+.+++++
T Consensus       255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111111111  111111234467999999999999987  9999999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-40  Score=281.82  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             hhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|.+.+.||+|++|.||+|.+.      .+..+++|.............+..|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4688999999999999999999864      3578888987655444445668889999999999999999999998889


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccc----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQ----VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---TAKV  152 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l  152 (309)
                      .++||||+++++|.+++......    ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++   .+++
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            99999999999999998755421    23577889999999999999999999   99999999999998654   5899


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      +|||++.................+..|+|||.+.   ++.++|||||||++|+|++ |..||........ ......   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~---  236 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-MEFVTG---  236 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHc---
Confidence            9999987652221111111222345799999875   8889999999999999997 9999864322211 000000   


Q ss_pred             ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                                    ......+...+..+.+++.+||+.||++|||+.+++++|.
T Consensus       237 --------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 --------------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                          0011112233456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.7e-40  Score=282.02  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=203.7

Q ss_pred             HhhcccccceeecccCceEEEEEEcCC-----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-TK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~   78 (309)
                      ...++|++.+.||+|+||.||+|.+.+     +..+++|.+...........+..|+.+++.++||||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456899999999999999999999655     688899987655444446678889999999999999999998765 57


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccc-----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQ-----VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                      ..+++++|+++++|.+++......     ..+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998754332     34678889999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      |||++..+.............++..|+|||.+.   ++.++||||||+++|++++ |..||.......  ......    
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLK----  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHH----
Confidence            999986543222211112233456699999876   7889999999999999998 999986432211  100000    


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                                  ..........+++.+.+++.+||+.||++|||+.++++.|..+..
T Consensus       234 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 ------------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ------------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                        000011112234669999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.7e-40  Score=284.41  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=200.5

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||++..      .++..+++|.+.........+.+..|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            356899999999999999999873      235689999877654444456789999999999 7999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..+++|||+++++|.+++..... ...++.++..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999875433 23578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ................++..|+|||.+.   ++.++|+||+|+++|+|++ |..||...........             
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-------------  255 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-------------  255 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-------------
Confidence            6553322111122234466799999876   7889999999999999998 8999754321110000             


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                          ..........+...++.+.+++.+||+.+|++|||+.++++.|.++
T Consensus       256 ----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 ----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ----HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                0000001111112335699999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-40  Score=284.52  Aligned_cols=266  Identities=27%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             HHhhcccccceeecccCceEEEEEEc--------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeee
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL--------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVC   74 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~--------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~   74 (309)
                      ....++|.+.+.||.|+||.||++..        .++..+++|.............+..|+..++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            34567899999999999999999963        124578999876543333356788999999999 799999999999


Q ss_pred             ecCCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040698           75 LETKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN  141 (309)
Q Consensus        75 ~~~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~n  141 (309)
                      ...+..+++|||+++++|.+++.....             ....+...+..++.|++.|+.|||+++   ++|+||+|+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence            999999999999999999999975432             123466788999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcc
Q 040698          142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALAS  217 (309)
Q Consensus       142 ilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~  217 (309)
                      |+++.++.++++|||.+................++..|+|||.+.   ++.++||||||+++|+|++ |..||.......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999987653322222222334456799999875   7889999999999999998 778865332111


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      ..  .               .+ ........+..++..+.+++.+||+.+|.+|||+.++++.|.++.....+
T Consensus       248 ~~--~---------------~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         248 LF--K---------------LL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             HH--H---------------HH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence            00  0               00 00001111223446699999999999999999999999999888776544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.9e-40  Score=281.19  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||+|++|.||+|.+ .++..+++|.+...........+..|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4789999999999999999985 568999999876543344456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|..+.       ..++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.....   
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---  147 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---  147 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc---
Confidence            9999986542       2366788899999999999999999   99999999999999999999999999865422   


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                       .......++..|+|||.+.   ++.++|+||||+++|+|++|..||..........          ..........+..
T Consensus       148 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~  216 (279)
T cd06619         148 -SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL----------MPLQLLQCIVDED  216 (279)
T ss_pred             -ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc----------chHHHHHHHhccC
Confidence             1223346788899999986   7889999999999999999999986532111000          0000011111111


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .........+..+.+++.+||+.||++||++.+++++-
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            11111122345689999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.8e-40  Score=285.10  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             hcccccceeecccCceEEEEEEcC--------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP--------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      .++|.+.+.||+|+||.||++.+.        ++..+++|.+...........+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            478999999999999999998742        23579999887543333345678899999998 799999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL  144 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv  144 (309)
                      +..++||||+++++|.+++.....             ....++.++..++.|++.|++|||+++   ++|+||+|+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999976432             123577889999999999999999999   9999999999999


Q ss_pred             cCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhh
Q 040698          145 DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM  220 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~  220 (309)
                      ++++.++++|||.+................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.......  .
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence            999999999999886542211111112222346799999875   7889999999999999998 888875432111  0


Q ss_pred             hhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      ..                ........+.+...+..+.+++.+||+.+|.+|||+.++++.|.++.+.
T Consensus       252 ~~----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         252 FK----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HH----------------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            00                0001111112223446799999999999999999999999999887665

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=294.52  Aligned_cols=238  Identities=29%  Similarity=0.449  Sum_probs=198.0

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ++.||.|+-|.||.|+. .++.||+|+++...        ..+++-|+.++||||+.+.|+|.+.--+|||||||..|.|
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            57899999999999998 46889999765432        4457889999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      ...|+...   ..+...+..|..+|+.||.|||.+.   |+|||||.=||||+-+..|||+|||-++....   ....-.
T Consensus       200 ~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMS  270 (904)
T KOG4721|consen  200 YEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMS  270 (904)
T ss_pred             HHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhh
Confidence            99997443   3466889999999999999999999   99999999999999998999999998866422   233334


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..|+..|||||++.   .++++|||||||+||||++|..||...+..                 ..+-..-....-.+.+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------------AIIwGVGsNsL~LpvP  333 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------------AIIWGVGSNSLHLPVP  333 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------------eeEEeccCCcccccCc
Confidence            67899999999998   789999999999999999999997655321                 1111222223334456


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ..|++.+.-||+.||+..|.+||||.+++.||.-..
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            678888999999999999999999999999997554

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-39  Score=276.49  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|++|.||+|... +|+.+++|.+...  ......+.+..|+.++++++|+|++++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999965 7899999977532  22333567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+++++|..++.... .....+...+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 2334577889999999999999999999   99999999999999999999999998865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......++..|+|||.+.   ++.++|+||||+++|+|++|..||..........               .....
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~  221 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---------------CKKIE  221 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---------------Hhhhh
Confidence            21  1122345677899999875   7778999999999999999999975332111000               00000


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ............+..+.++|.+||+.+|.+|||+.++++.|..++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            000000011134466999999999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.1e-40  Score=282.16  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=197.6

Q ss_pred             ccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +|++.+.||.|+||.||+|...      ....+++|.............+..|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            5899999999999999999842      2356888877654433334678889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040698           83 VYEFVPNGTLFQHVRYQSS---------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN  141 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~n  141 (309)
                      ++||+++++|.+++.....                     ...+++..++.++.|++.|+.|||+++   ++|+||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999998864321                     123567889999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcc
Q 040698          142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALAS  217 (309)
Q Consensus       142 ilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~  217 (309)
                      |++++++.++|+|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999986543222211222233456799999875   7889999999999999998 999976432111


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      . ..                 ..........+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       238 ~-~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 L-FN-----------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H-HH-----------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            0 00                 00000011112233456999999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.6e-40  Score=278.46  Aligned_cols=258  Identities=22%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|++|.||++.. .+|..+++|.+....  .......+..|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5799999999999999999994 578999999765432  2233457788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+++++|.+++.... .....++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886432 2345678889999999999999999999   99999999999999999999999998765422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......++..|+|||...   ++.++|+||||+++|+|++|..||...........               ..+.
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---------------~~~~  221 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---------------KKIE  221 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh---------------hhhh
Confidence            21  1122345677899999885   67789999999999999999999753221111100               0011


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ............++.+.+++.+||+.||.+|||+.++++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            111111112235567999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=280.94  Aligned_cols=256  Identities=26%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||.|+||.||+|..+      ++..+++|.+...........+..|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3578999999999999999999853      2478999987655444445567889999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS-------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                      .++||||+++++|.+++.....       ....++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.+++
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            9999999999999999865432       123467788999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      +|||++................++..|+|||.+.   ++.++|+||||+++|++++ |..||...+......        
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--------  232 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK--------  232 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH--------
Confidence            9999986543322222223344567799999875   7889999999999999998 898875432211110        


Q ss_pred             ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                               ... .......+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       233 ---------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 ---------FVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---------HHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                     000 00011112223466999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-40  Score=277.22  Aligned_cols=254  Identities=25%  Similarity=0.304  Sum_probs=206.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhh--hHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKIL--INEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+.|++++.||+|.-|.||++..++ +..+|+|++....-..  ...+.+.|-.+|+.++||.+..++..|+.++..|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            34678999999999999999999654 6999999987754322  23456778899999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      +||||+||+|..+.+.+... .+++..+.-++..++.||+|||-.|   |++|||||+||||-++|+|.++||.++....
T Consensus       155 ~meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EEecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            99999999999888877665 4577889999999999999999999   9999999999999999999999999874431


Q ss_pred             c---------------------------------cccc---------------------ccccccccccccCCCcccc--
Q 040698          163 S---------------------------------HDQT---------------------ATTTKEIETVGWLDPEYLF--  186 (309)
Q Consensus       163 ~---------------------------------~~~~---------------------~~~~~~~~~~~~~~PE~~~--  186 (309)
                      .                                 ....                     ......+||-.|+|||++.  
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            0                                 0000                     0112245788999999998  


Q ss_pred             -cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhc
Q 040698          187 -WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLR  265 (309)
Q Consensus       187 -~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  265 (309)
                       -+.++|+|.||+++|||+.|..||-.                 ......+..++.....++.....+..+++||++.|.
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG-----------------~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKG-----------------SNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCC-----------------CCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence             67789999999999999999999554                 344445555555555555555666779999999999


Q ss_pred             cCCCCCCC----HHHHHHH
Q 040698          266 TSGTERPT----MRQVSEQ  280 (309)
Q Consensus       266 ~dp~~Rps----~~~ll~~  280 (309)
                      +||.+|..    +.+|-+|
T Consensus       374 KdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cChhhhhccccchHHhhcC
Confidence            99999997    7777654

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-39  Score=279.83  Aligned_cols=268  Identities=28%  Similarity=0.337  Sum_probs=198.7

Q ss_pred             ccc-ccceeecccCceEEEEEE-----cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCc
Q 040698            8 KNY-DKRHLLGEGGFGFVYKGV-----LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKV   79 (309)
Q Consensus         8 ~~y-~i~~~lg~g~~g~v~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   79 (309)
                      ++| ++.+.||.|+||.||++.     ..++..+++|.............+.+|+.+++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            445 999999999999998864     235789999988765443445678889999999999999999998765  346


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .+++|||+++++|.+++...    ..++..++.++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            78999999999999988643    2578899999999999999999999   9999999999999999999999999986


Q ss_pred             cccccccccc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQTAT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      .......... .....++..|+|||...   ++.++|+||||+++|+|++|..||......-.....   ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~  232 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG---PKQGQMTVVR  232 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc---ccccccchhh
Confidence            5532111111 11223455699999876   788999999999999999999997644221111110   0000011111


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .............+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111111223344567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=294.51  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|+||.||++.. .+|+.||+|.+.....  ......+..|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999995 4689999998865421  222355778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999887543   3578889999999999999999999   999999999999999999999999988653211


Q ss_pred             cccc------------------------------------cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh
Q 040698          165 DQTA------------------------------------TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT  205 (309)
Q Consensus       165 ~~~~------------------------------------~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~  205 (309)
                      ....                                    ......|++.|+|||++.   ++.++|+|||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    011235788999999886   7889999999999999999


Q ss_pred             CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC---HHHHHHH
Q 040698          206 GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT---MRQVSEQ  280 (309)
Q Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~  280 (309)
                      |..||......... .....+ .             ...........++.+.+||.+|+. +|.+|++   +.+++++
T Consensus       235 G~~Pf~~~~~~~~~-~~i~~~-~-------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETY-RKIINW-K-------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHH-HHHHcC-C-------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99998644321110 000000 0             000011111234668999999997 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-40  Score=274.27  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=204.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCC-----
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKN-VVKILGVCLETK-----   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~-----   78 (309)
                      ...|+.++.||+|.||+||+|.. .+|+.||+|+++.... +..-....+|+.+++.++|+| |+.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            35688899999999999999994 5789999998866533 334456789999999999999 999999998877     


Q ss_pred             -ccEEEEEcCCCCCHHHHHHhhccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           79 -VPLLVYEFVPNGTLFQHVRYQSSQ-VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        79 -~~~iv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                       .+++||||++ .+|..++...... ...+...+..+++|++.|++|||+++   |+||||||.||+|+++|.+|++|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             7899999994 6999999866532 23455889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc-cCccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV-PYFPYPI  231 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~  231 (309)
                      +++....  .....+....+..|+|||++.    |+...||||+||++.||+++++-|+......+...... -..|...
T Consensus       166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9975421  223355677889999999987    89999999999999999999998876544322211111 1111112


Q ss_pred             cccchhhhhcccccCcc---ch-------HHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVADEN---EM-------EEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~---~~-------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+.+.+..+..   +.       ....+..+++.+||+.+|.+|.|+..++.|
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22222222222211110   11       111468999999999999999999999886

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.9e-40  Score=275.86  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=195.6

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .++|++.+.||+|++|.||.+.+.++..+++|.+.....  ..+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            357999999999999999999877777799998764432  235688899999999999999999999988899999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++.....  ..++..++.++.|++.|++|||+++   ++|+||+|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998875433  3577889999999999999999999   99999999999999999999999998765422111


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       .......++..|+|||...   ++.++|+||||+++|+|++ |..||................                
T Consensus       156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  218 (256)
T cd05113         156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL----------------  218 (256)
T ss_pred             -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC----------------
Confidence             1111223345699999986   6788999999999999998 999986543221110000000                


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                        ....+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       219 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 --RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              00011112356999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-39  Score=279.28  Aligned_cols=261  Identities=23%  Similarity=0.377  Sum_probs=197.8

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||.|+||.||+|.+. +|+    .+++|.............+..++..++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            478999999999999999999853 344    4777876544333334567778888899999999999998764 4568


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +++||+++++|.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++...
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999875432  3477889999999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............++..|+|||.+.   ++.++|+||||+++|++++ |..||.........  .               
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~--~---------------  222 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP--D---------------  222 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--H---------------
Confidence            3222222222334566799999875   7889999999999999998 99997643221100  0               


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                       ..........+..++.++.+++.+||..||.+|||+.++++.|..+..-.+.+
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         223 -LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             -HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence             00000000111112355889999999999999999999999998877655443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.7e-40  Score=279.61  Aligned_cols=261  Identities=24%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||.|+||.||+|.+ .+|+    .|++|.............+..|..++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            46899999999999999999984 3444    4789987665555556678889999999999999999999875 4568


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ++++|+++++|.+++.....  .+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999998865432  3577889999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............++..|+|||...   ++.++|+||||+++|+|++ |..||........                  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------------------~  221 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI------------------P  221 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------------------H
Confidence            3222211122223456799999886   7788999999999999998 8889764321110                  0


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                      ...........+..++..+.+++.+||+.||+.||++.++++.|..+...+.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05109         222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF  275 (279)
T ss_pred             HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence            000111111112234456899999999999999999999999988876655443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-40  Score=301.84  Aligned_cols=256  Identities=23%  Similarity=0.221  Sum_probs=200.2

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC---
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETK---   78 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   78 (309)
                      ....++|++.+.||+|+||.||++.. .+|+.||+|.+.... .......+..|+..+..++|+|++++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            45678999999999999999999984 569999999875432 2333456788999999999999999988775322   


Q ss_pred             -----ccEEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           79 -----VPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        79 -----~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                           .+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 3679999999999999886432 2345677889999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      +|||++................|++.|+|||.+.   ++.++||||||+++|+|++|..||..........         
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~---------  255 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH---------  255 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---------
Confidence            9999987653322222334456889999999986   7889999999999999999999986432211000         


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              ..... .....+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       256 --------~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 --------KTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --------HHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    00000 0011223345679999999999999999999999875

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=275.74  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=195.9

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ++|++.+.||.|++|.||.+.. .++..+++|.+.....    ......+..|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999985 4689999997654321    1123467889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ++||+++++|.+++....   ..+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999887543   3467888999999999999999999   9999999999999999999999999986543


Q ss_pred             ccccccc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTAT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ....... .....++..|+|||.+.   ++.++|+||||+++|+|++|..||...+.......                 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----------------  218 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----------------  218 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-----------------
Confidence            2111111 12334667899999987   67899999999999999999999764322111100                 


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........+...+..+.++|.+||+.+|.+|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000001111222344669999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.7e-40  Score=286.03  Aligned_cols=240  Identities=24%  Similarity=0.233  Sum_probs=188.9

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||++.. .+|..||+|.+.....  ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 4689999998765321  222345677899999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccc
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT  170 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~  170 (309)
                      +|..++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~  152 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence            9988886443   3477889999999999999999999   999999999999999999999999987643111  1122


Q ss_pred             cccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc
Q 040698          171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE  247 (309)
Q Consensus       171 ~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
                      ....|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+......                 .+.....  .
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-----------------~~~~~~~--~  213 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-----------------LILMEEI--R  213 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------------HHhcCCC--C
Confidence            2346788999999986   7889999999999999999999986432211100                 0000000  0


Q ss_pred             cchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          248 NEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       248 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .+...++.+.++|.+||+.||.+||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1122346699999999999999998     89988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-39  Score=279.32  Aligned_cols=259  Identities=25%  Similarity=0.369  Sum_probs=198.5

Q ss_pred             HhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      +..++|++.+.||+|+||.||+|..+      .+..+++|.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45789999999999999999998743      245799998765543333456788999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS-------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      ..++||||+++++|.+++.....       ....+...+..++.|++.|+.|||+++   ++|+||+|+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975432       123355678889999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCc
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ++|||++................++..|+|||...   ++.++|+||||+++|+|++ |..||..........       
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-------  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-------  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------
Confidence            99999886543222222222234456799999876   7889999999999999998 788875432211000       


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                                .+... .....+...+..+.+++.+||+.||.+|||+.++++.|.+.
T Consensus       233 ----------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 ----------FVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ----------HHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                      00000 00011112235699999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.6e-40  Score=281.86  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ..+|++.+.||.|+||.||+|...      ++..|++|.+.........+.+..|..++..++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            357899999999999999999843      25789999887655444456788999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQS-------------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      ++++||+.+++|.+++....             .....+...+..++.|++.|+.|||+++   ++||||+|.||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            99999999999999885321             1223566778899999999999999999   9999999999999999


Q ss_pred             CCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhc
Q 040698          148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRM  223 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~  223 (309)
                      +.++++|||++................+++.|+|||.+.   ++.++|+||||+++|+|++ |..||.......  ..  
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~--  236 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VI--  236 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH--
Confidence            999999999886543322222223344567899999875   7888999999999999998 787865432111  11  


Q ss_pred             ccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                                   ..+.. ......+..++..+.+++.+||+.+|.+|||+.+++..|+.
T Consensus       237 -------------~~i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 -------------EMIRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -------------HHHHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                         11111 01111223455669999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.7e-40  Score=291.50  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=191.9

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++.. .+++.+|+|.+.....  ......+..|..++..++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            5799999999999999999985 4589999998865321  222356788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999987543   3577889999999999999999999   999999999999999999999999998643211


Q ss_pred             ccc---------------------------------ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCC
Q 040698          165 DQT---------------------------------ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKH  208 (309)
Q Consensus       165 ~~~---------------------------------~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~  208 (309)
                      ...                                 .......|++.|+|||.+.   ++.++|+|||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            000                                 0012346889999999986   7889999999999999999999


Q ss_pred             CCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhc--cCCCCCCCHHHHHHH
Q 040698          209 PRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLR--TSGTERPTMRQVSEQ  280 (309)
Q Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~ll~~  280 (309)
                      ||......... ..... +.             .....+.....++.+.++|.+|+.  .++..||++.+++++
T Consensus       235 Pf~~~~~~~~~-~~i~~-~~-------------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQETY-KKVMN-WK-------------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHHHH-HHHHc-Cc-------------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            98643221111 00000 00             000011111233568888888665  233456899999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.3e-40  Score=285.96  Aligned_cols=240  Identities=24%  Similarity=0.217  Sum_probs=189.7

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||++.. .+|+.+|+|.+....  .......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999995 468999999876532  1222356778899999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccc
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT  170 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~  170 (309)
                      +|...+....   .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.....  .....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~  152 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATM  152 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--ccccc
Confidence            9988876443   3577889999999999999999999   99999999999999999999999998764321  11222


Q ss_pred             cccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc
Q 040698          171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE  247 (309)
Q Consensus       171 ~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
                      ....|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+.......                 +....  ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-----------------~~~~~--~~  213 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----------------ILMED--IK  213 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-----------------hccCC--cc
Confidence            3346788999999986   78899999999999999999999864322111000                 00000  01


Q ss_pred             cchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          248 NEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       248 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .+...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1122346689999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=287.28  Aligned_cols=251  Identities=25%  Similarity=0.310  Sum_probs=209.2

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhh--hhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKI--LINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   81 (309)
                      ....|++.+.||+|.||.||.+..+. |+.+|+|.+......  .....+.+|+.+|+++. ||||++++++|++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45689999999999999999999654 999999987665332  23468899999999998 999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCCeEEEeeec
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD----NYTAKVADFAS  157 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~----~~~v~l~d~g~  157 (309)
                      +|||++.||.|.+.+...    ..++..+..++.|++.+++|||+.|   ++|||++|+|+++..    ++.++++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999766    1588999999999999999999999   999999999999953    35799999999


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      +.....   .......+|++.|+|||++.   |+..+|+||+|+++|.|++|.+||-..+............+       
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------
Confidence            987633   44566789999999999997   89999999999999999999999765432222221111111       


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                              ....+.+...++.+.++|+.||..||..|+|+.++++|-
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence                    223344556678899999999999999999999999974

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-39  Score=281.25  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=198.2

Q ss_pred             cccccceeecccCceEEEEEEcCC-Cc--EEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPD-NT--LVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~-~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ++|++.+.||.|+||.||+|..++ +.  .+++|.+.........+.+..|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            589999999999999999998543 33  46777766433333356688899999999 799999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           84 YEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      +||+++++|.+++.....             ...+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999865331             123577889999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccC
Q 040698          151 KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      +|+|||++.....   .........+..|+|||.+.   ++.++|+||||+++|+|++ |..||......... .     
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-~-----  229 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-E-----  229 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H-----
Confidence            9999998753211   11111122244699999876   6889999999999999997 99997543211100 0     


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                                 .. ........+..++..+.+|+.+||+.+|.+|||+.++++.|..+...++.
T Consensus       230 -----------~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         230 -----------KL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -----------HH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                       00 00011111223446699999999999999999999999999887765544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=281.22  Aligned_cols=250  Identities=22%  Similarity=0.274  Sum_probs=195.3

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      +|++.+.||+|+||.||++.. .+++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            589999999999999999995 4689999998765322  2223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence            9999999988764432 34577889999999999999999999   999999999999999999999999988654221 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++|+||+|+++|+|++|..||...........             ....+.. 
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-------------~~~~~~~-  219 (285)
T cd05605         156 --ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-------------VERRVKE-  219 (285)
T ss_pred             --CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-------------HHHHhhh-
Confidence              1122346788899999986   78889999999999999999999864321110000             0000000 


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                       .....+...+..+.+|+.+||+.||.+||     ++.+++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             01111223456699999999999999999     88888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-39  Score=275.96  Aligned_cols=253  Identities=29%  Similarity=0.426  Sum_probs=197.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..+|.+.+.||.|++|.||+|.++ +++.+++|.......  ....+..|+.+++.++||||+++++++...+..+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            356899999999999999999954 588999998765432  23567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          83 FMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             eCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999999865433 23477888999999999999999999   9999999999999999999999999986653221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ... ......+..|+|||.+.   ++.++|+||||+++|+|++ |..||........ .....                 
T Consensus       159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~-----------------  219 (263)
T cd05052         159 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLE-----------------  219 (263)
T ss_pred             eec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH-----------------
Confidence            111 11122345699999876   7788999999999999998 8889764322111 00000                 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            0011122233446699999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-39  Score=281.49  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=198.5

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||+|+||.||++.+ .+|..+++|.+...........+..|+.++++++||||+++++++.+++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4799999999999999999985 458888988876554444456788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++....   .+++..+..++.|++.||.|||+ .+   ++|+||+|+||++++++.++++|||++.....  
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  152 (308)
T cd06615          81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  152 (308)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc--
Confidence            99999999987542   34778899999999999999997 58   99999999999999999999999998754321  


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc---------
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN---------  233 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  233 (309)
                        .......++..|+|||...   ++.++|+||||+++|+|++|..||...+.....  ............         
T Consensus       153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         153 --SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE--AMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH--HhhcCccccccccCCcccccC
Confidence              1123346678899999875   778899999999999999999998644321111  111000000000         


Q ss_pred             --------c----chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 --------N----SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 --------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                              .    ..................+..+.+|+.+||+.||++|||+.+++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    0    00000000001111112456699999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.4e-40  Score=291.30  Aligned_cols=249  Identities=23%  Similarity=0.292  Sum_probs=196.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++.. .+|+.+|+|.+.....  ......+..|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999995 4689999998765432  233456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++.....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999876532  3577888999999999999999999   999999999999999999999999998655322


Q ss_pred             cccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      .. .......+++.|+|||.+.         ++.++||||||+++|+|++|..||.........                
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~----------------  218 (330)
T cd05601         156 KM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY----------------  218 (330)
T ss_pred             Cc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH----------------
Confidence            11 1222346788999999874         567899999999999999999998643221110                


Q ss_pred             hhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ..+....  ...+.....+..+.+|+.+||+ ||.+|||+.+++++
T Consensus       219 -~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         219 -NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             0010000  0111112234669999999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-39  Score=282.69  Aligned_cols=266  Identities=26%  Similarity=0.391  Sum_probs=202.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC--------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeee
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP--------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCL   75 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   75 (309)
                      ...++|.+.+.||+|+||.||++...        ++..+++|.+...........+..|+.+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34578999999999999999999731        24578899876544333455678899999999 6999999999999


Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANI  142 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~ni  142 (309)
                      +.+..+++|||+++++|.+++.....             ....++..+..++.|++.|+.|||+++   ++|+||+|+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            98999999999999999999975432             123577888999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcch
Q 040698          143 LLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASN  218 (309)
Q Consensus       143 lv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~  218 (309)
                      +++.++.++++|||.+................++..|+|||.+.   ++.++|+||||+++|+|++ |..||....... 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            99999999999999986543222111122223345799999875   7889999999999999998 888875432111 


Q ss_pred             hhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          219 EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                       .....                ........+..++..+.+++.+||+.||++|||+.++++.|..+.....+.
T Consensus       245 -~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~  300 (314)
T cd05099         245 -LFKLL----------------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE  300 (314)
T ss_pred             -HHHHH----------------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCC
Confidence             00000                000001112233456899999999999999999999999998887544443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.3e-40  Score=292.06  Aligned_cols=251  Identities=20%  Similarity=0.269  Sum_probs=192.1

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .|++++.||+|+||.||+|.+ .++..+|+|.+....  .....+.+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            689999999999999999984 568999999886542  22224568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++|++|.+++....   ..++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999887543   3477888889999999999999999   9999999999999999999999999874321000


Q ss_pred             c---------------------------------------------cccccccccccccCCCcccc---cCCCcchhhHH
Q 040698          166 Q---------------------------------------------TATTTKEIETVGWLDPEYLF---WTEKSDVYSFG  197 (309)
Q Consensus       166 ~---------------------------------------------~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG  197 (309)
                      .                                             ........|++.|+|||.+.   ++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             00012346888999999986   78899999999


Q ss_pred             HHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhh--ccCCCCCCCHH
Q 040698          198 VVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCL--RTSGTERPTMR  275 (309)
Q Consensus       198 ~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~  275 (309)
                      |++|+|++|..||.............. +              ......+.....++.+.+||.+|+  ..+|..||++.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~-~--------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVIN-W--------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHc-c--------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            999999999999875432211111000 0              000011111123456889998854  55666699999


Q ss_pred             HHHHH
Q 040698          276 QVSEQ  280 (309)
Q Consensus       276 ~ll~~  280 (309)
                      ++++|
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-39  Score=281.81  Aligned_cols=258  Identities=28%  Similarity=0.420  Sum_probs=196.6

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc--EEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT--LVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||.|+||.||+|.++ ++.  .+++|.............+.+|+.++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            468999999999999999999854 454  45666655433334456788899999999 89999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           83 VYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      ||||+++++|.+++.....             ...+++..+..++.|++.|++|||+++   ++||||+|+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999999875432             124577889999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++|+|||++.....   .........+..|+|||.+.   ++.++|+||||+++|+|++ |..||..........  ..+
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~  237 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--KLP  237 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH--HHh
Confidence            99999998753211   11111122345699999876   6789999999999999998 999975432211100  000


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                                      .......+...+..+.+|+.+||+.+|.+|||+.+++..+..+....
T Consensus       238 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         238 ----------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             ----------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                            00001111223456899999999999999999999999987664433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=293.42  Aligned_cols=252  Identities=18%  Similarity=0.275  Sum_probs=192.4

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++++.||.|+||.||++.. .+|+.||+|.+....  .....+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            5799999999999999999985 568999999875432  2223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999886443   3477888899999999999999999   999999999999999999999999988532110


Q ss_pred             ccc------------c---------------------------------cccccccccccCCCcccc---cCCCcchhhH
Q 040698          165 DQT------------A---------------------------------TTTKEIETVGWLDPEYLF---WTEKSDVYSF  196 (309)
Q Consensus       165 ~~~------------~---------------------------------~~~~~~~~~~~~~PE~~~---~~~~~Diwsl  196 (309)
                      ...            .                                 ......|++.|+|||.+.   ++.++|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 001235788999999986   7889999999


Q ss_pred             HHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCC---CC
Q 040698          197 GVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTER---PT  273 (309)
Q Consensus       197 G~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps  273 (309)
                      ||++|+|++|..||........ ......+ .             .....+.....+..+.+||.+||. +|.+|   +|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~-~~~i~~~-~-------------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHET-YRKIINW-R-------------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHH-HHHHHcc-C-------------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999864322111 0000000 0             000001111233568999999997 77665   59


Q ss_pred             HHHHHHHH
Q 040698          274 MRQVSEQL  281 (309)
Q Consensus       274 ~~~ll~~l  281 (309)
                      +.+++.+-
T Consensus       299 ~~~~l~hp  306 (377)
T cd05629         299 AHEIKSHP  306 (377)
T ss_pred             HHHHhcCC
Confidence            99998873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=284.24  Aligned_cols=238  Identities=24%  Similarity=0.261  Sum_probs=186.8

Q ss_pred             ecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||+|+||.||++.+. +++.||+|.+....  .......+..|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999964 58899999876432  122234577899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ......
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~  152 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNT  152 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccc
Confidence            99887543   3477888999999999999999999   999999999999999999999999998643221  122234


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........                 ..+...  ....+
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-----------------~~~~~~--~~~~~  213 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-----------------RKILQE--PLRFP  213 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-----------------HHHHcC--CCCCC
Confidence            56788999999986   788999999999999999999998643211100                 001100  01112


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCC---HHHHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPT---MRQVSEQ  280 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~  280 (309)
                      ...++.+.++|.+||+.||.+||+   +.+++++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            234466999999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.8e-40  Score=281.44  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=188.4

Q ss_pred             cccccceeecccCceEEEEEEc-C-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhc---CCCccceeeeeee-----c
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-P-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQI---NHKNVVKILGVCL-----E   76 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~   76 (309)
                      ++|++.+.||+|+||.||+|.+ . +|..+|+|.+..... ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            5799999999999999999985 3 467899997654321 11123345566666554   6999999999875     3


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      ...+++||||++ ++|.+++...... ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456889999996 5888888654433 3577889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh--ccc-Ccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR--MVP-YFPYP  230 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~--~~~-~~~~~  230 (309)
                      ++......   .......+++.|+|||.+.   ++.++|+||||+++|+|++|.+||............  ... ..+..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            98654221   2233456788899999885   788999999999999999999998754322111000  000 00000


Q ss_pred             cccc--chhhhhcccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 IENN--SLRQILNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ~~~~--~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+..  ............   ......++.+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000  000000000000   0112244668999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-40  Score=285.49  Aligned_cols=266  Identities=19%  Similarity=0.259  Sum_probs=195.3

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.+...........+.+|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            468999999999999999999854 6889999987654433334467789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++ +|.+++.....  ..+...+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...... 
T Consensus        85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  157 (309)
T cd07872          85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP-  157 (309)
T ss_pred             CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC-
Confidence            9975 77777754432  3467888899999999999999999   999999999999999999999999988653221 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh--cc-cCcccccc----cc
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR--MV-PYFPYPIE----NN  234 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~~----~~  234 (309)
                       ........++..|+|||.+.    ++.++|+||||+++|+|++|..||...+........  .. .......+    ..
T Consensus       158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         158 -TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             -ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence             11222345678899999874    678899999999999999999998754322111000  00 00000000    00


Q ss_pred             chhhhhccccc----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNFQVA----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...........    .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            00000000000    00111234668999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-39  Score=290.42  Aligned_cols=260  Identities=22%  Similarity=0.364  Sum_probs=200.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   78 (309)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||+|.+.........+.+..|+.++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3467889999999999999999853      346899999876544444556889999999997 999999999999989


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc---------------------------------------------------------
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS---------------------------------------------------------  101 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~---------------------------------------------------------  101 (309)
                      ..++||||+++++|.+++.....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999865321                                                         


Q ss_pred             --------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698          102 --------------------------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus       102 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                                                            ...+++..+..++.|++.|+.|||+.+   ++|+||+|.||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  112355667889999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      +++++.++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.........
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            9999999999999987543222111222234567799999886   6788999999999999998 88897654221111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .......                 .....+..++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       352 ~~~~~~~-----------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNAIKRG-----------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1100000                 001112223466999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-39  Score=276.64  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=196.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.. .+++.+++|......... ...+..|+.+++.++||||+++++++...+..++||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch-HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            456899999999999999999995 568899999876543322 345788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.|+.|||+.+   ++|+|++|+||+++.++.++++|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            9999999999886433   3477889999999999999999999   999999999999999999999999998754221


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                        ........++..|+|||.+.      ++.++|+||+|+++|+|++|..||................+..+        
T Consensus       160 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  229 (267)
T cd06646         160 --IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP--------  229 (267)
T ss_pred             --ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC--------
Confidence              11122345677899999873      56789999999999999999999754321111000000000000        


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                            ........+..+.++|.+||+.||++|||+.++++++
T Consensus       230 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 ------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                  0001122345699999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-39  Score=274.83  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...++|++++.||.|+||.||+|..++++.+++|.+.....  ..+.+..|+.+++.++|||++++++++. .+..+++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            34678999999999999999999988899999998765432  2456888999999999999999999875 45689999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+.+++|.+++...... ..++.++..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999988654432 4577888999999999999999999   999999999999999999999999988654321


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      .. .......++..|+|||.+.   ++.++|+||||+++|++++ |..||........ .....                
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~----------------  217 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-IQNLE----------------  217 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHH----------------
Confidence            11 1111223456799999876   6788999999999999998 9999864322111 00000                


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                       .....+.+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       218 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 -RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             000111112234569999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.8e-40  Score=292.91  Aligned_cols=251  Identities=20%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+|++++.||+|+||.||+|.. .+++.+|+|.+.....  ......+..|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            3699999999999999999995 4688999998765432  223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999999886543   3477888899999999999999999   999999999999999999999999987432100


Q ss_pred             cc---------------------------------------------cccccccccccccCCCcccc---cCCCcchhhH
Q 040698          165 DQ---------------------------------------------TATTTKEIETVGWLDPEYLF---WTEKSDVYSF  196 (309)
Q Consensus       165 ~~---------------------------------------------~~~~~~~~~~~~~~~PE~~~---~~~~~Diwsl  196 (309)
                      ..                                             ........|++.|+|||++.   ++.++|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             00011235788999999986   7889999999


Q ss_pred             HHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC---
Q 040698          197 GVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT---  273 (309)
Q Consensus       197 G~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---  273 (309)
                      ||++|+|++|..||............. ..              ......+.....++.+.++|.+|+ .+|.+|++   
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~-~~--------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVI-NW--------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHH-cc--------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            999999999999986543221111100 00              000111111223456888998876 59999997   


Q ss_pred             HHHHHHH
Q 040698          274 MRQVSEQ  280 (309)
Q Consensus       274 ~~~ll~~  280 (309)
                      +.++++|
T Consensus       299 ~~ei~~h  305 (382)
T cd05625         299 ADEIKAH  305 (382)
T ss_pred             HHHHhcC
Confidence            8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=280.31  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             hcccccceeecccCceEEEEEEcCC---------------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceee
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD---------------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL   71 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~---------------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   71 (309)
                      .++|++.+.||+|+||.||++....               ...|++|.............+..|+++++.++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999987532               2358899887654444456789999999999999999999


Q ss_pred             eeeecCCccEEEEEcCCCCCHHHHHHhhccc---------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 040698           72 GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ---------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANI  142 (309)
Q Consensus        72 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~ni  142 (309)
                      +++...+..++||||+++++|.+++......         ...++..+..++.|++.|++|||+++   ++|+||+|+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            9999999999999999999999998654211         12467788999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh--CCCCCchhhhcc
Q 040698          143 LLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT--GKHPRSYVALAS  217 (309)
Q Consensus       143 lv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~--g~~p~~~~~~~~  217 (309)
                      ++++++.++++|||++................++..|+|||...   ++.++|+||||+++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999886542221111122233456799999875   7889999999999999988  556655432111


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .. ......+...          ........+...+..+.+|+.+||+.||.+|||+.++++.|.
T Consensus       241 ~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VI-ENTGEFFRNQ----------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HH-HHHHHhhhhc----------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            00 0000000000          000000111123356999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-39  Score=283.54  Aligned_cols=241  Identities=23%  Similarity=0.288  Sum_probs=189.2

Q ss_pred             ceeecccCceEEEEEEc----CCCcEEEEEecccchh---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698           13 RHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++.||+|+||.||++..    .+++.+|+|.+.....   ......+..|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999984    3578999998765321   1223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++....   ...+..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            999999998886543   3466788889999999999999999   999999999999999999999999988643221 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       ........|++.|+|||.+.   ++.++||||||+++|+|++|..||.........                 ..+...
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~-----------------~~~~~~  215 (323)
T cd05584         154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-----------------DKILKG  215 (323)
T ss_pred             -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH-----------------HHHHcC
Confidence             11223346788999999986   678999999999999999999998643221110                 011110


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .  ...+...++.+.++|.+||+.||++||     ++.+++++
T Consensus       216 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 K--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             C--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            0  111222345689999999999999999     88988875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.5e-40  Score=290.76  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      +....++|++.+.||+|+||.||++.++ +++.+|+|.+....  .......+..|..+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445689999999999999999999964 58899999875432  12223457789999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++...    ..++..+..++.|++.||+|||+++   ++||||||+||++++++.++|+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            99999999999999988643    2467888999999999999999999   9999999999999999999999999987


Q ss_pred             ccccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      ..... .........|++.|+|||.+.       ++.++|+||+|+++|+|++|..||........              
T Consensus       191 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------------  255 (370)
T cd05621         191 KMDET-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------------  255 (370)
T ss_pred             ecccC-CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--------------
Confidence            64221 111223456899999999875       56789999999999999999999864322111              


Q ss_pred             ccchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHH
Q 040698          233 NNSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~  280 (309)
                         ...+....  ...+.....+..+.+++.+||..++.+  |+|+.++++|
T Consensus       256 ---~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 ---YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               11111111  111111233466899999999865543  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-40  Score=289.07  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=190.7

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----CccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET-----KVPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   81 (309)
                      +|++.+.||+|+||.||+|.. .+|..||+|.+.... .......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            689999999999999999995 468999999876431 122234578899999999999999999987543     3479


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++ ++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888876443   3577889999999999999999999   999999999999999999999999998654


Q ss_pred             ccccc-cccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC--cccccc-
Q 040698          162 SSHDQ-TATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY--FPYPIE-  232 (309)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~-  232 (309)
                      ..... ........++..|+|||.+.     ++.++||||||+++|+|++|..||......... ......  .+.... 
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  232 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLITDLLGTPSPETI  232 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCCHHHH
Confidence            22111 11223456788999999863     678999999999999999999998643221100 000000  000000 


Q ss_pred             --------ccchhhhhccccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 --------NNSLRQILNFQVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 --------~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              ......+......  .......++.+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    0000000000000  00011234568999999999999999999999876

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-39  Score=285.81  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=195.5

Q ss_pred             hcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec-CC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE-TK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~   78 (309)
                      .++|++.+.||.|+||.||+|.+      .+++.||+|.+...........+..|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999973      347889999886543333345678899999999 68999999998765 45


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc---------------------------------------------------------
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS---------------------------------------------------------  101 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~---------------------------------------------------------  101 (309)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999865321                                                         


Q ss_pred             -------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccc
Q 040698          102 -------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI  174 (309)
Q Consensus       102 -------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~  174 (309)
                             ....++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   112466778889999999999999999   9999999999999999999999999986542221111222233


Q ss_pred             cccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccch
Q 040698          175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM  250 (309)
Q Consensus       175 ~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (309)
                      ++..|+|||.+.   ++.++|+||||+++|+|++ |..||...............                 ......+.
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-----------------GTRMRAPD  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-----------------cCCCCCCC
Confidence            456799999875   7889999999999999997 88887643211111000000                 00001111


Q ss_pred             HHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          251 EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       251 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ..++.+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            12356899999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-40  Score=294.50  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=193.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++++.||.|+||.||++.. .+++.||+|.+.....  ......+..|+.+++.++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999995 4689999998765322  122355788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999987543   3477888889999999999999999   999999999999999999999999987422100


Q ss_pred             c-----------------------------------------ccccccccccccccCCCcccc---cCCCcchhhHHHHH
Q 040698          165 D-----------------------------------------QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVL  200 (309)
Q Consensus       165 ~-----------------------------------------~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll  200 (309)
                      .                                         .........|++.|+|||.+.   ++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         000011236788999999986   78899999999999


Q ss_pred             HHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC---CHHHH
Q 040698          201 VELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP---TMRQV  277 (309)
Q Consensus       201 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~l  277 (309)
                      |+|++|..||........... ...+ .             ...........+..+.++|.+|+ .+|.+|+   |+.++
T Consensus       235 yell~G~~Pf~~~~~~~~~~~-i~~~-~-------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLK-VINW-E-------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHH-Hhcc-C-------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999999875432211110 0000 0             00001111123456889999976 5999999   89999


Q ss_pred             HHH
Q 040698          278 SEQ  280 (309)
Q Consensus       278 l~~  280 (309)
                      +++
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-39  Score=273.42  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +|++.+.||.|+||.||++... ++..+++|.+.........+.+..|+.+++.++||||+++++.+.+.+.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5899999999999999999954 689999998765443444567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++...... ..+...+..++.|++.|+.+||+++   ++|+||+|+||++++++.++++|||.+......  .
T Consensus        81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~  154 (255)
T cd08219          81 DGGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--G  154 (255)
T ss_pred             CCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--c
Confidence            999999888654332 3477889999999999999999999   999999999999999999999999988654221  1


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      .......++..|+|||.+.   ++.++|+||||+++|+|++|..||................                  
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  216 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------------  216 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC------------------
Confidence            1122345677899999986   7789999999999999999999986432111100000000                  


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....+...+..+.++|.+||+.||.+|||+.++++.
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            001112234568999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.6e-40  Score=285.54  Aligned_cols=243  Identities=25%  Similarity=0.263  Sum_probs=188.2

Q ss_pred             cccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHH---hhcCCCccceeeeeeecCCccEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRII---SQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      |++.+.||+|+||.||++.+ .+|+.||+|.+.....  ....+.+..|..++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999985 4689999998765421  12234456665544   566799999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|...+..    ..+++..+..++.|++.|+.|||+++   ++||||+|+||++++++.++|+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999877743    23577889999999999999999999   99999999999999999999999998754321


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                        .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||........                 ...+.
T Consensus       154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-----------------~~~i~  214 (324)
T cd05589         154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-----------------FDSIV  214 (324)
T ss_pred             --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHH
Confidence              112223456788999999886   78899999999999999999999864322111                 01111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....  ..+...+..+.++|.+||+.||.+||     ++.+++++
T Consensus       215 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         215 NDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             hCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            1111  11122346689999999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-39  Score=279.61  Aligned_cols=263  Identities=28%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-----------------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-----------------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV   68 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv   68 (309)
                      ..++|++++.||+|+||.||++....                 +..+++|.+.........+.+..|+.+++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            45789999999999999999987432                 2457889877654444567788999999999999999


Q ss_pred             eeeeeeecCCccEEEEEcCCCCCHHHHHHhhcc--------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040698           69 KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS--------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSA  140 (309)
Q Consensus        69 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~  140 (309)
                      ++++++..++..+++||++++++|.+++.....        ....++..++.++.|++.|++|||+++   ++|+||+|+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            999999999999999999999999999875441        124578899999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh--CCCCCchhhh
Q 040698          141 NILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT--GKHPRSYVAL  215 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~--g~~p~~~~~~  215 (309)
                      ||+++.++.++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++  +..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999886543222222222334466799999875   7889999999999999998  6667653321


Q ss_pred             cchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ... .......+...          ........+...+..+.+++.+||+.||.+|||+.++++.|.
T Consensus       240 ~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQV-IENAGHFFRDD----------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHH-HHHHHhccccc----------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            110 00000000000          000011112233466999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-39  Score=277.53  Aligned_cols=270  Identities=26%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             hcccccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET--KV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~   79 (309)
                      .+.|++++.||+|+||.||++..     .++..+++|.+...........+.+|+.+++.++|||++++++++.+.  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            35689999999999999999972     357899999887655455566789999999999999999999998765  56


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||++|++|.+++.....  ..++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++++|||++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            7899999999999999865432  3477889999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........ .......++..|+|||.+.   ++.++|+||||+++|+|++++.|+.........   .............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~---~~~~~~~~~~~~~  234 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK---MIGPTHGQMTVTR  234 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh---hcccccccccHHH
Confidence            65322211 1112334566799999875   778999999999999999987764322110000   0000000000000


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ...........+.+..++..+.+|+.+||+.||.+|||+.++++.++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000111111112233556799999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=274.82  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=194.6

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      .+|++.+.||.|++|.||++.++++..+++|.......  ....+..|+.+++.++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            57899999999999999999987778899998754322  2345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++.....  ..++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++++|||.+........ 
T Consensus        82 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          82 ANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence            99999999875443  4577889999999999999999999   99999999999999999999999998865421111 


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......++..|+|||.+.   ++.++|+||||+++|++++ |..||........... ..                 ..
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~-----------------~~  217 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VS-----------------AG  217 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HH-----------------cC
Confidence            1111112234699999875   7789999999999999998 8998764322211100 00                 00


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            01111223456699999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=289.31  Aligned_cols=260  Identities=19%  Similarity=0.215  Sum_probs=191.7

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||++.+ .+++.||+|...       ...+.+|+.+++.++||||+++++++......++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            36799999999999999999995 568999999643       2345789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ++. ++|..++....   ..++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...... 
T Consensus       164 ~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-  235 (391)
T PHA03212        164 RYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-  235 (391)
T ss_pred             cCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence            995 67877776443   3477889999999999999999999   999999999999999999999999998643211 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcc------hhhhhc---ccCcccccc-
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALAS------NEMTRM---VPYFPYPIE-  232 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~------~~~~~~---~~~~~~~~~-  232 (309)
                      .........|++.|+|||.+.   ++.++||||||+++|+|++|..||-......      ......   ....+...+ 
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            111223356889999999986   7889999999999999999998754321110      000000   000010000 


Q ss_pred             --ccchhhhh------ccccc-----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 --NNSLRQIL------NFQVA-----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 --~~~~~~~~------~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                        ........      .....     .......+.++.+||.+||+.||.+|||+.+++++-
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence              00000000      00000     011123456799999999999999999999998743

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=298.33  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=187.6

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--------   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   76 (309)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.+....     ....+|+.+++.++||||+++++++..        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            356899999999999999999996 468999999775432     223568899999999999999887642        


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEe
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVAD  154 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d  154 (309)
                      ...+++||||+++ +|.+++... .....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++ .++|+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence            1246799999975 676666532 23345678889999999999999999999   99999999999998654 799999


Q ss_pred             eecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ||++......   .......+++.|+|||.+.    ++.++|||||||++|+|++|.+||........... .......+
T Consensus       215 FGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-i~~~~~~p  290 (440)
T PTZ00036        215 FGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR-IIQVLGTP  290 (440)
T ss_pred             cccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCC
Confidence            9998754321   1222345688899999864    78889999999999999999999865432211110 00000000


Q ss_pred             ccc-----------cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          231 IEN-----------NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       231 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ...           ...............+...+.++.+||.+||+.||.+|||+.++++|-
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence            000           000000000000001122346799999999999999999999999763

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-39  Score=277.12  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=196.4

Q ss_pred             hcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ..+|.+.+.||+|+||.||++..      .++..+++|....... .....+..|+.+++.++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            56899999999999999999863      2356788887665433 3356788999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccc------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQ------------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                      +++|||+++++|.+++......            ..+++..+..++.|++.|++|||+++   ++|+||+|+||++++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            9999999999999998754321            23577889999999999999999999   99999999999999999


Q ss_pred             CeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcc
Q 040698          149 TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV  224 (309)
Q Consensus       149 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~  224 (309)
                      .++++|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||..........    
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----  235 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----
Confidence            99999999886542221111112223356799999876   7888999999999999998 899875432211110    


Q ss_pred             cCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                                   .... ......+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus       236 -------------~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 -------------CITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -------------HHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                         0000 0011112233456999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-39  Score=278.39  Aligned_cols=262  Identities=29%  Similarity=0.428  Sum_probs=195.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-----------------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccce
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-----------------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-----------------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   69 (309)
                      .++|++.+.||+|+||.||++.+.                 ++..+++|.............+..|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            467999999999999999998532                 244688888765544444567889999999999999999


Q ss_pred             eeeeeecCCccEEEEEcCCCCCHHHHHHhhccc--------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040698           70 ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ--------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN  141 (309)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~n  141 (309)
                      +++++...+..+++|||+++++|.+++......        ...++.++..++.|++.|++|||+.+   ++|+||+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            999999999999999999999999998754321        22456789999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh--CCCCCchhhhc
Q 040698          142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT--GKHPRSYVALA  216 (309)
Q Consensus       142 ilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~--g~~p~~~~~~~  216 (309)
                      |++++++.++++|||++.................+..|++||...   ++.++|+||||+++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999986542221111112223356799999765   7889999999999999998  66776543211


Q ss_pred             chhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          217 SNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .. .......+..          .......+.+..++..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       241 ~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QV-IENTGEFFRD----------QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH-HHHHHHHHhh----------ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            10 0000000000          0000011112234466999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-39  Score=289.12  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      +....++|++.+.||+|+||.||++.++ +++.+|+|.+....  .......+..|..+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            4456789999999999999999999964 58899999875432  12223457788999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++...    ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999988643    2467788889999999999999999   9999999999999999999999999987


Q ss_pred             ccccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      ..... .........|++.|+|||.+.       ++.++|+|||||++|+|++|..||........              
T Consensus       191 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--------------  255 (371)
T cd05622         191 KMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------------  255 (371)
T ss_pred             EcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--------------
Confidence            65321 111223456899999999875       56789999999999999999999864322111              


Q ss_pred             ccchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHHH
Q 040698          233 NNSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQL  281 (309)
Q Consensus       233 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~l  281 (309)
                         ...+....  ...+.....+..+.++|.+||..++.+  |+++.+++++.
T Consensus       256 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 ---YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               11111110  011111234466899999999844433  78999998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=288.55  Aligned_cols=262  Identities=26%  Similarity=0.380  Sum_probs=212.8

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .....+++.||+|.||.|.+|....+.+||+|+++.......+..|..|+++|.+++||||++++++|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34567899999999999999998778999999999988777788999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++|+|.+++..+.... .......+++.||+.||+||.+.+   ++||||.++|++++.++++||+|||+++-....+.
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999998775433 244667789999999999999999   99999999999999999999999999975544333


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh--CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT--GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .......+-..+|+|||.+.   ++.++|+|+||+.+||++.  ...||+............ ..+..          -.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~-~~~~~----------~~  761 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG-EFFRD----------QG  761 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh-hhcCC----------CC
Confidence            33333444578899999997   8999999999999999765  777877654333211100 00000          01


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .+.....|.-|+..+.++|.+||..+-++|||++++..+|.+
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            122233455677889999999999999999999999998854

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-39  Score=278.18  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             hhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||.|+||.||++..+      ++..+++|.+...........+..|+.+++.++||||+++++++.+++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4578999999999999999999853      4688999988765444455678899999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc-------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS-------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSA  140 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~  140 (309)
                      .+++|||+++++|.+++.....                   ...+++..++.++.|++.|+.|||+++   ++|+||+|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            9999999999999999874321                   123466788999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhc
Q 040698          141 NILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALA  216 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~  216 (309)
                      ||+++.++.++++|||++.................+..|+|||.+.   ++.++|+||||+++|+|++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999876542221111122223355699999875   7889999999999999997 77786432111


Q ss_pred             chhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          217 SNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .  ..               ..+.+.. ....+...+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       240 ~--~~---------------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 E--VI---------------YYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H--HH---------------HHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1  00               0000000 00111223456999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-39  Score=276.01  Aligned_cols=270  Identities=23%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             hcccccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   79 (309)
                      .+.|++.+.||+|+||.||.+..     .++..+++|.+...... ..+.+..|+.+++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH-HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            46899999999999999999873     35889999987654432 24568899999999999999999998653  356


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            7899999999999999864432  3477888999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccccc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQTAT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      .......... .....++..|+|||...   ++.++|+||||+++|+|++|..|+.........  ..............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  234 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR--MMGNDKQGQMIVYH  234 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh--hcccccccccchHH
Confidence            6532211111 11122334599999876   778899999999999999987765432111000  00000000000001


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      +............+..++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111122222334456799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=272.59  Aligned_cols=248  Identities=31%  Similarity=0.454  Sum_probs=198.5

Q ss_pred             eeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++....    +..+++|...........+.+..|+..+..++|+|++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999643    8899999887765444467788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhcc------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           90 GTLFQHVRYQSS------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        90 ~sL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ++|.+++.....      ...+++..++.++.|++.|+.+||+++   ++|+||+|+||++++++.++++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999976521      245688999999999999999999999   99999999999999999999999999876644


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ...........++..|+|||.+.   ++.++|+||||+++|+|++ |..||.........                 ..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----------------~~~  220 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-----------------EYL  220 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-----------------HHH
Confidence            33222233445677899999886   7889999999999999998 69997654221100                 001


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .. ......+...+..+.+++.+||+.||.+|||+.+++++|+
T Consensus       221 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         221 RK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             Hc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00 1111122233567999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-39  Score=276.99  Aligned_cols=245  Identities=21%  Similarity=0.227  Sum_probs=188.2

Q ss_pred             ecccCceEEEEEEc-CCCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||+|+||.||++.. .+|+.+|+|.+......  ...+.+..|+.+++.++||||+++.+++...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999985 46899999987653221  1224567889999999999999999999999999999999999999


Q ss_pred             HHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccc
Q 040698           93 FQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT  171 (309)
Q Consensus        93 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~  171 (309)
                      ...+.... ....+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++.......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            88775332 2334678889999999999999999999   9999999999999999999999999986543221  1222


Q ss_pred             ccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCcc
Q 040698          172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN  248 (309)
Q Consensus       172 ~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (309)
                      ...+++.|+|||.+.   ++.++|+||||+++|+|++|..||............             .......  ....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~-------------~~~~~~~--~~~~  220 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-------------KQRILND--SVTY  220 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH-------------HHhhccc--CCCC
Confidence            346788899999986   778999999999999999999998643211110000             0000000  0111


Q ss_pred             chHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          249 EMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       249 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      +...+..+.+++.+||+.||++||     ++++++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            223446699999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.1e-39  Score=273.74  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=190.9

Q ss_pred             cccceeecccCceEEEEEEcCC-Cc--EEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCc
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPD-NT--LVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE------TKV   79 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~-~~--~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~   79 (309)
                      |.+.+.||.|+||.||+|.+.+ +.  .+++|.+.... .....+.+..|+.+++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999999644 33  68888775532 22234667889999999999999999997643      235


Q ss_pred             cEEEEEcCCCCCHHHHHHhhc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      .+++|||+++++|.+++....   .....++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998875332   2233577889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      ++................+++.|++||...   ++.++|+||||+++|+|++ |..||......... .           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~-----------  225 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-D-----------  225 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H-----------
Confidence            987653322111122233456799999986   7889999999999999998 78887643221100 0           


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                           .+.. ......+...+..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       226 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 -----YLRQ-GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 0000 000111223345699999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.3e-39  Score=273.61  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             hcccccceeecccCceEEEEEEcC-C---CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-D---NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~---~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.+. +   +..+++|.+.........+.+..|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            468999999999999999999853 2   347899987654444446678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++.....  ..+...+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++++|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999875432  3477888999999999999999999   9999999999999999999999999887653


Q ss_pred             ccccccc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          163 SHDQTAT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       163 ~~~~~~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ....... .....++..|++||.+.   ++.++|+|+||+++|++++ |..||......... .......          
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-~~~~~~~----------  226 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-KAIEEGY----------  226 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-HHHhCCC----------
Confidence            2211111 11112245699999986   7889999999999999886 99997644321110 0000000          


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                             ..+.+...++.+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   0111223346699999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-39  Score=281.52  Aligned_cols=245  Identities=24%  Similarity=0.255  Sum_probs=189.3

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCC-ccceeeeeeecCCccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHK-NVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~iv~   84 (309)
                      +|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+..|..++..+.|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5899999999999999999854 57899999876532  122234567788888888764 6888999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence            9999999998886543   3467888999999999999999999   99999999999999999999999998754211 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       .........|++.|+|||.+.   ++.++|+||+|+++|+|++|..||..........                 .+..
T Consensus       154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~-----------------~i~~  215 (324)
T cd05587         154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-----------------SIME  215 (324)
T ss_pred             -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------------HHHc
Confidence             111223346788999999986   7789999999999999999999986432211110                 1111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      ...  ..+...+..+.+++.+||+.||.+|++.     .+++++
T Consensus       216 ~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         216 HNV--SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            100  1112234568999999999999999976     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-39  Score=276.03  Aligned_cols=249  Identities=32%  Similarity=0.469  Sum_probs=194.3

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhH-HHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      |++++.||+|+||.||++..+ +++.+|+|........... .....|+.++++++||||+++++++.+.+..+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            789999999999999999964 5779999988776443322 23456899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++...   ..++...+..++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||.+...  ....
T Consensus        81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            999999999833   23478999999999999999999999   999999999999999999999999998643  1223


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......++..|+|||...    .+.++|+||+|+++|+|++|..||...........              ........
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~--------------~~~~~~~~  218 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI--------------IEKILKRP  218 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH--------------HHHHHHTH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh--------------hhhccccc
Confidence            3444566788899999975    78899999999999999999999875411110000              00000000


Q ss_pred             ccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  .........+.++|.+||+.||++|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  0000011569999999999999999999999764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-39  Score=284.55  Aligned_cols=240  Identities=23%  Similarity=0.222  Sum_probs=188.3

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||++.. .+|..+|+|.+....  .......+..|+.++..++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 568999999876532  1222345677889999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      +|..++....   .+++..+..++.|++.||.|||+ .+   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~  152 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GAT  152 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccc
Confidence            9988876443   35778899999999999999997 78   999999999999999999999999987643211  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||..............                 ...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-----------------~~~--  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EEI--  213 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----------------CCC--
Confidence            23346888999999986   78899999999999999999999864322111100000                 000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ..+...++.+.++|.+||+.||++|+     ++.+++++
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            01112345689999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.4e-39  Score=282.23  Aligned_cols=262  Identities=27%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             hhcccccceeecccCceEEEEEEcC--------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP--------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      ...+|++++.||+|+||.||.+.+.        .+..+++|...........+.+..|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            4567999999999999999999742        12368999776544344456788899999999 79999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                      .+..++++||+++++|.+++.....             ....+...+..++.|++.|+.|||+++   ++|+||+|+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence            9999999999999999999875421             123566788899999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.++|+|||++................++..|+|||.+.   ++.++|+||||+++|+|++ |..||.........
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999986543222112222233345799999886   7789999999999999998 88887543211111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ...                  ........+..++..+.+++.+||+.+|++|||+.++++.|..+....
T Consensus       247 ~~~------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         247 KLL------------------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHH------------------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            000                  000111112233456999999999999999999999999998887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=285.15  Aligned_cols=254  Identities=19%  Similarity=0.280  Sum_probs=204.2

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEeccc-chhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM-VDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i   82 (309)
                      +....|+++++||+|+.+.||++...+.+.+++|.+.. ........-+..|+..|..++ |.+|+++++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            45678999999999999999999987778888886533 223344567899999999995 8999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||- ..+|..++++.....  +.-.+..++.|++.++.++|++|   |+|.||||.|+++- .|.+||+|||++..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~--~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSID--PDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCC--chHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99997 579999998766543  22378889999999999999999   99999999999987 5699999999998876


Q ss_pred             cccccccccccccccccCCCcccc--------------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-c
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF--------------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-F  227 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-~  227 (309)
                      ...........+||+.||+||.+.              .++++|||||||++|+|+.|++||+...+.-..+...+.+ -
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            655556667789999999999985              5678999999999999999999998775444333333222 1


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ....+.              .+..  ..+.++++.||..||++|||+.+||++-
T Consensus       591 ~Iefp~--------------~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  591 EIEFPD--------------IPEN--DELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             cccccC--------------CCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            111110              0111  2289999999999999999999999863

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-39  Score=276.89  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=196.7

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++++.||.|+||.||++.++ +|..+++|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47999999999999999999964 68999999776543333346788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|..++.........++..+..++.+++.|+.|||+ .+   ++|+||+|+||+++.++.++++|||.+...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999888754333355888999999999999999996 58   999999999999999999999999988654211 


Q ss_pred             ccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          166 QTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                         ......++..|+|||.+.         ++.++|+||||+++|+|++|..||........ .             ...
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-------------~~~  219 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-F-------------AQL  219 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-H-------------HHH
Confidence               122334667899999874         36789999999999999999999853211100 0             000


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..+... .....+...+.++.++|.+||+.+|.+||++.+++++
T Consensus       220 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         220 SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            001110 1111223355779999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=270.68  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=198.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||.|++|.||++... |+.+++|.......  ....+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            3578999999999999999999874 78899998876544  34568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...... ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          81 YMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             ecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999998755432 4578999999999999999999999   9999999999999999999999999886542111


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                           .....+..|+|||.+.   ++.++|+||||+++|++++ |..||.......... ...                 
T Consensus       157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~-----------------  213 (256)
T cd05039         157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVE-----------------  213 (256)
T ss_pred             -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHh-----------------
Confidence                 1223345699999875   6778999999999999997 999976442211100 000                 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .......+...++.+.++|++||+.+|.+|||+.++++.|..
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            000111122334669999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.9e-39  Score=271.96  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||.|++|.||++.. .++..+++|.............+..|+..++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            5799999999999999999995 468899999876544333456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++.........++..+..++.|++.|+.+||+++   ++|+||+|+||++++++.++++|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976544345577889999999999999999999   99999999999999999999999999866543222


Q ss_pred             cc--cccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          167 TA--TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       167 ~~--~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  ......++..|++||.+.    ++.++|+||||+++|+|++|..||................ +.           
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-----------  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PP-----------  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CC-----------
Confidence            21  122335677899999875    6778999999999999999999986543221111111100 00           


Q ss_pred             cccccC-ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVAD-ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        .... ......++.+.+++.+||+.||++|||+.+++++
T Consensus       226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 --SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0000 0012344668999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-39  Score=271.80  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=196.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|++|.||++...++..+++|.+......  .+.+..|+.+++.++|+|++++++++.. +..+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            45789999999999999999999878888999987654332  3568899999999999999999998754 56799999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...... ..++..+..++.+++.|+.|||+++   ++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          81 YMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             ecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999988754332 3477889999999999999999999   9999999999999999999999999986543221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .. ......++..|+|||...   ++.++|+||||+++|+|++ |..||......... .....                
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~----------------  218 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-EQVER----------------  218 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHc----------------
Confidence            11 111122345699999875   6779999999999999999 88887643211100 00000                


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                       ....+.+...+..+.+++.+||+.||.+|||+.++.+.|+.
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 -GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             00111122344669999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-38  Score=267.75  Aligned_cols=245  Identities=28%  Similarity=0.427  Sum_probs=192.0

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHH
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF   93 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~   93 (309)
                      +.||.|+||.||+|...++..+++|.............+..|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999987889999998766544444557888999999999999999999999999999999999999999


Q ss_pred             HHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccccc
Q 040698           94 QHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE  173 (309)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  173 (309)
                      +++.....  ..++..+..++.+++.++.|+|+++   ++|+||+|+||++++++.++++|||++....... .......
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~  154 (250)
T cd05085          81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLK  154 (250)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCC
Confidence            98865432  3467889999999999999999999   9999999999999999999999999885432111 1111122


Q ss_pred             ccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       174 ~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      .++..|+|||.+.   ++.++|+||||+++|++++ |..||...............                  .....+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------------~~~~~~  216 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------------YRMSCP  216 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------------------CCCCCC
Confidence            3355699999876   6778999999999999998 99998644222111110000                  000111


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            223466999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.1e-39  Score=273.39  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=197.4

Q ss_pred             hcccccceeecccCceEEEEEEcCC-C---cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-N---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-~---~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|..+. +   ..|++|.+...........+..|+.+++.++||||+++++++.++...++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            3579999999999999999998543 3   36999988765444446778999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++.....  ..+...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+....
T Consensus        83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999998875433  3477889999999999999999999   9999999999999999999999999886543


Q ss_pred             cccccccccccc---cccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccc
Q 040698          163 SHDQTATTTKEI---ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       163 ~~~~~~~~~~~~---~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ............   .+..|+|||.+.   ++.++|+||+|+++|++++ |..||......... .....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-~~i~~----------  226 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-NAIEQ----------  226 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-HHHHc----------
Confidence            221111111111   134699999986   6788999999999999886 99997543211100 00000          


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                             ....+.+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 -------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   001111223446699999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.4e-39  Score=273.30  Aligned_cols=252  Identities=25%  Similarity=0.315  Sum_probs=187.2

Q ss_pred             eeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||+|...   ++..+++|.+...........+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999853   346789998766544344456888999999999999999999999988999999999999


Q ss_pred             CHHHHHHhhcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           91 TLFQHVRYQSS--QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        91 sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +|.+++.....  ....+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999875432  123355677789999999999999999   9999999999999999999999999886432222212


Q ss_pred             cccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          169 TTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ......++..|+|||.+.          ++.++|+||||+++|+|++ |..||........... .........      
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~------  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVREQQLKL------  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HhhcccCCC------
Confidence            222334567799999874          3678999999999999996 9999865432221110 000000000      


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                            .........++.+.+++.+|| .+|++|||+.+|+..|+
T Consensus       231 ------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 ------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                  000011122345889999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-39  Score=272.28  Aligned_cols=254  Identities=29%  Similarity=0.433  Sum_probs=193.3

Q ss_pred             cccceeecccCceEEEEEEcC----CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc-----
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKV-----   79 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----   79 (309)
                      |++.+.||+|+||.||.|...    .+..+++|.+..... ......+..|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            678999999999999999853    247899998765322 2223567889999999999999999998765443     


Q ss_pred             -cEEEEEcCCCCCHHHHHHhhc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           80 -PLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        80 -~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                       .++++||+++++|..++....   .....++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885442   1234577889999999999999999999   999999999999999999999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      |++.................+..|+|||...   ++.++|+||||+++|+|++ |..||......... .          
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~----------  226 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-D----------  226 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-H----------
Confidence            9986553322211122223355799999875   7889999999999999998 88887543221110 0          


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                            .... ......+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       227 ------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 ------YLRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------HHHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0000 001111223446699999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=274.01  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=202.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ...+|++.+.||.|+||.||+|.++ +|+    .+++|.............+..|+.+++.++|||++++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            3578999999999999999999853 333    5888877665544445678899999999999999999999987 778


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +++|||+++++|.+++......  .++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++++|||++..
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence            9999999999999998754332  577899999999999999999999   99999999999999999999999999876


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ..............++..|+|||.+.   ++.++|+||||+++|++++ |..||.........                 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------  221 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-----------------  221 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----------------
Confidence            53222111111222345699999875   7789999999999999998 99997643211100                 


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                       ...........+..++..+.+++.+||..||..|||+.++++.|.++..-..++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05057         222 -DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY  275 (279)
T ss_pred             -HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence             000001111111223355899999999999999999999999999886544443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=300.84  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=221.7

Q ss_pred             ccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...|.++||.|.||.|+.|..+    ....||||.++....+..+..|..|..+|.+++||||+++.|+....+...||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4568899999999999999943    356899999999888888899999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++|+|+.||+.+..+  ++..++..+++.|+.||.||.+.+   ++||||..+||||+.+-..|++|||++++....
T Consensus       710 EyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999999999988765  467889999999999999999999   999999999999999999999999999876332


Q ss_pred             ccccccccccc--ccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIE--TVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~--~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                       .....+..-|  ..+|.|||.+.   ++.++|+||+|+++||.++ |..||=...                  ....-.
T Consensus       785 -~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS------------------NQdVIk  845 (996)
T KOG0196|consen  785 -PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------------------NQDVIK  845 (996)
T ss_pred             -CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc------------------hHHHHH
Confidence             2222222222  56799999997   8999999999999999777 888843321                  111222


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQK  295 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~  295 (309)
                      .+...+..+.|.+||..+.+||..||++|..+||.|.||+++|.+|...........
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~  902 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA  902 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence            334456667788999999999999999999999999999999999987776655443

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-39  Score=268.94  Aligned_cols=246  Identities=29%  Similarity=0.448  Sum_probs=192.6

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHH
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF   93 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~   93 (309)
                      +.||.|++|.||++...+++.|++|.............+..|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999976699999998776544444567899999999999999999999999999999999999999999


Q ss_pred             HHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccccc
Q 040698           94 QHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE  173 (309)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  173 (309)
                      +++.....  ..+...+..++.+++.++.|||+++   ++|+||+|+||+++.++.++++|||.+...............
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            98865432  3467888999999999999999999   999999999999999999999999988654221111111122


Q ss_pred             ccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       174 ~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..+..|+|||.+.   ++.++|+||||+++|+|++ |..||............ ..                 ......+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~-----------------~~~~~~~  217 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ES-----------------GYRMPAP  217 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hc-----------------CCCCCCC
Confidence            2345699999875   7889999999999999998 88887544321111100 00                 0001112


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            233456999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.3e-39  Score=280.00  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=195.4

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||.|+||.||+|..+ +++.|++|.+...........+..|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            468999999999999999999854 6889999987654333334567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++ ++|.+++.....  ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++...... 
T Consensus        85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  157 (301)
T cd07873          85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-  157 (301)
T ss_pred             ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC-
Confidence            997 588887765432  3467889999999999999999999   999999999999999999999999988653221 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc----cc----c
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP----IE----N  233 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~----~  233 (309)
                       ........++..|+|||.+.    ++.++|+||||+++|+|++|.+||...+..... .........+    ..    .
T Consensus       158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         158 -TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCChhhchhhhcc
Confidence             11222345577899999874    677899999999999999999998754332111 1100000000    00    0


Q ss_pred             cchhhhhccccc----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQVA----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............    .......++.+.+||.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000000000    00112234568999999999999999999999774

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-39  Score=282.20  Aligned_cols=240  Identities=28%  Similarity=0.263  Sum_probs=185.9

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++..+ +++.||+|.+....  .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 58899999876432  122234566777777765 699999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            99998886543   3477888999999999999999999   999999999999999999999999987643211  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........                 ..+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-----------------~~i~~~~~--  213 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-----------------EAILNDEV--  213 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-----------------HHHhcCCC--
Confidence            23346788999999886   788999999999999999999998654321110                 11111000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      ..+...+..+.++|++||+.||.+||++      ++++++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1111234568999999999999999998      666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-39  Score=282.73  Aligned_cols=249  Identities=23%  Similarity=0.273  Sum_probs=188.5

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.+ .+++.||+|.+.....  ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999995 4689999998865321  22234577888888888 799999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~  152 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence            99988876443   3578899999999999999999999   99999999999999999999999998754211  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|+..|+|||.+.   ++.++|+||||+++|+|++|..||...........        .........+...... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ--------NTEDYLFQVILEKQIR-  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccc--------cchHHHHHHHHcCCCC-
Confidence            23456788999999986   77899999999999999999999864321110000        0000000111111111 


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCC------HHHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPT------MRQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps------~~~ll~~  280 (309)
                       .+...+..+.++|.+||+.||.+|||      +.++++|
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             12233456899999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-38  Score=270.41  Aligned_cols=253  Identities=27%  Similarity=0.429  Sum_probs=196.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||.|++|.||+|.+.++..+++|.+.....  ..+.+..|+.+++.++||||+++++.+.+ +..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            3578999999999999999999976767899998875332  23568889999999999999999998754 55799999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          81 YMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             cCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999975432 23477889999999999999999999   9999999999999999999999999886543221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      . .......++..|+|||...   ++.++|+||||+++|+|++ |..||........ ..                .+..
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~----------------~~~~  218 (262)
T cd05071         157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LD----------------QVER  218 (262)
T ss_pred             c-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HH----------------HHhc
Confidence            1 1111233456799999875   7889999999999999999 8888764321110 00                0000


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                       ......+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             000111223456699999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=271.85  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=199.5

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...++|++.+.||.|++|.||++..+++..+++|.+.....  ..+.+..|+.+++.++|+|++++++++......+++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            45689999999999999999999987788899998765432  2456889999999999999999999999888999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...... .++...+..++.+++.|+.|||+++   ++|+||+|+||++++++.++++|||.+......
T Consensus        81 e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999998764432 3477889999999999999999999   999999999999999999999999988654321


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      .. ........+..|+|||.+.   ++.++|+||+|+++|++++ |..||....... ........+             
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~-------------  221 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGY-------------  221 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC-------------
Confidence            11 1111122345699999876   6788999999999999998 999975432111 111111000             


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                          ....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                011112224569999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=266.33  Aligned_cols=255  Identities=24%  Similarity=0.299  Sum_probs=203.7

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++-+.||+|.|+.|+++.+ .+|+.+++|.+.... .....+.+.+|..+-+.++||||+++++........|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            4578999999999999999999985 569999988664321 11234678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~~  159 (309)
                      |||.+.|+.|..-+-..   ...++..+-+...||+.++.|+|.++   |+|||++|+|+++.   ...-||++|||++.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999997655433   23366778899999999999999999   99999999999994   34569999999997


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...   .......+.|+|.|++||+..   |+.++|||+-|+++|-++.|.+||...+..                 ...
T Consensus       162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----------------rly  221 (355)
T KOG0033|consen  162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----------------RLY  221 (355)
T ss_pred             EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----------------HHH
Confidence            763   344556678999999999998   899999999999999999999997643222                 122


Q ss_pred             hhhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          237 RQILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       237 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      +++.....  +....+..++...+|+++||..||.+|.|+.+.++|-.-..
T Consensus       222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            22222221  12233455577999999999999999999999998754443

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-38  Score=269.75  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=197.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||++...++..+++|.+.....  ..+.+.+|+.+++.++|+||+++++++.+ ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            4678999999999999999999977788899998765432  24568889999999999999999999887 77899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999999875432 33467888999999999999999999   9999999999999999999999999886542211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      . .......++..|+|||.+.   ++.++|+||||+++|++++ |..||........... ...                
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~----------------  218 (260)
T cd05073         157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LER----------------  218 (260)
T ss_pred             c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhC----------------
Confidence            1 1111223456699999886   6778999999999999998 8999864322211100 000                


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                       ....+.+...+..+.+++.+||+.+|++||++.++.+.|..
T Consensus       219 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 -GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             00011112334569999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-38  Score=268.97  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|.+.+.||+|++|.+|++.. .+|+.+++|.+.... .......+..|+.+++.++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            588999999999999999995 468999999875431 233356788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++..... ...+...++.++.+++.|+.|||+.+   ++|+||+|+||++++++.++++|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-  155 (256)
T cd08529          81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-  155 (256)
T ss_pred             CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence            999999999876432 34577888999999999999999999   9999999999999999999999999886553221 


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                       .......+++.|+|||+..   ++.++|+||||+++|+|++|..||..........                 ......
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------------~~~~~~  217 (256)
T cd08529         156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL-----------------KIIRGV  217 (256)
T ss_pred             -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------------HHHcCC
Confidence             1122345677899999886   6789999999999999999999987543211100                 000000


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 -FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             001111344669999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=292.45  Aligned_cols=268  Identities=22%  Similarity=0.359  Sum_probs=215.6

Q ss_pred             hhcccccceeecccCceEEEEEEcC--CCc--EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP--DNT--LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++.++.+.||.|+||.|++|.|.  +|.  .||+|++....-...-..|.+|+.+|.+|+|||++++||+..+ ....
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            4567778899999999999999974  354  5688988765444356789999999999999999999999987 6778


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|||.+++|||.+.|.. ..+..+....+..++.||+.||.||..++   ++||||..+|+++.....|||+|||+++-.
T Consensus       187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence            99999999999999987 44556677899999999999999999999   999999999999998889999999999876


Q ss_pred             cccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...+.. .....+.-...|+|||.+.   ++.++|+|++||.+|||++ |..||...                 ... .+
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-----------------~g~-qI  324 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-----------------RGI-QI  324 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-----------------CHH-HH
Confidence            543322 2222333355699999998   8999999999999999999 78885532                 222 23


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhhhc
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKN  296 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~  296 (309)
                      -..++.+...+.+..|+++++++++.||..+|++||||..|.+.+-..++....-...++
T Consensus       325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d  384 (1039)
T KOG0199|consen  325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYD  384 (1039)
T ss_pred             HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeecc
Confidence            334456777788899999999999999999999999999998655444433333333333

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.5e-39  Score=274.00  Aligned_cols=246  Identities=21%  Similarity=0.258  Sum_probs=186.8

Q ss_pred             ecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||+|+||.||++.. .+|+.+++|.+.....  ......+..|+.+++.++||||+++++++.+....++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 4589999998754321  11233456689999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++...... ..++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||++......   .....
T Consensus        81 ~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~  153 (277)
T cd05607          81 KYHIYNVGER-GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQ  153 (277)
T ss_pred             HHHHHhcccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeec
Confidence            8887654432 3467888899999999999999999   999999999999999999999999988654221   12223


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..++..|+|||.+.   ++.++|+||+|+++|+|++|..||...........             ............ ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~~~~~~-~~  219 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-------------LKRRTLEDEVKF-EH  219 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH-------------HHHHhhcccccc-cc
Confidence            45788899999886   78899999999999999999999864321110000             000000000000 01


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ...++.+.+|+.+||+.||.+||++.++++.+.
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            123466899999999999999999977665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=273.60  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||.|++|.||++... +++.+++|.+...........+..|+.+++.++|+|++++++++.++..+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47999999999999999999954 68999999876654333345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++...    ..++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999988643    4577899999999999999999999   9999999999999999999999999987653221 


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                       .......++..|+|||.+.   ++.++|+|+||+++|+|++|..||......... .                .+....
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-~----------------~~~~~~  214 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-F----------------LIPKNN  214 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-H----------------HhhhcC
Confidence             1223345677899999886   788999999999999999999998643211100 0                000000


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........+..+.+++.+||..+|++|||+.+++++
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0000011144669999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7e-39  Score=302.78  Aligned_cols=261  Identities=22%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+...  ......+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999954 5899999987643  22344567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhcc--------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           85 EFVPNGTLFQHVRYQSS--------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      ||++|++|.+++.....        ....+...+..++.|++.||+|||+++   ++||||||+||+++.++.++++|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864321        112345677889999999999999999   9999999999999999999999999


Q ss_pred             ccccccccccc----------------ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcc
Q 040698          157 SSVLISSHDQT----------------ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALAS  217 (309)
Q Consensus       157 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~  217 (309)
                      ++.........                .......|++.|+|||.+.   ++.++|+|||||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            98755211100                0111245889999999886   7889999999999999999999986422111


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhhhh
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLRRL  287 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~~~  287 (309)
                      .......   .            .+ .........++.+.+++.+||+.||++|| ++.++++.|+.....
T Consensus       239 i~~~~~i---~------------~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISYRDVI---L------------SP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhhhc---c------------Ch-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0000000   0            00 00001123345689999999999999997 667777777666543

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.8e-39  Score=281.90  Aligned_cols=249  Identities=24%  Similarity=0.257  Sum_probs=186.4

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.. .+++.+|+|.+....  .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 458899999876532  222234567788877766 799999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   .+++..+..++.|++.|+.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            99988876443   3577889999999999999999999   999999999999999999999999988643111  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|+..|+|||.+.   ++.++|+||||+++|+|++|..||...........        .........+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--------~~~~~~~~~i~~~~--~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILEKQ--I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc--------ccHHHHHHHHhcCC--C
Confidence            23356788999999986   78899999999999999999999853221110000        00000000111111  1


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      ..+...+..+.++|++||+.||++|||+      .++++|
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1222344668999999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6e-39  Score=272.98  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=185.5

Q ss_pred             eeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||+|...   ....+++|.+...........+.+|+..++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            35899999999999743   345788887655443444556788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccc--cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           91 TLFQHVRYQSSQ--VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        91 sL~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +|.+++......  ...++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++++|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999765432  22356778899999999999999999   9999999999999999999999999875432221111


Q ss_pred             cccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          169 TTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ......++..|+|||...          ++.++|+||||+++|+|++ |..||............ .........     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~-----  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLP-----  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hhccCccCC-----
Confidence            122333456799999752          5778999999999999999 78887654322111000 000000000     


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                             ....+...+..+.+++..|| .||++|||+.+|++.|
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 -------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             -------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                   00111233455888999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-39  Score=277.02  Aligned_cols=266  Identities=19%  Similarity=0.241  Sum_probs=195.0

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||+|... +|..|++|.+..... ......+..|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999954 689999998754322 22235678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++ ++|.+++.........++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 588888876554455688899999999999999999999   999999999999999999999999988654221  


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh---cccCccccccc----cc
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR---MVPYFPYPIEN----NS  235 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~----~~  235 (309)
                      ........+++.|+|||.+.    ++.++|+||||+++|+|++|+.||............   ........+..    ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            11122335577899999874    577899999999999999999998643221111000   00000000000    00


Q ss_pred             hhhhhcc---cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNF---QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......   ..........++.+.++|.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000   00000111234668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-39  Score=280.83  Aligned_cols=240  Identities=23%  Similarity=0.229  Sum_probs=186.7

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|..+ +++.||+|.+.....  ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999954 588999998765321  22234466777787755 799999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~  152 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVT  152 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Ccc
Confidence            99988886443   3467888899999999999999999   999999999999999999999999988643211  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||..........                 .+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-----------------~i~~~~~--  213 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-----------------SILHDDV--  213 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH-----------------HHHcCCC--
Confidence            23346788999999886   7889999999999999999999986543221111                 1111000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCC-------CHHHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERP-------TMRQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rp-------s~~~ll~~  280 (309)
                      ..+...+..+.+++.+||+.||++||       ++.+++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11112345689999999999999999       88888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.8e-39  Score=272.28  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=195.6

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++.. .+++.+++|.+....... ...+.+|+.+++.++||||+++++++...+..+++|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            457899999999999999999985 468999999876543322 345778899999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999886443   3477899999999999999999999   999999999999999999999999988654221


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                        ........++..|+|||.+.      ++.++|+||||+++|+|++|..||.....................       
T Consensus       160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------  230 (267)
T cd06645         160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK-------  230 (267)
T ss_pred             --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc-------
Confidence              12223345788899999863      677899999999999999999997543211111000000000000       


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             .......+..+.+++.+||+.||++|||+.+++++
T Consensus       231 -------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 -------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                   00011223558999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=272.89  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC--
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETK--   78 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--   78 (309)
                      |++..++|++.+.||.|++|.||+|..+ +++.+++|.......  ..+.+..|+.+++++ +|+||+++++++....  
T Consensus         1 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             CCCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            4678899999999999999999999964 578999998765433  245688999999998 7999999999997644  


Q ss_pred             ----ccEEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           79 ----VPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        79 ----~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                          ..+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence                4799999999999999886543 2234577889999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      |||.+......  ........++..|+|||.+.        ++.++|+||||+++|+|++|..||.......... ....
T Consensus       156 d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~  232 (275)
T cd06608         156 DFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPR  232 (275)
T ss_pred             CCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-Hhhc
Confidence            99988654221  12223345678899999863        5678999999999999999999986432111110 0000


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                     ........+...++.+.++|.+||..||.+|||+.+++++
T Consensus       233 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 ---------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                           0000111122345679999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.8e-39  Score=271.02  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=195.9

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccch-----hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-----KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      +|++.+.||.|+||.||+|...+|+.+++|.+....     .......+..|+.+++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            589999999999999999998789999999765432     122235688899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      +||+++++|.+++....   ..++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++++|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999986543   3467888899999999999999999   99999999999999999999999998865422


Q ss_pred             ccc----cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          164 HDQ----TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       164 ~~~----~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...    ........++..|+|||.+.   ++.++|+||||+++|+|++|..||...+............          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR----------  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc----------
Confidence            111    11122345677899999986   6788999999999999999999986433221111000000          


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            ......+...+..+.++|.+||+.+|.+|||+.+++++
T Consensus       225 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         225 ------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  00011122344669999999999999999999999763

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.9e-39  Score=280.66  Aligned_cols=235  Identities=27%  Similarity=0.286  Sum_probs=180.5

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMR-IISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.+ .+|+.||+|.+.....  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999996 4689999998765321  111223344443 56778999999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~  152 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKT  152 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCc
Confidence            99998886543   3477888899999999999999999   99999999999999999999999998754311  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+.....                 ..+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-----------------~~i~~~~~--  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-----------------DNILNKPL--  213 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-----------------HHHHcCCC--
Confidence            23446788999999986   788999999999999999999998643221110                 00000000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR  275 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~  275 (309)
                      ..+...+..+.++|.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            01112245699999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.6e-39  Score=274.01  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC---
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET---   77 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~---   77 (309)
                      +.++.+.|++.+.||.|+||.||+|.. .+++.+++|.......  ....+..|+.++..+ +||||+++++++...   
T Consensus         1 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             CCChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            356789999999999999999999985 4588999998755432  245678888889888 699999999998753   


Q ss_pred             ---CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           78 ---KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        78 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                         ...+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+++   ++|+|++|+||++++++.++++|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence               457899999999999998875433 23577889999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      ||++......  ........++..|+|||.+.        ++.++|+||+|+++|+|++|..||.............   
T Consensus       155 fg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---  229 (272)
T cd06637         155 FGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---  229 (272)
T ss_pred             CCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---
Confidence            9998654221  12223345778899999873        6678999999999999999999985432111111000   


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                    ............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       230 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 --------------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             --------------cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                          0000011111234569999999999999999999999764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.8e-39  Score=279.39  Aligned_cols=245  Identities=23%  Similarity=0.243  Sum_probs=188.7

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +|++.+.||+|+||.||+|..+ +++.+|+|.+.....  ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999854 578999998764321  11223455666777666 5899999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|...+....   .+++..+..++.|++.||.|||+++   ++||||+|+||++++++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998886543   3477889999999999999999999   999999999999999999999999988643211


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        ........|++.|+|||.+.   ++.++|+|||||++|+|++|..||..........                 .+..
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~-----------------~i~~  215 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-----------------SIME  215 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH-----------------HHHh
Confidence              12223456788999999987   7889999999999999999999986543221111                 1111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      ...  ..+...+..+.+++.+||+.||.+|++.     .+++++
T Consensus       216 ~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         216 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            000  1112234668999999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.9e-39  Score=273.33  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=198.5

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||.|.+|.||++.++ +++.+++|.+...........+..|+.+++.++||||+++++++...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999964 68999999876654445567788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++....  ...++..+..++.|++.|+.|||+ .+   ++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999987553  345778889999999999999999 89   9999999999999999999999999876542211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                          .....++..|+|||.+.   ++.++|+||||+++|+|++|..||.........            ...........
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~  219 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVNE  219 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc------------HHHHHHHHhcC
Confidence                11155677899999876   788999999999999999999998644211000            00001111111


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........+..+.++|.+||..||++|||+.+++.+
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11111111145669999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-38  Score=268.49  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=197.8

Q ss_pred             ccccceeecccCceEEEEEE-cCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|+||.+|.+. ..+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58999999999999999998 4568999999865432 233345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++..... ...++..+..++.|++.++.|||+.+   ++|+||+|+||++++++.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999999999875532 34577889999999999999999999   99999999999999999999999998866533221


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                        ......++..|+|||...   ++.++|+||||+++|+|++|..||...............                  
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG------------------  216 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------------
Confidence              223445788899999875   677899999999999999999997643221111000000                  


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .........+..+.+++.+||+.+|.+|||+.++++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         217 NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            00111123346699999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-38  Score=282.24  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=191.0

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK----   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   78 (309)
                      ...++|++.+.||.|+||.||++.. .+|..+|+|.+... ........+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3468999999999999999999985 46899999987543 22223456778999999999999999999986543    


Q ss_pred             --ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           79 --VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        79 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                        ..++||||+++ +|.+.+..     ..+...+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              46899999975 55555432     2466788899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc-
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE-  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  232 (309)
                      ++.....   ........++..|+|||.+.   ++.++|+||||+++|+|++|..||...+....-. ........+.. 
T Consensus       169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~  244 (359)
T cd07876         169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN-KVIEQLGTPSAE  244 (359)
T ss_pred             Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCcHH
Confidence            9865321   11223346788899999986   7889999999999999999999997543211100 00000000000 


Q ss_pred             --c---cchhhhhcccc------------------cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 --N---NSLRQILNFQV------------------ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 --~---~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                        .   ...........                  ........++.+.+||.+||+.||++|||+.+++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence              0   00000000000                  0000111235689999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-38  Score=268.68  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             hcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||.|.+|.||++.+.+ +..+++|.+.....   .+.+.+|+..++.++||||+++++++.+....++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            4789999999999999999999654 88999998765433   5678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++....  ...++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++.......
T Consensus        79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            999999999886443  24578899999999999999999999   9999999999999999999999999987653221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .  ......++..|+|||.+.   ++.++|+||||+++|+|++|..||..............  .              .
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--~--------------~  215 (256)
T cd06612         154 A--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--K--------------P  215 (256)
T ss_pred             c--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--C--------------C
Confidence            1  122334677899999876   77889999999999999999999875432211111000  0              0


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00011122334569999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-38  Score=271.50  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=197.8

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|++.+.||.|+||.||+|..+      +...+++|.+.........+.+..|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            368999999999999999999853      24678889876654443456788999999999999999999999998999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcccc------ccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQV------LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                      ++||||+++++|.+++.......      .+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997655221      4578899999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ||++...... .........++..|+|||.+.   .+.++|+||||+++|++++ |..||.......  ....       
T Consensus       161 ~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~-------  230 (275)
T cd05046         161 LSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNR-------  230 (275)
T ss_pred             cccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHH-------
Confidence            9987533211 111122234466799999875   6778999999999999998 788875332111  1100       


Q ss_pred             ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          231 IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                              ..........+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       231 --------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 --------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                    00001111112233456999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-38  Score=269.32  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=191.9

Q ss_pred             eeecccCceEEEEEEcCC--Cc--EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLPD--NT--LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~--~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||.|++|.||++.+.+  +.  .+++|.+.........+.+..|+..+++++||||+++++.+.+ ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998533  33  6899988766543456778999999999999999999999988 888999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc-c
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT-A  168 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~-~  168 (309)
                      ++|.+++..... ...++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++......... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999876543 34578899999999999999999999   999999999999999999999999998765332111 1


Q ss_pred             cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......++..|+|||.+.   ++.++|+||||+++|+|++ |..||............ .                ....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~----------------~~~~  218 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-D----------------KEGE  218 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-H----------------hcCC
Confidence            111234566799999875   7889999999999999998 99998543222110000 0                0000


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            01111223456999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-39  Score=286.67  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++.. .+++.+|+|.+....  .......+..|..++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999985 468999999876432  2223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999886543   3477889999999999999999999   999999999999999999999999987643211


Q ss_pred             cc---------------------------------cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCC
Q 040698          165 DQ---------------------------------TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKH  208 (309)
Q Consensus       165 ~~---------------------------------~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~  208 (309)
                      ..                                 ........|++.|+|||.+.   ++.++|+|||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                 00112346889999999986   7889999999999999999999


Q ss_pred             CCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC---HHHHHHH
Q 040698          209 PRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT---MRQVSEQ  280 (309)
Q Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~  280 (309)
                      ||........... ....              ......+.....++.+.+||.+|+ .||.+|++   +.++++|
T Consensus       235 Pf~~~~~~~~~~~-i~~~--------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETYRK-VMNW--------------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHHHH-HHcC--------------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9864432211100 0000              000011111123456899999977 49999985   6777665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-38  Score=273.95  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeee----
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCL----   75 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~----   75 (309)
                      .+..+.++|++.+.||+|+||.||++.. .+++.+++|.......  ....+..|+.+++.+ +||||+++++++.    
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            3566889999999999999999999985 4588999998765322  234577888999988 6999999999874    


Q ss_pred             -cCCccEEEEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           76 -ETKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        76 -~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                       .++..++||||+++++|.+++... ......++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence             346789999999999999887643 22334577888999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      |||.+......  ........++..|+|||.+.        ++.++|+||+|+++|+|++|..||......... .....
T Consensus       167 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~  243 (286)
T cd06638         167 DFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-FKIPR  243 (286)
T ss_pred             cCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-hhccc
Confidence            99988654221  11223345788899999863        577899999999999999999997643211110 00000


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..               ......+...+..+.++|.+||+.||++|||+.+++++.
T Consensus       244 ~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         244 NP---------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cC---------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00               000001112235699999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=267.87  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=190.1

Q ss_pred             eeecccCceEEEEEEcC--C--CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP--D--NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~--~--~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|.+.  +  +..+++|...........+.+..|+.+++.+.||||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999742  2  36899998776544344567889999999999999999999876 4567999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|.+++....   ..++..+..++.|++.|++|||..+   ++|+||+|+||+++.++.++++|||++...........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999997554   3477899999999999999999999   99999999999999999999999999875532221111


Q ss_pred             -ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          170 -TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       170 -~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                       .....++..|+|||.+.   ++.++|+||||+++|+|++ |..||........  .......                .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--~~~~~~~----------------~  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--IAMLESG----------------E  215 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHcC----------------C
Confidence             11122345699999886   7889999999999999997 9999865432111  0000000                0


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ..+.+..++..+.++|.+||+.||.+|||+.++++.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1111223345699999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-38  Score=268.43  Aligned_cols=245  Identities=25%  Similarity=0.385  Sum_probs=188.7

Q ss_pred             eecccCceEEEEEEc---CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           15 LLGEGGFGFVYKGVL---PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~---~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      .||+|+||.||+|.+   .++..+++|.+.... .....+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999963   357899999876443 23345678889999999999999999998864 5678999999999


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc-c
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA-T  169 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~-~  169 (309)
                      +|.+++....   ..++..+..++.|++.|+.|||+++   ++|+||+|.||++++++.++++|||++.......... .
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999886443   3477889999999999999999999   9999999999999999999999999986553222111 1


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccccc
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA  245 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
                      .....++..|+|||.+.   ++.++|+||||+++|+|++ |..||.......  .....                .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i----------------~~~~~  216 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMI----------------ESGER  216 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----------------HCCCC
Confidence            11222346799999876   6778999999999999997 999986432211  00000                00011


Q ss_pred             CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ...+...++.+.++|.+||+.||.+|||+.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            112223456799999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-39  Score=279.56  Aligned_cols=253  Identities=19%  Similarity=0.279  Sum_probs=192.0

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++.. .+++.+|+|.+.....  ....+.+..|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            5799999999999999999995 4689999998764321  222345788899999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++.....  .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999865332  3477888999999999999999999   999999999999999999999999987554221


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      . ........|++.|+|||++.        ++.++|+||+|+++|+|++|..||........... .... .        
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-i~~~-~--------  224 (331)
T cd05597         156 G-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMNH-K--------  224 (331)
T ss_pred             C-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-HHcC-C--------
Confidence            1 11122345788999999874        56789999999999999999999864321111000 0000 0        


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCC--CCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGT--ERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~~ll~~  280 (309)
                          ............++.+.++|++||+.++.  .|+++.+++++
T Consensus       225 ----~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 ----EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                00000011112446689999998865444  37899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-39  Score=286.86  Aligned_cols=197  Identities=29%  Similarity=0.415  Sum_probs=169.9

Q ss_pred             cccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-C-----CccceeeeeeecCCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-H-----KNVVKILGVCLETKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~   80 (309)
                      -+|+|.+.||+|+||.|-+|. .++++.||||++++....  ......|+.+|..++ |     -|+|+++++|...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            389999999999999999999 467999999999887543  345578899999886 3     3899999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEEeeecc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--NYTAKVADFASS  158 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~  158 (309)
                      |||+|.+ ..+|.++++.....+ ++...+..++.||+.+|.+||+++   |+|.||||+|||+.+  ...|||+|||++
T Consensus       264 ciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            9999999 579999998776654 578999999999999999999999   999999999999953  447999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALA  216 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~  216 (309)
                      +..     ......+..+-.|+|||++.   |+.+.|||||||++.||++|.+-|+..+..
T Consensus       339 c~~-----~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  339 CFE-----SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             ccc-----CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            764     22333667788899999998   999999999999999999998888765433

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-38  Score=268.70  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=193.2

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL-ETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~iv~e   85 (309)
                      ..+|++.+.||+|++|.||++... |..+++|.......   .+.+..|+.+++.++|+|++++++++. +.+..++++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            468999999999999999999864 78899998765432   456788999999999999999999764 4567899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            9999999999875443 23577888999999999999999999   999999999999999999999999987643211 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                          ......+..|+|||...   ++.++|+||||+++|+|++ |..||........... .                 .
T Consensus       156 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~-----------------~  213 (256)
T cd05082         156 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-V-----------------E  213 (256)
T ss_pred             ----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H-----------------h
Confidence                11223345699999876   7788999999999999997 9998764321111000 0                 0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      .......+..++..+.+++.+||+.+|++|||+.++++.|..+
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0001111223346699999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-38  Score=269.49  Aligned_cols=255  Identities=25%  Similarity=0.421  Sum_probs=198.0

Q ss_pred             hcccccceeecccCceEEEEEEcC-CC---cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~---~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|+..+.||+|++|.||+|..+ ++   ..+++|.+.........+.+..|+.+++.++|||++++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            468999999999999999999854 23   37899987665444445678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++....  ...++..+..++.|++.|++|||+.+   ++|+|++|+||+++.++.++++|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999986543  23477888999999999999999999   9999999999999999999999999886553


Q ss_pred             cccccccc-cccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          163 SHDQTATT-TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       163 ~~~~~~~~-~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ........ .....+..|+|||.+.   ++.++|+||||+++|++++ |..||.......  ....              
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~--------------  222 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKA--------------  222 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHH--------------
Confidence            22111111 1112234699999876   6789999999999999997 999975432111  0000              


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                       +.. ....+.+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       223 -i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         223 -IND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             000 001111223346689999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.9e-39  Score=278.42  Aligned_cols=239  Identities=25%  Similarity=0.271  Sum_probs=182.5

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|.. .+++.||+|.+.....  ....+.+..|..++.. .+||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 4588999998765321  1122334455555554 4899999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~  152 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCc
Confidence            99998886543   3477888999999999999999999   999999999999999999999999998653221  122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+.....                 ..+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-----------------~~i~~~~--~  213 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-----------------DSILNDR--P  213 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHHcCC--C
Confidence            33456788999999986   788999999999999999999998643221100                 0000000  0


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH-HHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR-QVSE  279 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~  279 (309)
                      ..+...+..+.+++.+||+.||.+||++. ++++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            11122345689999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.9e-39  Score=275.22  Aligned_cols=259  Identities=24%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|++|.||++.. .+|..+++|.+...........+..|+.+++.++||||+++++++...+.+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            57899999999999999999995 45889999987655444456778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |+++++|..++....   ..++..+..++.+++.++.|||+ .+   ++|+||+|+||++++++.++++|||++..... 
T Consensus        84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-  156 (284)
T cd06620          84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-  156 (284)
T ss_pred             cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh-
Confidence            999999998886533   34778899999999999999997 57   99999999999999999999999998754311 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                         .......++..|+|||.+.   ++.++|+||||+++|++++|..||...........      ...........+..
T Consensus       157 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~  227 (284)
T cd06620         157 ---SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD------DPMGILDLLQQIVQ  227 (284)
T ss_pred             ---hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh------hhhHHHHHHHHHhh
Confidence               1112345788899999875   77899999999999999999999875432110000      00000000111111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ...........+..+.+|+.+||+.||.+|||+.+++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111111122456799999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.9e-38  Score=268.21  Aligned_cols=246  Identities=23%  Similarity=0.386  Sum_probs=188.8

Q ss_pred             eecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCC
Q 040698           15 LLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      .||.|+||.||+|.+.   ++..+++|...........+.+..|+.+++.++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999998743   3567999988766544455678999999999999999999998864 56799999999999


Q ss_pred             HHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc-cc
Q 040698           92 LFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA-TT  170 (309)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~-~~  170 (309)
                      |.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.......... ..
T Consensus        81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998864332  3577899999999999999999999   9999999999999999999999999886542221111 11


Q ss_pred             cccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       171 ~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      ....++..|+|||...   ++.++|+||||+++|++++ |..||.........                  .........
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------------------~~~~~~~~~  217 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------------------SFIEQGKRL  217 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH------------------HHHHCCCCC
Confidence            1122246799999875   6789999999999999996 99997643221100                  000001111


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ..+..+++++.++|.+||+.||++||++.++.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            12233456799999999999999999999999888653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-38  Score=273.82  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=193.5

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .|++.+.||+|+||.||++.+ .+++.+|+|.+.....  ......+..|+.+++.++|++++.+++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            478899999999999999985 4689999998754321  2223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...... .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~g~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-  155 (285)
T ss_pred             ecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC-
Confidence            99999999888654432 3577889999999999999999999   999999999999999999999999988654211 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++|+||+|+++|+|++|..||.........              .........
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--------------~~~~~~~~~  219 (285)
T cd05630         156 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--------------EEVERLVKE  219 (285)
T ss_pred             --ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--------------HHHHhhhhh
Confidence              1222346788899999986   788999999999999999999998643211000              000000000


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                       .....+...++.+.+|+.+||+.||.+|||     +.+++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence             000111223456899999999999999999     8888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-38  Score=277.59  Aligned_cols=266  Identities=19%  Similarity=0.303  Sum_probs=191.8

Q ss_pred             ccceeeccc--CceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698           11 DKRHLLGEG--GFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        11 ~i~~~lg~g--~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++++.||+|  +|+.||++.. .+|+.||+|.+.... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367889999  6789999985 579999999876542 223345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++...... .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+++.||+..........
T Consensus        81 ~~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999998754333 3577889999999999999999999   99999999999999999999999986533211111


Q ss_pred             c-----ccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc----
Q 040698          167 T-----ATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE----  232 (309)
Q Consensus       167 ~-----~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  232 (309)
                      .     .......++..|+|||++.     ++.++|+|||||++|+|++|..||.................+....    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0     0111233456699999874     6788999999999999999999987533222111111100000000    


Q ss_pred             --------------ccchhh-hh--------cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 --------------NNSLRQ-IL--------NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 --------------~~~~~~-~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                    ...... ..        ......+.....++.+.+|+.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                          000000 00        0000001122345679999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=287.42  Aligned_cols=247  Identities=26%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILI--NEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.|.-++.||.|+||.||-++ .++.+.||||++....+...  -..+..|+..|++++|||++.+.++|..+.+.|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            3567788899999999999999 46789999999877654322  24578899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||| -||-.+++.-...  ++.+.+|+.|+++.+.||+|||+++   .+|||||..||++++.|.||++|||.+..   
T Consensus       105 MEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi---  175 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI---  175 (948)
T ss_pred             HHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh---
Confidence            9999 5688888875543  4577889999999999999999999   99999999999999999999999998854   


Q ss_pred             ccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                         ..+....+|+|.|||||++.      |+-++||||||++..++...++|.=..                 .+...+.
T Consensus       176 ---~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----------------NAMSALY  235 (948)
T KOG0577|consen  176 ---MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----------------NAMSALY  235 (948)
T ss_pred             ---cCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----------------hHHHHHH
Confidence               45667789999999999997      899999999999999999999882111                 1222222


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .+-....+......+++.++.|+.+||++-|.+|||..+++.|-=
T Consensus       236 HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  236 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            233333333345677788999999999999999999999988753

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-38  Score=268.05  Aligned_cols=252  Identities=27%  Similarity=0.425  Sum_probs=195.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||.|++|.||++.+.++..+++|.+.....  ..+.+..|+.+++.++|||++++++++.. +..+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            3577999999999999999999987777899998764332  24567889999999999999999998754 56799999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999875432 23477888999999999999999999   9999999999999999999999999986542211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      . .......++..|+|||...   .+.++|+||||+++|+|++ |..||......... ........             
T Consensus       157 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~-------------  221 (260)
T cd05069         157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQVERGYR-------------  221 (260)
T ss_pred             c-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCC-------------
Confidence            1 1111223456799999875   6778999999999999999 89997643211100 00000000             


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                          ...+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                01112334669999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-38  Score=271.61  Aligned_cols=250  Identities=25%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||.|+||.||+|... ++..+++|........ ..+.+..|+.+++.++||||+++++++..++..++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH-HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            478999999999999999999964 5889999987654332 34567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|..++.....  .+++..+..++.|++.++.|||+++   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        90 ~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--  162 (292)
T cd06644          90 FCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--  162 (292)
T ss_pred             cCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--
Confidence            9999999887754432  3477899999999999999999999   99999999999999999999999998754311  


Q ss_pred             ccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          166 QTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .........++..|+|||.+.        ++.++|+||||+++|+|++|..||........... ......         
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~---------  232 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEP---------  232 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH-HhcCCC---------
Confidence            111222345677899999873        46689999999999999999999764322111100 000000         


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .....+...+..+.++|.+||+.||++||++.+++++
T Consensus       233 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 ------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  0001112334568999999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-38  Score=268.85  Aligned_cols=256  Identities=26%  Similarity=0.369  Sum_probs=197.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|.+.+.||.|+||.||+|.+.+    ...+++|...........+.+..|+.+++.++||||+++++++.+ +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            45679999999999999999998533    246888877665544456678999999999999999999998876 4568


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  ..++..+..++.+++.|+.|||+++   ++|+||+|+||+++.++.++++|||++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999875432  3477889999999999999999999   999999999999999999999999988654


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ..... .......+...|+|||.+.   ++.++|+||||+++|++++ |..||..........  ..             
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~--~~-------------  221 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG--RI-------------  221 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HH-------------
Confidence            22211 1111222345799999876   7789999999999999986 999986443221110  00             


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                        .. ......+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus       222 --~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         222 --EN-GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --Hc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              00 00011122344669999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=272.29  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+-|.+++.||+|+||.||++.++ +|+.+|+|.+.....   -+.+-.|+.++++.+.|+||++++.+.....+|||||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            345889999999999999999865 599999998877543   3456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ||..|++.+.++.++  +.+.+.++..++..-++||+|||...   -+|||||..||+++-+|..|++|||.+.....  
T Consensus       109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--  181 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--  181 (502)
T ss_pred             hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--
Confidence            999999999987554  35688999999999999999999998   89999999999999999999999999866521  


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh-c
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL-N  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (309)
                      .-...+...|++.|+|||++.   |..++||||||+...+|..|++||+..-                 +...+..+. +
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH-----------------PMRAIFMIPT~  244 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH-----------------PMRAIFMIPTK  244 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc-----------------ccceeEeccCC
Confidence            112234578999999999998   9999999999999999999999977541                 111111111 2


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +.+-+..+...+.++.+|+++||-.+|++|.|+.++++|-
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            2233445667788899999999999999999999999874

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-38  Score=277.95  Aligned_cols=240  Identities=25%  Similarity=0.253  Sum_probs=186.9

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.++ +++.+|+|.+.....  ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 588999998765421  22234556777788777 699999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   ..++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++......  ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  152 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT  152 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence            99988876543   3578889999999999999999999   999999999999999999999999987542111  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....++..|+|||.+.   ++.++|+|||||++|+|++|..||.........                 ..+.....  
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-----------------~~i~~~~~--  213 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-----------------QSILEDEV--  213 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-----------------HHHHcCCC--
Confidence            22345788999999986   788999999999999999999998644321110                 00111000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      ..+...+..+.+||.+||+.||.+|||+     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1112234669999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.9e-39  Score=286.56  Aligned_cols=264  Identities=20%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----ccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK-----VPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~   81 (309)
                      +|++.+.||.|+||.||++.. .+|+.||+|.+... ........+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            588999999999999999995 56899999987543 22223456788999999999999999999998766     789


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|+||+. ++|...+...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 5777766533   24577889999999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc---
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN---  234 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  234 (309)
                      ... .........++..|+|||.+.    ++.++|+||+||++|+|++|..||........ ..........+....   
T Consensus       154 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHH
Confidence            221 112223345677899999875    67889999999999999999999865432211 111100000000000   


Q ss_pred             ---chhhhh-ccccc-------CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          235 ---SLRQIL-NFQVA-------DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       235 ---~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                         ...... .....       .......++.+.+||.+||+.||++|||+.+++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence               000000 00000       001112246689999999999999999999998863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=277.89  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=209.6

Q ss_pred             HhhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ++++-|.+.+.||+|.|.+|-+++ ..+|++||+|++..... ......+.+|+..|+.++|||||++|++......+|+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            467889999999999999999998 47899999999876532 3334678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL-DDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv-~~~~~v~l~d~g~~~~~  161 (309)
                      |+|.-++|+|.+++-.+...  +.+.....++.||+.|+.|+|+..   ++||||||+||.+ ..-|-||+.|||.+..+
T Consensus        95 iLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999999999999877654  477889999999999999999999   9999999999876 57899999999987544


Q ss_pred             ccccccccccccccccccCCCcccc---c-CCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---W-TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~-~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                         .........+|+..|-|||.+.   | .++.|||||||++|.+++|++||...                 .+...+.
T Consensus       170 ---~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-----------------NDSETLT  229 (864)
T KOG4717|consen  170 ---QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-----------------NDSETLT  229 (864)
T ss_pred             ---CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-----------------cchhhhh
Confidence               3344556778999999999997   3 56789999999999999999997654                 3334444


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+++.++-.  |...+.++++||.+||..||++|.|.+++..+
T Consensus       230 mImDCKYtv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 MIMDCKYTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhcccccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            555555433  34556779999999999999999999998764

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=302.79  Aligned_cols=255  Identities=22%  Similarity=0.301  Sum_probs=193.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCcc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVP   80 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   80 (309)
                      ...++|++++.||.|+||.||++.+. ++..+++|.+.... .......+..|+.+++.++||||++++++|.+  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34579999999999999999999954 57888999775432 22335678899999999999999999998854  4568


Q ss_pred             EEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEEcC---------
Q 040698           81 LLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGS----PPIIHGDVKSANILLDD---------  146 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~----~~~~h~dl~~~nilv~~---------  146 (309)
                      +|||||+++++|.+++.... ....+++..++.|+.||+.||.|||+.+.    ..|+|+||+|+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999987532 23456889999999999999999998321    12999999999999964         


Q ss_pred             --------CCCeEEEeeecccccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          147 --------NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       147 --------~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                              .+.++|+|||++......   .......+++.|+|||++.     ++.++|||||||++|+|++|..||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    234899999998654221   1223346789999999874     678999999999999999999998643


Q ss_pred             hhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          214 ALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............                 .. .......+..+.+||..||+.+|.+|||+.+++.+
T Consensus       247 ~~~~qli~~lk~-----------------~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFSQLISELKR-----------------GP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHHHHHHHHhc-----------------CC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            222111111000                 00 00011224569999999999999999999999854

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-40  Score=273.39  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=189.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--C---ccE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET--K---VPL   81 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~   81 (309)
                      -.|+-.+++|+|+||.||+|.. .+++.||||++......     -..|+.+|+.++|||||++.-+|...  +   ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            3577889999999999999994 45899999988766443     25678999999999999999888642  2   345


Q ss_pred             EEEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEeeeccc
Q 040698           82 LVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSV  159 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~g~~~  159 (309)
                      +||||++ .+|.+.++.- ..+...+...+.-+.+||++|+.|||+.+   ++||||||.|+++|.+ |.+||||||.|.
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            9999997 5888877642 11223355667788999999999999999   9999999999999965 899999999998


Q ss_pred             ccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........   ..+.-+-.|+|||.+.    |+.+.||||.||++.||+.|++-|+..+.-. ++....+-+-.+.....
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            77333222   3334466799999997    9999999999999999999999987643222 22222222211111111


Q ss_pred             hhhhhc------c--cccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILN------F--QVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~------~--~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....+      +  +...   ......+++..+|+.++|.-+|.+|.++.+++.+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            110000      0  0000   1223445779999999999999999999999864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-38  Score=271.99  Aligned_cols=251  Identities=24%  Similarity=0.276  Sum_probs=194.8

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||.|+||.||++... ++..+++|........ ..+.+..|+.+++.++|||++++++++...+..++|+|
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH-HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456899999999999999999964 4778888877654332 24567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|..++....  ...++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++...... 
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-  156 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  156 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence            999999988775432  24577889999999999999999999   999999999999999999999999988654221 


Q ss_pred             ccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          166 QTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                       ........++..|+|||.+.        ++.++|+||+|+++|+|++|..||.................          
T Consensus       157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (282)
T cd06643         157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP----------  225 (282)
T ss_pred             -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC----------
Confidence             11223345678899999873        56689999999999999999999865432211111100000          


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                            .....+...+..+.++|.+||+.||.+|||+.+++++-
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         226 ------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                  00011122345699999999999999999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.1e-39  Score=278.02  Aligned_cols=239  Identities=24%  Similarity=0.247  Sum_probs=183.2

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.++ +|+.||+|.+.....  .........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999964 589999998765321  1123345566666664 4899999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   ..++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~  152 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNR  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCc
Confidence            99998886543   3477888899999999999999999   99999999999999999999999998754211  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|+..|+|||.+.   ++.++|+||||+++|+|++|..||...+...  .               ...+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~---------------~~~~~~~~~--  213 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--L---------------FESIRVDTP--  213 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--H---------------HHHHHhCCC--
Confidence            33456788999999986   7889999999999999999999986432211  0               000000000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH-HHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR-QVSE  279 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~  279 (309)
                      ..+...+..+.++|.+||+.||.+||++. ++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            01112345689999999999999999984 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=267.59  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=197.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||.|++|.||++.. .+++.+++|........ ....+..|+.+++.++||||+++++++.+.+.++++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            46899999999999999999995 45788999987654433 35678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++....  ..+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999999887542  23477889999999999999999999   9999999999999999999999999886543211


Q ss_pred             ccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                        .......++..|+|||.+.      ++.++|+||||+++|+|++|..||................+..          
T Consensus       156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~----------  223 (262)
T cd06613         156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP----------  223 (262)
T ss_pred             --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------
Confidence              1122345677899999874      5667999999999999999999986543222111110000000          


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          .........+..+.+++++||+.+|..|||+.+++.+
T Consensus       224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 ----PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ----ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0001123345679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-39  Score=281.29  Aligned_cols=237  Identities=27%  Similarity=0.305  Sum_probs=185.6

Q ss_pred             ceeecccCceEEEEEEc----CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      ++.||+|+||.||++..    .+|+.+|+|.+..... ......+..|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999874    3589999998765432 222345678899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  .
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~  152 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E  152 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence            9999998886432   3578899999999999999999999   999999999999999999999999988654221  1


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      .......|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+.....                 ..+.....
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----------------~~i~~~~~  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-----------------TMILKAKL  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-----------------HHHHcCCC
Confidence            1223456788999999886   788999999999999999999998643221111                 00111000


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQ  276 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  276 (309)
                        ..+...++.+.++|++||+.||.+|||+.+
T Consensus       216 --~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 --GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              111223456899999999999999999433

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-38  Score=271.91  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec---
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE---   76 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---   76 (309)
                      ++....+.|++.+.||.|+||.||+|.+ .+++.+++|.......  ....+..|+.+++.+ +||||+++++++..   
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            4556789999999999999999999995 5689999998755432  234577888888888 69999999999853   


Q ss_pred             ---CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           77 ---TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        77 ---~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                         .+..+++|||+++++|.+++...... ..++..+..++.|++.|+.|||+.+   ++|+|++|+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               45779999999999999988765433 3467788899999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      |||++......  ........++..|+|||.+.        ++.++|+||||+++|+|++|..||...........    
T Consensus       164 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----  237 (282)
T cd06636         164 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----  237 (282)
T ss_pred             eCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----
Confidence            99987654221  11222345678899999863        66789999999999999999999854321111100    


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                   .............++..+.+||.+||+.||.+|||+.+++++
T Consensus       238 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 -------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                         000001111112344669999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-38  Score=271.29  Aligned_cols=270  Identities=24%  Similarity=0.342  Sum_probs=201.2

Q ss_pred             hcccccceeecccCceEEEEEEcC-----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   79 (309)
                      .+.|++.+.||+|+||.||++.+.     ++..+++|.+...........+..|+..++.+.||||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            467899999999999999999842     3789999988765443345678999999999999999999999877  567


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .+++|||+++++|.+++.....  ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||.+.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            8999999999999999875443  3577889999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccccc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQTAT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      .......... .....+...|++||...   ++.++|+||||+++|+|++|..|+..........   ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~  234 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM---IGIAQGQMIVTR  234 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc---cccccccccHHH
Confidence            6532111111 11223345599999876   7788999999999999999998865432111000   000000000111


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      .............+..++..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111112222334456799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-38  Score=273.76  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=186.0

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhh---cCCCccceeeeeeec-----CC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQ---INHKNVVKILGVCLE-----TK   78 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~---l~h~~iv~~~~~~~~-----~~   78 (309)
                      +|++.+.||+|+||.||++.++ +|+.+|+|.+..... ......+..|+.+++.   ++||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999964 689999997754321 1112234455555554   479999999998764     34


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..+++|||+++ +|.+++..... ...++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999974 88888765433 23578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc----cccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF----PYPI  231 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~  231 (309)
                      ......   .......++..|+|||.+.   ++.++|+||+|+++|+|++|.+||........ ........    ....
T Consensus       156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~  231 (288)
T cd07863         156 RIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhC
Confidence            655221   1223345678899999886   78899999999999999999999854322111 00000000    0000


Q ss_pred             cc--cchhhhhcc---cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 EN--NSLRQILNF---QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~--~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..  .........   ..........++.+.+++.+||+.||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00  000000000   00001112344668999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=268.56  Aligned_cols=248  Identities=28%  Similarity=0.440  Sum_probs=188.4

Q ss_pred             eeecccCceEEEEEEcCC-Cc--EEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLPD-NT--LVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~-~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||.|+||.||+|..++ +.  .+++|...........+.+..|+.++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999643 43  46778776443333456788899999999 799999999999999999999999999


Q ss_pred             CCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           90 GTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        90 ~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      ++|.+++.....             ...+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999865431             123467889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      ++.....   .........+..|+|||.+.   ++.++|+||||+++|+|++ |..||........ ......       
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~-------  226 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQ-------  226 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-HHHHhC-------
Confidence            8743211   11111122345699999875   7789999999999999997 9999754321110 000000       


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                                ....+.+...+..+.+++.+||+.||.+|||+.++++.|..+.
T Consensus       227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                      0001111223456899999999999999999999999987663

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=271.70  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|++|.||++.+ .++..+++|......... .+.+..|+.+++.++||||+++++.+......++||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH-HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            467899999999999999999995 468999999876543332 456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++.....  .+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          82 EFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998875432  3577899999999999999999999   999999999999999999999999987554221


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                        ........++..|++||.+.        ++.++|+||||+++|+|++|..||........... .....         
T Consensus       157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~---------  224 (280)
T cd06611         157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILKSE---------  224 (280)
T ss_pred             --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH-HhcCC---------
Confidence              11122345677899999863        56689999999999999999999865422111100 00000         


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            ......+...+..+.++|.+||+.+|.+|||+.+++++
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 ------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  00111122334568999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-38  Score=276.98  Aligned_cols=239  Identities=25%  Similarity=0.263  Sum_probs=183.2

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|.+. +++.||+|.+.....  ....+....|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 588999998765421  1222345556667765 4899999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|..++....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence            99999887532   3467888899999999999999999   999999999999999999999999987643111  112


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|+..|+|||.+.   ++.++|+||+||++|+|++|..||.........                 ..+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-----------------~~i~~~~~--  213 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-----------------QSIRMDNP--  213 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHHhCCC--
Confidence            23345788999999986   788999999999999999999998643221100                 00000000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH-HHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR-QVSE  279 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~  279 (309)
                      ..+...+..+.+++.+||+.||.+||++. ++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            01112345689999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.2e-38  Score=274.12  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=195.8

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||+|+||.||++.+. +|+    .+++|.+...........+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            578999999999999999999853 444    57888776654444455688899999999999999999998754 467


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +++||+++++|.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            99999999999998875432  3467888999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............++..|+|||.+.   ++.++|+||||+++|++++ |..||.......  ....              
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~--------------  223 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDL--------------  223 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------------
Confidence            3222111122233456799999876   6788999999999999997 889975432111  0000              


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                        .........+..++..+.+++.+||..+|++||++.++++.|..+..-
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         224 --LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              000000111112335589999999999999999999999998876533

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-38  Score=269.62  Aligned_cols=248  Identities=30%  Similarity=0.463  Sum_probs=190.6

Q ss_pred             eeecccCceEEEEEEcCC-------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698           14 HLLGEGGFGFVYKGVLPD-------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~-------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +.||.|+||.||+|..++       +..+++|.+...........+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       2578888776543333456788899999999999999999999998999999999


Q ss_pred             CCCCCHHHHHHhhcc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-----CeEEEeeec
Q 040698           87 VPNGTLFQHVRYQSS----QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-----TAKVADFAS  157 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-----~v~l~d~g~  157 (309)
                      +++++|.+++.....    ....++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999865432    123467888999999999999999999   99999999999999877     899999998


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      +.................+..|+|||.+.   ++.++|+||||+++|+|++ |..||.........  ...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~--~~~---------  226 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL--QHV---------  226 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH--HHH---------
Confidence            86543222212222233456799999886   7889999999999999998 99998644222110  000         


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                             ........+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       227 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 -------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   000011122334567999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=275.88  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=196.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|++|.||++... +++.+++|.+......  .....+..|+.+++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999964 5899999987654322  23456888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++......
T Consensus        81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998875432 34577888999999999999999999   999999999999999999999999987654221


Q ss_pred             ccc---------------------------ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhh
Q 040698          165 DQT---------------------------ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVA  214 (309)
Q Consensus       165 ~~~---------------------------~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~  214 (309)
                      ...                           .......|+..|+|||...   ++.++|+||||+++|+|++|..||...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           0111235677899999886   7788999999999999999999986443


Q ss_pred             hcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC----HHHHHHH
Q 040698          215 LASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT----MRQVSEQ  280 (309)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~  280 (309)
                      ......                 .+.............+..+.+++.+||+.||++|||    +.+++.+
T Consensus       237 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDETFS-----------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHHHH-----------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            221111                 111111111111124567999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-38  Score=271.99  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ....+|++.+.||.|++|.||++.. .++..+++|.+....... ...+..|+.+++.+.||||+++++.+......++|
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            3457999999999999999999985 468899999876543332 45678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++...    ..+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999988532    2467888999999999999999999   99999999999999999999999998765422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......+++.|+|||.+.   ++.++|+|+||+++|+|++|..||........... ...               
T Consensus       169 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~---------------  230 (296)
T cd06654         169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IAT---------------  230 (296)
T ss_pred             cc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-Hhc---------------
Confidence            11  1122345677899999876   67899999999999999999999864322111100 000               


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........+...+..+.+++.+||..||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000011122334568999999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.6e-38  Score=270.94  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=189.0

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHH-HhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRI-ISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||.|+||.||++.++ +|+.||+|.+...........+..|+.. ++..+||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47999999999999999999964 6999999987654322223344555554 566789999999999999999999999


Q ss_pred             cCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           86 FVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        86 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |++ ++|.+++... ......++..+..++.|++.|+.|||++ +   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6887777643 2234568889999999999999999997 8   99999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .   .......++..|+|||.+.       ++.++|+|+||+++|+|++|..||............              
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------  219 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ--------------  219 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH--------------
Confidence            1   1122245677899999863       577899999999999999999997642211111110              


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ..............+..+.++|.+||+.+|.+|||+.+++++
T Consensus       220 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         220 --VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000000000111234669999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.4e-38  Score=267.45  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|+..+.||.|+||.||.|.+. ++..+++|.+...........+..|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            467899999999999999999964 5889999987655434445678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...    ..+...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999988632    2466788899999999999999999   9999999999999999999999999986543221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   .+.++|+||||+++|+|++|..||..........                 .. ..
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~-~~  215 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----------------LI-PK  215 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----------------hh-hc
Confidence              1122234567799999875   6788999999999999999999976432111000                 00 00


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ......+...+..+.+++.+||+.+|.+||++.+++++-.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            0011123345677999999999999999999999988743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=281.19  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             ccceeecccCceEEEEEEcC---CCc--EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698           11 DKRHLLGEGGFGFVYKGVLP---DNT--LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~---~~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.+.||.|.||.||+|...   .|+  .||+|..+.....+..+.|..|..+|+.++||||++++|++.+ ...|||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            34568999999999999832   233  5788888776556668899999999999999999999999985 56799999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      .++.|.|..+++.....  ++...+.-+++||+.||+|||+.+   ++||||..+||+|++..-||++|||+++......
T Consensus       471 L~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             cccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999876653  466888999999999999999999   9999999999999999999999999998763332


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .... ....-...|||||.+.   ++.++|+|.||+++||++. |..||....+.                 ..+.. ..
T Consensus       546 yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------------DVI~~-iE  606 (974)
T KOG4257|consen  546 YYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----------------DVIGH-IE  606 (974)
T ss_pred             hhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----------------ceEEE-ec
Confidence            2221 2233356699999997   8899999999999999887 99997654322                 12211 22


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....+.|+.||+.++.|+.+||+.+|.+||.++++...|.++..
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            333455677888999999999999999999999999999977664

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-38  Score=281.26  Aligned_cols=263  Identities=20%  Similarity=0.259  Sum_probs=191.6

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET-----   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   77 (309)
                      ...++|++.+.||+|+||.||++.+ ..++.+|+|.+.... .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3568999999999999999999995 458899999876432 222345677899999999999999999987543     


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                       ...++||||+++ +|...+..     ..+...+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence             356899999965 66666642     2366788899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc-
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE-  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  232 (309)
                      ++.....   ........++..|+|||.+.   ++.++|+|||||++|+|++|..||...+....... .......+.+ 
T Consensus       172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~  247 (364)
T cd07875         172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK-VIEQLGTPCPE  247 (364)
T ss_pred             CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHH
Confidence            9865422   12223346788899999986   78899999999999999999999975432221110 0000000000 


Q ss_pred             --------------------ccchhhhhcc---cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 --------------------NNSLRQILNF---QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 --------------------~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                          ..........   ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                0000000000   00001111123568999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-38  Score=272.14  Aligned_cols=248  Identities=21%  Similarity=0.356  Sum_probs=196.5

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..+|++.+.||.|++|.||++.. .+|+.+++|.+....... .+.+.+|+..++.++|||++++++++...+..++|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch-HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            45799999999999999999984 568999999876543322 4567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|..++...    .+++..+..++.+++.|+.|||+++   ++|+||+|+||+++.++.++++|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999999888532    3477899999999999999999999   9999999999999999999999999876543221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .  ......++..|+|||.+.   ++.++|+||||+++|++++|..||................                
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~----------------  231 (296)
T cd06655         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----------------  231 (296)
T ss_pred             c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Confidence            1  122345677899999876   6788999999999999999999986543222111100000                


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......+...+..+.++|.+||..||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            00011112234569999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=270.04  Aligned_cols=247  Identities=24%  Similarity=0.406  Sum_probs=194.9

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCccEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN---HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~iv   83 (309)
                      +.|++.+.||.|+||.||+|.+ .+++.+++|.+.........+.+..|+.+++.++   |||++++++++.++...+++
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            3688999999999999999995 5689999998765433333456788888888886   99999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++...    .+++..+..++.|++.++.|||+.+   ++|+||+|+||++++++.++++|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999999887542    4577889999999999999999999   99999999999999999999999998866533


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||........... ....             
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~-------------  217 (277)
T cd06917         154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKS-------------  217 (277)
T ss_pred             Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccC-------------
Confidence            22  2223345778899999875    57899999999999999999999865432211100 0000             


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ..........+..+.+++.+||+.||.+||++.+++++
T Consensus       218 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 ---KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               00000011134569999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-38  Score=266.87  Aligned_cols=248  Identities=26%  Similarity=0.437  Sum_probs=193.7

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--------ILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      +|.+.+.||.|++|.||+|.. .++..+++|.+.....        ....+.+..|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588999999999999999985 4588999997654321        1223568889999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++++||+++++|.+++....   .++...+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997543   3467888899999999999999999   9999999999999999999999999987


Q ss_pred             ccccccccc----cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          160 LISSHDQTA----TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       160 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      .........    ......++..|+|||.+.   ++.++|+|++|+++|+|++|..||...........           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----------  223 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-----------  223 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH-----------
Confidence            653211111    111234677899999876   67789999999999999999999865322111100           


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            ... ......+...+..+.++|.+||+.||.+||++.+++++
T Consensus       224 ------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         224 ------IGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------Hhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                  000 00011122344669999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.5e-38  Score=277.15  Aligned_cols=253  Identities=19%  Similarity=0.259  Sum_probs=192.7

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+....  .......+..|..++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            57999999999999999999954 57889999875432  2222345778889999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++.....  .+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999975432  3477888899999999999999999   999999999999999999999999988643221


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                       .........|++.|+|||.+.        ++.++|+||||+++|+|++|..||...+...............       
T Consensus       156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------  227 (332)
T cd05623         156 -GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-------  227 (332)
T ss_pred             -CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-------
Confidence             111222346889999999863        6778999999999999999999986432211111000000000       


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~  280 (309)
                             .........+..+.+|+++||..++.+  |+++.+++++
T Consensus       228 -------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 -------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                   000111233466899999999765544  7899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7e-38  Score=266.26  Aligned_cols=257  Identities=22%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ++....++......||+|+||.||+|.+ .++..+++|.+....... .+.+.+|+.+++.++|+||+++++++..++..
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH-HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            4555667777778999999999999995 457889999776543332 45688999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~  159 (309)
                      ++++||+++++|.+++.........+...+..++.|++.|+.|||+++   ++|+||+|+||+++. ++.++|+|||.+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            999999999999999875432222256778889999999999999999   999999999999975 6799999999886


Q ss_pred             ccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ......  .......++..|+|||.+.     ++.++|+||+|+++|+|++|..||.............           
T Consensus       158 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-----------  224 (268)
T cd06624         158 RLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-----------  224 (268)
T ss_pred             ecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-----------
Confidence            542211  1122234677899999874     5778999999999999999999976432211111000           


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           .........+...++.+.+++.+||+.+|.+|||+.+++.+
T Consensus       225 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 -----GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                 00001111223344669999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.9e-38  Score=270.98  Aligned_cols=264  Identities=21%  Similarity=0.246  Sum_probs=196.5

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||+|.+ .+|..+++|.+..... ......+..|+.++++++|||++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            589999999999999999995 4689999998765432 22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      + +++|.+++....  ...++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||.+........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999886544  34577899999999999999999999   99999999999999999999999998866532211


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc----cc----cc
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP----IE----NN  234 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~----~~  234 (309)
                       .......++..|+|||.+.    ++.++|+||+|+++|+|++|.+||........ ..........+    .+    ..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHHHcCCCChHHHhhccCcc
Confidence             1223345778899999874    57899999999999999999888754322111 00000000000    00    00


Q ss_pred             chhhhhcccc----cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNFQV----ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........    ........+..+.++|.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    000111234679999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.7e-38  Score=263.61  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=194.1

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e   85 (309)
                      .|++.+.||.|++|.||.+.. .+++.+++|.+.... .....+.+..|+.+++.++|+|++++++.+.. ...+++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            589999999999999999995 457889999875432 22234567889999999999999999998764 446789999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ..+++.++..++.+++.++.+||+++   ++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999998875433 23578899999999999999999999   9999999999999999999999999986653221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......+++.|+|||...   ++.++|+||+|+++++|++|..||...+...........                 
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-----------------  217 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-----------------  217 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------
Confidence              1223345678899999986   677899999999999999999997643221111100000                 


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       .....+...++.+.+++.+||+.||.+|||+.+++++
T Consensus       218 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 -KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             0011122344669999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-38  Score=270.30  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=193.5

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .|+..+.||.|+||.||++.+ .+++.+|+|.+.....  ......+..|+.+++.++|+|++.+.+++..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            478889999999999999985 5689999998754321  2223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            9999999988865433 24578899999999999999999999   999999999999999999999999988654221 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++|+||+|+++|+|++|..||........... ...            .....
T Consensus       156 --~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-~~~------------~~~~~  220 (285)
T cd05632         156 --ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-VDR------------RVLET  220 (285)
T ss_pred             --CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH------------hhhcc
Confidence              1223346788999999986   78889999999999999999999864322111000 000            00000


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                        ....+...+..+.+|+.+||+.||++||+     +.+++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              00111223456899999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-39  Score=260.29  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-------hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-------DKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-------~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      -++|+=.+.||+|..+.|-++.+ ++|..+++|++...       ......+.-..|+.+|+++ -||+|+++.++++..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            35677788999999999998874 56788888865432       1233345567789999988 599999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      ..+++|||.++.|.|.+++...-   .++++....++.|++.|+.|||.++   |+||||||+||+++++..++|+|||.
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence            99999999999999999997544   4588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      ++..   .........+|+++|+|||.+.         |+...|+|+.|+++|.++.|.+||=...              
T Consensus       170 a~~l---~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------------  232 (411)
T KOG0599|consen  170 ACQL---EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------------  232 (411)
T ss_pred             eecc---CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------------
Confidence            9876   3344556788999999999996         7788999999999999999999964331              


Q ss_pred             ccccccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          229 YPIENNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                         ....++.+...+..+  +.+.+.+....+||.+||+.||.+|.|+++++.|-
T Consensus       233 ---QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  233 ---QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ---HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence               111222222222222  23456667799999999999999999999998863

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.2e-38  Score=276.93  Aligned_cols=247  Identities=22%  Similarity=0.243  Sum_probs=187.1

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.. .+++.+|+|.+.....  ....+.+..|..++.++ +||+|+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 4588999998865422  22234577888888887 699999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   .+++..+..++.|++.|++|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~  152 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDT  152 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCc
Confidence            99988876443   3578899999999999999999999   99999999999999999999999998864211  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........          .........+...  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~----------~~~~~~~~~~~~~--~~  220 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM----------NTEDYLFQVILEK--PI  220 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc----------ccHHHHHHHHHhC--CC
Confidence            23456788999999986   788999999999999999999998643211000          0000000011111  11


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      ..+...+..+.+++.+||+.||.+|+++      .++++|
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            1222334568999999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-38  Score=272.23  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||.|++|.||++.. .+++.|++|.+....... .+.+..|+.+++.++||||+++++++...+..++|
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            3458999999999999999999995 569999999876543332 45678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++...    ..+...+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++++|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999988542    2467889999999999999999999   99999999999999999999999998865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..  .......+++.|+|||...   ++.++|+||||+++|++++|..||...+....... ...               
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~---------------  229 (297)
T cd06656         168 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT---------------  229 (297)
T ss_pred             Cc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc---------------
Confidence            11  1122345677899999886   67889999999999999999999864322111000 000               


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........+...+..+.+++.+||..||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111122334568999999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-38  Score=271.35  Aligned_cols=268  Identities=20%  Similarity=0.251  Sum_probs=193.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++++|++.+.||.|+||.||+|.. .+|..+++|.+...........+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3568999999999999999999985 468999999876543333334567889999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      +||+. +++.+++....  ...+...+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             Eeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            99996 67766665432  23466778889999999999999999   99999999999999999999999998865322


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc--cchh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN--NSLR  237 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  237 (309)
                      ..  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||................+..+...  ....
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            11  1122334577899999874    56789999999999999999999865432211111110000000000  0000


Q ss_pred             -------hhhccccc-----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 -------QILNFQVA-----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 -------~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             ........     .......+..+.+++.+|++.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                   00000000     00000113568999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-38  Score=283.78  Aligned_cols=261  Identities=22%  Similarity=0.247  Sum_probs=192.8

Q ss_pred             hcccccceeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..+|++++.||.|+||.||++...   .+..|++|.+...      ....+|+.+++.++||||+++++++...+..+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            457999999999999999999742   4678999977543      2345789999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||++. ++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus       165 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99995 6788777432   34578899999999999999999999   99999999999999999999999999876543


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcch--hhhhc---ccCcccccccc-
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN--EMTRM---VPYFPYPIENN-  234 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~--~~~~~---~~~~~~~~~~~-  234 (309)
                      ...........|+..|+|||.+.   ++.++|+|||||++|+|++|..||........  .+...   ....+...+.. 
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            32222333456889999999986   78899999999999999999999854322110  00000   00000000000 


Q ss_pred             ---chhh---hhcc-cccCcc-----chHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 ---SLRQ---ILNF-QVADEN-----EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ---~~~~---~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ....   .... +.....     ....+.++.++|++||..||++|||+.+++.+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0000   0000 000000     01234568999999999999999999999886

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=272.17  Aligned_cols=267  Identities=19%  Similarity=0.271  Sum_probs=193.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|++|.||+|..+ +++.|++|.+...........+..|+.++++++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            3578999999999999999999964 689999998765432222334667999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++ +|.+++.....  ..++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++++|||++......
T Consensus        83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            99975 89888765443  4577889999999999999999999   999999999999999999999999987543211


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc--cccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY--PIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  238 (309)
                        ........++..|+|||.+.    ++.++|+||+|+++|+|++|..||...................  .........
T Consensus       157 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         157 --SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             --CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence              11112234567799999864    6788999999999999999999986543211111100000000  000000000


Q ss_pred             ----------hhcccccCcc--chHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ----------ILNFQVADEN--EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ----------~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                ..........  .......+.+++.+||+.||++|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                      0000000000  00111558899999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7e-38  Score=265.28  Aligned_cols=249  Identities=28%  Similarity=0.436  Sum_probs=185.3

Q ss_pred             eeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCccEEEEEcCC
Q 040698           14 HLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL-ETKVPLLVYEFVP   88 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~iv~e~~~   88 (309)
                      +.||+|+||.||+|.+.    ++..+++|...........+.+..|+.+++.++||||+++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999843    245789998755433333567788999999999999999999765 4566889999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc--
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ--  166 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~--  166 (309)
                      +++|.+++.....  ..+...+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++........  
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999875433  2355677889999999999999999   99999999999999999999999998865422111  


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      ........++..|+|||...   ++.++|+||||+++|+|++| .+||..........                 .... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-----------------~~~~-  217 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-----------------YLLQ-  217 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----------------HHhc-
Confidence            11112233456799999875   77899999999999999995 55654321111000                 0000 


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ......+...++.+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0001111123356999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-38  Score=280.35  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=191.3

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET-----   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   77 (309)
                      ...++|++.+.||+|+||.||++.. ..++.+|+|.+.... .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4568999999999999999999985 458899999876532 223345677899999999999999999988643     


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                       ...++||||+++ ++.+.+..     ..+...+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             356899999965 56665542     2466788899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc-
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE-  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  232 (309)
                      ++.....   ........++..|+|||.+.   ++.++|+||||+++|+|++|..||........... .......+.+ 
T Consensus       165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~  240 (355)
T cd07874         165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLGTPCPE  240 (355)
T ss_pred             ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHH
Confidence            9865422   12223346788899999886   78899999999999999999999865432111000 0000000000 


Q ss_pred             -----ccchhhhh----------------cccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 -----NNSLRQIL----------------NFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 -----~~~~~~~~----------------~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ........                +...  ........+..+.+||.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 00000000                0000  000111223568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-37  Score=264.49  Aligned_cols=236  Identities=27%  Similarity=0.408  Sum_probs=180.6

Q ss_pred             eeecccCceEEEEEEcCC-------------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698           14 HLLGEGGFGFVYKGVLPD-------------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~-------------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      +.||+|+||.||+|...+             ...+++|.+..... .....+..++.++..++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998422             22578887665433 2345678888999999999999999999998899


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-------eEEE
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT-------AKVA  153 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~-------v~l~  153 (309)
                      +++|||+++++|..++.....  ..++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.       ++++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999888764332  3577889999999999999999999   999999999999986654       8999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHH-hCCCCCchhhhcchhhhhcccCcc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELL-TGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~-~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      |||++.....      .....++..|+|||.+.    ++.++||||||+++|+|+ .|..||..........        
T Consensus       155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--------  220 (262)
T cd05077         155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--------  220 (262)
T ss_pred             CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------
Confidence            9998754321      12234567799999874    677899999999999997 5888865432111100        


Q ss_pred             ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                .......  .....++.+.+||.+||+.||.+||++.++++.|
T Consensus       221 ----------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 ----------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                      0000000  0111235589999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-38  Score=275.53  Aligned_cols=235  Identities=26%  Similarity=0.276  Sum_probs=179.8

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHH-HHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKM-RIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.+ .+|+.+|+|.+....  .......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999996 458999999876432  112223344444 467788999999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~  152 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEET  152 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCc
Confidence            99988776432   3467888889999999999999999   99999999999999999999999998764311  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....+++.|+|||.+.   ++.++|+|||||++|+|++|..||...+.....                 ..+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----------------~~i~~~~--~  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-----------------DNILHKP--L  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-----------------HHHhcCC--C
Confidence            23456788999999986   788999999999999999999998644221111                 0111100  1


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR  275 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~  275 (309)
                      ..+...+..+.+++.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11122335689999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-38  Score=271.39  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||.|++|.||++..+ +|+.+++|.+.... .....+.+..|+.+++.++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            57999999999999999999965 58999999775432 22234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|..+.....   ..++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988877664332   3478899999999999999999999   9999999999999999999999999987653321


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcccc---ccccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYP---IENNS  235 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~---~~~~~  235 (309)
                      .  ......++..|+|||.+.    ++.++|+||||+++|+|++|..||..............   ...+..   .....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  122334567799999864    67789999999999999999999875432221110000   000000   00000


Q ss_pred             -hhhhhcccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 -LRQILNFQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 -~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ...........     ......+..+.+|+.+||+.||++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence             00000000000     0011234668999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5e-38  Score=274.23  Aligned_cols=239  Identities=22%  Similarity=0.243  Sum_probs=185.5

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +|+..+.||+|+||.||++.. .+|+.||+|.+.....  ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            588899999999999999985 4689999998765321  222345667778887775 578889999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|..++....   .+++..+..++.|++.|+.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998886443   3577889999999999999999999   999999999999999999999999988643211


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        ........|++.|+|||.+.   ++.++|+||+|+++|+|++|..||.........                 ..+..
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-----------------~~i~~  215 (323)
T cd05615         155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-----------------QSIME  215 (323)
T ss_pred             --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHHh
Confidence              11222345788999999886   788999999999999999999998654221111                 11111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTM  274 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  274 (309)
                      ...  ..+...+..+.+++.+||+.||.+|++.
T Consensus       216 ~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 HNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            000  1112234568999999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.1e-38  Score=265.02  Aligned_cols=245  Identities=28%  Similarity=0.446  Sum_probs=192.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||.|+||.||.+.. +++.+++|......   ..+.+..|+.+++.++|||++++++++... ..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            357899999999999999999875 67889999876532   245688899999999999999999998764 4699999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ...+...+..++.|++.|+.|||+++   ++||||+|+||+++.++.++++|||.+.....  
T Consensus        79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--  152 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM--  152 (254)
T ss_pred             CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc--
Confidence            9999999999875543 23577888999999999999999999   99999999999999999999999998865321  


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                         .......+..|+|||.+.   ++.++|+||||+++|+|++ |..||........... ..                 
T Consensus       153 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~-----------------  211 (254)
T cd05083         153 ---GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VE-----------------  211 (254)
T ss_pred             ---cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-Hh-----------------
Confidence               111223345699999875   7788999999999999997 9999865432211110 00                 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      .......+...+..+.+++.+||+.+|..||++.++++.|+
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            00011112233466899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=282.47  Aligned_cols=247  Identities=30%  Similarity=0.455  Sum_probs=207.7

Q ss_pred             ccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           11 DKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      ....+||.|.||.||.|.|+. .-.||+|.+.....+  -+.|..|..+|+.++|||+|+++++|..+-.+|||+||+..
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            345689999999999999865 778999988876554  46789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      |+|.++++....... +.-.++.++.||..||.||.+++   ++||||..+|+||.++..||++|||+++.+...-    
T Consensus       348 GNLLdYLRecnr~ev-~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT----  419 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSEV-PAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT----  419 (1157)
T ss_pred             ccHHHHHHHhchhhc-chhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc----
Confidence            999999998876644 55678899999999999999999   9999999999999999999999999998874322    


Q ss_pred             cccccc---ccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          170 TTKEIE---TVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       170 ~~~~~~---~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .+...|   .+.|.|||-+.   ++.++|+|+||++||++.+ |..||+..+..                  ....++..
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------------qVY~LLEk  481 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------------QVYGLLEK  481 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------------HHHHHHhc
Confidence            222222   44599999987   7889999999999999998 88887655322                  23334444


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .+.-+.+.+|++..++||+.||+++|.+||++.++-+.++.|-
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            5555566788899999999999999999999999999997764

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-38  Score=276.84  Aligned_cols=237  Identities=25%  Similarity=0.283  Sum_probs=180.5

Q ss_pred             eeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHH-HHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHK-MRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.++ +++.+|+|.+.....  ......+..+ ..+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 578899998764321  1112233333 3456778999999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|.+++....   ...+..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~  152 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGT  152 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCC
Confidence            99998886543   3366778889999999999999999   99999999999999999999999998864321  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........                 ..+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----------------~~i~~~~~--  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-----------------DNILNKPL--  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-----------------HHHHhCCc--
Confidence            33456889999999886   788999999999999999999998643221110                 00100000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMRQV  277 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l  277 (309)
                      ......+..+.+++.+||+.||.+||++.+.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  244 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDD  244 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence            1111234569999999999999999988743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-37  Score=263.36  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|+||.+|++.. .+|..+++|.+.... .......+..|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            589999999999999999984 468999999875432 223345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +.+++|.+.+...... ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+....... 
T Consensus        81 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-  155 (256)
T cd08218          81 CEGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-  155 (256)
T ss_pred             CCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence            9999999888654332 3467888999999999999999999   9999999999999999999999999886542221 


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                       .......++..|+|||...   .+.++|+||||+++++|++|..||................                 
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-----------------  217 (256)
T cd08218         156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-----------------  217 (256)
T ss_pred             -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-----------------
Confidence             1112234677899999876   6788999999999999999999976432211110000000                 


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ....+...+..+.++|.+||+.+|.+||++.+++++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             011122334669999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.4e-38  Score=274.71  Aligned_cols=194  Identities=23%  Similarity=0.371  Sum_probs=154.9

Q ss_pred             ceeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~   87 (309)
                      .+.||+|+||.||+|..+   ++..+|+|.+.....   ...+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999854   467899998765422   3346789999999999999999998854  45678999999


Q ss_pred             CCCCHHHHHHhhcc------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEEeeec
Q 040698           88 PNGTLFQHVRYQSS------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFAS  157 (309)
Q Consensus        88 ~~~sL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv----~~~~~v~l~d~g~  157 (309)
                      + ++|.+++.....      ...+++..+..++.|++.||.|||+++   ++||||+|+||++    +.++.++|+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 578777753321      123577889999999999999999999   9999999999999    4567899999999


Q ss_pred             ccccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          158 SVLISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                      +........ ........+++.|+|||.+.    ++.++|+||+||++|+|++|.+||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876532211 11223456788899999875    678899999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9e-38  Score=263.69  Aligned_cols=249  Identities=31%  Similarity=0.446  Sum_probs=195.2

Q ss_pred             cccceeecccCceEEEEEEcCC-----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +++.+.||.|+||.||++.+.+     +..+++|.+.........+.+..|+..+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678999999999999999643     48899998876654434667899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....... .++..+..++.|++.|+++||+.+   ++|+||+|+||++++++.++++|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999987554321 478899999999999999999999   999999999999999999999999998665332


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ...... ...++..|+|||.+.   ++.++|+|++|+++|+|++ |..||............                 .
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-----------------~  218 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL-----------------K  218 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------------h
Confidence            111111 122567799999875   7889999999999999998 78887543211110000                 0


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      . ......+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus       219 ~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 K-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             c-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0 000111122446699999999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.4e-38  Score=276.15  Aligned_cols=252  Identities=19%  Similarity=0.257  Sum_probs=191.6

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+....  .......+..|..++..++|++|+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999954 58899999876432  1222345778889999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++.....  .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999975432  3477888899999999999999999   999999999999999999999999998654321


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      . ........|++.|+|||.+.        ++.++|+||||+++|+|++|..||................          
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~----------  224 (331)
T cd05624         156 G-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE----------  224 (331)
T ss_pred             C-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC----------
Confidence            1 11222346889999999764        5678999999999999999999986432111100000000          


Q ss_pred             hhhhccccc-CccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHH
Q 040698          237 RQILNFQVA-DENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~  280 (309)
                           .+.. .......++.+.+++.+||+.++.+  |+++.+++++
T Consensus       225 -----~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         225 -----ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 0000 0001123466999999999876544  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.3e-38  Score=268.91  Aligned_cols=243  Identities=26%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|++|.||++.+. +++.+++|.+....  .....+.+..|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999954 68999999875432  1223456888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   .++...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999887553   4577889999999999999999999   999999999999999999999999988654222


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                           .....+++.|+|||.+.   .+.++|+||||+++|+|++|..||...........                 +..
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------------~~~  212 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-----------------ILE  212 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------Hhc
Confidence                 23345678899999876   67789999999999999999999865431110000                 000


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ..  ...+...+..+.+++.+||+.||.+|+     ++.+++++
T Consensus       213 ~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         213 GK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            00  011112235699999999999999999     77788765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.4e-38  Score=268.82  Aligned_cols=248  Identities=24%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||.|.||.||+|.+ .++..+++|...........+.+..|+.+++.++||||+++++++...+..++|+|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            45688899999999999999985 45889999987654434445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..    ...++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999988753    23467888999999999999999999   9999999999999999999999999886543211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++|+||||+++|+|++|..||...........                 ... 
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----------------~~~-  215 (277)
T cd06642         156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-----------------IPK-  215 (277)
T ss_pred             --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-----------------hhc-
Confidence              1122235677899999886   67789999999999999999999764321111100                 000 


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ......+...+..+.+++.+||+.+|.+|||+.+++++-
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            000111123345689999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.5e-38  Score=265.98  Aligned_cols=253  Identities=22%  Similarity=0.383  Sum_probs=193.3

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh---------hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK---------ILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      +|.+.+.||.|++|.||+|.. .+|+.+++|.+.....         ....+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588999999999999999985 4689999997653211         112345778999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||+++++|.+++....   .++...+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999887552   4577888899999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ................++..|+|||.+.     ++.++|+||||+++|++++|..||.................      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS------  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc------
Confidence            6543221111223345677899999875     57789999999999999999999853322111100000000      


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             ............+..+.++|.+||+.+|.+|||+.+++++
T Consensus       230 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 -------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                   0000001112234669999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-38  Score=284.16  Aligned_cols=261  Identities=22%  Similarity=0.250  Sum_probs=189.1

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ...|.+.+.||.|+||.||++.+. .+..|++|....       ..+.+|+.++++++|+||+++++++...+..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999964 588999995322       234678999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ++. ++|..++.....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus       241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            995 688877764332  4578999999999999999999999   9999999999999999999999999987543222


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCC-chhhh-----cchhhhhcccC-------ccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPR-SYVAL-----ASNEMTRMVPY-------FPY  229 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~-~~~~~-----~~~~~~~~~~~-------~~~  229 (309)
                      .........|+..|+|||++.   ++.++|||||||++|+|++|..|+ .....     ........+..       ++.
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            211222345788999999986   788999999999999999877653 21110     01111111111       110


Q ss_pred             cccccchhhhhc-----ccccCc---c--chHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 PIENNSLRQILN-----FQVADE---N--EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 ~~~~~~~~~~~~-----~~~~~~---~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............     ......   +  ....+.++.+||.+||+.||.+|||+.+++++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000000000     000000   0  01223468999999999999999999999885

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=264.84  Aligned_cols=252  Identities=23%  Similarity=0.302  Sum_probs=183.3

Q ss_pred             eeecccCceEEEEEEcCC---CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           14 HLLGEGGFGFVYKGVLPD---NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      +.||+|+||.||++...+   ...+++|.+...........+.+|...++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            358999999999997433   33556676555443444567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhhccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           91 TLFQHVRYQSSQ-VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        91 sL~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      +|.+++...... ...+...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999764322 23455677889999999999999999   99999999999999999999999998753221111122


Q ss_pred             ccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          170 TTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .....++..|+|||...          ++.++|+||||+++|+|++ |..||........ ...........        
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~--------  228 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKDQQVK--------  228 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhhcccc--------
Confidence            22345677899999863          4678999999999999997 5667653321110 00000000000        


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ...    ...+...++.+.+++..|| .+|++|||+.++++.|.
T Consensus       229 ~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFK----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCC----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            000    0111123356889999999 68999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.4e-38  Score=263.91  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=193.2

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      .+|++.+.||.|+||.||++.+.++..+++|.+.....  ....+..|+.++++++|||++++++++......+++|||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            57899999999999999999987788899998764322  2346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++.....  ..++..+..++.+++.++.+||+++   ++|+||+|+||+++.++.++++|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          82 EHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            99999988865432  3467888999999999999999999   99999999999999999999999998865422111 


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      ........+..|+|||.+.   ++.++|+||||+++|+|++ |..||...........                 +... 
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-----------------~~~~-  217 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-----------------INAG-  217 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-----------------HhCC-
Confidence            1111122345799999876   7778999999999999998 8999764321110000                 0000 


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .....+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            00000111235699999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=279.01  Aligned_cols=262  Identities=20%  Similarity=0.281  Sum_probs=190.6

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLET-----   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   77 (309)
                      ...++|++.+.||.|+||.||++.. .++..||+|.+..... ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999985 5688999998765322 22234567899999999999999999987543     


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                       ...+++++++ +++|.+++..    ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999998 7788877652    23577899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc--
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--  230 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  230 (309)
                      ++.....     ......++..|+|||.+.    ++.++||||||+++|+|++|..||......... .........+  
T Consensus       164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~  237 (343)
T cd07878         164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSP  237 (343)
T ss_pred             cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCH
Confidence            9865421     223446788899999874    678999999999999999999998643221110 0000000000  


Q ss_pred             -----ccccchhhhhcccccCc------cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 -----IENNSLRQILNFQVADE------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 -----~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           .................      .....++.+.+||.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000000000000000      001122457899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-37  Score=261.43  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||++.. .+++.+++|.+.... .......+..|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            689999999999999999985 468899999875532 233356788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++..... ...++..+..++.+++.++.|||+++   ++|+||+|+||+++++ +.++++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-  155 (256)
T cd08220          81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-  155 (256)
T ss_pred             CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence            999999999976443 23477889999999999999999999   9999999999999854 45799999988655322 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++|+||+|+++|+|++|..||...+.........                 ..
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-----------------~~  216 (256)
T cd08220         156 --SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-----------------SG  216 (256)
T ss_pred             --ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-----------------hc
Confidence              1222345677899999986   6788999999999999999999976432211110000                 00


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       .....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       217 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 -TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             0001112234669999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.1e-38  Score=271.91  Aligned_cols=264  Identities=23%  Similarity=0.351  Sum_probs=194.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||.|+||.||+|.++ +++.+++|...... .....+.+..|+.+++.++||||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            57999999999999999999965 58999999765432 22235567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|..+.....   ..++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999988887665332   2477899999999999999999999   9999999999999999999999999886542221


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcccc-----ccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYP-----IEN  233 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~-----~~~  233 (309)
                        .......++..|+|||.+.    ++.++|+||||+++|+|++|.+||........ .....   ..+...     ...
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccc
Confidence              1222345677899999864    56789999999999999999999864322110 00000   000000     000


Q ss_pred             cchhhhhcc-----cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNF-----QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........     ..........+..+.+|+.+||+.+|.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000000000     00000112345679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-37  Score=263.48  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=190.4

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch----hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD----KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   80 (309)
                      .+|++.+.||.|+||.||++.. .++..+++|.+....    .......+..|+.+++.++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4799999999999999999985 458999999765431    12233567889999999999999999998875  3577


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++++||+++++|.+++....   .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999886543   2467888899999999999999999   99999999999999999999999998865


Q ss_pred             ccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....... .......++..|+|||.+.   ++.++|+||+|+++|++++|..||...........               
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~---------------  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK---------------  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH---------------
Confidence            4221111 1112234677899999886   67889999999999999999999864422211110               


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ..........+...++.+.+++ +||..+|++|||+.++++|
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 --IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              0000001111223445688888 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-37  Score=263.92  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||.|++|.||++... +++.+++|.+...........+..|+..+..++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47999999999999999999965 59999999877665434467789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998754   345778999999999999999999 99   9999999999999999999999999886553221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .  ......++..|+|||.+.   ++.++|+|+||+++|+|++|..||.......              .......+...
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--------------~~~~~~~~~~~  218 (264)
T cd06623         155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--------------FFELMQAICDG  218 (264)
T ss_pred             C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--------------HHHHHHHHhcC
Confidence            1  112345677899999886   6778999999999999999999986553100              00001111111


Q ss_pred             cccCccchH-HHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEME-EIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .. ...+.. .+..+.++|.+||+.+|++|||+.+++++
T Consensus       219 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 PP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            10 111112 44679999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-37  Score=264.69  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=192.5

Q ss_pred             ccccceeecccCceEEEEEEcCC--CcEEEEEecccch---------hhhhHHHHHHHHHHHh-hcCCCccceeeeeeec
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPD--NTLVAVKKPKMVD---------KILINEVFQHKMRIIS-QINHKNVVKILGVCLE   76 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~--~~~v~ik~~~~~~---------~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~   76 (309)
                      .|++.+.||.|+||.||++....  +..+++|.+....         .......+..|+.++. .++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999654  7889999764321         1122234566777665 4799999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                      .+..+++|||+++++|.+++.... .....++..++.++.|++.++.|||+ .+   ++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999998885432 23345778899999999999999996 67   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ||.+.......   ......++..|++||.+.   ++.++|+||||+++|+|++|..||...........          
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~----------  224 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK----------  224 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH----------
Confidence            99987653322   233445678899999987   67889999999999999999999764322111100          


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                             ..............+..+.++|.+||+.||.+|||+.++.++++
T Consensus       225 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 -------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   00000000011123356999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-38  Score=263.68  Aligned_cols=246  Identities=26%  Similarity=0.393  Sum_probs=194.7

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      +|+..+.||+|++|.||+|..+ +++.+++|.+.....    ....+.+..|+.+++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5889999999999999999965 789999997654321    22345688899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      +||+++++|.+++....   ..++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999987543   3467888899999999999999999   99999999999999999999999998865422


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..   ......++..|++||.+.    ++.++|+|+||+++|+|++|..||........... ..               
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~---------------  215 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IG---------------  215 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HH---------------
Confidence            21   223345677899999875    56789999999999999999999865431111100 00               


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ........+...++.+.+++.+||+.+|.+|||+.+++.+
T Consensus       216 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         216 -RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             0000011122334668999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-37  Score=262.39  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=191.4

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch----hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD----KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   80 (309)
                      ++|++.+.||+|+||.||.+.. .+|..|++|.+....    .......+..|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5899999999999999999995 458999999765321    12224567889999999999999999998876  3567


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +++|||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999887443   2466788899999999999999999   99999999999999999999999998865


Q ss_pred             ccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....... .......++..|+|||.+.   ++.++|+||||+++|+|++|..||..........                
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----------------  219 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----------------  219 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----------------
Confidence            4221111 1122334677899999886   6788999999999999999999986432111110                


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ...........+...+..+.+++.+||. +|++||++++++++
T Consensus       220 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         220 -KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence             0000011112233445668999999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.5e-38  Score=270.32  Aligned_cols=264  Identities=19%  Similarity=0.271  Sum_probs=190.8

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||++.+. +|+.+++|.+..... ......+..|+.++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5899999999999999999964 689999998754321 22234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++ ++|.+++....  ...++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--  152 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--  152 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence            97 47777765433  23578899999999999999999999   999999999999999999999999988654221  


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc--cccccchhhhh
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY--PIENNSLRQIL  240 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  240 (309)
                      ........++..|+|||.+.    ++.++|+||||+++|+|++|..|+-..................  ...........
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            11222345577899999874    5788999999999999999988853221111111110000000  00000000000


Q ss_pred             ccccc---------CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVA---------DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +....         .......++.+.++|.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000         00112234678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.5e-38  Score=275.49  Aligned_cols=235  Identities=26%  Similarity=0.270  Sum_probs=180.1

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMR-IISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||++.. .+|+.+|+|.+.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 4689999998765321  112233444444 56778999999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~  152 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDT  152 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCC
Confidence            99988876433   3477889999999999999999999   99999999999999999999999998764311  1122


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....|+..|+|||.+.   ++.++|+||||+++|+|++|..||...+.....                 ..+.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-----------------~~~~~~~~--  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-----------------DNILHKPL--  213 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-----------------HHHHcCCc--
Confidence            23456788999999986   788999999999999999999998643221110                 00000000  


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMR  275 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~  275 (309)
                      ......+..+.+++.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            01112335588999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-37  Score=266.01  Aligned_cols=255  Identities=25%  Similarity=0.337  Sum_probs=195.0

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC---
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET---   77 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~---   77 (309)
                      +-++.++|++.+.||.|+||.||++.. .+++.+++|.+.....  ....+..|+.++..+ +|||++++++++...   
T Consensus        17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            445788999999999999999999995 4688999998765322  234567888888888 799999999998643   


Q ss_pred             --CccEEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           78 --KVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        78 --~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                        +..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence              35799999999999999886432 2234577889999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      ||.+........  ......++..|+|||.+.        ++.++|+||||+++|+|++|..||......... ......
T Consensus       172 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~  248 (291)
T cd06639         172 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRN  248 (291)
T ss_pred             cccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcC
Confidence            998865432111  112335677899999864        468899999999999999999997643221111 100000


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...               ....+...+..+.++|.+||+.||++|||+.+++++
T Consensus       249 ~~~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         249 PPP---------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCC---------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000               000111233569999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-37  Score=263.42  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=195.8

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-----ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +|++.+.||+|++|.||++.. .+++.+++|.+.....     ......+..|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            589999999999999999984 5689999998754321     2234678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~  161 (309)
                      |+||+++++|.+++....   ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++ .++++|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987543   3467888999999999999999999   99999999999998765 5999999998665


Q ss_pred             cccccc--ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQT--ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ......  .......++..|+|||.+.   ++.++|+|++|+++|++++|..||.........              ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------------~~~  220 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--------------ALI  220 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--------------HHH
Confidence            332111  1112235677899999875   788899999999999999999997643211100              000


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            01111111122233455779999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-37  Score=267.12  Aligned_cols=265  Identities=18%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +|++.+.||.|++|.||+|.++ +|..+++|.+.........+.+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            6899999999999999999964 589999998765543333456678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++ +|.+++.........++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++......  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence            75 88888876554445688899999999999999999999   999999999999999999999999988644221  1


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc--cccccccchhhhhc
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF--PYPIENNSLRQILN  241 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  241 (309)
                      .......++..|++||.+.    ++.++|+|+||+++|+|++|..||...+....... .....  +.......+.....
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCCChhhHHHHhcCch
Confidence            1122334567899999874    57789999999999999999999875432211110 00000  00000000000000


Q ss_pred             c--ccc-------CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 F--QVA-------DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~--~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .  ...       .......+..+.+++.+||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0  000       00011234668999999999999999999999764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.9e-38  Score=264.77  Aligned_cols=246  Identities=24%  Similarity=0.284  Sum_probs=195.1

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      +|++.+.||.|+||.||++... +++.+++|.+....  .....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999964 58999999876432  22335678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+.+++|..++...   ...++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988755   24477889999999999999999999   9999999999999999999999999886653221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                         ......++..|+|||.+.   ++.++|+||+|+++|+|++|..||...........               ......
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------------~~~~~~  216 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI---------------RAKQET  216 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH---------------HHHhcc
Confidence               223345677899999886   68899999999999999999999875432100000               000000


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCH--HHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTM--RQVSE  279 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~--~~ll~  279 (309)
                       .....+...+..+.++|.+||+.||.+||++  .++++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0111122334679999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-37  Score=267.99  Aligned_cols=251  Identities=21%  Similarity=0.230  Sum_probs=190.8

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||.|+||.||++..+ +++.|++|.+.....  ......+..|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999954 578999998765432  222356778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++....   ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++......
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999986543   3477888899999999999999999   999999999999999999999999987532100


Q ss_pred             cc-------------cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc
Q 040698          165 DQ-------------TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       165 ~~-------------~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      ..             ........++..|+|||.+.   ++.++|+||||+++|+|++|..||........          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~----------  224 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL----------  224 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            00             00111234567799999875   78899999999999999999999753321110          


Q ss_pred             ccccccchhhhhcccccC-ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          229 YPIENNSLRQILNFQVAD-ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                             ........... ......+..+.++|.+||+.||++||++..+.+.+
T Consensus       225 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         225 -------FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             -------HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence                   00010000000 01112346689999999999999999865444444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-38  Score=275.44  Aligned_cols=239  Identities=22%  Similarity=0.218  Sum_probs=179.9

Q ss_pred             ecccCceEEEEEEc-CCCcEEEEEecccchhh--hhHHHHHHHHHHHhhc---CCCccceeeeeeecCCccEEEEEcCCC
Q 040698           16 LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQI---NHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        16 lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      ||+|+||.||+|.+ .+|+.||+|.+......  ........|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999995 45899999987543211  1112234455555544   699999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|...+....   .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~  152 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKT  152 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCC
Confidence            99998886443   3477889999999999999999999   999999999999999999999999988643221  122


Q ss_pred             ccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccccc
Q 040698          170 TTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA  245 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
                      .....|+..|+|||.+.    ++.++|+||||+++|+|++|..||..........                 .+......
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~-----------------~i~~~~~~  215 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR-----------------NIAFGKVR  215 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH-----------------HHHcCCCC
Confidence            23456888999999874    6888999999999999999999986432211000                 00000000


Q ss_pred             CccchHHHHHHHHHHhHhhccCCCCCC----CHHHHHHH
Q 040698          246 DENEMEEIEIVAKLASKCLRTSGTERP----TMRQVSEQ  280 (309)
Q Consensus       246 ~~~~~~~~~~l~~li~~cl~~dp~~Rp----s~~~ll~~  280 (309)
                      .. ....++.+.+++++||+.||.+||    ++.+++++
T Consensus       216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            00 011335689999999999999998    57777664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-37  Score=261.55  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=195.4

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~   84 (309)
                      +|++.+.||.|++|.||++.+ .+|..+++|.+.... .....+.+..|+.+++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            589999999999999999984 568899999875432 23334568889999999999999999997754  45678999


Q ss_pred             EcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           85 EFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLH-----SLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ||+++++|.+++.... ....+++..++.++.|++.|+.+||     +.+   ++|+||+|+||+++.++.++++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999987542 2345577899999999999999999     888   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........  ......++..|+|||.+.   ++.++|+|+||+++|+|++|..||.......  .....           
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~-----------  222 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKI-----------  222 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHH-----------
Confidence            76533221  122345788899999986   6778999999999999999999987543111  10000           


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ........+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       223 -----~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 -----KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 0011111222344669999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=284.73  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=184.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC------CCccceeeeeeecC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN------HKNVVKILGVCLET   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~   77 (309)
                      ...++|++.+.||+|+||.||++.+ .+++.||+|++.....  .......|+.+++.++      |.+++++++++..+
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3467899999999999999999985 4588999998864322  1233455666666554      45688888888764


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCC-------
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNY-------  148 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~-------  148 (309)
                       ...++||+++ |++|.+++....   .+++..+..++.|++.||.|||+ .+   ++||||||+||+++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             5678999998 678888776543   35778899999999999999998 58   99999999999998665       


Q ss_pred             ---------CeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhc
Q 040698          149 ---------TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALA  216 (309)
Q Consensus       149 ---------~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~  216 (309)
                               .+||+|||.+...     ........++..|+|||++.   ++.++|||||||++|+|++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     4999999987432     12223456788999999986   788999999999999999999999754322


Q ss_pred             chh--hhhcccCccccccc----cchhhhhcc-----------------cccCccchHHHHHHHHHHhHhhccCCCCCCC
Q 040698          217 SNE--MTRMVPYFPYPIEN----NSLRQILNF-----------------QVADENEMEEIEIVAKLASKCLRTSGTERPT  273 (309)
Q Consensus       217 ~~~--~~~~~~~~~~~~~~----~~~~~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  273 (309)
                      ...  .......++.....    .....+...                 ...........+.+.+||.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            111  00111111100000    000000000                 0000000112355889999999999999999


Q ss_pred             HHHHHHH
Q 040698          274 MRQVSEQ  280 (309)
Q Consensus       274 ~~~ll~~  280 (309)
                      +.++++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999885

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-37  Score=266.14  Aligned_cols=255  Identities=24%  Similarity=0.271  Sum_probs=195.3

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~   84 (309)
                      ++|+..+.||.|.+|.||++.. .+++.+++|.+...........+.+|+.+++.++||||+++++++.+  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4789999999999999999996 45899999987755444446678899999999999999999998865  34689999


Q ss_pred             EcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+++++|.+++.... .....+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999998875432 2234577889999999999999999999   99999999999999999999999998765422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..    .....++..|+|||.+.   ++.++|+|+||+++|+|++|..||.........            .........
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~  221 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG------------PIELLSYIV  221 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC------------hHHHHHHHh
Confidence            11    11234567799999876   778999999999999999999998754220000            000000011


Q ss_pred             cc---ccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          241 NF---QVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       241 ~~---~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..   ...  .......++.+.+++.+||..||.+|||+.+++++-
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            00   000  000112356799999999999999999999998854

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.7e-37  Score=266.11  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=196.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||.|+||.||++.. .++..+++|.+....... .+.+..|+.+++.++||||+++++++...+..++|+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH-HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            357899999999999999999985 468889999875443332 456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...    ..+...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999988643    2367888999999999999999999   999999999999999999999999987654222


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .  .......++..|++||.+.   ++.++|+||||+++|++++|..||........... ...               .
T Consensus       169 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~~---------------~  230 (293)
T cd06647         169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT---------------N  230 (293)
T ss_pred             c--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hhc---------------C
Confidence            1  1222345677899999876   67889999999999999999999864322111000 000               0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+...+..+.++|.+||+.+|.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001111122234569999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=274.03  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=185.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...+|++.+.||.|+||.||+|... ++..||+|.....       ....|+.+++.++||||+++++++...+..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3567999999999999999999964 5788999964332       2245788999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |++. ++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus       137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-  209 (357)
T ss_pred             EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence            9995 57877775433  24578899999999999999999999   99999999999999999999999998864311 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCC-chhhhcc--------hhhhhcc---cCccc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPR-SYVALAS--------NEMTRMV---PYFPY  229 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~-~~~~~~~--------~~~~~~~---~~~~~  229 (309)
                        ........|+..|+|||.+.   ++.++|+||||+++|+|+++..|+ .......        .......   ...+.
T Consensus       210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence              11222345788899999986   788999999999999999854443 3211110        0000000   00000


Q ss_pred             ccc----ccchhhhhcc----cccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 PIE----NNSLRQILNF----QVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 ~~~----~~~~~~~~~~----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...    ..........    +...     ......+.++.+||.+||+.||++|||+.++++|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000    0000000000    0000     0011223457789999999999999999999876

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=266.64  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=194.7

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||+|.+|.||+|.++ +++.+++|.+.... .......+..|+.+++.++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999964 58899999875432 23334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++++.+..+.....   ..+...+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999876665554322   2477889999999999999999999   9999999999999999999999999987653322


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh--hcccCcccc----c-ccc
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT--RMVPYFPYP----I-ENN  234 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~----~-~~~  234 (309)
                      . .......++..|+|||.+.    ++.++|+||||+++|+|++|..||...........  ......+..    . ...
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            1 1223345677799999885    67789999999999999999999864322111000  000000000    0 000


Q ss_pred             chhh--hhcccc----cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQ--ILNFQV----ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~--~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  ......    ....+...+..+.+||++||+.+|.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000  000000    000111235779999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-37  Score=264.57  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=198.4

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..+.|++.+.||.|.+|.||++.+. ++..+++|.+.....  ..+.+..|+..++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4678999999999999999999965 688999998765543  3556788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....  ...+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999998654  24577889999999999999999999   999999999999999999999999987554221


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .  .......++..|+|||.+.   ++.++|+||||+++|+|++|..||..............                .
T Consensus       170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------------~  231 (286)
T cd06614         170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------------K  231 (286)
T ss_pred             h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------c
Confidence            1  1112234567899999876   78899999999999999999999764322111100000                0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........++..+.++|.+||+.+|.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            000111112244669999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-37  Score=267.58  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      +|++.+.||.|++|.||+|.. .+|+.|++|.+.....    ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999995 4689999998765432    22345567899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+ +++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999886543  24578889999999999999999999   99999999999999999999999999866532


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc--ccccchh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IENNSLR  237 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  237 (309)
                      ..  .......++..|+|||.+.    ++.++|+||||+++|+|++|.+||....... ...........+  .......
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcc
Confidence            21  1222234567799999874    6778999999999999999988775432211 111110000000  0000000


Q ss_pred             hhhcc---c-----ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNF---Q-----VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~---~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....   .     .........+..+.++|.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000   0     0000112334679999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-37  Score=262.36  Aligned_cols=236  Identities=26%  Similarity=0.390  Sum_probs=180.2

Q ss_pred             eeecccCceEEEEEEcCC-C-------cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698           14 HLLGEGGFGFVYKGVLPD-N-------TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~-~-------~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      +.||.|+||.||+|..+. +       ..+++|....... ...+.+..|..+++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999998532 2       3477777654332 234567889999999999999999999999889999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--------eEEEeeec
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT--------AKVADFAS  157 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~--------v~l~d~g~  157 (309)
                      |+++++|.+++.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.        ++++|||.
T Consensus        80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999875443  3477888899999999999999999   999999999999987665        68999998


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCC-CCCchhhhcchhhhhcccCcccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK-HPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      +.....      .....++..|+|||.+.    ++.++|+||||+++|+|++|. .|+...+...... ...        
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--------  219 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--------  219 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--------
Confidence            754321      12234567799999886    577899999999999999984 5654332211110 000        


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                               ..  ...+......+.+++.+||+.||.+|||+.++++.|
T Consensus       220 ---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 ---------DR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------cc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     00  001111224589999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.3e-37  Score=260.96  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=195.8

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+-|++.+.||.|+||.||+|.+ .+++.+++|...........+.+..|+.++..++||||+++++++..++..++|||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            45688999999999999999985 46899999987655444445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...    ..+...+..++.+++.++.+||+++   ++|+||+|+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999888532    3477889999999999999999999   9999999999999999999999999876542211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   .+.++|+||||+++|+|++|..||...........  ..               . 
T Consensus       156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~---------------~-  215 (277)
T cd06641         156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--IP---------------K-  215 (277)
T ss_pred             --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--Hh---------------c-
Confidence              1122235677799999875   67789999999999999999999864321110000  00               0 


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........+..+.+++.+||+.+|.+||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00001112234568999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-37  Score=262.06  Aligned_cols=236  Identities=27%  Similarity=0.376  Sum_probs=178.7

Q ss_pred             eecccCceEEEEEEcCC-------------------------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccce
Q 040698           15 LLGEGGFGFVYKGVLPD-------------------------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~-------------------------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   69 (309)
                      .||+|+||.||+|....                         ...|++|.+..... .....+.++..+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999987311                         13578887765433 33456788889999999999999


Q ss_pred             eeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-
Q 040698           70 ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-  148 (309)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-  148 (309)
                      +++++.+.+..++||||+++++|..++.....  ..++..+..++.|++.||.|||+++   ++||||+|+||++++.+ 
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            99999999999999999999999988864332  3477888999999999999999999   99999999999997543 


Q ss_pred             ------CeEEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHH-hCCCCCchhhhcc
Q 040698          149 ------TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELL-TGKHPRSYVALAS  217 (309)
Q Consensus       149 ------~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~-~g~~p~~~~~~~~  217 (309)
                            .++++|||.+.....      .....++..|+|||.+.    ++.++|+||||+++|+++ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  379999998643211      12234567799999775    678899999999999985 6888876442211


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ... ..                 ......  +......+.++|.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~-~~-----------------~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KER-FY-----------------EKKHRL--PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH-HH-----------------HhccCC--CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            100 00                 000000  0011245899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.4e-37  Score=269.23  Aligned_cols=194  Identities=22%  Similarity=0.370  Sum_probs=153.8

Q ss_pred             ceeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~   87 (309)
                      ...||+|+||.||+|..+   ++..+++|.+.....   ...+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999854   457899997765422   3356789999999999999999998854  56778999999


Q ss_pred             CCCCHHHHHHhhc------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEEeeec
Q 040698           88 PNGTLFQHVRYQS------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFAS  157 (309)
Q Consensus        88 ~~~sL~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv----~~~~~v~l~d~g~  157 (309)
                      + ++|.+++....      ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++    +.++.++|+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            6 47777764321      1123577888999999999999999999   9999999999999    4667899999999


Q ss_pred             cccccccccc-ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          158 SVLISSHDQT-ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                      +......... .......++..|+|||.+.    ++.++||||||+++|+|++|.+||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            8765322111 1223346688899999874    678899999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1e-36  Score=264.29  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=193.2

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+.|++.+.||.|++|.||++... +|+.|++|.+....  .......+..|+.+++.++|||++++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4567999999999999999999854 68999999775332  22333567889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |+||++ +++.+.+.....  ..++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++....
T Consensus        93 v~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999997 566666653332  3577889999999999999999999   9999999999999999999999999875432


Q ss_pred             cccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .      .....++..|+|||.+.      ++.++|+||||+++|+|++|..||...+.........             
T Consensus       167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-------------  227 (307)
T cd06607         167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------  227 (307)
T ss_pred             C------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-------------
Confidence            1      12345677899999862      6778999999999999999999975432211110000             


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                          ...........++..+.++|.+||+.||.+|||+.+++.+..
T Consensus       228 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         228 ----QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             ----cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence                000011112234566999999999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6e-37  Score=258.97  Aligned_cols=235  Identities=29%  Similarity=0.444  Sum_probs=180.7

Q ss_pred             eeecccCceEEEEEEcCCCc-----------EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698           14 HLLGEGGFGFVYKGVLPDNT-----------LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~-----------~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +.||+|+||.||+|...+..           .+++|........  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999965433           4677765544322  5678889999999999999999999887 77899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-------CeEEEee
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-------TAKVADF  155 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-------~v~l~d~  155 (309)
                      ||||+++++|.+++.....  .++...+..++.|++.||+|||+++   ++|+||+|+||+++.++       .++++||
T Consensus        78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999999876543  3477888999999999999999999   99999999999999877       7999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      |++.....      .....+...|+|||.+.     ++.++|+||||+++|++++ |..||.......... ....... 
T Consensus       153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~-  224 (259)
T cd05037         153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHR-  224 (259)
T ss_pred             Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCC-
Confidence            98865422      12234456799999874     5678999999999999999 577765442111100 0000000 


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                                        .+......+.+++.+||+.+|.+|||+.++++.|+
T Consensus       225 ------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         225 ------------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                              00000155899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.5e-37  Score=258.25  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=199.2

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccEEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPLLVY   84 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~iv~   84 (309)
                      +|.+.+.||+|++|.||+|... ++..+++|....... ....+.+..|+..+++++||||+++++.+.+.  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5888999999999999999965 689999998755432 23356788999999999999999999999988  8899999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....   ..++..+..++.|++.++.|||+.+   ++|+|++|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999987554   4577889999999999999999999   999999999999999999999999998765433


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ..........++..|+|||.+.   .+.++|+|+||+++|+|++|..||.............                ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------~~  218 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI----------------GS  218 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc----------------cc
Confidence            2211233455677899999886   7789999999999999999999987653111111000                00


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+...+..+.+++.+||+.||.+||++.+++.+
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            011111222334669999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.3e-37  Score=260.98  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=190.3

Q ss_pred             cccceeecccCceEEEEEEcC----CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETK------   78 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   78 (309)
                      |.+.+.||+|+||.||+|...    ++..+++|.+.... .....+.+.+|+.+++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999842    46889999875532 2223456788999999999999999999886532      


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc---ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS---QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                      ..+++++|+.+++|..++.....   ....+...+..++.|++.|++|||+++   ++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            23688999999999887753321   123477888999999999999999999   999999999999999999999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      |++................++..|++||...   ++.++|+||||+++|+|++ |..||.......... .....     
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~-----  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN-YLIKG-----  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH-HHHcC-----
Confidence            9887543222211222233456799999876   6788999999999999998 888876432211000 00000     


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                                  .....+...+..+.+++.+||+.+|.+|||+.+++..|+.+
T Consensus       232 ------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 ------------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        00011122345699999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.8e-37  Score=256.42  Aligned_cols=247  Identities=29%  Similarity=0.411  Sum_probs=197.0

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +|++.+.||.|.+|.||++... +++.+++|....... .....+..|+..++.++|+|++++++++...+..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            5889999999999999999964 689999998876543 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++....  ...++..+..++.|++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            9999999887553  24577889999999999999999999   99999999999999999999999998866533221 


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                        .....++..|+|||...   ++.++|+|+||+++|+|++|..||...+.............                .
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------~  215 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP----------------P  215 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC----------------C
Confidence              23445677899999886   67889999999999999999999865421111110000000                0


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........+..+.++|.+||+.||.+|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000111124569999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-37  Score=262.22  Aligned_cols=261  Identities=23%  Similarity=0.240  Sum_probs=186.9

Q ss_pred             cccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecC--CccEEEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLET--KVPLLVYE   85 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~iv~e   85 (309)
                      |++.+.||.|.||.||++.. .++..+++|................|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            78899999999999999985 4689999998765432222333456788888885 99999999999887  88999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++ ++|.+.+....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++...... 
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-  152 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK-  152 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC-
Confidence            997 47777775433  24578899999999999999999999   999999999999999 99999999998654221 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh--hcccCccccc-cccchhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT--RMVPYFPYPI-ENNSLRQ  238 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~  238 (309)
                        .......++..|+|||...    ++.++|+||+|+++|+|++|..||...+.......  ......+... .......
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence              1222345677899999763    57899999999999999999999864322110000  0000000000 0000000


Q ss_pred             hhcccccC-------ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVAD-------ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..+.....       ......+..+.++|.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000       0011345779999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.3e-37  Score=267.53  Aligned_cols=266  Identities=22%  Similarity=0.260  Sum_probs=191.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~   81 (309)
                      ..++|++.+.||.|+||.||+|.. .+|+.|++|.+..... ......+.+|+.++++++|+|++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            357899999999999999999995 4699999998754322 11123456789999999999999999998754  5679


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++ ++|.+++....  ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999996 47888776543  34577899999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc--ccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE--NNS  235 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~  235 (309)
                      ....  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||...+..... .........+..  ...
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL-DLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChhhchh
Confidence            3221  1122233466799999874    678999999999999999999998654322211 100000000000  000


Q ss_pred             hh------hhhcccccCc----cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LR------QILNFQVADE----NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..      ..........    .....++.+.++|.+||+.||++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00      0000000000    001134668999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-36  Score=258.29  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=195.3

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||++.. .++..+++|.+..... ......+..|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            689999999999999999985 4689999998765433 23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++....   ..++..+..++.+++.|+.|||+++   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999887542   3467888899999999999999999   99999999999999999999999999876533222


Q ss_pred             ccc--ccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          167 TAT--TTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       167 ~~~--~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...  .....++..|+|||.+.      .+.++|+|+||+++|++++|..||............ ...            
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~~~------------  221 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-VGA------------  221 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-Hhc------------
Confidence            111  12345677899999875      467899999999999999999998643211111000 000            


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ......+.....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              0000111112234568999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.9e-37  Score=269.63  Aligned_cols=264  Identities=20%  Similarity=0.281  Sum_probs=192.8

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLET-----   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   77 (309)
                      ...++|++.+.||+|+||.||++.. .+|+.+++|.+... ........+..|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4578899999999999999999995 46899999987542 2223345567899999999999999999988643     


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                       ...++||||+. ++|.+.+...     ++...+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence             35689999996 5777776532     467888899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc---
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP---  230 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---  230 (309)
                      ++......   .......++..|+|||.+.   ++.++|+||||+++|+|++|..||...+..... ......+..+   
T Consensus       164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~  239 (353)
T cd07850         164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW-NKIIEQLGTPSDE  239 (353)
T ss_pred             cceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHhcCCCCHH
Confidence            98654221   1122335677899999886   788999999999999999999998644321110 0000000000   


Q ss_pred             ------------------ccccchhhhhcc----cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          231 ------------------IENNSLRQILNF----QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       231 ------------------~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                        ............    ......+...++.+.++|.+||+.||.+|||+.+++.+=
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                              000000000000    000001123356689999999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-37  Score=265.92  Aligned_cols=265  Identities=21%  Similarity=0.258  Sum_probs=193.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh-hhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI-LINEVFQHKMRIISQINHKNVVKILGVCLET--KVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~i   82 (309)
                      .++|++.+.||.|.+|.||+|.++ +++.+++|.+...... .....+.+|+.+++.++||||+++++++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            468999999999999999999965 5889999987654322 2223466789999999999999999998877  88999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |+||++ ++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++....
T Consensus        84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999997 488888865443  4578899999999999999999999   9999999999999999999999999886553


Q ss_pred             cccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc------
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE------  232 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  232 (309)
                      ...  .......++..|+|||.+.    ++.++|+||+|+++|+|++|..||........ ..........+..      
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHh
Confidence            321  1222344577899999875    47789999999999999999999864432111 0000000000000      


Q ss_pred             ----c---cchhhhhcccccCccchH-HHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 ----N---NSLRQILNFQVADENEME-EIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ----~---~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          .   ...............+.. .++.+.++|++||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                0   000000000000001111 35668999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.9e-37  Score=263.83  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=192.4

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||+|.. .+|..+++|.+.... .......+..|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            589999999999999999985 468999999775432 222335678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++ ++|..++..... ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++++|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--  153 (284)
T cd07860          81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--  153 (284)
T ss_pred             cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence            96 588888765433 24577889999999999999999999   999999999999999999999999988654221  


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc--ccchhhhh
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE--NNSLRQIL  240 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  240 (309)
                      ........++..|+|||.+.    ++.++|+||||+++|+|++|..||......... .........+..  ........
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhhhhHHH
Confidence            11222334567799999775    467899999999999999999998643322111 100000000000  00000000


Q ss_pred             cc---------cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NF---------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..         ..........+..+.++|.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00         00000011233568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.3e-37  Score=265.42  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=194.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..+.|.....||.|+||.||++.. .++..+++|.+..... ...+.+..|+..++.++|||++++++.+...+..++||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            345677778899999999999985 4688999998765433 23556888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...    ..++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++......
T Consensus        99 e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          99 EFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             eCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999999887532    2467889999999999999999999   999999999999999999999999988654221


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        ........++..|+|||.+.   ++.++|+||||+++|+|++|..||......... .......+             
T Consensus       172 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~-------------  235 (292)
T cd06658         172 --VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLP-------------  235 (292)
T ss_pred             --cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCC-------------
Confidence              11122345678899999885   788999999999999999999997643211100 00000000             


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        .........+..+.+++.+||..||.+|||+.+++++
T Consensus       236 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 --PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              0001111233568999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-36  Score=264.01  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=196.2

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +.|...+.||+|+||.||++.. .+|..+++|.+....  .......+..|+.+++.++|||++++++++.+.+..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4588999999999999999995 468999999875432  2233456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++| +|.+.+....  ...++..+..++.+++.|+.|||+++   ++|+||+|+||+++.++.++++|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 7777665433  23577889999999999999999999   99999999999999999999999998754321 


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                           .....++..|+|||.+.      ++.++|+||||+++|+|++|..||...........                 
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-----------------  235 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----------------  235 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------
Confidence                 22345677899999862      67789999999999999999999754321111100                 


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      ..............++.+.+++.+||+.+|.+||++.+++++...+....+.
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            0000011111123345699999999999999999999999987655544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.4e-37  Score=258.13  Aligned_cols=248  Identities=24%  Similarity=0.359  Sum_probs=194.0

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|.+.+.||.|+||.||++..+ +|..+++|.+..... ....+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5889999999999999999954 588899998755321 12345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++...... ..++..+..++.|++.|+.|||+++   ++|+||+|+||++++++ .++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRGV-LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988754332 3477889999999999999999999   99999999999998775 46999999886553211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||...   ++.++|+||||+++|+|++|..||.................               
T Consensus       157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  219 (257)
T cd08225         157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---------------  219 (257)
T ss_pred             --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC---------------
Confidence              1222345677899999875   77899999999999999999999864432211111111100               


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         .......+..+.+++.+||+.+|++|||+.+++++
T Consensus       220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               00112233569999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-36  Score=255.52  Aligned_cols=249  Identities=28%  Similarity=0.340  Sum_probs=198.2

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.||++.+ .++..+++|.+..... ......+..|+.+++.++|||++++++.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            689999999999999999995 4689999998765432 23356688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+.+.... ....++...+..++.+++.|+.+||+++   ++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999887643 1234578899999999999999999999   9999999999999999999999999886653322


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......+++.|+|||...   ++.++|+|++|+++++|++|..||...+............                
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC----------------
Confidence              1223345677899999875   7788999999999999999999986543221111100000                


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       220 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 --YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              011111334569999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.2e-37  Score=258.79  Aligned_cols=240  Identities=28%  Similarity=0.313  Sum_probs=188.6

Q ss_pred             ecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||.|++|.||++... ++..+++|.+....  .....+.+..|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999964 58999999876432  223456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++....   ..+...+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.......   ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99987543   3477888999999999999999999   9999999999999999999999999887653221   2223


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..++..|++||.+.   ++.++|+|++|+++|+|++|..||..........               .............+
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~~  216 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI---------------YNDILKGNGKLEFP  216 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH---------------HHHHhccCCCCCCC
Confidence            45677899999875   7788999999999999999999987543111110               00111000111111


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCC-----HHHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPT-----MRQVSE  279 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~  279 (309)
                      ...++.+.++|.+||+.||.+||+     +.++++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222466999999999999999999     788876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.6e-37  Score=257.52  Aligned_cols=247  Identities=24%  Similarity=0.312  Sum_probs=197.1

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|++|.+|++.. .+++.+++|.+.... .......+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            589999999999999999984 468899999876532 223345667889999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      +++++|.+++..... ....++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999998865322 234577889999999999999999999   999999999999999999999999998765332 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                         ......++..|+|||...   ++.++|+||||+++|+|++|..||...+........                  ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------------------~~  215 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV------------------QR  215 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------hc
Confidence               222345677899999986   677899999999999999999998654322111110                  01


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11111222455779999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.2e-37  Score=263.57  Aligned_cols=267  Identities=20%  Similarity=0.224  Sum_probs=190.9

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCc-----
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQIN-HKNVVKILGVCLETKV-----   79 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----   79 (309)
                      ++|++.+.||.|+||.||+|.+ .+|+.|++|....... ......+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999995 4689999997654322 122346778999999995 6999999999887655     


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFA  156 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g  156 (309)
                      .++||||+++ +|.+++.....  ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++. ++.++++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888764432  234578999999999999999999999   999999999999998 8899999999


Q ss_pred             cccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-cccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-PYPI  231 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~  231 (309)
                      ++......  ........+++.|+|||.+.    ++.++|+||||+++|+|++|..||...+............. +...
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            88654221  11122234567799999764    67899999999999999999999865432221111000000 0000


Q ss_pred             cccchhhhhc----c--c--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILN----F--Q--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~----~--~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........    .  .  .........+..+.++|.+||+.||.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000000    0  0  0000012344669999999999999999999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=279.06  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .+-|+|++.||.|+||.||++..++...+|.-.+........-+.+.-|+.+|...+||+||++++.|..++.+||..|+
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            45689999999999999999998765555443333333344457788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      |.||-++..+-..+.  .+++.+|..+++|++.||.|||+++   |+||||+..||+++-+|.|+++|||.+.....  .
T Consensus       111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            999999988876654  4588999999999999999999999   99999999999999999999999998754311  2


Q ss_pred             cccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          167 TATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...-....|++.|||||+..        |..++||||||+.+.+|..+.+|......                 ...+-.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------------MRVllK  246 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------MRVLLK  246 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------------HHHHHH
Confidence            22334568999999999885        88899999999999999999999443310                 001111


Q ss_pred             hhcc-cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNF-QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +-.. .+-...|..++..+.+|+.+||..||..||++.++++|
T Consensus       247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1111 11112345666779999999999999999999999876

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-36  Score=264.79  Aligned_cols=265  Identities=19%  Similarity=0.272  Sum_probs=190.8

Q ss_pred             ceeeccc--CceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           13 RHLLGEG--GFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        13 ~~~lg~g--~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      ...||+|  +||.||.+.+ .+|+.||+|...... .....+.+..|+.+++.++||||+++++++..++..++++||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3456666  8899999996 479999999876532 22334678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +++|.+++...... ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999988765433 3577888899999999999999999   9999999999999999999999997553321111111


Q ss_pred             c-----ccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc------
Q 040698          169 T-----TTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE------  232 (309)
Q Consensus       169 ~-----~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  232 (309)
                      .     .....++..|+|||.+.     ++.++|+||+|+++|+|++|..||...................+..      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence            0     01112345699999875     5678999999999999999999987543222211111110000000      


Q ss_pred             -----------------ccchh-----hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 -----------------NNSLR-----QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 -----------------~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                       .....     ..............++..+.+|+++||+.||++|||+.+++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                             00000     00011111222345667899999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6e-37  Score=263.23  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=190.3

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+|+..+.||.|+||.||++.+ .+|+.+++|.+...........+..|+..+.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            5788889999999999999985 4589999998765443344567788999998886 9999999999999889999999


Q ss_pred             cCCCCCHHHHHHhh--ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           86 FVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        86 ~~~~~sL~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |++ +++.++....  .....+++..+..++.+++.|++|||+. +   ++||||+|+||+++.++.++++|||++....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            986 4655543321  1223457788999999999999999975 8   9999999999999999999999999986542


Q ss_pred             cccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ..   .......++..|+|||.+.      ++.++|+||+|+++|+|++|..||.................+.       
T Consensus       160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------  229 (288)
T cd06616         160 DS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP-------  229 (288)
T ss_pred             cC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC-------
Confidence            21   1112335677899999874      5678999999999999999999987543111111111000000       


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            ......+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       230 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00011112344669999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-36  Score=263.53  Aligned_cols=267  Identities=22%  Similarity=0.272  Sum_probs=190.6

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      |.+.+.+|.|+++.++++.. +++.+|+|.+... ........+..|+.+++.++||||+++++++.+.+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            44555555555555555544 6899999987654 223335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc--
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ--  166 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~--  166 (309)
                      +++|.+++...... ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++||+.+........  
T Consensus        83 ~~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          83 YGSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999998755333 3467888999999999999999999   99999999999999999999999998765422111  


Q ss_pred             ---cccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc-------cc
Q 040698          167 ---TATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY-------PI  231 (309)
Q Consensus       167 ---~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~  231 (309)
                         ........++..|+|||.+.     ++.++|+||+|+++|+|++|..||.................+.       +.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence               11112334566799999864     6788999999999999999999987543221111111000000       00


Q ss_pred             cccchhh--------hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          232 ENNSLRQ--------ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       232 ~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .......        ..............+..+.+|+.+||+.||++|||+.+++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            0000000        0000111112334556799999999999999999999998854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=262.71  Aligned_cols=264  Identities=21%  Similarity=0.259  Sum_probs=192.4

Q ss_pred             cccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           10 YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      |++.+.||.|.+|.||+|.+ .+|..|++|.+..... ......+..|+.+++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            78899999999999999985 4699999998764422 222356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      + ++|.+++..... ...++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++++|||++......  .
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~  153 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP--V  153 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC--c
Confidence            5 689888865442 23578899999999999999999999   999999999999999999999999998654221  1


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-cccccccchhhhhcc
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-PYPIENNSLRQILNF  242 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  242 (309)
                      .......++..|+|||.+.    ++.++|+||||+++|+|++|..||...+............. +............+.
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            1112234567799999774    57789999999999999999999865432211111000000 000000000000000


Q ss_pred             ---------cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 ---------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                               ..........+..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                     00000112233568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=277.18  Aligned_cols=243  Identities=24%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             eecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHH
Q 040698           15 LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF   93 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~   93 (309)
                      +||+|.||+||-|++.+ .-.+|||.+...++.. .+.+..|+.+-++++|.|||+++|.+.++..+-|.||.++||||.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh-hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            69999999999999765 5577888777665544 456889999999999999999999999999888999999999999


Q ss_pred             HHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeecccccccccccccccc
Q 040698           94 QHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      ++++..=+...-.+.++..+..||++||.|||.+.   |+|||||-+||+|+ -.|.+||+|||-+.....-  ..-...
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence            99986544333467889999999999999999999   99999999999995 7889999999988765221  112234


Q ss_pred             cccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc
Q 040698          173 EIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE  247 (309)
Q Consensus       173 ~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
                      ..|+..|||||++.     |..++|||||||.+.||.+|++||-....+..-+                ...--.+.-.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----------------FkVGmyKvHP~  799 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----------------FKVGMYKVHPP  799 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----------------hhhcceecCCC
Confidence            56899999999996     8999999999999999999999987664332221                11112222334


Q ss_pred             cchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       248 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      .|.+.+..++.||.+|+..||.+||++.+++.
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            45677788999999999999999999999965

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-36  Score=259.75  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=185.6

Q ss_pred             ecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||.|+||.||++.. .+|+.+++|.+....  .......+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999985 468999999875432  122244567899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++..... ...++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||.+.....   ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence            998875543 24577888999999999999999999   99999999999999999999999998865422   112223


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..++..|+|||...   ++.++|+||+|+++|+|++|..||..............             ....  .....+
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------~~~~--~~~~~~  218 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------------RTLE--MAVEYP  218 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------------cccc--ccccCC
Confidence            45667899999875   67789999999999999999999865432111000000             0000  011112


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCC-----CHHHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERP-----TMRQVSE  279 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~  279 (309)
                      ...++.+.++|.+||+.||.+||     ++.++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            22346699999999999999999     6666765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-37  Score=265.46  Aligned_cols=268  Identities=23%  Similarity=0.309  Sum_probs=191.1

Q ss_pred             ccccceeecccCceEEEEEEcC---CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~   81 (309)
                      +|++.+.||.|++|.||+|...   ++..+|+|.+....  .....+.+..|+.+++.++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5899999999999999999964   47999999876532  122235567889999999999999999999987  7899


Q ss_pred             EEEEcCCCCCHHHHHHhhcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCCeEEEee
Q 040698           82 LVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD----NYTAKVADF  155 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~----~~~v~l~d~  155 (309)
                      +||||+++ +|.+++.....  ....++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.    ++.++++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 67666654332  224577889999999999999999999   999999999999998    899999999


Q ss_pred             ecccccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcch--------hhhh
Q 040698          156 ASSVLISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASN--------EMTR  222 (309)
Q Consensus       156 g~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~--------~~~~  222 (309)
                      |++........ ........++..|+|||.+.    ++.++|+||||+++|+|++|.+||........        ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            98875432221 11222345677899999764    67789999999999999999999864432210        0000


Q ss_pred             cccCcccccc--------ccchhh----hhccccc-Cc------cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          223 MVPYFPYPIE--------NNSLRQ----ILNFQVA-DE------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       223 ~~~~~~~~~~--------~~~~~~----~~~~~~~-~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....+..+..        ......    ....... ..      .....+..+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000000        000000    0000000 00      001233568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=255.65  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=192.8

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccc----hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Ccc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV----DKILINEVFQHKMRIISQINHKNVVKILGVCLET--KVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~   80 (309)
                      .+|++.+.||+|++|.||++.. .+|..+++|.+...    ........+..|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999995 45899999976432    1223345788899999999999999999998764  467


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++++||+++++|.+++....   ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999886443   2467888899999999999999999   99999999999999999999999999865


Q ss_pred             ccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....... .......++..|+|||.+.   .+.++|+||||+++|++++|..||.........                 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------------  218 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-----------------  218 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-----------------
Confidence            4221111 1112234677899999886   678899999999999999999998643211111                 


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............+...++.+.+++.+||+ +|..|||+.+++.|
T Consensus       219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11111111122334455779999999999 57999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-36  Score=259.46  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=191.9

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +|.-.+.||.|++|.||++.. .+++.+++|.+...... ..+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            567778999999999999985 56899999987543332 2455788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++..    ...+...+..++.|++.|+++||+++   ++||||+|+||+++.++.++++|||.+.......  
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--  169 (285)
T cd06648          99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--  169 (285)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence            99999998865    23467888999999999999999999   9999999999999999999999999875442211  


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      .......++..|+|||...   ++.++|+||+|+++|+|++|..||...+....... .... ..              .
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-~~~~-~~--------------~  233 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-IRDN-LP--------------P  233 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-HHhc-CC--------------C
Confidence            1112345678899999886   78899999999999999999999754321111000 0000 00              0


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........+..+.+++.+||+.+|++|||+.+++++
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            000111234569999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=259.47  Aligned_cols=263  Identities=22%  Similarity=0.252  Sum_probs=191.3

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEEcC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      |++.+.||.|++|.||+|... +++.+++|.+.............+|+..++.++ |||++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            788999999999999999964 578899998755433222334456888898998 999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                       +++|.+.+..... ...++..+..++.|++.++.|||+++   ++|+||+|+||++++++.++++|||.+......   
T Consensus        81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---  152 (283)
T cd07830          81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---  152 (283)
T ss_pred             -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence             7788888865542 24477899999999999999999999   999999999999999999999999988654221   


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccCccccc-----cccc
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPYFPYPI-----ENNS  235 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~-----~~~~  235 (309)
                      .......++..|+|||.+.    ++.++|+||||+++|+|++|..||.............   ........     ....
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            1223345677899999874    6789999999999999999999986543221110000   00000000     0000


Q ss_pred             hhhhhcccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...........   ......+..+.+++++||+.||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000   0001113669999999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-36  Score=262.53  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=192.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ..|.....||.|+||.||++.. .++..+++|.+...... ..+.+.+|+.++..++|||++++++++..++..++++||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            4466677899999999999985 46899999987554332 345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|..++..    ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-  171 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-  171 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence            999999887743    23477889999999999999999999   9999999999999999999999999886542211 


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                       .......++..|+|||.+.   ++.++|+||||+++|+|++|..||......... ..... .+..             
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~-~~~~-------------  235 (297)
T cd06659         172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRD-SPPP-------------  235 (297)
T ss_pred             -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhc-cCCC-------------
Confidence             1122345778899999886   788899999999999999999998643221111 00000 0000             


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ........+..+.++|.+||+.+|.+||++.+++++-
T Consensus       236 -~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         236 -KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             -CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence             0001112235589999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=275.93  Aligned_cols=273  Identities=24%  Similarity=0.322  Sum_probs=209.7

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC------Cc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET------KV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   79 (309)
                      ...|..-+.||+|+||.||+|+ ..+|+.||+|...........+.+..|+++|++++|||||+++++-+..      +.
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            4567788899999999999999 4579999999988876777788999999999999999999999987653      45


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCC--CeEEEee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD--DNY--TAKVADF  155 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~--~~~--~v~l~d~  155 (309)
                      ..++||||.||||...++.......+++.+++.++.+++.||.|||+++   |+||||||.||++-  .+|  .-||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence            6899999999999999999988888999999999999999999999999   99999999999984  333  3599999


Q ss_pred             ecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc--Cccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP--YFPY  229 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~--~~~~  229 (309)
                      |.++...   ........+||..|++||...    |+..+|.|||||++|+..+|..||............+..  ..+.
T Consensus       169 G~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp  245 (732)
T KOG4250|consen  169 GAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP  245 (732)
T ss_pred             cccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence            9998773   334677789999999999886    788999999999999999999999766544321111110  0000


Q ss_pred             --------cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC--CHHHHHHHHhhhh
Q 040698          230 --------PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP--TMRQVSEQLDSLR  285 (309)
Q Consensus       230 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--s~~~ll~~l~~~~  285 (309)
                              ....+..++-.......-.......-+...+..+|..||++|-  .+.+....+..+.
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence                    0011111111111111112233335577888999999999999  6666665555443

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-36  Score=262.14  Aligned_cols=266  Identities=23%  Similarity=0.278  Sum_probs=190.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||.|.+|.||+|.++ +|+.+++|.+..... ......+..|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            67999999999999999999964 689999998754322 2223567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~~~~~~  164 (309)
                      |++ ++|.+.+...... ..+...+..++.|++.||.|||+++   ++|+||+|+||+++. ++.++++|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5777777544332 2366788899999999999999999   999999999999984 567999999988654221


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccCccccccc-cch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPYFPYPIEN-NSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~  236 (309)
                        ........++..|+|||.+.    ++.++|+||+|+++|+|++|..||...+.........   .......+.. ..+
T Consensus       157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 --VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             --ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence              11122345577899999874    5778999999999999999999986432221111000   0000000000 000


Q ss_pred             hhhhcccc--cC----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQV--AD----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~--~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........  ..    ......++.+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000000  00    0011234558999999999999999999999874

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-37  Score=273.19  Aligned_cols=245  Identities=23%  Similarity=0.358  Sum_probs=194.5

Q ss_pred             ccceeecccCceEEEEEEc-CCCcEEEEEecccc---hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc--cEEEE
Q 040698           11 DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV---DKILINEVFQHKMRIISQINHKNVVKILGVCLETKV--PLLVY   84 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~iv~   84 (309)
                      +....||+|+|-+||+|.+ .+|-.||.-.+...   ..+...++|..|+.+|+.|+||||++++++..+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4556899999999999995 34666665433322   334445789999999999999999999999887554  77999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~~~~~  163 (309)
                      |.+..|+|..+..+.+..   ..+.+..|+.||++||.|||++. |||+|||||=+||||+ ..|.|||+|+|+|...  
T Consensus       123 EL~TSGtLr~Y~kk~~~v---n~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~--  196 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRV---NIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL--  196 (632)
T ss_pred             ecccCCcHHHHHHHhccC---CHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh--
Confidence            999999999999877654   56899999999999999999996 8999999999999997 6789999999999875  


Q ss_pred             ccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        .........|||.|||||+..  |++..||||||+++.||+++.+||..=...-+.+-......++...    ..+. 
T Consensus       197 --r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl----~kV~-  269 (632)
T KOG0584|consen  197 --RKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL----SKVK-  269 (632)
T ss_pred             --hccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh----hccC-
Confidence              233344478999999999998  9999999999999999999999977543333332222222211110    0011 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                 .+.+++||.+||.. ...|||+.+||++
T Consensus       270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                       14599999999999 9999999999873

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-36  Score=260.37  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=195.9

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ++|++.+.||.|++|.||++... +|+.+++|......  .......+..|..+++++. ||||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            57999999999999999999954 68999999876521  2223456788899999998 99999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++....   .+++..+..++.|++.|+.+||+++   ++|+|++|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999987543   4578899999999999999999999   99999999999999999999999999866533


Q ss_pred             cccc------------------ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh
Q 040698          164 HDQT------------------ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR  222 (309)
Q Consensus       164 ~~~~------------------~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~  222 (309)
                      ....                  .......++..|+|||...   ++.++|+|+||++++++++|..||.........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---
Confidence            2211                  1112234567899999876   677899999999999999999998755321110   


Q ss_pred             cccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH----HHHHHH
Q 040698          223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM----RQVSEQ  280 (309)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~ll~~  280 (309)
                                    .....  .....+...++.+.+++.+||+.||.+|||+    .+++++
T Consensus       232 --------------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 --------------QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             --------------HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                          00000  0011112224569999999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.1e-36  Score=262.44  Aligned_cols=270  Identities=21%  Similarity=0.265  Sum_probs=190.2

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETK----   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   78 (309)
                      ...++|++.+.||.|+||.||++... +++.+++|.+.... .......+..|+.+++.++||||+++++++....    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            44678999999999999999999954 68999999775432 2222334567899999999999999999886543    


Q ss_pred             ----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           79 ----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        79 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                          ..++||||+. ++|.+.+....  ..+++.++..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence                3489999996 47777775433  23578899999999999999999999   99999999999999999999999


Q ss_pred             eeccccccccccc--ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh--hhhcccC
Q 040698          155 FASSVLISSHDQT--ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE--MTRMVPY  226 (309)
Q Consensus       155 ~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~--~~~~~~~  226 (309)
                      ||++.........  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||.........  .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9998655322211  1222345677899999864    567899999999999999999998643321110  0000000


Q ss_pred             cccc-cccc----chhhhhccccc------CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYP-IENN----SLRQILNFQVA------DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~-~~~~----~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+.. .+..    ...........      .....-.+..+.++|.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000 0000    00000000000      00000112457899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=266.71  Aligned_cols=265  Identities=20%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----Cc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET-----KV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~   79 (309)
                      .+++|++.+.||.|++|.||+|.+ .+|+.|++|.+...........+..|+.+++.++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            468999999999999999999985 568999999886544334456678899999999999999999887543     35


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++++||++ ++|.+.+..    ..+++..+..++.|++.||.+||+++   ++|+||+|+||+++.++.++++|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            789999996 477766642    23577889999999999999999999   9999999999999999999999999886


Q ss_pred             cccccccc-ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ........ .......++..|+|||.+.    ++.++|+||+|+++|+|++|..||......... .........+. ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~-~~  232 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPS-QE  232 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCC-HH
Confidence            54322111 1222345678899999753    678899999999999999999998643211100 00000000000 00


Q ss_pred             chhhhhcc-----------cccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNF-----------QVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~-----------~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....+...           .....   .....++.+.++|.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000           00000   011224568999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=258.30  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             cccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           10 YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      |++.+.||.|++|.||++.. .+|+.+++|.+...... .....+..|+.+++.++|+||+++++++.+.+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            77889999999999999995 46899999987654322 33467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++ +|.+++....  ...++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 8888776543  24577889999999999999999999   9999999999999999999999999886553322  


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc--cccccchhh---
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY--PIENNSLRQ---  238 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---  238 (309)
                      .......+...|+|||.+.    ++.++|+||||+++|+|++|..||...+........ ......  .........   
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI-FRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCchHhcccchhhhh
Confidence            1222345667799999875    677899999999999999999998654332211000 000000  000000000   


Q ss_pred             --hhccc-----ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 --ILNFQ-----VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 --~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        .....     .........+..+.++|.+||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence              00000     0001123456779999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=250.53  Aligned_cols=250  Identities=26%  Similarity=0.291  Sum_probs=195.9

Q ss_pred             hhcccccc-eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhh-cCCCccceeeeeeec----CC
Q 040698            6 ATKNYDKR-HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ-INHKNVVKILGVCLE----TK   78 (309)
Q Consensus         6 ~~~~y~i~-~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~   78 (309)
                      ++++|.+. ++||-|-.|.|-.+.+ .+|+++|+|++....+      .++|+++--. -.|||||.+++++++    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K------ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK------ARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH------HHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            56777775 4799999999999995 4699999998765432      3556654333 369999999999875    34


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~  155 (309)
                      .+.+|||.++||.|++.++.++.+. +++.++..|..||+.|++|||+.+   |.||||||+|+|.+   .+..+|++||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~a-fTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQA-FTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeEeeeecccchHHHHHHHHccccc-chHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence            5679999999999999998887764 478999999999999999999999   99999999999995   5678999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |.+.....   .......+-++.|.|||++.   |....|+||+||++|-|++|.+||-..-.             ....
T Consensus       209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-------------~ais  272 (400)
T KOG0604|consen  209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------LAIS  272 (400)
T ss_pred             ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-------------ccCC
Confidence            99987533   23334455688999999997   88899999999999999999999753210             0111


Q ss_pred             ccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 NNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      -+....+....+.+  +.+...+++..++|+.+|..+|++|.|+.++.++-
T Consensus       273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            11222233333323  34566778899999999999999999999998864

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=290.86  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=205.9

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ++.-..++|+|++.||+|+||.|.+++. .+++.+|+|++......  ...+-|..|-++|..-+.+.|++++..|++++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            3455678999999999999999999995 45899999988775332  12356888889999889999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ++|+||||++||+|..++....   .+++..+..++..++.|+.-+|+.|   ++|||+||+|||+|..|+|+++|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999997555   4588999999999999999999999   999999999999999999999999988


Q ss_pred             cccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      -.+. .+........+|||.|.+||+++        |+..+|+||+||++|+|+.|..||-.-..-.             
T Consensus       223 lkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-------------  288 (1317)
T KOG0612|consen  223 LKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-------------  288 (1317)
T ss_pred             HhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-------------
Confidence            6653 35566777789999999999996        7889999999999999999999986432211             


Q ss_pred             ccccchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCCCCC---HHHHHHH
Q 040698          231 IENNSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTERPT---MRQVSEQ  280 (309)
Q Consensus       231 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~  280 (309)
                          ....+++-+  ..++.....++...+||++.+. +|+.|..   +.++..|
T Consensus       289 ----TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  289 ----TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ----HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                111122211  1111123455778999998775 6777776   8888765

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=250.92  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=195.8

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|++.+.||.|.+|.+|++.++ ++..+++|....... ....+.+..|+++++.++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5899999999999999999854 578999998765532 12346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++++|.+++...   ...++..+..++.|++.++.+||+++   ++|+||+|+||+++.++.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988754   34578899999999999999999999   99999999999999999999999999876533221


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .  .....++..|+|||...   ++.++|+|++|+++|+|++|..||..............                  .
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------~  214 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------------------D  214 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------------------c
Confidence            1  22345677899999875   67889999999999999999999764332111111000                  0


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0011112234669999999999999999999999753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=253.62  Aligned_cols=247  Identities=23%  Similarity=0.210  Sum_probs=197.1

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|..+++||+|.||.|.+++ ..+|+.+|+|+++...-.  +.-+.-..|-++|+..+||.+..+...|+..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            56889999999999999999999 456999999987665321  112334567789999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||.+||.|.-.+++...   .++....-+...|+.||.|||+++   +++||+|.+|+++|.||++||+|||++..-.
T Consensus       246 VMeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999999888875443   366777788899999999999999   9999999999999999999999999997642


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  ........+|++.|+|||++.   |.++.|+|.+|+++|+|++|+.||-..+....-...+...             
T Consensus       320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------  384 (516)
T KOG0690|consen  320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------  384 (516)
T ss_pred             c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------
Confidence            2  334455679999999999998   9999999999999999999999987654332111111111             


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCC--CHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERP--TMRQVSE  279 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--s~~~ll~  279 (309)
                            ...|...+++...|+...|..||++|.  ..+++.+
T Consensus       385 ------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE  420 (516)
T KOG0690|consen  385 ------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE  420 (516)
T ss_pred             ------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence                  112233446689999999999999997  3444443

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.4e-36  Score=259.60  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=188.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||.|++|.||++.+++ +..+++|.+...........+..++.++... .||||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            45789999999999999999999754 8999999876543333344555666666655 499999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |||++ +++.++......  .+++..+..++.|++.|+.|||+ .+   ++|+||+|+||++++++.++|+|||++....
T Consensus        93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 577776654332  45778889999999999999997 58   9999999999999999999999999886542


Q ss_pred             cccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ..   .......++..|+|||.+.       ++.++|+||||+++|+|++|..||.......+...........      
T Consensus       167 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------  237 (296)
T cd06618         167 DS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP------  237 (296)
T ss_pred             CC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC------
Confidence            21   1112234567799999875       4678999999999999999999986432111111111000000      


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                               ........+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       238 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 ---------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     000001233569999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-36  Score=257.88  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=191.3

Q ss_pred             ccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCcc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVP   80 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   80 (309)
                      +|++.+.||.|+||.||.+..    .+|..+++|.+....   .....+.+..|+.+++++ +|+||++++++++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            589999999999999999985    368999999876432   222345678899999999 589999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++|+||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999887543   3467888889999999999999999   99999999999999999999999998865


Q ss_pred             cccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ..... ........++..|+|||...     .+.++|+||||+++|+|++|..||.........             ...
T Consensus       155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------~~~  220 (290)
T cd05613         155 FHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-------------AEI  220 (290)
T ss_pred             ccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH-------------HHH
Confidence            42221 11222345677899999875     467899999999999999999998632111000             000


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ........  .+.+...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       221 ~~~~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         221 SRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHhhccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            00000000  011222346689999999999999997     67777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-36  Score=267.20  Aligned_cols=271  Identities=23%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----C
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET-----K   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (309)
                      ..++|.+.+.||.|+||.||++.+ .+|+.|++|.+.... .......+..|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            467899999999999999999985 468999999875431 222234567899999999999999999988653     3


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++++||+. ++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999995 68888776432   3578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh--hhcccCccc-cc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM--TRMVPYFPY-PI  231 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~--~~~~~~~~~-~~  231 (309)
                      .......  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||...+......  ......... ..
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            6542221  2223345677899999764    6789999999999999999999986442111000  000000000 00


Q ss_pred             ---cccchhhhhc---cccc---CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH--Hhhhh
Q 040698          232 ---ENNSLRQILN---FQVA---DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ--LDSLR  285 (309)
Q Consensus       232 ---~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~~  285 (309)
                         ..........   ....   .......+..+.++|++||+.||++|||+.+++++  +..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence               0000000000   0000   01122345678999999999999999999999988  55443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-36  Score=255.97  Aligned_cols=242  Identities=27%  Similarity=0.314  Sum_probs=186.6

Q ss_pred             ecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||.|++|.||++.+. +|+.+++|.+.....  ....+.+..|+.++++++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 499999998765432  23356688899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc------
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ------  166 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~------  166 (309)
                      .+++....   ..++..+..++.|++.||+|||+++   ++|+||+|+||++++++.++++|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99887544   3477899999999999999999999   99999999999999999999999998865432211      


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      ........+...|++||...   .+.++|+|+||+++|++++|..||.........                 .......
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------------~~~~~~~  217 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-----------------QNILNGK  217 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHhcCC
Confidence            11223345677899999886   677899999999999999999998644321110                 0000000


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........+..+.+++.+||+.+|.+|||+..+.+.
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence            0000111124669999999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-36  Score=266.07  Aligned_cols=267  Identities=25%  Similarity=0.329  Sum_probs=192.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccc-hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC--Cc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV-DKILINEVFQHKMRIISQI-NHKNVVKILGVCLET--KV   79 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~   79 (309)
                      ...++|++.+.||.|+||.||+|.+. +|+.+++|.+... ........+..|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            45789999999999999999999964 6889999977432 1122234567899999999 999999999988643  46


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||++ ++|..++...    ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++++|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            799999997 5888777543    3466778889999999999999999   9999999999999999999999999887


Q ss_pred             cccccccc---ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc-
Q 040698          160 LISSHDQT---ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI-  231 (309)
Q Consensus       160 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  231 (309)
                      ........   .......++..|+|||.+.    ++.++|+||||+++|+|++|..||........ ............ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~  234 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Confidence            65332211   1222345678899999774    67789999999999999999999864322211 011000000000 


Q ss_pred             ----------cccchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ----------ENNSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ----------~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                ............  .........+..+.++|.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                      000000000000  0001111245679999999999999999999999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.4e-36  Score=254.60  Aligned_cols=243  Identities=22%  Similarity=0.242  Sum_probs=183.5

Q ss_pred             Hhhcccccceee--cccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCcc
Q 040698            5 KATKNYDKRHLL--GEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVP   80 (309)
Q Consensus         5 ~~~~~y~i~~~l--g~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~   80 (309)
                      ...++|++.+.+  |.|+||.||++.. .++..+++|..........      |...... .+|||++++++++...+..
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            345678888877  9999999999995 4688899998654322111      1112221 2799999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~  159 (309)
                      ++||||+++++|.+++....   ..++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++ .++++|||++.
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            99999999999999987543   4578999999999999999999999   99999999999999888 99999999876


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....      .....++..|+|||.+.   ++.++|+||+|+++|+|++|..||............             .
T Consensus       159 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-------------~  219 (267)
T PHA03390        159 IIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES-------------L  219 (267)
T ss_pred             ecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH-------------H
Confidence            5421      12235678899999986   778899999999999999999998633211100000             0


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-HHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-MRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~  280 (309)
                      ....  ..........+..+.++|.+||+.||.+||+ +++++++
T Consensus       220 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        220 LKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            0000  0011112234567999999999999999995 6998754

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.8e-36  Score=256.03  Aligned_cols=240  Identities=20%  Similarity=0.254  Sum_probs=180.7

Q ss_pred             eecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHH---HHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           15 LLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKM---RIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      .||+|+||.||++.. .+|+.+++|.+.....  ......+..+.   .++...+|||++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 4589999997754321  11112223333   33334479999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +++|..++....   .+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++......    
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            999998886443   3578899999999999999999999   999999999999999999999999988644221    


Q ss_pred             cccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          169 TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......++..|+|||...    ++.++|+||+|+++|+|++|..||.............               . ....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---------------~-~~~~  214 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------------M-TLTV  214 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH---------------H-hhcC
Confidence            122345788899999874    6788999999999999999999986432111110000               0 0001


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....+...+..+.++|++||+.||.+||     |+.++++|
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1112233456799999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-36  Score=260.39  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=192.4

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETK----   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   78 (309)
                      ...++|++.+.||.|++|.||+|..+ +|+.|++|.+..... ......+..|+.+++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            46789999999999999999999964 589999998764322 222345678999999999999999999887654    


Q ss_pred             ------ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           79 ------VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        79 ------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                            ..++++||+++ ++...+....  ...++..+..++.|++.||+|||+++   ++|+||+|+||++++++.++|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999976 6666665432  23577899999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc---
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP---  225 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~---  225 (309)
                      +|||.+........ .......++..|+|||.+.    .+.++|+|+||+++|+|++|.+||....... .......   
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~  235 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCG  235 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence            99998865532221 1122234466799999774    5778999999999999999999986432111 1100000   


Q ss_pred             -Cccccccc---cchhhhhcc-----cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          226 -YFPYPIEN---NSLRQILNF-----QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       226 -~~~~~~~~---~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ..+...+.   .......+.     ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00000000   000000000     00000111234669999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=246.48  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=193.6

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .++.+.++.||.|..|.||+++.+ +|...|+|.+.........+++...++++..- ++|+||+++|+|..+...+|.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            356677889999999999999954 58999999988776655566666666665544 4899999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |.+ +..+..++....  ...++..+-.+...++.||.||..+.+  ++|||+||+||++|+.|.||+||||++....  
T Consensus       171 elM-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv--  243 (391)
T KOG0983|consen  171 ELM-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV--  243 (391)
T ss_pred             HHH-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee--
Confidence            998 456666665443  345777788899999999999997643  9999999999999999999999999986542  


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                       .....+...|-+.|||||.+.      |.-.+|+||||+.++++.+|+.||..-....+.                +..
T Consensus       244 -dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----------------ltk  306 (391)
T KOG0983|consen  244 -DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----------------LTK  306 (391)
T ss_pred             -cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----------------HHH
Confidence             223334456778899999986      677899999999999999999997753322211                112


Q ss_pred             hhcccccC-ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVAD-ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +.+..++. ......++++++|+..||..|+.+||...++++|
T Consensus       307 vln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  307 VLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            22211111 1122356789999999999999999999999875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=252.75  Aligned_cols=237  Identities=24%  Similarity=0.226  Sum_probs=178.7

Q ss_pred             eeecccCceEEEEEEc-CCCcEEEEEecccchhh--hhHHHHHHHHHH-HhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI--LINEVFQHKMRI-ISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||.|++|.||+|.. .+|+.+++|.+......  .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999985 45899999987653221  111223344333 3455899999999999999999999999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      ++|.+++....   ..++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++++|||++.....      
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999987543   3477889999999999999999999   99999999999999999999999998754321      


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc--c
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ--V  244 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  244 (309)
                      .....++..|++||.+.   ++.++|+|++|+++|+|++|..||......... .                ......  .
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~----------------~~~~~~~~~  212 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-D----------------NILSRRINW  212 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-H----------------HHHhcccCC
Confidence            22334677899999876   678999999999999999999998643221100 0                000000  0


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      .......++..+.+++.+||+.||.+|||+.++.+
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            00111134466999999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-36  Score=276.49  Aligned_cols=270  Identities=16%  Similarity=0.202  Sum_probs=182.0

Q ss_pred             hhcccccceeecccCceEEEEEEcCC--CcEEEEE--------------eccc--chhhhhHHHHHHHHHHHhhcCCCcc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD--NTLVAVK--------------KPKM--VDKILINEVFQHKMRIISQINHKNV   67 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~ik--------------~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i   67 (309)
                      ..++|++++.||+|+||.||+|..+.  +...+.|              .+..  .........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35789999999999999999987422  2222222              0000  0112234567899999999999999


Q ss_pred             ceeeeeeecCCccEEEEEcCCCCCHHHHHHhhcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           68 VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        68 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      +++++++.+.+..+++++++. ++|..++.....  ........+..++.|++.||.|||+++   ++||||||+||+++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999995 566666643221  112234667789999999999999999   99999999999999


Q ss_pred             CCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCC-CCchhhhcc-hhh
Q 040698          146 DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKH-PRSYVALAS-NEM  220 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~-p~~~~~~~~-~~~  220 (309)
                      .++.++|+|||++....... ........|+..|+|||.+.   ++.++|||||||++|+|++|.. |+....... ...
T Consensus       302 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            99999999999987653211 11222346788999999986   7889999999999999999765 443221111 111


Q ss_pred             hhcccCccc---cccc--cchhhhhccc-cc---C-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          221 TRMVPYFPY---PIEN--NSLRQILNFQ-VA---D-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       221 ~~~~~~~~~---~~~~--~~~~~~~~~~-~~---~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........   ..+.  ..+....... ..   .     -.....+.++.++|.+||+.||.+|||+.+++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111110000   0000  0000000000 00   0     0001123457889999999999999999999875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.7e-36  Score=259.22  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=193.9

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+.|...+.||.|++|.||+|... +++.+++|.+...  ........+..|+.+++.++|+|++++++++...+..++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3456888999999999999999954 5888999977532  222233457789999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+. +++.+.+.....  ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++++|||++....
T Consensus        93 v~e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            999996 577776654332  3477888999999999999999999   9999999999999999999999999886542


Q ss_pred             cccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .      .....++..|+|||.+.      ++.++|+||||+++|+|++|..||..............            
T Consensus       167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------  228 (308)
T cd06634         167 P------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------  228 (308)
T ss_pred             C------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh------------
Confidence            2      12335677899999863      67789999999999999999999754321111110000            


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                           ...........+..+.++|.+||+.+|.+||++.+++++...+..
T Consensus       229 -----~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         229 -----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -----cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                 000111122344568999999999999999999999988665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-36  Score=265.79  Aligned_cols=269  Identities=19%  Similarity=0.241  Sum_probs=194.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE----TKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~   79 (309)
                      ..++|++.+.||.|++|.||++.. .+|+.|++|.+.... .......+..|+.+++.++||||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            458999999999999999999995 469999999876532 22334567789999999999999999998763    356


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+. ++|.+++....   ..++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            789999995 58888775432   3578999999999999999999999   9999999999999999999999999986


Q ss_pred             cccccccc--ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh--hhcccCccccc
Q 040698          160 LISSHDQT--ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM--TRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~  231 (309)
                      ........  .......++..|+|||.+.    ++.++|+||||+++|+|++|..||...+......  .......+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            54322111  1112345677899999864    6788999999999999999999985432211100  00000000000


Q ss_pred             ----cccchhhhhc---ccccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          232 ----ENNSLRQILN---FQVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       232 ----~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                          ..........   ......   .....+..+.++|++||+.+|.+|||+.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                0000000000   000000   0122357799999999999999999999998853

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-35  Score=257.16  Aligned_cols=244  Identities=25%  Similarity=0.346  Sum_probs=188.3

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +.|...+.||.|+||.||+|.. .+|+.+++|.+....  .......+..|+.+++.++|||++++++++.+.+..++||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            4467778899999999999985 468999999875432  2222346778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+. +++.+++.....  .+++..+..++.|++.++.|||+++   ++|+||+|+||+++.++.++++|||++...   
T Consensus       101 e~~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~---  171 (313)
T cd06633         101 EYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS---  171 (313)
T ss_pred             ecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc---
Confidence            9996 577777654332  3577888999999999999999999   999999999999999999999999987532   


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                         .......++..|+|||.+.      ++.++|+||||+++|+|++|..||...+...........             
T Consensus       172 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------------  235 (313)
T cd06633         172 ---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------  235 (313)
T ss_pred             ---CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Confidence               1222345677899999873      677899999999999999999997543221111100000             


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          ..........+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       236 ----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         236 ----DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00001111223458999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=258.00  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=192.2

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccEEEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPLLVYE   85 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~iv~e   85 (309)
                      |++.+.||.|++|.||+|... +|+.+++|.+.... .......+..|+.+++.++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            788999999999999999965 48899999876543 223345677899999999999999999999887  88999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++ +|.+++....  ...++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8887776443  24577889999999999999999999   9999999999999999999999999987653322


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc--ccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP--YPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  239 (309)
                      . .......++..|+|||.+.    ++.++|+|+||+++|+|++|..||........ .........  ..........+
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccc
Confidence            1 1223344567799999754    67899999999999999999999864432111 010000000  00000000000


Q ss_pred             ---hcccccCc--------cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 ---LNFQVADE--------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ---~~~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ........        ....++..+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               00000000        001125678999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=254.40  Aligned_cols=274  Identities=24%  Similarity=0.319  Sum_probs=209.4

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhh--cCCCccceeeeeeecC----C
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--INHKNVVKILGVCLET----K   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~   78 (309)
                      ..+++-.+++.+|+|.||.||+|.| .|+.||+|+....+    .+.+.+|.++.+-  ++|+||+.+++.--.+    .
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            4567889999999999999999999 58999999877654    3456777776664  5899999998876443    3


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-----LGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-----~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                      .+|+|++|.+.|||.++|...    .++....+.+++.++.||++||-     +|-|-+.|||||..||+|.++++..|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            678999999999999999853    23668889999999999999994     444669999999999999999999999


Q ss_pred             eeecccccccc--cccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh
Q 040698          154 DFASSVLISSH--DQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR  222 (309)
Q Consensus       154 d~g~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~  222 (309)
                      |+|++....+.  ......+.++||.+|||||++.         .-..+||||||.++||+.....--+-..........
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999765432  3345567889999999999996         123589999999999998754332222222222333


Q ss_pred             cccCccccccccchhhhhcccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          223 MVPYFPYPIENNSLRQILNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      +++..|.........+....++..   ....+....+.++|+.||..||.-|.|+-.+.+.|.++...
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            344444433343444444444333   34556778899999999999999999999999999887653

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=294.18  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=203.5

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...+-+|+-...+|.|.||.||-|.+ .+|+..|+|-+..... ...-..+.+|+.++..++|||+|+++|+-.+.+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34556888899999999999999995 4699999996544432 333456889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      |.||||++|+|.+.+.....   .++....-+-.|++.|+.|||++|   |+|||+||.||+++.+|.+|.+|||.+..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999875443   366667777899999999999999   999999999999999999999999999776


Q ss_pred             cccc--ccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          162 SSHD--QTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       162 ~~~~--~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ..+.  .........||+.|||||++.      -..+.|||||||++.||.+|+.||+..+..-+.+.. +...  .   
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-V~~g--h--- 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-VAAG--H--- 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-Hhcc--C---
Confidence            5432  223334678999999999997      355799999999999999999999977544322111 1100  0   


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                 .+..|...+..-.+||..||..||++|.++.|++++
T Consensus      1459 -----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                       011122255778999999999999999999998775

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-36  Score=264.60  Aligned_cols=255  Identities=24%  Similarity=0.260  Sum_probs=207.1

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+.|.+.+.||.|.|+.|..+++ -++..||+|.+.... .....+.+.+|+.+|+.++|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            46899999999999999999995 469999999876642 2333455899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+.+|.+.+++...+...   +.....++.|+++|++|||+++   ++|||||.+|++++.+..++|+|||++..+.  
T Consensus       135 eya~~ge~~~yl~~~gr~~---e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMK---EKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EeccCchhHHHHHhcccch---hhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence            9999999999998777653   3778889999999999999999   9999999999999999999999999987652  


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                       ........+|++.|.|||++.    ..+.+|+|++|+++|.+++|..||+..........                 .+
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-----------------vl  268 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-----------------VL  268 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-----------------he
Confidence             334455678899999999997    67889999999999999999999874422111100                 00


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      -.+.  --+...+.++.++|+++|-.+|.+|++.+++.++-........
T Consensus       269 ~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  269 RGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            0111  1122333558999999999999999999999887654443333

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=252.92  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=187.7

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhc---CCCccceeeeeeecCCc-----
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQI---NHKNVVKILGVCLETKV-----   79 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----   79 (309)
                      |++.+.||.|.+|.||++.++ +++.+++|.+..... ......+..|+.+++.+   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999975 489999998764322 11223455666665554   69999999999987766     


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .+++|||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+|++|+||++++++.++++|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 78888765433 23577899999999999999999999   9999999999999999999999999886


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc----cccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP----YPIE  232 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~  232 (309)
                      .....   .......++..|+|||.+.   ++.++|+||||+++|+|++|.+||......... ........    ....
T Consensus       156 ~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (287)
T cd07838         156 IYSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL-DKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH-HHHHHHcCCCChHhcC
Confidence            65322   1122234577799999886   788999999999999999999998643321111 00000000    0000


Q ss_pred             ccch--hhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSL--RQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~--~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  .......   .........+..+.++|.+||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000  0000000   0011112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-35  Score=255.11  Aligned_cols=253  Identities=24%  Similarity=0.277  Sum_probs=191.6

Q ss_pred             ccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCcc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVP   80 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   80 (309)
                      +|++.+.||.|++|.||++..    .+++.+++|.+....   .......+..|+.++.++ +||||+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            588999999999999999873    357889999875432   223345678899999999 599999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||+++++|.+++....   .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998886432   3467888899999999999999999   99999999999999999999999998765


Q ss_pred             cccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ...... .......++..|++||...     .+.++|+|+||+++|+|++|..||..........             ..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------------~~  220 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS-------------EI  220 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH-------------HH
Confidence            422211 1112234677899999875     4678999999999999999999985321110000             00


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .......  ....+...+..+.+++.+||+.||++|||+.++.+.|..
T Consensus       221 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         221 SRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0000000  011122234568999999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-35  Score=252.49  Aligned_cols=240  Identities=20%  Similarity=0.254  Sum_probs=180.3

Q ss_pred             eecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHH---HHHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           15 LLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHK---MRIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      .||.|+||.||++.. .+++.||+|.+.....  ......+..+   ...++...||+|+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4589999998754321  1111122233   234445579999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      |++|..++...   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++......    
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            99999888643   24578899999999999999999999   999999999999999999999999988644221    


Q ss_pred             cccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          169 TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......++..|+|||.+.    ++.++|+||+|+++|+|++|..||...........               ... ....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---------------~~~-~~~~  214 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---------------DRM-TLTM  214 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---------------HHH-hhcc
Confidence            122346788899999974    67889999999999999999999865421111000               000 0000


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1111222346699999999999999999     99999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-36  Score=284.02  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=187.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec---------
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE---------   76 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------   76 (309)
                      ..+|+.++.||+|+||.||+++++ ||..+|||++...........+.+|+.+|.+++|||||+++....+         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            467899999999999999999964 8999999988766566667888999999999999999999821100         


Q ss_pred             --------------------------------------------------------------------------------
Q 040698           77 --------------------------------------------------------------------------------   76 (309)
Q Consensus        77 --------------------------------------------------------------------------------   76 (309)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh
Q 040698           77 ----------------------T--------KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS  126 (309)
Q Consensus        77 ----------------------~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  126 (309)
                                            +        ..+||-||||+...+.+++.......  .....++++.+|+.|+.|+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence                                  0        12278899999877777776544322  347889999999999999999


Q ss_pred             cCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc----------------cccccccccccccccccCCCcccc----
Q 040698          127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS----------------SHDQTATTTKEIETVGWLDPEYLF----  186 (309)
Q Consensus       127 ~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~----------------~~~~~~~~~~~~~~~~~~~PE~~~----  186 (309)
                      .|   ++||||||.||+++++..|||+|||++....                ........+...||..|+|||.+.    
T Consensus       716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            99   9999999999999999999999999997721                111112445678899999999996    


Q ss_pred             --cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc--cchHHHHHHHHHHhH
Q 040698          187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE--NEMEEIEIVAKLASK  262 (309)
Q Consensus       187 --~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~  262 (309)
                        |+.|+|+||||++++||+.-   |+-.   .+.             ...+..+++...+.+  ...+..+.-..+|++
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~yP---F~Ts---MER-------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLYP---FGTS---MER-------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhcc---CCch---HHH-------------HHHHHhcccCCCCCCcccccccchHHHHHHHH
Confidence              88899999999999999863   3311   000             011111111111111  111222346789999


Q ss_pred             hhccCCCCCCCHHHHHHH
Q 040698          263 CLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       263 cl~~dp~~Rps~~~ll~~  280 (309)
                      |++.||.+||||.++++.
T Consensus       854 Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HhcCCCccCCCHHHHhhc
Confidence            999999999999999863

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8e-36  Score=257.03  Aligned_cols=258  Identities=18%  Similarity=0.246  Sum_probs=179.6

Q ss_pred             hhcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHH----------HHHHHHHHHhhcCCCccceee
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINE----------VFQHKMRIISQINHKNVVKIL   71 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~----------~~~~e~~~l~~l~h~~iv~~~   71 (309)
                      ..++|++.+.||+|+||.||+|.+.+    +..+++|...........+          ....+...+..++|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            45789999999999999999999544    4556666533222111011          112233445567899999999


Q ss_pred             eeeecCC----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           72 GVCLETK----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        72 ~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      ++.....    ..+++++++. .++.+.+.....   .++..+..++.|++.|+.|||+.+   ++||||||+||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            8765433    3367888874 466666554322   256778899999999999999999   9999999999999999


Q ss_pred             CCeEEEeeeccccccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh
Q 040698          148 YTAKVADFASSVLISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE  219 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~  219 (309)
                      +.++|+|||++.........     .......|++.|+|||...   ++.++||||||+++|+|++|..||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999998665321111     1122346888999999886   788999999999999999999998755222111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .....        ...+..+......   ...++..+.++++.||+.+|++||++.++++.|
T Consensus       243 ~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAK--------CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhH--------HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            10000        0000111111111   122346699999999999999999999998876

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-35  Score=255.34  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=189.4

Q ss_pred             cccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           10 YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      |.....||+|+||.||++.. .+|+.+++|.+.... ......+..|+.+++.++|+|++++++.+...+..+++|||++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            34456799999999999985 568999999875433 2335678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +++|.+++...    ..++..+..++.|++.+++|||+.+   ++|+||+|+||+++.++.++++|||++.......  .
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~  171 (292)
T cd06657         101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  171 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence            99998877532    2467888999999999999999999   9999999999999999999999999876542211  1


Q ss_pred             cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccccc
Q 040698          169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA  245 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
                      ......++..|+|||.+.   ++.++|+||+|+++|+|++|..||........... .....+.               .
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~---------------~  235 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPP---------------K  235 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhCCc---------------c
Confidence            122345677899999875   67889999999999999999999764321111000 0000000               0


Q ss_pred             CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       246 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+..+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            00111223558999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=260.22  Aligned_cols=265  Identities=21%  Similarity=0.262  Sum_probs=194.8

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----ccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETK-----VPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~   81 (309)
                      +|++.+.||.|++|.||+|... +|+.+++|.+..... ....+.+..|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6899999999999999999964 489999998765432 333567888999999999999999999988765     789


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ++|||++ ++|.+++....   .+++..+..++.+++.||.+||+++   ++|+||+|.||+++.++.++++|||.+...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 57877775433   4577889999999999999999999   999999999999999999999999998765


Q ss_pred             ccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc------
Q 040698          162 SSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP------  230 (309)
Q Consensus       162 ~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------  230 (309)
                      ..... ........++..|+|||.+.    ++.++|+||||+++|+|++|..||....................      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            33211 01223345677899999885    67789999999999999999999865543221111000000000      


Q ss_pred             ccccchhhhhc-ccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 IENNSLRQILN-FQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........... .....     ......+..+.++|.+||+.+|.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000000000 00000     0112235668999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=275.91  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=207.1

Q ss_pred             hcccccceeecccCceEEEEEEcC----C----CcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP----D----NTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~----~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      .++..+.+.||.|.||.|++|..+    .    ...||+|.+.........+.+..|+++|+.+ .|+||+.+++++.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344567779999999999999821    1    4578999887665556678899999999988 699999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhc------cc-------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQS------SQ-------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL  144 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~------~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv  144 (309)
                      ..+++|+||+..|+|..+++...      ..       ..+....++.+++||+.||+||++..   ++||||..+||++
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            99999999999999999998766      00       12567889999999999999999999   9999999999999


Q ss_pred             cCCCCeEEEeeecccccccccccccc-cccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          145 DDNYTAKVADFASSVLISSHDQTATT-TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      +++..+||+|||+++........... ....-...|||||.+.   ++.++|+||+|+++||+++ |..||+....    
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~----  527 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP----  527 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc----
Confidence            99999999999999765333322211 1111345599999997   8999999999999999999 8888654210    


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                                   ...+-.........+.|..|+++++++|+.||+.+|++||++.++.+.++..
T Consensus       528 -------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 -------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                         1111123334444556667778899999999999999999999999999885

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=259.02  Aligned_cols=249  Identities=22%  Similarity=0.269  Sum_probs=200.8

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      .+...+.|..-++||+|+||.|+-+.. .+|+.+|.|++..-  .+..-......|-.+|..++.+.||.+-..|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            355678899999999999999999985 46999999876442  112223456778889999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      +++|+..++||+|.-.+.+.+.. .+++..+.-++.+|+.||.+||+.+   |++||+||+||++|+.|+|+|+|+|++.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence            99999999999999888777653 4578888999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .+.   ...+...++||.+|||||++.   |+...|+|+|||++|+|+.|..||.....-              .....+
T Consensus       336 ei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~eEv  398 (591)
T KOG0986|consen  336 EIP---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKREEV  398 (591)
T ss_pred             ecC---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHHHH
Confidence            773   344556679999999999998   999999999999999999999998654211              111111


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT  273 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  273 (309)
                      +.... ....+.+...++++.+|.+..|..||.+|..
T Consensus       399 drr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  399 DRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            11111 0112234566788999999999999999863

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=260.25  Aligned_cols=269  Identities=21%  Similarity=0.232  Sum_probs=191.7

Q ss_pred             Hhhccccc-ceeecccCceEEEEEEc-CCCcEEEEEecccchhhh-------------hHHHHHHHHHHHhhcCCCccce
Q 040698            5 KATKNYDK-RHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKIL-------------INEVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus         5 ~~~~~y~i-~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~iv~   69 (309)
                      ...++|.. .+.||.|+||.||++.+ .+++.|++|.+.......             ....+..|+.+++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            35678875 57799999999999995 468999999775432211             0124678999999999999999


Q ss_pred             eeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           70 ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        70 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      +++++..++..+++|||++ ++|.+++....   ..++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence            9999999999999999996 58888876432   3577889999999999999999999   999999999999999999


Q ss_pred             eEEEeeeccccccccc------------ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          150 AKVADFASSVLISSHD------------QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~------------~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                      ++++|||.+.......            .........++..|+|||.+.    ++.++|+||||+++|+|++|..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999886553110            011112234567799999875    577899999999999999999998754


Q ss_pred             hhcchhhh---hcccCccccccccc---hhhhhcc---cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          214 ALASNEMT---RMVPYFPYPIENNS---LRQILNF---QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       214 ~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +.......   .........++...   .......   ..........+..+.++|.+||+.+|.+|||+.+++.+
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            32211100   00000000000000   0000000   00000011234668999999999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=253.33  Aligned_cols=261  Identities=23%  Similarity=0.295  Sum_probs=192.3

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      |++.+.||+|.+|.||+|... +++.+++|...... .....+.+..|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            678899999999999999964 59999999876543 2223456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      + ++|.+++....  ...++..+..++.+++.|+.+||+++   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  152 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--  152 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc--
Confidence            7 58999887653  23578899999999999999999999   9999999999999999999999999886542211  


Q ss_pred             ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc--c----------
Q 040698          168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--I----------  231 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~----------  231 (309)
                      ........+..|+|||.+.    ++.++|+|+||+++|++++|..||......... .........+  .          
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-FKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHHHhCCCcHHHHHhhccccc
Confidence            1222334466799999874    678899999999999999999998654321110 0000000000  0          


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......... ...........+..+.++|.+||+.||++||++.+++++
T Consensus       232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000000 000000111224669999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=261.09  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=192.4

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK--   78 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   78 (309)
                      +-...++|++.+.||.|++|.||++.. .+|..||+|.+... ........+..|+.+++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            344678999999999999999999984 56999999987532 22333456788999999999999999999987643  


Q ss_pred             ----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           79 ----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        79 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                          ..++||||+ +++|..++..    ...++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                348999999 7788877753    23577889999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ||++.....     ......++..|++||.+.    ++.++|+||||+++|++++|..||............+......+
T Consensus       162 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         162 FGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            998865421     122334577899999865    56789999999999999999999874432211111000000000


Q ss_pred             ------ccccc----hhhhhccccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 ------IENNS----LRQILNFQVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ------~~~~~----~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .....    ..........  .......+..+.++|.+||+.||.+|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000    0000000000  00012234568999999999999999999999853

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.3e-35  Score=256.23  Aligned_cols=265  Identities=18%  Similarity=0.277  Sum_probs=192.2

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   79 (309)
                      +..++++|++.+.||.|+||.||++.. .+|+.+++|.+... ......+.+..|+.+++.++||||+++++++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            456789999999999999999999985 47899999976542 222334567789999999999999999999865 567


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++++||+ +++|..++...    ..+...+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||.+.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999999 56888777532    2466778889999999999999999   9999999999999999999999999876


Q ss_pred             ccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh--hhhcccCcccccc-
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE--MTRMVPYFPYPIE-  232 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-  232 (309)
                      ....     ......++..|+|||.+.    ++.++|+|+||+++|+|++|..||.........  ........+.... 
T Consensus       157 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4311     112234567799999763    678899999999999999999998644321100  0000000000000 


Q ss_pred             ---ccchhhhh-cccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 ---NNSLRQIL-NFQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ---~~~~~~~~-~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ........ ......     ......++.+.++|++||+.+|++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000000 000000     0111234679999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.4e-36  Score=258.42  Aligned_cols=269  Identities=23%  Similarity=0.222  Sum_probs=187.9

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETK-----   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   78 (309)
                      ..++|++.+.||.|++|.||++.++ +++.+++|.+..... ......+.+|+.+++.++||||+++++++.+..     
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            3689999999999999999999954 689999997754322 112235678899999999999999999875433     


Q ss_pred             ---ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           79 ---VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        79 ---~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                         ..++|+||+.+ ++...+....  ...++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++++||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence               45899999964 6666654332  24578999999999999999999999   999999999999999999999999


Q ss_pred             eccccccccccc---------ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh-
Q 040698          156 ASSVLISSHDQT---------ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT-  221 (309)
Q Consensus       156 g~~~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~-  221 (309)
                      |++.........         .......++..|+|||.+.    ++.++|+||||+++|+|++|.+||........... 
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            988654322111         1112234567799999764    67889999999999999999999864322111100 


Q ss_pred             --hcccCcccccccc-chhh----hhcccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          222 --RMVPYFPYPIENN-SLRQ----ILNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       222 --~~~~~~~~~~~~~-~~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ......+...... ....    ........   .......+.+.++|.+||+.||.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence              0000000000000 0000    00000000   0001222568999999999999999999999764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8e-36  Score=262.41  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=188.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET-------   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------   77 (309)
                      ..++|++.+.||.|+||.||+|.. .+|..|++|.+..... ...+.+..|+.+++.++||||+++++++...       
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            357999999999999999999995 4689999998755443 2245678899999999999999999876543       


Q ss_pred             -------CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCC
Q 040698           78 -------KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYT  149 (309)
Q Consensus        78 -------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~  149 (309)
                             ...++||||++ ++|.+++...    .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++ +++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence                   35689999997 5887777532    3467889999999999999999999   99999999999997 5567


Q ss_pred             eEEEeeecccccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc
Q 040698          150 AKVADFASSVLISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV  224 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~  224 (309)
                      ++++|||.+........ ........++..|+|||.+.    ++.++|+||||+++|+|++|..||............ .
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~-~  232 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-L  232 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H
Confidence            89999998865422111 11112234577799999763    677899999999999999999998644322111111 0


Q ss_pred             cCcccccc---ccc---h-hhh----hccc-ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          225 PYFPYPIE---NNS---L-RQI----LNFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       225 ~~~~~~~~---~~~---~-~~~----~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...+....   ...   . ...    .... .........+..+.+||.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00010000   000   0 000    0000 0000011234668999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-35  Score=248.94  Aligned_cols=248  Identities=20%  Similarity=0.228  Sum_probs=186.4

Q ss_pred             ccccceeecccCceEEEEEEcCC-CcEEEEEeccc---ch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKM---VD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~---~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      +|.+.+.||.|+||.||++.+.. +..+++|....   .. .......+..|..+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58999999999999999998543 34444443322   11 111233466788899999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           84 YEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      +||+++++|.+++... ......++..+..++.|++.|+.|||+.+   ++|+||+|+||++++ +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888643 22335678899999999999999999999   999999999999975 579999999886542


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..  ........++..|+|||...   ++.++|+||+|+++|+|++|..||.............                
T Consensus       157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~----------------  218 (260)
T cd08222         157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV----------------  218 (260)
T ss_pred             CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----------------
Confidence            21  11122344677899999875   6778999999999999999999975432211111000                


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       . ......+...+..+.++|.+||+.||.+||++.+++++
T Consensus       219 -~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 -E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             0 00111223455679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=259.47  Aligned_cols=262  Identities=22%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc---
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKV---   79 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---   79 (309)
                      ...++|++.+.||.|++|.||+|.+. +++.+++|.+.... .......+..|+.+++.++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45788999999999999999999964 58899999875432 22234556789999999999999999998866544   


Q ss_pred             ---cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           80 ---PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        80 ---~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                         .++|+||+ +++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 6789888764    23577889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc--ccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF--PYP  230 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~  230 (309)
                      ++.....     ......++..|+|||...    ++.++|+||||+++|++++|..||........ ........  +..
T Consensus       164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~  237 (343)
T cd07851         164 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDE  237 (343)
T ss_pred             ccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCH
Confidence            9865422     123345677899999864    67889999999999999999999864432211 11000000  000


Q ss_pred             -----ccccchhhhhcc---cccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 -----IENNSLRQILNF---QVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 -----~~~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ............   ....   ......+..+.++|.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                 000000000000   0000   0011235679999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=243.68  Aligned_cols=256  Identities=23%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             eeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEEcCCCCC
Q 040698           14 HLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      +.||+|+|+.|--+. ..+|..+|+|++... ....++++.+|++++.+.+ |+||++++++|+++...|+|||.+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            579999999999888 578999999998776 3445788899999999885 9999999999999999999999999999


Q ss_pred             HHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEEeeeccccccccc---
Q 040698           92 LFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---TAKVADFASSVLISSHD---  165 (309)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l~d~g~~~~~~~~~---  165 (309)
                      |.+.+.++...   ++.++.++..+|+.||.|||.+|   |.|||+||+||+.....   -|||+||.+..-.....   
T Consensus       163 lLshI~~~~~F---~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQKRKHF---NEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHHhhhc---cHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            99999866654   77889999999999999999999   99999999999986443   48999999875432211   


Q ss_pred             --ccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc--cc
Q 040698          166 --QTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI--EN  233 (309)
Q Consensus       166 --~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  233 (309)
                        ........+|+..|||||+..        |..+.|.|||||++|-|++|.+||...=......   .+ .....  ..
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW---dr-Ge~Cr~CQ~  312 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW---DR-GEVCRVCQN  312 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc---cC-CCccHHHHH
Confidence              111223467888999999885        8889999999999999999999986432111110   00 00000  00


Q ss_pred             cchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...+.+-+.++.+  ..+...+....++|...|..|+.+|.++.+++++
T Consensus       313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            0111122222222  2244566779999999999999999999999874

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-35  Score=256.18  Aligned_cols=266  Identities=22%  Similarity=0.277  Sum_probs=192.0

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC---
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET---   77 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---   77 (309)
                      +-...++|++.+.||+|+||.||++.. .+|+.||+|.+.... .......+.+|+.++++++||||+++++++...   
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            455779999999999999999999984 578999999876432 222345677899999999999999999988643   


Q ss_pred             ---CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           78 ---KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        78 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                         +..+++++++ +++|.+++...    ..++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++++|
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEec
Confidence               3467888887 77888777532    2477889999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh--hcccCcc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT--RMVPYFP  228 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~--~~~~~~~  228 (309)
                      ||++.....     ......++..|+|||.+.    ++.++|+||||+++|+|++|..||...........  ......+
T Consensus       164 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         164 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            998865321     122345677899999864    67789999999999999999999864322111000  0000000


Q ss_pred             c----cccccchhhhhc---ccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          229 Y----PIENNSLRQILN---FQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       229 ~----~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .    ............   .....   ......+..+.++|.+||+.||.+|||+.+++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            0    000000000000   00000   00112345689999999999999999999998874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.8e-36  Score=244.19  Aligned_cols=271  Identities=22%  Similarity=0.281  Sum_probs=194.9

Q ss_pred             hcccccceeecccCceEEEEEE-cCC----CcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPD----NTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~----~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   79 (309)
                      ...|++.+.||+|.||.||++. .++    ...+|+|.+... +........-+|+.+++.++|||++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4579999999999999999996 222    236788876554 222334556789999999999999999999987 778


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CCeEEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN----YTAKVA  153 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~----~~v~l~  153 (309)
                      +++++||.+ .+|...+..+..  ...++...+..++.||+.|+.|||++.   +.||||||.||+|..+    |.|||+
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            899999996 588888865432  235577889999999999999999999   9999999999999766    999999


Q ss_pred             eeecccccccccccc-cccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh-----hhc
Q 040698          154 DFASSVLISSHDQTA-TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM-----TRM  223 (309)
Q Consensus       154 d~g~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~-----~~~  223 (309)
                      |+|+++.+...-... .....+-+..|+|||.+.    |+.+.|+|++||++.||++-.+.|...+.-....     ..+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999998874432222 233455688899999997    9999999999999999999887775433111110     000


Q ss_pred             ccC-----ccccccccchhhhh-------cccccCccc----------hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          224 VPY-----FPYPIENNSLRQIL-------NFQVADENE----------MEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       224 ~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~----------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .+.     .|.......+..+.       +.+.....+          ..-++...+|+.+||..||.+|.|+++.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            000     01111111111111       111000000          00113378999999999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=286.21  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=191.1

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ...|...+.||+|+||.||+|.. .+|..||+|.+......     ...|+..+++++||||+++++++.+.+..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            35677788999999999999995 57899999987654321     1345788899999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..      .++..+..++.|++.|++|||....+.++|||++|+||+++.++..++. ++.....    
T Consensus       764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~----  832 (968)
T PLN00113        764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL----  832 (968)
T ss_pred             CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc----
Confidence            9999999999852      4678889999999999999994422229999999999999988877765 5543221    


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......++..|+|||.+.   ++.++||||||+++|||++|+.||............+....   ..........++
T Consensus       833 --~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  907 (968)
T PLN00113        833 --CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC---YSDCHLDMWIDP  907 (968)
T ss_pred             --ccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh---cCccchhheeCc
Confidence              1112235678899999986   88899999999999999999999843211111111111000   000011111111


Q ss_pred             cc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          243 QV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       243 ~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ..  ...........+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            11  111223445568899999999999999999999999987765443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=244.13  Aligned_cols=237  Identities=32%  Similarity=0.336  Sum_probs=186.5

Q ss_pred             ecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           16 LGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        16 lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      ||.|++|.||.+... +++.+++|.+.....  ......+..|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999964 589999998765432  22345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccc
Q 040698           93 FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK  172 (309)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~  172 (309)
                      .+++....   .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||.+.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99987553   3477889999999999999999999   9999999999999999999999999886643221  12233


Q ss_pred             cccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       173 ~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      ..++..|++||...   .+.++|+|+||+++|++++|..||...+....                 ...+...  ....+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~--~~~~~  213 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-----------------YEKILKD--PLRFP  213 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHhcC--CCCCC
Confidence            45677899999876   67789999999999999999999865432110                 0000000  01111


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCH---HHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTM---RQVSE  279 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~---~~ll~  279 (309)
                      ...+..+.+++++||..||.+||++   .++++
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            1224568999999999999999999   56654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-35  Score=256.00  Aligned_cols=265  Identities=20%  Similarity=0.291  Sum_probs=190.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK------   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   78 (309)
                      .++|.+.+.||.|++|.||+|.+ .+|+.+|+|.+... ........+..|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            58999999999999999999995 46899999987543 22223445788999999999999999999987542      


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++|+||+. .+|.....     ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++++|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            4589999996 46655442     13477888999999999999999999   999999999999999999999999988


Q ss_pred             cccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc--
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE--  232 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  232 (309)
                      .....     ......++..|+|||.+.    ++.++|+||||+++|+|++|+.||........ ..........+.+  
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~  238 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEF  238 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence            65311     122335577799999864    67789999999999999999999875332111 1111100000000  


Q ss_pred             -----ccchhhhhcccccCc------cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH--Hhhhhh
Q 040698          233 -----NNSLRQILNFQVADE------NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ--LDSLRR  286 (309)
Q Consensus       233 -----~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~~~  286 (309)
                           ...............      .....+..+.+||.+||+.||.+|||+.+++.+  ++.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 000000000000000      001234568999999999999999999999976  666554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=263.92  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec----
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE----   76 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----   76 (309)
                      ++..+..|+|.+.+|.|.+|.||+++. ++++..|+|+.......  .+.+..|+++++.. +|||++..++++..    
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            455678899999999999999999994 56899999987765443  45678888998877 69999999999853    


Q ss_pred             -CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           77 -TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        77 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                       ++.+|+|||||.|||..++++... .....+..++.|++.++.|+.+||++.   ++|||++-.||+++.++.||++||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence             578999999999999999998777 445678999999999999999999999   999999999999999999999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      |.+.....  .........|++.|||||++.        |+..+|+||||++..||-.|.+|+...              
T Consensus       168 GvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm--------------  231 (953)
T KOG0587|consen  168 GVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM--------------  231 (953)
T ss_pred             eeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc--------------
Confidence            99876533  334455678999999999996        777899999999999999999995422              


Q ss_pred             cccccccchhhh-hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIENNSLRQI-LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         .+...+..+ .++.+....+...+..+.++|..||..|..+||+..++++|
T Consensus       232 ---HPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  232 ---HPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---chhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               111111111 12222223466777889999999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=248.55  Aligned_cols=263  Identities=24%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-C-C----ccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-H-K----NVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~~~~   78 (309)
                      ..++|+++..+|+|.||.|-.+.+ ..+..||+|+++...+-  +++..-|+++|+.++ + |    .++++.+||.-.+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            378999999999999999999884 34899999998877553  566778899999884 2 2    4778889999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC------------
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD------------  146 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~------------  146 (309)
                      +.+||+|.+ |-|+.+++...+-. ..+...+..+++|++.++++||+++   ++|.||||+||++.+            
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            999999999 67999999865544 4578999999999999999999999   999999999999831            


Q ss_pred             --------CCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          147 --------NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       147 --------~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                              ...|+++|||.+....     ......+.|-.|+|||++.   ++.++|+||+||+|+|+.+|...|...++
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                    2358999999886532     2224556788899999998   99999999999999999999998776552


Q ss_pred             cc--hhhhhcccCccccccccc-hhhhhc--------------ccccCc----------cchHHHHHHHHHHhHhhccCC
Q 040698          216 AS--NEMTRMVPYFPYPIENNS-LRQILN--------------FQVADE----------NEMEEIEIVAKLASKCLRTSG  268 (309)
Q Consensus       216 ~~--~~~~~~~~~~~~~~~~~~-~~~~~~--------------~~~~~~----------~~~~~~~~l~~li~~cl~~dp  268 (309)
                      .+  ..++....++|....... ......              .+....          ........+.+|+++||..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            22  112222222222111111 000000              000001          123344559999999999999


Q ss_pred             CCCCCHHHHHHH
Q 040698          269 TERPTMRQVSEQ  280 (309)
Q Consensus       269 ~~Rps~~~ll~~  280 (309)
                      .+|+|+.+++.|
T Consensus       395 ~~RiTl~EAL~H  406 (415)
T KOG0671|consen  395 ARRITLREALSH  406 (415)
T ss_pred             cccccHHHHhcC
Confidence            999999999874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=267.28  Aligned_cols=263  Identities=24%  Similarity=0.419  Sum_probs=211.6

Q ss_pred             ccccceeecccCceEEEEEEc-CCC----cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~----~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..+..++||.|+||.||+|.| +.|    -+|++|.+...........+..|.-+|.+++|||++++++++.... +-||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345578999999999999995 444    4778888877777766778899999999999999999999998655 7899


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ++|+++|+|.++++.++..  +-.+.++.|++||++||.|||.++   ++||||-.+||||.....||+.|||+++....
T Consensus       776 tq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999999876654  355889999999999999999999   99999999999999999999999999987644


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ....-......-.+.|+|=|.+.   ++.++|+|+|||.+||+++ |..|+....                  ...+..+
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------------~~eI~dl  912 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------------AEEIPDL  912 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------------HHHhhHH
Confidence            33222222222244577777766   8999999999999999998 888865432                  1222333


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQK  295 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~  295 (309)
                      +.......-|+.++-++.-++.+||..|+..||+|+++...+.++..-...+..-+
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence            33333455567788889999999999999999999999999999887666655554

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-34  Score=253.24  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=186.2

Q ss_pred             ccccceeecccCceEEEEEEcC-C--CcEEEEEecccch-hhhhHHHHHHHHHHHhhc-CCCccceeeeeeec----CCc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-D--NTLVAVKKPKMVD-KILINEVFQHKMRIISQI-NHKNVVKILGVCLE----TKV   79 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~--~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~   79 (309)
                      +|++.+.||.|+||.||++... +  +..+|+|.+.... .......+..|+.+++.+ +||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5899999999999999999953 4  7899999876432 222345677889999988 59999999987532    245


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++++++++ ++|.+++...   ...++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688999985 6888887533   24577889999999999999999999   9999999999999999999999999986


Q ss_pred             cccccccc--ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc-
Q 040698          160 LISSHDQT--ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE-  232 (309)
Q Consensus       160 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  232 (309)
                      ........  .......++..|+|||...    ++.++|+||+|+++|+|++|..||......... .........+.. 
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL-NQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH-HHHHHHhCCCCHH
Confidence            54322111  1122346788899999764    677899999999999999999998653311100 000000000000 


Q ss_pred             ------ccchhhh---hcccccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 ------NNSLRQI---LNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ------~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .......   .......   ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                  0000000   0000000   0011124569999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=260.63  Aligned_cols=240  Identities=27%  Similarity=0.304  Sum_probs=189.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..+.|++...+|.|+|+.|..+.+ .+++..++|.+....     ....+|..++.. -+|||++++++++.+....|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            467899999999999999999984 568888889876651     122344444433 3799999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCCeEEEeeecccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL-DDNYTAKVADFASSVLIS  162 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv-~~~~~v~l~d~g~~~~~~  162 (309)
                      ||.+.|+-+.+.+......    ...+.+|+.+|+.|+.|||.+|   ++||||||+||++ +..++++|+|||.+....
T Consensus       395 ~e~l~g~ell~ri~~~~~~----~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEF----CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHhcchh----HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999998877766544332    2677889999999999999999   9999999999999 589999999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..     ....+-+..|.|||+..   |++++||||||++||+|++|+.||...... .++..++...+           
T Consensus       468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~-----------  530 (612)
T KOG0603|consen  468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPK-----------  530 (612)
T ss_pred             hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCc-----------
Confidence            32     22335577899999997   999999999999999999999997654222 12222222211           


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                              .....++.+++|+.+||+.||.+||++.++..+-.
T Consensus       531 --------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  531 --------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             --------cccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence                    11344567999999999999999999999987643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=243.26  Aligned_cols=267  Identities=25%  Similarity=0.347  Sum_probs=217.1

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEcCC------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL   75 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (309)
                      +|.....+++..-.+-+|.||.||.|.|.+      .+.|.+|.+...-+..--..+..|.-.+..+.|||++.+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            455566778888899999999999996543      45566777665544443456777778888889999999999874


Q ss_pred             -cCCccEEEEEcCCCCCHHHHHHhhcc-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           76 -ETKVPLLVYEFVPNGTLFQHVRYQSS-----QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        76 -~~~~~~iv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                       +..++++++.+.+-|+|..++.....     -...+..++..++.|++.||+|||+++   ++|.||..+|++|++.-.
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence             56788999999999999999984432     223355788899999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ||++|-.+++..-..+.............||+||.+.   |+.++|+||||+++|||++ |+.|+...+.++        
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------  506 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------  506 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence            9999999988776666666666666778899999998   9999999999999999998 999988764433        


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                                +...+.......-|.+||+.+..+|..||..+|++||++.|++.-|+++.....
T Consensus       507 ----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  507 ----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             ----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence                      233334444555677888999999999999999999999999999988876543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-35  Score=247.74  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc--h----hhhhHHHHHHHHHHHhhcCCCccceeeeeee-
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--D----KILINEVFQHKMRIISQINHKNVVKILGVCL-   75 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   75 (309)
                      +...++|-++.+||+|+|+.||++++ ...+-||+|+-...  .    +..-.+...+|+++-+.++||.||+++++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            44678899999999999999999994 45788888864322  1    1112234678899999999999999999996 


Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEE
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKV  152 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l  152 (309)
                      +.+.+|-|+|||+|.+|+-++.++...   +++++..|+.||+.||.||.... +||+|-||||.||++..   -|.+||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklm---SEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLM---SEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhh---hHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence            567889999999999999999876644   78999999999999999999997 77999999999999853   467999


Q ss_pred             Eeeeccccccccccc-----ccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh
Q 040698          153 ADFASSVLISSHDQT-----ATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM  220 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~  220 (309)
                      +|||++..+......     ....-..|+.+|+|||++.       ++.++|+||+||++|..+.|+.||+........+
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            999999887432222     1223456789999999996       6789999999999999999999998653222111


Q ss_pred             hhcccCccccccccchhhhhccc-ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ..             ..++... ..++.-+-.+.+...||++||+--.++|.+..++..+
T Consensus       695 -qe-------------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  695 -QE-------------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             -hh-------------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence             00             0111111 1122222334668999999999999999999888653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=217.41  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=199.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+|.-.+.||+|.||+||++++ .+++.||+|.++..+ .........+|+-+++.++|.|||+++++...++.+-+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            4678889999999999999995 458999999876653 23334566889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ||. ..|..+....+.  ..+.+....++.|+++|+.|+|+++   +.|||++|.|.+|+.+|++|++|||+++-..-  
T Consensus        82 ~cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--  153 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--  153 (292)
T ss_pred             Hhh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--
Confidence            995 577777765544  3466788899999999999999999   99999999999999999999999999865421  


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcc-cCccccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV-PYFPYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  239 (309)
                      ...-.....-+..|+||.++.    |+...|+||-||++.|+.. |.+.|+..+...+-..... -..+.......+..+
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            111122345578899999986    8999999999999999988 6666765543332211111 111223333344444


Q ss_pred             hcccccCccch---------HHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEM---------EEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+.+.....+.         .....-++++++.|.-+|..|.+++..+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            44443332221         112336789999999999999999998764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.8e-33  Score=233.74  Aligned_cols=216  Identities=24%  Similarity=0.186  Sum_probs=167.3

Q ss_pred             cCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHHHHH
Q 040698           19 GGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR   97 (309)
Q Consensus        19 g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~   97 (309)
                      |.+|.||++.+ .+|+.+++|.+.....      ...+...+....|||++++++++.+.+..+++|||++|++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999995 5689999998765432      2233344445579999999999999999999999999999999886


Q ss_pred             hhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccccccccc
Q 040698           98 YQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV  177 (309)
Q Consensus        98 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~  177 (309)
                      ...   ..++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||.+......     .....++.
T Consensus        78 ~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          78 KFL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             Hhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence            543   2577889999999999999999999   999999999999999999999999976543221     11223456


Q ss_pred             ccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHH
Q 040698          178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIE  254 (309)
Q Consensus       178 ~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (309)
                      .|+|||...   ++.++|+||+|+++|+|++|..|+.......              .         .......+...++
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~---------~~~~~~~~~~~~~  203 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------N---------THTTLNIPEWVSE  203 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------c---------cccccCCcccCCH
Confidence            699999875   6778999999999999999998754221000              0         0000011122345


Q ss_pred             HHHHHHhHhhccCCCCCCCH
Q 040698          255 IVAKLASKCLRTSGTERPTM  274 (309)
Q Consensus       255 ~l~~li~~cl~~dp~~Rps~  274 (309)
                      .+.++|.+||+.||.+|||+
T Consensus       204 ~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCC
Confidence            69999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-33  Score=262.64  Aligned_cols=147  Identities=26%  Similarity=0.330  Sum_probs=129.6

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||.|+||.||+|.+. +++.||+|.+....  .......+..|+.++..++||||+++++++...+..++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            478999999999999999999964 68999999876432  223345678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      |||+.|++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999886543   3467888999999999999999999   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=242.00  Aligned_cols=272  Identities=27%  Similarity=0.402  Sum_probs=199.3

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHh--hcCCCccceeeeeeecCC----ccE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS--QINHKNVVKILGVCLETK----VPL   81 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~----~~~   81 (309)
                      .+-++.+.+|+|.||.||+|.. +++.||+|+.....    .+.|..|.++..  .++|+||+++++.-....    .++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            4567788999999999999998 45999999887654    455777777766  458999999998876554    789


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL------GSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                      +|++|.+.|||.++|..+-    .++....+++..+++||+|||+.      .-++|+|||||.+||||..|++..|+||
T Consensus       285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999997554    37899999999999999999962      1245999999999999999999999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc----cC-----CCcchhhHHHHHHHHHhCCCCC--chhhhcchhhhhcc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF----WT-----EKSDVYSFGVVLVELLTGKHPR--SYVALASNEMTRMV  224 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~-----~~~DiwslG~ll~~~~~g~~p~--~~~~~~~~~~~~~~  224 (309)
                      |++..+............+||.+|||||++.    ..     .+.||||+|.++|||++...-+  +.....+-..+..+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9998775444444445588999999999997    22     2579999999999999865443  11111111111111


Q ss_pred             cCccccccccchhhhhcccccCccc-----hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          225 PYFPYPIENNSLRQILNFQVADENE-----MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      +.-|  .....-.-.+..+.....+     -.....+++.+..||+.||+.|.|+.=+-+.+..+.-..+.
T Consensus       441 G~hP--t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  441 GNHP--TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             cCCC--CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            1111  1111111111112222111     13346699999999999999999999998888877765544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=248.06  Aligned_cols=244  Identities=20%  Similarity=0.268  Sum_probs=194.7

Q ss_pred             ceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           13 RHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      .+.||.|.||+||-|.+ ++|+.||+|.+..... ..-.+.++.|+.+|+++.||.||.+...|+..+..++|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            36899999999999995 5799999998765432 22246789999999999999999999999999999999999965 


Q ss_pred             CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeeccccccccccc
Q 040698           91 TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        91 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++.+.+.... .+.+++.....++.||+.||.|||-++   |+|.||||+||++.   +...||+||||.++.+.+.   
T Consensus       648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---  720 (888)
T KOG4236|consen  648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---  720 (888)
T ss_pred             hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence            5555543332 234577777888899999999999999   99999999999995   4567999999999988543   


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......+|++.|+|||++.   |++..|+||.|+++|--++|..||..-+.-+++    +...             ...+
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----IQNA-------------aFMy  783 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----IQNA-------------AFMY  783 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----hhcc-------------cccc
Confidence            3334568999999999998   899999999999999999999997743222111    1111             1123


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +...+.+.++...+||...|+..-.+|.|.++.+.+.
T Consensus       784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            3334455667799999999999999999999887764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=233.50  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=193.5

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHH-hhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRII-SQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.+-++.||+|+||.|++-.+ ++|...|+|.++.........++..|.+.. +.-++||||+++|....+...||.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3455677899999999999885 569999999987766655667778887654 45579999999999999999999999


Q ss_pred             cCCCCCHHHHHHhh--ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           86 FVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        86 ~~~~~sL~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      .+ ..||+.+...-  ..+..++++.+-.+..-.+.||.||...-.  ++|||+||+||+++..|.||+||||++.... 
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv-  219 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV-  219 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH-
Confidence            99 47887765422  223345777788888888999999987632  9999999999999999999999999986652 


Q ss_pred             ccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                        .....+...|-..|+|||.+.     |.-++|+||||+++||+.+|..|+.....--+++......-+ +....    
T Consensus       220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp-p~l~~----  292 (361)
T KOG1006|consen  220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP-PILLF----  292 (361)
T ss_pred             --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC-CeecC----
Confidence              222333445666799999997     666799999999999999999998766543333222221111 11111    


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             ...+...+..+..+|.-||.+|...||+..++.++
T Consensus       293 -------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 -------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                   11123345669999999999999999999999774

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-32  Score=229.03  Aligned_cols=235  Identities=29%  Similarity=0.346  Sum_probs=184.9

Q ss_pred             CceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHHHHHh
Q 040698           20 GFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRY   98 (309)
Q Consensus        20 ~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~   98 (309)
                      +||.||+|.+. +|+.+++|.............+..|+..++.++|+|++++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999965 48999999876654433256788999999999999999999999998999999999999999998875


Q ss_pred             hccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccc
Q 040698           99 QSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG  178 (309)
Q Consensus        99 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~  178 (309)
                      ...   .+...+..++.+++.++.+||+.+   ++|+||+|+||++++++.++++|||.+.......   ......+...
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            443   577889999999999999999999   9999999999999999999999999987653321   2234456778


Q ss_pred             cCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchH-HHH
Q 040698          179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEME-EIE  254 (309)
Q Consensus       179 ~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  254 (309)
                      |++||...   ++.++|+|++|++++++++|..||..............                ........... .+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~  215 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----------------KPKPPFPPPEWKISP  215 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------------ccCCCCccccccCCH
Confidence            99999875   77899999999999999999999764211111111111                00000000000 345


Q ss_pred             HHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          255 IVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       255 ~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      .+.+++.+||..+|.+||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            6999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-33  Score=245.22  Aligned_cols=198  Identities=24%  Similarity=0.345  Sum_probs=165.7

Q ss_pred             cccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698           10 YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILI--NEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      |..++.||-|+||.|-++... +...+|+|.++..+.-.-  ....+.|-++|...+.+.||+++..|++.+.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            667889999999999999843 477889998877643221  23467788999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc----
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS----  162 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~----  162 (309)
                      ++||++-.+|.+.+.   +++..+..++..+.+|+++.|+-|   ++||||||+|||||.+|+|||+|||+|.=..    
T Consensus       711 IPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             cCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999886654   477888889999999999999999   9999999999999999999999999984321    


Q ss_pred             -----ccc-------------------------------ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHH
Q 040698          163 -----SHD-------------------------------QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVEL  203 (309)
Q Consensus       163 -----~~~-------------------------------~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~  203 (309)
                           ..+                               ........+|++.|+|||++.   ++..+|+|+.||+||+|
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 000                               001112346899999999997   89999999999999999


Q ss_pred             HhCCCCCchh
Q 040698          204 LTGKHPRSYV  213 (309)
Q Consensus       204 ~~g~~p~~~~  213 (309)
                      +.|++||-..
T Consensus       865 ~~g~~pf~~~  874 (1034)
T KOG0608|consen  865 LVGQPPFLAD  874 (1034)
T ss_pred             hhCCCCccCC
Confidence            9999998654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-32  Score=255.17  Aligned_cols=261  Identities=19%  Similarity=0.231  Sum_probs=165.4

Q ss_pred             hhcccccceeecccCceEEEEEEcC-C----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeee------e
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-D----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV------C   74 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~   74 (309)
                      ..++|++.+.||+|+||.||+|... +    +..||+|.+.....   .+....+  .+....+.++......      .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999953 4    68999997654321   1111111  1222222222222111      2


Q ss_pred             ecCCccEEEEEcCCCCCHHHHHHhhcccc-----------------ccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040698           75 LETKVPLLVYEFVPNGTLFQHVRYQSSQV-----------------LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV  137 (309)
Q Consensus        75 ~~~~~~~iv~e~~~~~sL~~~l~~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl  137 (309)
                      ......++|+||+++++|.+++.......                 ......+..++.|++.||.|||+++   ++||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence            45667899999999999999886442110                 0122446679999999999999999   999999


Q ss_pred             CCCcEEEcC-CCCeEEEeeecccccccccccccccccccccccCCCcccc-------------------------cCCCc
Q 040698          138 KSANILLDD-NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-------------------------WTEKS  191 (309)
Q Consensus       138 ~~~nilv~~-~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-------------------------~~~~~  191 (309)
                      ||+||+++. ++.++|+|||++....... ........+++.|+|||.+.                         ++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 6799999999986542211 11223456788899999653                         23356


Q ss_pred             chhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccccc------CccchHHHHHHHHHHhHhhc
Q 040698          192 DVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA------DENEMEEIEIVAKLASKCLR  265 (309)
Q Consensus       192 DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~  265 (309)
                      ||||+||++|+|+++..|++.....-.........     ....+.........      ............+||.+||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY-----DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC-----cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999999776644221100000000000     00000000000000      00001112335689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 040698          266 TSGTERPTMRQVSEQ  280 (309)
Q Consensus       266 ~dp~~Rps~~~ll~~  280 (309)
                      .||.+|||+.++++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-34  Score=228.39  Aligned_cols=265  Identities=22%  Similarity=0.261  Sum_probs=194.8

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLE--------   76 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   76 (309)
                      .+.|+-...+|+|.||.||+++. ++|++|++|++... .+...-....+|+++|..++|+|++.+++++..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            46788889999999999999995 45888898865442 233334456889999999999999998887643        


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      ...+|+||++|+ .+|..++.....  .++..++..++.++..||.|+|.+.   ++|||+|+.|++|+.+|.++++|||
T Consensus        96 r~t~ylVf~~ce-hDLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCE-HDLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhh-hhHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            235789999995 578777764432  3467899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccc--cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh---hccc--
Q 040698          157 SSVLISSH--DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT---RMVP--  225 (309)
Q Consensus       157 ~~~~~~~~--~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~---~~~~--  225 (309)
                      +++.....  ......+.++-+..|++||.+.    |+.+.|+|.-||++.+|+++.+.+...+...+-..   .+..  
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99655332  2223345566788999999997    89999999999999999999988765433222111   0111  


Q ss_pred             --Cccccccccchhhh-------------hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          226 --YFPYPIENNSLRQI-------------LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       226 --~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                        -||..........+             .+...    +..-.+...+|+.++|..||.+|+++++++++.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k----p~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK----PYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcc----cccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence              12221111111111             11111    111124588999999999999999999998764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=233.86  Aligned_cols=240  Identities=24%  Similarity=0.271  Sum_probs=185.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhH--HHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILIN--EVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+|..+.+||.|+||.|.++.-+ +.+.+|||++....-.+..  +--..|-++|... +.|.+++++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457889999999999999999854 4789999977654221111  1123344555544 57899999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+.||+|--.+++-+..   -+..+.-++..|+-||-+||+++   |++|||+.+||+++.+|+|||+|||++...-
T Consensus       428 VMEyvnGGDLMyhiQQ~GkF---KEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKF---KEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhccc---CCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999998888766654   34667788999999999999999   9999999999999999999999999997642


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  ........+|++.|+|||.+.   |+.++|+|++|+++|||+.|++||+..+..+.                 ...+
T Consensus       502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-----------------F~aI  562 (683)
T KOG0696|consen  502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----------------FQAI  562 (683)
T ss_pred             c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------------HHHH
Confidence            2  234445678999999999997   78899999999999999999999875433221                 1111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCC
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPT  273 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  273 (309)
                      .+-.  ...|...+.+..++.+..|...|.+|..
T Consensus       563 ~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 MEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence            1111  1123345566889999999999999963

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=227.34  Aligned_cols=248  Identities=23%  Similarity=0.278  Sum_probs=190.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|.++++||+|+|..|-.+.. ++.+.+|+|+++....  .....-.+.|-.+..+. +||.+|.++.+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            457899999999999999999984 5688999997755421  11123355666666655 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|.||++||+|--.++++.   .++++.+..+...|+.||.|||+.|   +++||||.+|++++..|++|++|||++...
T Consensus       328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999977666443   4578888889999999999999999   999999999999999999999999999764


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  ........+|++.|.|||.+.   |....|+|+||+++++|+.|+.||+-....+.+..         .......-
T Consensus       402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n---------tedylfqv  470 (593)
T KOG0695|consen  402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN---------TEDYLFQV  470 (593)
T ss_pred             CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc---------hhHHHHHH
Confidence            22  233455678999999999998   89999999999999999999999986543322111         01111111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCC
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERP  272 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  272 (309)
                      ++......+.  ..+-....+++.-|++||++|.
T Consensus       471 ilekqiripr--slsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 ILEKQIRIPR--SLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             Hhhhcccccc--eeehhhHHHHHHhhcCCcHHhc
Confidence            2222222221  2223367889999999999985

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=242.12  Aligned_cols=249  Identities=24%  Similarity=0.266  Sum_probs=199.3

Q ss_pred             hcccccceeecccCceEEEEEEcCCCc-EEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~-~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..+++++..||.|+||.|-++..++.. .+|+|++....  ...-.+.+..|-.+|...+.|+||+++..|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            457788899999999999999865433 48888765542  233355678888999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||-|-||.|++.++..+..   +..+..-++.-++.|++|||.++   +++|||||+|++++.+|-+|+.|||.+..+. 
T Consensus       499 mEaClGGElWTiLrdRg~F---dd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-  571 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSF---DDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-  571 (732)
T ss_pred             HHhhcCchhhhhhhhcCCc---ccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence            9999999999999877654   55777788889999999999999   9999999999999999999999999998763 


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                        ........+|++.|.|||.+.   -..++|.|+||+++||+++|.+||+..+.-                 .....++
T Consensus       572 --~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----------------ktYn~IL  632 (732)
T KOG0614|consen  572 --SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----------------KTYNLIL  632 (732)
T ss_pred             --cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----------------HHHHHHH
Confidence              344556789999999999998   677899999999999999999998765321                 1111222


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQL  281 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~l  281 (309)
                      ..-.....|...+....+||++....+|.+|..     +.++.+|.
T Consensus       633 kGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  633 KGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            222222333444455899999999999999985     55665553

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=4.3e-31  Score=239.07  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=176.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-----------------CCCcEEEEEecccchhhhh-------------HHHHHHH
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-----------------PDNTLVAVKKPKMVDKILI-------------NEVFQHK   55 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-----------------~~~~~v~ik~~~~~~~~~~-------------~~~~~~e   55 (309)
                      ..++|++.++||+|+||.||+|..                 ..++.||+|.+........             .+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357999999999999999999863                 2356899998764322111             1122335


Q ss_pred             HHHHhhcCCCcc-----ceeeeeeec--------CCccEEEEEcCCCCCHHHHHHhhcc---------------------
Q 040698           56 MRIISQINHKNV-----VKILGVCLE--------TKVPLLVYEFVPNGTLFQHVRYQSS---------------------  101 (309)
Q Consensus        56 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~~---------------------  101 (309)
                      +..+.+++|.++     +++++++..        ....++||||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            556666655543     556666542        3467999999999999998864211                     


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCC
Q 040698          102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD  181 (309)
Q Consensus       102 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~  181 (309)
                      ....++..+..++.|++.++.|||+.+   ++||||+|+||+++.++.++|+|||++....... .........++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence            112245678889999999999999999   9999999999999999999999999986542211 111112234678999


Q ss_pred             Cccccc-------------------------CCCcchhhHHHHHHHHHhCCC-CCchhhhcchhhhhcccCccccccccc
Q 040698          182 PEYLFW-------------------------TEKSDVYSFGVVLVELLTGKH-PRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       182 PE~~~~-------------------------~~~~DiwslG~ll~~~~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ||.+..                         ..+.|+||+||++++|++|.. |+........+.......      ...
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~------~~~  452 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND------LNR  452 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch------HHH
Confidence            998741                         124699999999999999875 665332222111110000      000


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCC---CCCCCHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSG---TERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~ll~~  280 (309)
                      .................++...+|+.+||..+|   .+|+|+.++++|
T Consensus       453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            001111111222233345679999999999876   689999999886

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=2.7e-32  Score=213.60  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=185.8

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeec--CCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLE--TKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~i   82 (309)
                      .++|++.+.+|+|-|+.||.|. ..+++++++|.+.+..+    +.+.+|+++|..+. ||||++++++..+  ...+.+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4789999999999999999998 45789999999887654    45789999999997 9999999999876  467889


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~~~  161 (309)
                      ||||+++.+...+...      ++.-.+..++++++.||.|+|+.|   +.|||+||.|++|+ ....++++|||++..+
T Consensus       113 iFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999999887665542      244668889999999999999999   99999999999998 4567999999999776


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccC--------
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPY--------  226 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~--------  226 (309)
                      -   .....+-++.+--|--||.+.    |..+.|+|||||++..|+..+.||=.-....+++...   ...        
T Consensus       184 H---p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 H---PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             C---CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            1   122222333444466899987    8889999999999999999888863211111111110   000        


Q ss_pred             -----cccc-------ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 -----FPYP-------IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 -----~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ++..       .....+....+.....    -.++++.+|+.+.|.-|..+|+|+.+...|
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                 0000       0000111111111111    112568899999999999999999998653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.1e-31  Score=231.93  Aligned_cols=266  Identities=20%  Similarity=0.248  Sum_probs=202.4

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC------CCccceeeeeeecC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN------HKNVVKILGVCLET   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~   77 (309)
                      ....+|++....|.|-|++|-.|.+ +.|..||||++.+..  .+...=..|+.+|+.|+      --|+++++..|...
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3567999999999999999999985 448899999987753  34555678889999885      23889999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeee
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFA  156 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g  156 (309)
                      +++|+|||-+ ..+|.+++..-+....+...++..++.|++.||..|-+.+   ++|.||+|+||||++ ...+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999999 5799999998888888888999999999999999999999   999999999999985 4568999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh--hhhcccCccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE--MTRMVPYFPYPI  231 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~~  231 (309)
                      .+....    ....+.+.-+-.|.|||.+.   |....|+||.||+||++.+|+.-|+..++..--  ...+...+|...
T Consensus       583 SA~~~~----eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFAS----ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccc----cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            986542    23334455567799999997   899999999999999999999998876543211  111111111110


Q ss_pred             c--ccchhh------------------------hhcccc-------------cCccchHHHHHHHHHHhHhhccCCCCCC
Q 040698          232 E--NNSLRQ------------------------ILNFQV-------------ADENEMEEIEIVAKLASKCLRTSGTERP  272 (309)
Q Consensus       232 ~--~~~~~~------------------------~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rp  272 (309)
                      .  .....+                        +.+.++             ...........+.+|+.+||..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            0  000000                        000000             1111223335689999999999999999


Q ss_pred             CHHHHHHH
Q 040698          273 TMRQVSEQ  280 (309)
Q Consensus       273 s~~~ll~~  280 (309)
                      |..++|.|
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=204.87  Aligned_cols=209  Identities=23%  Similarity=0.304  Sum_probs=169.6

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhh-cCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ-INHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +.++...-+..||+|++|.|-+-++ .+|...|+|.+......+..+.+..++++..+ ..+|++|+++|....+...+|
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            3455566678899999999988884 57999999998887666667778888876654 479999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      .||.+ ..||+.+..+- ......++..+-.++..++.||.|||++-+  ++|||+||+|||++.+|.||+||||++...
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceee
Confidence            99999 57888776533 233455788899999999999999998743  999999999999999999999999998665


Q ss_pred             ccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE  219 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~  219 (309)
                      ..   ....+...|...|+|||.+.       |+-++||||||+.+.||.+++.||+....+.+.
T Consensus       200 ~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q  261 (282)
T KOG0984|consen  200 VD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ  261 (282)
T ss_pred             hh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence            22   22223345566799999886       788999999999999999999998866544433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3e-29  Score=204.40  Aligned_cols=208  Identities=36%  Similarity=0.539  Sum_probs=176.2

Q ss_pred             ecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHH
Q 040698           16 LGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQ   94 (309)
Q Consensus        16 lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~   94 (309)
                      ||.|.+|.||++... +|+.+++|...........+.+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999964 4899999988766543235678999999999999999999999999899999999999999999


Q ss_pred             HHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeeeccccccccccccccccc
Q 040698           95 HVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFASSVLISSHDQTATTTKE  173 (309)
Q Consensus        95 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~~~~~~~~~~~~~~~  173 (309)
                      ++....  ...+...+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++++|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            987543  23477889999999999999999999   999999999999998 89999999998865422211  12334


Q ss_pred             ccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          174 IETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       174 ~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      .+...|++||...    .+.++|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            4567799999875    45789999999999999                                              


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          ..+.+++.+|++.||.+||++.+++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                128999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-31  Score=237.65  Aligned_cols=241  Identities=25%  Similarity=0.352  Sum_probs=178.3

Q ss_pred             ceeecccCceE-EEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEcCCCC
Q 040698           13 RHLLGEGGFGF-VYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        13 ~~~lg~g~~g~-v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      .+.+|.|+.|+ ||+|.. +|+.||+|++-..    ......+|+..|+.- +|||||++++.-.+....||..|.| ..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            45678888864 588887 6889999976543    234567889888866 6999999999999999999999999 57


Q ss_pred             CHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---C--CCeEEEeeecccccccc
Q 040698           91 TLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---N--YTAKVADFASSVLISSH  164 (309)
Q Consensus        91 sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~--~~v~l~d~g~~~~~~~~  164 (309)
                      +|.+++..... .........+.++.|++.|+++||+.+   ++||||+|.||+|+.   +  ..++|+|||++......
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            99999987411 111111345778899999999999999   999999999999964   3  46899999999776432


Q ss_pred             -cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          165 -DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       165 -~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                       ..........|+.+|+|||.+.   .+.++||+||||++|+.++| ..||+..-.-+..+.  .       ....+..+
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--~-------~~~~L~~L  735 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--T-------GNYTLVHL  735 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--c-------Cccceeee
Confidence             2222344567899999999998   56689999999999998884 899885522111100  0       00000000


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .       ...++  ...+||.+|++.+|..||++.+|+.|
T Consensus       736 ~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 E-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             c-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0       01111  58999999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=215.43  Aligned_cols=131  Identities=27%  Similarity=0.418  Sum_probs=111.7

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-----C---Cccceeeeeeec-
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-----H---KNVVKILGVCLE-   76 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~-   76 (309)
                      .++|.+.++||-|.|++||++.+ .+.+.||+|+.+...-  -.+....|+++|++++     +   .+||++++.|.. 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            37899999999999999999985 4578999998876543  2456788999999883     3   479999999864 


Q ss_pred             ---CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEE
Q 040698           77 ---TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILL  144 (309)
Q Consensus        77 ---~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv  144 (309)
                         +.++|+|+|++ |.+|..++....-++ ++...+.+|++|++.||.|||.. +   ++|.||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecg---IIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECG---IIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcC---ccccCCCcceeee
Confidence               57889999999 789999998776654 47899999999999999999975 6   9999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=231.19  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...+|+++..+|.|.||.||++++ .+++..|+|+++..-... .+.+++|+-+++..+||||+.+++.+...+.+||.|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            457899999999999999999995 568999999876653332 456788899999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||.||+|.+...   ....+.+.++..++...+++++|||+.+   -+|||+|-.||++++.|.|++.|||.+..+...
T Consensus        92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999987654   2335577899999999999999999999   999999999999999999999999998766432


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-cccccccchh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-PYPIENNSLR  237 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (309)
                        ........|++.|+|||+-.      |...+|+|++|+...++-.-++|.-.. ...+.+..+.+.. ..+.      
T Consensus       166 --i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr~l~LmTkS~~qpp~------  236 (829)
T KOG0576|consen  166 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMRALFLMTKSGFQPPT------  236 (829)
T ss_pred             --hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHHHHHHhhccCCCCCc------
Confidence              22233467899999999885      899999999999999998877772110 1111111111111 1110      


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              .......++.+-+|++.||..+|++|||++.++.|
T Consensus       237 --------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  237 --------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             --------ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                    11122344669999999999999999999988764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=203.22  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=182.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeee-eecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGV-CLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~   81 (309)
                      ...+.|.|.+.||+|.||.+-++.++ ++..+++|.+......  .+.|.+|...=-.+ .|.||+.-+++ |+..+..+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            35688999999999999999999975 4788899987665443  45677776433233 58899988775 56667888


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEEeeeccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD--DNYTAKVADFASSV  159 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~--~~~~v~l~d~g~~~  159 (309)
                      +++||++.|+|.+-+...+    +-+.....++.|+++|+.|||+++   ++|||||.+||||.  +..+||+||||...
T Consensus        99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999987775433    345667889999999999999999   99999999999993  55689999999875


Q ss_pred             ccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ..     .......-....|.+||...        ..+.+|+|.||+++|..++|+.||.....-...+.....+.....
T Consensus       172 k~-----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  172 KV-----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             cc-----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence            43     11222223345588888775        567899999999999999999999855444444443333333222


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      .          +. .......++.+..+.++-|..++++|--+.++.+
T Consensus       247 ~----------~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  247 P----------AL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             c----------cC-chhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            1          11 1111223355889999999999999955444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-27  Score=197.30  Aligned_cols=197  Identities=36%  Similarity=0.484  Sum_probs=166.2

Q ss_pred             cccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      |.+.+.||.|++|.||++...+ ++.+++|...........+.+..|+..++.++|+|++++++++...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999654 899999987764332235678889999999999999999999998899999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      +++|.+++......  .++..+..++.+++.++.+||+.+   ++|+|+++.||+++.++.++++|||.+....... ..
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence            99999998755431  477889999999999999999999   9999999999999999999999999887653321 01


Q ss_pred             cccccccccccCCCccc-c---cCCCcchhhHHHHHHHHHhCCCCCch
Q 040698          169 TTTKEIETVGWLDPEYL-F---WTEKSDVYSFGVVLVELLTGKHPRSY  212 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~-~---~~~~~DiwslG~ll~~~~~g~~p~~~  212 (309)
                      ......+...|++||.. .   ++.++|+|+||+++++|++|..||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334566779999987 3   66799999999999999999999865

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-29  Score=219.56  Aligned_cols=195  Identities=24%  Similarity=0.389  Sum_probs=165.0

Q ss_pred             HhhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhH--------HHHHHHHHHHhhcC---CCccceeee
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILIN--------EVFQHKMRIISQIN---HKNVVKILG   72 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~iv~~~~   72 (309)
                      +...+|...+.+|.|+||.|+.|.++. ...|++|.+....- ...        -..-.|+.+|..++   |+||+++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRI-L~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERI-LVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhh-hhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            344579999999999999999999654 67888887655321 000        12455888999887   999999999


Q ss_pred             eeecCCccEEEEEcCC-CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 040698           73 VCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        73 ~~~~~~~~~iv~e~~~-~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      +|++++.+||+||... |.+|++++..+...   .+.+...|+.|++.|+++||+.+   |+|||||-+|++++.+|.+|
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m---~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRM---DEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhhccCcc---chHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence            9999999999999754 56889999876654   77888999999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCC
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPR  210 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~  210 (309)
                      ++|||.+.+.    ...+....+|+..|.|||++.    .....|||+||+++|.++....||
T Consensus       711 lidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  711 LIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             Eeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9999998765    556677789999999999997    566789999999999999888775

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=207.55  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=185.8

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----CccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLET-----KVPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   81 (309)
                      +.+=-+.||-|.||.||.+.+ ++|+.|++|++.+. .+-...+.+.+|+++|+.++|.|++..+++.+-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344567899999999999985 57999999976553 3344467789999999999999999988876543     2456


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +++|.+ ..+|...+-..   ..++...+.-+++||++||.|||+.+   |.||||||.|.+++++..+||||||+++.-
T Consensus       134 V~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            777877 45665555322   23355677888999999999999999   999999999999999999999999999764


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-ccccc-----
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-FPYPI-----  231 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-----  231 (309)
                      . .+.....+..+-+-.|+|||.+.    |+.+.||||.||++.|++..+..|.....-  +...++.. +-.+.     
T Consensus       207 e-~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  207 D-QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             c-hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHH
Confidence            2 23333444455567799999987    999999999999999999877766433211  11111111 11111     


Q ss_pred             -cccchhhhh-ccc-ccC--------ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          232 -ENNSLRQIL-NFQ-VAD--------ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       232 -~~~~~~~~~-~~~-~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ..+..+..+ ... ...        ..+.........+++.++..||.+|.+..+.+.++
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence             001111100 000 000        11223335578899999999999999999988775

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=204.41  Aligned_cols=262  Identities=22%  Similarity=0.246  Sum_probs=183.6

Q ss_pred             hcccccceeecccCceEEEEEE-cCCCcEEEEEeccc-chhhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKNVVKILGVCLE------TK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~   78 (309)
                      ..+|.-++.+|.|.- .|--+. .-.++.|++|.+.. .......++..+|..++..++|+|+++++.+|.-      ..
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777788888887 343343 33578899886532 2333445677889999999999999999999853      34


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..|+|||++. .+|...+....     +-..+..+++|+++|++|||+.+   ++||||||+||++..+..+||.|||++
T Consensus        95 e~y~v~e~m~-~nl~~vi~~el-----DH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILMEL-----DHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHHhc-----chHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            5689999994 68887776222     34678899999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhc---chhhhhcccCc-----
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALA---SNEMTRMVPYF-----  227 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~---~~~~~~~~~~~-----  227 (309)
                      ..-   +..-..+....+-.|.|||++.   +.+.+||||+||++.+|+.|..-|...+.-   ...........     
T Consensus       166 r~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  166 RTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             ccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            643   2223455666777899999997   889999999999999999998887633211   11111111000     


Q ss_pred             -------------cccccccchhhhhcc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 -------------PYPIENNSLRQILNF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 -------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                   +........+...+.  ....+.+.--...+++++.+||..||++|.|+.+++.|-
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                         000000000000000  000111112235589999999999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2.3e-27  Score=200.89  Aligned_cols=267  Identities=20%  Similarity=0.283  Sum_probs=194.7

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeec
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLE   76 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   76 (309)
                      +++...+.|.++.++|.|.|+.||++...    ..+.|++|.+.....+   +.+..|++.|..+. +.||+++.+++..
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            46778899999999999999999999842    4789999988776554   35788999999885 7899999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADF  155 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~  155 (309)
                      ++..++|+||++.....++....      +...+..+++.++.||.++|++|   |+|||+||.|++.+ ..+.-.|+||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~l------~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRSL------SLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhcC------CHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence            99999999999998888877633      45778899999999999999999   99999999999997 4566799999


Q ss_pred             eccccccccc------c-------c---------------cc--------------ccccccccccCCCcccc----cCC
Q 040698          156 ASSVLISSHD------Q-------T---------------AT--------------TTKEIETVGWLDPEYLF----WTE  189 (309)
Q Consensus       156 g~~~~~~~~~------~-------~---------------~~--------------~~~~~~~~~~~~PE~~~----~~~  189 (309)
                      |++.......      .       .               .+              .-.+.|+++|+|||++.    -+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9986220000      0       0               00              01245799999999997    577


Q ss_pred             CcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc----------------c--Cccc---ccc---ccch-----hhhh
Q 040698          190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV----------------P--YFPY---PIE---NNSL-----RQIL  240 (309)
Q Consensus       190 ~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~----------------~--~~~~---~~~---~~~~-----~~~~  240 (309)
                      +.||||-|+++.-++++..||-.....-.-+....                .  .+..   +..   ....     ..+.
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            89999999999999999999754332211111110                0  0000   000   0000     0111


Q ss_pred             c-cc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 N-FQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~-~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      . ..   .........+..+.+|+.+|+..||.+|.|++++|+|
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            1 00   0011122333469999999999999999999999886

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-27  Score=189.40  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=188.0

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      ...+..+|.....|..|+|+|..+ .++.|++.... .......|..|...|+-+.||||+.+++.+.....+.+|.-|+
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            445667888999999999999544 45556655443 3444567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE--eeeccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA--DFASSVLISSHD  165 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~--d~g~~~~~~~~~  165 (309)
                      +.+||...+....+- ..+-.++.+++.++++||+|||+.. +-+.--.|+..+++|+++.+.+|.  |-..+.      
T Consensus       270 p~gslynvlhe~t~v-vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------  341 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------  341 (448)
T ss_pred             cchHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee------
Confidence            999999988755443 3355788899999999999999986 334445789999999999887775  322211      


Q ss_pred             ccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                         ....+...+.|++||.++      .-+++|+|||++++||+.+...||+....-+...-                 +
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----------------i  401 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----------------I  401 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------------h
Confidence               112234478899999997      45679999999999999999999886532221110                 1


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      --.......+++.+.-+..|+.-|++.||.+||.++.++-.|++|+
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            1111122234455567999999999999999999999999998875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.3e-26  Score=221.49  Aligned_cols=194  Identities=18%  Similarity=0.202  Sum_probs=132.6

Q ss_pred             cCC-Cccceeeeee-------ecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 040698           62 INH-KNVVKILGVC-------LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII  133 (309)
Q Consensus        62 l~h-~~iv~~~~~~-------~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~  133 (309)
                      ++| +||+.+++++       .+...++.++||+ +++|.+++....  ..++...+..++.||+.||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            445 5777788877       2334667888988 569999996432  33577899999999999999999999   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEE-------------------eeecccccccccc--------------cccccccccccccC
Q 040698          134 HGDVKSANILLDDNYTAKVA-------------------DFASSVLISSHDQ--------------TATTTKEIETVGWL  180 (309)
Q Consensus       134 h~dl~~~nilv~~~~~v~l~-------------------d~g~~~~~~~~~~--------------~~~~~~~~~~~~~~  180 (309)
                      ||||||+|||++..+.++++                   |||++........              ........+++.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999665555555                   4444432110000              00001134677799


Q ss_pred             CCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHH
Q 040698          181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVA  257 (309)
Q Consensus       181 ~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  257 (309)
                      |||++.   ++.++|||||||++|||++|.+|+............  ...+                  +..........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~~~~  242 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--RVLP------------------PQILLNWPKEA  242 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--hhcC------------------hhhhhcCHHHH
Confidence            999986   889999999999999999998886532211100000  0000                  00001113356


Q ss_pred             HHHhHhhccCCCCCCCHHHHHHHH
Q 040698          258 KLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       258 ~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .++.+||+.||.+|||+.+++++-
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhch
Confidence            889999999999999999998764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-25  Score=182.15  Aligned_cols=257  Identities=18%  Similarity=0.224  Sum_probs=201.7

Q ss_pred             cccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      -.|+++++||+|+||+++.|. .-+++.||||.-.....   +..+..|+...+.+. .++|..++-+.+.+.+..+|+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            479999999999999999999 45799999996544322   557888888888775 6899999999999888899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CCeEEEeeecccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-----YTAKVADFASSVL  160 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-----~~v~l~d~g~~~~  160 (309)
                      .+ |-||.++..-.+..  ++.++++.++.|++.-++++|++.   +++|||||+|+||...     ..|.++|||++..
T Consensus       105 LL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99 88999988766654  478999999999999999999999   9999999999999643     3589999999988


Q ss_pred             ccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          161 ISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       161 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      +......     .......|+.+||+-.+..   -++..|+-+||.++++.+.|..||.........             
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-------------  245 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-------------  245 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-------------
Confidence            7433222     2223456899999987776   678899999999999999999998765333211             


Q ss_pred             ccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          233 NNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       233 ~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                       ...+.+-+.+   ...+.+.+.|..+...+...-..+=.+-|+.+-+...+.++.+-
T Consensus       246 -~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  246 -EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             -HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence             1112222222   22234556777889999998888888999999998888776643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=3.8e-25  Score=176.07  Aligned_cols=166  Identities=20%  Similarity=0.162  Sum_probs=120.6

Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      |+|.+++....  ..+++..++.++.|++.||.|||+++         ||+||+++.++.+++  ||.+......     
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            57888887543  24588999999999999999999975         999999999999999  9988654221     


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                        ...+++.|+|||.+.   ++.++||||||+++|+|++|..||......................           ...
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~  129 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP-----------RDR  129 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----------ccc
Confidence              125678899999986   7889999999999999999999986432222111111110000000           000


Q ss_pred             ccchHHHH--HHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          247 ENEMEEIE--IVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       247 ~~~~~~~~--~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ........  .+.+++.+||+.||.+|||+.++++++..+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            01122222  59999999999999999999999999876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2e-24  Score=187.97  Aligned_cols=167  Identities=20%  Similarity=0.221  Sum_probs=128.2

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC--CCcEEEEEecccc----hhhhhHHHHHHHHHHHhhcCCCccce-eeeeee
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP--DNTLVAVKKPKMV----DKILINEVFQHKMRIISQINHKNVVK-ILGVCL   75 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~   75 (309)
                      .+...++|++.+.||+|+||.||+|.++  +++.+|+|.+...    ......+.+.+|+.+|++++|+|++. ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            4567889999999999999999999854  5778899975432    12334567899999999999999985 4432  


Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCCeEEEe
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV-KSANILLDDNYTAKVAD  154 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl-~~~nilv~~~~~v~l~d  154 (309)
                        +..++||||++|++|.. ..   ..   .   ...++.+++.++.|||+.+   ++|||| ||+||+++.++.++|+|
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-AR---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hC---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence              45799999999999862 11   11   1   1457789999999999999   999999 99999999899999999


Q ss_pred             eeccccccccccccc------ccccccccccCCCcccc
Q 040698          155 FASSVLISSHDQTAT------TTKEIETVGWLDPEYLF  186 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~------~~~~~~~~~~~~PE~~~  186 (309)
                      ||++...........      .....++..|.+||.+.
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999976633211111      12345677789999886

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=9.6e-24  Score=183.74  Aligned_cols=258  Identities=21%  Similarity=0.223  Sum_probs=190.2

Q ss_pred             ccccceeecccCceEEEEEEcCC--CcEEEEEecccchhhhhHHHHHHHHHHHhhcC----CCccceeeeee-ecCCccE
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPD--NTLVAVKKPKMVDKILINEVFQHKMRIISQIN----HKNVVKILGVC-LETKVPL   81 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~   81 (309)
                      +|.+.+.||.|+||.||.+...+  ...+|+|........... .+..|..++..+.    .+++..+++.+ ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            89999999999999999999654  357888876654333222 5677777777776    36899999999 5778889


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CCeEEEeee
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-----YTAKVADFA  156 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-----~~v~l~d~g  156 (309)
                      |||+.+ |.+|.++..... ...++..+...++.|++.+|.++|+.|   ++|||+||.|+++...     ..+.+.|||
T Consensus        98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            999999 889999886665 445577999999999999999999999   9999999999999744     469999999


Q ss_pred             ccc--cccccccc-----cc-ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          157 SSV--LISSHDQT-----AT-TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       157 ~~~--~~~~~~~~-----~~-~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      +++  .+......     .. ....+|+..|+++.+..   .+++.|+||++.++.++..|..||...........    
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~----  248 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK----  248 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH----
Confidence            998  33222111     11 23455899999999887   78899999999999999999999865432211100    


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                                .................+..+.++...+-..+...+|....+...+.....
T Consensus       249 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  249 ----------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             ----------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence                      000000000000112233457778777888999999999999998765543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1e-23  Score=166.83  Aligned_cols=260  Identities=19%  Similarity=0.212  Sum_probs=197.5

Q ss_pred             hhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-KNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~iv   83 (309)
                      -.++|.+++.||+|+||.+|.|. ..+|+.||+|.-...-.   ...+..|..+.+.+++ ..|..+..++.+.+.-++|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            35789999999999999999999 46799999997654322   3456777788887764 6788888888888899999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~g~~~~  160 (309)
                      ||.+ |-||.++.+.....  .+.++.+.++-|++.-++|+|.++   ++||||||+|++..-   -..+.++|||++..
T Consensus        90 MdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            9999 88999988766543  377889999999999999999999   999999999999853   34689999999977


Q ss_pred             cccc-----cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          161 ISSH-----DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       161 ~~~~-----~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      +...     ..........|+..|.+-....   -++..|+-|+|.++.++-.|..||.........             
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-------------  230 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-------------  230 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-------------
Confidence            6322     1122233456788888766554   678899999999999999999998765433211             


Q ss_pred             ccchhhhhccccc---CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          233 NNSLRQILNFQVA---DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       233 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                       ...+.+...+..   ...|.+.|.++.-.+..|-..-=++-|+..-+.+.+..+....
T Consensus       231 -QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  231 -QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             -HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence             111222222211   1235566677889999999998899999999888887665443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=5.4e-24  Score=196.91  Aligned_cols=252  Identities=22%  Similarity=0.255  Sum_probs=178.3

Q ss_pred             ccceeecccCceEEEEEEc-CCCcEEEEEecc----cchhh-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698           11 DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPK----MVDKI-LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~----~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .....+|.|.+|.++.... ...+.+..|...    ..... .....+-.|+-+-..+.|||++.......+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999997777662 334444444322    11111 11111444555556678999988888877766666669


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||++ +|..++...   .......+--++.|++.|++|+|..|   +.|||++++|++++.+|.++|+|||.+....-.
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99998 998888754   23355677888999999999999999   999999999999999999999999998765433


Q ss_pred             ccc--ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQT--ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~--~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...  .......|+..|+|||++.    -.+..||||.|+++..|..|+.||-......+..          .......+
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~~~~~~~  543 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KTNNYSDQ  543 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hhhccccc
Confidence            332  4445667888899999997    4567899999999999999999987665444321          00000011


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      ..............+...+.+|.+||+.||++|.|+.++++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11111111122344566899999999999999999999976

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.4e-22  Score=164.60  Aligned_cols=172  Identities=12%  Similarity=0.128  Sum_probs=128.0

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchh--hhhHH------HHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK--ILINE------VFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~--~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||.|+||.||+... ++..+|+|.+.....  ....+      .+.+|+..+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999766 577899998865432  11111      267888899999999999999886643


Q ss_pred             --------CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           78 --------KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        78 --------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                              ...+++|||++|.+|.++..       .+.    ....+++.++..+|+.|   ++|||++|+||+++++| 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977632       122    23558999999999999   99999999999999988 


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccccCCCcchhhHHHHHHHHH
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELL  204 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~DiwslG~ll~~~~  204 (309)
                      ++++|||..................           .+..++|+|+||+.+....
T Consensus       173 i~liDfg~~~~~~e~~a~d~~vler-----------~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKDRIDLER-----------HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHHHHHHHh-----------HhcccccccceeEeehHHH
Confidence            9999999775432111110000000           0456899999999876554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.5e-22  Score=167.06  Aligned_cols=234  Identities=21%  Similarity=0.239  Sum_probs=143.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcC----------CCccceeee
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQIN----------HKNVVKILG   72 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~----------h~~iv~~~~   72 (309)
                      ...+....+.||.|.++.||.+++. +|+.+++|.......  ....+.+.+|.-....+.          |-.++..++
T Consensus        10 ~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   10 RPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             -EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             CceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            3456778889999999999999964 599999996533322  212334444442222221          223444444


Q ss_pred             eeec------------CC-----ccEEEEEcCCCCCHHHHHHhhc---cc-cccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 040698           73 VCLE------------TK-----VPLLVYEFVPNGTLFQHVRYQS---SQ-VLKTWKTCLRIAAETASALDYLHSLGSPP  131 (309)
Q Consensus        73 ~~~~------------~~-----~~~iv~e~~~~~sL~~~l~~~~---~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  131 (309)
                      ...-            .+     +.+++|+-. .++|.+++....   .. ..........+..|+++.+++||..|   
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---  165 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---  165 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---
Confidence            3321            11     225677777 568887765321   11 11233445566689999999999999   


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc-----------cCCCcchhhHHHHH
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----------WTEKSDVYSFGVVL  200 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----------~~~~~DiwslG~ll  200 (309)
                      ++|+||+|+|++++++|.+.++||+........     ......+..|.|||...           ++.+.|.|+||+++
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l  240 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL  240 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence            999999999999999999999999876543221     11122235588888652           57788999999999


Q ss_pred             HHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCC
Q 040698          201 VELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTER  271 (309)
Q Consensus       201 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  271 (309)
                      |.|++|..||+..........                       .+..|...++.++.||..+|+.||.+|
T Consensus       241 y~lWC~~lPf~~~~~~~~~~~-----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  241 YSLWCGRLPFGLSSPEADPEW-----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHSS-STCCCGGGSTSGG-----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHccCCCCCCCccccccc-----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999999999875432211100                       333455677889999999999999987

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=7.8e-21  Score=165.22  Aligned_cols=257  Identities=30%  Similarity=0.402  Sum_probs=190.7

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchhhh--hHHHHHHHHHHHhhcCCC-ccceeeeeeecCCccEEEEEc
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKIL--INEVFQHKMRIISQINHK-NVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      |++.+.||.|.||.||.+...  ..+++|.+.......  ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            788999999999999999976  778888776654433  366788899999999988 799999999777778999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSHD  165 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~~~~~  165 (309)
                      +.++++.+++................+..|++.++.++|+.+   ++|||++|+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966654432124477889999999999999999999   99999999999999888 79999999987543322


Q ss_pred             ccc----cccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhc--chhhhhcccCcccc-cc
Q 040698          166 QTA----TTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALA--SNEMTRMVPYFPYP-IE  232 (309)
Q Consensus       166 ~~~----~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~-~~  232 (309)
                      ...    ......++..|++||...      .....|+|++|+++++++.|..||......  .............. ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    345667889999999774      456789999999999999999996655321  01111000000000 00


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .         .............+.+++..|+..+|..|.+..+....
T Consensus       237 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 S---------PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c---------ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0         00000001222458999999999999999998887765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=6.6e-23  Score=191.51  Aligned_cols=247  Identities=20%  Similarity=0.223  Sum_probs=176.4

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHH--HhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRI--ISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +|...+.||.+.|=.|.++++..|. |++|+.-..+....-..+.+.+.-  ...+++||++.+..+.+.++.-|+|-.|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6888899999999999999998887 777865444321112223333222  4456899999999888888888999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc--ccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI--SSH  164 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~--~~~  164 (309)
                      + ..+|.+.+..   +.++..-+..=|+.|++.|+..+|+.|   ++|||||.+||+|+.=.=+.++||...+..  +..
T Consensus       103 v-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 V-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             H-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            9 4588877763   344555666667899999999999999   999999999999997777899999865332  222


Q ss_pred             ccccc---ccccccccccCCCcccc--------------cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccC
Q 040698          165 DQTAT---TTKEIETVGWLDPEYLF--------------WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       165 ~~~~~---~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      +....   ......-..|.|||.+.              .+++-||||+||++.|+++ |++||...+...      .+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a------Yr~  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA------YRS  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh------Hhc
Confidence            22111   11223344599999884              3557799999999999988 788887654332      011


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .........++.+.+            ..++++|..|++.||.+|.|+++.++.-
T Consensus       250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            111122222333333            2399999999999999999999998873

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2.5e-21  Score=155.32  Aligned_cols=141  Identities=16%  Similarity=0.151  Sum_probs=107.3

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhhh-------------------------hHHHHHHHHHHHhhcCCCc
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKIL-------------------------INEVFQHKMRIISQINHKN   66 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~-------------------------~~~~~~~e~~~l~~l~h~~   66 (309)
                      +.+.||+|++|.||+|...+|+.||+|.+.......                         .......|+..+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357899999999999998789999999876542110                         0122345889999998877


Q ss_pred             cceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEc
Q 040698           67 VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL-HSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        67 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~~~h~dl~~~nilv~  145 (309)
                      +.....+..  ...+|||||++|+++.......   ...+...+..++.|++.++.++ |+.+   ++|||+||+||+++
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            654443322  2238999999987765443222   2346788999999999999999 7999   99999999999998


Q ss_pred             CCCCeEEEeeeccccc
Q 040698          146 DNYTAKVADFASSVLI  161 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~~  161 (309)
                       ++.++++|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2.9e-20  Score=149.64  Aligned_cols=141  Identities=19%  Similarity=0.192  Sum_probs=109.1

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhh-------------------------hhHHHHHHHHHHHhhcCCCc
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI-------------------------LINEVFQHKMRIISQINHKN   66 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~~   66 (309)
                      +.+.||+|++|.||+|...+|+.||+|.+......                         .....+..|...+.++.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999999778999999987654210                         01223467888999999988


Q ss_pred             cceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEc
Q 040698           67 VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        67 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~  145 (309)
                      +.....+....  .++||||++|+++.......   ...+......++.|++.++.++|+ .|   ++|+||+|.||+++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            76555444332  48999999987554332211   233567888999999999999999 99   99999999999999


Q ss_pred             CCCCeEEEeeeccccc
Q 040698          146 DNYTAKVADFASSVLI  161 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~~  161 (309)
                       ++.++++|||++...
T Consensus       153 -~~~~~liDFG~a~~~  167 (190)
T cd05145         153 -DGKPYIIDVSQAVEL  167 (190)
T ss_pred             -CCCEEEEEcccceec
Confidence             889999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=7.1e-21  Score=169.00  Aligned_cols=215  Identities=23%  Similarity=0.377  Sum_probs=158.7

Q ss_pred             HhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040698           59 ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK  138 (309)
Q Consensus        59 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~  138 (309)
                      |+++.|.|+.++.+.+.++...++|.+||+.|+|.+.+.....  ..++.....++.+++.||.|+|...  ...|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4568899999999999999999999999999999999986332  3366778889999999999999976  24999999


Q ss_pred             CCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHhCCC
Q 040698          139 SANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLTGKH  208 (309)
Q Consensus       139 ~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~g~~  208 (309)
                      ..|++++..+.+|+.|||+.....................|.|||.+.          .+.+.|+||+|++++++++..-
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999986653211111222222355599999987          2556899999999999999999


Q ss_pred             CCchhhhcchh--hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          209 PRSYVALASNE--MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       209 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ||+........  ........          .....++.........+.+..++..||..+|..||++.++...++.+..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~----------~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKG----------GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHhc----------CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            98865333321  11111100          0000111111111333468999999999999999999999988877766


Q ss_pred             h
Q 040698          287 L  287 (309)
Q Consensus       287 ~  287 (309)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            4

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=9e-20  Score=145.24  Aligned_cols=182  Identities=15%  Similarity=0.108  Sum_probs=134.1

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchh---hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..+...|++|.||.|+.+.. .+.+++.+.+.....   ......+.+|+++|+++. ++++.+++++    +..+++|+
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            45678899999999997765 678888776554433   222335789999999995 5789999886    34689999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV-KSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl-~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |+.|.+|......         . -..++.|++.++.++|++|   ++|+|| +|.||+++.++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9999988643311         1 1346778999999999999   999999 799999999999999999999754322


Q ss_pred             ccc----cc-------ccccccccccCCCcccc----cC-CCcchhhHHHHHHHHHhCCCC
Q 040698          165 DQT----AT-------TTKEIETVGWLDPEYLF----WT-EKSDVYSFGVVLVELLTGKHP  209 (309)
Q Consensus       165 ~~~----~~-------~~~~~~~~~~~~PE~~~----~~-~~~DiwslG~ll~~~~~g~~p  209 (309)
                      ...    ..       ......++.+++|+...    .+ ...+.++.|.-+|.+++++.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~  206 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL  206 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence            110    00       11123466677777665    22 235777899999999999887

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=7.5e-20  Score=154.68  Aligned_cols=201  Identities=22%  Similarity=0.225  Sum_probs=141.1

Q ss_pred             CCCccceeeeeeec---------------------------CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHH
Q 040698           63 NHKNVVKILGVCLE---------------------------TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA  115 (309)
Q Consensus        63 ~h~~iv~~~~~~~~---------------------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~  115 (309)
                      +|||||++++.|.+                           ..++|+||..++ .+|..++-.+..    +....+-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~~----s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRHR----SYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCCC----chHHHHHHHH
Confidence            59999999876632                           345689998885 588888853332    3456677889


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCC--CeEEEeeecccccccccc----cccccccccccccCCCcccc-
Q 040698          116 ETASALDYLHSLGSPPIIHGDVKSANILL--DDNY--TAKVADFASSVLISSHDQ----TATTTKEIETVGWLDPEYLF-  186 (309)
Q Consensus       116 ~i~~~l~~lh~~~~~~~~h~dl~~~nilv--~~~~--~v~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~-  186 (309)
                      |+++|+.|||++|   +.|||+|.+||++  ++|+  .++++|||.+---....-    .....+..|...-+|||... 
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   9999999999998  4444  368899996632211111    11122344666789999886 


Q ss_pred             --------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHH
Q 040698          187 --------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAK  258 (309)
Q Consensus       187 --------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  258 (309)
                              .-.++|.|+.|.+.||++....||-....-.-+             .   .. .........+..+++.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------------~---r~-Yqe~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------------T---RT-YQESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-------------h---hh-hhhhhCCCCcccCChHHHH
Confidence                    345899999999999999999997643111100             0   00 0111112234456677999


Q ss_pred             HHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          259 LASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       259 li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ++...|+.||.+|+|+.-..+.|.-..+-.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~LsLw~~  518 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLNLSLWRM  518 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence            999999999999999998888886555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.5e-21  Score=171.42  Aligned_cols=232  Identities=25%  Similarity=0.254  Sum_probs=177.2

Q ss_pred             eecccCceEEEEEEc----CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEEcCC
Q 040698           15 LLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~   88 (309)
                      .+|.|.||.|+++..    ..|..+++|.+....- .........|..++...+ ||.+++++..++.+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998762    3477888886544321 111114455667777776 9999999999999999999999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA  168 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~  168 (309)
                      |+.|...+.....   ..+.....+...++.+++++|+.+   ++|+|+|++||+++.+|.+++.|||+.+..-.     
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~-----  149 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-----  149 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh-----
Confidence            9988776654433   244556667788999999999999   99999999999999999999999998865422     


Q ss_pred             cccccccccccCCCcccc-cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCc
Q 040698          169 TTTKEIETVGWLDPEYLF-WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE  247 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~-~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
                       ....+|+..|||||.+. ...++|.||+|++.++|++|..||..                     .....+.  +....
T Consensus       150 -~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~---------------------~~~~~Il--~~~~~  205 (612)
T KOG0603|consen  150 -EKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG---------------------DTMKRIL--KAELE  205 (612)
T ss_pred             -hhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch---------------------HHHHHHh--hhccC
Confidence             12228899999999999 88899999999999999999999764                     1111111  11223


Q ss_pred             cchHHHHHHHHHHhHhhccCCCCCCCH--HHHHHHH
Q 040698          248 NEMEEIEIVAKLASKCLRTSGTERPTM--RQVSEQL  281 (309)
Q Consensus       248 ~~~~~~~~l~~li~~cl~~dp~~Rps~--~~ll~~l  281 (309)
                      .+...+..+++++..++..+|.+|.-.  ..+.++.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            345566779999999999999999844  4555444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2e-19  Score=170.50  Aligned_cols=197  Identities=22%  Similarity=0.318  Sum_probs=152.5

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN---HKNVVKILGVCLETKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   79 (309)
                      +.+.++.|.|.+.+|.|+||.||+|...+|+.||+|.-.+...=...    --..++.+|+   -+.|..+...+.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            45678899999999999999999999878999999975544221100    0012222333   3556666666666778


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-------CCCCeEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-------DNYTAKV  152 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-------~~~~v~l  152 (309)
                      .++|++|.+.|+|.++++   ..+..++.....++.|++..+..||..+   |+||||||+|+++.       +...++|
T Consensus       769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            899999999999999998   3334477889999999999999999999   99999999999993       3446899


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCC
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP  209 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p  209 (309)
                      +|||.+..+............+++-.+-.+|+..   ++..+|.|.|+.+++-|+.|..-
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999886554433334455566677788888886   88999999999999999998843

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=2.6e-20  Score=162.79  Aligned_cols=169  Identities=25%  Similarity=0.364  Sum_probs=124.4

Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +|.|++|...+|.+|+.........+......++.|++.++.|   ++   .+|+|++|.||+...+..++|+|||+...
T Consensus       332 yI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  332 YIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             hhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheee
Confidence            6888899999999999877666666788899999999999999   77   99999999999999998999999999865


Q ss_pred             ccccc----ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccc
Q 040698          161 ISSHD----QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       161 ~~~~~----~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      .....    .....+...|+..||+||.+.   |+.++|||+||+++++++. -..++.......               
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~---------------  470 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT---------------  470 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh---------------
Confidence            53322    122445667899999999998   9999999999999999998 233322111110               


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQ  276 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  276 (309)
                           .+.+...+.....+. +.-..|+.+++...|.+||++..
T Consensus       471 -----d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  471 -----DIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -----hhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence                 111111110000011 22458999999999999994443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=6.2e-18  Score=138.53  Aligned_cols=134  Identities=21%  Similarity=0.274  Sum_probs=111.0

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccch-------hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-------KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      +.||+|.+|.||+|.+ .|..+++|......       .......+..|+.++..+.|+++..+..++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67788888643221       112234577889999999999988888777777888999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ++|++|.+++....      . ....++.+++.++.++|+.+   ++|+|++|.||+++ ++.++++|||.+.
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence            99999998885322      1 67788999999999999999   99999999999999 7899999999764

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=5.9e-18  Score=137.13  Aligned_cols=133  Identities=16%  Similarity=0.193  Sum_probs=101.3

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-----CCCccceeeeeeecCC---ccE-E
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-----NHKNVVKILGVCLETK---VPL-L   82 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-i   82 (309)
                      -.+.||+|++|.||.  +++....++|........ ..+.+.+|+..++.+     +||||++++++++++.   ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999996  444333468877654322 245689999999999     5799999999998863   333 7


Q ss_pred             EEEc--CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEEcC----CCCeEEEee
Q 040698           83 VYEF--VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL-DYLHSLGSPPIIHGDVKSANILLDD----NYTAKVADF  155 (309)
Q Consensus        83 v~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~~~h~dl~~~nilv~~----~~~v~l~d~  155 (309)
                      |+||  +.+++|.+++....    .++.  ..++.+++.++ +|||+++   ++|+||||+||+++.    ++.++|+|+
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  55799999996532    2333  35677888777 9999999   999999999999974    347999994


Q ss_pred             e
Q 040698          156 A  156 (309)
Q Consensus       156 g  156 (309)
                      +
T Consensus       154 ~  154 (210)
T PRK10345        154 I  154 (210)
T ss_pred             C
Confidence            4

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=1e-17  Score=135.84  Aligned_cols=142  Identities=23%  Similarity=0.257  Sum_probs=109.8

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchh---------------------hhhHHHHHHHHHHHhh
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---------------------ILINEVFQHKMRIISQ   61 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~---------------------~~~~~~~~~e~~~l~~   61 (309)
                      +......|.+.+.||.|+||.||++..++|+.+++|.......                     ......+..|+..+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            4455566999999999999999999988899999997543210                     0112235678888888


Q ss_pred             cCCCc--cceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040698           62 INHKN--VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKS  139 (309)
Q Consensus        62 l~h~~--iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~  139 (309)
                      +.+++  +..+++    ....+++|||++|++|......         .....++.+++.++.++|+.+   ++|+||+|
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            87764  444443    2455899999999988654320         234567889999999999999   99999999


Q ss_pred             CcEEEcCCCCeEEEeeecccc
Q 040698          140 ANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       140 ~nilv~~~~~v~l~d~g~~~~  160 (309)
                      .||+++.++.++++|||++..
T Consensus       154 ~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             ccEEEcCCCcEEEEECCcccc
Confidence            999999999999999998844

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=7.5e-17  Score=149.71  Aligned_cols=138  Identities=19%  Similarity=0.264  Sum_probs=109.4

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccc------hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMV------DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..|...+.||+|+||.||++.+.....++.+.....      ......+.+..|+.+++.++|++++.+..+..+....+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            445678899999999999998754433332222111      11122356889999999999999998887777777789


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +||||++|++|.+++.           ....++.+++.++.+||+.+   ++|||++|+||++ .++.++++|||++..
T Consensus       413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999988775           23567889999999999999   9999999999999 577999999998854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=2.7e-17  Score=133.45  Aligned_cols=131  Identities=18%  Similarity=0.296  Sum_probs=104.5

Q ss_pred             eecccCceEEEEEEcCCCcEEEEEecccch-------hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698           15 LLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-------KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      .||+|.+|.||++.+ +|..+++|......       .......+..|+.++..+.++++..+..++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 56788888643211       1122356778999999998887666655566667779999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +|++|.+++.....          .++.+++.++.++|+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999887653211          67889999999999999   99999999999999 78999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=3.1e-17  Score=136.00  Aligned_cols=145  Identities=19%  Similarity=0.157  Sum_probs=109.4

Q ss_pred             hhcccccceeecccCceEEEEEE--cCCCcEEEEEecccchh-----------------------hhhHHHHHHHHHHHh
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGV--LPDNTLVAVKKPKMVDK-----------------------ILINEVFQHKMRIIS   60 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~--~~~~~~v~ik~~~~~~~-----------------------~~~~~~~~~e~~~l~   60 (309)
                      -..-|.+.+.||.|++|.||+|.  ..+|+.||+|.......                       ......+..|+..+.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34468999999999999999998  56899999998754321                       011234678899999


Q ss_pred             hcCCC--ccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040698           61 QINHK--NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK  138 (309)
Q Consensus        61 ~l~h~--~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~  138 (309)
                      ++.+.  .+.++++.    ...++||||++|.+|.......   ..........++.|++.++.+||+.+.  ++|+|++
T Consensus       106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik  176 (237)
T smart00090      106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS  176 (237)
T ss_pred             HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence            88753  33444442    2358999999998876544221   122445667899999999999999862  9999999


Q ss_pred             CCcEEEcCCCCeEEEeeecccc
Q 040698          139 SANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       139 ~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      |+||+++ ++.++++|||.+..
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhc
Confidence            9999999 88999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=1.6e-17  Score=155.54  Aligned_cols=207  Identities=22%  Similarity=0.284  Sum_probs=137.0

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...+|+.++.+..|+||.||.++++. .+.+++|+-+...      .+++   ++.....|.+|                
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc---cccccCCccee----------------
Confidence            45789999999999999999998764 6777774322110      0011   22222333333                


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                           |+=...+.   ..+.++.        +.+.+++|+|+.+   ++|+|++|+|.+|+.-|++|++|||+.......
T Consensus       136 -----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 22222222   2223343        2378899999999   999999999999999999999999987543110


Q ss_pred             ------------cccc-cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc
Q 040698          165 ------------DQTA-TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       165 ------------~~~~-~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                                  +... .....+|++.|.|||++.   |...+|+|++|+++|+.+-|+.||...+.+            
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------------  264 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------------  264 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH------------
Confidence                        0001 112347899999999997   899999999999999999999997643211            


Q ss_pred             ccccccchhhhhccc-ccCccchHHHHHHHHHHhHhhccCCCCCCC
Q 040698          229 YPIENNSLRQILNFQ-VADENEMEEIEIVAKLASKCLRTSGTERPT  273 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  273 (309)
                           ....+++... ...+.-...+.++++++.+.|..+|..|--
T Consensus       265 -----elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  265 -----ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                 1111111111 111122233366999999999999999973

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=1.6e-15  Score=121.74  Aligned_cols=137  Identities=20%  Similarity=0.223  Sum_probs=95.9

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhh--hhHH---------------------HHHHHHHHHhhcCCC--c
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI--LINE---------------------VFQHKMRIISQINHK--N   66 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~--~~~~---------------------~~~~e~~~l~~l~h~--~   66 (309)
                      +.+.||+|+||.||++...+|+.||+|........  ....                     ....|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            35789999999999999878999999976543211  1011                     113455555555433  2


Q ss_pred             cceeeeeeecCCccEEEEEcCCCCCHHH-HHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEE
Q 040698           67 VVKILGVCLETKVPLLVYEFVPNGTLFQ-HVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILL  144 (309)
Q Consensus        67 iv~~~~~~~~~~~~~iv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv  144 (309)
                      +.+++++    ...+++|||++++.+.. .+.....    . ..+..++.+++.++.++|. .+   ++|+||+|+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~----~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL----L-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhh----c-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            4444443    24589999999854321 1111100    1 4567888999999999999 88   9999999999999


Q ss_pred             cCCCCeEEEeeeccccc
Q 040698          145 DDNYTAKVADFASSVLI  161 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~  161 (309)
                      + ++.++++|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 889999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=4.6e-15  Score=114.50  Aligned_cols=135  Identities=24%  Similarity=0.211  Sum_probs=109.3

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCccEEEEEcCCC
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH--KNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +++.||.|.++.||++...+ ..+++|.......   ...+..|...+..+.+  .++.+++.+....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            56789999999999999744 7889998765433   4567888888888876  5888999988888889999999998


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ..+..+          +......++.+++.++..+|......++|+|++|.||++++.+.++++|||.+..
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777543          3345567788999999999985212299999999999999889999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=7.7e-17  Score=149.58  Aligned_cols=255  Identities=20%  Similarity=0.283  Sum_probs=186.5

Q ss_pred             hcccccceeecccCceEEEEEEcCC--CcEEEEEecccch-hhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD--NTLVAVKKPKMVD-KILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...|.+.+.||.|+|+.+-......  ...++.|.+.... ..........|..+-+.+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            5689999999999999998877533  3455555443332 2222333445666656665 9999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEcCCC-CeEEEeeecccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH-SLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVL  160 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~  160 (309)
                      ++++..|+++...+...... ..+....-.++.|+..++.|+| ..+   +.|+|++|+|.+++..+ .+++.|||++..
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~-~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST-GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCCcc-CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999998777322211 1233455678899999999999 888   99999999999999888 999999999987


Q ss_pred             ccc-cccccccccccc-ccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          161 ISS-HDQTATTTKEIE-TVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       161 ~~~-~~~~~~~~~~~~-~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      +.. ...........| ++.|.+||...    .....|+||.|+++..+++|..||............+...-      .
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~------~  248 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK------G  248 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc------c
Confidence            765 444445556677 89999999987    36788999999999999999999887654442222221110      0


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                              ...............+++.+++..+|..|.+.+++..
T Consensus       249 --------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 --------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                    0001111122244788999999999999999988854

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=2.8e-14  Score=118.58  Aligned_cols=135  Identities=16%  Similarity=0.181  Sum_probs=100.3

Q ss_pred             eeec-ccCceEEEEEEcCCCcEEEEEecccch------------hhhhHHHHHHHHHHHhhcCCCcc--ceeeeeeecCC
Q 040698           14 HLLG-EGGFGFVYKGVLPDNTLVAVKKPKMVD------------KILINEVFQHKMRIISQINHKNV--VKILGVCLETK   78 (309)
Q Consensus        14 ~~lg-~g~~g~v~~~~~~~~~~v~ik~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~   78 (309)
                      ..|| .|+.|.+|.+... +..+++|......            .......+.+|+.++..+.|+++  +.++++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4576 7888888888764 6778888653211            01223567889999999988775  66676644322


Q ss_pred             ----ccEEEEEcCCC-CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           79 ----VPLLVYEFVPN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        79 ----~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                          ..++|||+++| .+|.+++...    ..+..    .+.+++.++.+||++|   ++|+||+|.||+++.++.++++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 6888877532    22322    3568999999999999   9999999999999988899999


Q ss_pred             eeecccc
Q 040698          154 DFASSVL  160 (309)
Q Consensus       154 d~g~~~~  160 (309)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=2.2e-13  Score=123.12  Aligned_cols=166  Identities=18%  Similarity=0.196  Sum_probs=123.9

Q ss_pred             cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHH
Q 040698           29 LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWK  108 (309)
Q Consensus        29 ~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~  108 (309)
                      ..++..|.+........ ...+...+.++.|+-++||||+++++..+.+...|||+|.+  ..|..++....      ..
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KE  104 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HH
Confidence            34567776666555444 33455677789999999999999999999999999999998  47777776554      24


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCccccc-
Q 040698          109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW-  187 (309)
Q Consensus       109 ~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-  187 (309)
                      ...--++||+.||.|||...+  ++|++++..+|+|+..|..+|++|.++........  +.........|..|+.+.. 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            455567999999999985432  99999999999999999999999998865422221  1222222334667776542 


Q ss_pred             CCCcchhhHHHHHHHHHhCC
Q 040698          188 TEKSDVYSFGVVLVELLTGK  207 (309)
Q Consensus       188 ~~~~DiwslG~ll~~~~~g~  207 (309)
                      .-..|.|.||+++++++.|.
T Consensus       181 ~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccchhhhhHHHHHHHHhCcc
Confidence            22469999999999999983

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=1.8e-13  Score=123.38  Aligned_cols=141  Identities=18%  Similarity=0.111  Sum_probs=94.8

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHH---------------------------------------HHH
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINE---------------------------------------VFQ   53 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~---------------------------------------~~~   53 (309)
                      .+.||.|++|.||+|+.++|+.||+|+.++........                                       .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46899999999999999999999999876542111110                                       122


Q ss_pred             HHHHHHhhc----C-CCccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHH-HHHHHHhc
Q 040698           54 HKMRIISQI----N-HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS-ALDYLHSL  127 (309)
Q Consensus        54 ~e~~~l~~l----~-h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~~  127 (309)
                      .|...+.++    + ++++.-..-+....+..++||||++|.+|.+........  ..   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence            333333333    2 333322222222234568999999999998876532211  12   2234445554 47888999


Q ss_pred             CCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       128 ~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      |   ++|+|++|.||++++++.++++|||++...
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            9   999999999999999999999999987553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.5e-14  Score=120.10  Aligned_cols=206  Identities=23%  Similarity=0.301  Sum_probs=138.4

Q ss_pred             HHHhhcCCCccceeeeeeecC-----CccEEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 040698           57 RIISQINHKNVVKILGVCLET-----KVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSP  130 (309)
Q Consensus        57 ~~l~~l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  130 (309)
                      .-|-++-|.|+|+.+.+..+.     ....++.||++.|++.++|++.. .+..+......+|+.||+.||.|||+.. |
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            444456799999999887653     34678999999999999997553 3444566788899999999999999996 8


Q ss_pred             CeEecCCCCCcEEEcCCCCeEEEeeec--ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh
Q 040698          131 PIIHGDVKSANILLDDNYTAKVADFAS--SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT  205 (309)
Q Consensus       131 ~~~h~dl~~~nilv~~~~~v~l~d~g~--~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~  205 (309)
                      +++|++++-+.|++..+|-|+++--.-  .................+.+.|.+||...   .+.++|||++|+...+|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            899999999999999888888753211  11100000001111234567799999876   6678999999999999988


Q ss_pred             CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          206 GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      +...-...+ ..-...        ......+....+            .-=++++.+|++..|..||++..++-|.-.+
T Consensus       278 lEiq~tnse-S~~~~e--------e~ia~~i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  278 LEIQSTNSE-SKVEVE--------ENIANVIIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             heeccCCCc-ceeehh--------hhhhhheeeccC------------ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            765411110 000000        000000000000            0135789999999999999999998776443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.45  E-value=4.8e-12  Score=97.41  Aligned_cols=145  Identities=19%  Similarity=0.242  Sum_probs=111.0

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecc-------cchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPK-------MVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~-------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ....+-+|+-+.|+.+.+ .|+..++|.-.       ..+....+.+..+|.+.|.++..-.|....-++.+.+.-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            678889999999999987 67888888321       1133444567788888888877667776777788888888999


Q ss_pred             EcCCC-CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEEeeecccc
Q 040698           85 EFVPN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---TAKVADFASSVL  160 (309)
Q Consensus        85 e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l~d~g~~~~  160 (309)
                      ||++| .++.+++........ .......++.++-+.+.-||.++   ++||||+.+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 367777765544433 22444788899999999999999   99999999999986443   358999998865


Q ss_pred             c
Q 040698          161 I  161 (309)
Q Consensus       161 ~  161 (309)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=5.4e-13  Score=121.88  Aligned_cols=149  Identities=15%  Similarity=0.135  Sum_probs=92.4

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhh---------------------------------hHHH
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKIL---------------------------------INEV   51 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~---------------------------------~~~~   51 (309)
                      ....|+. +.||.|++|.||+|..++ |+.||+|+.++.....                                 ..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 899999999999999877 9999999886542111                                 1112


Q ss_pred             HHHHHH------HHhhc----CCCccceeeeeeec-CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHH
Q 040698           52 FQHKMR------IISQI----NHKNVVKILGVCLE-TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA  120 (309)
Q Consensus        52 ~~~e~~------~l~~l----~h~~iv~~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~  120 (309)
                      +..|++      .+.++    .+...+.+-.++.+ .+..++||||++|+.+.+........  .+...+.....+  .-
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~la~~~v~--~~  272 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKLLAERGVE--VF  272 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHHHHHHHHH--HH
Confidence            222332      22222    12222333333322 34567999999999997743211111  111222221111  12


Q ss_pred             HHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEeeecccccc
Q 040698          121 LDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVADFASSVLIS  162 (309)
Q Consensus       121 l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d~g~~~~~~  162 (309)
                      +..+...|   ++|+|++|.||+++.++    .++++|||++....
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            34455688   99999999999999887    99999999987653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=2.4e-13  Score=121.50  Aligned_cols=249  Identities=22%  Similarity=0.193  Sum_probs=177.6

Q ss_pred             hcccccceeecc--cCceEEEEEEc---CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCc
Q 040698            7 TKNYDKRHLLGE--GGFGFVYKGVL---PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~--g~~g~v~~~~~---~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (309)
                      .+.+.+.+.+|.  |.+|.+|.+..   .++..+++|.-... ..+.....-.+++...+.+ .|++.++-+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            456778889999  99999999874   45888888863222 1111111222333333334 48899998888888899


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEe
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS----ALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVAD  154 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d  154 (309)
                      .++-+|.+. .+|.++.....  ...+...++..+.+...    |+.++|..+   ++|-|++|.||++..+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999999994 66666554332  23466888888888888    999999999   9999999999999988 7889999


Q ss_pred             eeccccccccccccccc--c-cccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          155 FASSVLISSHDQTATTT--K-EIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~--~-~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      ||+...+..........  . ..+...|++||...  ++...|++++|.++.+...|..+....                
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g----------------  330 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG----------------  330 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC----------------
Confidence            99987775443222221  2 25677799999998  888999999999999988876652211                


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                        ....+.++...-.+.+.+...+..+...+..|++.+|..|+++..+.+
T Consensus       331 --~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  331 --KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              111222222222344444455566788999999999999999887765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=2e-12  Score=102.05  Aligned_cols=130  Identities=18%  Similarity=0.106  Sum_probs=93.2

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEcCCCCC
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      ++.|+.|.++.+|++... +..+++|........  ...+..|+..++.+.+.++ .+++.+..  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            467899999999999864 778999986554321  2245677888887754443 34554433  34589999999988


Q ss_pred             HHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           92 LFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG--SPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      +...       .    .....+..+++.+++.||+.+  ...++|+|++|.||+++ ++.++++||+.+.
T Consensus        78 l~~~-------~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE-------D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc-------c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7532       0    011234578999999999987  01139999999999999 6689999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=1.6e-11  Score=94.87  Aligned_cols=132  Identities=21%  Similarity=0.294  Sum_probs=98.3

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEe-cccc------hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKK-PKMV------DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~-~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ..+++|+-+.++.+.+.+ ..+++|. +...      +.......-..|..++..+.--.|..+.-++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357889999999987744 3466663 2221      2222234567788888888766666666666777777899999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++|..|.+.+....          ..++..+-.-+.-||.++   ++||||+++|++++.++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999988887541          345666777788999999   99999999999998664 99999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.34  E-value=6.2e-11  Score=104.57  Aligned_cols=228  Identities=15%  Similarity=0.138  Sum_probs=157.9

Q ss_pred             CceEEEEEE-cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee----cCCccEEEEEcCCCC-CHH
Q 040698           20 GFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL----ETKVPLLVYEFVPNG-TLF   93 (309)
Q Consensus        20 ~~g~v~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~iv~e~~~~~-sL~   93 (309)
                      .-.+.|++. ..||..+++|++....... -.....-+..++++.|+|||++.++|.    .+..+++|++|+++. +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346778888 5689999999883322111 112344578899999999999999887    345678999999864 554


Q ss_pred             HHHHhh------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           94 QHVRYQ------------SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        94 ~~l~~~------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +.--..            ......++..+|.++.|+..||.++|+.|   +..+-|.+.+|+++.+.+++|...|+..+.
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence            433111            12234577899999999999999999999   999999999999998889999988877655


Q ss_pred             ccccccccccccccccccCCCcccccCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ....              .  +.+.-..+-|.-.||.++..+.+|..---..+                .....      
T Consensus       444 ~~d~--------------~--~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d----------------~~~~s------  485 (655)
T KOG3741|consen  444 QEDP--------------T--EPLESQQQNDLRDLGLLLLALATGTENSNRTD----------------STQSS------  485 (655)
T ss_pred             cCCC--------------C--cchhHHhhhhHHHHHHHHHHHhhccccccccc----------------chHHH------
Confidence            2221              0  11222356799999999999999863200000                00000      


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH-hhhhhhhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL-DSLRRLHENFW  292 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l-~~~~~~~~~~~  292 (309)
                        ........++.+++++|......++++ -++.+++.++ +.+-.+++...
T Consensus       486 --~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q  534 (655)
T KOG3741|consen  486 --HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQ  534 (655)
T ss_pred             --HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHH
Confidence              000112345577999999999999998 7889888776 55555555443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=7.9e-11  Score=93.97  Aligned_cols=138  Identities=15%  Similarity=0.132  Sum_probs=95.6

Q ss_pred             cceeecccCceEEEEEEcCC-------CcEEEEEecccch---------------------hhhhHHH----HHHHHHHH
Q 040698           12 KRHLLGEGGFGFVYKGVLPD-------NTLVAVKKPKMVD---------------------KILINEV----FQHKMRII   59 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~-------~~~v~ik~~~~~~---------------------~~~~~~~----~~~e~~~l   59 (309)
                      +...||.|--+.||.|...+       +..+|+|..+...                     +......    ...|+..|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999998543       4789999322110                     0111222    34888888


Q ss_pred             hhcCC--CccceeeeeeecCCccEEEEEcCCCCCHHH-HHHhhccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 040698           60 SQINH--KNVVKILGVCLETKVPLLVYEFVPNGTLFQ-HVRYQSSQVLKTWKTCLRIAAETASALDYL-HSLGSPPIIHG  135 (309)
Q Consensus        60 ~~l~h--~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~~~h~  135 (309)
                      +++..  -++.+++++    ...+|||||+.+..+.. .+..    ...+......+..+++.+|..+ |+.+   ++||
T Consensus        81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            88853  455666654    45689999997653321 1211    1123345667788999999998 8999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          136 DVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       136 dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||++.||+++ ++.+.++|||.+...
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999997 468999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=5.3e-11  Score=98.02  Aligned_cols=143  Identities=20%  Similarity=0.279  Sum_probs=99.6

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC--CccceeeeeeecC---CccEEEEEcCC
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH--KNVVKILGVCLET---KVPLLVYEFVP   88 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~iv~e~~~   88 (309)
                      +.|+.|..+.+|++...+|..+++|.............+..|..+++.+.+  ..+.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            678999999999998766789999987654332234567888898988865  3456777776653   36689999999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG----------------------------------------  128 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------------------------------------  128 (309)
                      |.++...+..    ...+......++.+++.++..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9877553311    11233444455555555555555310                                        


Q ss_pred             -------------CCCeEecCCCCCcEEEcC--CCCeEEEeeecccc
Q 040698          129 -------------SPPIIHGDVKSANILLDD--NYTAKVADFASSVL  160 (309)
Q Consensus       129 -------------~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~  160 (309)
                                   -..++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         122799999999999998  66789999997743

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.23  E-value=2.8e-10  Score=98.29  Aligned_cols=263  Identities=20%  Similarity=0.182  Sum_probs=160.7

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeee------ecCC-ccEEE
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVC------LETK-VPLLV   83 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~------~~~~-~~~iv   83 (309)
                      ....||+|+-+.+|-.-.. +. .+.|+........ .+   +.+..|... .||-+-.=+.|-      -+.. ..-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh-hc-hhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4567999999999865421 12 2335443322211 11   112223322 455433212111      1222 24578


Q ss_pred             EEcCCCCC-HHHHH---HhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           84 YEFVPNGT-LFQHV---RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        84 ~e~~~~~s-L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      |..++|.. +..++   .+..+.....+..+.+++..++.+.+-||..|   ..-||++++|+++++++.|.+.|-+...
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            88887652 22222   22334445578899999999999999999999   8999999999999999999999866443


Q ss_pred             ccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchh---hhhcccCc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNE---MTRMVPYF  227 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~---~~~~~~~~  227 (309)
                      ..   .......+.+|...|+|||...        -+...|.|.||+++++++.| +.||+........   .+.-+..+
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32   2333445677899999999886        45678999999999998875 9998765322211   00000000


Q ss_pred             cccccccchhhhhccc-ccCcc-chHHHHHHHHHHhHhhccC--CCCCCCHHHHHHHHhhhhhhhh
Q 040698          228 PYPIENNSLRQILNFQ-VADEN-EMEEIEIVAKLASKCLRTS--GTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~cl~~d--p~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ...  . ..+.-...+ .+... ..-.+++++-|..+|+...  +.-|||++..+..|..++....
T Consensus       243 ~f~--y-a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         243 RFA--Y-ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eee--e-chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            000  0 000000111 11111 1233477899999999865  5689999999999988876544

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.18  E-value=5.1e-10  Score=91.77  Aligned_cols=137  Identities=19%  Similarity=0.212  Sum_probs=100.3

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccchh---------------------hhhHHHHHHHHHHHhhcCCC--
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---------------------ILINEVFQHKMRIISQINHK--   65 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--   65 (309)
                      =+.+...||-|--+.||.|..++|.++++|.-+....                     ...+...++|+.+|..+...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3567789999999999999999999999994322110                     12234467888888887544  


Q ss_pred             ccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           66 NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        66 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      .|.++++    .+..++|||+++|..|...--        .....-.++..|+..+..+-..|   ++|||+++.||+++
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            5666665    456689999999876643211        12233445556666666666888   99999999999999


Q ss_pred             CCCCeEEEeeecccc
Q 040698          146 DNYTAKVADFASSVL  160 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~  160 (309)
                      ++|.+.++||..+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999987644

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=5.4e-11  Score=106.65  Aligned_cols=244  Identities=18%  Similarity=0.197  Sum_probs=162.2

Q ss_pred             hcccccceeecccCceEEEEEEc--CCCcEEEEEecccchhhhhHHHH-HHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL--PDNTLVAVKKPKMVDKILINEVF-QHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~--~~~~~v~ik~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+|..+..||.|.|+.++.+..  .++.++++|...+.......+.+ ..|+-+...+ .|.+++..+..+...+..+|
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            46788899999999999998773  45788888866554332222222 2233333333 47888888777777777789


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~g~~~~~  161 (309)
                      =-|||+++++.......   ....+...+.+..|++.++.++|+..   ++|+|++|+||++..+ +.-+++|++.....
T Consensus       344 p~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            99999999887655322   22355677888999999999999999   9999999999999875 77788999877532


Q ss_pred             ccccccccccccccccccCC-Ccccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQTATTTKEIETVGWLD-PEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~-PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ......     .....++.| +|.+.    +..+.|+++||.-+.+..+|.+- ...                   ....
T Consensus       418 ~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~-------------------~~~~  472 (524)
T KOG0601|consen  418 AFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SES-------------------GVQS  472 (524)
T ss_pred             ceeccc-----ccccccccccchhhccccccccccccccccccccccccCccc-Ccc-------------------cccc
Confidence            111111     111222331 33333    67789999999999998876543 111                   0000


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      ..+....  .+........++.+.+.++..++..||.+.++..+..-
T Consensus       473 ~~i~~~~--~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  473 LTIRSGD--TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeeeccc--ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            1111111  11111122558999999999999999999988766543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.12  E-value=2.3e-09  Score=90.26  Aligned_cols=140  Identities=13%  Similarity=0.031  Sum_probs=94.6

Q ss_pred             eecccCceEEEEEEcCCCcEEEEEecccchhhh-hH---------HHHHHHHHHHhhcCCCc--cceeeeeeec-----C
Q 040698           15 LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKIL-IN---------EVFQHKMRIISQINHKN--VVKILGVCLE-----T   77 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~-~~---------~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~   77 (309)
                      .+.......|.+... +|+.+.+|......... ..         ..+..|...+..+..-+  +..++++.+.     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344334444556554 67889999654332111 11         13678888777774333  3344455543     2


Q ss_pred             CccEEEEEcCCCC-CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------CCC
Q 040698           78 KVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-------NYT  149 (309)
Q Consensus        78 ~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-------~~~  149 (309)
                      ...++|+|++++. +|.+++..... ..........++.+++..+..||..|   ++|+|++++||+++.       ++.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3467999999886 88888754322 12244566788999999999999999   999999999999975       467


Q ss_pred             eEEEeeeccc
Q 040698          150 AKVADFASSV  159 (309)
Q Consensus       150 v~l~d~g~~~  159 (309)
                      +.++||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=1.8e-09  Score=85.81  Aligned_cols=126  Identities=27%  Similarity=0.303  Sum_probs=81.7

Q ss_pred             EEEEEEcCCCcEEEEEecccc-------------------------hhhhhHHHHHHHHHHHhhcCCC--ccceeeeeee
Q 040698           23 FVYKGVLPDNTLVAVKKPKMV-------------------------DKILINEVFQHKMRIISQINHK--NVVKILGVCL   75 (309)
Q Consensus        23 ~v~~~~~~~~~~v~ik~~~~~-------------------------~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~   75 (309)
                      .||.|...+|..+|+|.....                         ...........|+..|..+...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            378888888999999933221                         1122234578899999999765  456666542 


Q ss_pred             cCCccEEEEEcCC--CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           76 ETKVPLLVYEFVP--NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-LHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        76 ~~~~~~iv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                         ..+|||||++  |..+..+......     ......++.+++..+.. +|+.|   ++||||++.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~~~-----~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVDLS-----PEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCGGG-----GSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcccc-----chhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  7666554432211     12345566677775554 57999   9999999999999977 9999


Q ss_pred             Eeeeccccc
Q 040698          153 ADFASSVLI  161 (309)
Q Consensus       153 ~d~g~~~~~  161 (309)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.04  E-value=5.4e-11  Score=112.58  Aligned_cols=246  Identities=20%  Similarity=0.190  Sum_probs=163.6

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhh--HHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILI--NEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      -..+.+.+.+.+|.++.++...- ..|..+..+......+...  .+....+-.++-...+|.++...-.+......+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            35677888888999999988773 3465566554433322211  01111122222223346666555555667788999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ++|+++++|...+...+..   ...........+..+..+||...   +.|+|++|.|.++..++...+.|++.......
T Consensus       883 ~~~~~~~~~~Skl~~~~~~---saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCL---SAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hHHhccCCchhhhhcCCCc---ccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999998888655522   33455566677888999999998   89999999999999999999999983322100


Q ss_pred             c-----------------------------cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          164 H-----------------------------DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       164 ~-----------------------------~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                      .                             +.........+++.|.+||...   -...+|+|+.|+.+++.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                             0001122245688899999887   5667899999999999999999976


Q ss_pred             hhhhcchhhhhcccCccccccccchhhhhcccccCc-cchHHHHHHHHHHhHhhccCCCCCCCHH
Q 040698          212 YVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE-NEMEEIEIVAKLASKCLRTSGTERPTMR  275 (309)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~  275 (309)
                      .....                 ...+.+.+...... .+...+..+++++...+..+|.+|..+.
T Consensus      1037 a~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            54222                 22222222222221 2233445689999999999999998876

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.94  E-value=9.3e-09  Score=93.71  Aligned_cols=141  Identities=17%  Similarity=0.134  Sum_probs=92.0

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHH---------------------------------------HHH
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV---------------------------------------FQH   54 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~---------------------------------------~~~   54 (309)
                      +.++.++-|.||+|+.++|+.||+|+.++.-......+                                       +..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68899999999999999999999998776644333322                                       111


Q ss_pred             HHHHHhhc-----CCCccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 040698           55 KMRIISQI-----NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS  129 (309)
Q Consensus        55 e~~~l~~l-----~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~  129 (309)
                      |...+.++     +.|++.-..=+.+-.+.-+++|||++|..+.+........  .+.+.+.....+++  +..+-..| 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHH--HHHHHhcC-
Confidence            22222221     1222222111222234558999999999998875433321  24344444433333  34444567 


Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          130 PPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       130 ~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                        ++|.|.+|.||+++.+|.+.+.|||+....
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecC
Confidence              999999999999999999999999998665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.90  E-value=3.4e-08  Score=79.45  Aligned_cols=136  Identities=17%  Similarity=0.233  Sum_probs=90.3

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHH---------HHHHHHHHhhcCC---Cccceeeee
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV---------FQHKMRIISQINH---KNVVKILGV   73 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~---------~~~e~~~l~~l~h---~~iv~~~~~   73 (309)
                      ..++|.+.+.+.......|.+... +|..+++|..+...... .+.         ..+.+..+..+..   .....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            467899999999888887777765 67999999877654321 222         2233333333322   222233333


Q ss_pred             eec-----CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           74 CLE-----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        74 ~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                      .+.     ....+++|||++|..|.+....       ++    .+.-.+..++..+|+.|   +.|||.+|.|++++++ 
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i-------~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDI-------DE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchhc-------CH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence            332     2344689999999887654321       11    23345777899999999   9999999999999865 


Q ss_pred             CeEEEeeecc
Q 040698          149 TAKVADFASS  158 (309)
Q Consensus       149 ~v~l~d~g~~  158 (309)
                      .++++|++..
T Consensus       172 ~i~iID~~~k  181 (229)
T PF06176_consen  172 GIRIIDTQGK  181 (229)
T ss_pred             cEEEEECccc
Confidence            5999999854

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=5.4e-08  Score=78.02  Aligned_cols=139  Identities=16%  Similarity=0.032  Sum_probs=97.6

Q ss_pred             cccCceEEEEEEcCCCcEEEEEecccchh-----hhhHHHHHHHHHHHhhcCCC--ccceeeeeeec----CCccEEEEE
Q 040698           17 GEGGFGFVYKGVLPDNTLVAVKKPKMVDK-----ILINEVFQHKMRIISQINHK--NVVKILGVCLE----TKVPLLVYE   85 (309)
Q Consensus        17 g~g~~g~v~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~----~~~~~iv~e   85 (309)
                      |+|+-+.|+.... +|..+.+|.-.+...     +.-...|.+|+..++.+..-  .+.++......    ...-+||+|
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            5688888888665 455788886542211     22357899999999888532  24454422211    123469999


Q ss_pred             cCCC-CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eEEEeeecccc
Q 040698           86 FVPN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT--AKVADFASSVL  160 (309)
Q Consensus        86 ~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~--v~l~d~g~~~~  160 (309)
                      -++| .+|.+++...... ..+......++.+++.+++-||+.|   +.|+|+.+.||+++.++.  |+++||+-+..
T Consensus       106 ~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8764 4888887544322 2244666788999999999999999   999999999999986666  99999986643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=7.1e-08  Score=78.49  Aligned_cols=106  Identities=17%  Similarity=0.190  Sum_probs=79.9

Q ss_pred             HHHHHHHHHHHhhcCC--CccceeeeeeecC----CccEEEEEcCCCC-CHHHHHHhhccccccCHHHHHHHHHHHHHHH
Q 040698           49 NEVFQHKMRIISQINH--KNVVKILGVCLET----KVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAETASAL  121 (309)
Q Consensus        49 ~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~----~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l  121 (309)
                      ......|...+..+..  -.+..++++.+..    ...++|+|++++. +|.+++.....   .+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            3456777777766642  2345566665542    2347999999885 78888875333   24456678889999999


Q ss_pred             HHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEEeeecccc
Q 040698          122 DYLHSLGSPPIIHGDVKSANILLDDNY---TAKVADFASSVL  160 (309)
Q Consensus       122 ~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l~d~g~~~~  160 (309)
                      +-||.+|   ++|+|+++.||+++.++   .+.++||+.+..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   99999999999998776   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=4.8e-09  Score=95.87  Aligned_cols=147  Identities=22%  Similarity=0.272  Sum_probs=97.9

Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc-cccc------cccccccccCCCcccc--
Q 040698          116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ-TATT------TKEIETVGWLDPEYLF--  186 (309)
Q Consensus       116 ~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~-~~~~------~~~~~~~~~~~PE~~~--  186 (309)
                      +++.|+.|+|..-  .++|+++.|++|.++..+.+|++.|+.+........ ....      ........|.+||++.  
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558899999853  399999999999999999999999998754322111 0000      1122366799999997  


Q ss_pred             -cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhc
Q 040698          187 -WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLR  265 (309)
Q Consensus       187 -~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  265 (309)
                       .+.++|++|+|+++|.+..|+.+--......              .....................+.++++=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--------------~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--------------LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCc--------------chhhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence             7788999999999999996555422111111              1111111111111222224555779999999999


Q ss_pred             cCCCCCCCHHHHH
Q 040698          266 TSGTERPTMRQVS  278 (309)
Q Consensus       266 ~dp~~Rps~~~ll  278 (309)
                      .++.-||++..+.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999777764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=5.3e-07  Score=74.38  Aligned_cols=139  Identities=14%  Similarity=0.145  Sum_probs=82.9

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceeeeeeecCCccEEEEEcCCCCC
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      ..++.|..+.+|+.   .|..+++|.......   .....+|.++++.+..-  .+.+++++..+.+...++||+++|..
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   355678887665332   33468888888887533  34677888777777889999999863


Q ss_pred             -HHHHH--------------H-----hhccc-cccCHHH-HHHHHHH----------HHHH-HHHHHh-cCCCCeEecCC
Q 040698           92 -LFQHV--------------R-----YQSSQ-VLKTWKT-CLRIAAE----------TASA-LDYLHS-LGSPPIIHGDV  137 (309)
Q Consensus        92 -L~~~l--------------~-----~~~~~-~~~~~~~-~~~i~~~----------i~~~-l~~lh~-~~~~~~~h~dl  137 (309)
                       +...+              .     -+... ....... ...+..+          +... ..+|.. ...+.++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111              0     00000 0000000 0111000          0111 111111 11233799999


Q ss_pred             CCCcEEEcCCCCeEEEeeeccc
Q 040698          138 KSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       138 ~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      +|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999887 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.65  E-value=5.8e-07  Score=73.29  Aligned_cols=147  Identities=18%  Similarity=0.197  Sum_probs=93.1

Q ss_pred             HHhhcccccce---eecccCceEEEEEEcCCCcEEEEEecccchhhh-----------------------hHHHHHHHHH
Q 040698            4 VKATKNYDKRH---LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKIL-----------------------INEVFQHKMR   57 (309)
Q Consensus         4 ~~~~~~y~i~~---~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~-----------------------~~~~~~~e~~   57 (309)
                      .....+..+..   .|+.|--+.||+|...++..+|+|+........                       .......|+.
T Consensus        41 ~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~  120 (268)
T COG1718          41 RRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR  120 (268)
T ss_pred             HHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence            33444455544   455566778899888789999999654432111                       1112455677


Q ss_pred             HHhhcCCC--ccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 040698           58 IISQINHK--NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIH  134 (309)
Q Consensus        58 ~l~~l~h~--~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h  134 (309)
                      -|.++...  .+.+.+++..    ..+|||+++....  -.-.. ............+..++++.+.-|-. .+   ++|
T Consensus       121 NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~--pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVH  190 (268)
T COG1718         121 NLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL--PAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVH  190 (268)
T ss_pred             HHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC--CCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcC---ccc
Confidence            77766433  3344444333    4799999964311  00000 11111222566677788888888877 78   999


Q ss_pred             cCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          135 GDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       135 ~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||+..|||+. ++.+.++|+|.+...
T Consensus       191 gDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         191 GDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             ccchhhheEEE-CCeEEEEECcccccc
Confidence            99999999999 789999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=1.8e-06  Score=71.50  Aligned_cols=78  Identities=19%  Similarity=0.209  Sum_probs=54.6

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceeeeeee---cCCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKILGVCL---ETKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~iv~e~~   87 (309)
                      ++.|+.|..+.+|.+...+ ..+++|.....   .....+..|..+++.+...  .+.+++....   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999999866 68999986655   2345667777777777422  3456665432   233468999999


Q ss_pred             CCCCHHH
Q 040698           88 PNGTLFQ   94 (309)
Q Consensus        88 ~~~sL~~   94 (309)
                      +|..+..
T Consensus        78 ~g~~~~~   84 (239)
T PF01636_consen   78 PGRPLDD   84 (239)
T ss_dssp             SSEEHHH
T ss_pred             ccccccc
Confidence            9988776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=2.4e-06  Score=77.99  Aligned_cols=141  Identities=17%  Similarity=0.192  Sum_probs=86.0

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHH------------------------------------HHHHH
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV------------------------------------FQHKM   56 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~------------------------------------~~~e~   56 (309)
                      -+.|+..+.|.||+++.++|+.||+|+-++.........                                    |..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468999999999999999999999997655433221111                                    11122


Q ss_pred             H----HHhhcCCCccce---eeeeeec-CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHH-HHHHHhc
Q 040698           57 R----IISQINHKNVVK---ILGVCLE-TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA-LDYLHSL  127 (309)
Q Consensus        57 ~----~l~~l~h~~iv~---~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~-l~~lh~~  127 (309)
                      +    ..+.+.|-+...   +=.++.+ ....+++|||++|..+.+.-...... . +...   ++..+.++ ..-+=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i-~~~~---i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-I-SPHD---ILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-C-CHHH---HHHHHHHHHHHHHHhc
Confidence            1    222223333111   1112222 23558999999999776553322211 1 2233   33344443 3334456


Q ss_pred             CCCCeEecCCCCCcEEEcC----CCCeEEEeeeccccc
Q 040698          128 GSPPIIHGDVKSANILLDD----NYTAKVADFASSVLI  161 (309)
Q Consensus       128 ~~~~~~h~dl~~~nilv~~----~~~v~l~d~g~~~~~  161 (309)
                      |   ++|.|-+|.||++.+    ++.+.+.|+|+....
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            6   999999999999983    678999999998665

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=5.4e-06  Score=69.37  Aligned_cols=75  Identities=13%  Similarity=0.042  Sum_probs=51.2

Q ss_pred             eecccCc-eEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEEcCCCCCH
Q 040698           15 LLGEGGF-GFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYEFVPNGTL   92 (309)
Q Consensus        15 ~lg~g~~-g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~~sL   92 (309)
                      .|..|.. ..||+.... +..+++|......    ...+..|+.+++.+. +--+.+++++....+..++||++++|.++
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3445555 788988764 4788888765543    224566777777663 33455777777766678999999999877


Q ss_pred             HH
Q 040698           93 FQ   94 (309)
Q Consensus        93 ~~   94 (309)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            64

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.39  E-value=7.8e-06  Score=80.13  Aligned_cols=79  Identities=10%  Similarity=0.237  Sum_probs=56.7

Q ss_pred             ceeecccCceEEEEEEcCCC---cEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCcc--ceeeeeeecC---CccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNV--VKILGVCLET---KVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~iv   83 (309)
                      ++.++.|.+..+|.....++   ..+++|+............+.+|+.+++.+. |+++  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999875443   4677787654332222456789999999885 6654  6777777654   467899


Q ss_pred             EEcCCCCC
Q 040698           84 YEFVPNGT   91 (309)
Q Consensus        84 ~e~~~~~s   91 (309)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=9.2e-06  Score=62.88  Aligned_cols=129  Identities=18%  Similarity=0.192  Sum_probs=88.2

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccc-eeeeeeecCCccEEEEEcCC
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV-KILGVCLETKVPLLVYEFVP   88 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~e~~~   88 (309)
                      -+..+.|+.|.+|.||.|.+.. ..+++|.-+...   .+..+..|.++|..++..++. +++.+..+    ++.|||+.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRG-GEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccC-ceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            3556789999999999999954 467777544433   256788899999888766554 45554443    35599999


Q ss_pred             CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC-CcEEEcCCCCeEEEeeeccc
Q 040698           89 NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKS-ANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        89 ~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~-~nilv~~~~~v~l~d~g~~~  159 (309)
                      |-+|.++-...      +.+.    ...++....-|...|   +-|+.|+- ...++..++.+.|+||..+.
T Consensus        96 G~~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            98887655321      1123    234556666677778   89998863 34444445599999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.11  E-value=1.3e-05  Score=78.12  Aligned_cols=194  Identities=19%  Similarity=0.203  Sum_probs=130.7

Q ss_pred             HHHHHHHHHhhcCCCccceeeeeeecCCcc----EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh
Q 040698           51 VFQHKMRIISQINHKNVVKILGVCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS  126 (309)
Q Consensus        51 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  126 (309)
                      ...-|...+..+.|+|++.++.|.......    .+..++++..++...++....   .+....+.+..++.+|++++|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHH
Confidence            345566777778999999999987654322    245678888888877765443   4668888899999999999999


Q ss_pred             cCCCCeEecCCCCC---cEEEcCCCCeEEE--eeecccccccccccccccccccccccCCCcccc-----cCCCcchhhH
Q 040698          127 LGSPPIIHGDVKSA---NILLDDNYTAKVA--DFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSF  196 (309)
Q Consensus       127 ~~~~~~~h~dl~~~---nilv~~~~~v~l~--d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~Diwsl  196 (309)
                      ..   ..|.-|..+   +..++..+.+.++  ||+.......   ............+.+||...     .....|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHH
Confidence            87   777777766   4444566677776  8876654421   11122222344466777665     3445799999


Q ss_pred             HHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHH
Q 040698          197 GVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQ  276 (309)
Q Consensus       197 G~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  276 (309)
                      |.+...+..|..+-....                    ....+...        .....+.++..+|+..++++|+++.+
T Consensus       379 gll~~~~~~~~~i~~~~~--------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA--------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHhhhhhcCccccccc--------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhh
Confidence            999999998776522110                    00000000        00013788999999999999999999


Q ss_pred             HHHHH
Q 040698          277 VSEQL  281 (309)
Q Consensus       277 ll~~l  281 (309)
                      ++.+.
T Consensus       431 ll~~~  435 (1351)
T KOG1035|consen  431 LLTHP  435 (1351)
T ss_pred             hhhch
Confidence            98865

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.07  E-value=9.3e-06  Score=68.86  Aligned_cols=136  Identities=18%  Similarity=0.190  Sum_probs=94.6

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchh---------------------hhhHHHHHHHHHHHhhcCC-C-c
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---------------------ILINEVFQHKMRIISQINH-K-N   66 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h-~-~   66 (309)
                      +-+++.||-|--+.+|.+-..+|...++|.-+....                     -..+-....|+..|+.+.- . -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            567889999999999999998999999984322211                     0111124556777776642 2 2


Q ss_pred             cceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 040698           67 VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD  146 (309)
Q Consensus        67 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~  146 (309)
                      |.+.++    .+..++|||.+.|..|...-.      .....   .+...+...+..|-.+|   ++|+|++--||++++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            334333    456689999999888754321      11222   34445566677888999   999999999999999


Q ss_pred             CCCeEEEeeeccccc
Q 040698          147 NYTAKVADFASSVLI  161 (309)
Q Consensus       147 ~~~v~l~d~g~~~~~  161 (309)
                      ++.++++||..+...
T Consensus       238 d~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVST  252 (465)
T ss_pred             CCCEEEeechHhhcc
Confidence            999999999977544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.04  E-value=2.9e-05  Score=62.07  Aligned_cols=105  Identities=21%  Similarity=0.277  Sum_probs=79.2

Q ss_pred             HHHHHHHhhcCC-CccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 040698           53 QHKMRIISQINH-KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP  131 (309)
Q Consensus        53 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  131 (309)
                      ..|.-+++.+++ +++.+++|++-.    +++.||++.+++.............++..++.++.+++..+.+++......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            346677777765 699999999843    689999987655421000001112378999999999999999999854444


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +...|++++|+-++++++++++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=7.2e-05  Score=62.19  Aligned_cols=73  Identities=16%  Similarity=0.230  Sum_probs=43.9

Q ss_pred             eeecccCce-EEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC---ccceeeeeeecC---CccEEEEEc
Q 040698           14 HLLGEGGFG-FVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK---NVVKILGVCLET---KVPLLVYEF   86 (309)
Q Consensus        14 ~~lg~g~~g-~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~iv~e~   86 (309)
                      +.++.|+.. .||+.    +..+++|......   ....+..|..++..+...   .+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 58875    2347778654422   234678888888776421   234444443322   245889999


Q ss_pred             CCCCCHH
Q 040698           87 VPNGTLF   93 (309)
Q Consensus        87 ~~~~sL~   93 (309)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.01  E-value=3.8e-05  Score=64.74  Aligned_cols=139  Identities=14%  Similarity=0.049  Sum_probs=76.5

Q ss_pred             eecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEcCCCCCHH
Q 040698           15 LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEFVPNGTLF   93 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~~~~sL~   93 (309)
                      .+..|-...+|+... +|+.+++|......... .-....|..+++.+....+ .+++....    .++|+||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            466788889998874 57788888755432211 0124667777777753322 33443332    36999999987653


Q ss_pred             H-----------H---HH-hhcc---ccccC-HHHHHHHHHHH---------HHHHHHHHhcC-----CCCeEecCCCCC
Q 040698           94 Q-----------H---VR-YQSS---QVLKT-WKTCLRIAAET---------ASALDYLHSLG-----SPPIIHGDVKSA  140 (309)
Q Consensus        94 ~-----------~---l~-~~~~---~~~~~-~~~~~~i~~~i---------~~~l~~lh~~~-----~~~~~h~dl~~~  140 (309)
                      .           .   +. -+..   ..... ...+..+..++         ...+..+....     ...++|+|+.+.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            2           1   11 0100   00111 11222222111         11122222110     112899999999


Q ss_pred             cEEEcCCCCeEEEeeecccc
Q 040698          141 NILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~  160 (309)
                      ||++++++ +.++||+.+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999997743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.01  E-value=9.7e-05  Score=61.35  Aligned_cols=74  Identities=19%  Similarity=0.195  Sum_probs=47.7

Q ss_pred             ceeecccCceEEEEEEcCC--CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEEEEEcCCC
Q 040698           13 RHLLGEGGFGFVYKGVLPD--NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      ++.|..|-...+|++...+  ++.+++|.........  .....|+.+++.+...+ ..+++..+.    ..++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            4678889999999998664  6789999765432211  12246777777774333 344544332    2489999998


Q ss_pred             CCH
Q 040698           90 GTL   92 (309)
Q Consensus        90 ~sL   92 (309)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.96  E-value=0.00025  Score=61.09  Aligned_cols=79  Identities=10%  Similarity=0.082  Sum_probs=54.9

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC---Cccceeeeeeec---CCccEEE
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH---KNVVKILGVCLE---TKVPLLV   83 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~iv   83 (309)
                      -.-.+.||.|..+.+|.....++ ++++|......   ....+..|...|+.+..   -.+.++++++..   .+..++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            33456899999999999986555 46666533211   13467888888887743   357778877654   3667999


Q ss_pred             EEcCCCCCH
Q 040698           84 YEFVPNGTL   92 (309)
Q Consensus        84 ~e~~~~~sL   92 (309)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.95  E-value=0.00012  Score=63.17  Aligned_cols=149  Identities=18%  Similarity=0.167  Sum_probs=83.7

Q ss_pred             HHHhhccccc-----ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceeeee--
Q 040698            3 LVKATKNYDK-----RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKILGV--   73 (309)
Q Consensus         3 ~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~--   73 (309)
                      |....++|.+     .+.+..|....+|+.... +..+++|......    ...+..|+.++..+.+.  .+.+++..  
T Consensus         4 l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~   78 (296)
T cd05153           4 LASFLADYDLGELLSFEGISAGIENTNYFVTTD-SGRYVLTLFEKVS----AEELPFFLALLDHLAERGLPVPRPIADRD   78 (296)
T ss_pred             HHHHHHHcCCCchhheecccCccccceEEEEeC-CCcEEEEEcCCCC----hHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence            4444455554     556777888899988764 4578888765421    33456666666666422  24444432  


Q ss_pred             ----eecCCccEEEEEcCCCCCHHH-----------HHH-hh---cccc-------ccCHH-HHH---------HHHHHH
Q 040698           74 ----CLETKVPLLVYEFVPNGTLFQ-----------HVR-YQ---SSQV-------LKTWK-TCL---------RIAAET  117 (309)
Q Consensus        74 ----~~~~~~~~iv~e~~~~~sL~~-----------~l~-~~---~~~~-------~~~~~-~~~---------~i~~~i  117 (309)
                          ....+..+++++|++|..+..           .+. -+   ....       ...+. ...         .....+
T Consensus        79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  158 (296)
T cd05153          79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL  158 (296)
T ss_pred             CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence                123456689999999876421           010 00   0000       00000 000         001112


Q ss_pred             HHHHHHHHh-------cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          118 ASALDYLHS-------LGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       118 ~~~l~~lh~-------~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ..++.++.+       .+   ++|+|++|.|+++++++.+.|+||+.+.
T Consensus       159 ~~~~~~l~~~~~~~~~~~---l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         159 ADELARQDAFDPSDLPRG---VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HHHHHHHHhhhhhcCCCc---CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            233344432       34   8999999999999988777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00055  Score=61.03  Aligned_cols=77  Identities=14%  Similarity=0.114  Sum_probs=52.7

Q ss_pred             ceeecccCceEEEEEEcCCC-cEEEEEecccch------hhhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCccEE
Q 040698           13 RHLLGEGGFGFVYKGVLPDN-TLVAVKKPKMVD------KILINEVFQHKMRIISQIN---HKNVVKILGVCLETKVPLL   82 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~-~~v~ik~~~~~~------~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~i   82 (309)
                      .+.||.|.+..||++...+| +.+++|.-.+..      .+...++...|...|..+.   ..++.+++.+.  ....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            36789999999999998776 589999743221      1223445666777776652   34566777763  355789


Q ss_pred             EEEcCCCCC
Q 040698           83 VYEFVPNGT   91 (309)
Q Consensus        83 v~e~~~~~s   91 (309)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.88  E-value=0.00025  Score=56.72  Aligned_cols=126  Identities=28%  Similarity=0.429  Sum_probs=86.8

Q ss_pred             cccccceeecccCc-eEEEEEEcCCCcEEEEEeccc---chh----------h-------hhHHHHHHHHHHHhhc---C
Q 040698            8 KNYDKRHLLGEGGF-GFVYKGVLPDNTLVAVKKPKM---VDK----------I-------LINEVFQHKMRIISQI---N   63 (309)
Q Consensus         8 ~~y~i~~~lg~g~~-g~v~~~~~~~~~~v~ik~~~~---~~~----------~-------~~~~~~~~e~~~l~~l---~   63 (309)
                      .+++.++.||.|.- |.||++.. +|..+|+|....   ...          .       .-...|..|.+...++   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 99999987 678999997111   100          0       1112467777666655   4


Q ss_pred             CCcc--ceeeeeeecC------------------CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHH
Q 040698           64 HKNV--VKILGVCLET------------------KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY  123 (309)
Q Consensus        64 h~~i--v~~~~~~~~~------------------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~  123 (309)
                      +.++  ++++||..-.                  ....||.||++...            .....    -+.++.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            5566  8999987311                  11258899886543            11212    23466777899


Q ss_pred             HHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698          124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus       124 lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      +|+.|   ++-+|+++.|..   +|  +++|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR---GG--KLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc---CC--EEEecccC
Confidence            99999   999999999986   33  89999853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.86  E-value=0.00022  Score=61.41  Aligned_cols=150  Identities=18%  Similarity=0.227  Sum_probs=84.5

Q ss_pred             ccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC--CccceeeeeeecCC--ccEEEEEc
Q 040698           11 DKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH--KNVVKILGVCLETK--VPLLVYEF   86 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~iv~e~   86 (309)
                      .+++....|..-.+|..... +++++++...............+|+.+++.+.-  --+...++++.++.  ..+.||+|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             ceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            34444444555555555543 788998844333344445667888888887643  23345566666655  77999999


Q ss_pred             CCCCCHHH----------HHH--------hh-c-------ccc---ccCHHHHHHHHHHH--------------HHHHHH
Q 040698           87 VPNGTLFQ----------HVR--------YQ-S-------SQV---LKTWKTCLRIAAET--------------ASALDY  123 (309)
Q Consensus        87 ~~~~sL~~----------~l~--------~~-~-------~~~---~~~~~~~~~i~~~i--------------~~~l~~  123 (309)
                      +.|..+.+          +..        .. .       ...   ......+..+..+.              .....+
T Consensus       107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            99843321          111        00 0       000   00001111111111              112233


Q ss_pred             HHhcC-----CCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          124 LHSLG-----SPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       124 lh~~~-----~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ++.+.     -..++|||+++.|+++++++.+-|.||+++.+.
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            33322     233899999999999998888999999988653

>PRK05231 homoserine kinase; Provisional

Probab=97.82  E-value=0.00035  Score=60.92  Aligned_cols=28  Identities=25%  Similarity=0.456  Sum_probs=24.6

Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ++|+|+++.||+++.+....++||+.+.
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEeccccc
Confidence            9999999999999866556899999774

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.81  E-value=5e-06  Score=76.01  Aligned_cols=186  Identities=20%  Similarity=0.153  Sum_probs=122.0

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv~e   85 (309)
                      +.-|..-.-+++++++.+++.+....+....+.+...      ....-++++|.+.+||| .+..++-++.+...++.++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            4445555667788888888877322222223433332      22355678999999999 6677777777888999999


Q ss_pred             cCCCC-CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ++.++ +......  .....+..-++..++..-+++++++|+..   -+|+|    ||+.++ +.++.+|++....+...
T Consensus       315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            99877 2211111  00011122234455566677889999874   47777    776664 57899999987655322


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                      .   ......+++.++|||+..   +....|.|++|.-..++--|-+|..
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            1   334556788899999876   7778899999987777777777743

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.77  E-value=0.00046  Score=59.86  Aligned_cols=140  Identities=20%  Similarity=0.220  Sum_probs=76.3

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceeeeee------ecCCccEEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKILGVC------LETKVPLLVY   84 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~------~~~~~~~iv~   84 (309)
                      .+.++.|....+|+....+| .+++|.......   .+.+..+..++..+...  .+.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677787789998876444 677886544322   12334455555555321  233443321      2245668999


Q ss_pred             EcCCCCCHH-----------HHHH-hh---ccc--c------ccCHHHHH------------HHHHHHHHHHHHHHh---
Q 040698           85 EFVPNGTLF-----------QHVR-YQ---SSQ--V------LKTWKTCL------------RIAAETASALDYLHS---  126 (309)
Q Consensus        85 e~~~~~sL~-----------~~l~-~~---~~~--~------~~~~~~~~------------~i~~~i~~~l~~lh~---  126 (309)
                      +|++|..+.           ..+. -+   ...  .      ...+....            .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999985431           1110 00   000  0      00000000            001112233444432   


Q ss_pred             ----cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          127 ----LGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       127 ----~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                          .+   ++|+|+++.|+++++++.+.++||+.+.
T Consensus       183 ~~~~~~---l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRG---VIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCc---cCCCCCCcCcEEEECCceEEEeeccccc
Confidence                45   9999999999999988767899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.76  E-value=0.00075  Score=54.27  Aligned_cols=129  Identities=18%  Similarity=0.185  Sum_probs=85.5

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccch---------------hhhhHHHHHHHHHHHhhc------CCCccceee
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD---------------KILINEVFQHKMRIISQI------NHKNVVKIL   71 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~---------------~~~~~~~~~~e~~~l~~l------~h~~iv~~~   71 (309)
                      ...||+|+.=.||.  +++....+||+.....               ..........|+.....+      .+.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35688888888874  5667778888776655               001123345555444333      378999999


Q ss_pred             eeeecCCccEEEEEcCCC------CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           72 GVCLETKVPLLVYEFVPN------GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        72 ~~~~~~~~~~iv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      |+.+.+..+-+|+|.+.+      .+|.+++....    .+. .+..   .+-.-..+|-+++   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999998888899887543      26677774222    232 3332   3344567888888   99999999999995


Q ss_pred             C---CC-CeEEEe
Q 040698          146 D---NY-TAKVAD  154 (309)
Q Consensus       146 ~---~~-~v~l~d  154 (309)
                      .   +. .+.++|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            2   22 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.45  E-value=0.0018  Score=56.27  Aligned_cols=142  Identities=17%  Similarity=0.188  Sum_probs=89.6

Q ss_pred             ccceeecccCceEEEEEEcCCCcEEEEEecccc-------------------------hhhhhHHHHHHHHHHHhhcCCC
Q 040698           11 DKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMV-------------------------DKILINEVFQHKMRIISQINHK   65 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~-------------------------~~~~~~~~~~~e~~~l~~l~h~   65 (309)
                      +|.+.|..|--+.||-+...+|+.+|||+..-.                         ......-....|+.-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456678889999999999889999999943211                         0111122356677777777655


Q ss_pred             ccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEE
Q 040698           66 NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH-SLGSPPIIHGDVKSANILL  144 (309)
Q Consensus        66 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~~~h~dl~~~nilv  144 (309)
                      .|.-.--+..  ...++||+++....   +..-.-....+....+..+-.+++.-|.-|- ..+   ++|.||+-.|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~---LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR---LVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc---eeccchhhhhheE
Confidence            5432222222  23479999995321   1111111122233455666666666666664 456   9999999999998


Q ss_pred             cCCCCeEEEeeeccccc
Q 040698          145 DDNYTAKVADFASSVLI  161 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~  161 (309)
                      - +|.+.++|.+.+...
T Consensus       299 h-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             E-CCEEEEEEccccccC
Confidence            6 668999999977654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.37  E-value=0.0023  Score=54.51  Aligned_cols=30  Identities=23%  Similarity=0.608  Sum_probs=25.0

Q ss_pred             CeEecCCCCCcEEEcCCCC-eEEEeeecccc
Q 040698          131 PIIHGDVKSANILLDDNYT-AKVADFASSVL  160 (309)
Q Consensus       131 ~~~h~dl~~~nilv~~~~~-v~l~d~g~~~~  160 (309)
                      .++|+|+++.||++++++. +-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997555 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.27  E-value=0.0029  Score=55.76  Aligned_cols=141  Identities=17%  Similarity=0.223  Sum_probs=77.3

Q ss_pred             ceeecccCceEEEEEEcCC-----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEc
Q 040698           13 RHLLGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~   86 (309)
                      ...|..|-.-.+|++...+     ++.+++|.......... . -..|..+++.+..-++ .++++.+..+    .|.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-d-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-D-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-c-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            4456668888999987432     36889997655432211 1 2567777776643333 3555665432    57899


Q ss_pred             CCCCCHHHH--------------HH-hhccc-----cccCHHHHHHHHHHHH-----------------HHHHH----HH
Q 040698           87 VPNGTLFQH--------------VR-YQSSQ-----VLKTWKTCLRIAAETA-----------------SALDY----LH  125 (309)
Q Consensus        87 ~~~~sL~~~--------------l~-~~~~~-----~~~~~~~~~~i~~~i~-----------------~~l~~----lh  125 (309)
                      +++.++...              +. .+...     .......+..+..++.                 ..+..    +.
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987665311              00 00100     0111222333321111                 11111    11


Q ss_pred             h-cCCCCeEecCCCCCcEEEcC-CCCeEEEeeeccc
Q 040698          126 S-LGSPPIIHGDVKSANILLDD-NYTAKVADFASSV  159 (309)
Q Consensus       126 ~-~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~  159 (309)
                      . .....++|+|+++.||++++ ++.+.++||+.+.
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1 11112899999999999976 4689999999764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.20  E-value=0.0043  Score=53.59  Aligned_cols=75  Identities=21%  Similarity=0.254  Sum_probs=46.9

Q ss_pred             ceeecccCceEEEEEEcCC-------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD-------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLLVY   84 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~-------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv~   84 (309)
                      ++.|..|-...+|++...+       ++.+++|........  ......|..++..+.... ..++++++..    .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            3567778888999988654       578999985543221  223466777777664322 2345555432    3689


Q ss_pred             EcCCCCCHH
Q 040698           85 EFVPNGTLF   93 (309)
Q Consensus        85 e~~~~~sL~   93 (309)
                      +|++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            998887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.10  E-value=0.009  Score=52.40  Aligned_cols=74  Identities=15%  Similarity=0.146  Sum_probs=46.2

Q ss_pred             eecccCceEEEEEEcCCC-cEEEEEeccc------chhhhhHHHHHHHHHHHhhcC--CC-ccceeeeeeecCCccEEEE
Q 040698           15 LLGEGGFGFVYKGVLPDN-TLVAVKKPKM------VDKILINEVFQHKMRIISQIN--HK-NVVKILGVCLETKVPLLVY   84 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~~-~~v~ik~~~~------~~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+|.|....||++..++| +.+++|.-.+      ...+....+..-|...|+...  .| .+.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999997654 5799984321      122333445556666666542  34 44455443  345556999


Q ss_pred             EcCCCC
Q 040698           85 EFVPNG   90 (309)
Q Consensus        85 e~~~~~   90 (309)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.06  E-value=0.011  Score=52.80  Aligned_cols=74  Identities=14%  Similarity=0.185  Sum_probs=47.9

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchh------hhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK------ILINEVFQHKMRIISQIN---HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.+|.|....||+.... +..+++|.-.....      +....+...|...|+...   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999998874 45688886542111      111223344455555443   347778888777  445789


Q ss_pred             EEcCCC
Q 040698           84 YEFVPN   89 (309)
Q Consensus        84 ~e~~~~   89 (309)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.04  E-value=0.0085  Score=51.24  Aligned_cols=75  Identities=17%  Similarity=0.190  Sum_probs=46.0

Q ss_pred             ccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc---CCCccceeeeeeecCCccEEEEEcC
Q 040698           11 DKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI---NHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +-.+.++.|....+|... .+++.+.+|.-....    ...+..|..-|+.+   ..-.+.+++++....+..++++||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345578889999999988 467788888765221    34567777666666   3456778999888777789999999


Q ss_pred             CCC
Q 040698           88 PNG   90 (309)
Q Consensus        88 ~~~   90 (309)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.92  E-value=0.018  Score=50.00  Aligned_cols=29  Identities=17%  Similarity=0.463  Sum_probs=26.5

Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +||+|+.++|+++++++.+.++||..++.
T Consensus       198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       198 LVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            99999999999999998999999997753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.85  E-value=0.0099  Score=52.80  Aligned_cols=76  Identities=16%  Similarity=0.130  Sum_probs=48.7

Q ss_pred             ceeecccCceEEEEEEcCC-CcEEEEEeccc-----chhhhhHHHHHHHHHHHhhcC--CC-ccceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD-NTLVAVKKPKM-----VDKILINEVFQHKMRIISQIN--HK-NVVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.||.|.-..||++..++ ++.++||.-.+     .+.+...++..-|...|+...  .| ++.+++.+-  .....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence            5678999999999999743 56788884221     122444556666777776553  34 455555543  4455688


Q ss_pred             EEcCCCC
Q 040698           84 YEFVPNG   90 (309)
Q Consensus        84 ~e~~~~~   90 (309)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9888643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.72  E-value=0.0079  Score=54.64  Aligned_cols=186  Identities=16%  Similarity=0.168  Sum_probs=101.1

Q ss_pred             EEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCccEEEEEcCCCCCHHHHHHhhccc
Q 040698           24 VYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPLLVYEFVPNGTLFQHVRYQSSQ  102 (309)
Q Consensus        24 v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~  102 (309)
                      ++.+..+.|..+ ..-+.....   ...+......++.+.|+|..+.+++... ..+..+|+|++ +.||.+.+.... .
T Consensus         5 ~~~a~~~~~~~c-~nglplt~~---s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l   78 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTPN---SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-L   78 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCCc---HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-c
Confidence            355555555554 332222211   2345566678888999999999988754 34577899999 689988876544 1


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCC
Q 040698          103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP  182 (309)
Q Consensus       103 ~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~P  182 (309)
                      ...+          +.       .++   +.|-+     +       ++.+| -++..      .              |
T Consensus        79 ~~~s----------~~-------~~~---~~~~~-----~-------~~~td-~~~t~------~--------------~  105 (725)
T KOG1093|consen   79 KDES----------LL-------AHG---VLHLN-----I-------IYITD-HFLTK------Y--------------P  105 (725)
T ss_pred             chhh----------hc-------ccc---cceeh-----h-------hhccc-ccccc------C--------------C
Confidence            1101          10       222   22222     1       12222 00000      0              0


Q ss_pred             cccccCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhH
Q 040698          183 EYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASK  262 (309)
Q Consensus       183 E~~~~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  262 (309)
                      -.  ..+++|||++|.++.++.-|...+......+ ......+.+........+.+--      ..-..+.....++..+
T Consensus       106 ~~--~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~-~l~~i~k~~~~d~~~~~~a~e~------~~~~~~d~~~~~~~~~  176 (725)
T KOG1093|consen  106 SP--IGPKSDVWSLGFIILELYLGISLEAELTESE-YLEILLKYYTDDQELLSTAMEH------LIQLLADKKRLPLLKK  176 (725)
T ss_pred             CC--CCcchhhhhHHHHHHHHHHhhHHHHHHHHHH-HHHHHHHhccCchhHHHHHHHH------HHHHhhhHhHHHHhcc
Confidence            00  1248999999999999999887765543222 2222222222222111111111      1122344558899999


Q ss_pred             hhccCCCCCCCHHHH
Q 040698          263 CLRTSGTERPTMRQV  277 (309)
Q Consensus       263 cl~~dp~~Rps~~~l  277 (309)
                      |+-..|..||...++
T Consensus       177 c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  177 CLWLEPIIRPLPMEL  191 (725)
T ss_pred             CCccccccccchhHH
Confidence            999999988865544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.65  E-value=0.067  Score=46.33  Aligned_cols=27  Identities=37%  Similarity=0.434  Sum_probs=24.0

Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ++|||+++.||+++. +.+.++||+.+.
T Consensus       189 liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       189 FCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            899999999999987 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.59  E-value=0.017  Score=50.64  Aligned_cols=74  Identities=18%  Similarity=0.219  Sum_probs=43.8

Q ss_pred             ceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~   87 (309)
                      ++.|..|-...+|+....+    +..+++|..........  .-..|..+++.+..-++ .++++++.. .   +|.+|+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I--dR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi   92 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI--DRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFI   92 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe--chHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehhh
Confidence            4556668888899887432    34788887654322111  12566677776654333 345555532 1   588898


Q ss_pred             CCCCH
Q 040698           88 PNGTL   92 (309)
Q Consensus        88 ~~~sL   92 (309)
                      +|..+
T Consensus        93 ~g~~l   97 (330)
T PLN02421         93 NARTL   97 (330)
T ss_pred             cCCCC
Confidence            87654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.48  E-value=0.00031  Score=70.79  Aligned_cols=207  Identities=10%  Similarity=-0.052  Sum_probs=123.7

Q ss_pred             HHHhhcccccceeecccCceEEEEEE-cCCCcEEEEEecccchh----hhhHHHHHHHHHHHhhcCCCccceeeeeeec-
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKILGVCLE-   76 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~-~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   76 (309)
                      ++-+.+.|++.--++.+.++..-.-. ..++  +.+++....+-    .-..+....|.+-++...|+++.....=... 
T Consensus      1224 M~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1224 MFSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred             HHHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence            44556667766555555554321111 1122  23333222221    1123334445555556678887765554332 


Q ss_pred             -CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHH-HHHHHHHHh--cCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           77 -TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET-ASALDYLHS--LGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        77 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i-~~~l~~lh~--~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                       ....++.++|+.+|.+.+.+...........+......+++ +....-+|.  ++++-.+|.++++-|.+|..+..|++
T Consensus      1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred             CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence             34567899999999999988654433222223344444554 444343332  22233588999999999998989999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchh
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~  213 (309)
                      +++|+.+.-  ...........+++-|+.|+...   ++.++|+|..|+.+|....|..+|-+.
T Consensus      1382 gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1382 GKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred             ccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH
Confidence            999998621  11222233344555666776655   677799999999999999999886543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.44  E-value=0.018  Score=50.17  Aligned_cols=75  Identities=24%  Similarity=0.165  Sum_probs=58.1

Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                      +....|++|++. |+++..       .......++..++.+.+..++-+.++.  ++-||+++..||+|+ .|.|.++||
T Consensus       297 e~~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             CceEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            345667889887 666531       122255778888888888888888764  389999999999999 999999999


Q ss_pred             eccccc
Q 040698          156 ASSVLI  161 (309)
Q Consensus       156 g~~~~~  161 (309)
                      .+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            998753

>PRK06148 hypothetical protein; Provisional

Probab=96.26  E-value=0.072  Score=53.82  Aligned_cols=29  Identities=34%  Similarity=0.564  Sum_probs=24.5

Q ss_pred             eEecCCCCCcEEEcCCC--Ce-EEEeeecccc
Q 040698          132 IIHGDVKSANILLDDNY--TA-KVADFASSVL  160 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~--~v-~l~d~g~~~~  160 (309)
                      ++|+|+++.||+++.++  .+ -|+|||.+..
T Consensus       205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        205 VIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            89999999999998775  45 4999997754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.16  E-value=0.035  Score=45.12  Aligned_cols=88  Identities=16%  Similarity=0.203  Sum_probs=57.2

Q ss_pred             HHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 040698           49 NEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG  128 (309)
Q Consensus        49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~  128 (309)
                      ...+..+++++.++.  .|+++..-  +....-+|.|+|-....            .+..    ++..-+.+|.-.|+..
T Consensus       102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N----~i~agi~~L~~fH~~~  161 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSN----FITAGIKDLMDFHSEN  161 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhH----HHHHhHHHHHHhhccC
Confidence            445677788887764  35555521  33445599999843211            0111    1112245677888543


Q ss_pred             CCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698          129 SPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus       129 ~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                       ..+.|||-.|+||+-|..|-+|+.|-+.
T Consensus       162 -~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  162 -QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -CCeecCCCChhheeecCCCCEEecChhh
Confidence             3399999999999999999999999764

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.09  E-value=0.088  Score=47.06  Aligned_cols=76  Identities=21%  Similarity=0.273  Sum_probs=44.2

Q ss_pred             cceeecccCceEEEEEEcCCC--c-----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEE
Q 040698           12 KRHLLGEGGFGFVYKGVLPDN--T-----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLV   83 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~--~-----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv   83 (309)
                      ..+.|..|-...+|++...++  .     .|+++......... . .-..|+.+++.+...++ .++++.+..    +++
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-I-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-e-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            345666799999999975432  2     24444322211111 1 12556777877754433 456666653    589


Q ss_pred             EEcCCCCCHH
Q 040698           84 YEFVPNGTLF   93 (309)
Q Consensus        84 ~e~~~~~sL~   93 (309)
                      .||++|.+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999987653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.40  E-value=0.43  Score=41.74  Aligned_cols=71  Identities=13%  Similarity=-0.009  Sum_probs=41.6

Q ss_pred             cCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceee---e--eeecCCccEEEEEcCCCCC
Q 040698           19 GGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKIL---G--VCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        19 g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~iv~e~~~~~s   91 (309)
                      +.-..||.....+|..+++|.......  ....+..|...+..+...  .++...   +  +...++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            344668888877788899998754322  234456666666655311  122221   1  1222456678999998764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.34  E-value=0.27  Score=40.40  Aligned_cols=74  Identities=19%  Similarity=0.211  Sum_probs=48.7

Q ss_pred             eecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc---CCCccceeeeeeecCCccEEEEEcCCCCC
Q 040698           15 LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI---NHKNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        15 ~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      .+..|.--..|...+ +..++.+|+-....    ...|..|..-|..+   +.-.|.+++.+..+.+..|+|+||++-+.
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~~~----~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQREQ----LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecchhh----HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            444455455555543 45678888654432    34456666555544   45667888888888999999999999766


Q ss_pred             HH
Q 040698           92 LF   93 (309)
Q Consensus        92 L~   93 (309)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.34  E-value=0.079  Score=44.39  Aligned_cols=79  Identities=16%  Similarity=0.060  Sum_probs=54.3

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC-CCCC
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV-PNGT   91 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~-~~~s   91 (309)
                      ...+..|..+.|+.+...+|...++|..........  . ......|+..+-...|++++.-.+  .-.+.+|.+ ++.+
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~--E-~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~g~~   81 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH--E-ARGEAALRWWNGRGAVRLLAADPE--RGALLLERLDPGRS   81 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh--h-hhHHhHhheeCCCCceeeeccccc--cchhhhhhccCCCc
Confidence            445678999999999998999999998765432111  1 111245777788888999887644  345888888 5556


Q ss_pred             HHHHH
Q 040698           92 LFQHV   96 (309)
Q Consensus        92 L~~~l   96 (309)
                      |.+..
T Consensus        82 L~~~~   86 (253)
T PF04655_consen   82 LASLP   86 (253)
T ss_pred             hhhcc
Confidence            65443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.30  E-value=0.27  Score=43.00  Aligned_cols=136  Identities=18%  Similarity=0.245  Sum_probs=73.3

Q ss_pred             CceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc--cee----ee----eeecCCccEEEEEcCCC
Q 040698           20 GFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV--VKI----LG----VCLETKVPLLVYEFVPN   89 (309)
Q Consensus        20 ~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~----~~----~~~~~~~~~iv~e~~~~   89 (309)
                      .-..+|+....+|.. ++|..... ..  ...+..|...+..+.-..+  ...    =|    ........+-+++|++|
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            456678887766665 88887765 22  4456677777777632211  111    11    11111366789999999


Q ss_pred             CCHHH-H-----------H-------Hhhc-----cccccCHHH-------------HHHHHHHHHHHHHHHHh------
Q 040698           90 GTLFQ-H-----------V-------RYQS-----SQVLKTWKT-------------CLRIAAETASALDYLHS------  126 (309)
Q Consensus        90 ~sL~~-~-----------l-------~~~~-----~~~~~~~~~-------------~~~i~~~i~~~l~~lh~------  126 (309)
                      ..+.. .           +       +...     ......+..             -.....++...+..+..      
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            87762 1           0       0000     000001110             00011222223333332      


Q ss_pred             -cCCCCeEecCCCCCcEEEcCCCC-eEEEeeeccc
Q 040698          127 -LGSPPIIHGDVKSANILLDDNYT-AKVADFASSV  159 (309)
Q Consensus       127 -~~~~~~~h~dl~~~nilv~~~~~-v~l~d~g~~~  159 (309)
                       .+...++|+|+.+.||+++.+.. +.++||+.+.
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             11122799999999999998874 8999999764

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.63  E-value=0.089  Score=44.61  Aligned_cols=46  Identities=24%  Similarity=0.217  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698          114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       114 ~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      +..+-.++.-.+... ..+||+|+.|.|++.++.+.+.++||..+..
T Consensus       138 ~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         138 LKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            333444444444440 1289999999999999989999999997753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	309
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-30
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-22
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-22
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-22
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-22
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-22
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-17
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-06
3soa_A	444	Full-Length Human Camkii Length = 444		6e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		9e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 100/286 (34%), Positives = 158/286 (55%), Gaps = 5/286 (1%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           EL  A+ N+  +++LG GGFG VYKG L D TLVAVK+ K          FQ ++ +IS 
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISM 91
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASA 120
             H+N++++ G C+     LLVY ++ NG++   +R +  SQ    W    RIA  +A  
Sbjct: 92  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 151
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L YLH    P IIH DVK+ANILLD+ + A V DF  + L+   D          T+G +
Sbjct: 152 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR-GTIGHI 210
Query: 181 DPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PEYL     +EK+DV+ +GV+L+EL+TG+       LA+++   ++ +    ++   L 
Sbjct: 211 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 270
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
            +++  +    + EE+E + ++A  C ++S  ERP M +V   L+ 
Sbjct: 271 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 99/287 (34%), Positives = 160/287 (55%), Gaps = 7/287 (2%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV-FQHKMRIIS 60
           EL  A+ N+  +++LG GGFG VYKG L D  LVAVK+ K  ++    E+ FQ ++ +IS
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE-ERTQGGELQFQTEVEMIS 82
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETAS 119
              H+N++++ G C+     LLVY ++ NG++   +R +  SQ    W    RIA  +A 
Sbjct: 83  MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLH    P IIH DVK+ANILLD+ + A V DF  + L+   D           +G 
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR-GXIGH 201
Query: 180 LDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           + PEYL     +EK+DV+ +GV+L+EL+TG+       LA+++   ++ +    ++   L
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
             +++  +    + EE+E + ++A  C ++S  ERP M +V   L+ 
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 108/294 (36%), Positives = 158/294 (53%), Gaps = 12/294 (4%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           +L +AT N+D + L+G G FG VYKGVL D   VA+K+ +  +     E F+ ++  +S 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEIETLSF 91
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETAS 119
             H ++V ++G C E    +L+Y+++ NG L +H+ Y S    +  +W+  L I    A 
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-YGSDLPTMSMSWEQRLEICIGAAR 150
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLH+     IIH DVKS NILLD+N+  K+ DF  S   +  DQT        T+G+
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           +DPEY      TEKSDVYSFGVVL E+L  +   + V     EM  +  +      N  L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
            QI++  +AD+   E +      A KCL  S  +RP+M  V  +L+   RL E+
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 157/294 (53%), Gaps = 12/294 (4%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           +L +AT N+D + L+G G FG VYKGVL D   VA+K+ +  +     E F+ ++  +S 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEIETLSF 91
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSS--QVLKTWKTCLRIAAETAS 119
             H ++V ++G C E    +L+Y+++ NG L +H+ Y S    +  +W+  L I    A 
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-YGSDLPTMSMSWEQRLEICIGAAR 150
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLH+     IIH DVKS NILLD+N+  K+ DF  S   +   QT        T+G+
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           +DPEY      TEKSDVYSFGVVL E+L  +   + V     EM  +  +      N  L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
            QI++  +AD+   E +      A KCL  S  +RP+M  V  +L+   RL E+
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/301 (30%), Positives = 157/301 (52%), Gaps = 33/301 (10%)
Query: 2   ELVKATKNYDKRHL------LGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKIL--INEVF 52
           EL   T N+D+R +      +GEGGFG VYKG + +NT VAVKK   MVD     + + F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
             +++++++  H+N+V++LG   +     LVY ++PNG+L   +         +W    +
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
           IA   A+ +++LH       IH D+KSANILLD+ +TAK++DF  +       QT   ++
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 173 EIETVGWLDPEYLFW--TEKSDVYSFGVVLVELLTG-------KHPRSYVALASNEMTRM 223
            + T  ++ PE L    T KSD+YSFGVVL+E++TG       + P+  + +        
Sbjct: 195 IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254
Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
                Y      + + +N     + +   +E +  +AS+CL     +RP +++V + L  
Sbjct: 255 KTIEDY------IDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 284 L 284
           +
Sbjct: 304 M 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/301 (30%), Positives = 156/301 (51%), Gaps = 33/301 (10%)
Query: 2   ELVKATKNYDKRHL------LGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKIL--INEVF 52
           EL   T N+D+R +      +GEGGFG VYKG + +NT VAVKK   MVD     + + F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
             +++++++  H+N+V++LG   +     LVY ++PNG+L   +         +W    +
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
           IA   A+ +++LH       IH D+KSANILLD+ +TAK++DF  +       QT    +
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 173 EIETVGWLDPEYLFW--TEKSDVYSFGVVLVELLTG-------KHPRSYVALASNEMTRM 223
            + T  ++ PE L    T KSD+YSFGVVL+E++TG       + P+  + +        
Sbjct: 195 IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254
Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
                Y      + + +N     + +   +E +  +AS+CL     +RP +++V + L  
Sbjct: 255 KTIEDY------IDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 284 L 284
           +
Sbjct: 304 M 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 155/301 (51%), Gaps = 33/301 (10%)
Query: 2   ELVKATKNYDKRHL------LGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKIL--INEVF 52
           EL   T N+D+R +      +GEGGFG VYKG + +NT VAVKK   MVD     + + F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 71
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
             +++++++  H+N+V++LG   +     LVY ++PNG+L   +         +W    +
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 131
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
           IA   A+ +++LH       IH D+KSANILLD+ +TAK++DF  +       Q     +
Sbjct: 132 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 173 EIETVGWLDPEYLFW--TEKSDVYSFGVVLVELLTG-------KHPRSYVALASNEMTRM 223
            + T  ++ PE L    T KSD+YSFGVVL+E++TG       + P+  + +        
Sbjct: 189 IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 248
Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
                Y      + + +N     + +   +E +  +AS+CL     +RP +++V + L  
Sbjct: 249 KTIEDY------IDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297
Query: 284 L 284
           +
Sbjct: 298 M 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/298 (30%), Positives = 148/298 (49%), Gaps = 33/298 (11%)
Query: 2   ELVKATKNYDKRHL------LGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKIL--INEVF 52
           EL   T N+D+R +       GEGGFG VYKG + +NT VAVKK   MVD     + + F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 68
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
             ++++ ++  H+N+V++LG   +     LVY + PNG+L   +         +W    +
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCK 128
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
           IA   A+ +++LH       IH D+KSANILLD+ +TAK++DF  +       Q    ++
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 173 EIETVGWLDPEYLFW--TEKSDVYSFGVVLVELLTG-------KHPRSYVALASNEMTRM 223
            + T  +  PE L    T KSD+YSFGVVL+E++TG       + P+  + +        
Sbjct: 186 IVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 245
Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
                Y  +             ++ +   +E    +AS+CL     +RP +++V + L
Sbjct: 246 KTIEDYIDKK-----------XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 122/220 (55%), Gaps = 35/220 (15%)
Query: 10  YDKRHLLGEGGFGFVYKGVL-PDNTLVAVK---------KPKMVDKILINEVFQHKMRII 59
           Y+K+  +G+GGFG V+KG L  D ++VA+K         + +M++K    + FQ ++ I+
Sbjct: 23  YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF---QEFQREVFIM 77
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           S +NH N+VK+ G  L    P +V EFVP G L+  +  ++  +   W   LR+  + A 
Sbjct: 78  SNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIAL 133
Query: 120 ALDYLHSLGSPPIIHGDVKSANILL---DDN--YTAKVADFASSVLISSHDQTATTTKEI 174
            ++Y+ +  +PPI+H D++S NI L   D+N    AKVADF +S          + +  +
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLL 187
Query: 175 ETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHP 209
               W+ PE +      +TEK+D YSF ++L  +LTG+ P
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 122/220 (55%), Gaps = 35/220 (15%)
Query: 10  YDKRHLLGEGGFGFVYKGVL-PDNTLVAVK---------KPKMVDKILINEVFQHKMRII 59
           Y+K+  +G+GGFG V+KG L  D ++VA+K         + +M++K    + FQ ++ I+
Sbjct: 23  YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF---QEFQREVFIM 77
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           S +NH N+VK+ G  L    P +V EFVP G L+  +  ++  +   W   LR+  + A 
Sbjct: 78  SNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIAL 133
Query: 120 ALDYLHSLGSPPIIHGDVKSANILL---DDN--YTAKVADFASSVLISSHDQTATTTKEI 174
            ++Y+ +  +PPI+H D++S NI L   D+N    AKVADF+ S          + +  +
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLL 187
Query: 175 ETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHP 209
               W+ PE +      +TEK+D YSF ++L  +LTG+ P
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 121/220 (55%), Gaps = 35/220 (15%)
Query: 10  YDKRHLLGEGGFGFVYKGVL-PDNTLVAVK---------KPKMVDKILINEVFQHKMRII 59
           Y+K+  +G+GGFG V+KG L  D ++VA+K         + +M++K    + FQ ++ I+
Sbjct: 23  YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF---QEFQREVFIM 77
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           S +NH N+VK+ G  L    P +V EFVP G L+  +  ++  +   W   LR+  + A 
Sbjct: 78  SNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIAL 133
Query: 120 ALDYLHSLGSPPIIHGDVKSANILL---DDN--YTAKVADFASSVLISSHDQTATTTKEI 174
            ++Y+ +  +PPI+H D++S NI L   D+N    AKVADF  S          + +  +
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLL 187
Query: 175 ETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHP 209
               W+ PE +      +TEK+D YSF ++L  +LTG+ P
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 150/318 (47%), Gaps = 44/318 (13%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
            + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 59
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMAT 118
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 119 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 174
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 216
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 270
Query: 292 WAQKNSEETEQLLGESST 309
                S+E E+ LG+  T
Sbjct: 271 QESSISDEVEKELGKRGT 288

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 151/318 (47%), Gaps = 44/318 (13%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
           ++ NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 64
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMAT 123
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 124 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 179
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 221
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 275
Query: 292 WAQKNSEETEQLLGESST 309
                S+E E+ LG+  T
Sbjct: 276 QESSISDEVEKELGKRGT 293

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 150/318 (47%), Gaps = 44/318 (13%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
            + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 59
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMAT 118
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 119 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 174
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 216
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 270
Query: 292 WAQKNSEETEQLLGESST 309
                S+E E+ LG+  T
Sbjct: 271 QESSISDEVEKELGKRGT 288

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 144/298 (48%), Gaps = 34/298 (11%)
Query: 13  RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +H LG G FG VY+GV    +L    K    D + + E F  +  ++ +I H N+V++LG
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC       ++ EF+  G L  ++R  + Q +      L +A + +SA++YL        
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN---F 130
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE--- 189
           IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L + +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSI 189
Query: 190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADEN 248
           KSDV++FGV+L E            +A+  M+      PYP I+ + + ++L      E 
Sbjct: 190 KSDVWAFGVLLWE------------IATYGMS------PYPGIDPSQVYELLEKDYRMER 231
Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLLGE 306
                E V +L   C + + ++RP+  ++ +  +++      F     S+E E+ LG+
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQESSISDEVEKELGK 283

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 150/316 (47%), Gaps = 44/316 (13%)
Query: 5   KATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQH 54
           + + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  
Sbjct: 13  QGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLK 71
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           +  ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMA 130
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    + 
Sbjct: 131 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 175 ETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP- 230
             + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP 
Sbjct: 188 -PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPG 228
Query: 231 IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
           I+ + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      
Sbjct: 229 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------ 282
Query: 291 FWAQKNSEETEQLLGE 306
           F     S+E E+ LG+
Sbjct: 283 FQESSISDEVEKELGK 298

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 149/314 (47%), Gaps = 44/314 (14%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 61
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 120
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-P 176
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 218
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 219 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 272
Query: 293 AQKNSEETEQLLGE 306
               S+E E+ LG+
Sbjct: 273 ESSISDEVEKELGK 286

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 149/314 (47%), Gaps = 44/314 (14%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 62
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 121
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-P 177
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 219
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 220 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 273
Query: 293 AQKNSEETEQLLGE 306
               S+E E+ LG+
Sbjct: 274 ESSISDEVEKELGK 287

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 148/314 (47%), Gaps = 44/314 (14%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
            + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 59
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMAT 118
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 119 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 174
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 216
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 270
Query: 292 WAQKNSEETEQLLG 305
                S+E E+ LG
Sbjct: 271 QESSISDEVEKELG 284

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 149/314 (47%), Gaps = 44/314 (14%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 61
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 120
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 121 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-P 176
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 218
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 219 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 272
Query: 293 AQKNSEETEQLLGE 306
               S+E E+ LG+
Sbjct: 273 ESSISDEVEKELGK 286

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 148/314 (47%), Gaps = 44/314 (14%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
            + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 59
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMAT 118
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 119 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 174
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 216
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 270
Query: 292 WAQKNSEETEQLLG 305
                S+E E+ LG
Sbjct: 271 QESSISDEVEKELG 284

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 150/317 (47%), Gaps = 44/317 (13%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
           ++ NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 64
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMAT 123
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 124 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 179
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 221
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------F 275
Query: 292 WAQKNSEETEQLLGESS 308
                S+E E+ LG+  
Sbjct: 276 QESSISDEVEKELGKQG 292

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 149/314 (47%), Gaps = 44/314 (14%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 62
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 121
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 122 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 177
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 219
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 220 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 273
Query: 293 AQKNSEETEQLLGE 306
               S+E E+ LG+
Sbjct: 274 ESSISDEVEKELGK 287

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 148/312 (47%), Gaps = 44/312 (14%)
Query: 9   NYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRI 58
           NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 64
Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           + +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A + +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQIS 123
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
           SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   + 
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 179
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENN 234
           W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+ +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGIDLS 221
Query: 235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ 294
            + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F   
Sbjct: 222 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQES 275
Query: 295 KNSEETEQLLGE 306
             S+E E+ LG+
Sbjct: 276 SISDEVEKELGK 287

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 150/317 (47%), Gaps = 44/317 (13%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 209 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 267
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQ 326
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH ++ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 327 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 382
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 424
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 425 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 478
Query: 293 AQKNSEETEQLLGESST 309
               S+E E+ LG+  T
Sbjct: 479 ESSISDEVEKELGKRGT 495

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
           ++ NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 64
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMAT 123
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 124 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF- 179
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 221
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
           ++ NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 64
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMAT 123
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 124 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 179
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 221
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 6   ATKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK 55
           ++ NYDK          +H LG G +G VY+GV    +L    K    D + + E F  +
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 64
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A 
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVLLYMAT 123
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +  
Sbjct: 124 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF- 179
Query: 176 TVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-I 231
            + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGI 221
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           + + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 38/292 (13%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 64
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 123
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 124 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 179
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 221
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 38/292 (13%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 60
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 119
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 175
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 217
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 144/298 (48%), Gaps = 34/298 (11%)
Query: 13  RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +H LG G +G VY+GV    +L    K    D + + E F  +  ++ +I H N+V++LG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC       ++ EF+  G L  ++R  + Q +      L +A + +SA++YL        
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN---F 130
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE--- 189
           IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L + +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPESLAYNKFSI 189
Query: 190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADEN 248
           KSDV++FGV+L E            +A+  M+      PYP I+ + + ++L      E 
Sbjct: 190 KSDVWAFGVLLWE------------IATYGMS------PYPGIDPSQVYELLEKDYRMER 231
Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLLGE 306
                E V +L   C + + ++RP+  ++ +  +++      F     S+E E+ LG+
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQESSISDEVEKELGK 283

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 38/292 (13%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 60
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 119
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH D+ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 175
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 217
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 28/276 (10%)
Query: 13  RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +H LG G +G VY+GV    +L    K    D + + E F  +  ++ +I H N+V++LG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 74
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC       ++ EF+  G L  ++R  + Q +      L +A + +SA++YL        
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN---F 130
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE--- 189
           IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L + +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSI 189
Query: 190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADEN 248
           KSDV++FGV+L E            +A+  M+      PYP I+ + + ++L      E 
Sbjct: 190 KSDVWAFGVLLWE------------IATYGMS------PYPGIDPSQVYELLEKDYRMER 231
Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                E V +L   C + + ++RP+  ++ +  +++
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 32/280 (11%)
Query: 16  LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +G G FG V+ G L  DNTLVAVK  +      +   F  + RI+ Q +H N+V+++GVC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            + +   +V E V  G     +R + +++    KT L++  + A+ ++YL    S   IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKS 191
            D+ + N L+ +    K++DF  S   +     A+       V W  PE   Y  ++ +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 192 DVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADENEM 250
           DV+SFG++L E  +         L ++         PYP + N   R+ +  +       
Sbjct: 297 DVWSFGILLWETFS---------LGAS---------PYPNLSNQQTREFV--EKGGRLPC 336
Query: 251 EEI--EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
            E+  + V +L  +C      +RP+   + ++L S+R+ H
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 149/314 (47%), Gaps = 44/314 (14%)
Query: 7   TKNYDK----------RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM 56
           + NYDK          +H LG G +G VY+GV    +L    K    D + + E F  + 
Sbjct: 248 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEA 306
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            ++ +I H N+V++LGVC       ++ EF+  G L  ++R  + Q +      L +A +
Sbjct: 307 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVLLYMATQ 365
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            +SA++YL        IH ++ + N L+ +N+  KVADF  S L++    TA    +   
Sbjct: 366 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 421
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IE 232
           + W  PE L + +   KSDV++FGV+L E            +A+  M+      PYP I+
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWE------------IATYGMS------PYPGID 463
Query: 233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            + + ++L      E      E V +L   C + + ++RP+  ++ +  +++      F 
Sbjct: 464 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQ 517
Query: 293 AQKNSEETEQLLGE 306
               S+E E+ LG+
Sbjct: 518 ESSISDEVEKELGK 531

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 32/280 (11%)
Query: 16  LGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +G G FG V+ G L  DNTLVAVK  +      +   F  + RI+ Q +H N+V+++GVC
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            + +   +V E V  G     +R + +++    KT L++  + A+ ++YL    S   IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKS 191
            D+ + N L+ +    K++DF  S   +     A+       V W  PE   Y  ++ +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 192 DVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVADENEM 250
           DV+SFG++L E  +         L ++         PYP + N   R+ +  +       
Sbjct: 297 DVWSFGILLWETFS---------LGAS---------PYPNLSNQQTREFV--EKGGRLPC 336
Query: 251 EEI--EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
            E+  + V +L  +C      +RP+   + ++L S+R+ H
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 128
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 187
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 188 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 226
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 227 PPECPESLHDLMCQCWRKEPEERPTF 252

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 131
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 190
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 191 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 229
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 230 PPECPESLHDLMCQCWRKEPEERPTF 255

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ +I H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 364 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 402
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 364 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 402
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 36/265 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPT 273
             E  E +  L  +C R    ERPT
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 447 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 485
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 486 PPECPESLHDLMCQCWRKEPEERPTF 511

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 364 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 402
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 15/205 (7%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKNVVKILGVC 74
           +G G FG VYKG    +  VAVK  K+VD      + F++++ ++ +  H N++  +G  
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            +  + + V ++    +L++H+  Q ++        + IA +TA  +DYLH+     IIH
Sbjct: 102 TKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---IIH 155
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE----- 189
            D+KS NI L +  T K+ DF  + + S    +    +   +V W+ PE +   +     
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 190 -KSDVYSFGVVLVELLTGKHPRSYV 213
            +SDVYS+G+VL EL+TG+ P S++
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYSHI 240

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 129
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 189 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 227
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 228 PPECPESLHDLMCQCWRKDPEERPTF 253

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 127
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 186
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 187 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 225
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 226 PPECPESLHDLMCQCWRKDPEERPTF 251

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 36/265 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPT 273
             E  E +  L  +C R    ERPT
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + ++A+ AS + Y+  +     +H 
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRL-PQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSD 194
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 195 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 233
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 234 PPECPESLHDLMCQCWRKEPEERPTF 259

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ ++ + L+     + ++A+ AS + Y+  +     +H 
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRL-PQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 194
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 195 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 233
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 234 PPECPESLHDLMCQCWRKEPEERPTF 259

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 34/279 (12%)
Query: 13  RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +H LG G +G VY GV    +L    K    D + + E F  +  ++ +I H N+V++LG
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 95
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC       +V E++P G L  ++R + ++   T    L +A + +SA++YL        
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEYLEKKN---F 151
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE--- 189
           IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L +     
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNTFSI 210
Query: 190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE 249
           KSDV++FGV+L E            +A+  M+      PYP     L Q+ +  +     
Sbjct: 211 KSDVWAFGVLLWE------------IATYGMS------PYP--GIDLSQVYDL-LEKGYR 249
Query: 250 MEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           ME+ E     V +L   C + S  +RP+  +  +  +++
Sbjct: 250 MEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K  +  +  E F  + +++ ++ H+ +V++  V  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 305
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ +N   KVADF    LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 364
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 365 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 403
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 404 PPECPESLHDLMCQCWRKDPEERPTF 429

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 36/266 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG+G FG V+ G     T VA+K  K     +  E F  + +++ ++ H+ +V++  V  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E  +  +V E++  G+L   ++ +  + L+     + +AA+ AS + Y+  +     +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ +ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM-- 250
           V+SFG++L EL T                      PYP   N  R++L+ QV     M  
Sbjct: 198 VWSFGILLTELTTKGR------------------VPYPGMVN--REVLD-QVERGYRMPC 236
Query: 251 --EEIEIVAKLASKCLRTSGTERPTM 274
             E  E +  L  +C R    ERPT 
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G FG V++      + VAVK     D     +NE F  ++ I+ ++ H N+V  +G 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMGA 102
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             +     +V E++  G+L++ +    ++     +  L +A + A  ++YLH+  +PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISS---HDQTATTTKEIETVGWLDPEYLF---W 187
           H D+KS N+L+D  YT KV DF  S L +S     + A  T E     W+ PE L     
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPE-----WMAPEVLRDEPS 216
Query: 188 TEKSDVYSFGVVLVELLTGKHP 209
            EKSDVYSFGV+L EL T + P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 40/277 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V+ G    NT VA+K  KP  +      E F  + +I+ ++ H  +V++  V
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             E  +  +V E++  G+L   ++    + LK     + +AA+ A+ + Y+  +     I
Sbjct: 73  VSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKL-PNLVDMAAQVAAGMAYIERMN---YI 127
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEK 190
           H D++SANIL+ +    K+ADF  + LI  ++ TA    +   + W  PE   Y  +T K
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIK 186
Query: 191 SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           SDV+SFG++L EL+T                      PYP  NN  R++L  QV     M
Sbjct: 187 SDVWSFGILLTELVTKGR------------------VPYPGMNN--REVLE-QVERGYRM 225
Query: 251 ---EEIEI-VAKLASKCLRTSGTERPTMRQVSEQLDS 283
              ++  I + +L   C +    ERPT   +   L+ 
Sbjct: 226 PCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLED 262

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      +LP  D  LVAVK  K   +    + FQ +  +++ + H+++V+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQS--SQVLKTWKTC----------LRIAAET 117
             GVC E +  L+V+E++ +G L + +R     +++L   +            L +A++ 
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A+ + YL  L     +H D+ + N L+      K+ DF  S  I S D      + +  +
Sbjct: 145 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 178 GWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            W+ PE   Y  +T +SDV+SFGVVL E+ T GK P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      +LP  D  LVAVK  K   +    + FQ +  +++ + H+++V+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIVR 78
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQS--SQVLKTWKTC----------LRIAAET 117
             GVC E +  L+V+E++ +G L + +R     +++L   +            L +A++ 
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A+ + YL  L     +H D+ + N L+      K+ DF  S  I S D      + +  +
Sbjct: 139 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 178 GWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            W+ PE   Y  +T +SDV+SFGVVL E+ T GK P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 16  LGEGGFGFVY----KGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      +LP  D  LVAVK  K   +    + FQ +  +++ + H+++V+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIVR 107
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQS--SQVLKTWKTC----------LRIAAET 117
             GVC E +  L+V+E++ +G L + +R     +++L   +            L +A++ 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A+ + YL  L     +H D+ + N L+      K+ DF  S  I S D      + +  +
Sbjct: 168 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 178 GWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            W+ PE   Y  +T +SDV+SFGVVL E+ T GK P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G FG V++      + VAVK     D     +NE F  ++ I+ ++ H N+V  +G 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMGA 102
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             +     +V E++  G+L++ +    ++     +  L +A + A  ++YLH+  +PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISS---HDQTATTTKEIETVGWLDPEYLF---W 187
           H ++KS N+L+D  YT KV DF  S L +S     ++A  T E     W+ PE L     
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE-----WMAPEVLRDEPS 216
Query: 188 TEKSDVYSFGVVLVELLTGKHP 209
            EKSDVYSFGV+L EL T + P
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 140/284 (49%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 71
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+   +S+     K  + IA +TA  +DYLH+  
Sbjct: 72  LFMGYSTKPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA-- 126
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 127 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 187 ----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
               ++ +SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R     
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCP- 243
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                      + + +L ++CL+    ERP+  ++  +++ L R
Sbjct: 244 -----------KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 116/240 (48%), Gaps = 36/240 (15%)
Query: 16  LGEGGFGFVYK----GVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +GEG FG V++    G+LP    T+VAVK  K      +   FQ +  ++++ ++ N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWK------------------TC- 110
           +LGVC   K   L++E++  G L + +R  S   + +                    +C 
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 111 --LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA 168
             L IA + A+ + YL        +H D+ + N L+ +N   K+ADF  S  I S D   
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
               +   + W+ PE +F   +T +SDV+++GVVL E+ + G  P  Y  +A  E+   V
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAHEEVIYYV 289

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 198
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 199 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 239
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 240 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 273

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 87  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 200
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 201 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 241
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 242 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 275

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 139/284 (48%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 83
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+   +S+     K  + IA +TA  +DYLH+  
Sbjct: 84  LFMGYSTKPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              IIH D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE +   
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 187 ----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
               ++ +SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R     
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCP- 255
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                      + + +L ++CL+    ERP+  ++  +++ L R
Sbjct: 256 -----------KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 88  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 201
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 202 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 242
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 243 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 276

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 192
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 193 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 233
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 234 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 89  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 202
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 203 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 243
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 244 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 277

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 81  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 194
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 195 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 235
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 236 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 269

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 192
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 193 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 233
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 234 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 80  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 193
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 194 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 234
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 235 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 268

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 198
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 199 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 239
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 240 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 273

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  +  ++ +++H  +V++ GVCL
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EASVIHR 127
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 187 VWSFGVLMWEVFSEGKIP 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 84  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 197
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 198 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 238
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 239 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 272

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 135/285 (47%), Gaps = 45/285 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 74  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 187
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 188 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 228
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
           N  EE+  + +L   C +    +RPT        D LR + E+F+
Sbjct: 229 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDFF 263

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKNVVKILGVC 74
           +G G FG VYKG    +  VAVK   +        + F++++ ++ +  H N++  +G  
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
              ++ + V ++    +L+ H+   +S+     K  + IA +TA  +DYLH+     IIH
Sbjct: 90  TAPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF------WT 188
            D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE +       ++
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
            +SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R           
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCP------- 255
Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                + + +L ++CL+    ERP+  ++  +++ L R
Sbjct: 256 -----KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  +  ++ +++H  +V++ GVCL
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHR 125
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 185 VWSFGVLMWEVFSEGKIP 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  +  ++ +++H  +V++ GVCL
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHR 127
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 187 VWSFGVLMWEVFSEGKIP 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  +  ++ +++H  +V++ GVCL
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHR 130
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 190 VWSFGVLMWEVFSEGKIP 207

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 192
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 193 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 233
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 234 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 133/298 (44%), Gaps = 52/298 (17%)
Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKI 70
           ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++ +H N++ +
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       L  E+ P+G L   +R   S+VL+T                +  L  AA
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A  +DYL        IH D+ + NIL+ +NY AK+ADF    L    +     T    
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 193
Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 245
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
           +   L + LN    DE        V  L  +C R    ERP+  Q+   L SL R+ E
Sbjct: 246 QGYRLEKPLN--CDDE--------VYDLMRQCWREKPYERPSFAQI---LVSLNRMLE 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 141/289 (48%), Gaps = 41/289 (14%)
Query: 12  KRHLLGEGGFGFVYKGVLPDNT-----LVAVK--KPKMVDKILINEVFQHKMRIISQINH 64
           ++ ++G G FG VYKG+L  ++      VA+K  K    +K  ++  F  +  I+ Q +H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSH 105
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQ--VLKTWKTCLRIAAETASALD 122
            N++++ GV  + K  +++ E++ NG L + +R +  +  VL+       IAA     + 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA----GMK 161
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLD 181
           YL ++     +H D+ + NIL++ N   KV+DF  S VL    + T TT+     + W  
Sbjct: 162 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 182 PE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           PE   Y  +T  SDV+SFG+V+ E++T G+ P  Y  L+++E+ + +        N+  R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAI--------NDGFR 268
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                       M+    + +L  +C +     RP    +   LD L R
Sbjct: 269 L--------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 133/298 (44%), Gaps = 52/298 (17%)
Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKI 70
           ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++ +H N++ +
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       L  E+ P+G L   +R   S+VL+T                +  L  AA
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A  +DYL        IH D+ + NIL+ +NY AK+ADF    L    +     T    
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 203
Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 255
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
           +   L + LN    DE        V  L  +C R    ERP+  Q+   L SL R+ E
Sbjct: 256 QGYRLEKPLN--CDDE--------VYDLMRQCWREKPYERPSFAQI---LVSLNRMLE 300

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 26/229 (11%)
Query: 16  LGEGGFGFVYKG----VLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+      + P  D  LVAVK  K        + F  +  +++ + H+++VK
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-FHREAELLTNLQHEHIVK 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAETAS 119
             GVC+E    ++V+E++ +G L + +R      +           T    L IA + A+
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            + Y   L S   +H D+ + N L+ +N   K+ DF  S  + S D        +  + W
Sbjct: 140 GMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 180 LDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + PE   Y  +T +SDV+S GVVL E+ T GK P  +  L++NE+   +
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECI 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 152
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +L    D     T     V W+  E L  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  K  +  +  + F  +  ++ +++H  +V++ GVCL
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK--EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV+EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHR 147
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 207 VWSFGVLMWEVFSEGKIP 224

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 165
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 166 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 282
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 283 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 311

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 138
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 139 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 255
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 256 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 45/285 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 75  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           ++++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE   Y  +T KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 188
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 189 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 229
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
           N  EE+  + +L   C +    +RPT        D LR + E+F+
Sbjct: 230 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDFF 264

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 155
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 156 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 272
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 273 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 301

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           K  +   ++G G FG V K        VA+K+   ++     + F  ++R +S++NH N+
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD-VAIKQ---IESESERKAFIVELRQLSRVNHPNI 64
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLF------QHVRYQSSQVLKTWKTCLRIAAETASAL 121
           VK+ G CL      LV E+   G+L+      + + Y ++    +W  CL+ +   A   
Sbjct: 65  VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW--CLQCSQGVA--- 117
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATTTKEIETVGWL 180
            YLHS+    +IH D+K  N+LL    T  K+ DF ++  I +H      T    +  W+
Sbjct: 118 -YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWM 171
Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE      ++EK DV+S+G++L E++T + P   +   +  +   V        +N  R
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV--------HNGTR 223
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             L      +N  + IE    L ++C     ++RP+M ++ + +  L R
Sbjct: 224 PPL-----IKNLPKPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           K  +   ++G G FG V K        VA+K+   ++     + F  ++R +S++NH N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD-VAIKQ---IESESERKAFIVELRQLSRVNHPNI 63
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLF------QHVRYQSSQVLKTWKTCLRIAAETASAL 121
           VK+ G CL      LV E+   G+L+      + + Y ++    +W  CL+ +   A   
Sbjct: 64  VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW--CLQCSQGVA--- 116
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATTTKEIETVGWL 180
            YLHS+    +IH D+K  N+LL    T  K+ DF ++  I +H      T    +  W+
Sbjct: 117 -YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWM 170
Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE      ++EK DV+S+G++L E++T + P   +   +  +   V        +N  R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV--------HNGTR 222
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             L      +N  + IE    L ++C     ++RP+M ++ + +  L R
Sbjct: 223 PPL-----IKNLPKPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G G FG V+ G   +   VA+K  +  +  +  E F  +  ++ +++H  +V++ GVCL
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           E     LV EF+ +G L  ++R Q    L   +T L +  +    + YL       +IH 
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHR 128
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+ +N   KV+DF  +  +   DQ  ++T     V W  PE   +  ++ KSD
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 193 VYSFGVVLVELLT-GKHP 209
           V+SFGV++ E+ + GK P
Sbjct: 188 VWSFGVLMWEVFSEGKIP 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E + NG+L   +R   +Q   T    + +    AS + YL  +G+ 
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGA- 168
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  + ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 52/298 (17%)
Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKI 70
           ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++ +H N++ +
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---------------WKTCLRIAA 115
           LG C       L  E+ P+G L   +R   S+VL+T                +  L  AA
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + A  +DYL        IH ++ + NIL+ +NY AK+ADF    L    +     T    
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 200
Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI 231
            V W+  E   Y  +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P      
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP------ 252
Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
           +   L + LN    DE        V  L  +C R    ERP+  Q+   L SL R+ E
Sbjct: 253 QGYRLEKPLN--CDDE--------VYDLMRQCWREKPYERPSFAQI---LVSLNRMLE 297

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 149
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 152
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 127/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF    ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 95
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 96  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 150
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 151 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 266
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 267 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 151
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 94
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 95  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 149
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 150 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 265
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 266 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E + NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 284
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 313

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 156
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 210
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 72
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 73  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 127
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 243
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 244 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L    S
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 151
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+ +T KVADF  A  +     D     T     V W+  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L EL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 72
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 73  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 127
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 243
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 244 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 69
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 70  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 124
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 125 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 240
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 241 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 21/269 (7%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV  ++K  ++V E + NG+L   +R   +Q   T    + +    AS + YL  +G  
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG-- 138
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y  
Sbjct: 139 -YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           +T  SDV+S+G+VL E+++ G+ P        V  A +E  R+ P    P     L  +L
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--ML 255
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGT 269
           +    D N   + E +  +  K +R  G+
Sbjct: 256 DCWQKDRNNRPKFEQIVSILDKLIRNPGS 284

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 136/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 67
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 68  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 122
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 238
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 239 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 138 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 238

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 32  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 262
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 263 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 287 LHEN 290
           L  N
Sbjct: 308 LTTN 311

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 247

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 45/284 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G  G V+ G    +T VAVK  K     +  + F  +  ++ Q+ H+ +V++  V  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++        IH 
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+++ANIL+ D  + K+ADF  + LI   + TA    +   + W  PE   Y  +T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF-PIKWTAPEAINYGTFTIKSD 192
Query: 193 VYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-----VADE 247
           V+SFG++L E++T  H R                 PYP   N    I N +     V  +
Sbjct: 193 VWSFGILLTEIVT--HGR----------------IPYPGMTNP-EVIQNLERGYRMVRPD 233
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           N  EE+  + +L   C +    +RPT        D LR + E+F
Sbjct: 234 NCPEELYQLMRL---CWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 35  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 265
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 266 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 287 LHEN 290
           L  N
Sbjct: 311 LTTN 314

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 150
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP----VKWMALE 206
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 67
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G     ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 68  LFMGYSTAPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 122
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 238
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 239 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   ++ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILI-NEVFQHKMRIISQINHKNVV 68
           LGEG FG V+           D  LVAVK  K  D  L   + FQ +  +++ + H+++V
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLTNLQHEHIV 80
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVL-------------KTWKTCLRIAA 115
           K  GVC +    ++V+E++ +G L + +R      +                   L IA+
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           + AS + Y   L S   +H D+ + N L+  N   K+ DF  S  + S D        + 
Sbjct: 141 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHP 209
            + W+ PE   Y  +T +SDV+SFGV+L E+ T GK P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 30  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 260
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 261 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 287 LHEN 290
           L  N
Sbjct: 306 LTTN 309

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 151
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----VKWMALE 207
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 89  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L +++R +    ++             T+K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 319
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 320 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 287 LHEN 290
           L  N
Sbjct: 365 LTTN 368

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 150
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----VKWMALE 206
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 143
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL----PVKWMALE 199
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 148
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL----PVKWMALE 204
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 170
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----VKWMALE 226
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 149
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL----PVKWMALE 205
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 169
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----VKWMALE 225
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 151
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----VKWMALE 207
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + YL    S
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 146
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA------SSVLISSHDQTATTTKEIETVGWLDPE 183
              +H D+ + N +LD+ +T KVADF            S H++T         V W+  E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL----PVKWMALE 202
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    +T KSDV+SFGV+L EL+T   P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 144/298 (48%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 68
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ EF+P G+L ++++    ++       L+  ++ 
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI--KLLQYTSQI 126
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 244 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-- 126
            +LG C      L++ E+   G L   +R + S+VL+T      IA  TAS  D LH   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLET-DPAFAIANSTASTRDLLHFSS 171
Query: 127 --------LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
                   L S   IH DV + N+LL + + AK+ DF  +  I +             V 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IEN 233
           W+ PE +F   +T +SDV+S+G++L E+ +         L  N         PYP  + N
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PYPGILVN 273
Query: 234 NSLRQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVS----EQLDSLR 285
           +   ++    V D  +M +     K    +   C     T RPT +Q+     EQ    R
Sbjct: 274 SKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329
Query: 286 R 286
           R
Sbjct: 330 R 330

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 87
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 88  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 142
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE +   
Sbjct: 143 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 258
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 259 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 95
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 96  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 150
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE +   
Sbjct: 151 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 266
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 267 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 40/284 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK-------KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG    +  VAVK        P+ +      + F++++ ++ +  H N++
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL------QAFKNEVGVLRKTRHVNIL 67
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G   + ++ + V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 68  LFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA-- 122
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              IIH D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE +   
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 189 EK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
           +K      SDVY+FG+VL EL+TG+ P S +    +++  MV       + + +R   N 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRS--NC 238
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
             A          + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 239 PKA----------MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 140 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 240

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 15  LLGEGGFGFVYKGVLP--DNT--LVAVKKPKMVDKILINEV--FQHKMRIISQINHKNVV 68
           +LGEG FG V +G L   D T   VAVK  K+ D     E+  F  +   +   +H NV+
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 69  KILGVCLETKV-----PLLVYEFVPNGTLFQHVRYQSSQVLKT---WKTCLRIAAETASA 120
           ++LGVC+E        P+++  F+  G L  ++ Y   +        +T L+   + A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL +      +H D+ + N +L D+ T  VADF  S  I S D           V W+
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
             E L    +T KSDV++FGV + E+ T G  P  Y  + ++EM      + Y +  + L
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNHEM------YDYLLHGHRL 268
Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +Q        E+ ++E+    ++   C RT   +RPT   +  QL+ L
Sbjct: 269 KQ-------PEDCLDEL---YEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 247

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 246

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++  +   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 253

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 246

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 175 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 275

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 144 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 244

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPK----MVDKILINEVFQH-------KMRIISQIN- 63
           LGEG FG V   V+ +   +   KPK    +  K+L ++  +        +M ++  I  
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++  +   G L +++R +    ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +    + A  ++YL    S   IH D+ + N+L+ +N   K+ADF  +  I++ D    T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV++ E+ T G  P  Y  +   E+ +++  
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEELFKLLK- 273
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 274 -----EGHRMDKPANCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 287 LHEN 290
           L  N
Sbjct: 319 LTTN 322

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 90
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 149 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDX 205
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 263
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 264 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 308 RIVALTSN 315

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 139
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   ++T++   +   V W  PE L +++ 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF-PVRWSPPEVLMYSKF 198
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 79
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 80  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 138 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 194
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 252
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 253 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 297 RIVALTSN 304

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 82
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 83  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 141 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 197
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 255
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 256 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 300 RIVALTSN 307

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 90
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 149 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 263
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 264 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 308 RIVALTSN 315

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 131
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 132 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 190 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 304
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 305 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 349 RIVALTSN 356

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 53/304 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV-----------FQHKMRIISQIN- 63
           LGEG FG V   VL +   +   KP  V K+ +  +              +M ++  I  
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           HKN++ +LG C +     ++ E+   G L ++++ +    L+             + K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D    T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY 226
           T     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +++  
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFKLLK- 266
Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                E + + +  N      NE+        +   C     ++RPT +Q+ E LD +  
Sbjct: 267 -----EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 287 LHEN 290
           L  N
Sbjct: 312 LTSN 315

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 144/298 (48%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 68
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++  + ++       L+  ++ 
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI--KLLQYTSQI 126
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 244 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R       ++ VL   +    +++A E A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 143 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 243

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 36/275 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G+G FG V  G    N  VAVK    +      + F  +  +++Q+ H N+V++LGV +
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL        +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKS 191
            D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L    ++ KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKS 367
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           DV+SFG++L E+ + G+                VPY   P+++   R    +++   +  
Sbjct: 368 DVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 411
Query: 251 EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                V  +   C       RPT  Q+ EQL+ +R
Sbjct: 412 P--PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQH---KMRIISQINHKNVVKIL 71
           ++G GGFG VY+     +  VAVK  +      I++  ++   + ++ + + H N++ + 
Sbjct: 14  IIGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           GVCL+     LV EF   G L + +  +     +L  W      A + A  ++YLH    
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAI 126
Query: 130 PPIIHGDVKSANILL--------DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            PIIH D+KS+NIL+          N   K+ DF     ++      T         W+ 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFG----LAREWHRTTKMSAAGAYAWMA 182
Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMVPYFPYPIENNSLR 237
           PE +    +++ SDV+S+GV+L ELLTG+ P R    LA            Y +  N L 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----------VAYGVAMNKLA 232
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             +             E  AKL   C       RP+   + +QL ++
Sbjct: 233 LPIPSTCP--------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 90
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 91  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 149 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 263
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 264 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 308 RIVALTSN 315

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 75
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 76  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 134 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 248
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 249 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 293 RIVALTSN 300

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R       ++ VL   +    +++A E A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 137/308 (44%), Gaps = 61/308 (19%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI----------------LINEVFQHKMRII 59
           LGEG FG V   VL +   +   KP  V K+                LI+E+    M++I
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM--EMMKMI 83
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            +  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 84  GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL    S   IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 142 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 198
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 256
Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           ++       E + + +  N      NE+        +   C     ++RPT +Q+ E LD
Sbjct: 257 LLK------EGHRMDKPSNCT----NEL------YMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 283 SLRRLHEN 290
            +  L  N
Sbjct: 301 RIVALTSN 308

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 22/226 (9%)
Query: 16  LGEGGFGFVY----KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY    KGV+ D   T VA+K       +     F ++  ++ + N  +VV+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVR-----YQSSQVLK--TWKTCLRIAAETASALD 122
           +LGV  + +  L++ E +  G L  ++R      +++ VL   +    +++A E A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N  + +++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 140 YLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 183 EYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 240

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 123
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKF 182
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 68
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 126
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 244 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 124
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKF 183
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 70
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 128
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 129 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 246 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 295

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 83
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 141
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 142 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 258
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 259 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 83
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 141
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 142 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 258
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 259 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 65
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 123
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 241 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 119
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKF 178
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 69
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 127
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 128 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 245 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 294

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 64
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 122
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 123 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 240 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 289

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 63
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 121
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 122 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 239 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 65
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 123
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 241 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 71
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 129
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 130 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 247 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 296

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 96
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 154
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 272 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 139
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKF 198
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 130
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKF 189
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 130/301 (43%), Gaps = 54/301 (17%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-- 126
            +LG C      L++ E+   G L   +R + S+VL+T      IA  T S  D LH   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLET-DPAFAIANSTLSTRDLLHFSS 171
Query: 127 --------LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
                   L S   IH DV + N+LL + + AK+ DF  +  I +             V 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IEN 233
           W+ PE +F   +T +SDV+S+G++L E+ +         L  N         PYP  + N
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PYPGILVN 273
Query: 234 NSLRQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVS----EQLDSLR 285
           +   ++    V D  +M +     K    +   C     T RPT +Q+     EQ    R
Sbjct: 274 SKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329
Query: 286 R 286
           R
Sbjct: 330 R 330

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 72
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 130
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 131 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 248 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 297

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VA+K  K  +  +  + F  + +++  ++H+ +V++ GVC 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 76  ETKVPLLVYEFVPNGTLFQHV-----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           + +   ++ E++ NG L  ++     R+Q+ Q+L+       +  +   A++YL    S 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKDVCEAMEYLE---SK 124
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE- 189
             +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +++ 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKF-PVRWSPPEVLMYSKF 183
Query: 190 --KSDVYSFGVVLVELLT-GKHP 209
             KSD+++FGV++ E+ + GK P
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 27/220 (12%)
Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVKKP---KMVDKILINEVFQ---HKMRIISQINH 64
           K  +LG G FG V+KGV +P+    ++K P   K+++     + FQ     M  I  ++H
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            ++V++LG+C  + + L V +++P G+L  HVR        Q+L  W        + A  
Sbjct: 93  AHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKG 145
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + YL   G   ++H ++ + N+LL      +VADF  + L+   D+    ++    + W+
Sbjct: 146 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 202
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALA 216
             E +    +T +SDV+S+GV + EL+T G  P + + LA
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 242

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 65
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 123
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL   G+   IH D+ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 241 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 27/220 (12%)
Query: 12  KRHLLGEGGFGFVYKGV-LPDNTLVAVKKP---KMVDKILINEVFQ---HKMRIISQINH 64
           K  +LG G FG V+KGV +P+    ++K P   K+++     + FQ     M  I  ++H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            ++V++LG+C  + + L V +++P G+L  HVR        Q+L  W        + A  
Sbjct: 75  AHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKG 127
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + YL   G   ++H ++ + N+LL      +VADF  + L+   D+    ++    + W+
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALA 216
             E +    +T +SDV+S+GV + EL+T G  P + + LA
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 15  LLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G  G V  G L      +  VA+K  K          F  +  I+ Q +H N++++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV    ++ ++V E++ NG+L   +R    Q   T    + +     + + YL  LG  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+L+D N   KV+DF  S VL    D   TTT     + W  PE   +  
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           ++  SDV+SFGVV+ E+L  G+ P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 15  LLGEGGFGFVYKGVLPDNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G+G FG VY G   D        A+K    + ++   E F  +  ++  +NH NV+ +
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +G+ L  + +P ++  ++ +G L Q +R  S Q   T K  +    + A  ++YL     
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 130 PPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
              +H D+ + N +LD+++T KVADF  A  +L   +            V W   E L  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +T KSDV+SFGV+L ELLT   P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 131
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 132 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 234

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 36/275 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G+G FG V  G    N  VAVK    +      + F  +  +++Q+ H N+V++LGV +
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL        +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKS 191
            D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L    ++ KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKS 180
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           DV+SFG++L E+ + G+                VPY   P+++   R    +++   +  
Sbjct: 181 DVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 224
Query: 251 EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                V ++   C       RP+  Q+ EQL+ ++
Sbjct: 225 P--PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 36/275 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G+G FG V  G    N  VAVK    +      + F  +  +++Q+ H N+V++LGV +
Sbjct: 29  IGKGEFGDVMLGDYRGNK-VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL        +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKS 191
            D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L    ++ KS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKS 195
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           DV+SFG++L E+ + G+                VPY   P+++   R    +++   +  
Sbjct: 196 DVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 239
Query: 251 EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                V ++   C       RP+  Q+ EQL+ ++
Sbjct: 240 P--PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+      +T VAVK   M    +  E F  +  ++  + H  +VK+  V  
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV- 79
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
            TK P+ ++ EF+  G+L   ++    S Q L      +  +A+ A  + ++        
Sbjct: 80  -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---Y 132
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTE 189
           IH D+++ANIL+  +   K+ADF  + +I  ++ TA    +   + W  PE   +  +T 
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 191
Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY-FPYPIENNSLRQILNFQVADE 247
           KSDV+SFG++L+E++T G+ P  Y  +++ E+ R +   +  P   N   ++ N  +   
Sbjct: 192 KSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALERGYRMPRPENCPEELYNIMM--- 246
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                         +C +    ERPT   +   LD  
Sbjct: 247 --------------RCWKNRPEERPTFEYIQSVLDDF 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 36/275 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           +G+G FG V  G    N  VAVK    +      + F  +  +++Q+ H N+V++LGV +
Sbjct: 20  IGKGEFGDVMLGDYRGNK-VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL        +H
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKS 191
            D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L    ++ KS
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTKS 186
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEM 250
           DV+SFG++L E+ + G+                VPY   P+++   R    +++   +  
Sbjct: 187 DVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 230
Query: 251 EEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                V ++   C       RP+  Q+ EQL+ ++
Sbjct: 231 P--PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 131
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 132 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 15  LLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G  G V  G L      +  VA+K  K          F  +  I+ Q +H N++++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GV    ++ ++V E++ NG+L   +R    Q   T    + +     + + YL  LG  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+L+D N   KV+DF  S VL    D   TTT     + W  PE   +  
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           ++  SDV+SFGVV+ E+L  G+ P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 133
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 134 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 236

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 14  HLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V  G L      +  VA+K  K+         F  +  I+ Q +H NVV 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV    K  ++V EF+ NG L   +R    Q   T    + +    A+ + YL  +G 
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF--TVIQLVGMLRGIAAGMRYLADMG- 165
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA-TTTKEIETVGWLDPE---YL 185
              +H D+ + NIL++ N   KV+DF  S +I    +   TTT     V W  PE   Y 
Sbjct: 166 --YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP---YFPYPIENNSLRQILN 241
            +T  SDV+S+G+V+ E+++ G+ P  Y  +++ ++ + +      P P++  +      
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIKAIEEGYRLPAPMDCPAG----- 276
Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                         + +L   C +    ERP   Q+   LD + R
Sbjct: 277 --------------LHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 131
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 132 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 38/277 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+      +T VAVK   M    +  E F  +  ++  + H  +VK+  V  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV- 252
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
            TK P+ ++ EF+  G+L   ++    S Q L      +  +A+ A  + ++        
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---Y 305
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTE 189
           IH D+++ANIL+  +   K+ADF  + +I  ++ TA    +   + W  PE   +  +T 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 364
Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY-FPYPIENNSLRQILNFQVADE 247
           KSDV+SFG++L+E++T G+ P  Y  +++ E+ R +   +  P   N   ++ N  +   
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALERGYRMPRPENCPEELYNIMM--- 419
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                         +C +    ERPT   +   LD  
Sbjct: 420 --------------RCWKNRPEERPTFEYIQSVLDDF 442

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I + +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  +VAVKK +   +  + + F+ ++ I+
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 66
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             + H N+VK  GVC     +   L+ E++P G+L  +++    ++       L+  ++ 
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQI 124
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++Y   LG+   IH ++ + NIL+++    K+ DF  + ++    +     +  E+ 
Sbjct: 125 CKGMEY---LGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-----GKHPRSYVALASNE-MTRMVPYF 227
           + W  PE L    ++  SDV+SFGVVL EL T        P  ++ +  N+   +M+ + 
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
              +  N+ R        DE        +  + ++C   +  +RP+ R ++ ++D +R
Sbjct: 242 LIELLKNNGRLPRPDGCPDE--------IYMIMTECWNNNVNQRPSFRDLALRVDQIR 291

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 136
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 137 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 239

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 130
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 131 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 233

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 131
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 132 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 80  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 132
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 133 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 133
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 134 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 236

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 9   NYDKRHL-----LGEGGFGFVYKGVLP---DNT--LVAVK--KPKMVDKILINEVFQHKM 56
           +++KR L     LGEG FG V         DNT   VAVK  KP+     + +   + ++
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEI 74
Query: 57  RIISQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H+N+VK  G+C E       L+ EF+P+G+L +++    +++    K  L+ A
Sbjct: 75  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYA 132
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    +DYL   GS   +H D+ + N+L++  +  K+ DF  +  I +  +  T   + 
Sbjct: 133 VQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 175 ET-VGWLDPEYLFWTE---KSDVYSFGVVLVELLT 205
           ++ V W  PE L  ++    SDV+SFGV L ELLT
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 9   NYDKRHL-----LGEGGFGFVYKGVLP---DNT--LVAVK--KPKMVDKILINEVFQHKM 56
           +++KR L     LGEG FG V         DNT   VAVK  KP+     + +   + ++
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEI 62
Query: 57  RIISQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H+N+VK  G+C E       L+ EF+P+G+L +++    +++    K  L+ A
Sbjct: 63  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYA 120
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    +DYL   GS   +H D+ + N+L++  +  K+ DF  +  I +  +  T   + 
Sbjct: 121 VQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 175 ET-VGWLDPEYLFWTE---KSDVYSFGVVLVELLT 205
           ++ V W  PE L  ++    SDV+SFGV L ELLT
Sbjct: 178 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW--CVQI----AKG 130
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 131 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 31/226 (13%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL-------INEVFQHKMRIISQINHKN 66
           +LG G FG VYKG+ +P+     VK P  + KIL        N  F  +  I++ ++H +
Sbjct: 45  VLGSGAFGTVYKGIWVPEGE--TVKIPVAI-KILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASALD 122
           +V++LGVCL   +  LV + +P+G L ++V        SQ+L  W  C++I    A  + 
Sbjct: 102 LVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQI----AKGMM 154
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL       ++H D+ + N+L+      K+ DF  + L+   ++          + W+  
Sbjct: 155 YLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 183 E---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E   Y  +T +SDV+S+GV + EL+T G  P  Y  + + E+  ++
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLL 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 31/226 (13%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL-------INEVFQHKMRIISQINHKN 66
           +LG G FG VYKG+ +P+     VK P  + KIL        N  F  +  I++ ++H +
Sbjct: 22  VLGSGAFGTVYKGIWVPEGE--TVKIPVAI-KILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASALD 122
           +V++LGVCL   +  LV + +P+G L ++V        SQ+L  W  C++I    A  + 
Sbjct: 79  LVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQI----AKGMM 131
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL       ++H D+ + N+L+      K+ DF  + L+   ++          + W+  
Sbjct: 132 YLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 183 E---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           E   Y  +T +SDV+S+GV + EL+T G  P  Y  + + E+  ++
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP--YDGIPTREIPDLL 232

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 87  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 139
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 140 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 242

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
            +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +NH+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
            +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ PE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 186 ----FWTEKSDVYSFGVVLVELLTGKHP 209
               F  E  DV+S G+VL  +L G+ P
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 132
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 133 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 235

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 102 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 154
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 155 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 257

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 132
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 133 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 235

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 131
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 132 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 234

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 83  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 135
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 136 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 238

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 80  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 132
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 133 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 235

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 136
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 137 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 239

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV 242

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 38/292 (13%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V      ++   L Q 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV------MDGGYLDQP 254
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
            N            E V  L   C + +   RPT  ++   L     LH +F
Sbjct: 255 DNCP----------ERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 294

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 123
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 124 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +LG G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AEG 126
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 127 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 229

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T+   T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +LG+G FG   K    +   V V K  +         F  +++++  + H NV+K +GV 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
            + K    + E++  GTL   ++   SQ    W   +  A + AS + YLHS+    IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHD---------QTATTTKEIETVG---WLDP 182
            D+ S N L+ +N    VADF  + L+             +     K    VG   W+ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 183 EYL---FWTEKSDVYSFGVVLVELL 204
           E +    + EK DV+SFG+VL E++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 139
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 192
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 148
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y HS     +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 118/233 (50%), Gaps = 35/233 (15%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM---------VDKILINEVFQHKMRII 59
           + K  +LG G FG VYKG+ +P+   V +    M          +K +++E +     ++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY-----VM 105
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAA 115
           + +++ +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++IA 
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA- 161
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++         
Sbjct: 162 ---KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            + W+  E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 127
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 180
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQINH 64
           +++D    LG+G FG VY      +  +   K      ++K  +    + ++ I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT-ELANALSYC 128
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     +IH D+K  N+LL  N   K+ADF  SV    H  ++  T    T+ +L PE 
Sbjct: 129 HS---KRVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181
Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP 209
           +      EK D++S GV+  E L G  P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 123
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP 176
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 127
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP 180
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           V   +++D    LGEG  G V   V       VAVK   M   +   E  + ++ I   +
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH+NVVK  G   E  +  L  E+   G LF  +      +        R   +  + + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ P
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 183 EYL----FWTEKSDVYSFGVVLVELLTGKHP 209
           E L    F  E  DV+S G+VL  +L G+ P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 132/283 (46%), Gaps = 36/283 (12%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++G G FG V  G L         VA+K  K    DK   +  F  +  I+ Q +H N++
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNII 93
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            + GV  + K  +++ E++ NG+L   +R    +   T    + +     S + YL  + 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMS 151
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---Y 184
           +   +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y
Sbjct: 152 A---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
             +T  SDV+S+G+V+ E+++ G+ P  Y  +++ ++ + +       E   L   ++  
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIKAIE------EGYRLPPPMDCP 260
Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +A          + +L   C +   ++RP   Q+   LD L R
Sbjct: 261 IA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 121
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 174
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 43/291 (14%)
Query: 14  HLLGEGGFGFVYKGVLP--DNTLVAVKKPKMVDKILIN---EVFQHKMRIISQINHKNVV 68
            +LG+G FG V +  L   D + V V    +   I+ +   E F  +   + + +H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 69  KILGVCLETK------VPLLVYEFVPNGTLFQHVRYQSSQVLKT-----WKTCLRIAAET 117
           K++GV L ++      +P+++  F+ +G L  H    +S++ +       +T +R   + 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDL--HAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A  ++YL S      IH D+ + N +L ++ T  VADF  S  I S D           V
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            WL  E L    +T  SDV++FGV + E++T G+ P  Y  + + E+      + Y I  
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIENAEI------YNYLIGG 255
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           N L+Q            E +E V  L  +C      +RP+   +  +L+++
Sbjct: 256 NRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 126
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 179
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY     ++  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   ++    L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV   S  + A       T+ +L P
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG----TLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 20/225 (8%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 38/292 (13%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V      ++   L Q 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV------MDGGYLDQP 254
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
            N            E V  L   C + +   RPT  ++   L     LH +F
Sbjct: 255 DNCP----------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 294

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P G +++ +  Q        +T   I  E A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT-ELANALS 127
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y HS     +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 180
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY         +   K      ++K  +    + ++ I S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 172
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 41/290 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G   ++T VAVK  K     +  + F  +  ++  + H  +V++  V  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 76  ETKVPLLVYEFVPNGTLFQHVRY-QSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
             +   ++ E++  G+L   ++  +  +VL      +  +A+ A  + Y+        IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 133
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKS 191
            D+++AN+L+ ++   K+ADF  + +I  ++ TA    +   + W  PE   +  +T KS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKS 192
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN-----SLRQILNFQVA 245
           DV+SFG++L E++T GK                    PYP   N     +L Q       
Sbjct: 193 DVWSFGILLYEIVTYGK-------------------IPYPGRTNADVMTALSQGYRMPRV 233
Query: 246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQK 295
            EN  +E+  + K+   C +    ERPT   +   LD      E  + Q+
Sbjct: 234 -ENCPDELYDIMKM---CWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 279

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +L  G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L++ + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 84  PHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 136
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 137 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 239

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 127
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++  T    T+ +L P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 180
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+ G   ++T VAVK  K     +  + F  +  ++  + H  +V++  V  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 76  ETKVPLLVYEFVPNGTLFQHVRY-QSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIH 134
           + +   ++ EF+  G+L   ++  +  +VL      +  +A+ A  + Y+        IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAYIERKN---YIH 132
Query: 135 GDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKS 191
            D+++AN+L+ ++   K+ADF  + +I  ++ TA    +   + W  PE   +  +T KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKS 191
Query: 192 DVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN-----SLRQILNFQVA 245
           +V+SFG++L E++T GK                    PYP   N     +L Q       
Sbjct: 192 NVWSFGILLYEIVTYGK-------------------IPYPGRTNADVMSALSQGYRMPRM 232
Query: 246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQK 295
            EN  +E+  + K+   C +    ERPT   +   LD      E  + Q+
Sbjct: 233 -ENCPDELYDIMKM---CWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 116/228 (50%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +L  G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 116/228 (50%), Gaps = 25/228 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
           + K  +L  G FG VYKG+ +P+       VA+K+ +       N+    +  +++ +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASA 120
            +V ++LG+CL + V L+  + +P G L  +VR       SQ L  W  C++I    A  
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 136
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          + W+
Sbjct: 137 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E +    +T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 239

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV   S  + A       T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG----TLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++G G FG V  G L         VA+K  K    DK   +  F  +  I+ Q +H N++
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNII 78
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            + GV  + K  +++ E++ NG+L   +R    +   T    + +     S + YL  + 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMS 136
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---Y 184
               +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y
Sbjct: 137 ---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
             +T  SDV+S+G+V+ E+++ G+ P  Y  +++ ++ + +       E   L   ++  
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIKAIE------EGYRLPPPMDCP 245
Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +A          + +L   C +   ++RP   Q+   LD L R
Sbjct: 246 IA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 278

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 15  LLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVVK 69
           +LG+G FG V+   K   PD+  +   K      + + +  + KM   I++ +NH  VVK
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 70  ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            L    +T+  L L+ +F+  G LF  +   S +V+ T +      AE A  LD+LHSLG
Sbjct: 95  -LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHLHSLG 150
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              II+ D+K  NILLD+    K+ DF  S     H++ A +     TV ++ PE +   
Sbjct: 151 ---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF--CGTVEYMAPEVVNRQ 205
Query: 186 FWTEKSDVYSFGVVLVELLTGKHP 209
             +  +D +S+GV++ E+LTG  P
Sbjct: 206 GHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 15  LLGEGGFG--FVYKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVV 68
           +LG+G FG  F+ K +   +   L A+K  K    + + +  + KM   I+ ++NH  +V
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           K L    +T+  L L+ +F+  G LF  +   S +V+ T +      AE A ALD+LHSL
Sbjct: 90  K-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
           G   II+ D+K  NILLD+    K+ DF  S     H++ A +     TV ++ PE +  
Sbjct: 146 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVVNR 200
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
              T+ +D +SFGV++ E+LTG  P
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 148
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y HS     +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 124
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP 177
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV   S  + A       T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG----TLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 15  LLGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++G G FG V  G L         VA+K  K    DK   +  F  +  I+ Q +H N++
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD--FLSEASIMGQFDHPNII 72
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            + GV  + K  +++ E++ NG+L   +R    +   T    + +     S + YL  + 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMS 130
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---Y 184
               +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   Y
Sbjct: 131 ---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
             +T  SDV+S+G+V+ E+++ G+ P  Y  +++ ++ + +       E   L   ++  
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIKAIE------EGYRLPPPMDCP 239
Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +A          + +L   C +   ++RP   Q+   LD L R
Sbjct: 240 IA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT-------WKTCLRIAAETASAL 121
            +LG C      L++ E+   G L   +R ++   L          +  L  +++ A  +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            +L    S   IH DV + N+LL + + AK+ DF  +  I +             V W+ 
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IENNSL 236
           PE +F   +T +SDV+S+G++L E+ +         L  N         PYP  + N+  
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PYPGILVNSKF 272
Query: 237 RQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVS----EQLDSLRR 286
            ++    V D  +M +     K    +   C     T RPT +Q+     EQ    RR
Sbjct: 273 YKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 326

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 124
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+A+F  SV    H  ++  T    T+ +L P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPP 177
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 15  LLGEGGFG--FVYKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVV 68
           +LG+G FG  F+ K +   +   L A+K  K    + + +  + KM   I+ ++NH  +V
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILVEVNHPFIV 89
Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           K L    +T+  L L+ +F+  G LF  +   S +V+ T +      AE A ALD+LHSL
Sbjct: 90  K-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
           G   II+ D+K  NILLD+    K+ DF  S     H++ A +     TV ++ PE +  
Sbjct: 146 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVVNR 200
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
              T+ +D +SFGV++ E+LTG  P
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V  G       VAVK  K  +  +  + F  + + + +++H  +VK  GVC 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK--EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 76  ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG 135
           +     +V E++ NG L  ++R     +  +    L +  +    + +L    S   IH 
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 136 DVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSD 192
           D+ + N L+D +   KV+DF  +  +   DQ  ++      V W  PE   Y  ++ KSD
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 193 VYSFGVVLVELLT-GKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD 246
           V++FG+++ E+ + GK P      S V L  ++  R+  Y P+ + ++++ QI+      
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--YRPH-LASDTIYQIMY----- 239
Query: 247 ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                           C      +RPT +Q+   ++ LR
Sbjct: 240 ---------------SCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 15  LLGEGGFG--FVYKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMR--IISQINHKNVV 68
           +LG+G FG  F+ K +   +   L A+K  K    + + +  + KM   I+ ++NH  +V
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILVEVNHPFIV 90
Query: 69  KILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           K L    +T+  L L+ +F+  G LF  +   S +V+ T +      AE A ALD+LHSL
Sbjct: 91  K-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
           G   II+ D+K  NILLD+    K+ DF  S     H++ A +     TV ++ PE +  
Sbjct: 147 G---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVVNR 201
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
              T+ +D +SFGV++ E+LTG  P
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKK-PKMVDKILINEVFQHKMRIISQINHK 65
           + Y+K   +GEG +G V+K    D   +VA+KK  +  D  +I ++   ++R++ Q+ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V +L V    +   LV+E+  +  L +  RYQ        K+   I  +T  A+++ H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS---ITWQTLQAVNFCH 119
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                  IH DVK  NIL+  +   K+ DF  + L++    +     E+ T  +  PE L
Sbjct: 120 KHNC---IHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELL 174
Query: 186 F----WTEKSDVYSFGVVLVELLT------GKHPRSYVALASNEMTRMVPYFPYPIENNS 235
                +    DV++ G V  ELL+      GK     + L    +  ++P        N 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN- 233
Query: 236 LRQILNFQVADENEMEEIEI--------VAKLASKCLRTSGTERPTMRQV 277
            +     ++ D  +ME +E+           L   CL    TER T  Q+
Sbjct: 234 -QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+A+F  SV    H  ++  T    T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQINH 64
           +++D    LG+G FG VY      +  +   K      ++K  +    + ++ I S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYIT-ELANALSYC 128
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     +IH D+K  N+LL  N   K+ADF  SV    H  ++       T+ +L PE 
Sbjct: 129 HS---KRVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEM 181
Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP 209
           +      EK D++S GV+  E L G  P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 38/292 (13%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H ++ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V      ++   L Q 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV------MDGGYLDQP 254
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
            N            E V  L   C + +   RPT  ++   L     LH +F
Sbjct: 255 DNCP----------ERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 294

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 37/232 (15%)
Query: 12  KRHLLGEGGFGFVYKGV-LPDN----TLVAVK------KPKMVDKILINEVFQHKMRIIS 60
           K  +LG G FG VYKG+ +PD       VA+K       PK  +K +++E +     +++
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAY-----VMA 74
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAE 116
            +    V ++LG+CL + V L V + +P G L  HVR       SQ L  W  C++IA  
Sbjct: 75  GVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW--CMQIA-- 129
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               + YL  +    ++H D+ + N+L+      K+ DF  + L+   +           
Sbjct: 130 --KGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + W+  E +    +T +SDV+S+GV + EL+T G  P  Y  + + E+  ++
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP--YDGIPAREIPDLL 234

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 38/292 (13%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H ++ + N ++  ++T K+ DF  +  I   D      K +  V W+ P
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V      ++   L Q 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV------MDGGYLDQP 255
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
            N            E V  L   C + +   RPT  ++   L     LH +F
Sbjct: 256 DNCP----------ERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 295

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 123
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  S    S  +T  +     T+ +L P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSG----TLDYLPP 176
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 25  FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+    +R   +   Q+    K  L+        LDY
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-------GLDY 135
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL +    K+ADF  +  ++  D        + T  W+ PE
Sbjct: 136 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE 190
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
            +    +  K+D++S G+  +EL  G+ P S       +M  M   F  P +NN    + 
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNS-------DMHPMRVLFLIP-KNNPPTLVG 242
Query: 241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           +F  +            +    CL    + RPT +++
Sbjct: 243 DFTKS----------FKEFIDACLNKDPSFRPTAKEL 269

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 122
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP 175
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 123
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDTLCGTLDYLPP 176
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 18/226 (7%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNV 67
           +D    LGEG +G VYK +  +   +VA+K+ P   D   + E+ + ++ I+ Q +  +V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIK-EISIMQQCDSPHV 86
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           VK  G   +     +V E+   G++   +R ++  +  T      I   T   L+YLH +
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFM 144
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
                IH D+K+ NILL+    AK+ADF  +  ++  D  A     I T  W+ PE    
Sbjct: 145 RK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQE 199
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP 230
           + +   +D++S G+  +E+  GK P  Y  +       M+P  P P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP--YADIHPMRAIFMIPTNPPP 243

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 125/301 (41%), Gaps = 52/301 (17%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-- 126
            +LG C      L++ E+   G L   +R +    L+          E  S+ D LH   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 127 --------LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
                   L S   IH DV + N+LL + + AK+ DF  +  I +             V 
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IEN 233
           W+ PE +F   +T +SDV+S+G++L E+ +         L  N         PYP  + N
Sbjct: 234 WMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PYPGILVN 275
Query: 234 NSLRQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVS----EQLDSLR 285
           +   ++    V D  +M +     K    +   C     T RPT +Q+     EQ    R
Sbjct: 276 SKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 331
Query: 286 R 286
           R
Sbjct: 332 R 332

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT-------WKTCLRIAAETASAL 121
            +LG C      L++ E+   G L   +R ++   L          +  L  +++ A  +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            +L    S   IH DV + N+LL + + AK+ DF  +  I +             V W+ 
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP--IENNSL 236
           PE +F   +T +SDV+S+G++L E+ +         L  N         PYP  + N+  
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PYPGILVNSKF 264
Query: 237 RQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVSEQL 281
            ++    V D  +M +     K    +   C     T RPT +Q+   L
Sbjct: 265 YKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P GT+++ +  Q        +T   I  E A+AL 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYI-TELANALS 125
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H   S  +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPP 178
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 35/225 (15%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++    LG GGFG V++     D+   A+K+ ++ ++ L  E    +++ ++++ H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW------------KTCLRIAA 115
           V+     LE      +    P   L+  ++    + LK W              CL I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT-------- 167
           + A A+++LHS G   ++H D+K +NI    +   KV DF    L+++ DQ         
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG---LVTAMDQDEEEQTVLT 179
Query: 168 -----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELL 204
                A  T ++ T  ++ PE +    ++ K D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQI 62
           A ++++    LG+G FG VY      +  +   K      ++K  +    + ++ I S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++ G   +     L+ E+ P G +++ +  Q        +T   I  E A+AL 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT-ELANALS 127
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y HS     +IH D+K  N+LL      K+ADF  SV    H  ++       T+ +L P
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLPP 180
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           E +      EK D++S GV+  E L GK P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 38/292 (13%)
Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VY+G   D       T VAVK       +     F ++  ++      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRY-------QSSQVLKTWKTCLRIAAETASALD 122
           +LGV  + +  L+V E + +G L  ++R           +   T +  +++AAE A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YL++      +H D+ + N ++  ++T K+ DF  +  I          K +  V W+ P
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 183 EYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E L    +T  SD++SFGVVL E +T    + Y  L++ ++ + V      ++   L Q 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV------MDGGYLDQP 254
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
            N            E V  L   C + +   RPT  ++   L     LH +F
Sbjct: 255 DNCP----------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 294

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 32/282 (11%)
Query: 14  HLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V  G L         VA+K  K+         F  +  I+ Q +H N++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV  ++K  ++V E++ NG+L   ++    Q   T    + +    ++ + YL  +G 
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF--TVIQLVGMLRGISAGMKYLSDMG- 144
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YL 185
              +H D+ + NIL++ N   KV+DF  S ++    + A TT+  +  + W  PE   + 
Sbjct: 145 --YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
            +T  SDV+S+G+V+ E+++ G+ P  Y  + + ++ + V       E   L   ++   
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERP--YWEMTNQDVIKAVE------EGYRLPSPMDCPA 254
Query: 245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           A          + +L   C +     RP   ++   LD L R
Sbjct: 255 A----------LYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 16  LGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVK 69
           LGE  FG VYKG L    P     AV    + DK    + E F+H+  + +++ H NVV 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQ-------HVRYQSSQVLKTWKTCL------RIAAE 116
           +LGV  + +   +++ +  +G L +       H    S+   +T K+ L       + A+
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A+ ++Y   L S  ++H D+ + N+L+ D    K++D      + + D        +  
Sbjct: 154 IAAGMEY---LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + W+ PE + + +    SD++S+GVVL E+ + G  P  Y   ++ ++  M+
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEMI 260

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 67  VVKILGVCLETKVPLLVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+   L +      +Q+     T LR   E    LDY
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 134
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL ++   K+ADF  +  ++  D        + T  W+ PE
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPE 189
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            +    +  K+D++S G+  +EL  G+ P S
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 132/300 (44%), Gaps = 43/300 (14%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  LVAVK+ +        + FQ +++I+
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 62
Query: 60  SQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             ++   +VK  GV      P   LV E++P+G L   ++   +++  +    L  +++ 
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQI 120
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-SHDQTATTTKEIET 176
              ++YL   GS   +H D+ + NIL++     K+ADF  + L+    D           
Sbjct: 121 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYV---ALASNEMTRM------V 224
           + W  PE L    ++ +SDV+SFGVVL EL T      Y       S E  RM      V
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDV 231
Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P     +E     Q L    A   E+ E      L   C   S  +RP+   +  QLD L
Sbjct: 232 PALCRLLELLEEGQRLPAPPACPAEVHE------LMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 67  VVKILGVCLETKVPLLVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+   L +      +Q+     T LR   E    LDY
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 119
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL ++   K+ADF  +  ++  D        + T  W+ PE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPE 174
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            +    +  K+D++S G+  +EL  G+ P S
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 111/232 (47%), Gaps = 28/232 (12%)
Query: 16  LGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVK 69
           LGE  FG VYKG L    P     AV    + DK    + E F+H+  + +++ H NVV 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQ-------HVRYQSSQVLKTWKTCL------RIAAE 116
           +LGV  + +   +++ +  +G L +       H    S+   +T K+ L       + A+
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A+ ++Y   L S  ++H D+ + N+L+ D    K++D      + + D        +  
Sbjct: 137 IAAGMEY---LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 177 VGWLDPEYLFWTE---KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + W+ PE + + +    SD++S+GVVL E+ + G  P  Y   ++ ++  M+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEMI 243

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 67  VVKILGVCLETKVPLLVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+   L +      +Q+     T LR   E    LDY
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 119
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL ++   K+ADF  +  ++  D        + T  W+ PE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE 174
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            +    +  K+D++S G+  +EL  G+ P S
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG V+KG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 29  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 67  VVKILGVCLETKVPLLVYEFVPNGT---LFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V K  G  L+     ++ E++  G+   L +      +Q+     T LR   E    LDY
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 139
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS      IH D+K+AN+LL ++   K+ADF  +  ++  D        + T  W+ PE
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE 194
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            +    +  K+D++S G+  +EL  G+ P S
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHS 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--------KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LG GG   VY   L ++T++ +K         P+  ++ L  + F+ ++   SQ++H+N+
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETL--KRFEREVHNSSQLSHQNI 73
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V ++ V  E     LV E++   TL +++    S    +  T +    +    + + H +
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
               I+H D+K  NIL+D N T K+ DF  +  +S    T  T   + TV +  PE    
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKG 186
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVP 225
               E +D+YS G+VL E+L G+ P    + V++A   +   VP
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS++NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 255
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 256 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 14  HLLGEGGFGFVYKGVLPDNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            +LGEG FG VY+GV  ++      VAVK  K    +   E F  +  I+  ++H ++VK
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           ++G+ +E +   ++ E  P G L  H   ++   LK   T +  + +   A+ YL S+  
Sbjct: 74  LIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESINC 130
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+   NIL+      K+ DF  S  I   D    +   +  + W+ PE   +  
Sbjct: 131 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRR 186
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           +T  SDV+ F V + E+L+ GK P
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 49/311 (15%)
Query: 9   NYDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +Y+ + ++G G    V      P    VA+K+  +       +    +++ +SQ +H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRY------QSSQVLKTWKTCLRIAAETASAL 121
           V      +      LV + +  G++   +++        S VL    T   I  E    L
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE-STIATILREVLEGL 134
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE--IETVG 178
           +YLH  G    IH DVK+ NILL ++ + ++ADF  S+ L +  D T    ++  + T  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 179 WLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN 234
           W+ PE +     +  K+D++SFG+  +EL TG                  PY  YP    
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG----------------AAPYHKYPPMKV 235
Query: 235 SLRQILNFQVADENEMEEIEIVA-------KLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
            +  + N   + E  +++ E++        K+ S CL+    +RPT  ++      LR  
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL------LR-- 287
Query: 288 HENFWAQKNSE 298
           H+ F   KN E
Sbjct: 288 HKFFQKAKNKE 298

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 14  HLLGEGGFGFVYKGVLPDNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            +LGEG FG VY+GV  ++      VAVK  K    +   E F  +  I+  ++H ++VK
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           ++G+ +E +   ++ E  P G L  H   ++   LK   T +  + +   A+ YL S+  
Sbjct: 90  LIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESINC 146
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+   NIL+      K+ DF  S  I   D    +   +  + W+ PE   +  
Sbjct: 147 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRR 202
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           +T  SDV+ F V + E+L+ GK P
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQP 226

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 281
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 282 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 14  HLLGEGGFGFVYKGVLPDNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            +LGEG FG VY+GV  ++      VAVK  K    +   E F  +  I+  ++H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           ++G+ +E +   ++ E  P G L  H   ++   LK   T +  + +   A+ YL S+  
Sbjct: 78  LIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESINC 134
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+   NIL+      K+ DF  S  I   D    +   +  + W+ PE   +  
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRR 190
Query: 187 WTEKSDVYSFGVVLVELLT-GKHP 209
           +T  SDV+ F V + E+L+ GK P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS++NH+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 269
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 270 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDN---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           + K   +G+G FG VYKG+  DN    +VA+K   + +     E  Q ++ ++SQ +   
Sbjct: 21  FTKLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW-KTCLRIAAETASALDYLH 125
           + +  G  L++    ++ E++  G+    ++     + +T+  T LR   E    LDYLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR---EILKGLDYLH 133
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           S      IH D+K+AN+LL +    K+ADF  +  ++  D        + T  W+ PE +
Sbjct: 134 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188
Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHPRS 211
               +  K+D++S G+  +EL  G+ P S
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 271
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 272 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 261
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 262 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 254
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 255 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 254
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 255 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 295
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 296 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 255
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 256 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 269
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 270 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 255
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 256 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 272
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 273 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 246
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 247 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 14  HLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V +G L       + VA+K  K          F  +  I+ Q  H N+++
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV   +   +++ EF+ NG L   +R    Q   T    + +    AS + YL  +  
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF--TVIQLVGMLRGIASGMRYLAEMS- 138
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE---TVGWLDPE--- 183
              +H D+ + NIL++ N   KV+DF  S  +  +    T T  +     + W  PE   
Sbjct: 139 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 184 YLFWTEKSDVYSFGVVLVELLT-GKHP 209
           +  +T  SD +S+G+V+ E+++ G+ P
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG G FG VY+G +      P    VAVK    V        F  +  IIS+ NH+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 70  ILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLK-TWKTCLRIAAETASALDYLH 125
            +GV L++    ++ E +  G L    +  R + SQ         L +A + A    YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
                  IH D+ + N LL        AK+ DF  +  I            +  V W+ P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +T K+D +SFGV+L E+ +                  + Y PYP ++N  +++
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS------------------LGYMPYPSKSN--QEV 269
Query: 240 LNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLD 282
           L F V     M+  +     V ++ ++C +    +RP    + E+++
Sbjct: 270 LEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 128/311 (41%), Gaps = 65/311 (20%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVV 68
           LG G FG V +    G+  ++ +  VAVK  K        E    +++I+S +  H+N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT--------------------WK 108
            +LG C      L++ E+   G L   +R ++  +L                       +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA 168
             L  +++ A  + +L    S   IH DV + N+LL + + AK+ DF  +  I +     
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
                   V W+ PE +F   +T +SDV+S+G++L E+ +         L  N       
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------- 259
Query: 226 YFPYP--IENNSLRQILNFQVADENEMEEIEIVAK----LASKCLRTSGTERPTMRQVS- 278
             PYP  + N+   ++    V D  +M +     K    +   C     T RPT +Q+  
Sbjct: 260 --PYPGILVNSKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 313
Query: 279 ---EQLDSLRR 286
              EQ    RR
Sbjct: 314 FLQEQAQEDRR 324

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 14  HLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V +G L       + VA+K  K          F  +  I+ Q  H N+++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV   +   +++ EF+ NG L   +R    Q   T    + +    AS + YL  +  
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF--TVIQLVGMLRGIASGMRYLAEMS- 136
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE---TVGWLDPE--- 183
              +H D+ + NIL++ N   KV+DF  S  +  +    T T  +     + W  PE   
Sbjct: 137 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 184 YLFWTEKSDVYSFGVVLVELLT-GKHP 209
           +  +T  SD +S+G+V+ E+++ G+ P
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQIN 63
           +  Y+   +LG GG   V+    L D+  VAVK  +  +         F+ + +  + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 64  HKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           H  +V +      ET    +P +V E+V   TL   V  +      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVG 178
           AL++ H  G   IIH DVK ANIL+      KV DF  +  +  S +    T   I T  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQIN 63
           +  Y+   +LG GG   V+    L D+  VAVK  +  +         F+ + +  + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 64  HKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           H  +V +      ET    +P +V E+V   TL   V  +      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-IETVG 178
           AL++ H  G   IIH DVK ANI++      KV DF  +  I+    + T T   I T  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 9   NYDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +Y+ + ++G G    V      P    VA+K+  +       +    +++ +SQ +H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRY------QSSQVL--KTWKTCLRIAAETAS 119
           V      +      LV + +  G++   +++        S VL   T  T LR   E   
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR---EVLE 127
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE--IET 176
            L+YLH  G    IH DVK+ NILL ++ + ++ADF  S+ L +  D T    ++  + T
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE 232
             W+ PE +     +  K+D++SFG+  +EL TG                  PY  YP  
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG----------------AAPYHKYPPM 228
Query: 233 NNSLRQILNFQVADENEMEEIEIVA-------KLASKCLRTSGTERPTMRQV 277
              +  + N   + E  +++ E++        K+ S CL+    +RPT  ++
Sbjct: 229 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 123/277 (44%), Gaps = 48/277 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL 75
           LG G FG V+      +T VAVK   M    +  E F  +  ++  + H  +VK+  V  
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV- 246
Query: 76  ETKVPL-LVYEFVPNGTLFQHVRYQ--SSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
            TK P+ ++ EF+  G+L   ++    S Q L      +  +A+ A  + ++        
Sbjct: 247 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---Y 299
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTE 189
           IH D+++ANIL+  +   K+ADF  + + +              + W  PE   +  +T 
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFGSFTI 348
Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY-FPYPIENNSLRQILNFQVADE 247
           KSDV+SFG++L+E++T G+ P  Y  +++ E+ R +   +  P   N   ++ N  +   
Sbjct: 349 KSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALERGYRMPRPENCPEELYNIMM--- 403
Query: 248 NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                         +C +    ERPT   +   LD  
Sbjct: 404 --------------RCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQIN 63
           +  Y+   +LG GG   V+    L D+  VAVK  +  +         F+ + +  + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 64  HKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           H  +V +      ET    +P +V E+V   TL   V  +      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-IETVG 178
           AL++ H  G   IIH DVK ANI++      KV DF  +  I+    + T T   I T  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 78  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 130
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 131 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 188
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 14  HLLGEGGFGFVYKG--VLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V  G   LP      VA+K  K          F  +  I+ Q +H NV+ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV  ++   +++ EF+ NG+L   +R    Q   T    + +    A+ + YL  +  
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN- 155
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE---TVGWLDPE--- 183
              +H D+ + NIL++ N   KV+DF  S  +       T T  +     + W  PE   
Sbjct: 156 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 184 YLFWTEKSDVYSFGVVLVELLT-GKHP 209
           Y  +T  SDV+S+G+V+ E+++ G+ P
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL----ASLILYAYQLSTALAYLE-- 128
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 129 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINF 186
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 79  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 131
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 132 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 189
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 125
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 183
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 81  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 133
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 191
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 63  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 118
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 176 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 62  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 117
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 175 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 128
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 129 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 186
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 104 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE-- 156
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 157 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 214
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 16  LGEGGFGFVYKGVL--PDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK++
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL    S
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDL----ASLILYAYQLSTALAYLE---S 129
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 188
Query: 187 WTEKSDVYSFGVVLVELL 204
           +T  SDV+ FGV + E+L
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 116
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 174 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 46/225 (20%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKK------PKMVDKILINEVFQHKMR 57
           ++ + Y+   L+GEG +G V K    D   +VA+KK       KMV KI + E+     +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI-----K 76
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKT 106
           ++ Q+ H+N+V +L VC + K   LV+EFV           PNG  +Q V+    Q++  
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII-- 134
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                       + + + HS     IIH D+K  NIL+  +   K+ DF  +  +++  +
Sbjct: 135 ------------NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
                 E+ T  +  PE L     + +  DV++ G ++ E+  G+
Sbjct: 180 VYDD--EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 60  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 115
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 173 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLV-YEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AA 115
           ++S+++H   VK L  C +    L     +  NG L +++R    ++    +TC R   A
Sbjct: 90  VMSRLDHPFFVK-LYFCFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTA 144
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           E  SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + 
Sbjct: 145 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 176 TVGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
           T  ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 202 TAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 141
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 199 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 52  FQHKMRIISQINHKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
           F+ + +  + +NH  +V +      ET    +P +V E+V   TL   V  +      T 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TP 115
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
           K  + + A+   AL++ H  G   IIH DVK ANI++      KV DF  +  I+    +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 168 ATTTKE-IETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
            T T   I T  +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 137
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 195 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 86  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 141
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 199 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 82  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 137
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 195 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 138
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 138
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 138
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 138
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 196 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 88  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 143
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 201 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 85  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 140
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 198 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 134/320 (41%), Gaps = 61/320 (19%)
Query: 10  YDKRHL-----LGEGGFG----FVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG    + Y    P N     +VAVK  K          ++ ++
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 57  RIISQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H++++K  G C +       LV E+VP G+L  ++   S  + +     L  A
Sbjct: 85  DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFA 140
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE 173
            +    + YLH+      IH D+ + N+LLD++   K+ DF  +  +   H+        
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 174 IETVGWLDP----EYLFWTEKSDVYSFGVVLVELLT----GKHPRS----YVALASNEMT 221
              V W  P    EY F+   SDV+SFGV L ELLT     + P +     + +A  +MT
Sbjct: 198 DSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 222 RMVPYFPYPIENNSLRQIL----NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            +            L ++L         D+   E    V  L   C  T  + RPT   +
Sbjct: 257 VL-----------RLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENL 301
Query: 278 SEQLDSLRRLHENFWAQKNS 297
              +  L+ +HE +  Q  S
Sbjct: 302 ---IPILKTVHEKYQGQAPS 318

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 16  LGEGGFGFVYKGVL--PDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL    S
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDL----ASLILYAYQLSTALAYLE---S 509
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE   +  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 568
Query: 187 WTEKSDVYSFGVVLVELL 204
           +T  SDV+ FGV + E+L
Sbjct: 569 FTSASDVWMFGVCMWEIL 586

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           ++S+++H   VK+     + +       +  NG L +++R    ++    +TC R   AE
Sbjct: 67  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAE 122
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
             SAL+YLH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 177 VGWLDPEYLFWTEK-----SDVYSFGVVLVELLTGKHP 209
             ++ PE L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 180 AQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 50/316 (15%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  LVAVK+ +        + FQ +++I+
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 78
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             ++   +VK  GV      +   LV E++P+G L   ++   +++  +    L  +++ 
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQI 136
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-SHDQTATTTKEIET 176
              ++YL   GS   +H D+ + NIL++     K+ADF  + L+    D           
Sbjct: 137 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYV---ALASNEMTRM------V 224
           + W  PE L    ++ +SDV+SFGVVL EL T      Y       S E  RM      V
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDV 247
Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P     +E     Q L    A   E+ E      L   C   S  +RP+   +  QLD L
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHE------LMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 285 RRLHENFWAQKNSEET 300
                  W+     ET
Sbjct: 302 -------WSGSRGCET 310

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 132/300 (44%), Gaps = 43/300 (14%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  LVAVK+ +        + FQ +++I+
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 65
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             ++   +VK  GV      +   LV E++P+G L   ++   +++  +    L  +++ 
Sbjct: 66  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQI 123
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-SHDQTATTTKEIET 176
              ++YL   GS   +H D+ + NIL++     K+ADF  + L+    D           
Sbjct: 124 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYV---ALASNEMTRM------V 224
           + W  PE L    ++ +SDV+SFGVVL EL T      Y       S E  RM      V
Sbjct: 181 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGSERDV 234
Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P     +E     Q L    A   E+ E      L   C   S  +RP+   +  QLD L
Sbjct: 235 PALSRLLELLEEGQRLPAPPACPAEVHE------LMKLCWAPSPQDRPSFSALGPQLDML 288

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 52  FQHKMRIISQINHKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
           F+ + +  + +NH  +V +      ET    +P +V E+V   TL   V  +      T 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TP 115
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
           K  + + A+   AL++ H  G   IIH DVK ANI++      KV DF  +  I+    +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 168 ATTTKE-IETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
            T T   I T  +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 139
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 233

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 50/316 (15%)
Query: 10  YDKRHL-----LGEGGFGFV---YKGVLPDNT--LVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DNT  LVAVK+ +        + FQ +++I+
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 66
Query: 60  SQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             ++   +VK  GV      +   LV E++P+G L   ++   +++  +    L  +++ 
Sbjct: 67  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQI 124
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-SHDQTATTTKEIET 176
              ++YL   GS   +H D+ + NIL++     K+ADF  + L+    D           
Sbjct: 125 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYV---ALASNEMTRM------V 224
           + W  PE L    ++ +SDV+SFGVVL EL T      Y       S E  RM      V
Sbjct: 182 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDV 235
Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P     +E     Q L    A   E+ E      L   C   S  +RP+   +  QLD L
Sbjct: 236 PALCRLLELLEEGQRLPAPPACPAEVHE------LMKLCWAPSPQDRPSFSALGPQLDML 289
Query: 285 RRLHENFWAQKNSEET 300
                  W+     ET
Sbjct: 290 -------WSGSRGCET 298

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 129
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 125/307 (40%), Gaps = 66/307 (21%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK------KPKMVDKILINEVFQHKMRIISQIN 63
           LGEG FG V K            T VAVK       P  +  +L       +  ++ Q+N
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL------SEFNVLKQVN 84
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK------------------ 105
           H +V+K+ G C +    LL+ E+   G+L   +R +S +V                    
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 106 ----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
               T    +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF  S  +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN 218
              D     ++    V W+  E LF   +T +SDV+SFGV+L E++T         L  N
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGN 251
Query: 219 EMTRMVPYFPYP-IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                    PYP I    L  +L      E      E + +L  +C +    +RP    +
Sbjct: 252 ---------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 278 SEQLDSL 284
           S+ L+ +
Sbjct: 303 SKDLEKM 309

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 133
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 10  YDKRHL-----LGEGGFG----FVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG    + Y    P N     +VAVK  K      +   +Q ++
Sbjct: 5   FHKRYLKKIRDLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKEGCGPQLRSGWQREI 61
Query: 57  RIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H+++VK  G C +   K   LV E+VP G+L  ++      + +     L  A
Sbjct: 62  EILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL----LLFA 117
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE 173
            +    + YLH+      IH  + + N+LLD++   K+ DF  +  +   H+        
Sbjct: 118 QQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 174 IETVGWLDPEYL----FWTEKSDVYSFGVVLVELLT 205
              V W  PE L    F+   SDV+SFGV L ELLT
Sbjct: 175 DSPVFWYAPECLKECKFYY-ASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 10  YDKRHL-----LGEGGFG----FVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG    + Y    P N     +VAVK  K      +   +Q ++
Sbjct: 6   FHKRYLKKIRDLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKEGCGPQLRSGWQREI 62
Query: 57  RIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H+++VK  G C +   K   LV E+VP G+L  ++      + +     L  A
Sbjct: 63  EILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL----LLFA 118
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE 173
            +    + YLH+      IH  + + N+LLD++   K+ DF  +  +   H+        
Sbjct: 119 QQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 174 IETVGWLDPEYL----FWTEKSDVYSFGVVLVELLT 205
              V W  PE L    F+   SDV+SFGV L ELLT
Sbjct: 176 DSPVFWYAPECLKECKFYY-ASDVWSFGVTLYELLT 210

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 139
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 125/307 (40%), Gaps = 66/307 (21%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK------KPKMVDKILINEVFQHKMRIISQIN 63
           LGEG FG V K            T VAVK       P  +  +L       +  ++ Q+N
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL------SEFNVLKQVN 84
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK------------------ 105
           H +V+K+ G C +    LL+ E+   G+L   +R +S +V                    
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 106 ----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
               T    +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF  S  +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN 218
              D     ++    V W+  E LF   +T +SDV+SFGV+L E++T         L  N
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGN 251
Query: 219 EMTRMVPYFPYP-IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                    PYP I    L  +L      E      E + +L  +C +    +RP    +
Sbjct: 252 ---------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 278 SEQLDSL 284
           S+ L+ +
Sbjct: 303 SKDLEKM 309

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 129
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 53/299 (17%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           +N +   +LG G FG V             +  VAVK  K        E    ++++++Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 62  I-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR------------YQSSQVLK--- 105
           + +H+N+V +LG C  +    L++E+   G L  ++R            Y++ + L+   
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 106 -----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL 160
                T++  L  A + A  +++L        +H D+ + N+L+      K+ DF  +  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALAS 217
           I S             V W+ PE LF   +T KSDV+S+G++L E+ +         L  
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS---------LGV 272
Query: 218 NEMTRMVPYFPYPIENNSLRQILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTM 274
           N      PY   P++ N  + I N    D+     EEI I+ +    C      +RP+ 
Sbjct: 273 N------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSF 322

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 52  FQHKMRIISQINHKNVVKILGVC-LETK---VPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
           F+ + +  + +NH  +V +      ET    +P +V E+V   TL   V  +      T 
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TP 132
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
           K  + + A+   AL++ H  G   IIH DVK ANI++      KV DF  +  I+    +
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 168 ATTTKE-IETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
            T T   I T  +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 129
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 223

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 16  LGEGGFGFVYKGVL--PDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G    P    V+V     KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   + + V E  P G+L   +R      L    T  R A + A  + YL S   
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES--- 133
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYL--- 185
              IH D+ + N+LL      K+ DF     L  + D             W  PE L   
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
            ++  SD + FGV L E+ T G+ P  ++ L  +++
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQI 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 1   SELVKATKNYDK---RHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD----KILINEVF 52
           S+L++    YD+   R +LG+G +G VY G  L +   +A+K+    D    + L  E+ 
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 71
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
            HK      + HKN+V+ LG   E     +  E VP G+L   +R +   +    +T   
Sbjct: 72  LHK-----HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATT 170
              +    L YLH      I+H D+K  N+L+ + Y+   K++DF +S  ++  +    T
Sbjct: 127 YTKQILEGLKYLH---DNQIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 171 TKEIETVGWLDPEYL-----FWTEKSDVYSFGVVLVELLTGKHP 209
                T+ ++ PE +      + + +D++S G  ++E+ TGK P
Sbjct: 183 F--TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 62/274 (22%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI-LINEVFQHKMRIISQINHKNVVK-ILG 72
           L+G G +G VYKG L D   VAVK     ++   INE   +++ ++    H N+ + I+G
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLME---HDNIARFIVG 75
Query: 73  ---VCLETKVP-LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-- 126
              V  + ++  LLV E+ PNG+L +++   +S     W +  R+A      L YLH+  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGLAYLHTEL 131
Query: 127 -LGS---PPIIHGDVKSANILLDDNYTAKVADFASSV------LISSHDQTATTTKEIET 176
             G    P I H D+ S N+L+ ++ T  ++DF  S+      L+   ++      E+ T
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 177 VGWLDPEYLFWT----------EKSDVYSFGVVLVELL---------------------- 204
           + ++ PE L             ++ D+Y+ G++  E+                       
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251
Query: 205 TGKHP--RSYVALASNEMTRMVPYFPYPIENNSL 236
            G HP       L S E  R  P FP   + NSL
Sbjct: 252 VGNHPTFEDMQVLVSREKQR--PKFPEAWKENSL 283

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 125/307 (40%), Gaps = 66/307 (21%)
Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK------KPKMVDKILINEVFQHKMRIISQIN 63
           LGEG FG V K            T VAVK       P  +  +L       +  ++ Q+N
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL------SEFNVLKQVN 84
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK------------------ 105
           H +V+K+ G C +    LL+ E+   G+L   +R +S +V                    
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 106 ----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
               T    +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF  S  +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN 218
              D     ++    V W+  E LF   +T +SDV+SFGV+L E++T         L  N
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGGN 251
Query: 219 EMTRMVPYFPYP-IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                    PYP I    L  +L      E      E + +L  +C +    +RP    +
Sbjct: 252 ---------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 278 SEQLDSL 284
           S+ L+ +
Sbjct: 303 SKDLEKM 309

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 10  YDKRHL-----LGEGGFG----FVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG    + Y    P N     +VAVK  K          ++ ++
Sbjct: 11  FHKRYLKKIRDLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKADCGPQHRSGWKQEI 67
Query: 57  RIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H++++K  G C +   K   LV E+VP G+L  ++   S  + +     L  A
Sbjct: 68  DILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFA 123
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE 173
            +    + YLHS      IH ++ + N+LLD++   K+ DF  +  +   H+        
Sbjct: 124 QQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 174 IETVGWLDPE----YLFWTEKSDVYSFGVVLVELLT 205
              V W  PE    Y F+   SDV+SFGV L ELLT
Sbjct: 181 DSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLT 215

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 16  LGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQ---HKMRIISQINHKNVVKIL 71
           +G G FG VY      N+ +VA+KK     K   NE +Q    ++R + ++ H N ++  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASALDYLHSLG 128
           G  L      LV E+             +S +L+  K  L+   IAA T  AL  L  L 
Sbjct: 121 GCYLREHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
           S  +IH DVK+ NILL +    K+ DF S+ ++      A     + T  W+ PE +   
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAM 225
Query: 187 ----WTEKSDVYSFGVVLVELLTGKHP 209
               +  K DV+S G+  +EL   K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 16  LGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQ---HKMRIISQINHKNVVKIL 71
           +G G FG VY      N+ +VA+KK     K   NE +Q    ++R + ++ H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAAETASALDYLHSLG 128
           G  L      LV E+             +S +L+  K  L+   IAA T  AL  L  L 
Sbjct: 82  GCYLREHTAWLVMEYCLGS---------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
           S  +IH DVK+ NILL +    K+ DF S+ ++      A     + T  W+ PE +   
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAM 186
Query: 187 ----WTEKSDVYSFGVVLVELLTGKHP 209
               +  K DV+S G+  +EL   K P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L  + F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 14  HLLGEGGFGFVYKG--VLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG V  G   LP      VA+K  K          F  +  I+ Q +H NV+ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV  ++   +++ EF+ NG+L   +R    Q   T    + +    A+ + YL  +  
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN- 129
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE---TVGWLDPE--- 183
              +H  + + NIL++ N   KV+DF  S  +       T T  +     + W  PE   
Sbjct: 130 --YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 184 YLFWTEKSDVYSFGVVLVELLT-GKHP 209
           Y  +T  SDV+S+G+V+ E+++ G+ P
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 77
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 130
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 227

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 436
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 490
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 550 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 586

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR----IISQINH 64
           ++D    LG+G FG VY      N  +   K  +    L  E  +H++R    I S + H
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N++++     + K   L+ EF P G L++ ++       +   T +    E A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EELADALHYC 131
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H      +IH D+K  N+L+      K+ADF  SV    H  +        T+ +L PE 
Sbjct: 132 HERK---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEM 184
Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP 209
           +      EK D++  GV+  E L G  P
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 93
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 93
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 207 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 243

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 435
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 489
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 585

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 10  YDKRHL-----LGEGGFG----FVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM 56
           + KR+L     LGEG FG    + Y    P N     +VAVK  K          ++ ++
Sbjct: 11  FHKRYLKKIRDLGEGHFGKVSLYCYD---PTNDGTGEMVAVKALKADCGPQHRSGWKQEI 67
Query: 57  RIISQINHKNVVKILGVCLET--KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
            I+  + H++++K  G C +   K   LV E+VP G+L  ++   S  + +     L  A
Sbjct: 68  DILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFA 123
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKE 173
            +    + YLH+      IH ++ + N+LLD++   K+ DF  +  +   H+        
Sbjct: 124 QQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 174 IETVGWLDPE----YLFWTEKSDVYSFGVVLVELLT 205
              V W  PE    Y F+   SDV+SFGV L ELLT
Sbjct: 181 DSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLT 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 83
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 136
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 108
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 166
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 220
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 71
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 124
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 185 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 221

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 91
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 145
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 205 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 241

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 86
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 144
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 198
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 73
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 126
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 37/289 (12%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVR--------YQSSQVLKTWKTCLRIAAETAS 119
            +LG C +   PL+V  EF   G L  ++R        Y+   + K + T   +   +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
               +  L S   IH D+ + NILL +    K+ DF  +  I               + W
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           + PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R             
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------R 263
Query: 236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 75
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 133
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 187
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 14  HLLGEGGFGFVYKGVL--PDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 70  ILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           ++GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL----ASLILYAYQLSTALAYLE-- 128
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---Y 184
            S   +H D+ + N+L+      K+ DF  S  +        +  ++  + W+ PE   +
Sbjct: 129 -SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINF 186
Query: 185 LFWTEKSDVYSFGVVLVELL 204
             +T  SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 93
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 151
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 205
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 82
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 140
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 194
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 16  LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG            V + K +  D  L +E+   +  ++ Q+++  +V++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 77
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L +++  Q ++ +K  K  + +  + +  + YL      
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 130
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  L +  +     T     V W  PE   Y  
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 227

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 86
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 144
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 198
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 16  LGEGGFGFVYKGVL--PDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +GEG FG V++G+   P+N    VA+K  K      + E F  +   + Q +H ++VK++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           GV  E  V  ++ E    G L  F  VR  S  +     + +  A + ++AL YL    S
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDL----ASLILYAYQLSTALAYLE---S 509
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
              +H D+ + N+L+      K+ DF  S  +        +  ++  + W+ PE   +  
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 568
Query: 187 WTEKSDVYSFGVVLVELL 204
           +T  SDV+ FGV + E+L
Sbjct: 569 FTSASDVWMFGVCMWEIL 586

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L  + F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L  + F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR----IISQINH 64
           ++D    LG+G FG VY      N  +   K  +    L  E  +H++R    I S + H
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N++++     + K   L+ EF P G L++ ++       +   T +    E A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EELADALHYC 130
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H      +IH D+K  N+L+      K+ADF  SV    H  +        T+ +L PE 
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEM 183
Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP 209
           +      EK D++  GV+  E L G  P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 78
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 136
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 190
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 108
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 166
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 220
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 74
Query: 67  VVKIL------GVCLETKVPLLVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++       G   +     LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 35/269 (13%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG+G FG VY      +  +   K      ++K  +    + ++ I + ++H N++++  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
              + +   L+ E+ P G L++ +  Q S      +T   I  E A AL Y H      +
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTAT-IMEELADALMYCHGKK---V 144
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTE 189
           IH D+K  N+LL      K+ADF  SV    H  +        T+ +L PE +      E
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPPEMIEGRMHNE 200
Query: 190 KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE 249
           K D++  GV+  ELL G  P  + + + NE  R +           ++  L F  +    
Sbjct: 201 KVDLWCIGVLCYELLVGNPP--FESASHNETYRRI-----------VKVDLKFPASVPTG 247
Query: 250 MEEIEIVAKLASKCLRTSGTERPTMRQVS 278
            ++      L SK LR + +ER  + QVS
Sbjct: 248 AQD------LISKLLRHNPSERLPLAQVS 270

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 153
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 211
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 265
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 102
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 160
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 214
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 74
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 132
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 186
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 87
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 145
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 199
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 112
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 170
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 224
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 110
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 168
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 222
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 9   NYDKRHLLGEGGFGFV--YKGVLPDNTLVAVKKPKMVDKILINEVFQHKM----RIISQI 62
           NY  +  +G+G F  V   + VL     VAVK   ++DK  +N     K+    RI+  +
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGRE-VAVK---IIDKTQLNPTSLQKLFREVRIMKIL 71
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           NH N+VK+  V    K   LV E+   G +F ++        K  +   R   +  SA+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 128
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           Y H      I+H D+K+ N+LLD +   K+ADF  S   +  ++  T      +  +  P
Sbjct: 129 YCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG---SPPYAAP 182
Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E LF  +K      DV+S GV+L  L++G  P
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 29/214 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDKILINEVFQHK-MRIISQINHKN 66
           +Y    ++G G FG VY+  L D+  LVA+K      K+L ++ F+++ ++I+ +++H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCN 79
Query: 67  VVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCLRIAAETA 118
           +V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L +  +  
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLF 137
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I + 
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 191
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   DV+S G VL ELL G+
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 13  RHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD----KILINEVFQHKMRIISQINHKNV 67
           R +LG+G +G VY G  L +   +A+K+    D    + L  E+  HK      + HKN+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK-----HLKHKNI 67
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V+ LG   E     +  E VP G+L   +R +   +    +T      +    L YLH  
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-- 125
Query: 128 GSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
               I+H D+K  N+L+ + Y+   K++DF +S  ++  +    T     T+ ++ PE +
Sbjct: 126 -DNQIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEII 181
Query: 186 -----FWTEKSDVYSFGVVLVELLTGKHP 209
                 + + +D++S G  ++E+ TGK P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 16  LGEGGFGFV-----YKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V     Y  +  D  + VAVK  K    +   E    +++++S + NH N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--------------- 113
            +LG C      L++ E+   G L   +R +    + + KT   I               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS-KTSPAIMEDDELALDLEDLLS 172
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  + +   L S   IH D+ + NILL      K+ DF  +  I +         
Sbjct: 173 FSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G+ L EL +         L S+      PY   
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSS------PYPGM 274
Query: 230 PIENNSLRQIL-NFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           P+++   + I   F+ ++ E+   E+  + K    C      +RPT +Q+ + ++
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 326

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL---------KTWKTCLRIAAETA 118
            +LG C +   PL+V  EF   G L  ++R + ++ +         K + T   +   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
                +  L S   IH D+ + NILL +    K+ DF  +  I               + 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN 234
           W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R            
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------ 262
Query: 235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 16  LGEGGFGFVYKG-VLPDNTLVAVKKPKMVDKI-------LINEVFQHKMRIISQINHKNV 67
           +G G F  VY+   L D   VA+KK ++ D +        I E+      ++ Q+NH NV
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-----DLLKQLNHPNV 94
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVR-YQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +K     +E     +V E    G L + ++ ++  + L   +T  +   +  SAL+++HS
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                ++H D+K AN+ +      K+ D       SS  +T      + T  ++ PE + 
Sbjct: 155 RR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 209
Query: 187 ---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYPIENNS--LRQ 238
              +  KSD++S G +L E+   + P     +    + + +    Y P P ++ S  LRQ
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 239 ILNFQVADENEMEE----IEIVAKLASKCLRTS 267
           ++N  +  + E       +  VAK    C  +S
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 16  LGEGGFGFV-----YKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V     Y  +  D  + VAVK  K    +   E    +++++S + NH N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--------------- 113
            +LG C      L++ E+   G L   +R +    + + KT   I               
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS-KTSPAIMEDDELALDLEDLLS 165
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  + +   L S   IH D+ + NILL      K+ DF  +  I +         
Sbjct: 166 FSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G+ L EL +         L S+      PY   
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSS------PYPGM 267
Query: 230 PIENNSLRQIL-NFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           P+++   + I   F+ ++ E+   E+  + K    C      +RPT +Q+ + ++
Sbjct: 268 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 319

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 16  LGEGGFGFV-----YKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V     Y  +  D  + VAVK  K    +   E    +++++S + NH N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--------------- 113
            +LG C      L++ E+   G L   +R +    + + KT   I               
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS-KTSPAIMEDDELALDLEDLLS 149
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  + +   L S   IH D+ + NILL      K+ DF  +  I +         
Sbjct: 150 FSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G+ L EL +         L S+      PY   
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSS------PYPGM 251
Query: 230 PIENNSLRQIL-NFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           P+++   + I   F+ ++ E+   E+  + K    C      +RPT +Q+ + ++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 16  LGEGGFGFV-----YKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V     Y  +  D  + VAVK  K    +   E    +++++S + NH N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--------------- 113
            +LG C      L++ E+   G L   +R +    + + KT   I               
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS-KTSPAIMEDDELALDLEDLLS 167
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  + +   L S   IH D+ + NILL      K+ DF  +  I +         
Sbjct: 168 FSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G+ L EL +         L S+      PY   
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSS------PYPGM 269
Query: 230 PIENNSLRQIL-NFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           P+++   + I   F+ ++ E+   E+  + K    C      +RPT +Q+ + ++
Sbjct: 270 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 321

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 253
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 254 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 253
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 254 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 16  LGEGGFGFV-----YKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVV 68
           LG G FG V     Y  +  D  + VAVK  K    +   E    +++++S + NH N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--------------- 113
            +LG C      L++ E+   G L   +R +    + + KT   I               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS-KTSPAIMEDDELALDLEDLLS 172
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  + +   L S   IH D+ + NILL      K+ DF  +  I +         
Sbjct: 173 FSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G+ L EL +         L S+      PY   
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGSS------PYPGM 274
Query: 230 PIENNSLRQIL-NFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           P+++   + I   F+ ++ E+   E+  + K    C      +RPT +Q+ + ++
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 326

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 213
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 266
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 321
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 262
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 263 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 35/287 (12%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL------KTWKTCLRIAAETASAL 121
            +LG C +   PL+V  EF   G L  ++R + ++ +      K + T   +   +    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
             +  L S   IH D+ + NILL +    K+ DF  +  I               + W+ 
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 182 PEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
           PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R             L+
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------RLK 261
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 262 EGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 13  RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--------INH 64
           R +L EGGF FVY+        V   +   + ++L NE  + K R I Q          H
Sbjct: 33  RRVLAEGGFAFVYEA-----QDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGH 85
Query: 65  KNVVKILGVCLETK-------VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
            N+V+        K          L+   +  G L + ++   S+   +  T L+I  +T
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS-------SHDQTATT 170
             A+ ++H    PPIIH D+K  N+LL +  T K+ DF S+  IS       S  + A  
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 171 TKEI---ETVGWLDPEYLFW------TEKSDVYSFGVVLVELLTGKHP 209
            +EI    T  +  PE +         EK D+++ G +L  L   +HP
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 41/290 (14%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVLK---------TWKTCLRIAAETA 118
            +LG C +   PL+V  EF   G L  ++R + ++ +          T +  +  + + A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             +++L    S   IH D+ + NILL +    K+ DF  +  I               + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN 234
           W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R            
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFXR------------ 258
Query: 235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
            L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 304

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 136
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 189
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 244
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++ +  LG GGFG+V + +  D    VA+K+ +        E +  +++I+ ++NH NVV
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 69  KI------LGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASAL 121
                   L       +PLL  E+   G L +++ ++++   LK       + ++ +SAL
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLSDISSAL 135
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH      IIH D+K  NI+L       +            DQ    T+ + T+ +L 
Sbjct: 136 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           PE L    +T   D +SFG +  E +TG  P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++ +  LG GGFG+V + +  D    VA+K+ +        E +  +++I+ ++NH NVV
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 69  KI------LGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASAL 121
                   L       +PLL  E+   G L +++ ++++   LK       + ++ +SAL
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLSDISSAL 134
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH      IIH D+K  NI+L       +            DQ    T+ + T+ +L 
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           PE L    +T   D +SFG +  E +TG  P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
           K Y +   +G+G  G VY  + +     VA+++      PK   +++INE+      ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEIL-----VMR 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAET 117
           +  + N+V  L   L      +V E++  G+L   V        Q+    + CL+     
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 127
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     +IH D+KS NILL  + + K+ DF     I     T   +K  E V
Sbjct: 128 --ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----TPEQSKRSEMV 177
Query: 178 G---WLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           G   W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 93
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 146
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 201
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 262
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 263 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 253
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 254 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVD----KILINEVFQHKMRIISQ 61
            K Y+K   LGEG F  VYK    + N +VA+KK K+      K  IN     +++++ +
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           ++H N++ +L          LV++F+        V  + + ++ T          T   L
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
           +YLH      I+H D+K  N+LLD+N   K+ADF  +    S ++      ++ T  +  
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYXHQVVTRWYRA 180
Query: 182 PEYLF----WTEKSDVYSFGVVLVELL 204
           PE LF    +    D+++ G +L ELL
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 253
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 254 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
           K Y +   +G+G  G VY  + +     VA+++      PK   +++INE+      ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEIL-----VMR 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAET 117
           +  + N+V  L   L      +V E++  G+L   V        Q+    + CL+     
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 127
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     +IH D+KS NILL  + + K+ DF     I+      +T   + T 
Sbjct: 128 --ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTP 180
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 264
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 265 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 310

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   L+ E+   G +F ++
Sbjct: 43  KIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 102
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  ++  R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 103 VAHGRMKEKEARSKFR---QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFG 156
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +   +  T      +  +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 157 FSNEFTVGGKLDTFCG---SPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 7   TKNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
            ++YD   ++G G FG V    +K       +  + K +M+ K   +  F  +  I++  
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFA 132
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           N   VV++     + K   +V E++P G L   +   +  V + W       AE   ALD
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY--TAEVVLALD 188
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            +HS+G   +IH DVK  N+LLD +   K+ADF + + +         T  + T  ++ P
Sbjct: 189 AIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISP 244
Query: 183 EYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
           E L       ++  + D +S GV L E+L G  P
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 91
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 144
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 199
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 299
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 300 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 16  LGEGGFGFVYK----GVLPDNTL--VAVKKPKMVDKILINEVFQHKMRIISQINHK-NVV 68
           LG G FG V +    G+    T   VAVK  K       +     +++I+  I H  NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 69  KILGVCLETKVPLLVY-EFVPNGTLFQHVRYQSSQVL----------KTWKTCLRIAAET 117
            +LG C +   PL+V  EF   G L  ++R + ++ +          K + T   +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                 +  L S   IH D+ + NILL +    K+ DF  +  I               +
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +F   +T +SDV+SFGV+L E+ + G  P   V +   E  R           
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR----------- 262
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             L++    +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 263 -RLKEGTRMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  KIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++  T      +  +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 159 FSNEFTFGNKLDTFCG---SPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  KIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++  T      +  +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 159 FSNEFTFGNKLDTFCG---SPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   TKNYDKRHLLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           +  Y  + +LG+G FG V      +      V V   + V +    E    +++++ Q++
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASAL 121
           H N++K+     +     LV E    G LF  +  R + S+V        RI  +  S +
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGI 163
Query: 122 DYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKE-IETV 177
            Y+H      I+H D+K  N+LL+    +   ++ DF     +S+H + +   K+ I T 
Sbjct: 164 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTA 216
Query: 178 GWLDPEYLFWT--EKSDVYSFGVVLVELLTGKHP 209
            ++ PE L  T  EK DV+S GV+L  LL+G  P
Sbjct: 217 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   TKNYDKRHLLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           +  Y  + +LG+G FG V      +      V V   + V +    E    +++++ Q++
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASAL 121
           H N++K+     +     LV E    G LF  +  R + S+V        RI  +  S +
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGI 162
Query: 122 DYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKE-IETV 177
            Y+H      I+H D+K  N+LL+    +   ++ DF     +S+H + +   K+ I T 
Sbjct: 163 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTA 215
Query: 178 GWLDPEYLFWT--EKSDVYSFGVVLVELLTGKHP 209
            ++ PE L  T  EK DV+S GV+L  LL+G  P
Sbjct: 216 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   TKNYDKRHLLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           +  Y  + +LG+G FG V      +      V V   + V +    E    +++++ Q++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASAL 121
           H N++K+     +     LV E    G LF  +  R + S+V        RI  +  S +
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGI 139
Query: 122 DYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKE-IETV 177
            Y+H      I+H D+K  N+LL+    +   ++ DF     +S+H + +   K+ I T 
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTA 192
Query: 178 GWLDPEYLFWT--EKSDVYSFGVVLVELLTGKHP 209
            ++ PE L  T  EK DV+S GV+L  LL+G  P
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 86
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 139
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 194
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFV-YKGVLPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V    V     LVAVKK  +  +    +L NEV      I+    H+NVV++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-----IMRDYQHENVVEM 82
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+      CL +      AL  LH+ 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----QALSVLHAQ 135
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISR 190
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   TKNYDKRHLLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           +  Y  + +LG+G FG V      +      V V   + V +    E    +++++ Q++
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASAL 121
           H N++K+     +     LV E    G LF  +  R + S+V        RI  +  S +
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGI 145
Query: 122 DYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKE-IETV 177
            Y+H      I+H D+K  N+LL+    +   ++ DF     +S+H + +   K+ I T 
Sbjct: 146 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTA 198
Query: 178 GWLDPEYLFWT--EKSDVYSFGVVLVELLTGKHP 209
            ++ PE L  T  EK DV+S GV+L  LL+G  P
Sbjct: 199 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   L+ E+   G +F ++
Sbjct: 46  KIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 105
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  ++  R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 106 VAHGRMKEKEARSKFR---QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFG 159
Query: 157 SSVLISSHDQTATTTKEIETVGWLD-----PEY----LFWTEKS-----DVYSFGVVLVE 202
            S              E    G LD     P Y    LF  +K      DV+S GV+L  
Sbjct: 160 FS-------------NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYT 206
Query: 203 LLTGKHP 209
           L++G  P
Sbjct: 207 LVSGSLP 213

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 55/291 (18%)
Query: 16  LGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILIN--EVFQHKMRIISQINHK 65
           LG+G F  ++KGV  +         T V +K   ++DK   N  E F     ++S+++HK
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLK---VLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           ++V   GVC+     +LV EFV  G+L  +++   + +   WK  L +A + A+A+   H
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAM---H 127
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTA-----KVADFASSVLISSHDQTATTTKEIETV 177
            L    +IHG+V + NILL   +D  T      K++D   S+ +   D         E +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ERI 181
Query: 178 GWLDPEYLFWTEK----SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +   +     +D +SFG  L E+ +G   +   AL                  
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-KPLSAL------------------ 222
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +S R++  ++   +    +   +A L + C+      RP+ R +   L+SL
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           +++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++  T      +  +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 159 FSNEFTFGNKLDTFCG---SPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQIN 63
           ++++   +LG+G FG V+       N   A+K  K  D +L+++  +  M   R++S   
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAW 76
Query: 64  HKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
               +  +    +TK  L  V E++  G L  H+  QS       +     AAE    L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF-YAAEIILGLQ 133
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           +LHS G   I++ D+K  NILLD +   K+ADF         D  A T +   T  ++ P
Sbjct: 134 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNEFCGTPDYIAP 188
Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           E L    +    D +SFGV+L E+L G+ P
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 25/181 (13%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           +++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVG---WLDPEYLFWTEKS-----DVYSFGVVLVELLTGKH 208
            S      ++     K  E  G   +  PE LF  +K      DV+S GV+L  L++G  
Sbjct: 159 FS------NEFTFGNKLDEFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 209 P 209
           P
Sbjct: 212 P 212

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN---EVFQHKMRIISQINHKNVVKILG 72
           +G G F  VYKG L   T V V   ++ D+ L     + F+ +   +  + H N+V+   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 73  VCLET----KVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
               T    K  +LV E   +GTL    +  +    +VL++W  C +I       L +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW--CRQIL----KGLQFLH 146
Query: 126 SLGSPPIIHGDVKSANILLDD-NYTAKVADFASSVLI-SSHDQTATTTKEIETVGWLDPE 183
           +  +PPIIH D+K  NI +     + K+ D   + L  +S  +    T E       + +
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 184 YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
           Y    E  DVY+FG   +E  T ++P S    A+    R+
Sbjct: 206 Y---DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRV 242

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 130/310 (41%), Gaps = 46/310 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQ 61
              N++   +LG+G FG V    + +   L AVK  K  D IL ++  +  M   RI+S 
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-DVILQDDDVECTMTEKRILSL 79
Query: 62  INHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
             +   +  L  C +T   L  V EFV  G L  H+  Q S+     +     AAE  SA
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEIISA 136
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L +LH  G   II+ D+K  N+LLD     K+ADF   +         TT     T  ++
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG--MCKEGICNGVTTATFCGTPDYI 191
Query: 181 DPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE L    +    D ++ GV+L E+L G  P                 F    E++   
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-----------------FEAENEDDLFE 234
Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMR--QVSEQLDSLRRLHENF---- 291
            ILN +V     + E       A+  L++  T+ PTMR   +++  +     H  F    
Sbjct: 235 AILNDEVVYPTWLHED------ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288
Query: 292 WAQKNSEETE 301
           WAQ N  + E
Sbjct: 289 WAQLNHRQIE 298

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           L+G GGFG V+K     D     +K+ K       NE  + +++ +++++H N+V   G 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNG- 71
Query: 74  CLE-----------------TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           C +                 TK   +  EF   GTL Q +  +  + L      L +  +
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV-LALELFEQ 130
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               +DY+HS     +I+ D+K +NI L D    K+ DF    L++S        +   T
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFG---LVTSLKNDGKRXRSKGT 184
Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELL 204
           + ++ PE +    + ++ D+Y+ G++L ELL
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR 57
           +L    ++Y+   ++G G FG V    +K       +  + K +M+ K   +  F  +  
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERD 121
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           I++  N   VV++     + +   +V E++P G L   +   +  V + W       AE 
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEV 177
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             ALD +HS+G    IH DVK  N+LLD +   K+ADF + + ++        T  + T 
Sbjct: 178 VLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTP 233
Query: 178 GWLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
            ++ PE L       ++  + D +S GV L E+L G  P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR 57
           +L    ++Y+   ++G G FG V    +K       +  + K +M+ K   +  F  +  
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERD 126
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           I++  N   VV++     + +   +V E++P G L   +   +  V + W       AE 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEV 182
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             ALD +HS+G    IH DVK  N+LLD +   K+ADF + + ++        T  + T 
Sbjct: 183 VLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTP 238
Query: 178 GWLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
            ++ PE L       ++  + D +S GV L E+L G  P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 6   ATKNYDKRHLLGEGGFG--FVYKGVLPDNT-----LVAVKKPKMVDKILINEVFQHKMRI 58
             +N++   +LG G +G  F+ + +   +T     +  +KK  +V K    E  + + ++
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 59  ISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
           +  I     +  L    +T+  L L+ +++  G LF H+    SQ  +  +  ++I   E
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGE 167
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
              AL++LH LG   II+ D+K  NILLD N    + DF  S    + D+T        T
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGT 223
Query: 177 VGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP------RSYVALASNEMTRMVP 225
           + ++ P+ +   +       D +S GV++ ELLTG  P      ++  A  S  + +  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 226 YFPYPIENNSLRQIL 240
             PYP E ++L + L
Sbjct: 284 --PYPQEMSALAKDL 296

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 2   ELVKATKNYDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR 57
           +L    ++Y+   ++G G FG V    +K       +  + K +M+ K   +  F  +  
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERD 126
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           I++  N   VV++     + +   +V E++P G L   +   +  V + W       AE 
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEV 182
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             ALD +HS+G    IH DVK  N+LLD +   K+ADF + + ++        T  + T 
Sbjct: 183 VLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTP 238
Query: 178 GWLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHP 209
            ++ PE L       ++  + D +S GV L E+L G  P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDK----ILINEVFQHKMRIISQINHKNVVKI 70
           +GEG  G V           VAVKK  +  +    +L NEV      I+   +H NVV +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-----IMRDYHHDNVVDM 107
Query: 71  LGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
               L      +V EF+  G L     H R    Q+     + LR       AL YLH+ 
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR-------ALSYLHNQ 160
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY--- 184
           G   +IH D+KS +ILL  +   K++DF     +S   +       + T  W+ PE    
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKXLVGTPYWMAPEVISR 215
Query: 185 LFWTEKSDVYSFGVVLVELLTGKHP 209
           L +  + D++S G++++E++ G+ P
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 38  KIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 97
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 98  VAHGWMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 151
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++  T      +  +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 152 FSNEFTFGNKLDTFCG---SPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
           K Y +   +G+G  G VY  + +     VA+++      PK   +++INE+      ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEIL-----VMR 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAET 117
           +  + N+V  L   L      +V E++  G+L   V        Q+    + CL+     
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 127
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     +IH D+KS NILL  + + K+ DF     I+   + +  +  + T 
Sbjct: 128 --ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTP 180
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
           K Y +   +G+G  G VY  + +     VA+++      PK   +++INE+      ++ 
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEIL-----VMR 73
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAET 117
           +  + N+V  L   L      +V E++  G+L   V        Q+    + CL+     
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 128
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     +IH D+KS NILL  + + K+ DF     I+   + +  +  + T 
Sbjct: 129 --ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTP 181
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
           K Y +   +G+G  G VY  + +     VA+++      PK   +++INE+      ++ 
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEIL-----VMR 73
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR---YQSSQVLKTWKTCLRIAAET 117
           +  + N+V  L   L      +V E++  G+L   V        Q+    + CL+     
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 128
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     +IH ++KS NILL  + + K+ DF     I+      +T   + T 
Sbjct: 129 --ALEFLHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTP 181
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            W+ PE +    +  K D++S G++ +E++ G+ P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNVVKILGV 73
           LG+G FG VYK    + +++A  K  ++D     E+  +  ++ I++  +H N+VK+L  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
                   ++ EF   G +   V  +  + L T      +  +T  AL+YLH      II
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDALNYLHD---NKII 157
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYLF---- 186
           H D+K+ NIL   +   K+ADF  S        T T  +    +G   W+ PE +     
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 187 ----WTEKSDVYSFGVVLVELLTGKHP 209
               +  K+DV+S G+ L+E+   + P
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 55/291 (18%)
Query: 16  LGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILIN--EVFQHKMRIISQINHK 65
           LG+G F  ++KGV  +         T V +K   ++DK   N  E F     ++S+++HK
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLK---VLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           ++V   GVC      +LV EFV  G+L  +++   + +   WK  L +A + A A+   H
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAWAM---H 127
Query: 126 SLGSPPIIHGDVKSANILL---DDNYTA-----KVADFASSVLISSHDQTATTTKEIETV 177
            L    +IHG+V + NILL   +D  T      K++D   S+ +   D         E +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ERI 181
Query: 178 GWLDPEYLFWTEK----SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +   +     +D +SFG  L E+ +G   +   AL                  
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-KPLSAL------------------ 222
Query: 234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +S R++  ++   +    +   +A L + C+      RP+ R +   L+SL
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 15  LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           L+G GGFG V+K     D     +++ K       NE  + +++ +++++H N+V   G 
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYN-----NEKAEREVKALAKLDHVNIVHYNGC 73
Query: 74  -------------CLE----------------TKVPLLVYEFVPNGTLFQHVRYQSSQVL 104
                         LE                TK   +  EF   GTL Q +  +  + L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 105 KTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH 164
                 L +  +    +DY+HS     +IH D+K +NI L D    K+ DF    L++S 
Sbjct: 134 DKV-LALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG---LVTSL 186
Query: 165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELL 204
                 T+   T+ ++ PE +    + ++ D+Y+ G++L ELL
Sbjct: 187 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI+  +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  KIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++            +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 159 FSNEFTFGNKLDAFCG---APPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNVVKILGV 73
           LG+G FG VYK    + +++A  K  ++D     E+  +  ++ I++  +H N+VK+L  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
                   ++ EF   G +   V  +  + L T      +  +T  AL+YLH      II
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDALNYLHD---NKII 157
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF------- 186
           H D+K+ NIL   +   K+ADF  S   +   Q   +   I T  W+ PE +        
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF--IGTPYWMAPEVVMCETSKDR 215
Query: 187 -WTEKSDVYSFGVVLVELLTGKHP 209
            +  K+DV+S G+ L+E+   + P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 19  GGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS--QINHKNVVKILGV--- 73
           G FG V+K  L  N  VAVK   + DK    + +Q++  + S   + H+N+++ +G    
Sbjct: 35  GRFGCVWKAQLL-NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKR 89
Query: 74  CLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH------- 125
                V L L+  F   G+L   ++      + +W     IA   A  L YLH       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
               P I H D+KS N+LL +N TA +ADF  ++   +      T  ++ T  ++ PE L
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 186 -----FWTE---KSDVYSFGVVLVELLT 205
                F  +   + D+Y+ G+VL EL +
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+G FG V+       N   A+K  K  D +L+++  +  M   R++S       +  
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 71  LGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +    +TK  L  V E++  G L  H+  QS       +     AAE    L +LHS G 
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF-YAAEIILGLQFLHSKG- 138
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
             I++ D+K  NILLD +   K+ADF         D  A T     T  ++ PE L    
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNXFCGTPDYIAPEILLGQK 194
Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +    D +SFGV+L E+L G+ P
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 7   TKNYDKRHLLGEGGFGFVY---KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           +  Y  + +LG+G FG V      +      V V   + V +    E    +++++ Q++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASAL 121
           H N+ K+     +     LV E    G LF  +  R + S+V        RI  +  S +
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGI 139
Query: 122 DYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKE-IETV 177
            Y H      I+H D+K  N+LL+    +   ++ DF     +S+H + +   K+ I T 
Sbjct: 140 TYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG----LSTHFEASKKXKDKIGTA 192
Query: 178 GWLDPEYLFWT--EKSDVYSFGVVLVELLTGKHP 209
            ++ PE L  T  EK DV+S GV+L  LL+G  P
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 16  LGEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V +GV         VA+K  K   +    E    + +I+ Q+++  +V+++G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC + +  +LV E    G L + +  +  ++  +      +  + +  + YL        
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN---F 131
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWLDPE---YLFWT 188
           +H D+ + N+LL + + AK++DF  S  + + D   T     +  + W  PE   +  ++
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 189 EKSDVYSFGVVLVELLT-GKHP 209
            +SDV+S+GV + E L+ G+ P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 41/233 (17%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           ++   ++++  +LG+G FG V K     D+   A+KK +  ++ L       ++ +++ +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASL 59
Query: 63  NHKNVVKILGVCLETK-------------VPLLVYEFVPNGTLFQ--HVRYQSSQVLKTW 107
           NH+ VV+     LE +                +  E+  NGTL+   H    + Q  + W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS--------- 158
               R+  +   AL Y+HS G   IIH D+K  NI +D++   K+ DF  +         
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 159 VLISSHDQTATT---TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELL 204
           + + S +   ++   T  I T  ++  E L     + EK D+YS G++  E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQI 62
           K + NYD +  LG+G F  V + V     L    K     K+   +    + + RI  ++
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N+V++     E     LV++ V  G LF+ +  +          C++   E+   + 
Sbjct: 86  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IA 142
Query: 123 YLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +          T G+
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG---TPGY 196
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           L PE L    +++  D+++ GV+L  LL G  P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           L+G G +G VYKG       +A  K   V      E+ Q    +    +H+N+    G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 75  LETKVP------LLVYEFVPNGTLFQHVRYQSSQVLKT-WKTCLRIAAETASALDYLHSL 127
           ++   P       LV EF   G++   ++      LK  W     I  E    L +LH  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQH 148
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-IETVGWLDPEYLF 186
               +IH D+K  N+LL +N   K+ DF  S  +   D+T       I T  W+ PE + 
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 202
Query: 187 WTE--------KSDVYSFGVVLVELLTGKHP 209
             E        KSD++S G+  +E+  G  P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNVVKILGV 73
           LG+G FG VYK    + +++A  K  ++D     E+  +  ++ I++  +H N+VK+L  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
                   ++ EF   G +   V  +  + L T      +  +T  AL+YLH      II
Sbjct: 103 FYYENNLWILIEFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDALNYLHD---NKII 157
Query: 134 HGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF------- 186
           H D+K+ NIL   +   K+ADF  S   +   Q       I T  W+ PE +        
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF--IGTPYWMAPEVVMCETSKDR 215
Query: 187 -WTEKSDVYSFGVVLVELLTGKHP 209
            +  K+DV+S G+ L+E+   + P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 48  INEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT 106
           + E  + +  I+ Q+  H +++ ++     +    LV++ +  G LF    Y + +V  +
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD---YLTEKVALS 198
Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K    I      A+ +LH+     I+H D+K  NILLDDN   +++DF      S H +
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG----FSCHLE 251
Query: 167 TATTTKEI-ETVGWLDPEYL---------FWTEKSDVYSFGVVLVELLTGKHP 209
                +E+  T G+L PE L          + ++ D+++ GV+L  LL G  P
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQI 62
           K + NYD +  LG+G F  V + V     L    K     K+   +    + + RI  ++
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N+V++     E     LV++ V  G LF+ +  +          C++   E+   + 
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IA 118
Query: 123 YLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +          T G+
Sbjct: 119 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG---TPGY 172
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           L PE L    +++  D+++ GV+L  LL G  P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 20/193 (10%)
Query: 54  HKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCL 111
           +++ ++  ++H N++K+  V  + K   LV EF   G LF+ +  R++  +         
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC-----DAA 149
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVADFASSVLISSHDQTA 168
            I  +  S + YLH      I+H D+K  NILL++  +    K+ DF  S   S   +  
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDY 203
Query: 169 TTTKEIETVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
                + T  ++ PE L   + EK DV+S GV++  LL G  P  +      ++ + V  
Sbjct: 204 KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDIIKKVEK 261
Query: 227 FPYPIENNSLRQI 239
             Y  + N  + I
Sbjct: 262 GKYYFDFNDWKNI 274

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQI 62
           K + NYD +  LG+G F  V + V     L    K     K+   +    + + RI  ++
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N+V++     E     LV++ V  G LF+ +  +          C++   E+   + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IA 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +          T G+
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG---TPGY 173
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           L PE L    +++  D+++ GV+L  LL G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQI 62
           K + NYD +  LG+G F  V + V     L    K     K+   +    + + RI  ++
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N+V++     E     LV++ V  G LF+ +  +          C++   E+   + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IA 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +          T G+
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG---TPGY 173
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           L PE L    +++  D+++ GV+L  LL G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 19/178 (10%)
Query: 41  KMVDKILINEVFQHKM----RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV 96
           K++DK  +N     K+    RI   +NH N+VK+  V    K   LV E+   G +F ++
Sbjct: 45  KIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL 104
Query: 97  RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA 156
                   K  +   R   +  SA+ Y H      I+H D+K+ N+LLD +   K+ADF 
Sbjct: 105 VAHGRXKEKEARAKFR---QIVSAVQYCHQ---KFIVHRDLKAENLLLDADXNIKIADFG 158
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            S   +  ++            +  PE LF  +K      DV+S GV+L  L++G  P
Sbjct: 159 FSNEFTFGNKLDAFCG---APPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK-MRIISQINHKNVV 68
           Y    ++G G FG V++  L ++  VA+K      K+L ++ F+++ ++I+  + H NVV
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIK------KVLQDKRFKNRELQIMRIVKHPNVV 95
Query: 69  KILGVCL-----ETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ETAS 119
            +          + +V L LV E+VP  T+++  R+ +   LK     L I     +   
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK--LKQTMPMLLIKLYMYQLLR 152
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASS-VLISSHDQTATTTKEIETV 177
           +L Y+HS+G   I H D+K  N+LLD  +   K+ DF S+ +LI+     +         
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 178 GWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            +  PE +F    +T   D++S G V+ EL+ G+
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++S + H  ++++ G   + +   ++ +++  G LF  +R   SQ           AAE 
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPN-PVAKFYAAEV 115
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL+YLHS     II+ D+K  NILLD N   K+ DF  +  +        T     T 
Sbjct: 116 CLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTP 167
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYF 227
            ++ PE +    + +  D +SFG+++ E+L G  P       ++Y  + + E+ R  P+F
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFF 226

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 19  GGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--INHKNVVKIL----- 71
           G FG V+K  L  N  VAVK   + DK    + +Q +  I S   + H+N+++ +     
Sbjct: 26  GRFGCVWKAQLM-NDFVAVKIFPLQDK----QSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS----- 126
           G  LE ++  L+  F   G+L  +++      + TW     +A   +  L YLH      
Sbjct: 81  GSNLEVEL-WLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 127 ---LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
                 P I H D KS N+LL  + TA +ADF  +V          T  ++ T  ++ PE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 184 YL-----FWTE---KSDVYSFGVVLVELLT 205
            L     F  +   + D+Y+ G+VL EL++
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNT-------LVAVKKPKMVDKILINEVFQHKMR 57
           ++ + Y +   +GEG FG   K +L  +T       +  +   +M  K    E  + ++ 
Sbjct: 21  QSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKE--REESRREVA 75
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           +++ + H N+V+      E     +V ++   G LF+ +  Q   VL      L    + 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQI 134
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL ++H      I+H D+KS NI L  + T ++ DF  + +++S  + A     I T 
Sbjct: 135 CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTP 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
            +L PE      +  KSD+++ G VL EL T KH     A  +  M  +V
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKH-----AFEAGSMKNLV 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 122/310 (39%), Gaps = 67/310 (21%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINE----VFQHKMRIISQINHKNVVKI 70
           L+G+G FG VY G       +     +++D    NE     F+ ++    Q  H+NVV  
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAI-----RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G C+      ++       TL+  VR  +  VL   KT  +IA E    + YLH+ G  
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKT-RQIAQEIVKGMGYLHAKG-- 150
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA----SSVLISSHDQTATTTKEIETVGWL------ 180
            I+H D+KS N+   DN    + DF     S VL +   +     +     GWL      
Sbjct: 151 -ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQN----GWLCHLAPE 204
Query: 181 ---------DPEYLFWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFP 228
                    + + L +++ SDV++ G +  EL   + P   +   A+     T M P   
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264
Query: 229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL---- 284
                  +  IL F  A E E                    ERPT  ++ + L+ L    
Sbjct: 265 QIGMGKEISDILLFCWAFEQE--------------------ERPTFTKLMDMLEKLPKRN 304
Query: 285 RRLHE--NFW 292
           RRL    +FW
Sbjct: 305 RRLSHPGHFW 314

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 16  LGEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V +GV         VA+K  K   +    E    + +I+ Q+++  +V+++G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC + +  +LV E    G L + +  +  ++  +      +  + +  + YL        
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN---F 457
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWLDPE---YLFWT 188
           +H ++ + N+LL + + AK++DF  S  + + D   T     +  + W  PE   +  ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 189 EKSDVYSFGVVLVELLT-GKHP 209
            +SDV+S+GV + E L+ G+ P
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 10  YDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           Y +   +GEG +G V   Y  V    T VA+KK    +     +    +++I+ +  H+N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHV--RKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 67  VVKILGV----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           V+ I  +     LE    + + + +    L++ ++   SQ L     C     +    L 
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK---SQQLSNDHICY-FLYQILRGLK 158
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLD 181
           Y+HS     ++H D+K +N+L++     K+ DF  + +    HD T   T+ + T  +  
Sbjct: 159 YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 182 PEYLF----WTEKSDVYSFGVVLVELLT------GKH 208
           PE +     +T+  D++S G +L E+L+      GKH
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN----EVFQHKMRIISQINHKNVVKI 70
           +LG+G FG V K    D         K+++K             ++ ++ +++H N++K+
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +  ++    +V E    G LF  +  R + S+         RI  +  S + Y+H   
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMHK-- 139
Query: 129 SPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
              I+H D+K  NILL+    +   K+ DF    L +   Q       I T  ++ PE L
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 186 FWT--EKSDVYSFGVVLVELLTGKHP 209
             T  EK DV+S GV+L  LL+G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           ++   ++++  +LG+G FG V K     D+   A+KK +  ++ L       ++ +++ +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASL 59
Query: 63  NHKNVVKILGVCLETK-------------VPLLVYEFVPNGTLFQ--HVRYQSSQVLKTW 107
           NH+ VV+     LE +                +  E+  N TL+   H    + Q  + W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS--------- 158
               R+  +   AL Y+HS G   IIH D+K  NI +D++   K+ DF  +         
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 159 VLISSHDQTATT---TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELL 204
           + + S +   ++   T  I T  ++  E L     + EK D+YS G++  E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 15  LLGEGGFGFVYKGVLPDNT----LVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG   K +L D      L A+K  K  D ++ ++  +  M   R+++ ++    
Sbjct: 26  VLGKGSFG---KVMLADRKGTEELYAIKILKK-DVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKT-CLRIAAETASALDYLH 125
           +  L  C +T   L  V E+V  G L  H++    QV K  +   +  AAE +  L +LH
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPE- 183
             G   II+ D+K  N++LD     K+ADF    +   H     TT+E   T  ++ PE 
Sbjct: 138 KRG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMMDGVTTREFCGTPDYIAPEI 191
Query: 184 --YLFWTEKSDVYSFGVVLVELLTGKHP 209
             Y  + +  D +++GV+L E+L G+ P
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 15  LLGEGGFGFVYKGVLPDNTL-VAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LLG+G F  VY+       L VA+K   K  M    ++  V Q++++I  Q+ H +++++
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRV-QNEVKIHCQLKHPSILEL 76
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR-IAAETASALDYLHSLGS 129
                ++    LV E   NG +    RY  ++V    +   R    +  + + YLHS G 
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG- 132
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
             I+H D+  +N+LL  N   K+ADF  ++ L   H++  T      T  ++ PE    +
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYISPEIATRS 187
Query: 189 E---KSDVYSFGVVLVELLTGKHP 209
               +SDV+S G +   LL G+ P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 10  YDKRHLLGEGGFGFV-----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN- 63
           Y  R  LGEG FG V     YK        VA+K    + + L+ +   H MR+  +I+ 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYK----TQQKVALK---FISRQLLKKSDMH-MRVEREISY 62
Query: 64  -----HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
                H +++K+  V       ++V E+   G LF ++  +      T     R   +  
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRM---TEDEGRRFFQQII 118
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
            A++Y H      I+H D+K  N+LLDDN   K+ADF  S +++  +   T+     +  
Sbjct: 119 CAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG---SPN 172
Query: 179 WLDPEY----LFWTEKSDVYSFGVVLVELLTGKHP 209
           +  PE     L+   + DV+S G+VL  +L G+ P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 15  LLGEGGFG--FVYKGVLPDN--TLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +LG G F   F+ K  L      L  +KK P   D  L NE+      ++ +I H+N+V 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI-----AVLKKIKHENIVT 70
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +  +   T    LV + V  G LF  +  +    + T K    +  +  SA+ YLH  G 
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 130 PPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
             I+H D+K  N+L    ++N    + DF     +S  +Q    +    T G++ PE L 
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFG----LSKMEQNGIMSTACGTPGYVAPEVLA 180
Query: 187 ---WTEKSDVYSFGVVLVELLTGKHP 209
              +++  D +S GV+   LL G  P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 16  LGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VYK      G L    ++  K  + ++  ++      ++ I++  +H  +VK
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCDHPYIVK 80
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +LG         ++ EF P G +   +  +  + L T      +  +   AL++LHS   
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLEALNFLHS--- 135
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYLF 186
             IIH D+K+ N+L+      ++ADF  S          T  K    +G   W+ PE + 
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 187 --------WTEKSDVYSFGVVLVELLTGKHP 209
                   +  K+D++S G+ L+E+   + P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 12  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 65
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 121
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 177
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 231
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 232 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 291
Query: 280 QLDSL 284
            L  L
Sbjct: 292 TLSQL 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 35/242 (14%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI----NHKNVVKI 70
           LGEG F    K V    N   AVK       I+   +  +  + I+ +     H N+VK+
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK-------IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQS--SQVLKTWKTCLRIAAETASALDYLHSLG 128
             V  +     LV E +  G LF+ ++ +   S+   ++     I  +  SA+ ++H +G
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IMRKLVSAVSHMHDVG 126
Query: 129 SPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
              ++H D+K  N+L    +DN   K+ DF  + L    +Q   T     T+ +  PE L
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAPELL 181
Query: 186 ---FWTEKSDVYSFGVVLVELLTGK-----HPRSYVALASNEMTRMVPYFPYPIENNSLR 237
               + E  D++S GV+L  +L+G+     H RS    ++ E+ + +    +  E  + +
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 238 QI 239
            +
Sbjct: 242 NV 243

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 17  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 70
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 126
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 182
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 236
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 237 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 296
Query: 280 QLDSL 284
            L  L
Sbjct: 297 TLSQL 301

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKN 66
           + Y K   +GEG +G VYK       +VA+K+ ++  +   I      ++ ++ +++H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +V ++ V    +   LV+EF+              +VL   KT L+ +         L  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDL---------KKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 127 LG---SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +       I+H D+K  N+L++ +   K+ADF  +          + T E+ T+ +  P+
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPD 189
Query: 184 YLFWTEKS----DVYSFGVVLVELLTGK 207
            L  ++K     D++S G +  E++TGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 14  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 67
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 123
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 179
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 233
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 234 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 293
Query: 280 QLDSL 284
            L  L
Sbjct: 294 TLSQL 298

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 11  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 64
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 120
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 176
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 230
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
Query: 280 QLDSL 284
            L  L
Sbjct: 291 TLSQL 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 23/250 (9%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK--PK-MVDKILINEVFQHKMRIISQ 61
           +  K Y +   LG+GGF   Y+    D   V   K  PK M+ K    E    ++ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +++ +VV   G   +     +V E     +L +  + + +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH+     +IH D+K  N+ L+D+   K+ DF  +  I    +   T     T  ++ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL--CGTPNYIA 210
Query: 182 PEYLFWTEKS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPI 231
           PE L     S   D++S G +L  LL GK P        +Y+ +  NE +  VP    P+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS--VPRHINPV 268
Query: 232 ENNSLRQILN 241
            +  +R++L+
Sbjct: 269 ASALIRRMLH 278

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKN 66
           + Y K   +GEG +G VYK       +VA+K+ ++  +   I      ++ ++ +++H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +V ++ V    +   LV+EF+              +VL   KT L+ +         L  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDL---------KKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 127 LG---SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +       I+H D+K  N+L++ +   K+ADF  +          + T E+ T+ +  P+
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTLWYRAPD 189
Query: 184 YLFWTEKS----DVYSFGVVLVELLTGK 207
            L  ++K     D++S G +  E++TGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN----EVFQHKMRIISQINHKNVVKI 70
           +LG+G FG V K    D         K+++K             ++ ++ +++H N++K+
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +  ++    +V E    G LF  +  R + S+         RI  +  S + Y+H   
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMHKHN 141
Query: 129 SPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
              I+H D+K  NILL+    +   K+ DF    L +   Q       I T  ++ PE L
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 186 FWT--EKSDVYSFGVVLVELLTGKHP 209
             T  EK DV+S GV+L  LL+G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 37  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 90
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 146
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 202
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 256
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 257 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 316
Query: 280 QLDSL 284
            L  L
Sbjct: 317 TLSQL 321

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN----EVFQHKMRIISQINHKNVVKI 70
           +LG+G FG V K    D         K+++K             ++ ++ +++H N++K+
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +  ++    +V E    G LF  +  R + S+         RI  +  S + Y+H   
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGITYMHKHN 141
Query: 129 SPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
              I+H D+K  NILL+    +   K+ DF    L +   Q       I T  ++ PE L
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 186 FWT--EKSDVYSFGVVLVELLTGKHP 209
             T  EK DV+S GV+L  LL+G  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 16  LGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG VYK      G L    ++  K  + ++  ++      ++ I++  +H  +VK
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCDHPYIVK 72
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +LG         ++ EF P G +   +  +  + L T      +  +   AL++LHS   
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLEALNFLHS--- 127
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG---WLDPEYLF 186
             IIH D+K+ N+L+      ++ADF  S          T  K    +G   W+ PE + 
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 187 --------WTEKSDVYSFGVVLVELLTGKHP 209
                   +  K+D++S G+ L+E+   + P
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + ++  + LLGEG +G V      P   +VA+KK +  DK L       +++I+    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 66  NVVKILGV----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           N++ I  +      E    + + + +    L    R  S+Q+L        I  +T  A+
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIY-QTLRAV 125
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI--SSHDQTATT------TKE 173
             LH      +IH D+K +N+L++ N   KV DF  + +I  S+ D +  T      T+ 
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 174 IETVGWLDPEYLF----WTEKSDVYSFGVVLVELL 204
           + T  +  PE +     ++   DV+S G +L EL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 56/305 (18%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G FG V++G       VAVK     ++       E++Q  M     + H+N++  + 
Sbjct: 50  IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVM-----LRHENILGFIA 103
Query: 73  VCLETKVPL----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
              +         LV ++  +G+LF ++   +  V    +  +++A  TAS L +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEI 159
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE------TV 177
             + G P I H D+KS NIL+  N T  +AD   +V    HD +AT T +I       T 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHD-SATDTIDIAPNHRVGTK 215
Query: 178 GWLDPEYL--------FWT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF- 227
            ++ PE L        F + +++D+Y+ G+V  E+          ++        +PY+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA------RRCSIGGIHEDYQLPYYD 269
Query: 228 --PYPIENNSLRQILNFQVADEN------EMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
             P       +R+++  Q    N        E + ++AK+  +C   +G  R T  ++ +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 280 QLDSL 284
            L  L
Sbjct: 330 TLSQL 334

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/270 (21%), Positives = 109/270 (40%), Gaps = 80/270 (29%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++    +G GGFG V++     D+   A+K+ ++ ++ L  E    +++ ++++ H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 68  VKILGVCLE-------------------TKVPL-----------------------LVYE 85
           V+     LE                   T  PL                        V +
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 86  FVPNGT---LFQHVRYQSSQVLKTW------------KTCLRIAAETASALDYLHSLGSP 130
             P+     L+  ++    + LK W              CL I  + A A+++LHS G  
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT-------------ATTTKEIETV 177
            ++H D+K +NI    +   KV DF    L+++ DQ              AT   ++ T 
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFG---LVTAMDQDEEEQTVLTPMPAYATHXGQVGTK 240
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELL 204
            ++ PE +    ++ K D++S G++L ELL
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 16  LGEGGFGFVYKGVLPD---NTLVAVKKPKMVDKILIN---EVFQHKMRIISQINHKNVVK 69
           +G G FG     ++ D   N LVAVK  +  +KI  N   E+  H+      + H N+V+
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIAANVKREIINHR-----SLRHPNIVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLH 125
              V L      +V E+   G LF+ +    R+   +    ++  +       S + Y H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 132
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           ++    + H D+K  N LLD +     K+ DF  S     H Q  +T   + T  ++ PE
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPE 186
Query: 184 YLFWTEK----SDVYSFGVVLVELLTGKHP 209
            L   E     +DV+S GV L  +L G +P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 23/171 (13%)
Query: 45  KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSS 101
           ++L NEV      I+    H NVV++    L  +   ++ EF+  G L      VR    
Sbjct: 87  ELLFNEVV-----IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE 141
Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
           Q+    +  L+       AL YLH+ G   +IH D+KS +ILL  +   K++DF     I
Sbjct: 142 QIATVCEAVLQ-------ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 162 SSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           S           + T  W+ PE +    +  + D++S G++++E++ G+ P
Sbjct: 192 SK--DVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + ++  + LLGEG +G V      P   +VA+KK +  DK L       +++I+    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 66  NVVKILGV----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           N++ I  +      E    + + + +    L    R  S+Q+L        I  +T  A+
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIY-QTLRAV 125
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI--SSHDQTATT------TKE 173
             LH      +IH D+K +N+L++ N   KV DF  + +I  S+ D +  T      T+ 
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 174 IETVGWLDPEYLF----WTEKSDVYSFGVVLVELL 204
           + T  +  PE +     ++   DV+S G +L EL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LLGEG +  V   V L +    AVK  +       + VF+    +     +KN+++++  
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
             +     LV+E +  G++  H++ Q        +   R+  + A+ALD+LH+ G   I 
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRDVAAALDFLHTKG---IA 133
Query: 134 HGDVKSANILLDDN---YTAKVADFA-SSVLISSHDQTATTTKEIET----VGWLDPEYL 185
           H D+K  NIL +        K+ DF   S +  ++  T  TT E+ T      ++ PE +
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 186 --------FWTEKSDVYSFGVVLVELLTGKHP 209
                   F+ ++ D++S GVVL  +L+G  P
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 15  LLGEGGFGFVY--KGVLPDNT-----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +LG+GG+G V+  + V   NT     +  +KK  +V         + +  I+ ++ H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V ++          L+ E++  G LF  +  +   +  T   C  +A E + AL +LH  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--ACFYLA-EISMALGHLHQK 140
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW 187
           G   II+ D+K  NI+L+     K+ DF      S HD T T T    T+ ++ PE L  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTF-CGTIEYMAPEILMR 195
Query: 188 TEKS---DVYSFGVVLVELLTGKHP 209
           +  +   D +S G ++ ++LTG  P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKM-RIIS 60
           AT  Y+    +G G +G VYK   P +     L +V+ P   + + I+ V +  + R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 61  QINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW------- 107
              H NVV+++ VC       E KV L+          F+HV     Q L+T+       
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLV----------FEHV----DQDLRTYLDKAPPP 107
Query: 108 ----KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
               +T   +  +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S 
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164
Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
               A     + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 165 QMALAPV---VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 28/237 (11%)
Query: 7   TKN-YDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMV-------DKILINEVFQHKMR 57
           TKN + +  +LG+GGFG V    V     + A KK +         + + +NE      +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-----KQ 236
Query: 58  IISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           I+ ++N + VV  L    ETK  L LV   +  G L  H+ Y   Q        +  AAE
Sbjct: 237 ILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHI-YHMGQAGFPEARAVFYAAE 294
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L+ LH      I++ D+K  NILLDD+   +++D   +V +    +  T    + T
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGT 348
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP--RSYVALASNEMTRMVPYFP 228
           VG++ PE +    +T   D ++ G +L E++ G+ P  +    +   E+ R+V   P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 28/237 (11%)
Query: 7   TKN-YDKRHLLGEGGFGFVYKG-VLPDNTLVAVKKPKMV-------DKILINEVFQHKMR 57
           TKN + +  +LG+GGFG V    V     + A KK +         + + +NE      +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-----KQ 236
Query: 58  IISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           I+ ++N + VV  L    ETK  L LV   +  G L  H+ Y   Q        +  AAE
Sbjct: 237 ILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHI-YHMGQAGFPEARAVFYAAE 294
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L+ LH      I++ D+K  NILLDD+   +++D   +V +    +  T    + T
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGT 348
Query: 177 VGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP--RSYVALASNEMTRMVPYFP 228
           VG++ PE +    +T   D ++ G +L E++ G+ P  +    +   E+ R+V   P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 21/156 (13%)
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAET 117
             H +++K+  V        +V E+V  G LF    +H R +  +  + ++  L      
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL------ 121
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SA+DY H      ++H D+K  N+LLD +  AK+ADF  S ++S  +   T+     + 
Sbjct: 122 -SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG---SP 174
Query: 178 GWLDPEY----LFWTEKSDVYSFGVVLVELLTGKHP 209
            +  PE     L+   + D++S GV+L  LL G  P
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 16  LGEGGFGFVYKGVLPD---NTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG     ++ D   N LVAVK   + + +D+ +  E+  H+      + H N+V+
Sbjct: 27  IGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKREIINHR-----SLRHPNIVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLH 125
              V L      +V E+   G LF+ +    R+   +    ++  +       S + Y H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYAH 132
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           ++    + H D+K  N LLD +     K+ADF  S     H Q  +    + T  ++ PE
Sbjct: 133 AMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA---VGTPAYIAPE 186
Query: 184 YLFWTEK----SDVYSFGVVLVELLTGKHP 209
            L   E     +DV+S GV L  +L G +P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + ++  + LLGEG +G V      P   +VA+KK +  DK L       +++I+    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 66  NVVKILGV----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           N++ I  +      E    + + + +    L    R  S+Q+L        I  +T  A+
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIY-QTLRAV 125
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI--SSHDQTATTTKE------ 173
             LH      +IH D+K +N+L++ N   KV DF  + +I  S+ D +  T ++      
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 174 IETVGWLDPEYLF----WTEKSDVYSFGVVLVELL 204
           + T  +  PE +     ++   DV+S G +L EL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 47/234 (20%)
Query: 10  YDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKNV 67
           Y+ RHL+G G +G V +     +  +VA+KK   V + LI+ +    ++ I++++NH +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 68  VKILGVCLETKVP-----LLVYEFVPNG--TLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           VK+L + +   V       +V E   +    LF+   Y +   +KT    L +  +    
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK---- 170
Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA------------SSVLISSHDQ-- 166
             Y+HS G   I+H D+K AN L++ + + KV DF             S + IS  +   
Sbjct: 171 --YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 167 ---TATTTKEIE--------TVGWLDPEYLF----WTEKSDVYSFGVVLVELLT 205
              T   TK ++        T  +  PE +     +TE  DV+S G +  ELL 
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 16  LGEGGFGFVYKGVLPD---NTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG     ++ D   N LVAVK   + + +D+ +  E+  H+      + H N+V+
Sbjct: 26  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHR-----SLRHPNIVR 78
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLH 125
              V L      +V E+   G LF+ +    R+   +    ++  +       S + Y H
Sbjct: 79  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 131
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           ++    + H D+K  N LLD +     K+ DF  S     H Q  +T   + T  ++ PE
Sbjct: 132 AMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPE 185
Query: 184 YLFWTEK----SDVYSFGVVLVELLTGKHP 209
            L   E     +DV+S GV L  +L G +P
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK----------ILINEVFQHKM 56
           +  Y +   LG G +G V   +  D    A +  K++ K           L++EV     
Sbjct: 3   SDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEV----- 55
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIA 114
            ++ Q++H N++K+     + +   LV E    G LF  +  R + S+V         I 
Sbjct: 56  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-----DAAVIM 110
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTT 171
            +  S   YLH      I+H D+K  N+LL+    +   K+ DF     +S+H +     
Sbjct: 111 KQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFG----LSAHFEVGGKM 163
Query: 172 KE-IETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHP 209
           KE + T  ++ PE L   + EK DV+S GV+L  LL G  P
Sbjct: 164 KERLGTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK----------ILINEVFQHKM 56
           +  Y +   LG G +G V   +  D    A +  K++ K           L++EV     
Sbjct: 20  SDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEV----- 72
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIA 114
            ++ Q++H N++K+     + +   LV E    G LF  +  R + S+V         I 
Sbjct: 73  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-----DAAVIM 127
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTT 171
            +  S   YLH      I+H D+K  N+LL+    +   K+ DF     +S+H +     
Sbjct: 128 KQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFG----LSAHFEVGGKM 180
Query: 172 KE-IETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHP 209
           KE + T  ++ PE L   + EK DV+S GV+L  LL G  P
Sbjct: 181 KERLGTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 23/250 (9%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK--PK-MVDKILINEVFQHKMRIISQ 61
           +  K Y +   LG+GGF   Y+    D   V   K  PK M+ K    E    ++ I   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +++ +VV   G   +     +V E     +L +  + + +      +  +R   +T   +
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 139
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH+     +IH D+K  N+ L+D+   K+ DF  +  I    +         T  ++ 
Sbjct: 140 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIA 194
Query: 182 PEYLFWTEKS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPI 231
           PE L     S   D++S G +L  LL GK P        +Y+ +  NE +  VP    P+
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS--VPRHINPV 252
Query: 232 ENNSLRQILN 241
            +  +R++L+
Sbjct: 253 ASALIRRMLH 262

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 23/250 (9%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK--PK-MVDKILINEVFQHKMRIISQ 61
           +  K Y +   LG+GGF   Y+    D   V   K  PK M+ K    E    ++ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +++ +VV   G   +     +V E     +L +  + + +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH+     +IH D+K  N+ L+D+   K+ DF  +  I    +         T  ++ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL--CGTPNYIA 210
Query: 182 PEYLFWTEKS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPI 231
           PE L     S   D++S G +L  LL GK P        +Y+ +  NE +  VP    P+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS--VPRHINPV 268
Query: 232 ENNSLRQILN 241
            +  +R++L+
Sbjct: 269 ASALIRRMLH 278

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AA 115
           RI+  +N   +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAA 148
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +     +YLHSL    +I+ D+K  N+L+D     KVADF  +  +         T E  
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-- 203
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
              +L PE +    + +  D ++ GV++ E+  G  P
Sbjct: 204 ---YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 23/250 (9%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK--PK-MVDKILINEVFQHKMRIISQ 61
           +  K Y +   LG+GGF   Y+    D   V   K  PK M+ K    E    ++ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +++ +VV   G   +     +V E     +L +  + + +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            YLH+     +IH D+K  N+ L+D+   K+ DF  +  I    +         T  ++ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIA 210
Query: 182 PEYLFWTEKS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPI 231
           PE L     S   D++S G +L  LL GK P        +Y+ +  NE +  VP    P+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS--VPRHINPV 268
Query: 232 ENNSLRQILN 241
            +  +R++L+
Sbjct: 269 ASALIRRMLH 278

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 54
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAE 116
           ++ ++NH N+VK+L V        LV+EF+      F      +   L   K+ L    +
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQ 111
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L + HS     ++H D+K  N+L++     K+ADF  +          T T E+ T
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVT 166
Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           + +  PE L    +++   D++S G +  E++T +
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
             +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 107
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVV 165
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 54
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 55  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 108
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVV 166
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 58
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 171
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 54
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 167
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +     T   T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 54
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 167
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 166
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 61
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 174
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 166
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 61
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 174
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 45  KILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPL-LVYEFVPNGTLFQHVR--YQS 100
           ++L++EV      ++ ++ H N+V+     ++ T   L +V E+   G L   +    + 
Sbjct: 50  QMLVSEV-----NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 101 SQVLKTWKTCLRIAAETASALDYLH--SLGSPPIIHGDVKSANILLDDNYTAKVADFASS 158
            Q L   +  LR+  +   AL   H  S G   ++H D+K AN+ LD     K+ DF  +
Sbjct: 105 RQYLDE-EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
Query: 159 VLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVAL 215
            ++ +HD +   T  + T  ++ PE    + + EKSD++S G +L EL     P  + A 
Sbjct: 164 RIL-NHDTSFAKTF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF 219
Query: 216 ASNEMT--------RMVPYFPYPIENNSLRQILNFQVADENEMEEI 253
           +  E+         R +PY      N  + ++LN +      +EEI
Sbjct: 220 SQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 87
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 88  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 143
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +     T   T E     +L PE 
Sbjct: 144 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----YLAPEI 195
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 73  V----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 152
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 73  V----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 73  V----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 146
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 45  KILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPL-LVYEFVPNGTLFQHVRY--QS 100
           ++L++EV      ++ ++ H N+V+     ++ T   L +V E+   G L   +    + 
Sbjct: 50  QMLVSEV-----NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 101 SQVLKTWKTCLRIAAETASALDYLH--SLGSPPIIHGDVKSANILLDDNYTAKVADFASS 158
            Q L   +  LR+  +   AL   H  S G   ++H D+K AN+ LD     K+ DF  +
Sbjct: 105 RQYLDE-EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
Query: 159 VLISSHDQTATTTKEIETVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVAL 215
            ++ +HD T+     + T  ++ PE    + + EKSD++S G +L EL     P  + A 
Sbjct: 164 RIL-NHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF 219
Query: 216 ASNEMT--------RMVPYFPYPIENNSLRQILNFQVADENEMEEI 253
           +  E+         R +PY      N  + ++LN +      +EEI
Sbjct: 220 SQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 45/227 (19%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKM-RIIS 60
           AT  Y+    +G G +G VYK   P +     L +V+ P   + + I+ V +  + R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 61  QINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW------- 107
              H NVV+++ VC       E KV L+          F+HV     Q L+T+       
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLV----------FEHV----DQDLRTYLDKAPPP 107
Query: 108 ----KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
               +T   +  +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S 
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164
Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
                     + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 165 Q---MALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + +   +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 164
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 47/236 (19%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           ++   ++++  +LG+G FG V K     D+   A+KK +  ++ L       ++ +++ +
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVXLLASL 59
Query: 63  NHKNVVKILGVCLETK-------------VPLLVYEFVPNGTLFQ--HVRYQSSQVLKTW 107
           NH+ VV+     LE +                +  E+  N TL+   H    + Q  + W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA----------- 156
               R+  +   AL Y+HS G   IIH ++K  NI +D++   K+ DF            
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 157 ----SSVLISSHDQTATTTKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELL 204
               S  L  S D     T  I T  ++  E L     + EK D YS G++  E +
Sbjct: 173 LKLDSQNLPGSSD---NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 15  LLGEGGFGFVY--KGVLPDNT-----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +LG+GG+G V+  + V   NT     +  +KK  +V         + +  I+ ++ H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V ++          L+ E++  G LF  +  +   +  T   C  +A E + AL +LH  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--ACFYLA-EISMALGHLHQK 140
Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW 187
           G   II+ D+K  NI+L+     K+ DF      S HD T T      T+ ++ PE L  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXF-CGTIEYMAPEILMR 195
Query: 188 TEKS---DVYSFGVVLVELLTGKHP 209
           +  +   D +S G ++ ++LTG  P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+ +  H+N++ I  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C     +    L Y+HS  
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN 164
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 94
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 150
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 151 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 202
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 52  FQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL 111
           F+++++II+ I ++  +   G+        ++YE++ N ++ +   Y    VL    TC 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF--VLDKNYTCF 147
Query: 112 -------RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISS 163
                   I     ++  Y+H+     I H DVK +NIL+D N   K++DF  S  ++  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 164 HDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPR----SYVALASNE 219
             + +  T E     +   E  +   K D++S G+ L  +     P     S V L +N 
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 220 MTRMVPY------FPYPIEN 233
            T+ + Y      F YP+ N
Sbjct: 266 RTKNIEYPLDRNHFLYPLTN 285

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI   +N  
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RIQQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     KVADF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AA 115
           RI+  +N   +VK+     +     +V E++P G +F H+R    ++ +  +   R  AA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR----RIGRFSEPHARFYAA 148
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +     +YLHSL    +I+ D+K  N+L+D     KVADF  +  +         T E  
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-- 203
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
              +L PE +    + +  D ++ GV++ E+  G  P
Sbjct: 204 ---YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AA 115
           RI+  +N   +VK+     +     +V E++P G +F H+R    ++ +  +   R  AA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR----RIGRFSEPHARFYAA 148
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +     +YLHSL    +I+ D+K  N+L+D     KVADF  +  +         T E  
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-- 203
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
              +L PE +    + +  D ++ GV++ E+  G  P
Sbjct: 204 ---YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 142
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 149
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 150
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 141
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 122
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 178
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 179 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 230
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 142
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 45/227 (19%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKM-RIIS 60
           AT  Y+    +G G +G VYK   P +     L +V+ P   + + I+ V +  + R + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 61  QINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW------- 107
              H NVV+++ VC       E KV L+          F+HV     Q L+T+       
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLV----------FEHV----DQDLRTYLDKAPPP 107
Query: 108 ----KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
               +T   +  +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S 
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164
Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
                     + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 165 Q---MALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 21/156 (13%)
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAET 117
             H +++K+  V        +V E+V  G LF    +H R +  +  + ++  L      
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL------ 121
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SA+DY H      ++H D+K  N+LLD +  AK+ADF  S ++S  +    +     + 
Sbjct: 122 -SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCG---SP 174
Query: 178 GWLDPEY----LFWTEKSDVYSFGVVLVELLTGKHP 209
            +  PE     L+   + D++S GV+L  LL G  P
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 16  LGEGGFGFVYKG---VLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V  G   +      V +   + +  + +    + +++ +    H +++K+  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           V        +V E+V  G LF ++           K   R+  +  S +DY H      +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY----LFWT 188
           +H D+K  N+LLD +  AK+ADF  S ++S  +    +     +  +  PE     L+  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCG---SPNYAAPEVISGRLYAG 194
Query: 189 EKSDVYSFGVVLVELLTGKHP 209
            + D++S GV+L  LL G  P
Sbjct: 195 PEVDIWSSGVILYALLCGTLP 215

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 94
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 150
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 151 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 202
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 9   NYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           NY     LGEG FG V   Y         + +   K++ K  +    + ++  +  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +++K+  V       ++V E+  N  LF ++  +      + +   R   +  SA++Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKM---SEQEARRFFQQIISAVEYCH 130
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY- 184
                 I+H D+K  N+LLD++   K+ADF  S +++  +   T+     +  +  PE  
Sbjct: 131 R---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 184
Query: 185 ---LFWTEKSDVYSFGVVLVELLTGKHP 209
              L+   + DV+S GV+L  +L  + P
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 46/294 (15%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 123
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI   D+ A     + T  ++ PE
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DEMANEF--VGTRSYMSPE 176
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALAS------NEMTRMVPYFPY----- 229
            L    ++ +SD++S G+ LVE+  G++PR  +A+        NE    +P   +     
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQ 236
Query: 230 ----------PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT 273
                     P E   L+Q++       ++ EE++    L S    T G  +P+
Sbjct: 237 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS----TIGLNQPS 286

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
            +LG GGFG V+   +     +   K     ++   + +Q  M   +I+++++ + +V  
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS- 249
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--AAETASALDYLHSLG 128
           L    ETK  L +   + NG   ++  Y   +    ++    I   A+  S L++LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              II+ D+K  N+LLDD+   +++D   +V + +  QT T      T G++ PE L   
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGY-AGTPGFMAPELLLGE 364
Query: 189 EKS---DVYSFGVVLVELLTGKHP 209
           E     D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++    Q L     C  +  +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---CQHLSNDHICYFLY-QILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
            +LG GGFG V+   +     +   K     ++   + +Q  M   +I+++++ + +V  
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS- 249
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--AAETASALDYLHSLG 128
           L    ETK  L +   + NG   ++  Y   +    ++    I   A+  S L++LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              II+ D+K  N+LLDD+   +++D   +V + +  QT T      T G++ PE L   
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGY-AGTPGFMAPELLLGE 364
Query: 189 EKS---DVYSFGVVLVELLTGKHP 209
           E     D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
            +LG GGFG V+   +     +   K     ++   + +Q  M   +I+++++ + +V  
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS- 249
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--AAETASALDYLHSLG 128
           L    ETK  L +   + NG   ++  Y   +    ++    I   A+  S L++LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              II+ D+K  N+LLDD+   +++D   +V + +  QT T      T G++ PE L   
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGY-AGTPGFMAPELLLGE 364
Query: 189 EKS---DVYSFGVVLVELLTGKHP 209
           E     D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 9   NYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           NY     LGEG FG V   Y         + +   K++ K  +    + ++  +  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +++K+  V       ++V E+  N  LF ++  +      + +   R   +  SA++Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKM---SEQEARRFFQQIISAVEYCH 129
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY- 184
                 I+H D+K  N+LLD++   K+ADF  S +++  +   T+     +  +  PE  
Sbjct: 130 R---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 183
Query: 185 ---LFWTEKSDVYSFGVVLVELLTGKHP 209
              L+   + DV+S GV+L  +L  + P
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
            +LG GGFG V+   +     +   K     ++   + +Q  M   +I+++++ + +V  
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS- 249
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI--AAETASALDYLHSLG 128
           L    ETK  L +   + NG   ++  Y   +    ++    I   A+  S L++LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              II+ D+K  N+LLDD+   +++D   +V + +  QT T      T G++ PE L   
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGY-AGTPGFMAPELLLGE 364
Query: 189 EKS---DVYSFGVVLVELLTGKHP 209
           E     D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP-KMVDKILI----NEVFQHKMRIISQINH 64
           Y +   LG G +G V   +L  + +  V++  K++ K  +    N     ++ ++  ++H
Sbjct: 39  YQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALD 122
            N++K+     + +   LV E    G LF  +  R + ++V         I  +  S + 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----DAAVIIKQVLSGVT 150
Query: 123 YLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           YLH      I+H D+K  N+LL+    +   K+ DF  S +  +  +     + + T  +
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYY 204
Query: 180 LDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN---- 233
           + PE L   + EK DV+S GV+L  LL G  P  +      E+ R V    Y  ++    
Sbjct: 205 IAPEVLRKKYDEKCDVWSIGVILFILLAGYPP--FGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 234 -------NSLRQILNF----QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
                  + ++Q+L F    +++ +  +E    + ++ SK  + SG E P++    E +
Sbjct: 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEH-PWIKEMCSK--KESGIELPSLANAIENM 318

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+    H+N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 73  VC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C  +  +    L Y+HS  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLY-QILRGLKYIHSAN 146
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +GEG +G V   Y  V  +   VA+KK    +     +    +++I+    H+N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 73  V----CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +     +E    + + + +    L++ ++   +Q L     C  +  +    L Y+HS  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLY-QILRGLKYIHSAN 146
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
              ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +  
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 187 ---WTEKSDVYSFGVVLVELLTGK 207
              +T+  D++S G +L E+L+ +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 9   NYDKRHLL---GEGGFGFVYKGVLPD-NTLVAVK---KPKMVDKILINEVFQHKMRIISQ 61
           N+D   +L   G+G FG V      D   + A+K   K K V++  +  VF+ +++I+  
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQG 71
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           + H  +V +     + +   +V + +  G L  H++     V    +T      E   AL
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMAL 128
Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
           DYL +     IIH D+K  NILLD++    + DF  + ++    Q  T      T  ++ 
Sbjct: 129 DYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG---TKPYMA 182
Query: 182 PEYLFWTEKSDVYSF-------GVVLVELLTGKHP 209
           PE +F + K   YSF       GV   ELL G+ P
Sbjct: 183 PE-MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 79/305 (25%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG+G +G V+K +      +VAVKK      +       F+  M +     H+N+V +L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 73  VC--------------LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           V               +ET +  ++   +      Q+V YQ  +V+K             
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK------------- 123
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA------------SSVLISSHDQ 166
               YLHS G   ++H D+K +NILL+     KVADF             +++ +S ++ 
Sbjct: 124 ----YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 167 TAT-------TTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVAL 215
           T          T  + T  +  PE L     +T+  D++S G +L E+L GK        
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-------- 228
Query: 216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMR 275
                    P FP     N L +I+   V D    E++E +    +K +  S  E+  +R
Sbjct: 229 ---------PIFPGSSTMNQLERIIG--VIDFPSNEDVESIQSPFAKTMIESLKEKVEIR 277
Query: 276 QVSEQ 280
           Q +++
Sbjct: 278 QSNKR 282

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 9   NYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           NY     LGEG FG V   Y         + +   K++ K  +    + ++  +  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +++K+  V       ++V E+  N  LF ++  +      + +   R   +  SA++Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKM---SEQEARRFFQQIISAVEYCH 124
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY- 184
                 I+H D+K  N+LLD++   K+ADF  S +++  +   T+     +  +  PE  
Sbjct: 125 R---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 178
Query: 185 ---LFWTEKSDVYSFGVVLVELLTGKHP 209
              L+   + DV+S GV+L  +L  + P
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 29/227 (12%)
Query: 45  KILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPL-LVYEFVPNGTLFQHVRY--QS 100
           ++L++EV      ++ ++ H N+V+     ++ T   L +V E+   G L   +    + 
Sbjct: 50  QMLVSEV-----NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 101 SQVLKTWKTCLRIAAETASALDYLH--SLGSPPIIHGDVKSANILLDDNYTAKVADFASS 158
            Q L   +  LR+  +   AL   H  S G   ++H D+K AN+ LD     K+ DF  +
Sbjct: 105 RQYLDE-EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
Query: 159 VLISSHDQTATTTKE-IETVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVA 214
            ++ +HD+     KE + T  ++ PE    + + EKSD++S G +L EL     P  + A
Sbjct: 164 RIL-NHDEDF--AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTA 218
Query: 215 LASNEMT--------RMVPYFPYPIENNSLRQILNFQVADENEMEEI 253
            +  E+         R +PY      N  + ++LN +      +EEI
Sbjct: 219 FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 9   NYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           NY     LGEG FG V   Y         + +   K++ K  +    + ++  +  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +++K+  V       ++V E+  N  LF ++  +      + +   R   +  SA++Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKM---SEQEARRFFQQIISAVEYCH 120
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY- 184
                 I+H D+K  N+LLD++   K+ADF  S +++  +   T+     +  +  PE  
Sbjct: 121 R---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVI 174
Query: 185 ---LFWTEKSDVYSFGVVLVELLTGKHP 209
              L+   + DV+S GV+L  +L  + P
Sbjct: 175 SGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF     L Q + ++  +  L      L I 
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPL-IK 106
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           +     L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 164
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAE 116
           ++ ++NH N+VK+L V        LV+E V      F      +   L   K+ L    +
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL---FQ 110
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L + HS     ++H D+K  N+L++     K+ADF  +          T T E+ T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVT 165
Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           + +  PE L    +++   D++S G +  E++T +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA++K    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 122
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 178
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +     T   T E     +L PE 
Sbjct: 179 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE-----YLAPEI 230
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF+  +   F      +   L   K+ L   
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL--- 112
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 167
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG V     KG    + L AVK  K  D ++ ++  +  M   R+++       
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKILKK-DVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALD 122
           +  L  C +T   L  V E+V  G L  H+    R++    +         AAE A  L 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-------FYAAEIAIGLF 456
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLD 181
           +L S G   II+ D+K  N++LD     K+ADF    +   +     TTK    T  ++ 
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKXFCGTPDYIA 510
Query: 182 PE---YLFWTEKSDVYSFGVVLVELLTGKHP 209
           PE   Y  + +  D ++FGV+L E+L G+ P
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF+      F      +   L   K+ L   
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL--- 112
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 167
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 107
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 165
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 54
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 55  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 108
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 166
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 110
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 168
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 55
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 56  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 109
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 167
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ T+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTL 166
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 55
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 56  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 109
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 167
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 107
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 165
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 54
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 55  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 108
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 166
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 54
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF+  +   F      +   L   K+ L   
Sbjct: 55  -SLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL--- 110
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 165
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 113/259 (43%), Gaps = 47/259 (18%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKK-PKMVDKILINEVFQHKMRIISQ 61
           VK   NY+ +HL+G G +G+VY     + N  VA+KK  +M + ++  +    ++ I+++
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +    ++++  +     +P  + +F     L+  +    S + K +KT + +  +    +
Sbjct: 84  LKSDYIIRLHDLI----IPEDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEQHVKTI 136
Query: 122 DYLHSLG-----SPPIIHGDVKSANILLDDNYTAKVADFASSVLISS------------- 163
            Y   LG        IIH D+K AN LL+ + + K+ DF  +  I+S             
Sbjct: 137 LYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 164 --------HDQT--ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP 209
                   H++      T  + T  +  PE +     +T   D++S G +  ELL     
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM-- 254
Query: 210 RSYVALASNEMTRMVPYFP 228
           +S++    N  T   P FP
Sbjct: 255 KSHI----NNPTNRFPLFP 269

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 57
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 58  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 111
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 169
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-YQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF     L Q ++ +  +  L      L I 
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPL-IK 106
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           +     L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 164
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 55
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 56  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 109
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 167
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 53
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 54  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 107
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 165
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ T+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTL 166
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+ K ++      V    I E+      
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALXKIRLDTETEGVPSTAIREI-----S 54
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 167
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP------KMVDKILINEV-----FQH 54
             +++D   ++G G +  V         LV +KK       K+V K L+N+       Q 
Sbjct: 18  GLQDFDLLRVIGRGSYAKV--------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 69
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           +  +  Q ++   +  L  C +T+  L  V E+V  G L  H++ Q     K  +   R 
Sbjct: 70  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARF 125
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            +AE + AL+YLH  G   II+ D+K  N+LLD     K+ D+   +         TT+ 
Sbjct: 126 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG--MCKEGLRPGDTTSX 180
Query: 173 EIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGKHPRSYVALASN 218
              T  ++ PE L   +     D ++ GV++ E++ G+ P   V  + N
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 229

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+ K ++      V    I E+      
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALXKIRLDTETEGVPSTAIREI-----S 53
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T T E+ T+
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTL 166
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
             ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 110
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
                L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVV 168
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
           T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 16  LGEGGFGFVYKGVLPD---NTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG     ++ D   N LVAVK   + + +D+ +  E+  H+      + H N+V+
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHR-----SLRHPNIVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLH 125
              V L      +V E+   G LF+ +    R+   +    ++  +       S + Y H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 132
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           ++    + H D+K  N LLD +     K+  F  S     H Q  +T   + T  ++ PE
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VGTPAYIAPE 186
Query: 184 YLFWTEK----SDVYSFGVVLVELLTGKHP 209
            L   E     +DV+S GV L  +L G +P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHKMR 57
           +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+      
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI-----S 55
Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           ++ ++NH N+VK+L V        LV+EF     L Q ++        T      I +  
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L  L    S  ++H D+K  N+L++     K+ADF  +          T   E+ T+
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTL 168
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            +  PE L    +++   D++S G +  E++T +
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+VP G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNV 67
           +LG+G FG V     KG    + L AVK  K  D ++ ++  +  M   R+++       
Sbjct: 27  VLGKGSFGKVMLSERKGT---DELYAVKILKK-DVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKT--CLRIAAETASALDYL 124
           +  L  C +T   L  V E+V  G L  H+     Q +  +K    +  AAE A  L +L
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI-ETVGWLDPE 183
            S G   II+ D+K  N++LD     K+ADF    +   +     TTK    T  ++ PE
Sbjct: 138 QSKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKXFCGTPDYIAPE 191
Query: 184 ---YLFWTEKSDVYSFGVVLVELLTGKHP 209
              Y  + +  D ++FGV+L E+L G+ P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 55
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF+  +   F      +   L   K+ L   
Sbjct: 56  -SLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL--- 111
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 166
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+EF+  +   F      +   L   K+ L   
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL--- 112
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 167
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKNVVKILGVC 74
           LG G FG V+      + L  V K    D+  +  E  + ++ ++  ++H N++KI  V 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 75  LETKVPLLVYEFVPNGTLFQH-VRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPII 133
            +     +V E    G L +  V  Q+     +      +  +  +AL Y H   S  ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 134 HGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--T 188
           H D+K  NIL  D   +   K+ DF  + L  S +    +T    T  ++ PE      T
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRDVT 203
Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVAL 215
            K D++S GVV+  LLTG  P +  +L
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLPFTGTSL 230

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP------KMVDKILINE-----VFQH 54
             +++D   ++G G +  V         LV +KK       K+V K L+N+       Q 
Sbjct: 3   GLQDFDLLRVIGRGSYAKV--------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 54
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           +  +  Q ++   +  L  C +T+  L  V E+V  G L  H++ Q     K  +   R 
Sbjct: 55  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARF 110
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            +AE + AL+YLH  G   II+ D+K  N+LLD     K+ D+   +         TT+ 
Sbjct: 111 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG--MCKEGLRPGDTTSX 165
Query: 173 EIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGKHPRSYVALASN 218
              T  ++ PE L   +     D ++ GV++ E++ G+ P   V  + N
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 214

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 148
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T    + + T  +  PE +    
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           +GEG +G V       N + VA+KK    +     +    +++I+ +  H+N++ I  + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 75  ----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               +E    + + + +    L++ ++   +Q L     C     +    L Y+HS    
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICY-FLYQILRGLKYIHSAN-- 149
Query: 131 PIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF--- 186
            ++H D+K +N+LL+     K+ DF  + V    HD T    + + T  +  PE +    
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 187 -WTEKSDVYSFGVVLVELLTGK 207
            +T+  D++S G +L E+L+ +
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKK-PKMVDKILINEVFQHKMRIISQI 62
           K ++ +  LG G F  V   VL +      L AVK  PK   K   + + ++++ ++ +I
Sbjct: 22  KIFEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSI-ENEIAVLRKI 77
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H+N+V +  +        LV + V  G LF  +  +     K   T +R   +   A+ 
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR---QVLDAVY 134
Query: 123 YLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           YLH +G   I+H D+K  N+L    D+     ++DF  S +    D  +T      T G+
Sbjct: 135 YLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG---TPGY 188
Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           + PE L    +++  D +S GV+   LL G  P
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 88
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 89  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 144
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D+    +V DF  +  +         T E     +L PE 
Sbjct: 145 HSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 196
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 78/346 (22%), Positives = 137/346 (39%), Gaps = 84/346 (24%)
Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV-------FQHK 55
           L++  K Y  +  +G+G +G V   +  +N   A++  K+++K  I ++        + +
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQ--------------------- 94
           +R++ +++H N+ ++  V  + +   LV E    G L                       
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 95  ----------------HVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK 138
                           H   +S   ++  K    I  +  SAL YLH+ G   I H D+K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIK 195
Query: 139 SANILLDDN--YTAKVADFASS---VLISSHDQTATTTKEIETVGWLDPEYLFWTE---- 189
             N L   N  +  K+ DF  S     +++ +    TTK   T  ++ PE L  T     
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYG 254
Query: 190 -KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
            K D +S GV+L  LL G  P                 FP   + +++ Q+LN ++  EN
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVP-----------------FPGVNDADTISQVLNKKLCFEN 297
Query: 249 EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ 294
                 +++ LA   L          R V E+ D++R L   + +Q
Sbjct: 298 --PNYNVLSPLARDLLSNL-----LNRNVDERFDAMRALQHPWISQ 336

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 96
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 97  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 152
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 153 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 204
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 122
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 178
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 179 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 230
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP------KMVDKILINEV-----FQH 54
             +++D   ++G G +  V         LV +KK       K+V K L+N+       Q 
Sbjct: 7   GLQDFDLLRVIGRGSYAKV--------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 58
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           +  +  Q ++   +  L  C +T+  L  V E+V  G L  H++ Q     K  +   R 
Sbjct: 59  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARF 114
Query: 114 -AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            +AE + AL+YLH  G   II+ D+K  N+LLD     K+ D+   +         TT+ 
Sbjct: 115 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG--MCKEGLRPGDTTSX 169
Query: 173 EIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGKHPRSYVALASN 218
              T  ++ PE L   +     D ++ GV++ E++ G+ P   V  + N
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 11/131 (8%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V +++  G LF H++ +   +    +     AAE ASAL YLHSL    I++ D+K  N
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHSLN---IVYRDLKPEN 169
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGV 198
           ILLD      + DF   +   + +  +TT+    T  +L PE L    +    D +  G 
Sbjct: 170 ILLDSQGHIVLTDFG--LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 199 VLVELLTGKHP 209
           VL E+L G  P
Sbjct: 228 VLYEMLYGLPP 238

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 37/254 (14%)
Query: 16  LGEGGFGFV--YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LGEGGF +V   +G L D    A+K+  +  +    E  Q +  +    NH N+++++  
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKR-ILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 74  CLETKVP----LLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           CL  +       L+  F   GTL+  + R +      T    L +       L+ +H+ G
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-------TVGWLD 181
                H D+K  NILL D     + D  S      H + +     ++       T+ +  
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 182 PE------YLFWTEKSDVYSFGVVLVELLTGKHPRSY-------VALA-SNEMTRMVPYF 227
           PE      +    E++DV+S G VL  ++ G+ P          VALA  N+++  +P  
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS--IPQS 269
Query: 228 PYPIENNSLRQILN 241
           P    +++L Q+LN
Sbjct: 270 PR--HSSALWQLLN 281

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++           LV++ +  G LF ++  + +   K  +  +R   E   AL 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            L+      I+H D+K  NILLDD+   K+ DF  S  +   ++  +      T  +L P
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCG---TPSYLAP 192
Query: 183 EYL---------FWTEKSDVYSFGVVLVELLTGKHP 209
           E +          + ++ D++S GV++  LL G  P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP------KMVDKILINEV-----FQHKM 56
           +++D   ++G G +  V         LV +KK       ++V K L+N+       Q + 
Sbjct: 52  QDFDLLRVIGRGSYAKV--------LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 57  RIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-A 114
            +  Q ++   +  L  C +T+  L  V E+V  G L  H++ Q     K  +   R  +
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYS 159
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE + AL+YLH  G   II+ D+K  N+LLD     K+ D+   +         TT+   
Sbjct: 160 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG--MCKEGLRPGDTTSTFC 214
Query: 175 ETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGKHPRSYVALASN 218
            T  ++ PE L   +     D ++ GV++ E++ G+ P   V  + N
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 52/260 (20%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLPDNTL--VAVKK-PKMVDKILINEVFQHKMRIIS 60
           V    NY  +HL+G G +G+VY      NT   VA+KK  +M + ++  +    ++ I++
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAY-DKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           ++    ++++  +     +P  + +F     L+  +    S + K +KT + +  E    
Sbjct: 81  RLKSDYIIRLYDLI----IPDDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 121 L--------DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT-- 170
           +        +++H  G   IIH D+K AN LL+ + + KV DF  +  I+S   T     
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 171 ------------------TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKH 208
                             T  + T  +  PE +     +T+  D++S G +  ELL    
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML- 249
Query: 209 PRSYVALASNEMTRMVPYFP 228
            +S++    N+ T   P FP
Sbjct: 250 -QSHI----NDPTNRFPLFP 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFAEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNT-LVAVKKPKMVDK------ILINEVFQHKM-R 57
           AT  Y+    +G G +G VYK   P +   VA+K  ++ +       + I+ V +  + R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 58  IISQINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW---- 107
            +    H NVV+++ VC       E KV L+          F+HV     Q L+T+    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLV----------FEHV----DQDLRTYLDKA 112
Query: 108 -------KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL 160
                  +T   +  +    LD+LH+     I+H D+K  NIL+    T K+ADF  + +
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
Query: 161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            S        T  + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 170 YSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 16  LGEGGFGFVYKGVLPD---NTLVAVK---KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG     ++ D   N LVAVK   + + +D+ +  E+  H+      + H N+V+
Sbjct: 27  IGSGNFGVAR--LMRDKQSNELVAVKYIERGEKIDENVKREIINHR-----SLRHPNIVR 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLH 125
              V L      +V E+   G LF+ +    R+   +    ++  +       S + Y H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 132
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           ++    + H D+K  N LLD +     K+  F  S     H Q   T   + T  ++ PE
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTPAYIAPE 186
Query: 184 YLFWTEK----SDVYSFGVVLVELLTGKHP 209
            L   E     +DV+S GV L  +L G +P
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 26/218 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHK----MRI 58
           ++ Y     LG G FGFV+  V  +      +  +KK K+++   I +    K    + I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQS--SQVLKTWKTCLRIAA 115
           +S++ H N++K+L +        LV E   +G  LF  +       + L ++     I  
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-----IFR 137
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +  SA+ YL       IIH D+K  NI++ +++T K+ DF S+  +       T    IE
Sbjct: 138 QLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 176 TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              +  PE L    +   + +++S GV L  L+  ++P
Sbjct: 195 ---YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G +G V++G       VAVK     D+       E++   M     + H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFRETELYNTVM-----LRHENILGFIA 69
Query: 73  VCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
             + ++       L+  +   G+L+ +++  +   +    +CLRI    AS L +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEI 125
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL--ISSHDQTATTTKEIETVGWLD 181
             + G P I H D+KS NIL+  N    +AD   +V+   S++         + T  ++ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 182 PEYLFWT---------EKSDVYSFGVVLVEL 203
           PE L  T         ++ D+++FG+VL E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 55  KMRIISQINHKNVVKILGVCLETKV--PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
           ++RI S   H NV+ +LG C       P L+  ++P G+L+ +V ++ +  +      ++
Sbjct: 60  RLRIFS---HPNVLPVLGACQSPPAPHPTLITHWMPYGSLY-NVLHEGTNFVVDQSQAVK 115
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            A + A  + +LH+L  P I    + S ++++D++ TA+++       ++    +  +  
Sbjct: 116 FALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARIS-------MADVKFSFQSPG 167
Query: 173 EIETVGWLDPEYLFWTEK------SDVYSFGVVLVELLTGKHP 209
            +    W+ PE L    +      +D++SF V+L EL+T + P
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 139
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 192
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G +G V++G       VAVK     D+       E++   M     + H+N++  + 
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFRETELYNTVM-----LRHENILGFIA 69
Query: 73  VCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
             + ++       L+  +   G+L+ +++  +   +    +CLRI    AS L +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEI 125
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL--ISSHDQTATTTKEIETVGWLD 181
             + G P I H D+KS NIL+  N    +AD   +V+   S++         + T  ++ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 182 PEYLFWT---------EKSDVYSFGVVLVEL 203
           PE L  T         ++ D+++FG+VL E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 48/222 (21%)
Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI---- 70
           LG GG G V+  V  D +  VA+KK  + D   +    + +++II +++H N+VK+    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEIL 77
Query: 71  ----------LGVCLETKVPLLVYEF--------VPNGTLFQ-HVRYQSSQVLKTWKTCL 111
                     +G   E     +V E+        +  G L + H R    Q+L+      
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR------ 131
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATT 170
                    L Y+HS     ++H D+K AN+ ++ ++   K+ DF  + ++  H      
Sbjct: 132 --------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 171 TKEIETVGWL-DPEYLF----WTEKSDVYSFGVVLVELLTGK 207
             E     W   P  L     +T+  D+++ G +  E+LTGK
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 111/258 (43%), Gaps = 52/258 (20%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKIL-INEVFQHKMRIISQINHK 65
           + Y+K   +GEG +G V+K    + + +VA+K+ ++ D    +      ++ ++ ++ HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 66  NVVKILGVCLETKVPLLVYEFVP----------NGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           N+V++  V    K   LV+EF            NG L         +++K++        
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-------DPEIVKSF------LF 108
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +    L + HS     ++H D+K  N+L++ N   K+ADF  +            + E+ 
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRCYSAEVV 163
Query: 176 TVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP------------RSYVALAS-- 217
           T+ +  P+ LF    ++   D++S G +  EL     P            R +  L +  
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 218 ----NEMTRMVPYFPYPI 231
                 MT++  Y PYP+
Sbjct: 224 EEQWPSMTKLPDYKPYPM 241

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++           LV++ +  G LF ++  + +   K  +  +R   E   AL 
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 128
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            L+      I+H D+K  NILLDD+   K+ DF  S  +   ++         T  +L P
Sbjct: 129 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG---TPSYLAP 179
Query: 183 EYL---------FWTEKSDVYSFGVVLVELLTGKHP 209
           E +          + ++ D++S GV++  LL G  P
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 147
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 200
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++++           LV++ +  G LF ++  + +   K  +  +R   E   AL 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            L+      I+H D+K  NILLDD+   K+ DF  S  +   ++         T  +L P
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG---TPSYLAP 192
Query: 183 EYL---------FWTEKSDVYSFGVVLVELLTGKHP 209
           E +          + ++ D++S GV++  LL G  P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 9   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 117
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 118 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKTFCGTP 172
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 182
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 183 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 235
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILG 72
           +G+G +G V++G       VAVK     D+       E++   M     + H+N++  + 
Sbjct: 45  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFRETELYNTVM-----LRHENILGFIA 98
Query: 73  VCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--- 125
             + ++       L+  +   G+L+ +++  +   +    +CLRI    AS L +LH   
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEI 154
Query: 126 --SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL--ISSHDQTATTTKEIETVGWLD 181
             + G P I H D+KS NIL+  N    +AD   +V+   S++         + T  ++ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 182 PEYLFWT---------EKSDVYSFGVVLVEL 203
           PE L  T         ++ D+++FG+VL E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 6   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKXFCGTP 169
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 6   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKXFCGTP 169
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 120
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 173
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 120
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 173
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T E+ T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPEVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 11  DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 119
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 120 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKXFCGTP 174
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKM------VDKILINEVFQHK 55
           + +N+ K   +GEG +G VYK     N L    VA+KK ++      V    I E+    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREI---- 56
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIA 114
             ++ ++NH N+VK+L V        LV+E V      F      +   L   K+ L   
Sbjct: 57  -SLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL--- 112
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +    L + HS     ++H D+K  N+L++     K+ADF  +          T   E+
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEV 167
Query: 175 ETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGK 207
            T+ +  PE L    +++   D++S G +  E++T +
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 6   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKXFCGTP 169
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +N   K+ DF  +  I  +            + W+ PE +F
Sbjct: 215 LSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIF 274
Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              ++ KSDV+S+GV+L E+ + G  P   V +  +  +R             LR+ +  
Sbjct: 275 DKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSR-------------LREGMRM 321
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +  + +  E  +I+      C      ERP   ++ E+L  L
Sbjct: 322 RAPEYSTPEIYQIML----DCWHRDPKERPRFAELVEKLGDL 359

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 120
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 173
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 6   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKTFCGTP 169
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E      L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 120
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 173
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            + K+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQINHKN 66
           ++D   LLG+G FG V         LV  K        KIL  EV   K  +   +    
Sbjct: 6   DFDYLKLLGKGTFGKV--------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 67  VVK--------ILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           V++         L    +T   L  V E+   G LF H+   S + + T +      AE 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SAL+YLHS     +++ D+K  N++LD +   K+ DF   +        AT      T 
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG--LCKEGISDGATMKTFCGTP 169
Query: 178 GWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
            +L PE L    +    D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ ++  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYL 124
           V   G         +  E +  G+L Q ++       Q+L       +++      L YL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIAVIKGLTYL 120
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE 183
                  I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ PE
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPE 173
Query: 184 YL---FWTEKSDVYSFGVVLVELLTGKHP 209
            L    ++ +SD++S G+ LVE+  G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            + K+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK--------- 55
           K Y     +G G  G V   Y  +L  N  VA+KK        ++  FQ++         
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK--------LSRPFQNQTHAKRAYRE 73
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           + ++  +NHKN++ +L V    K    + EF     + + +    SQV++      R++ 
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSY 130
Query: 116 ---ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
              +    + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T 
Sbjct: 131 LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTP 184
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            + T  +  PE +    + E  D++S GV++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNT------LVAVKKPKMVDKILINEVFQHKMRI 58
           + T +Y     LG+G F  V + V    T      ++  KK    D    ++  + + RI
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD----HQKLEREARI 83
Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
              + H N+V++     E     LV++ V  G LF+ +  +          C+    E+ 
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILES- 142
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIE 175
             ++++H      I+H D+K  N+LL         K+ADF  ++ +    Q         
Sbjct: 143 --VNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--G 195
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           T G+L PE L    + +  D+++ GV+L  LL G  P
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 39/180 (21%)
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATT 170
           +I   T  AL++L    +  IIH D+K +NILLD +   K+ DF  S  L+ S       
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAK 182
Query: 171 TKEIETVGWLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
           T++     ++ PE +        +  +SDV+S G+ L EL TG+                
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR---------------- 226
Query: 224 VPYFPYPIENNSLRQILNF------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
              FPYP  N+   Q+         Q+++  E E         + CL    ++RP  +++
Sbjct: 227 ---FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 102
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            + K+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 103 FLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 158
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     KV DF  +  +         T E     +L PE 
Sbjct: 159 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 210
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK--------- 55
           K Y     +G G  G V   Y  +L  N  VA+KK        ++  FQ++         
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKK--------LSRPFQNQTHAKRAYRE 73
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           + ++  +NHKN++ +L V    K    + EF     + + +    SQV++      R++ 
Sbjct: 74  LVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSY 130
Query: 116 ---ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
              +    + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T 
Sbjct: 131 LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTP 184
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            + T  +  PE +    + E  D++S GV++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 38/271 (14%)
Query: 53  QHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
           + ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC  
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKL 118
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTAT 169
              +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+ 
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSL 172
Query: 170 TTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHP----RSYVALASNE 219
                 T  +L PE L       +    D +S GV+L   L+G  P    R+ V+L    
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
            +    + P              +V  E   + +++V KL     +   T    +R    
Sbjct: 233 TSGKYNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278
Query: 280 QLDSLRRLHENFWAQKN-SEETEQLLGESST 309
           Q + ++R  ++  +++N S    Q+L + ST
Sbjct: 279 QDEDMKRKFQDLLSEENESTALPQVLAQPST 309

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+ P G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+++D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 14/167 (8%)
Query: 49  NEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWK 108
           ++  + + RI   + H N+V++     E     LV++ V  G LF+ +  +         
Sbjct: 47  HQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS 106
Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA---KVADFASSVLISSHD 165
            C++   +   A+ + H +G   ++H D+K  N+LL         K+ADF  ++ +    
Sbjct: 107 HCIQ---QILEAVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160
Query: 166 QTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           Q         T G+L PE L    + +  D+++ GV+L  LL G  P
Sbjct: 161 QAWFGFA--GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 31/257 (12%)
Query: 15  LLGEGGFGFVYKG-VLPDNTLVAVKK-PK--------MVDKILINEVFQHKMRIISQINH 64
           LLG+GGFG V+ G  L D   VA+K  P+        + D +          ++ +   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 65  KNVVKILGVCLETKVPLLVYEF-VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
             V+++L      +  +LV E  +P   LF ++  +   + +    C     +  +A+ +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCF--FGQVVAAIQH 154
Query: 124 LHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTAT---TTKEIETVGW 179
            HS G   ++H D+K  NIL+D     AK+ DF S  L+  HD+  T    T+      W
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVYSPPEW 209
Query: 180 LDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS---L 236
           +   + +    + V+S G++L +++ G  P         E+     +FP  +  +    +
Sbjct: 210 IS-RHQYHALPATVWSLGILLYDMVCGDIPFER----DQEILEAELHFPAHVSPDCCALI 264
Query: 237 RQILNFQVADENEMEEI 253
           R+ L  + +    +EEI
Sbjct: 265 RRCLAPKPSSRPSLEEI 281

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 119
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 120 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 173
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMT 221
               T  +L PE L       +    D +S GV+L   L+G  P    R+ V+L     +
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 233
Query: 222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
               + P              +V  E   + +++V KL     +   T    +R    Q 
Sbjct: 234 GKYNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279
Query: 282 DSLRRLHENFWAQKN-SEETEQLLGESST 309
           + ++R  ++  +++N S    Q+L + ST
Sbjct: 280 EDMKRKFQDLLSEENESTALPQVLAQPST 308

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 120
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 174
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMT 221
               T  +L PE L       +    D +S GV+L   L+G  P    R+ V+L     +
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
               + P              +V  E   + +++V KL     +   T    +R    Q 
Sbjct: 235 GKYNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
Query: 282 DSLRRLHENFWAQKN-SEETEQLLGESST 309
           + ++R  ++  +++N S    Q+L + ST
Sbjct: 281 EDMKRKFQDLLSEENESTALPQVLAQPST 309

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 120
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 174
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMT 221
               T  +L PE L       +    D +S GV+L   L+G  P    R+ V+L     +
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
               + P              +V  E   + +++V KL     +   T    +R    Q 
Sbjct: 235 GKYNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
Query: 282 DSLRRLHENFWAQKN-SEETEQLLGESST 309
           + ++R  ++  +++N S    Q+L + ST
Sbjct: 281 EDMKRKFQDLLSEENESTAKPQVLAQPST 309

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 126
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 127 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 180
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMT 221
               T  +L PE L       +    D +S GV+L   L+G  P    R+ V+L     +
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 240
Query: 222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
               + P              +V  E   + +++V KL     +   T    +R    Q 
Sbjct: 241 GKYNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286
Query: 282 DSLRRLHENFWAQKN-SEETEQLLGESST 309
           + ++R  ++  +++N S    Q+L + ST
Sbjct: 287 EDMKRKFQDLLSEENESTALPQVLAQPST 315

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 245
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 246 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 299
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRS 211
               T  +L PE L       +    D +S GV+L   L+G  P S
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC 74
           LG G +  VYKG+       VA+K+ K+  +         ++ ++ ++ H+N+V++  V 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 75  LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG---SPP 131
                  LV+EF+ N       +Y  S+ +      L +          L  L       
Sbjct: 73  HTENKLTLVFEFMDNDL----KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----W 187
           I+H D+K  N+L++     K+ DF  +          T + E+ T+ +  P+ L     +
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 188 TEKSDVYSFGVVLVELLTGK 207
           +   D++S G +L E++TGK
Sbjct: 187 STSIDIWSCGCILAEMITGK 206

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +D+   LG G FG V    +K       +  + K K+V    I      K RI+  +N  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L P  
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPAI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +    SQV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           ++ I+ ++NH  ++KI     + +   +V E +  G LF  V    ++ LK   TC    
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKE-ATCKLYF 259
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++    +T+   
Sbjct: 260 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMR 313
Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRS 211
               T  +L PE L       +    D +S GV+L   L+G  P S
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 132 IIHGDVKSANILLDDNYTAKVADFASS---VLISSHDQTATTTKEI--ETVGWLDPEYLF 186
           +IH DVK +NILLD+    K+ DF  S   V   + D++A     +  E +   DP    
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +  ++DV+S G+ LVEL TG+ P
Sbjct: 206 YDIRADVWSLGISLVELATGQFP 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/258 (22%), Positives = 111/258 (43%), Gaps = 52/258 (20%)
Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKI-LINEVFQHKMRIISQINHK 65
           + Y+K   +GEG +G V+K    + + +VA+K+ ++ D    +      ++ ++ ++ HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 66  NVVKILGVCLETKVPLLVYEFVP----------NGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           N+V++  V    K   LV+EF            NG L         +++K++        
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-------DPEIVKSF------LF 108
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +    L + HS     ++H D+K  N+L++ N   K+A+F  +            + E+ 
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVV 163
Query: 176 TVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP------------RSYVALAS-- 217
           T+ +  P+ LF    ++   D++S G +  EL     P            R +  L +  
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 218 ----NEMTRMVPYFPYPI 231
                 MT++  Y PYP+
Sbjct: 224 EEQWPSMTKLPDYKPYPM 241

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDN-----TLVAVKKPKMVDKILINEVFQHKMRIIS 60
           T  Y     LG+G F  V + + +P        ++  KK    D    ++  + + RI  
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD----HQKLEREARICR 58
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
            + H N+V++     E     LV++ V  G LF+ +  +          C++   E+   
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES--- 115
Query: 121 LDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           +++ H  G   I+H D+K  N+LL         K+ADF  ++ +    Q         T 
Sbjct: 116 VNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTP 170
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           G+L PE L    + +  D+++ GV+L  LL G  P
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 10  YDKRHLLGEGGFGFVY--KGVLPDN--TLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           +++   LG G FG V   K +   N   +  + K K+V    I      K RI+  +N  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK-RILQAVNFP 101
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYL 124
            +VK+     +     +V E+V  G +F H+R    ++ +  +   R  AA+     +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HSL    +I+ D+K  N+L+D     +V DF  +  +         T E     +L PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEI 209
Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHP 209
           +    + +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +    SQV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 228 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 282
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGV 198
           ++LD +   K+ DF   +        AT      T  +L PE L    +    D +  GV
Sbjct: 283 LMLDKDGHIKITDFG--LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 340
Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 341 VMYEMMCGRLP 351

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 87  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 141
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGV 198
           ++LD +   K+ DF   +        AT      T  +L PE L    +    D +  GV
Sbjct: 142 LMLDKDGHIKITDFG--LCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 199
Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 200 VMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 85  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 139
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGV 198
           ++LD +   K+ DF   +        AT      T  +L PE L    +    D +  GV
Sbjct: 140 LMLDKDGHIKITDFG--LCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 197
Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 198 VMYEMMCGRLP 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQ-HKMRIISQINHKNVVKIL 71
           LG G FG V++  + D       AVKK ++       EVF+  ++   + +    +V + 
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLY 132
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   E     +  E +  G+L Q V+ Q           L    +    L+YLHS     
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCL---PEDRALYYLGQALEGLEYLHSRR--- 186
Query: 132 IIHGDVKSANILL-DDNYTAKVADFASSVLISSHDQTATTTKEIETVGW-------LDPE 183
           I+HGDVK+ N+LL  D   A + DF  +V +    Q     K++ T  +       + PE
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCL----QPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 184 YLFWTE---KSDVYSFGVVLVELLTGKHP 209
            +       K DV+S   +++ +L G HP
Sbjct: 243 VVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 86  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 140
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGV 198
           ++LD +   K+ DF   +        AT      T  +L PE L    +    D +  GV
Sbjct: 141 LMLDKDGHIKITDFG--LCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 198
Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 199 VMYEMMCGRLP 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN 141
            V E+   G LF H+   S + + +        AE  SALDYLHS     +++ D+K  N
Sbjct: 225 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLEN 279
Query: 142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL---FWTEKSDVYSFGV 198
           ++LD +   K+ DF   +        AT      T  +L PE L    +    D +  GV
Sbjct: 280 LMLDKDGHIKITDFG--LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 199 VLVELLTGKHP 209
           V+ E++ G+ P
Sbjct: 338 VMYEMMCGRLP 348

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNT-----LVAVKKPKMVDKILINEVFQHKMRIIS 60
           T  Y     LG+G F  V + + +P        ++  KK    D    ++  + + RI  
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD----HQKLEREARICR 58
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
            + H N+V++     E     LV++ V  G LF+ +  +          C++   E+   
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES--- 115
Query: 121 LDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           +++ H  G   I+H D+K  N+LL         K+ADF  ++ +    Q         T 
Sbjct: 116 VNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTP 170
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           G+L PE L    + +  D+++ GV+L  LL G  P
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +    SQV++      R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 82  LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-----LGSPPIIHGD 136
           L+ ++  NG+L+ +++   S  L   K+ L++A  + S L +LH+      G P I H D
Sbjct: 112 LITDYHENGSLYDYLK---STTLDA-KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 137 VKSANILLDDNYTAKVADFASSV-LISSHDQT-ATTTKEIETVGWLDPEYL--------F 186
           +KS NIL+  N T  +AD   +V  IS  ++        + T  ++ PE L        F
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 187 WTE-KSDVYSFGVVLVEL 203
            +   +D+YSFG++L E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ----HKMRIISQINH 64
           Y+K   +G+G FG V+K         VA+KK  M ++    E F      +++I+  + H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKH 76
Query: 65  KNVVKILGVCLETKVPL--------LVYEFVPN--GTLFQHV--RYQSSQVLKTWKTCLR 112
           +NVV ++ +C     P         LV++F  +    L  +V  ++  S++ +  +  L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL- 135
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATT 170
                 + L Y+H      I+H D+K+AN+L+  +   K+ADF  A +  ++ + Q    
Sbjct: 136 ------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT 205
              + T+ +  PE L     +    D++  G ++ E+ T
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKK----PKMVDKILINEVFQHKMRIISQINHK 65
           YD    LG G FG V++ V      V V K    P  +DK  +    ++++ I++Q++H 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISIMNQLHHP 108
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
            ++ +     +    +L+ EF+  G LF  +  +  ++ +     +    +    L ++H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA--EVINYMRQACEGLKHMH 166
Query: 126 SLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHD--QTATTTKEIETVGWLD 181
                 I+H D+K  NI+ +    +  K+ DF  +  ++  +  +  T T E      +D
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223
Query: 182 PEYL-FWTEKSDVYSFGVVLVELLTGKHP 209
            E + F+T   D+++ GV+   LL+G  P
Sbjct: 224 REPVGFYT---DMWAIGVLGYVLLSGLSP 249

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 30/170 (17%)
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATT 170
           +IA     AL++LHS  S  +IH DVK +N+L++     K+ DF  S  L+ S  +T   
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 171 -TKEIETVGWLDPEY--LFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--- 224
             K       ++PE     ++ KSD++S G+ ++EL   + P         ++ ++V   
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 274
Query: 225 -PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT 273
            P  P                AD+   E ++      S+CL+ +  ERPT
Sbjct: 275 SPQLP----------------ADKFSAEFVD----FTSQCLKKNSKERPT 304

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 9   NYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           ++++   LG G  G V K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL-----RIAAETASALD 122
           V   G         +  E +  G+L         QVLK  K        +++      L 
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSL--------DQVLKEAKRIPEEILGKVSIAVLRGLA 128
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLD 181
           YL       I+H DVK +NIL++     K+ DF  S  LI S   +   T+      ++ 
Sbjct: 129 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMA 181
Query: 182 PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           PE L    ++ +SD++S G+ LVEL  G++P
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGVLPDN--TLVAVKKPKM------VDKILINEVFQH 54
           L +A + Y+    +GEG +G V+K     N    VA+K+ ++      +    I EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--A 63
Query: 55  KMRIISQINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW- 107
            +R +    H NVV++  VC       ETK+ L+          F+HV     Q L T+ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV----------FEHV----DQDLTTYL 109
Query: 108 ----------KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS 157
                     +T   +  +    LD+LHS     ++H D+K  NIL+  +   K+ADF  
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           + + S   Q A T+  + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 167 ARIYSF--QMALTSV-VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +    SQV++      R++    + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVK-------KPKMVDKILINEVFQHKMRIIS 60
           ++    ++G GGFG VY     D   + A+K       K K  + + +NE       ++S
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLS 243
Query: 61  QINHKNVVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
            ++  +   I+ +      P     + + +  G L  H+    SQ     +  +R  AAE
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAE 299
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L+++H+     +++ D+K ANILLD++   +++D   +   S     A+    + T
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352
Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRM 223
            G++ PE L     +   +D +S G +L +LL G  P R +     +E+ RM
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 404

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVK-------KPKMVDKILINEVFQHKMRIIS 60
           ++    ++G GGFG VY     D   + A+K       K K  + + +NE       ++S
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLS 244
Query: 61  QINHKNVVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAE 116
            ++  +   I+ +      P     + + +  G L  H+    SQ     +  +R  AAE
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAE 300
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L+++H+     +++ D+K ANILLD++   +++D   +   S     A+    + T
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 177 VGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRM 223
            G++ PE L     +   +D +S G +L +LL G  P R +     +E+ RM
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++         T  +
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI---FGTPAF 183
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           + PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGVLPDN--TLVAVKKPKM------VDKILINEVFQH 54
           L +A + Y+    +GEG +G V+K     N    VA+K+ ++      +    I EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--A 63
Query: 55  KMRIISQINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW- 107
            +R +    H NVV++  VC       ETK+ L+          F+HV     Q L T+ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV----------FEHV----DQDLTTYL 109
Query: 108 ----------KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS 157
                     +T   +  +    LD+LHS     ++H D+K  NIL+  +   K+ADF  
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           + + S   Q A T+  + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 167 ARIYSF--QMALTSV-VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQ-HKMRIISQINHKNVVKIL 71
           LG G FG V++  + D       AVKK ++       EVF+  ++   + +    +V + 
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLY 151
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   E     +  E +  G+L Q V+ Q           L    +    L+YLHS     
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCL---PEDRALYYLGQALEGLEYLHSRR--- 205
Query: 132 IIHGDVKSANILL-DDNYTAKVADFASSVLISSH--DQTATTTKEIE-TVGWLDPEYLFW 187
           I+HGDVK+ N+LL  D   A + DF  +V +      ++  T   I  T   + PE +  
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 188 TE---KSDVYSFGVVLVELLTGKHP 209
                K DV+S   +++ +L G HP
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 16  LGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G F  V +      G      ++  KK    D    ++  + + RI   + H N+V+
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD----HQKLEREARICRLLKHPNIVR 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +     E     L+++ V  G LF+ +  +          C++   +   A+ + H +G 
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAVLHCHQMG- 141
Query: 130 PPIIHGDVKSANILLDDNYTA---KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
             ++H D+K  N+LL         K+ADF  ++ +    Q         T G+L PE L 
Sbjct: 142 --VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLR 197
Query: 187 ---WTEKSDVYSFGVVLVELLTGKHP 209
              + +  D+++ GV+L  LL G  P
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ----HKMRIISQINH 64
           Y+K   +G+G FG V+K         VA+KK  M ++    E F      +++I+  + H
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKH 75
Query: 65  KNVVKILGVCLETKVPL--------LVYEFVPN--GTLFQHV--RYQSSQVLKTWKTCLR 112
           +NVV ++ +C     P         LV++F  +    L  +V  ++  S++ +  +  L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL- 134
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATT 170
                 + L Y+H      I+H D+K+AN+L+  +   K+ADF  A +  ++ + Q    
Sbjct: 135 ------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT 205
              + T+ +  PE L     +    D++  G ++ E+ T
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVK-------KPKMVDKILINEVFQHKMRIIS 60
           ++    ++G GGFG VY     D   + A+K       K K  + + +NE       ++S
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLS 244
Query: 61  QINHKNVVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
            ++  +   I+ +      P     + + +  G L  H+   S   + +       AAE 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEI 301
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L+++H+     +++ D+K ANILLD++   +++D   +   S     A+    + T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 354
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRM 223
           G++ PE L     +   +D +S G +L +LL G  P R +     +E+ RM
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVK-------KPKMVDKILINEVFQHKMRIIS 60
           ++    ++G GGFG VY     D   + A+K       K K  + + +NE       ++S
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLS 244
Query: 61  QINHKNVVKILGVCLETKVP---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
            ++  +   I+ +      P     + + +  G L  H+   S   + +       AAE 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEI 301
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L+++H+     +++ D+K ANILLD++   +++D   +   S     A+    + T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 354
Query: 178 GWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRM 223
           G++ PE L     +   +D +S G +L +LL G  P R +     +E+ RM
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 43/218 (19%)
Query: 16  LGEGGFGFVYKGVLP-DNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VA+KK P   D +   +    +++I+    H N++ I  +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 74  CLETKVPLLVYEFV-----------------PNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            L   VP   ++ V                       +HVRY   Q+L+           
Sbjct: 123 -LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR----------- 170
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEI 174
               L Y+HS     +IH D+K +N+L+++N   K+ DF  A  +  S  +     T+ +
Sbjct: 171 ---GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 175 ETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKH 208
            T  +  PE +     +T+  D++S G +  E+L  + 
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ----HKMRIISQINH 64
           Y+K   +G+G FG V+K         VA+KK  M ++    E F      +++I+  + H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKH 76
Query: 65  KNVVKILGVCLETKVPL--------LVYEFVPN--GTLFQHV--RYQSSQVLKTWKTCLR 112
           +NVV ++ +C     P         LV++F  +    L  +V  ++  S++ +  +  L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL- 135
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATT 170
                 + L Y+H      I+H D+K+AN+L+  +   K+ADF  A +  ++ + Q    
Sbjct: 136 ------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT 205
              + T+ +  PE L     +    D++  G ++ E+ T
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 12  KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           K  +LG G FG V+K       L    K      +   E  ++++ +++Q++H N++++ 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
                    +LV E+V  G LF  +  +S  +  T    +    +    + ++H +    
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTILFMKQICEGIRHMHQM---Y 207
Query: 132 IIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLF 186
           I+H D+K  NIL    D    K+ DF    L   +           T  +L PE   Y F
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
            +  +D++S GV+   LL+G  P
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQ----HKMRIISQINH 64
           Y+K   +G+G FG V+K         VA+KK  M ++    E F      +++I+  + H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKILQLLKH 76
Query: 65  KNVVKILGVCLETKVPL--------LVYEFVPN--GTLFQHV--RYQSSQVLKTWKTCLR 112
           +NVV ++ +C     P         LV++F  +    L  +V  ++  S++ +  +  L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL- 135
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATT 170
                 + L Y+H      I+H D+K+AN+L+  +   K+ADF  A +  ++ + Q    
Sbjct: 136 ------NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 171 TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT 205
              + T+ +  PE L     +    D++  G ++ E+ T
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 3   LVKATKNYDKRHLLGEGGFGFVYKGVLPDN--TLVAVKKPKM------VDKILINEVFQH 54
           L +A + Y+    +GEG +G V+K     N    VA+K+ ++      +    I EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--A 63
Query: 55  KMRIISQINHKNVVKILGVCL------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW- 107
            +R +    H NVV++  VC       ETK+ L+          F+HV     Q L T+ 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV----------FEHV----DQDLTTYL 109
Query: 108 ----------KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS 157
                     +T   +  +    LD+LHS     ++H D+K  NIL+  +   K+ADF  
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           + + S   Q A T+  + T+ +  PE L    +    D++S G +  E+   K
Sbjct: 167 ARIYSF--QMALTSV-VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQINHKNVVKI 70
           +G G +G V   +       VA+KK   + +   +E+F  +    + ++  + H+NV+ +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKK---LSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 71  LGVCLETKVPLLVYEF---VPNGTLFQHVRYQSSQVLKTWKTCLR-IAAETASALDYLHS 126
           L V          Y+F   +P    F     Q    LK  +  ++ +  +    L Y+HS
Sbjct: 89  LDVFTPASSLRNFYDFYLVMP----FMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE--- 183
            G   ++H D+K  N+ ++++   K+ DF     ++ H   A  T  + T  +  PE   
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFG----LARH-ADAEMTGYVVTRWYRAPEVIL 196
Query: 184 -YLFWTEKSDVYSFGVVLVELLTGK 207
            ++ + +  D++S G ++ E+LTGK
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQINHKNVVKIL 71
           +G G +G V   V  D    A    K + +   +E+F  +    +R++  + H+NV+ +L
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 72  GVCLETKVP------LLVYEFVPN--GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
            V    +         LV  F+    G L +H +    ++         +  +    L Y
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ-------FLVYQMLKGLRY 143
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           +H+ G   IIH D+K  N+ ++++   K+ DF  +    S       T+         PE
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRA-----PE 195
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ +T+  D++S G ++ E++TGK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQINHKNVVK 69
           +GEG +G VYK         A+KK ++      +    I E+      I+ ++ H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-----SILKELKHSNIVK 64
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG- 128
           +  V    K  +LV         F+H+     ++L   +  L      +  L  L+ +  
Sbjct: 65  LYDVIHTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 129 --SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                ++H D+K  N+L++     K+ADF  +            T EI T+ +  P+ L 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLM 173
Query: 187 WTEKS----DVYSFGVVLVELLTG 206
            ++K     D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 43/217 (19%)
Query: 16  LGEGGFGFVYKGVLP-DNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VA+KK P   D +   +    +++I+    H N++ I  +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 74  CLETKVPLLVYEFV-----------------PNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            L   VP   ++ V                       +HVRY   Q+L+           
Sbjct: 122 -LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR----------- 169
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKEI 174
               L Y+HS     +IH D+K +N+L+++N   K+ DF  A  +  S  +     T+ +
Sbjct: 170 ---GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 175 ETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            T  +  PE +     +T+  D++S G +  E+L  +
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNV 67
           Y   + +G G +G V   V     +   +  K + K  + +V  F+ ++ I+  ++H N+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIR--RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           +++     +     LV E    G LF+ V ++  +V +      RI  +  SA+ Y H L
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRE-SDAARIMKDVLSAVAYCHKL 142
Query: 128 GSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
               + H D+K  N L      +   K+ DF  +          T   ++ T  ++ P+ 
Sbjct: 143 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQV 196
Query: 185 L--FWTEKSDVYSFGVVLVELLTGKHPRS 211
           L   +  + D +S GV++  LL G  P S
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCGYPPFS 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 79  XVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 124
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG---LARTAGT 178
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 137
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +   T     T  ++ PE L    
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKG 193
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE +  +P    P         
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP--------- 242
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                          + A L  K L+T  T RPT+ ++
Sbjct: 243 ---------------VAASLIQKMLQTDPTARPTINEL 265

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINHKNV 67
           Y   + +G G +G V   V     +   +  K + K  + +V  F+ ++ I+  ++H N+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIR--RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           +++     +     LV E    G LF+ V ++  +V +      RI  +  SA+ Y H L
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRE-SDAARIMKDVLSAVAYCHKL 125
Query: 128 GSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
               + H D+K  N L      +   K+ DF  +          T   ++ T  ++ P+ 
Sbjct: 126 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQV 179
Query: 185 L--FWTEKSDVYSFGVVLVELLTGKHPRS 211
           L   +  + D +S GV++  LL G  P S
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPPFS 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   A+D +H L     +H D+K  NIL+D N   ++ADF S + +   D T  ++  +
Sbjct: 182 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAV 237
Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 79
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 80  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 190
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 128
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 129 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 184
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 185 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK--------- 55
           K Y     +G G  G V   Y  VL  N  VA+KK        ++  FQ++         
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK--------LSRPFQNQTHAKRAYRE 73
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           + ++  +NHKN++ +L V    K    + EF     + + +     QV++      R++ 
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSY 130
Query: 116 ---ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
              +    + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T 
Sbjct: 131 LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTP 184
Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 81
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 137
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +   T     T  ++ PE L    
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKG 193
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE +  +P    P         
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP--------- 242
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                          + A L  K L+T  T RPT+ ++
Sbjct: 243 ---------------VAASLIQKMLQTDPTARPTINEL 265

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 85
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 141
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +   T     T  ++ PE L    
Sbjct: 142 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL--CGTPNYIAPEVLSKKG 197
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE               S+ + 
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------SIPKH 243
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           +N             + A L  K L+T  T RPT+ ++
Sbjct: 244 IN------------PVAASLIQKMLQTDPTARPTINEL 269

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 59/229 (25%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK--------- 55
           K Y     +G G  G V   Y  VL  N  VA+KK        ++  FQ++         
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK--------LSRPFQNQTHAKRAYRE 73
Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRI 113
           + ++  +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I
Sbjct: 74  LVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVI 119
Query: 114 AAE------------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
             E                + +LHS G   IIH D+K +NI++  + T K+ DF    L 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LA 173
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +   +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 79
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 80  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 125
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 179
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 128
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 129 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 184
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 185 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 73  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 118
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 172
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 5   KATKNYDKRHLLGEGGFGFVYKGV--LPDNTLVAV----KKPKMVDKILINEVFQHKMRI 58
           + T+ Y     LG+G F  V + V  L      A+    KK    D    ++  + + RI
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARI 63
Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
              + H N+V++     E     L+++ V  G LF+ +  +          C++   +  
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---QIL 120
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTA---KVADFASSVLISSHDQTATTTKEIE 175
            A+ + H +G   ++H ++K  N+LL         K+ADF  ++ +    Q         
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--G 175
Query: 176 TVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           T G+L PE L    + +  D+++ GV+L  LL G  P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 79  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 124
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 178
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 79
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 80  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 125
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 179
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 8   KNYDKRHLLGEGGFGFVYKGV--LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           + Y K   LGEG +  VYKG   L DN LVA+K+ ++  +         ++ ++  + H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V +  +    K   LV+E++ +  L Q++      ++      L +  +    L Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLD-DCGNIINMHNVKLFLF-QLLRGLAYCH 117
Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                 ++H D+K  N+L+++    K+ADF  +   S    T T   E+ T+ +  P+ L
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDIL 172
Query: 186 F----WTEKSDVYSFGVVLVELLTGK 207
                ++ + D++  G +  E+ TG+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 71
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 72  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 117
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 171
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 77
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 78  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 123
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 124 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 177
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 178 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 73  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 118
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 172
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  XVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQINHKNVVK 69
           +GEG +G VYK         A+KK ++      +    I E+      I+ ++ H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-----SILKELKHSNIVK 64
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG- 128
           +  V    K  +LV         F+H+     ++L   +  L      +  L  L+ +  
Sbjct: 65  LYDVIHTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 129 --SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                ++H D+K  N+L++     K+ADF  +            T E+ T+ +  P+ L 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEVVTLWYRAPDVLM 173
Query: 187 WTEKS----DVYSFGVVLVELLTG 206
            ++K     D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQINHKNVVK 69
           +GEG +G VYK         A+KK ++      +    I E+      I+ ++ H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-----SILKELKHSNIVK 64
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG- 128
           +  V    K  +LV         F+H+     ++L   +  L      +  L  L+ +  
Sbjct: 65  LYDVIHTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 129 --SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                ++H D+K  N+L++     K+ADF  +            T E+ T+ +  P+ L 
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEVVTLWYRAPDVLM 173
Query: 187 WTEKS----DVYSFGVVLVELLTG 206
            ++K     D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +     E+ T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMEPEVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 116
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 162
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 216
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 49/224 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 116
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIQMELD 162
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 216
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
           +   T  + T  +  PE +    + E  D++S G ++ E++  K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            E   A+D +H L     +H D+K  N+LLD N   ++ADF S + ++  D T  ++  +
Sbjct: 182 GEMVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAV 237
Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-----I 174
           ALDY+H +G    +H  VK+++IL+  +    ++   S++ + SH Q      +     +
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 175 ETVGWLDPEYL-----FWTEKSDVYSFGVVLVELLTGKHP 209
           + + WL PE L      +  KSD+YS G+   EL  G  P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ K   + +  E  + ++ I+ +I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 129
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASSVLISSHDQTATTTKEIETVGW 179
           LHSL    I H D+K  NI+L D        K+ DF  +  I   ++        E V  
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA- 185
Query: 180 LDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             PE + +     ++D++S GV+   LL+G  P
Sbjct: 186 --PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            E   A+D +H L     +H D+K  N+LLD N   ++ADF S + ++  D T  ++  +
Sbjct: 198 GEMVLAIDSIHQL---HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMND-DGTVQSSVAV 253
Query: 175 ETVGWLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
            T  ++ PE L   E        + D +S GV + E+L G+ P
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 55  KMRIISQINHKNVVKILGVCLETKV--PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR 112
           ++RI S   H NV+ +LG C       P L+  + P G+L+ +V ++ +  +      ++
Sbjct: 60  RLRIFS---HPNVLPVLGACQSPPAPHPTLITHWXPYGSLY-NVLHEGTNFVVDQSQAVK 115
Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            A + A    +LH+L  P I    + S ++ +D++ TA+++         S  +      
Sbjct: 116 FALDXARGXAFLHTL-EPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP-- 172
Query: 173 EIETVGWLDPEYLFWTEK------SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
                 W+ PE L    +      +D +SF V+L EL+T + P  +  L++ E+   V
Sbjct: 173 -----AWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP--FADLSNXEIGXKV 223

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE-----I 174
           ALDY+H +G    +H  VK+++IL+  +    ++   S++ + SH Q      +     +
Sbjct: 124 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 180
Query: 175 ETVGWLDPEYL-----FWTEKSDVYSFGVVLVELLTGKHP 209
           + + WL PE L      +  KSD+YS G+   EL  G  P
Sbjct: 181 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK----GVLPDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI 62
           +Y+    LG G F  V K    G   +     +KK ++    + +  E  + ++ I+ +I
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++ +  +       +L+ E V  G LF  +  + S         L+        LD
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILD 140
Query: 123 YLHSLGSPPIIHGDVKSANILLDD----NYTAKVADFASSVLISSHDQTATTTKEIETVG 178
            +H L S  I H D+K  NI+L D    N   K+ DF  +  I + ++        E V 
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
              PE + +     ++D++S GV+   LL+G  P
Sbjct: 201 ---PEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK----GVLPDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI 62
           +Y+    LG G F  V K    G   +     +KK ++    + +  E  + ++ I+ +I
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++ +  +       +L+ E V  G LF  +  + S         L+        LD
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILD 119
Query: 123 YLHSLGSPPIIHGDVKSANILLDD----NYTAKVADFASSVLISSHDQTATTTKEIETVG 178
            +H L S  I H D+K  NI+L D    N   K+ DF  +  I + ++        E V 
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
              PE + +     ++D++S GV+   LL+G  P
Sbjct: 180 ---PEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQINHKNVVKI 70
           +G G +G V   +       VA+KK   + +   +E+F  +    + ++  + H+NV+ +
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKK---LSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           L V          Y+F       Q    +   +  + +    +  +    L Y+HS G  
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG-- 164
Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----YLF 186
            ++H D+K  N+ ++++   K+ DF     ++ H   A  T  + T  +  PE    ++ 
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFG----LARH-ADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 187 WTEKSDVYSFGVVLVELLTGK 207
           + +  D++S G ++ E+LTGK
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  VL  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 71
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 72  CVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTR 182
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 49/223 (21%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y +   +G G  G V   +  VL  N  VAVKK   + +   N+    +    + ++ 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGIN--VAVKK---LSRPFQNQTHAKRAYRELVLLK 76
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 77  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIHMELD 122
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAST 176
Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
               T  + T  +  PE +    + E  D++S G ++ EL+ G
Sbjct: 177 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 16  LGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI--NHKNVVKILGV 73
           +G+G +G V++G+    + VAVK     D+    + +  +  I + +   H N++  +  
Sbjct: 16  VGKGRYGEVWRGLWHGES-VAVKIFSSRDE----QSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 74  CLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH---- 125
            + ++       L+  +  +G+L+  ++ Q+ +        LR+A   A  L +LH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP----HLALRLAVSAACGLAHLHVEIF 126
Query: 126 -SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT-----TTKEIETVGW 179
            + G P I H D KS N+L+  N    +AD   +V+   H Q +          + T  +
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM---HSQGSDYLDIGNNPRVGTKRY 183
Query: 180 LDPEYL--------FWTEK-SDVYSFGVVLVEL 203
           + PE L        F + K +D+++FG+VL E+
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 9   NYDKRHLLGEGGFGFVYK----GVLPDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI 62
           +Y+    LG G F  V K    G   +     +KK ++    + +  E  + ++ I+ +I
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++ +  +       +L+ E V  G LF  +  + S         L+        LD
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILD 126
Query: 123 YLHSLGSPPIIHGDVKSANILLDD----NYTAKVADFASSVLISSHDQTATTTKEIETVG 178
            +H L S  I H D+K  NI+L D    N   K+ DF  +  I + ++        E V 
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
              PE + +     ++D++S GV+   LL+G  P
Sbjct: 187 ---PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 48  INEVFQHKMRIISQINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLK 105
           I +V+Q ++ I+ +++H NVVK++ V  +       +V+E V  G + +         + 
Sbjct: 80  IEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---------VP 129
Query: 106 TWKTCLRIAA-----ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL 160
           T K      A     +    ++YLH      IIH D+K +N+L+ ++   K+ADF  S  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 161 ISSHDQTATTTKEIETVGWLDPEYLFWTEKS------DVYSFGVVLVELLTGKHP 209
               D   + T  + T  ++ PE L  T K       DV++ GV L   + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +    K+ DF  +  I               + W+ PE +F
Sbjct: 207 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 266
Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T +SDV+SFGV+L E+ + G  P   V +   E  R             L++    
Sbjct: 267 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------RLKEGTRM 313
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 314 RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +    K+ DF  +  I               + W+ PE +F
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T +SDV+SFGV+L E+ + G  P   V +   E  R             L++    
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------RLKEGTRM 315
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 316 RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 353

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +     E+ T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMEPEVVTR 189
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 42/192 (21%)
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
           +IA     AL++LHS  S  +IH DVK +N+L++     K+ DF  S  +          
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-----VDDVA 165
Query: 172 KEIETVG--WLDPEYL-------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR 222
           K+I+     ++ PE +        ++ KSD++S G+ ++EL   + P         ++ +
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ 225
Query: 223 MV----PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS 278
           +V    P  P                AD+   E ++      S+CL+ +  ERPT  ++ 
Sbjct: 226 VVEEPSPQLP----------------ADKFSAEFVD----FTSQCLKKNSKERPTYPELM 265
Query: 279 EQLDSLRRLHEN 290
           +       LHE+
Sbjct: 266 QH--PFFTLHES 275

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +    K+ DF  +  I               + W+ PE +F
Sbjct: 214 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 273
Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T +SDV+SFGV+L E+ + G  P   V +   E  R             L++    
Sbjct: 274 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------RLKEGTRM 320
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 321 RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 358

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +LG+G    V++G       L A+K    +  +   +V   +  ++ ++NHKN+VK+  +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 74  CLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
             E  T+  +L+ EF P G+L+  +   S+         L +  +    +++L   G   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 132 IIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
           I+H ++K  NI+     D     K+ DF ++  +   +Q  +     E   +L P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---YLHPDMYER 189
Query: 186 ---------FWTEKSDVYSFGVVLVELLTGKHP 209
                     +    D++S GV      TG  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
           L S   IH D+ + NILL +    K+ DF  +  I               + W+ PE +F
Sbjct: 216 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 275
Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T +SDV+SFGV+L E+ + G  P   V +   E  R             L++    
Sbjct: 276 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR------------RLKEGTRM 322
Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           +  D    E  + +      C     ++RPT  ++ E L +L
Sbjct: 323 RAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK-MRIISQINHKNVVKIL 71
           +G G +G V   Y   L     VAVKK     + LI+    ++ +R++  + H+NV+ +L
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQV---LKTWKTCLRIAAETAS------- 119
            V            F P  ++  F  V   ++ +   L     C  ++ E          
Sbjct: 86  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 120 -ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             L Y+HS G   IIH D+K +N+ ++++   ++ DF    L    D+  T    + T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG---LARQADEEMTGY--VATRW 185
Query: 179 WLDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
           +  PE    ++ + +  D++S G ++ ELL GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  K    I+  +    ++R++  + H+NV+ +L V
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 102 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 209
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK-MRIISQINHKNVVKIL 71
           +G G +G V   Y   L     VAVKK     + LI+    ++ +R++  + H+NV+ +L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 72  GVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQV---LKTWKTCLRIAAETAS------- 119
            V            F P  ++  F  V   ++ +   L     C  ++ E          
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 120 -ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             L Y+HS G   IIH D+K +N+ ++++   ++ DF    L    D+  T    + T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG---LARQADEEMTGY--VATRW 193
Query: 179 WLDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
           +  PE    ++ + +  D++S G ++ ELL GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 135
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +         T  ++ PE L    
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKG 191
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE +  +P    P         
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINP--------- 240
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                          + A L  K L+T  T RPT+ ++
Sbjct: 241 ---------------VAASLIQKMLQTDPTARPTINEL 263

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/159 (23%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +LG+G    V++G       L A+K    +  +   +V   +  ++ ++NHKN+VK+  +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 74  CLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
             E  T+  +L+ EF P G+L+  +   S+         L +  +    +++L   G   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 132 IIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQ 166
           I+H ++K  NI+     D     K+ DF ++  +   +Q
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 95  F----TPARSLEEFNDVYLVTHL---MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 202
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 80
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 81  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +      + T 
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMVPFVVTR 191
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
            +  PE +    + E  D++S G ++ E++ G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 103
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 159
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +         T  ++ PE L    
Sbjct: 160 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKG 215
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE               S+ + 
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------SIPKH 261
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           +N             + A L  K L+T  T RPT+ ++
Sbjct: 262 IN------------PVAASLIQKMLQTDPTARPTINEL 287

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 47/215 (21%)
Query: 16  LGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK-MRIISQINHKNVVKIL 71
           +G G +G V   Y   L     VAVKK     + LI+    ++ +R++  + H+NV+ +L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 72  GV--------------CLETKVPLLVYEFVPNGTLF-QHVRYQSSQVLKTWKTCLRIAAE 116
            V               + T +   +   V +  L  +HV++   Q+L+           
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR----------- 142
Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L Y+HS G   IIH D+K +N+ ++++   ++ DF    L    D+  T    + T
Sbjct: 143 ---GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG---LARQADEEMTGY--VAT 191
Query: 177 VGWLDPE----YLFWTEKSDVYSFGVVLVELLTGK 207
             +  PE    ++ + +  D++S G ++ ELL GK
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 33/258 (12%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI--------NHK 65
           LLG GGFG VY G+ + DN  VA+K  +  D+I       +  R+  ++           
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 66  NVVKILGVCLETKVPLLVYEFV-PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            V+++L         +L+ E + P   LF  +  + +   +  ++      +   A+ + 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF---WQVLEAVRHC 130
Query: 125 HSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T      + +     PE
Sbjct: 131 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS----PPE 183
Query: 184 YL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS---L 236
           ++    +    + V+S G++L +++ G  P  +      E+ R   +F   + +     +
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQHLI 239
Query: 237 RQILNFQVADENEMEEIE 254
           R  L  + +D    EEI+
Sbjct: 240 RWCLALRPSDRPTFEEIQ 257

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 83
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 84  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 194
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI-----NEVFQHKMRIISQINHKNVVK 69
            LG+GGF   ++  + D     V   K+V K L+      E    ++ I   + H++VV 
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
             G   +     +V E     +L +  + + +      +  LR   +      YLH    
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRNR- 161
Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             +IH D+K  N+ L+++   K+ DF  +  +    +         T  ++ PE L    
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKG 217
Query: 190 KS---DVYSFGVVLVELLTGKHP-------RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
            S   DV+S G ++  LL GK P        +Y+ +  NE               S+ + 
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------SIPKH 263
Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           +N             + A L  K L+T  T RPT+ ++
Sbjct: 264 IN------------PVAASLIQKMLQTDPTARPTINEL 289

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y     +G G  G V   Y  +L  N  VA+KK   + +   N+    +    + ++ 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKK---LSRPFQNQTHAKRAYRELVLMK 72
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA---ET 117
            +NHKN++ +L V    K    + EF     + + +     QV++      R++    + 
Sbjct: 73  CVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              + +LHS G   IIH D+K +NI++  + T K+ DF    L  +   +   T  + T 
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTR 183
Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
            +  PE +    + E  D++S G ++ E++  K
Sbjct: 184 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 16  LGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           LG G    VY    KG      L  +KK   VDK    ++ + ++ ++ +++H N++K+ 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKK--TVDK----KIVRTEIGVLLRLSHPNIIKLK 114
Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            +  ET   + LV E V  G LF  +  +     +     ++   +   A+ YLH  G  
Sbjct: 115 EI-FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILEAVAYLHENG-- 168
Query: 131 PIIHGDVKSANILLDD---NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL-- 185
            I+H D+K  N+L      +   K+ADF  S ++       T      T G+  PE L  
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG---TPGYCAPEILRG 224
Query: 186 -FWTEKSDVYSFGVVLVELLTGKHP 209
             +  + D++S G++   LL G  P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H      T  + T  +  PE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARH-TADEMTGYVATRWYRAPE 199
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 118 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 173
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 174 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 217
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 218 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 269
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 270 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 300

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 95  F----TPARSLEEFNDVYLVTHL---MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 202
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 96  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 203
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H      T  + T  +  PE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARH-TADEMTGYVATRWYRAPE 199
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 90  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 145
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 146 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 189
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 190 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 241
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 242 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 272

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 146
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 147 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 191 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 242
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 243 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 273

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGX-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 158
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 159 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 203 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 254
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 285

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 96  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 203
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 199
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 197
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 131
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 132 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 175
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 176 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 227
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 228 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 258

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 89  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 191
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 101 F----TPARSLEEFNDVYLVTHL---MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 154 SADIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 208
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 102 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 209
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 92  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 199
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 102 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 209
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 96  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 149 SADIIHRDLKPSNLAVNEDSELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 203
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 92  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 199
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 113 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 215
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 75  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 130
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 131 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 174
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 175 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 226
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 227 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 257

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H      T  + T  +  PE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARH-TADEMTGYVATRWYRAPE 199
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 90  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 127 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 171 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 222
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 74  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 129
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 130 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 173
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 174 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 225
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 226 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 256

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 197
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 101 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 154 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 208
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 194
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 131
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 132 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 175
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 176 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 227
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 228 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 258

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 92  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 145 SADIIHRDLKPSNLAVNEDSELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 199
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 110 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 165
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 166 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 210 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 261
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 131
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 132 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 175
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 176 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 227
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   + +     +R  L  + +D    EEI+
Sbjct: 228 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 258

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 110 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 212
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 109 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 211
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 87  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 189
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 87  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 189
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 146
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 147 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 191 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 242
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 243 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 273

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 YLF----WTEKSDVYSFGVVLVELLTGK 207
            +     + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 188
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 90  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 145
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 146 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 189
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 190 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 241
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 242 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 272

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 88  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 190
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVD-------------KILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 118 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 173
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 174 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 217
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 218 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 269
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 270 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 300

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVD-------------KILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 123 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 178
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 179 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 222
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 223 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 274
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 275 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 305

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +LGEG    V   + L  +   AVK  +     + + VF+    +     H+NV++++  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 74  CLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
             E     LV+E +  G++  H+  R   +++  +      +  + ASALD+LH+ G   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-----VVVQDVASALDFLHNKG--- 131
Query: 132 IIHGDVKSANILLDDN---YTAKVADFA-SSVLISSHDQTATTTKEIET----VGWLDPE 183
           I H D+K  NIL +        K+ DF   S +  + D +  +T E+ T      ++ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 184 YL--------FWTEKSDVYSFGVVLVELLTGKHP 209
            +         + ++ D++S GV+L  LL+G  P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISS-HDQTAT 169
           +IA     AL++LHS  S  +IH DVK +N+L++     K  DF  S  L+         
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 170 TTKEIETVGWLDPEY--LFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--- 224
             K       ++PE     ++ KSD++S G+  +EL   + P         ++ ++V   
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP 257
Query: 225 -PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
            P  P                AD+   E ++      S+CL+ +  ERPT  ++ +    
Sbjct: 258 SPQLP----------------ADKFSAEFVD----FTSQCLKKNSKERPTYPELXQH--P 295
Query: 284 LRRLHEN 290
              LHE+
Sbjct: 296 FFTLHES 302

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 98  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 153
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 154 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 197
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 198 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 249
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 250 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 280

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 57/227 (25%)
Query: 8   KNYDKRHLLGEGGFGFV---YKGVLPDNTLVAVKKPKMVDKILINEVFQHK----MRIIS 60
           K Y +   +G G  G V   +  VL  N  VAVKK   + +   N+    +    + ++ 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGIN--VAVKK---LSRPFQNQTHAKRAYRELVLLK 78
Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTL--FQHVRYQSSQVLKTWKTCLRIAAE-- 116
            +NHKN++ +L V            F P  TL  FQ V Y   +++     C  I  E  
Sbjct: 79  CVNHKNIISLLNV------------FTPQKTLEEFQDV-YLVMELMDA-NLCQVIHMELD 124
Query: 117 ----------TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
                         + +LHS G   IIH D+K +NI++  + T K+ DF  +       +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-------R 174
Query: 167 TATT----TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
           TA T    T  + T  +  PE +    +    D++S G ++ EL+ G
Sbjct: 175 TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKT----CLRIAAETASALDYLHSLG 128
                 P    E   +  L  H+     + ++K  K        +  +    L Y+HS  
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
              IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 146 ---IIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 66/233 (28%)
Query: 16  LGEGGFGFVYKGV--LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN------V 67
           LGEG FG V + +        VAVK  K VD+    E  + +++++  +N  +       
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC--EAARSEIQVLEHLNTTDPNSTFRC 79
Query: 68  VKIL-------GVCLETKV-PLLVYEFVP-NGTL---FQHVRYQSSQVLKTWKTCLRIAA 115
           V++L        +C+  ++  L  Y+F+  NG L     H+R  + Q+ K+         
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS--------- 130
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL-DDNYTA------------------KVADFA 156
                +++LHS     + H D+K  NIL    +YT                   KV DF 
Sbjct: 131 -----VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
           S+     H  T  +T+         PE +    W++  DV+S G +L+E   G
Sbjct: 183 SATYDDEHHSTLVSTRHYRA-----PEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKT----CLRIAAETASALDYLHSLG 128
                 P    E   +  L  H+     + ++K  K        +  +    L Y+HS  
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
              IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQS-SQVLKTWKT----CLRIAAETASALDYLHSLG 128
                 P    E   +  L  H+     + ++K+ K        +  +    L Y+HS  
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
              IIH D+K +N+ ++++   K+ DF     +  H     T   + T  +  PE    +
Sbjct: 146 ---IIHRDLKPSNLAVNEDSELKILDFG----LCRHTDDEMTGY-VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   A+D +H LG    +H D+K  NILLD     ++ADF S + + + D T  +   +
Sbjct: 169 AEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAV 224
Query: 175 ETVGWLDPEYL----------FWTEKSDVYSFGVVLVELLTGKHP 209
            T  +L PE L           +  + D ++ GV   E+  G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 146
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 147 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 190
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 191 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 242
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  +  D    EEI+
Sbjct: 243 FRQRVSXECQHLIRWCLALRPXDRPTFEEIQ 273

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ D+     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 59/271 (21%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 127 -------------HNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
              + +     PE++    +    + V+S G++L +++ G  P  +      E+ R   +
Sbjct: 171 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVF 222
Query: 227 FPYPIENNS---LRQILNFQVADENEMEEIE 254
           F   +       +R  L  + +D    EEI+
Sbjct: 223 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQ 253

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +LGEG    V   + L  +   AVK  +     + + VF+    +     H+NV++++  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 74  CLETKVPLLVYEFVPNGTLFQHV--RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
             E     LV+E +  G++  H+  R   +++  +      +  + ASALD+LH+ G   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-----VVVQDVASALDFLHNKG--- 131
Query: 132 IIHGDVKSANILLDDN---YTAKVADF--ASSVLISSHDQTATTTKEIETVG---WLDPE 183
           I H D+K  NIL +        K+ DF   S + ++      +T + +   G   ++ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 184 YL--------FWTEKSDVYSFGVVLVELLTGKHP 209
            +         + ++ D++S GV+L  LL+G  P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 96  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 203
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V       + L +AVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 119 F----TPATSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 171
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 172 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 226
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + +    D++S G ++ ELLTG+
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 100 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 202
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 113 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 165
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H         + T  +  PE    +
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMXGY-VATRWYRAPEIMLNW 220
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLPDNTLV--AVKKPKMVDKILINEV---FQHKMRI 58
            K    Y    LLGEG +G V K VL   TL   AVK  K      I       + ++++
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 59  ISQINHKNVVKILGVCL--ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA-- 114
           + ++ HKNV++++ V    E +   +V E+   G          S   K +  C      
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM----QEMLDSVPEKRFPVCQAHGYF 115
Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTT- 171
            +    L+YLHS G   I+H D+K  N+LL    T K++    A ++   + D T  T+ 
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 172 -----KEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHP 209
                +  E    LD    F   K D++S GV L  + TG +P
Sbjct: 173 GSPAFQPPEIANGLD---TFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQ-HKMRIISQINHKNVVKIL 71
           LG G FG V++  + D       AVKK ++       EVF+  ++   + ++   +V + 
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLY 130
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   E     +  E +  G+L Q ++             L    +    L+YLH+     
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCL---PEDRALYYLGQALEGLEYLHTR---R 184
Query: 132 IIHGDVKSANILL-DDNYTAKVADFASSVLISSH--DQTATTTKEIE-TVGWLDPEYLF- 186
           I+HGDVK+ N+LL  D   A + DF  ++ +      ++  T   I  T   + PE +  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 187 --WTEKSDVYSFGVVLVELLTGKHP 209
                K D++S   +++ +L G HP
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 47  LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTL-FQHVRYQSSQVLK 105
           L  E  + +  I   + H ++V++L       +  +V+EF+    L F+ V+   +  + 
Sbjct: 68  LSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 127
Query: 106 TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLIS 162
           +         +   AL Y H      IIH DVK  N+LL   +++   K+ DF  ++ + 
Sbjct: 128 SEAVASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
                A     + T  ++ PE +    + +  DV+  GV+L  LL+G  P
Sbjct: 185 ESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 188
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 110 F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE    +
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPEIMLNW 217
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 109 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 211
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGY-VATRWYRAPE 188
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDF----YLARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 159
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 160 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 204 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVD-------------KILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 159
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 160 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 204 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 158
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 159 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 203 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 159
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 160 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 204 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 159
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 160 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 203
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 204 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 158
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 159 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 203 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 158
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 159 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 202
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 203 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGV 73
           LG G +  V++ + + +N  V VK  K V K  I    + +++I+  +    N++ +  +
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKI----KREIKILENLRGGPNIITLADI 100
Query: 74  CLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
             +  ++ P LV+E V N T F+    Q  Q L  +     +  E   ALDY HS+G   
Sbjct: 101 VKDPVSRTPALVFEHV-NNTDFK----QLYQTLTDYDIRFYMY-EILKALDYCHSMG--- 151
Query: 132 IIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATTTKEIETVGWLDPE----YLF 186
           I+H DVK  N+++D  +   ++ D+    L   +         + +  +  PE    Y  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
           +    D++S G +L  ++  K P
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 47/121 (38%), Gaps = 36/121 (29%)
Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNY------------------------- 148
             E   AL+YL  +    + H D+K  NILLDD Y                         
Sbjct: 143 CIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 149 TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT 205
             K+ DF  +   S +  +   T++        PE +    W   SD++SFG VL EL T
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRA-----PEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 206 G 206
           G
Sbjct: 255 G 255

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-------------ILINEV---FQH 54
           LLG GGFG VY G+ + DN  VA+K   K ++ D              +L+ +V   F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 55  KMRIISQINHKNVVKILGVCLETKVPLL-VYEFVPNGTLFQH--VRYQSSQVLKTWKTCL 111
            +R++      +   ++   LE   P+  +++F+      Q    R    QVL+  + C 
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-KVADFASSVLISSHDQTATT 170
                        H+ G   ++H D+K  NIL+D N    K+ DF S  L+     T   
Sbjct: 127 -------------HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 171 TKEIETVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
              + +     PE++    +    + V+S G++L +++ G  P
Sbjct: 171 GTRVYS----PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 36/168 (21%)
Query: 53  QHKMRIISQINHK-----NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
            H ++++   NHK     +VV +  V  E  + L + ++   G    +V+  S Q+L   
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYVKQISKQLL--- 141
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL------DDNYTAKVADFASSVLI 161
                        LDY+H      IIH D+K  N+L+      ++    K+AD  ++   
Sbjct: 142 -----------LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
             H   +  T+E  +     PE L    W   +D++S   ++ EL+TG
Sbjct: 189 DEHYTNSIQTREYRS-----PEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 36/168 (21%)
Query: 53  QHKMRIISQINHK-----NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
            H ++++   NHK     +VV +  V  E  + L + ++   G    +V+  S Q+L   
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYVKQISKQLL--- 141
Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL------DDNYTAKVADFASSVLI 161
                        LDY+H      IIH D+K  N+L+      ++    K+AD  ++   
Sbjct: 142 -----------LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
             H   +  T+E  +     PE L    W   +D++S   ++ EL+TG
Sbjct: 189 DEHYTNSIQTREYRS-----PEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I+ Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N++ +  V       +L+ E V  G LF  +  + S   +   + ++   +    ++Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNY 130
Query: 124 LHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI-ETVG 178
           LH+     I H D+K  NI LLD N      K+ DF     ++   +     K I  T  
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNIFGTPE 183
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+  F     ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-----------PKMVDKILIN 49
           +EL      Y  +  +  G +G V  GV  +   VA+K+             + D  L  
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 50  EVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKT 109
            V + ++R+++  +H N++ +  + +  + P +   ++    + + +R   +QV+   + 
Sbjct: 75  RVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLAQVIHDQRI 129
Query: 110 CL---RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            +    I       L  LH L    ++H D+   NILL DN    + DF    L      
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTA 186
Query: 167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            A  T  +    +  PE +     +T+  D++S G V+ E+   K
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/225 (21%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-----------PKMVDKILIN 49
           +EL      Y  +  +  G +G V  GV  +   VA+K+             + D  L  
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 50  EVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKT 109
            V + ++R+++  +H N++ +  + +  + P +   ++    + + +R   +QV+   + 
Sbjct: 75  RVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLAQVIHDQRI 129
Query: 110 CL---RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            +    I       L  LH L    ++H D+   NILL DN    + DF    L      
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTA 186
Query: 167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            A  T  +    +  PE +     +T+  D++S G V+ E+   K
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF  +    + D+ A     + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 90  F----TPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ DF  +    + D+ A     + T  +  PE    +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQ-HKMRIISQINHKNVVKIL 71
           +G G FG V++  + D       AVKK ++       EVF+  ++   + ++   +V + 
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLY 116
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   E     +  E +  G+L Q ++             L    +    L+YLH+     
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCL---PEDRALYYLGQALEGLEYLHTR---R 170
Query: 132 IIHGDVKSANILL-DDNYTAKVADFASSVLISSHDQTATTTKEIETVGW-------LDPE 183
           I+HGDVK+ N+LL  D   A + DF  ++ +    Q     K + T  +       + PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCL----QPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 184 YLF---WTEKSDVYSFGVVLVELLTGKHP 209
            +       K D++S   +++ +L G HP
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
            H N++ +  V  + K   LV E +  G L   +  Q     +     L    +T   ++
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT---VE 135
Query: 123 YLHSLGSPPIIHGDVKSANILLDDNY----TAKVADFASSVLISSHDQTATTTKEIETVG 178
           YLHS G   ++H D+K +NIL  D        ++ DF  +  + + +    T     T  
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT--PCYTAN 190
Query: 179 WLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           ++ PE L    + E  D++S G++L  +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 16  LGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQ-HKMRIISQINHKNVVKIL 71
           +G G FG V++  + D       AVKK ++       EVF+  ++   + ++   +V + 
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLY 132
Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   E     +  E +  G+L Q ++             L    +    L+YLH+     
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCL---PEDRALYYLGQALEGLEYLHTR---R 186
Query: 132 IIHGDVKSANILL-DDNYTAKVADFASSVLISSH--DQTATTTKEIE-TVGWLDPEYLF- 186
           I+HGDVK+ N+LL  D   A + DF  ++ +      ++  T   I  T   + PE +  
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 187 --WTEKSDVYSFGVVLVELLTGKHP 209
                K D++S   +++ +L G HP
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ D      ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY-----LHSLG 128
                 P    E   +  L  H+       L     C ++  +    L Y     L  + 
Sbjct: 90  F----TPARSLEEFNDVYLVTHL---MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE----Y 184
           S  IIH D+K +N+ ++++   K+ D      ++ H     T   + T  +  PE    +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDRG----LARHTDDEMTGY-VATRWYRAPEIMLNW 197
Query: 185 LFWTEKSDVYSFGVVLVELLTGK 207
           + + +  D++S G ++ ELLTG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N++ +  V  + K   LV E +  G L   +  Q     +     L    +T   ++Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT---VEY 136
Query: 124 LHSLGSPPIIHGDVKSANILLDDNY----TAKVADFASSVLISSHDQTATTTKEIETVGW 179
           LHS G   ++H D+K +NIL  D        ++ DF  +  + + +    T     T  +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANF 191
Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           + PE L    + E  D++S G++L  +L G  P
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I+ Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S   +   + ++   +    ++Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNY 130
Query: 124 LHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI-ETVG 178
           LH+     I H D+K  NI LLD N      K+ DF     ++   +     K I  T  
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNIFGTPE 183
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I+ Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S   +   + ++   +    ++Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNY 130
Query: 124 LHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI-ETVG 178
           LH+     I H D+K  NI LLD N      K+ DF     ++   +     K I  T  
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNIFGTPE 183
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 110 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF     ++ H         + T  +  PE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMXGX-VATRWYRAPE 212
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I+ Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S   +   + ++   +    ++Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNY 130
Query: 124 LHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI-ETVG 178
           LH+     I H D+K  NI LLD N      K+ DF     ++   +     K I  T  
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNIFGTPE 183
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V           VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 86  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ DF  +    + D+ A     + T  +  PE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGF---VATRWYRAPE 188
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 10  YDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I+ Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S   +   + ++   +    ++Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNY 130
Query: 124 LHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI-ETVG 178
           LH+     I H D+K  NI LLD N      K+ DF     ++   +     K I  T  
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNIFGTPE 183
Query: 179 WLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
           ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 5   KATKNYDKRHLLGEGGFGFVYK------GVLPDNTLVAVKKPKMVDKILINEVFQHKMRI 58
           K    YD    LG G F  V K      G+      +  ++ +   + +  E  + ++ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           + Q+ H NV+ +  V       +L+ E V  G LF  +  + S   +   + ++   +  
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QIL 125
Query: 119 SALDYLHSLGSPPIIHGDVKSANI-LLDDNYT---AKVADFASSVLISSHDQTATTTKEI 174
             ++YLH+     I H D+K  NI LLD N      K+ DF     ++   +     K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIEDGVEFKNI 178
Query: 175 -ETVGWLDPEYLFWTE---KSDVYSFGVVLVELLTGKHP 209
             T  ++ PE + +     ++D++S GV+   LL+G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 16  LGEGGFGFVYKGVLPDNTL-VAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +G G +G V         L VAVKK  +    I+  +    ++R++  + H+NV+ +L V
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 74  CLETKVPLLVYEFVPNGTLFQH-----VRYQSSQVLKTWKTCLRIAAETASALDY----- 123
                       F P  +L +      V +     L     C ++  +    L Y     
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           L  + S  IIH D+K +N+ ++++   K+ D      ++ H     T   + T  +  PE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGG----LARHTDDEMTGY-VATRWYRAPE 192
Query: 184 ----YLFWTEKSDVYSFGVVLVELLTGK 207
               ++ + +  D++S G ++ ELLTG+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 8   KNYDKRHLLGEGGFGFVYK-GVLPDNTLVAVKK-------PKMVDKILINEVFQHKMRII 59
           +++ +   LG G +G V+K     D  L AVK+       PK   + L  EV  H+   +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEK--V 113
Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQV--LKTWKTCLRIAAET 117
            Q  H   V++     E  +  L  E     +L QH     + +   + W   LR   +T
Sbjct: 114 GQ--HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY-LR---DT 166
Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL +LHS G   ++H DVK ANI L      K+ DF   +L+      A   +E +  
Sbjct: 167 LLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG--LLVELGTAGAGEVQEGDPR 221
Query: 178 GWLDPEYL--FWTEKSDVYSFGVVLVEL 203
            ++ PE L   +   +DV+S G+ ++E+
Sbjct: 222 -YMAPELLQGSYGTAADVFSLGLTILEV 248

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 66/233 (28%)
Query: 16  LGEGGFGFVYKGV--LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN------V 67
           LGEG FG V + +        VAVK  K VD+    E  + +++++  +N  +       
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC--EAARSEIQVLEHLNTTDPNSTFRC 79
Query: 68  VKIL-------GVCLETKV-PLLVYEFVP-NGTL---FQHVRYQSSQVLKTWKTCLRIAA 115
           V++L        +C+  ++  L  Y+F+  NG L     H+R  + Q+ K+         
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS--------- 130
Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL-DDNYTA------------------KVADFA 156
                +++LHS     + H D+K  NIL    +YT                   KV DF 
Sbjct: 131 -----VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG 206
           S+     H  T    +         PE +    W++  DV+S G +L+E   G
Sbjct: 183 SATYDDEHHSTLVXXRHYRA-----PEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N++ +  V  + K   +V E +  G L   +  Q     +     L    +T   ++Y
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT---VEY 131
Query: 124 LHSLGSPPIIHGDVKSANILLDDNY----TAKVADFASSVLISSHDQTATTTKEIETVGW 179
           LH+ G   ++H D+K +NIL  D      + ++ DF  +  + + +    T     T  +
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186
Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           + PE L    +    D++S GV+L  +LTG  P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIET 176
           S L  L +L    IIH D+K  NILL     +  KV DF SS     H +  T    I++
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTX---IQS 262
Query: 177 VGWLDPEYLFWTEKS---DVYSFGVVLVELLTG 206
             +  PE +         D++S G +L ELLTG
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIET 176
           S L  L +L    IIH D+K  NILL     +  KV DF SS     H +  T    I++
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTX---IQS 262
Query: 177 VGWLDPEYLFWTEKS---DVYSFGVVLVELLTG 206
             +  PE +         D++S G +L ELLTG
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	309
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-82
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  275 bits (705), Expect = 7e-92
 Identities = 107/294 (36%), Positives = 155/294 (52%), Gaps = 10/294 (3%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
            +L +AT N+D + L+G G FG VYKGVL D   VA+K+        I E F+ ++  +S
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLS 90

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIAAETAS 119
              H ++V ++G C E    +L+Y+++ NG L +H+       +  +W+  L I    A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLH+     IIH DVKS NILLD+N+  K+ DF  S   +  DQT  +T    T+G+
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207

Query: 180 LDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           +DPEY      TEKSDVYSFGVVL E+L  +           EM  +  +      N  L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS--LPREMVNLAEWAVESHNNGQL 265

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
            QI++  +AD+   E +      A KCL  S  +RP+M  V  +L+   RL E+
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  260 bits (666), Expect = 5e-86
 Identities = 100/287 (34%), Positives = 159/287 (55%), Gaps = 5/287 (1%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
            EL  A+ N+  +++LG GGFG VYKG L D TLVAVK+ K          FQ ++ +IS
Sbjct: 23  RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIAAETAS 119
              H+N++++ G C+     LLVY ++ NG++   +R +        W    RIA  +A 
Sbjct: 83  MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L YLH    P IIH DVK+ANILLD+ + A V DF  + L+  +  T  TT    T+G 
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGH 201

Query: 180 LDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           + PEYL     +EK+DV+ +GV+L+EL+TG+       LA+++   ++ +    ++   L
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
             +++  +    + EE+E + ++A  C ++S  ERP M +V   L+ 
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  250 bits (642), Expect = 1e-82
 Identities = 92/300 (30%), Positives = 153/300 (51%), Gaps = 29/300 (9%)

Query: 1   SELVKATKNYDKR------HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI---NEV 51
            EL   T N+D+R      + +GEGGFG VYKG + +NT VAVKK   +  I      + 
Sbjct: 18  YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQ 76

Query: 52  FQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL 111
           F  +++++++  H+N+V++LG   +     LVY ++PNG+L   +         +W    
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
           +IA   A+ +++LH       IH D+KSANILLD+ +TAK++DF  +       QT  T+
Sbjct: 137 KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193

Query: 172 KEIETVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-P 228
           + + T  ++ PE L    T KSD+YSFGVVL+E++TG            E   ++     
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLDIKEE 249

Query: 229 YPIENNSLRQILNFQVADEN----EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
              E  ++         D+     +   +E +  +AS+CL     +RP +++V + L  +
Sbjct: 250 IEDEEKTIEDY-----IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  213 bits (545), Expect = 7e-68
 Identities = 67/316 (21%), Positives = 123/316 (38%), Gaps = 40/316 (12%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
             L   +       +   G FG V+K     N  VAVK   + DK   +   ++++  + 
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ--SWQNEYEVYSLP 73

Query: 61  QINHKNVVKILGVCLE----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            + H+N+++ +G             L+  F   G+L   ++   + V+ +W     IA  
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVV-SWNELCHIAET 129

Query: 117 TASALDYLHS-------LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
            A  L YLH           P I H D+KS N+LL +N TA +ADF  ++   +      
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 170 TTKEIETVGWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT 221
           T  ++ T  ++ PE L            + D+Y+ G+VL EL +                
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE----- 244

Query: 222 RMVPYFPYPIENNSLRQILNFQVADE---------NEMEEIEIVAKLASKCLRTSGTERP 272
            M+P+     ++ SL  +    V  +          +   + ++ +   +C       R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 273 TMRQVSEQLDSLRRLH 288
           +   V E++  ++RL 
Sbjct: 305 SAGCVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (496), Expect = 1e-60
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 37/283 (13%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             +G G FG V++      + VAVK    +      +NE F  ++ I+ ++ H N+V  +
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFM 100

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G   +     +V E++  G+L++ +    ++     +  L +A + A  ++YLH+   PP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PP 159

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WT 188
           I+H ++KS N+L+D  YT KV DF  S L        ++     T  W+ PE L      
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
           EKSDVYSFGV+L EL T +                 P+      N +  Q++   V  + 
Sbjct: 218 EKSDVYSFGVILWELATLQ----------------QPW-----GNLNPAQVV-AAVGFKC 255

Query: 249 EMEEI-----EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +  EI       VA +   C      +RP+   + + L  L +
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (486), Expect = 2e-59
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 42/288 (14%)

Query: 14  HLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDKILINEV---FQHKMRIISQINHKN 66
             +G+GGFG V+KG  + D ++VA+K         +  + E    FQ ++ I+S +NH N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +VK+ G+      P +V EFVP G L+  +  ++  +   W   LR+  + A  ++Y+ +
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIALGIEYMQN 140

Query: 127 LGSPPIIHGDVKSANILLD-----DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
              PPI+H D++S NI L          AKVADF  S          + +  +    W+ 
Sbjct: 141 QN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNFQWMA 194

Query: 182 PEYLFW-----TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           PE +       TEK+D YSF ++L  +LTG+ P  +     +E +     F   I    L
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGP--F-----DEYSYGKIKFINMIREEGL 247

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           R  +               +  +   C      +RP    + ++L  L
Sbjct: 248 RPTIPEDCPPR--------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (480), Expect = 3e-58
 Identities = 65/283 (22%), Positives = 120/283 (42%), Gaps = 43/283 (15%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
            ++G G FG V K        VA+K+ +   +    + F  ++R +S++NH N+VK+ G 
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER---KAFIVELRQLSRVNHPNIVKLYGA 69

Query: 74  CLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           CL    P+ LV E+   G+L+  +         T    +    + +  + YLHS+    +
Sbjct: 70  CLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 133 IHGDVKSANILLDDNYT-AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WT 188
           IH D+K  N+LL    T  K+ DF ++      D     T    +  W+ PE      ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181

Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
           EK DV+S+G++L E++T + P                   +        +I         
Sbjct: 182 EKCDVFSWGIILWEVITRRKP-------------------FDEIGGPAFRI--MWAVHNG 220

Query: 249 EMEEI-----EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
               +     + +  L ++C     ++RP+M ++ + +  L R
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (475), Expect = 5e-58
 Identities = 56/288 (19%), Positives = 114/288 (39%), Gaps = 48/288 (16%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             L E   G ++KG       + VK  K +        + F  +   +   +H NV+ +L
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNVLPVL 73

Query: 72  GVCLETKVPLL--VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           G C     P    +  ++P G+L+  +   ++ V+      ++ A + A  + +LH+L  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLE- 131

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE------ 183
           P I    + S ++++D++ TA+++             +  +   +    W+ PE      
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKP 184

Query: 184 YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
                  +D++SF V+L EL+T + P  +      +++ M              +I   +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP--F-----ADLSNM--------------EIG-MK 222

Query: 244 VADENEMEEI-----EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           VA E     I       V+KL   C+     +RP    +   L+ ++ 
Sbjct: 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 2e-56
 Identities = 73/290 (25%), Positives = 132/290 (45%), Gaps = 48/290 (16%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             +G G FG VYKG    +  VAVK           +   F++++ ++ +  H N++  +
Sbjct: 30  QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFM 86

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           G    T   L +V ++    +L+ H+    ++     K  + IA +TA  +DYLH+    
Sbjct: 87  GYS--TAPQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHA---K 139

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE------Y 184
            IIH D+KS NI L ++ T K+ DF  +   S    +    +   ++ W+ PE       
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 185 LFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
             ++ +SDVY+FG+VL EL+TG+                    PY    N+  QI+   V
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ-------------------LPYS-NINNRDQII-EMV 238

Query: 245 ADENEMEEI--------EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
              +   ++        + + +L ++CL+    ERP+  ++  +++ L R
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (463), Expect = 3e-56
 Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 50/290 (17%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKK---PKMVDKILINEVFQHKMRIISQINHKNVVKI 70
            ++G GGFG VY+        VAVK        D     E  + + ++ + + H N++ +
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            GVCL+     LV EF   G L + +  +           +  A + A  ++YLH     
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 131 PIIHGDVKSANILLD--------DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           PIIH D+KS+NIL+          N   K+ DF  +       + +          W+ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG----AYAWMAP 183

Query: 183 E---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E      +++ SDV+S+GV+L ELLTG+                VP+            +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE----------------VPF-----RGIDGLAV 222

Query: 240 LNFQVADENEMEEI-----EIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             + VA       I     E  AKL   C       RP+   + +QL ++
Sbjct: 223 A-YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  178 bits (454), Expect = 2e-54
 Identities = 58/297 (19%), Positives = 115/297 (38%), Gaps = 53/297 (17%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
            L+G+G FG VY G    +  VA++    +  ++  +   F+ ++    Q  H+NVV  +
Sbjct: 39  ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKA-FKREVMAYRQTRHENVVLFM 95

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G C+      ++       TL+  VR     +        +IA E    + YLH+     
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVL--DVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 132 IIHGDVKSANILLDDNYTAKVADF-ASSV--LISSHDQTATTTKEIETVGWLDPEYLFW- 187
           I+H D+KS N+  D+     + DF   S+  ++ +  +      +   +  L PE +   
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 188 -----------TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
                      ++ SDV++ G +  EL   +                 P+     +    
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE----------------WPF-----KTQPA 248

Query: 237 RQILNFQVADENEMEEIEI-----VAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
             I+ +Q+    +    +I     ++ +   C      ERPT  ++ + L+ L + +
Sbjct: 249 EAII-WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (445), Expect = 7e-53
 Identities = 67/330 (20%), Positives = 122/330 (36%), Gaps = 53/330 (16%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRII 59
           SE      N     L+G G +G VYKG L D   VAVK       +  INE     +  +
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK---NIYRV 61

Query: 60  SQINHKNVVKILGVCLETKVP-----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIA 114
             + H N+ + +              LLV E+ PNG+L +++   +S     W +  R+A
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLA 117

Query: 115 AETASALDYLHS------LGSPPIIHGDVKSANILLDDNYTAKVADF------ASSVLIS 162
                 L YLH+         P I H D+ S N+L+ ++ T  ++DF        + L+ 
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 163 SHDQTATTTKEIETVGWLDPEYL----------FWTEKSDVYSFGVVLVELLTGKHPRSY 212
             ++      E+ T+ ++ PE L             ++ D+Y+ G++  E+      R  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM----RCT 233

Query: 213 VALASNEMTRM-VPYFPYPIENNSLRQILNFQVADENEMEEI-----------EIVAKLA 260
                  +    + +      + +   +    V+ E +  +              + +  
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVL-VSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 261 SKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
             C       R T +   E++  L  + E 
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWER 322

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  173 bits (441), Expect = 2e-52
 Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 50/295 (16%)

Query: 14  HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
            +LG+G FG   K        ++ +K+    D+      F  +++++  + H NV+K +G
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLEHPNVLKFIG 74

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           V  + K    + E++  GTL   ++   SQ    W   +  A + AS + YLHS+    I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAKDIASGMAYLHSMN---I 129

Query: 133 IHGDVKSANILLDDNYTAKVADF------------ASSVLISSHDQTATTTKEIETVGWL 180
           IH D+ S N L+ +N    VADF               +              +    W+
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 181 DPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE      + EK DV+SFG+VL E++   +                   P  +      
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----------------DPDYLPRTM-- 230

Query: 238 QILNFQVADENEME-EI-----EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
              +F +     ++             +  +C      +RP+  ++   L++LR 
Sbjct: 231 ---DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  173 bits (440), Expect = 2e-52
 Identities = 62/302 (20%), Positives = 117/302 (38%), Gaps = 46/302 (15%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
             +G+G +G V++G       VAVK      +K    E    ++     + H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRET---ELYNTVMLRHENILGFIA 69

Query: 73  VCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL- 127
             + ++       L+  +   G+L+ +++  +        +CLRI    AS L +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL----DTVSCLRIVLSIASGLAHLHIEI 125

Query: 128 ----GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETVGWLD 181
               G P I H D+KS NIL+  N    +AD   +V+ S             + T  ++ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 182 PEYL---------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE 232
           PE L            ++ D+++FG+VL E+         V           P++     
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE------DYKPPFYDVVPN 239

Query: 233 NNSLRQILNFQVADENEMEEI----------EIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           + S   +    V  + +   I            +AKL  +C   + + R T  ++ + L 
Sbjct: 240 DPSFEDMRKV-VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 283 SL 284
            +
Sbjct: 299 KI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 2e-51
 Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 44/306 (14%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
             +G+G +G V+ G       VAVK     ++   +   + ++     + H+N++  +  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA--SWFRETEIYQTVLMRHENILGFIAA 99

Query: 74  CLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-- 127
            ++         L+ ++  NG+L+ +++   S  L   K+ L++A  + S L +LH+   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK---STTL-DAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 128 ---GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS--HDQTATTTKEIETVGWLDP 182
              G P I H D+KS NIL+  N T  +AD   +V   S  ++        + T  ++ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 183 EYLFWT---------EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
           E L  +           +D+YSFG++L E+         V          +PY      +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE------EYQLPYHDLVPSD 269

Query: 234 NSLRQILNFQVADEN----------EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
            S   +    V  +             E +  + KL ++C   +   R T  +V + L  
Sbjct: 270 PSYEDMREI-VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

Query: 284 LRRLHE 289
           +    +
Sbjct: 329 MSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  167 bits (425), Expect = 9e-50
 Identities = 65/304 (21%), Positives = 124/304 (40%), Gaps = 46/304 (15%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
             +G+G FG V++G       VAVK      ++    E    ++     + H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIA 103

Query: 73  VCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-- 126
              +         LV ++  +G+LF ++   +     T +  +++A  TAS L +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV----TVEGMIKLALSTASGLAHLHMEI 159

Query: 127 ---LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETVGWLD 181
               G P I H D+KS NIL+  N T  +AD   +V   S   T        + T  ++ 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 182 PEYLFWT---------EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE 232
           PE L  +         +++D+Y+ G+V  E+                    +PY+     
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE------DYQLPYYDLVPS 273

Query: 233 NNSLRQILNFQVADEN----------EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           + S+ ++    V ++             E + ++AK+  +C   +G  R T  ++ + L 
Sbjct: 274 DPSVEEMRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

Query: 283 SLRR 286
            L +
Sbjct: 333 QLSQ 336

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  148 bits (375), Expect = 1e-42
 Identities = 62/305 (20%), Positives = 109/305 (35%), Gaps = 55/305 (18%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVD-KILINEVFQHKMRIISQI 62
           K+Y     LGEGGF +V     L D    A+K+    +  D +    E       +    
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA-----DMHRLF 83

Query: 63  NHKNVVKILGVCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIAAET 117
           NH N+++++  CL  +       L+  F   GTL+  +     +    T    L +    
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS----VLISSHDQTATTTKE 173
              L+ +H+       H D+K  NILL D     + D  S     + +    Q  T    
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 174 IETVG---------WLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
                         +    +    E++DV+S G VL  ++ G+ P   V    + +   V
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260

Query: 225 ---PYFP-YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
                 P  P  +++L Q+L                    +  +     +RP +  +  Q
Sbjct: 261 QNQLSIPQSPRHSSALWQLL--------------------NSMMTVDPHQRPHIPLLLSQ 300

Query: 281 LDSLR 285
           L++L+
Sbjct: 301 LEALQ 305

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (375), Expect = 5e-42
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 40/284 (14%)

Query: 16  LGEGGFGFVYKGVL-PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +G G FG V+ G L  DNTLVAVK  +  +   +     F  + RI+ Q +H N+V+++G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLIG 179

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC + +   +V E V  G     +R + +++    KT L++  + A+ ++YL S      
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLLQMVGDAAAGMEYLESKC---C 234

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWTE 189
           IH D+ + N L+ +    K++DF  S   +     A+       V W  PE   Y  ++ 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294

Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
           +SDV+SFG++L E  + G  P                   YP  N S +Q     V    
Sbjct: 295 ESDVWSFGILLWETFSLGASP-------------------YP--NLSNQQTRE-FVEKGG 332

Query: 249 EMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
            +   E     V +L  +C      +RP+   + ++L S+R+ H
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  139 bits (353), Expect = 1e-39
 Identities = 69/299 (23%), Positives = 131/299 (43%), Gaps = 38/299 (12%)

Query: 11  DKRHL-----LGEGGFGFVYKGV---LPDN--TLVAVK--KPKMVDKILINEVFQHKMRI 58
           ++RHL     LG+G FG V       L DN   +VAVK  +    + +     F+ ++ I
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 64

Query: 59  ISQINHKNVVKILGVCLET-KVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           +  + H N+VK  GVC    +  L L+ E++P G+L  +++    ++       L+  ++
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               ++YL +      IH D+ + NIL+++    K+ DF  + ++    +     +  E+
Sbjct: 123 ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

Query: 177 -VGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE 232
            + W  PE      ++  SDV+SFGVVL EL T              M          + 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ--GQMI 237

Query: 233 NNSLRQILNFQVADENE-MEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
              L ++L       N  +   +     +  + ++C   +  +RP+ R ++ ++D +R 
Sbjct: 238 VFHLIELL-----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (351), Expect = 3e-39
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 34/297 (11%)

Query: 11  DKRHL-----LGEGGFGFVYKGVLP-----DNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
           +KR L     LGEG FG V               VAVK  K           + ++ I+ 
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 61  QINHKNVVKILGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
            + H+N+VK  G+C E       L+ EF+P+G+L +++    +++    K  L+ A +  
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQIC 136

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-V 177
             +DYL S      +H D+ + N+L++  +  K+ DF  +  I +  +  T   + ++ V
Sbjct: 137 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193

Query: 178 GWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W  PE      +   SDV+SFGV L ELLT      S +AL    +        +    
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP-----THGQMT 248

Query: 234 NSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
               +++N  + +   +         V +L  KC     + R + + + E  ++L +
Sbjct: 249 V--TRLVN-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (347), Expect = 8e-39
 Identities = 86/307 (28%), Positives = 144/307 (46%), Gaps = 48/307 (15%)

Query: 14  HLLGEGGFGFVYKGVL-PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           H LG G +G VY+GV    +  VAVK  K   ++     E F  +  ++ +I H N+V++
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQL 74

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LGVC       ++ EF+  G L  ++R  + Q + +    L +A + +SA++YL      
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN-- 131

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---W 187
             IH D+ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L    +
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKF 189

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD 246
           + KSDV++FGV+L E+ T G  P                   YP     L Q+    +  
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-------------------YP--GIDLSQVYE-LLEK 227

Query: 247 ENEMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQ 302
           +  ME      E V +L   C + + ++RP+  ++ +  +++      F     S+E E+
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQESSISDEVEK 281

Query: 303 LLGESST 309
            LG+  T
Sbjct: 282 ELGKRGT 288

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (348), Expect = 1e-38
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 26/228 (11%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LG+G FG VY+GV          T VA+K        +  I   F ++  ++ + N  +V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCHHV 90

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------TWKTCLRIAAETASA 120
           V++LGV  + +  L++ E +  G L  ++R     +         +    +++A E A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +  V W+
Sbjct: 151 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            PE L    +T  SDV+SFGVVL E+ T  + P  Y  L++ ++ R V
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV 253

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (347), Expect = 2e-38
 Identities = 67/298 (22%), Positives = 129/298 (43%), Gaps = 36/298 (12%)

Query: 11  DKRHL-----LGEGGFGFVYKGV---LPDN--TLVAVK--KPKMVDKILINEVFQHKMRI 58
           ++RHL     LG+G FG V       L DN   +VAVK  +    + +     F+ ++ I
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEI 95

Query: 59  ISQINHKNVVKILGVCLETKV-PL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
           +  + H N+VK  GVC       L L+ E++P G+L  +++    ++       L+  ++
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               ++YL +      IH D+ + NIL+++    K+ DF  + ++    +     +  E+
Sbjct: 154 ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 177 -VGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE 232
            + W  PE      ++  SDV+SFGVVL EL T              M          + 
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ--GQMI 268

Query: 233 NNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
              L +     + +   +   +     +  + ++C   +  +RP+ R ++ ++D +R 
Sbjct: 269 VFHLIE----LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (344), Expect = 4e-38
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 25/228 (10%)

Query: 16  LGEGGFGFVYKGVLPDN----TLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +  L         VAVK  K  ++    I E F  +   + + +H +V K
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDHPHVAK 89

Query: 70  ILGVCLE------TKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETASA 120
           ++GV L         +P+++  F+ +G L       R   +      +T +R   + A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           ++YL S      IH D+ + N +L ++ T  VADF  S  I S D           V WL
Sbjct: 150 MEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             E L    +T  SDV++FGV + E++T G+ P  Y  + + E+   +
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIENAEIYNYL 252

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 5e-38
 Identities = 70/318 (22%), Positives = 120/318 (37%), Gaps = 64/318 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD-------KILINEVFQHKMRII 59
            N+     +G G F  VY+   L D   VA+KK ++ D          I E+      ++
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-----DLL 86

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETA 118
            Q+NH NV+K     +E     +V E    G L + +  ++  + L   +T  +   +  
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
           SAL+++HS     ++H D+K AN+ +      K+ D       SS    A +      VG
Sbjct: 147 SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVG 198

Query: 179 ---WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHP-----RSYVALASNEMTRMV 224
              ++ PE      Y     KSD++S G +L E+   + P      +  +L         
Sbjct: 199 TPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 255

Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P  P    +  LRQ++                    + C+     +RP +  V    D  
Sbjct: 256 PPLPSDHYSEELRQLV--------------------NMCINPDPEKRPDVTYV---YDVA 292

Query: 285 RRLHENFWAQKNSEETEQ 302
           +R+H       + E    
Sbjct: 293 KRMHA--CTASSLEHHHH 308

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (342), Expect = 7e-38
 Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 35/293 (11%)

Query: 16  LGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LGEG FG V              +VAVK  K          ++ ++ I+  + H++++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 71  LGVCLETKVP--LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
            G C +       LV E+VP G+L  ++   S          L  A +    + YLH+  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH 154

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE---Y 184
               IH D+ + N+LLD++   K+ DF  +  +   H+           V W  PE    
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 185 LFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNF 242
             +   SDV+SFGV L ELLT     +S        +           +    L ++L  
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI-----AQGQMTVLRLTELL-- 264

Query: 243 QVADENE-MEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
              +  E +   +     V  L   C  T  + RPT   +   L ++   ++ 
Sbjct: 265 ---ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (343), Expect = 7e-38
 Identities = 78/322 (24%), Positives = 134/322 (41%), Gaps = 40/322 (12%)

Query: 10  YDKRHL-----LGEGGFGFVYKGV---LPDN--TLVAVKKPKMVDKILINEVFQHKMRII 59
           +++RHL     LG+G FG V       L DN   LVAVK+ +        + FQ +++I+
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 78

Query: 60  SQINHKNVVKILGVCLETKV-PL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
             ++   +VK  GV        L LV E++P+G L   ++   +++       L  +++ 
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQI 136

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET- 176
              ++YL S      +H D+ + NIL++     K+ADF  + L+          +  ++ 
Sbjct: 137 CKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 177 VGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE 232
           + W  PE      ++ +SDV+SFGVVL EL T      S  A     M            
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD----VPA 249

Query: 233 NNSLRQILNFQVADENE-MEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
            + L ++L     +E + +         V +L   C   S  +RP+   +  QLD L   
Sbjct: 250 LSRLLELL-----EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

Query: 288 HENFWAQKNSEETEQLLGESST 309
                  +    T    G+  +
Sbjct: 305 SRG---CETHAFTAHPEGKHHS 323

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (342), Expect = 8e-38
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 24/229 (10%)

Query: 14  HLLGEGGFGFVYKGVLPD----NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
            +LGEG FG V +G L      +  VAVK  K     +  I E F  +   +   +H NV
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNV 98

Query: 68  VKILGVCLETK-----VPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAAETAS 119
           +++LGVC+E        P+++  F+  G L     + R ++       +T L+   + A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            ++YL +      +H D+ + N +L D+ T  VADF  S  I S D           V W
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           +  E L    +T KSDV++FGV + E+ T G  P  Y  + ++EM   +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNHEMYDYL 262

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 9e-38
 Identities = 65/218 (29%), Positives = 116/218 (53%), Gaps = 20/218 (9%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             LG+G FG V+ G     T VA+K  KP  +      E F  + +++ ++ H+ +V++ 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLY 245

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            V   ++ P+ +V E++  G+L   ++ ++ + L      + +AA+ AS + Y+  +   
Sbjct: 246 AVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN-- 300

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
             +H D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   +   
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRF 358

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T KSDV+SFG++L EL T G+ P  Y  + + E+   V
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV 394

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (352), Expect = 1e-37
 Identities = 65/218 (29%), Positives = 116/218 (53%), Gaps = 20/218 (9%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             LG+G FG V+ G     T VA+K  KP  +      E F  + +++ ++ H+ +V++ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLY 328

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            V   ++ P+ +V E++  G+L   ++ ++ + L      + +AA+ AS + Y+  +   
Sbjct: 329 AVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN-- 383

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
             +H D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE   +   
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRF 441

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T KSDV+SFG++L EL T G+ P  Y  + + E+   V
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQV 477

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (341), Expect = 1e-37
 Identities = 53/218 (24%), Positives = 106/218 (48%), Gaps = 17/218 (7%)

Query: 16  LGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG VYKG+           VA+K+ +       N+    +  +++ +++ +V ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LG+CL + V  L+ + +P G L  +VR     +    +  L    + A  ++YL      
Sbjct: 83  LGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRR-- 137

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
            ++H D+ + N+L+      K+ DF  + L+ + ++          + W+  E +     
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  133 bits (337), Expect = 2e-37
 Identities = 61/287 (21%), Positives = 119/287 (41%), Gaps = 42/287 (14%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             LG G FG V  G       VAVK  K   + +    + F  + + + +++H  +VK  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFY 69

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           GVC +     +V E++ NG L  ++R     +       L +  +    + +L S     
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL--EPSQLLEMCYDVCEGMAFLESHQ--- 124

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW---T 188
            IH D+ + N L+D +   KV+DF  +  +      ++   +   V W  PE   +   +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-PVKWSAPEVFHYFKYS 183

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADE 247
            KSDV++FG+++ E+ + GK                    PY     +  +++  +V+  
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM-------------------PYD--LYTNSEVVL-KVSQG 221

Query: 248 NEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
           + +         + ++   C      +RPT +Q+   ++ LR   ++
Sbjct: 222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 2e-37
 Identities = 69/290 (23%), Positives = 123/290 (42%), Gaps = 42/290 (14%)

Query: 16  LGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +G+G FG VY G   D        A+K    + ++   E F  +  ++  +NH NV+ ++
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 72  GVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           G+ L  + +P ++  ++ +G L Q +R        T K  +    + A  ++YL      
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP--TVKDLISFGLQVARGMEYLAEQK-- 144

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET--VGWLDPEYLF-- 186
             +H D+ + N +LD+++T KVADF  +  I   +  +          V W   E L   
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203

Query: 187 -WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
            +T KSDV+SFGV+L ELLT G  P                   Y   +     + +F +
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPP-------------------YRHIDP--FDLTHF-L 241

Query: 245 ADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
           A    + + E     + ++  +C       RPT R +  +++ +      
Sbjct: 242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (338), Expect = 2e-37
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)

Query: 14  HLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
            ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 70  ILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           +LG+CL ++   L V  ++ +G L   +R ++     T K  +    + A  + YL S  
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLASKK 148

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET--VGWLDPEYLF 186
               +H D+ + N +LD+ +T KVADF  +  +   +  +   K      V W+  E L 
Sbjct: 149 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 187 ---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              +T KSDV+SFGV+L EL+T G                     PYP  N     I  +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNT--FDITVY 244

Query: 243 QVADENEMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
            +     + +     + + ++  KC       RP+  ++  ++ ++      
Sbjct: 245 -LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (347), Expect = 3e-37
 Identities = 84/305 (27%), Positives = 143/305 (46%), Gaps = 48/305 (15%)

Query: 16  LGEGGFGFVYKGVL-PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G +G VY+GV    +  VAVK  K   ++     E F  +  ++ +I H N+V++LG
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQLLG 283

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC       ++ EF+  G L  ++R  + Q + +    L +A + +SA++YL        
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---F 339

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTE 189
           IH ++ + N L+ +N+  KVADF  S L++    TA    +   + W  PE L    ++ 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398

Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADEN 248
           KSDV++FGV+L E+ T G                     PYP     L Q+    +  + 
Sbjct: 399 KSDVWAFGVLLWEIATYGMS-------------------PYP--GIDLSQVYE-LLEKDY 436

Query: 249 EMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQLL 304
            ME      E V +L   C + + ++RP+  ++ +  +++      F     S+E E+ L
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM------FQESSISDEVEKEL 490

Query: 305 GESST 309
           G+  T
Sbjct: 491 GKRGT 495

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  134 bits (339), Expect = 3e-37
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 50/294 (17%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LG G FG VY+G +      P    VAVK       ++  ++  F  +  IIS+ NH+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNI 95

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK----TWKTCLRIAAETASALDY 123
           V+ +GV L++    ++ E +  G L   +R    +  +         L +A + A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 124 LHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L        IH D+ + N LL        AK+ DF  +  I            +  V W+
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
            PE      +T K+D +SFGV+L E+ + G  P                   YP ++N  
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-------------------YPSKSN-- 251

Query: 237 RQILNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +++L F V     M+  +     V ++ ++C +    +RP    + E+++   +
Sbjct: 252 QEVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  132 bits (335), Expect = 3e-37
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 18/217 (8%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             +G G FG V+ G   +   VA+K  +   + +    E F  +  ++ +++H  +V++ 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLY 69

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           GVCLE     LV EF+ +G L  ++R Q        +T L +  +    + YL       
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEAC--- 124

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW---T 188
           +IH D+ + N L+ +N   KV+DF  +  +     T++T  +   V W  PE   +   +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-PVKWASPEVFSFSRYS 183

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            KSDV+SFGV++ E+ + GK P  Y   +++E+   +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDI 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (340), Expect = 4e-37
 Identities = 62/289 (21%), Positives = 111/289 (38%), Gaps = 57/289 (19%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDK---ILINEVFQHKMRIIS 60
           + Y +   +GEG FG         D     +K+    +M  K       EV      +++
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV-----AVLA 78

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
            + H N+V+      E     +V ++   G LF+ +  Q   + +     L    +   A
Sbjct: 79  NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQICLA 137

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG-- 178
           L ++H      I+H D+KS NI L  + T ++ DF  + +++S  + A        +G  
Sbjct: 138 LKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-----CIGTP 189

Query: 179 -WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFP 228
            +L PE      Y     KSD+++ G VL EL T KH     S   L    ++   P   
Sbjct: 190 YYLSPEICENKPY---NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS 246

Query: 229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
               +  LR ++                    S+  + +  +RP++  +
Sbjct: 247 LHY-SYDLRSLV--------------------SQLFKRNPRDRPSVNSI 274

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  132 bits (334), Expect = 6e-37
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 18/217 (8%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             LG G FG V  G       VA+K  K   + +    + F  + +++  ++H+ +V++ 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLY 85

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           GVC + +   ++ E++ NG L  ++R    +     +  L +  +   A++YL S     
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLESKQ--- 140

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW---T 188
            +H D+ + N L++D    KV+DF  S  +   + T++   +   V W  PE L +   +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKFS 199

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            KSD+++FGV++ E+ + GK P  Y    ++E    +
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAEHI 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (335), Expect = 1e-36
 Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 58/305 (19%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+           D  LVAVK  K   +    + FQ +  +++ + H+++V+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTMLQHQHIVR 107

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK------------TWKTCLRIAAET 117
             GVC E +  L+V+E++ +G L + +R                         L +A++ 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A+ + YL  L     +H D+ + N L+      K+ DF  S  I S D      + +  +
Sbjct: 168 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224

Query: 178 GWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            W+ PE +    +T +SDV+SFGVVL E+ T GK                    P+   +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ-------------------PWYQLS 265

Query: 234 NSLRQILNFQVADENEME-------EIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           N   + ++  +    E+E       E+     +   C +    +R +++ V  +L +L +
Sbjct: 266 N--TEAIDC-ITQGRELERPRACPPEVY---AIMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 287 LHENF 291
               +
Sbjct: 320 APPVY 324

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (333), Expect = 1e-36
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 53/298 (17%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LGEG FG V+           D  LVAVK  K        + FQ +  +++ + H+++VK
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-FQREAELLTNLQHEHIVK 81

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC-------------LRIAAE 116
             GVC +    ++V+E++ +G L + +R      +                   L IA++
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            AS + YL S      +H D+ + N L+  N   K+ DF  S  + S D        +  
Sbjct: 142 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 177 VGWLDPE---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIE 232
           + W+ PE   Y  +T +SDV+SFGV+L E+ T GK P                   +   
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------------WFQL 239

Query: 233 NNSLRQILNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           +N   +++   +     +E        V  +   C +    +R  ++++ + L +L +
Sbjct: 240 SN--TEVIEC-ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (331), Expect = 2e-36
 Identities = 65/218 (29%), Positives = 114/218 (52%), Gaps = 20/218 (9%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             LG G FG V+ G    +T VAVK  K   +      + F  +  ++ Q+ H+ +V++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74

Query: 72  GVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
            V   T+ P+  + E++ NG+L   ++  S   L T    L +AA+ A  + ++      
Sbjct: 75  AVV--TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN-- 129

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---W 187
             IH D+++ANIL+ D  + K+ADF  + LI  ++ TA    +   + W  PE +    +
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTF 187

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T KSDV+SFG++L E++T G+ P  Y  + + E+ + +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQNL 223

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 2e-36
 Identities = 71/294 (24%), Positives = 122/294 (41%), Gaps = 46/294 (15%)

Query: 14  HLLGEGGFGFVYKGVLPDN----TLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
            ++G G FG VY G L DN       AVK          +    F  +  I+   +H NV
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNV 152

Query: 68  VKILGVCLETKVPLL-VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           + +LG+CL ++   L V  ++ +G L   +R ++     T K  +    + A  + +L S
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLAS 210

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET--VGWLDPEY 184
                 +H D+ + N +LD+ +T KVADF  +  +   +  +   K      V W+  E 
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 185 LF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL 240
           L    +T KSDV+SFGV+L EL+T G                     PYP  N     I 
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNT--FDIT 306

Query: 241 NFQVADENEMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN 290
            + +     + +     + + ++  KC       RP+  ++  ++ ++      
Sbjct: 307 VY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (332), Expect = 3e-36
 Identities = 73/329 (22%), Positives = 123/329 (37%), Gaps = 54/329 (16%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVD-KILINEVFQHKMRIISQI 62
                R +L EGGF FVY+   +      A+K     +    + +I EV   K       
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK----KLS 83

Query: 63  NHKNVVKILGVCLETKVP-------LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
            H N+V+        K          L+   +  G L + ++   S+   +  T L+I  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +T  A+ ++H    PPIIH D+K  N+LL +  T K+ DF S+  IS +   + + +   
Sbjct: 144 QTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 176 TVGWLD----------PE------YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNE 219
            V              PE           EK D+++ G +L  L   +HP          
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------- 252

Query: 220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
                  F    E+ +  +I+N + +      +  +   L    L+ +  ER ++ +V  
Sbjct: 253 -------F----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301

Query: 280 QLDSLRRLHENFWAQKNSEETEQLLGESS 308
           QL  +            +E  EQ  G  S
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYGS 330

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (334), Expect = 3e-36
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 48/293 (16%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LG G FG VY+G +      P    VAVK       ++  ++  F  +  IIS+ NH+N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKFNHQNI 136

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK----TWKTCLRIAAETASALDY 123
           V+ +GV L++    ++ E +  G L   +R    +  +         L +A + A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 124 LHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L        IH D+ + N LL        AK+ DF  +  I            +  V W+
Sbjct: 197 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            PE      +T K+D +SFGV+L E+ +         L            PYP ++N  +
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS---------LGYM---------PYPSKSN--Q 293

Query: 238 QILNFQVADENEMEEIE----IVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
           ++L F V     M+  +     V ++ ++C +    +RP    + E+++   +
Sbjct: 294 EVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (337), Expect = 4e-36
 Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 50/285 (17%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             +G+G FG V  G       VAVK  K     +  + E       +++Q+ H N+V++L
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAE-----ASVMTQLRHSNLVQLL 252

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           GV +E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL      
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEGNN-- 309

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---W 187
             +H D+ + N+L+ ++  AKV+DF     ++    +   T ++  V W  PE L    +
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKL-PVKWTAPEALREKKF 363

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYP-IENNSLRQILNFQVA 245
           + KSDV+SFG++L E+ + G+                    PYP I    +      +V 
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVP----RVE 400

Query: 246 DENEMEE----IEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
              +M+        V  +   C       RPT  Q+ EQL+ +R 
Sbjct: 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (328), Expect = 4e-36
 Identities = 55/280 (19%), Positives = 108/280 (38%), Gaps = 51/280 (18%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK------KPKMVDKILINEVFQHKMRIISQINHKNV 67
            +G G F  VYKG+       VA          K   +    E       ++  + H N+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA-----EMLKGLQHPNI 87

Query: 68  VKILGVCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           V+       T       +LV E + +GTL  +++      +K  +       +    L +
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQF 144

Query: 124 LHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           LH+   PPIIH D+K  NI +     + K+ D      +++  + +     I T  ++ P
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG----LATLKRASFAKAVIGTPEFMAP 199

Query: 183 EYL--FWTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMTRMVPYFPYPIENNSL 236
           E     + E  DVY+FG+ ++E+ T ++P    ++   +     + + P     +    +
Sbjct: 200 EMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQ 276
           ++I+                      C+R +  ER +++ 
Sbjct: 260 KEII--------------------EGCIRQNKDERYSIKD 279

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (331), Expect = 4e-36
 Identities = 53/218 (24%), Positives = 106/218 (48%), Gaps = 17/218 (7%)

Query: 16  LGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG VYKG+           VA+K+ +       N+    +  +++ +++ +V ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LG+CL + V  L+ + +P G L  +VR     +    +  L    + A  ++YL      
Sbjct: 83  LGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRR-- 137

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
            ++H D+ + N+L+      K+ DF  + L+ + ++          + W+  E +     
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T +SDV+S+GV + EL+T G  P  Y  + ++E++ ++
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL 232

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (328), Expect = 5e-36
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)

Query: 16  LGEGGFGFVYKGVL----PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           LG+G FG V +G           VAVK  KP ++ +    + F  ++  +  ++H+N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV L   +  +V E  P G+L   +R           T  R A + A  + YL S   
Sbjct: 86  LYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHF--LLGTLSRYAVQVAEGMGYLESKR- 141

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YL 185
              IH D+ + N+LL      K+ DF     +  +D      +  +    W  PE     
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            ++  SD + FGV L E+ T G+ P  ++ L  +++   +
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKI 237

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (327), Expect = 7e-36
 Identities = 60/322 (18%), Positives = 115/322 (35%), Gaps = 78/322 (24%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
            ++ +  L+G GGFG V+K     D     +K+ K  ++    EV     + +++++H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREV-----KALAKLDHVN 65

Query: 67  VVKILGVCLETKVPL----------------LVYEFVPNGTLFQHVRYQSSQVLKTWKTC 110
           +V   G                         +  EF   GTL Q +  +  + L      
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-VLA 124

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           L +  +    +DY+HS     +I+ D+K +NI L D    K+ DF     + +  +    
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR- 180

Query: 171 TKEIETVG---WLDPE------YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM 220
                + G   ++ PE      Y    ++ D+Y+ G++L ELL             ++  
Sbjct: 181 -----SKGTLRYMSPEQISSQDY---GKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232

Query: 221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
             ++      I +   + +L                     K L     +RP   ++   
Sbjct: 233 DGIIS----DIFDKKEKTLL--------------------QKLLSKKPEDRPNTSEI--- 265

Query: 281 LDSLRRLHENFWAQKNSEETEQ 302
                 L      +K+ E+ E+
Sbjct: 266 ------LRTLTVWKKSPEKNER 281

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  131 bits (330), Expect = 1e-35
 Identities = 53/293 (18%), Positives = 98/293 (33%), Gaps = 27/293 (9%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKP---KMVDKILINEVFQHK-- 55
           +E    +K     HLLGEG F  VY+    D      K+    K+       E +     
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 56  MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW--KTCLRI 113
           M  +        +K     L     +LV E    GTL   +    +   K       +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA-----------KVADFASSVLIS 162
           A      ++ +H      IIHGD+K  N +L + +              + D   S+ + 
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE 219
              +    T + ET G+   E L    W  + D +     +  +L G + +        +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294

Query: 220 MTRMVP-YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTER 271
              +        + N     +LN  + D + +  ++++ +   K  +   T +
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLN--IPDCHHLPSLDLLRQKLKKVFQQHYTNK 345

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (325), Expect = 1e-35
 Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 56/293 (19%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDK---ILINEVFQHKMRIIS 60
           ++Y+  + +G G +G   K     D  ++  K+     M +    +L++EV      ++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-----NLLR 60

Query: 61  QINHKNVVKILGVCLETKVPLL--VYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAET 117
           ++ H N+V+     ++     L  V E+   G L   + +    +     +  LR+  + 
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 118 ASALDYLHSLGSPP--IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
             AL   H        ++H D+K AN+ LD     K+ DF  + +++     A T   + 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VG 178

Query: 176 TVGWLDPE------YLFWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPY 226
           T  ++ PE      Y    EKSD++S G +L EL     P    S   LA          
Sbjct: 179 TPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235

Query: 227 FP--YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            P  Y  E   L +I+                    ++ L      RP++ ++
Sbjct: 236 IPYRYSDE---LNEII--------------------TRMLNLKDYHRPSVEEI 265

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (325), Expect = 1e-35
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 24/218 (11%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
             +G+G FG V  G       VAVK  K     +  + E       +++Q+ H N+V++L
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAE-----ASVMTQLRHSNLVQLL 80

Query: 72  GVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           GV +E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL      
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEGNN-- 137

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
             +H D+ + N+L+ ++  AKV+DF     ++    +   T ++  V W  PE L     
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKL-PVKWTAPEALREKKF 191

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           + KSDV+SFG++L E+ + G+ P  Y  +   ++   V
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRV 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  129 bits (326), Expect = 2e-35
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 17/218 (7%)

Query: 16  LGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V+KGV           V +K  +        +     M  I  ++H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           LG+C  + +  LV +++P G+L  HVR     +    +  L    + A  + YL   G  
Sbjct: 81  LGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGAL--GPQLLLNWGVQIAKGMYYLEEHG-- 135

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--- 187
            ++H ++ + N+LL      +VADF  + L+   D+    ++    + W+  E + +   
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 188 TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           T +SDV+S+GV + EL+T G  P  Y  L   E+  ++
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEP--YAGLRLAEVPDLL 230

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (333), Expect = 2e-35
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)

Query: 16  LGEGGFGFVYKGVLPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           LG G FG V+      +T VAVK  KP  +      E F  +  ++  + H  +VK+  V
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKLVKLHAV 251

Query: 74  CLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
              TK P+ ++ EF+  G+L   ++             +  +A+ A  + ++        
Sbjct: 252 V--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---Y 305

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW---TE 189
           IH D+++ANIL+  +   K+ADF  + +I  ++ TA    +   + W  PE + +   T 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 364

Query: 190 KSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           KSDV+SFG++L+E++T G+ P  Y  +++ E+ R +
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRAL 398

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (326), Expect = 2e-35
 Identities = 72/308 (23%), Positives = 121/308 (39%), Gaps = 68/308 (22%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LGEG FG V K            T VAVK  K       L +     +  ++ Q+NH +V
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD--LLSEFNVLKQVNHPHV 88

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK---------------------T 106
           +K+ G C +    LL+ E+   G+L   +R                             T
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
               +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF  S  +   D 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
               ++    V W+  E LF   +T +SDV+SFGV+L E++T         L        
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LGG------ 250

Query: 224 VPYFPYPIENNSLRQILNFQVADENEME-------EIEIVAKLASKCLRTSGTERPTMRQ 276
               PYP       ++ N  +   + ME       E+    +L  +C +    +RP    
Sbjct: 251 ---NPYPGIPP--ERLFNL-LKTGHRMERPDNCSEEMY---RLMLQCWKQEPDKRPVFAD 301

Query: 277 VSEQLDSL 284
           +S+ L+ +
Sbjct: 302 ISKDLEKM 309

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 3e-35
 Identities = 44/219 (20%), Positives = 81/219 (36%), Gaps = 36/219 (16%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
                 +  +G G FG V++          AVKK      + +      ++   + ++  
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSP 110

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKT-----CLRIAAETASA 120
            +V + G   E     +  E +  G+L         Q++K          L    +    
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSL--------GQLIKQMGCLPEDRALYYLGQALEG 162

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFASSVLISSHDQTATTTKEIETVG- 178
           L+YLH+     I+HGDVK+ N+LL  +   A + DF  ++ +       +        G 
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 179 --WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHP 209
              + PE            K D++S   +++ +L G HP
Sbjct: 220 ETHMAPEVVMGKPC---DAKVDIWSSCCMMLHMLNGCHP 255

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (326), Expect = 3e-35
 Identities = 73/300 (24%), Positives = 125/300 (41%), Gaps = 57/300 (19%)

Query: 16  LGEGGFGFVYKGVLPD--------NTLVAVK--KPKMVDKILINEVFQHKMRIISQI-NH 64
           LGEG FG V                  VAVK  K    +K L +     +M ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGKH 100

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC-------------L 111
           KN++ +LG C +     ++ E+   G L +++R +    ++                  +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
               + A  ++YL S      IH D+ + N+L+ +N   K+ADF  +  I++ D    TT
Sbjct: 161 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
                V W+ PE LF   +T +SDV+SFGV++ E+ T         L            P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LGG---------SP 259

Query: 229 YPIENNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           YP       ++    + + + M++       +  +   C     ++RPT +Q+ E LD +
Sbjct: 260 YPGIPV--EELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (324), Expect = 3e-35
 Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 63/303 (20%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQI-NHKN 66
           LG G FG V +              VAVK  K               +++I+  I +H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92

Query: 67  VVKILGVCLETKVPLLV-YEFVPNGTLFQHVRYQSSQVLKTWKTC-------------LR 112
           VV +LG C +   PL+V  EF   G L  ++R + ++ +                   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            + + A  +++L S      IH D+ + NILL +    K+ DF  +  I           
Sbjct: 153 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               + W+ PE +F   +T +SDV+SFGV+L E+ +         L ++         PY
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGAS---------PY 251

Query: 230 P-IENNSLRQILNFQVADENEME-------EIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
           P ++ +   +     + +   M        E+    +    C     ++RPT  ++ E L
Sbjct: 252 PGVKID--EEFCRR-LKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHL 305

Query: 282 DSL 284
            +L
Sbjct: 306 GNL 308

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  127 bits (322), Expect = 4e-35
 Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 32/234 (13%)

Query: 16  LGEGGFGFVYKGVL------PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           LGE  FG VYKG L           VA+K  K K    +     F+H+  + +++ H NV
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE--FRHEAMLRARLQHPNV 74

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC-------------LRIA 114
           V +LGV  + +   +++ +  +G L + +  +S                       + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           A+ A+ ++YL S     ++H D+ + N+L+ D    K++D      + + D        +
Sbjct: 135 AQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             + W+ PE +    ++  SD++S+GVVL E+ + G  P  Y   ++ ++  M+
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVVEMI 243

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (323), Expect = 5e-35
 Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 58/301 (19%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVK--KPKMVDKILINEVFQHKMRIISQI-NHKN 66
           LG G FG V +              VAVK  KP              +++++S + NH N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYLGNHMN 88

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVR---------------YQSSQVLKTWKTCL 111
           +V +LG C      L++ E+   G L   +R                +  ++    +  L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
             + + A  + +L S      IH D+ + NILL      K+ DF  +  I +        
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
                V W+ PE +F   +T +SDV+S+G+ L EL +         L S          P
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LGS---------SP 247

Query: 229 YP-IENNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDS 283
           YP +  +   +     + +   M   E     +  +   C      +RPT +Q+ + ++ 
Sbjct: 248 YPGMPVD--SKFYKM-IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 284 L 284
            
Sbjct: 305 Q 305

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (320), Expect = 6e-35
 Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 21/219 (9%)

Query: 16  LGEGGFGFVYKGVLPD----NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +GEG FG V++G+          VA+K  K    D +     F  +   + Q +H ++VK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 80

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           ++GV  E  V  ++ E    G L   ++ +   +     + +  A + ++AL YL S   
Sbjct: 81  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR- 136

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW-- 187
              +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE + +  
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 193

Query: 188 -TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            T  SDV+ FGV + E+L  G  P  +  + +N++   +
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRI 230

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (325), Expect = 7e-35
 Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 57/300 (19%)

Query: 16  LGEGGFGFVYKGVL--------PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQI-NH 64
           LGEG FG V              +   VAVK  K    +K L +     +M ++  I  H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGKH 146

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC-------------L 111
           KN++ +LG C +     ++ E+   G L +++R +    ++                  +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
               + A  ++YL S      IH D+ + N+L+ +N   K+ADF  +  I++ D    TT
Sbjct: 207 SCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
                V W+ PE LF   +T +SDV+SFGV++ E+ T         L  +         P
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LGGS---------P 305

Query: 229 YPIENNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           YP       ++    + + + M++       +  +   C     ++RPT +Q+ E LD +
Sbjct: 306 YPGIPV--EELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  127 bits (321), Expect = 1e-34
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)

Query: 16  LGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G  G V  G L      +  VA+K  K    ++   +  F  +  I+ Q +H N+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD--FLSEASIMGQFDHPNIIR 114

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV    ++ ++V E++ NG+L   +R    Q   T    + +     + + YL  LG 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLG- 171

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPEYLFW- 187
              +H D+ + N+L+D N   KV+DF  S ++      A TT   +  + W  PE + + 
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 188 --TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             +  SDV+SFGVV+ E+L  G+ P  Y  + + ++   V
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVISSV 267

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (322), Expect = 1e-34
 Identities = 73/314 (23%), Positives = 128/314 (40%), Gaps = 68/314 (21%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNV 67
           +GEG FG V++   P        T+VAVK  K +    +  +  FQ +  ++++ ++ N+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFDNPNI 112

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC----------------- 110
           VK+LGVC   K   L++E++  G L + +R  S   + +                     
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 111 ----LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
               L IA + A+ + YL        +H D+ + N L+ +N   K+ADF  S  I S D 
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
                 +   + W+ PE +F   +T +SDV+++GVVL E+ +                  
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGL------ 274

Query: 224 VPYFPYPIENNSLRQILNFQVADENEME-------EIEIVAKLASKCLRTSGTERPTMRQ 276
               PY    +   +++ + V D N +        E+     L   C      +RP+   
Sbjct: 275 ---QPYYGMAH--EEVIYY-VRDGNILACPENCPLELY---NLMRLCWSKLPADRPSFCS 325

Query: 277 VSEQLDSLRRLHEN 290
           +   L  +    E 
Sbjct: 326 IHRILQRMCERAEG 339

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (319), Expect = 1e-34
 Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 67/305 (21%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMRIIS 60
            +++    LG GGFG V++     D+   A+K+          +K++  EV     + ++
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REV-----KALA 58

Query: 61  QINHKNVVKILGVCLE---------TKVPLLVY---EFVPNGTLFQHVRYQSSQVLKTWK 108
           ++ H  +V+     LE         +   + +Y   +      L   +  + +   +   
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA 168
            CL I  + A A+++LHS G   ++H D+K +NI    +   KV DF     +   ++  
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 169 TTTKEIET-------VG---WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHPRSY 212
           T    +         VG   ++ PE      Y   + K D++S G++L ELL   +P S 
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY---SHKVDIFSLGLILFELL---YPFS- 228

Query: 213 VALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP 272
                 E  R +      + N     +   +   E           +    L  S  ERP
Sbjct: 229 ---TQMERVRTL----TDVRNLKFPPLFTQKYPCEY---------VMVQDMLSPSPMERP 272

Query: 273 TMRQV 277
               +
Sbjct: 273 EAINI 277

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 1e-34
 Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 16/220 (7%)

Query: 13  RHLLGEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK 69
              LG G FG V +GV         VA+K  K   +    E    + +I+ Q+++  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           ++GVC    + +LV E    G L + +  +  ++         +  + +  + YL     
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN- 130

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWLDPE---YL 185
              +H D+ + N+LL + + AK++DF  S  + + D   T     +  + W  PE   + 
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 186 FWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            ++ +SDV+S+GV + E L+ G+ P  Y  +   E+   +
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFI 226

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  128 bits (323), Expect = 2e-34
 Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 41/242 (16%)

Query: 14  HLLGEGGFGFVYKGVLPD--------NTLVAVKKPK----MVDKI-LINEVFQHKMRIIS 60
             LGEG FG V                T VAVK  K      D   LI+E     M ++ 
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE-----MEMMK 129

Query: 61  QI-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC--------- 110
            I  HKN++ +LG C +     ++ E+   G L ++++ +    L+              
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 111 ----LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
               +  A + A  ++YL S      IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 190 SKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTR 222
              TT     V W+ PE LF   +T +SDV+SFGV+L E+ T G  P  Y  +   E+ +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFK 304

Query: 223 MV 224
           ++
Sbjct: 305 LL 306

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 3e-34
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTL---VAVK--KPKMVDKILINEVFQHKMRIISQINH 64
           Y     LG GG   VY     D  L   VA+K       +K    + F+ ++   SQ++H
Sbjct: 13  YKIVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           +N+V ++ V  E     LV E++   TL +++         +  T +    +    + + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL---SVDTAINFTNQILDGIKHA 127

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H +    I+H D+K  NIL+D N T K+ DF  +  +S    T T    + TV +  PE 
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPEQ 183

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP 209
                  E +D+YS G+VL E+L G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (318), Expect = 4e-34
 Identities = 76/310 (24%), Positives = 123/310 (39%), Gaps = 68/310 (21%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPK----MVDKI-LINEVFQHKMRIISQI-N 63
           LG G FG V +              VAVK  K      +K  L++E     ++I+S +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE-----LKIMSHLGQ 108

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-----------TWKTCLR 112
           H+N+V +LG C      L++ E+   G L   +R +S  +             + +  L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTK 172
            +++ A  + +L S      IH DV + N+LL + + AK+ DF  +  I +         
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
               V W+ PE +F   +T +SDV+S+G++L E+ +         L  N         PY
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN---------PY 267

Query: 230 P-IENNSLRQILNFQVADENEME-------EIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
           P I  N   +     V D  +M         I     +   C     T RPT +Q+   L
Sbjct: 268 PGILVN--SKFYKL-VKDGYQMAQPAFAPKNIY---SIMQACWALEPTHRPTFQQICSFL 321

Query: 282 DSLRRLHENF 291
                  E+ 
Sbjct: 322 QEQ--AQEDR 329

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  125 bits (316), Expect = 6e-34
 Identities = 71/305 (23%), Positives = 132/305 (43%), Gaps = 55/305 (18%)

Query: 16  LGEGGFGFVYKGVL-----PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVV 68
           +G G FG VYKG+L          VA+K  K    +K  ++  F  +  I+ Q +H N++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNII 109

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
           ++ GV  + K  +++ E++ NG L + +R +  +   +    + +    A+ + YL ++ 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANMN 167

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG------WLDP 182
               +H D+ + NIL++ N   KV+DF  S ++    +   TT      G      W  P
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAP 219

Query: 183 E---YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           E   Y  +T  SDV+SFG+V+ E++T G+                    PY   +N   +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER-------------------PYWELSN--HE 258

Query: 239 ILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ 294
           ++   + D   +         + +L  +C +     RP    +   LD L R  ++    
Sbjct: 259 VMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317

Query: 295 KNSEE 299
            + + 
Sbjct: 318 ADFDP 322

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  126 bits (318), Expect = 6e-34
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 18/205 (8%)

Query: 16  LGEGGFGFVYKGVLP----DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
           +G G FG V  G L         VA+K  K    +K   +  F  +  I+ Q +H N+++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD--FLGEASIMGQFDHPNIIR 110

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           + GV  ++K  ++V E++ NG+L   +R   +Q   T    + +    AS + YL  +G 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG- 167

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YL 185
              +H D+ + NIL++ N   KV+DF    ++    + A TT+  +  + W  PE   Y 
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 186 FWTEKSDVYSFGVVLVELLT-GKHP 209
            +T  SDV+S+G+VL E+++ G+ P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (310), Expect = 2e-33
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 17/217 (7%)

Query: 16  LGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           LGEG FG VY+GV      +   VAVK  K    +   E F  +  I+  ++H ++VK++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           G+  E     ++ E  P G L  ++    + +     T +  + +   A+ YL S+    
Sbjct: 80  GIIEEEPT-WIIMELYPYGELGHYLERNKNSL--KVLTLVLYSLQICKAMAYLESIN--- 133

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE---YLFWT 188
            +H D+   NIL+      K+ DF  S  I   D    +   +  + W+ PE   +  +T
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFT 192

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             SDV+ F V + E+L+ GK P  +  L + ++  ++
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP--FFWLENKDVIGVL 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 2e-33
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 17/217 (7%)

Query: 16  LGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKIL 71
           +GEG FG V++G+          VA+K  K      + E F  +   + Q +H ++VK++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 72  GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           GV  E  V  ++ E    G L   ++ +   +     + +  A + ++AL YL S     
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESKR--- 511

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW---T 188
            +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE + +   T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFT 570

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
             SDV+ FGV + E+L  G  P  +  + +N++   +
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRI 605

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (311), Expect = 4e-33
 Identities = 63/309 (20%), Positives = 118/309 (38%), Gaps = 69/309 (22%)

Query: 16  LGEGGFGFVYKGVLPD------NTLVAVKKPK----MVDKI-LINEVFQHKMRIISQI-N 63
           LG G FG V             +  VAVK  K      ++  L++E     +++++Q+ +
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE-----LKMMTQLGS 107

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC------------- 110
           H+N+V +LG C  +    L++E+   G L  ++R +  +  +                  
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 111 -------LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
                  L  A + A  +++L        +H D+ + N+L+      K+ DF  +  I S
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM 220
                        V W+ PE LF   +T KSDV+S+G++L E+ +         L     
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS---------LGV--- 272

Query: 221 TRMVPYFPYP-IENNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMR 275
                  PYP I  +         + +  +M++       +  +   C      +RP+  
Sbjct: 273 ------NPYPGIPVD--ANFYKL-IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323

Query: 276 QVSEQLDSL 284
            ++  L   
Sbjct: 324 NLTSFLGCQ 332

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (307), Expect = 5e-33
 Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 57/292 (19%)

Query: 16  LGEGGFGFVYKGVL--------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           LG+G F  ++KGV            T V +K          +E F     ++S+++HK++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKHL 74

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V   GVC+     +LV EFV  G+L  +++   + +   WK  L +A + A+A+ +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEEN 132

Query: 128 GSPPIIHGDVKSANILLD--------DNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
               +IHG+V + NILL         +    K++D   S+ +   D             W
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------W 183

Query: 180 LDPE----YLFWTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN 234
           + PE           +D +SFG  L E+ + G  P                       ++
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------------------LSALDS 224

Query: 235 SLRQILNFQVADENEME--EIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
             ++ L F   D +++   +   +A L + C+      RP+ R +   L+SL
Sbjct: 225 --QRKLQF-YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (309), Expect = 6e-33
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 33/235 (14%)

Query: 14  HLLGEGGFGFVYKGVL---PDNTLVAVK--KPKMVDKILINEVFQHKMRIISQI-NHKNV 67
            ++GEG FG V K  +         A+K  K         +  F  ++ ++ ++ +H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD--FAGELEVLCKLGHHPNI 88

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTCLRIA 114
           + +LG C       L  E+ P+G L   +R                     + +  L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           A+ A  +DYL        IH D+ + NIL+ +NY AK+ADF    L    +     T   
Sbjct: 149 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGR 202

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP 225
             V W+  E L    +T  SDV+S+GV+L E+++ G  P  Y  +   E+   +P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLP 255

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (306), Expect = 8e-33
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 20/219 (9%)

Query: 16  LGEGGFGFVYKGVLPDN---TLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG          VAVK  K +  D  L +E    +  ++ Q+++  +V++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-LLAEANVMQQLDNPYIVRM 83

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C      +LV E    G L ++++          K  + +  + +  + YL      
Sbjct: 84  IGICEAESW-MLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEESN-- 137

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET-VGWLDPE---YLF 186
             +H D+ + N+LL   + AK++DF  S  + + +         +  V W  PE   Y  
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML 233

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (315), Expect = 2e-32
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 16/217 (7%)

Query: 16  LGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V +GV         VA+K  K   +    E    + +I+ Q+++  +V+++G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC    + +LV E    G L + +  +  ++         +  + +  + YL        
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN---F 457

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWLDPE---YLFWT 188
           +H ++ + N+LL + + AK++DF  S  + + D   T     +  + W  PE   +  ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 189 EKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV 224
            +SDV+S+GV + E L+ G+ P  Y  +   E+   +
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFI 552

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (302), Expect = 3e-32
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
               R +LG+G +G VY G  L +   +A+K+    D      +   ++ +   + HKN+
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIALHKHLKHKNI 81

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V+ LG   E     +  E VP G+L   +R +   +    +T      +    L YLH  
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141

Query: 128 GSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE--- 183
               I+H D+K  N+L++  +   K++DF +S  ++  +    T     T+ ++ PE   
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIID 196

Query: 184 -----YLFWTEKSDVYSFGVVLVELLTGKHP 209
                Y    + +D++S G  ++E+ TGK P
Sbjct: 197 KGPRGY---GKAADIWSLGCTIIEMATGKPP 224

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (302), Expect = 4e-32
 Identities = 63/304 (20%), Positives = 127/304 (41%), Gaps = 60/304 (19%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQI 62
             ++++  +LG+G FG V K     D+   A+KK +  ++    +++EV      +++ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-----MLLASL 59

Query: 63  NHKNVVKILGVCLETKVPL-------------LVYEFVPNGTLFQHVRYQSSQVLKTWKT 109
           NH+ VV+     LE +  +             +  E+  NGTL+  +  ++    +    
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DE 117

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTA 168
             R+  +   AL Y+HS G   IIH D+K  NI +D++   K+ DF  +  +  S D   
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 169 TTTKEIE-----------TVGWLDPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYV 213
             ++ +            T  ++  E L     + EK D+YS G++  E++         
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227

Query: 214 ALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT 273
              S  M R+            LR + + +   + +  ++++  K+    +     +RP 
Sbjct: 228 --FSTGMERVNIL-------KKLRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277

Query: 274 MRQV 277
            R +
Sbjct: 278 ARTL 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 6e-32
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTL---VAVK--KPKMVDKILINEVFQHKMRI----IS 60
           Y+   +LG GG   V+     D      VAVK  +  +      +  F  + R      +
Sbjct: 14  YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLAR----DPSFYLRFRREAQNAA 67

Query: 61  QINHKNVVKILGVCLET----KVPLLVYEFVPNGTLFQHVRYQSSQVLK-----TWKTCL 111
            +NH  +V +            +P +V E+V   TL          ++      T K  +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL--------RDIVHTEGPMTPKRAI 119

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
            + A+   AL++ H  G   IIH DVK ANI++      KV DF  +  I+    + T T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 172 KEIE-TVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHP 209
             +  T  +L PE         +SDVYS G VL E+LTG+ P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 2e-31
 Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 39/219 (17%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTL---VAVK--KPKMVDKILINEVFQHKMR----IIS 60
           Y  R L+G GG G VY+    D      VA+K     +      + VF+ +M+       
Sbjct: 36  YRLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSS----DPVFRTRMQREARTAG 89

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-----TWKTCLRIAA 115
           ++   +VV I           +    +    L        + +L+          + I  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL--------AAMLRRQGPLAPPRAVAIVR 141

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTATTTKE 173
           +  SALD  H+ G     H DVK  NIL+  +  A + DF  AS+       Q   T   
Sbjct: 142 QIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--- 195

Query: 174 IETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           + T+ ++ PE       T ++D+Y+   VL E LTG  P
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (298), Expect = 2e-31
 Identities = 53/220 (24%), Positives = 82/220 (37%), Gaps = 40/220 (18%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK---ILINEVFQHKMRIIS 60
           +++ +   LG G +G V+K     D  L AVK    P    K     + EV  H+     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE----K 112

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL------RIA 114
              H   V++     E  +  L  E     +L QH         + W   L         
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH--------CEAWGASLPEAQVWGYL 163

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            +T  AL +LHS G   ++H DVK ANI L      K+ DF   V + +         + 
Sbjct: 164 RDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QE 217

Query: 175 ETVGWLDPE-----YLFWTEKSDVYSFGVVLVELLTGKHP 209
               ++ PE     Y      +DV+S G+ ++E+      
Sbjct: 218 GDPRYMAPELLQGSY---GTAADVFSLGLTILEVACNMEL 254

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  120 bits (302), Expect = 3e-31
 Identities = 56/285 (19%), Positives = 110/285 (38%), Gaps = 44/285 (15%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQIN-HKN 66
           ++  + +LG G  G +    + DN  VAVK+           EV     +++ + + H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV-----QLLRESDEHPN 79

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           V++      + +   +  E     TL +    +           + +  +T S L +LHS
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQE--YVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 127 LGSPPIIHGDVKSANILL-----DDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWL 180
           L    I+H D+K  NIL+          A ++DF     ++    + +    +  T GW+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 181 DPEYLFW------TEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN 233
            PE L        T   D++S G V   +++ G HP                 F   ++ 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-----------------FGKSLQR 236

Query: 234 NSLRQILNFQVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            +   +    +   +  +  +++A+ L  K +     +RP+ + V
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (305), Expect = 5e-31
 Identities = 46/225 (20%), Positives = 88/225 (39%), Gaps = 42/225 (18%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTL----VAVKKPKMVDKILIN-------EVFQHKMRI 58
           Y+ +  +  GG G++Y  +  D  +    V +K        L++        +   + + 
Sbjct: 82  YEVKGCIAHGGLGWIYLAL--DRNVNGRPVVLK-------GLVHSGDAEAQAMAMAERQF 132

Query: 59  ISQINHKNVVKIL-----GVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI 113
           ++++ H ++V+I             V  +V E+V   +L +       Q L      +  
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKL-PVAEAIAY 187

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE 173
             E   AL YLHS+G   +++ D+K  NI+L +    K+ D      +S  +        
Sbjct: 188 LLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLG---AVSRINSFGYL--- 237

Query: 174 IETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALA 216
             T G+  PE +    T  +D+Y+ G  L  L      R+   + 
Sbjct: 238 YGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (287), Expect = 8e-30
 Identities = 50/326 (15%), Positives = 115/326 (35%), Gaps = 67/326 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV----FQHKMRIISQIN 63
           + Y     +G GG   V++ +     + A+   K V+    +      +++++  ++++ 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAI---KYVNLEEADNQTLDSYRNEIAYLNKLQ 84

Query: 64  HKN--VVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAET 117
             +  ++++    +  +   +V E   N  L     +       +    WK         
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK-------NM 136

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             A+  +H  G   I+H D+K AN L+ D    K+ DF  +  +     +     ++ TV
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 178 GWLDPE--------------YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
            ++ PE                  + KSDV+S G +L  +  GK P   +    +++  +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252

Query: 224 V-PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
           + P       +          + D            +   CL+    +R ++ ++     
Sbjct: 253 IDPNHEIEFPDI-----PEKDLQD------------VLKCCLKRDPKQRISIPELLA--- 292

Query: 283 SLRRLHENFWAQKNSEETEQLLGESS 308
                H   + Q  +    Q+   ++
Sbjct: 293 -----HP--YVQIQTHPVNQMAKGTT 311

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (283), Expect = 1e-29
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK-ILINEVFQHKMR----IISQ 61
           +++   +LLG+G F  VY+   +     VA+K   M+DK  +       +++    I  Q
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           + H +++++     E    + LV E   NG + ++++    +     +       +  + 
Sbjct: 68  LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEAR-HFMHQIITG 124

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           + YLHS G   I+H D+  +N+LL  N   K+ADF  +  +    +   T       G  
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTP 176

Query: 181 D---PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           +   PE         +SDV+S G +   LL G+ P
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (283), Expect = 1e-29
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------RI 58
           ++++    LG+G FG VY         ++A+K   ++ K    ++ +  +         I
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALK---VLFK---AQLEKAGVEHQLRREVEI 62

Query: 59  ISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
            S + H N++++ G        + L+ E+ P GT+++ ++          +T      E 
Sbjct: 63  QSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTA-TYITEL 118

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
           A+AL Y HS     +IH D+K  N+LL      K+ADF  SV   +     T        
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD-----LC 168

Query: 178 GWLD---PEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
           G LD   PE +      EK D++S GV+  E L GK P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (285), Expect = 2e-29
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 34/218 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--------KPKMVDKILINEVFQHKMRI 58
           + Y +   LG+GGF   ++        + A K        KP   +K+   E+      I
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-MEI-----SI 94

Query: 59  ISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
              + H++VV   G   E    + +V E     +L +  + +  + L   +       + 
Sbjct: 95  HRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEAR-YYLRQI 150

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                YLH      +IH D+K  N+ L+++   K+ DF  +  +    +           
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LC 202

Query: 178 GWLD---PEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           G  +   PE L     + + DV+S G ++  LL GK P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  112 bits (282), Expect = 2e-29
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 34/218 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--------KPKMVDKILINEVFQHKMRI 58
           + Y +   LG+GGF   ++        + A K        KP   +K+   E+      I
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM-SMEI-----SI 68

Query: 59  ISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
              + H++VV   G   E    + +V E     +L +  + +  + L   +       + 
Sbjct: 69  HRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEAR-YYLRQI 124

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
                YLH      +IH D+K  N+ L+++   K+ DF  +  +    +           
Sbjct: 125 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LC 176

Query: 178 GWLD---PEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           G  +   PE L     + + DV+S G ++  LL GK P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (281), Expect = 6e-29
 Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 24/220 (10%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMR---IISQIN 63
             +    +LG+G    V++G       L A+K   + + I        +MR   ++ ++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65

Query: 64  HKNVVKILGV--CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           HKN+VK+  +     T+  +L+ EF P G+L+  +   S+         L +  +    +
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 122 DYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATT--TKE-- 173
           ++L   G   I+H ++K  NI+     D     K+ DF ++  +   +Q  +   T+E  
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 174 ----IETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHP 209
                E           +    D++S GV      TG  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (283), Expect = 8e-29
 Identities = 50/230 (21%), Positives = 82/230 (35%), Gaps = 40/230 (17%)

Query: 7   TKNYDKRHLLGEG--GFGFVYKGV-LPDNTLVAVKK------PKMVDKILINEVFQHKMR 57
              Y+   ++G+G      V      P    V V++         +   L  E+      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL-----H 78

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA-- 115
           +    NH N+V      +      +V  F+  G+    +       +      L IA   
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LAIAYIL 134

Query: 116 -ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
                ALDY+H +G    +H  VK+++IL+  +    ++   S++ + SH Q      + 
Sbjct: 135 QGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 175 ET--VG---WLDPE--------YLFWTEKSDVYSFGVVLVELLTGKHPRS 211
               V    WL PE        Y     KSD+YS G+   EL  G  P  
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGY---DAKSDIYSVGITACELANGHVPFK 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  111 bits (280), Expect = 1e-28
 Identities = 48/295 (16%), Positives = 103/295 (34%), Gaps = 57/295 (19%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR----IISQIN 63
           + Y     +G GG   V++ +     + A+   K V+    +       R     ++++ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAI---KYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 64  HKN--VVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAET 117
             +  ++++    +  +   +V E   N  L     +       +    WK         
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK-------NM 117

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             A+  +H  G   I+H D+K AN L+ D    K+ DF  +  +     +     ++ TV
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 178 GWLDPE--------------YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
            ++ PE                  + KSDV+S G +L  +  GK P   +    +++  +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233

Query: 224 V-PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           + P       +          + D            +   CL+    +R ++ ++
Sbjct: 234 IDPNHEIEFPDI-----PEKDLQD------------VLKCCLKRDPKQRISIPEL 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 2e-28
 Identities = 66/303 (21%), Positives = 106/303 (34%), Gaps = 57/303 (18%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQI-NHK 65
                  +LG G  G V          VAVK+       I + E+     +++++  +H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI-----KLLTESDDHP 69

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETASAL 121
           NV++        +   +  E   N  L   V        +  L+     + +  + AS +
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 122 DYLHSLGSPPIIHGDVKSANILLD-------------DNYTAKVADFASSVLISSHDQTA 168
            +LHSL    IIH D+K  NIL+              +N    ++DF     + S   + 
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 169 TTTKEIE--TVGWLDPEYLF----------WTEKSDVYSFGVVLVELLT-GKHPRSYVAL 215
            T       T GW  PE L            T   D++S G V   +L+ GKHP      
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP------ 239

Query: 216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAK-LASKCLRTSGTERPTM 274
                        Y  E+N +R I +           +   A  L S+ +     +RPT 
Sbjct: 240 ---------FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

Query: 275 RQV 277
            +V
Sbjct: 291 MKV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (280), Expect = 2e-28
 Identities = 54/305 (17%), Positives = 108/305 (35%), Gaps = 34/305 (11%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMR---IISQIN 63
             +    +LG+G    V++G       L A+K   + + I        +MR   ++ ++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65

Query: 64  HKNVVKILGV--CLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           HKN+VK+  +     T+  +L+ EF P G+L+  +   S+         L +  +    +
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 122 DYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATT--TKE-- 173
           ++L   G   I+H ++K  NI+     D     K+ DF ++  +   +Q  +   T+E  
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 174 ----IETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGK---HPRSYVALASNEMTRM--- 223
                E           +    D++S GV      TG     P          M ++   
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 224 ----VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE 279
                       EN  +    +  V+         ++  + +  L     +     Q   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 280 QLDSL 284
           +   +
Sbjct: 303 ETSDI 307

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (280), Expect = 2e-28
 Identities = 41/321 (12%), Positives = 79/321 (24%), Gaps = 70/321 (21%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK-------KPKMVDKILINEVF 52
           SEL +  +   +  +LG+       +           V         P    K +  EV 
Sbjct: 71  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130

Query: 53  QHK-----------------MRIISQINHKNVVKILGVCLETKVPLLVYEFV----PNGT 91
           + +                 +     +      K++ V L+ +   ++  F         
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190

Query: 92  LFQHVRYQSSQVLK----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN 147
           L        S             L++  +    L  LH  G   ++H  ++  +I+LD  
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247

Query: 148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW--------TEKSDVYSFGVV 199
               +  F   V   +   +                 L +        T   D ++ G+ 
Sbjct: 248 GGVFLTGFEHLVRDGASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306

Query: 200 LVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEI-EIVAK 258
           +  +     P                             I           + I + V  
Sbjct: 307 IYWIWCADLP-----------------NTDDAALGGSEWIF-------RSCKNIPQPVRA 342

Query: 259 LASKCLRTSGTERPTMRQVSE 279
           L    LR    +R    Q  E
Sbjct: 343 LLEGFLRYPKEDRLLPLQAME 363

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (278), Expect = 4e-28
 Identities = 46/295 (15%), Positives = 106/295 (35%), Gaps = 57/295 (19%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEV----FQHKMRIISQIN 63
           + Y     +G GG   V++ +     + A+   K V+    +      +++++  ++++ 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAI---KYVNLEEADNQTLDSYRNEIAYLNKLQ 112

Query: 64  HKN--VVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAET 117
             +  ++++    +  +   +V E   N  L     +       +    WK         
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK-------NM 164

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             A+  +H  G   I+H D+K AN L+ D    K+ DF  +  +     +     ++  V
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 178 GWLDPE--------------YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
            ++ PE                  + KSDV+S G +L  +  GK P   +    +++  +
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280

Query: 224 V-PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
           + P       +          + D            +   CL+    +R ++ ++
Sbjct: 281 IDPNHEIEFPDI-----PEKDLQD------------VLKCCLKRDPKQRISIPEL 318

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 4e-28
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 44/221 (19%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------RII 59
           ++D    LG+G FG VY      +  ++A+K   ++ K   +++ +  +         I 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALK---VLFK---SQLEKEGVEHQLRREIEIQ 68

Query: 60  SQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           S + H N++++       +  + L+ EF P G L++ +  Q        ++      E A
Sbjct: 69  SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA-TFMEELA 124

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIET 176
            AL Y H      +IH D+K  N+L+      K+ADF  SV  +   +  T   T     
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRTMCGT----- 175

Query: 177 VGWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
                 +YL           EK D++  GV+  E L G  P
Sbjct: 176 -----LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (276), Expect = 5e-28
 Identities = 29/314 (9%), Positives = 76/314 (24%), Gaps = 55/314 (17%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKM 56
           S L +  +       L  G    V+    +      A+K         +  + E      
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL-ERLHEAT 113

Query: 57  RIISQINHKNVVKILGVCLETKVP--------------------------LLVYEFVPNG 90
              +++  ++  +                                     LL+     + 
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASV 172

Query: 91  TLFQHV----RYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD 146
            L             +  +       + A+       L S G   ++HG     N+ +  
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMP 229

Query: 147 NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTG 206
           +    + D ++   + +    ++         +L+     +T   + +  G+ +  +   
Sbjct: 230 DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 207 KHP---RSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKC 263
             P    +     S +   +       +   S   +              + V  L  + 
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP-------------DFVKTLIGRF 336

Query: 264 LRTSGTERPTMRQV 277
           L      R    + 
Sbjct: 337 LNFDRRRRLLPLEA 350

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  108 bits (272), Expect = 6e-28
 Identities = 44/237 (18%), Positives = 78/237 (32%), Gaps = 50/237 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDKI---LINEVFQHKMRII 59
           T  + +   +G G FG V+K V   D  + A+K+   P          + EV+ H     
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA---- 65

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-YQSSQVLKTWKTCLRIAAETA 118
               H +VV+      E    L+  E+   G+L   +                 +  +  
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDN-------------------YTAKVADFASSV 159
             L Y+HS+    ++H D+K +NI +                         K+ D     
Sbjct: 126 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 160 LISSHDQTATTTKEIETVGWLDPE-------YLFWTEKSDVYSFGVVLVELLTGKHP 209
            ISS         E     +L  E       +L    K+D+++  + +V     +  
Sbjct: 183 RISS------PQVEEGDSRFLANEVLQENYTHLP---KADIFALALTVVCAAGAEPL 230

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 2e-27
 Identities = 37/319 (11%), Positives = 82/319 (25%), Gaps = 69/319 (21%)

Query: 1   SELVKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--------------------- 38
           SEL +  +   +  +LG+       +           V                      
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 39  ------KPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF-VPNGT 91
                   K   +  ++  F     ++     K ++++     +  V    + +      
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 92  LFQH----VRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN 147
           L       + + S+         L++  +    L  LH  G   ++H  ++  +I+LD  
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 242

Query: 148 YTAKVADFASSVLISSHDQTATTT--------KEIETVGWLDPEYLFWTEKSDVYSFGVV 199
               +  F   V   +   ++ +             T+ +        T   D ++ G+V
Sbjct: 243 GGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 200 LVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEI-EIVAK 258
           +  +     P                             I           + I + V  
Sbjct: 303 IYWIWCADLP-----------------ITKDAALGGSEWIFRSC-------KNIPQPVRA 338

Query: 259 LASKCLRTSGTERPTMRQV 277
           L    LR    +R    Q 
Sbjct: 339 LLEGFLRYPKEDRLLPLQA 357

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (264), Expect = 2e-26
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 42/223 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQIN 63
            + +D    LGEG +G VYK +      +VA+K+  +   +  +I E+      I+ Q +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEI-----SIMQQCD 82

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAA---ET 117
             +VVK  G   +     +V E+   G++        S +++     L    IA     T
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSV--------SDIIRLRNKTLTEDEIATILQST 134

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L+YLH +     IH D+K+ NILL+    AK+ADF  +  +     T T  K    +
Sbjct: 135 LKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL-----TDTMAKRNTVI 186

Query: 178 G---WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHPRS 211
           G   W+ PE      Y      +D++S G+  +E+  GK P +
Sbjct: 187 GTPFWMAPEVIQEIGY---NCVADIWSLGITAIEMAEGKPPYA 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (263), Expect = 2e-26
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 32/225 (14%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK---PKMVDKI--LINEVFQHKMRIISQ 61
            +Y+ + ++G G    V      P    VA+K+    K    +  L+ E+       +SQ
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ-----AMSQ 69

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC--LRIAA---E 116
            +H N+V      +      LV + +  G++   +++  ++            IA    E
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
               L+YLH  G    IH DVK+ NILL ++ + ++ADF  S  +++             
Sbjct: 130 VLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 177 VG---WLDPE-------YLFWTEKSDVYSFGVVLVELLTGKHPRS 211
           VG   W+ PE       Y     K+D++SFG+  +EL TG  P  
Sbjct: 187 VGTPCWMAPEVMEQVRGY---DFKADIWSFGITAIELATGAAPYH 228

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (269), Expect = 2e-26
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 50/288 (17%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQI 62
           +  Y  + +LG+G FG V            AVK   K ++  K     + + +++++ Q+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQL 83

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAAETA 118
           +H N++K+     +     LV E    G LF  +    R+      +  +  L       
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL------- 136

Query: 119 SALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           S + Y+H      I+H D+K  N+LL     +   ++ DF  S      + +     +I 
Sbjct: 137 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIG 190

Query: 176 TVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
           T  ++ PE L   + EK DV+S GV+L  LL+G                     P+   N
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG-------------------CPPFNGAN 231

Query: 234 NS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
               L+++   +   +  + +++   AK L  K L    + R + R  
Sbjct: 232 EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (256), Expect = 1e-25
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
            + + K   +G+G FG V+KG+      +VA+K   + +     E  Q ++ ++SQ +  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAA---ETAS 119
            V K  G  L+     ++ E++  G+           +L+     L    IA    E   
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA--------LDLLEP--GPLDETQIATILREILK 130

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG- 178
            LDYLHS      IH D+K+AN+LL ++   K+ADF  +  +     T T  K    VG 
Sbjct: 131 GLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL-----TDTQIKRNTFVGT 182

Query: 179 --WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHPRS 211
             W+ PE      Y     K+D++S G+  +EL  G+ P S
Sbjct: 183 PFWMAPEVIKQSAY---DSKADIWSLGITAIELARGEPPHS 220

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  104 bits (262), Expect = 2e-25
 Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 53/289 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMV---DKILINEVFQHKMRII 59
           ++ Y +   LG G +G V        +   A+K   K  +    +  L+ EV      ++
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV-----AVL 90

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKTCLRIAA 115
             ++H N++K+     + +   LV E    G LF  +    ++         K  L    
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL---- 146

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTK 172
              S + YLH      I+H D+K  N+LL   + +   K+ DF  S +    +      +
Sbjct: 147 ---SGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKE 197

Query: 173 EIETVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP 230
            + T  ++ PE L   + EK DV+S GV+L  LL G  P                 F   
Sbjct: 198 RLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP-----------------FGGQ 240

Query: 231 IENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            +   LR++   +   D  E + +   AK L  + L+     R + +Q 
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  101 bits (254), Expect = 3e-25
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV--DKILINEVFQHKMRIISQIN 63
            + ++    LG+G FG VYK        L A K  +    +++   E +  ++ I++  +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCD 74

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAA---ET 117
           H  +VK+LG         ++ EF P G +          ++      L    I     + 
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVVCRQM 126

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
             AL++LHS     IIH D+K+ N+L+      ++ADF  S          T  K    +
Sbjct: 127 LEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN-----LKTLQKRDSFI 178

Query: 178 G---WLDPEYLFWTE--------KSDVYSFGVVLVELLTGKHPRS 211
           G   W+ PE +            K+D++S G+ L+E+   + P  
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (253), Expect = 3e-25
 Identities = 35/203 (17%), Positives = 66/203 (32%), Gaps = 47/203 (23%)

Query: 15  LLGEGGFGFVYKGVLPDNTL---VAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVK 69
             G       ++ +  D  L   VA+    P+ V    + +    +   +S+I+   V +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKT---WKTCLRIAAETASALDYLHS 126
           +L V       L+V E++  G+L         +V  T       +R     A+A D  H 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSL--------QEVADTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
            G   +       + + +  +    +A  A                   T+   +P+   
Sbjct: 148 AG---VALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDANPQ--- 182

Query: 187 WTEKSDVYSFGVVLVELLTGKHP 209
                D+   G  L  LL  + P
Sbjct: 183 ----DDIRGIGASLYALLVNRWP 201

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (255), Expect = 4e-25
 Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 41/231 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVK--------KPKMVDKILINEVFQHKM---- 56
           +Y     L +G F  +      DN   A+K        K +   K   +++         
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 57  ----RIISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQ-----SSQVLKT 106
               +II+ I ++  +   G+ +     + ++YE++ N ++ +   Y      +      
Sbjct: 91  KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            +    I     ++  Y+H+  +  I H DVK +NIL+D N   K++DF  S  +   D+
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK 205

Query: 167 TATTTKEIETVGWLD---PEYL-----FWTEKSDVYSFGVVLVELLTGKHP 209
                    + G  +   PE+      +   K D++S G+ L  +     P
Sbjct: 206 KIKG-----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  101 bits (253), Expect = 4e-25
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 46/223 (20%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQ 61
            K Y +   +G+G  G VY  + +     VA+++  +  +    ++INE+      ++ +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-----LVMRE 73

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAA--- 115
             + N+V  L   L      +V E++  G+L        + V+   +TC+    IAA   
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSL--------TDVVT--ETCMDEGQIAAVCR 123

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           E   AL++LHS     +IH D+KS NILL  + + K+ DF     I     T   +K   
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----TPEQSKRST 175

Query: 176 TVG---WLDPE------YLFWTEKSDVYSFGVVLVELLTGKHP 209
            VG   W+ PE      Y     K D++S G++ +E++ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPP 215

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (258), Expect = 7e-25
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMR---IIS 60
           +    ++ +  LG GGFG+V + +       VA+   K   + L  +  +       I+ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAI---KQCRQELSPKNRERWCLEIQIMK 67

Query: 61  QINHKNVVKILGV------CLETKVPLLVYEFVPNGTLFQH-VRYQSSQVLKTWKTCLRI 113
           ++NH NVV    V           +PLL  E+   G L ++  ++++   LK       +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTL 126

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVLISSHDQTATT 170
            ++ +SAL YLH      IIH D+K  NI+L         K+ D   +  +   +     
Sbjct: 127 LSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183

Query: 171 TKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
              + T+ +L PE L    +T   D +SFG +  E +TG  P
Sbjct: 184 ---VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (257), Expect = 1e-24
 Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 54/295 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHK------- 55
            ++Y K   LG G +G V        ++  A+K   K +       ++    +       
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 56  --MRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHV----RYQSSQVLKTWKT 109
             + ++  ++H N++K+  V  + K   LV EF   G LF+ +    ++         K 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQ 166
            L       S + YLH      I+H D+K  NILL   +     K+ DF  S   S   +
Sbjct: 155 IL-------SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 167 TATTTKEIETVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
                  + T  ++ PE L   + EK DV+S GV++  LL G  P               
Sbjct: 205 L---RDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP--------------- 246

Query: 225 PYFPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
             F    + + ++++   +   D N+ + I   AK L    L     +R T  + 
Sbjct: 247 --FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (250), Expect = 2e-24
 Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 39/223 (17%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQIN 63
            K +     +G G FG VY    + ++ +VA+KK     K    +      ++R + ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLR---IAA---ET 117
           H N ++  G  L      LV E+             +S +L+  K  L+   IAA     
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGS---------ASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
              L YLHS     +IH DVK+ NILL +    K+ DF S+         +        V
Sbjct: 164 LQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA---------SIMAPANSFV 211

Query: 178 G---WLDPEYLFWTE------KSDVYSFGVVLVELLTGKHPRS 211
           G   W+ PE +   +      K DV+S G+  +EL   K P  
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQ 61
               D    +GEG  G V           VAVK   +  +    +L NEV      I+  
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEV-----VIMRD 98

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTL---FQHVRYQSSQVLKTWKTCLRIAA--- 115
             H NVV++    L  +   ++ EF+  G L      VR    Q          IA    
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATVCE 148

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
               AL YLH+ G   +IH D+KS +ILL  +   K++DF     I     +    K   
Sbjct: 149 AVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKS 200

Query: 176 TVG---WLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRS 211
            VG   W+ PE +    +  + D++S G++++E++ G+ P  
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (252), Expect = 3e-24
 Identities = 72/292 (24%), Positives = 113/292 (38%), Gaps = 59/292 (20%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK---ILINEVFQHKMRII 59
            + Y+   +LG+G FG V K          AVK   K    +K    ++ EV      ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV-----ELL 75

Query: 60  SQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIA 114
            +++H N++K+  +  E      +V E    G LF    +  R+      +  K      
Sbjct: 76  KKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF--- 131

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
               S + Y+H      I+H D+K  NILL   + +   K+ DF  S       Q     
Sbjct: 132 ----SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMK 181

Query: 172 KEIETVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
             I T  ++ PE L   + EK DV+S GV+L  LL+G                     P+
Sbjct: 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG-------------------TPPF 222

Query: 230 PIENNS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
             +N    L+++   + A D  +   I   AK L  K L    + R T  Q 
Sbjct: 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 98.2 bits (245), Expect = 9e-24
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 50/234 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV---DKILINEVFQHKMRIISQI 62
              ++   L+G G +G VYKG  +    L A+K   +    ++ +  E+      ++ + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEI-----NMLKKY 77

Query: 63  -NHKNVVKILGVCLETKVPL------LVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIA 114
            +H+N+    G  ++   P       LV EF   G++   ++      LK  W     IA
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IA 132

Query: 115 A---ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
               E    L +LH      +IH D+K  N+LL +N   K+ DF  S  +       T  
Sbjct: 133 YICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVG 184

Query: 172 KEIETVG---WLDPE-----------YLFWTEKSDVYSFGVVLVELLTGKHPRS 211
           +    +G   W+ PE           Y     KSD++S G+  +E+  G  P  
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATY---DFKSDLWSLGITAIEMAEGAPPLC 235

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHK----MRIISQIN 63
           NY     +G+G F  V     +     VA+K   ++DK  +N     K    +RI+  +N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 72

Query: 64  HKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           H N+VK+  V +ET+  L L+ E+   G +F ++   +   +K  K       +  SA+ 
Sbjct: 73  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYL--VAHGRMKE-KEARSKFRQIVSAVQ 128

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD- 181
           Y H      I+H D+K+ N+LLD +   K+ADF  S   +   +           G    
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA------FCGAPPY 179

Query: 182 --PEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
             PE     +    + DV+S GV+L  L++G  P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.2 bits (235), Expect = 9e-23
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 55/228 (24%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIIS---QINH 64
           ++D    LGEG +G V   V       VAV   K+VD     +  ++  + I     +NH
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAV---KIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA----- 118
           +NVVK  G          L  E+   G LF  +                +    A     
Sbjct: 65  ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFH 112

Query: 119 ---SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
              + + YLH +G   I H D+K  N+LLD+    K++DF  + +   +++         
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-------- 161

Query: 176 TVGWLD----------PEYL----FWTEKSDVYSFGVVLVELLTGKHP 209
               L+          PE L    F  E  DV+S G+VL  +L G+ P
Sbjct: 162 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 64/294 (21%), Positives = 99/294 (33%), Gaps = 53/294 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMR----I 58
              Y     LG G  G V           VA++   K K              +     I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIA 114
           + ++NH  ++KI           +V E +  G LF     + R           TC    
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL-------KEATCKLYF 245

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++       T  
Sbjct: 246 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL- 301

Query: 172 KEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
               T  +L PE L       +    D +S GV+L   L+G +P               P
Sbjct: 302 --CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-YP---------------P 343

Query: 226 YFPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           +  +  + +   QI + +         E+   A  L  K L      R T  + 
Sbjct: 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 55/228 (24%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIIS---QINH 64
           ++D    LGEG +G V   V       VAV   K+VD     +  ++  + I     +NH
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAV---KIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA----- 118
           +NVVK  G          L  E+   G LF  +                +    A     
Sbjct: 65  ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFH 112

Query: 119 ---SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
              + + YLH +G   I H D+K  N+LLD+    K++DF  + +   +++         
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-------- 161

Query: 176 TVGWLD----------PEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
               L+          PE L   E      DV+S G+VL  +L G+ P
Sbjct: 162 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 58/306 (18%)

Query: 10  YDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           ++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 69  KILGVCL-ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL-----RIAAETASALD 122
              G    + ++  +  E +  G+L         QVLK           +++      L 
Sbjct: 95  GFYGAFYSDGEI-SICMEHMDGGSL--------DQVLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTATTTKEIETVGWLD 181
           YL       I+H DVK +NIL++     K+ DF  S  LI S   +      + T  ++ 
Sbjct: 146 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMS 198

Query: 182 PE------YLFWTEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMTRMVPYFPYPI 231
           PE      Y   + +SD++S G+ LVE+  G++P     +                  P 
Sbjct: 199 PERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255

Query: 232 ENNSLRQILNFQVADENEMEEI-----EIVAKLA----------------SKCLRTSGTE 270
              +  + LN    D      I      IV +                  +KCL  +  E
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315

Query: 271 RPTMRQ 276
           R  ++Q
Sbjct: 316 RADLKQ 321

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 5e-22
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHK----MRII 59
           + Y     LG G FGFV+  V    N  V VK   K K+++   I +    K    + I+
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 60  SQINHKNVVKILGVCLETKVPL-LVYEFVPNGT-LFQHVRYQSSQVLKTWKTCLRIAAET 117
           S++ H N++K+L +  E +    LV E   +G  LF  +       L        I  + 
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDE-PLASYIFRQL 139

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            SA+ YL       IIH D+K  NI++ +++T K+ DF S+  +       T        
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT------FC 190

Query: 178 GWLD---PEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
           G ++   PE L        + +++S GV L  L+  ++P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.8 bits (231), Expect = 8e-22
 Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 43/218 (19%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRII-SQINHKNVVKILGV 73
           +G G +G V K V  P   ++AVK+ +        +     + ++    +   +V+  G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 74  CL-ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL----------RIAAETASALD 122
              E     +  E +              +  K   + L          +I   T  AL+
Sbjct: 90  LFREGDC-WICMELMSTS---------FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLD 181
           +L       IIH D+K +NILLD +   K+ DF  S  L+ S  +T           ++ 
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMA 193

Query: 182 PE----------YLFWTEKSDVYSFGVVLVELLTGKHP 209
           PE          Y     +SDV+S G+ L EL TG+ P
Sbjct: 194 PERIDPSASRQGY---DVRSDVWSLGITLYELATGRFP 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 60/341 (17%), Positives = 111/341 (32%), Gaps = 94/341 (27%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAV------KKPKMVDKILI-----------N 49
            +++    +G GGFG V++     D+   A+       +    +K++             
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 50  EVFQH----------------------------------------KMRIISQINHKNVVK 69
            V                                           K+R +   + KN V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
            L          +  +      L   +  + S   +    CL I  + A A+++LHS G 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 130 PPIIHGDVKSANILLDDNYTAKVADF----------ASSVLISSHDQTATTTKEIETVGW 179
             ++H D+K +NI    +   KV DF              +++     AT T ++ T  +
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           + PE +    ++ K D++S G++L ELL   +  S         T+M        E   +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL---YSFS---------TQM--------ERVRI 282

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
              +          ++      +    L  S TERP    +
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 70/294 (23%), Positives = 114/294 (38%), Gaps = 63/294 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK---ILINEVFQHKMRII 59
            + Y+   +LG+G FG V K          AVK   K    +K    ++ EV      ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV-----ELL 75

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAA 115
            +++H N++K+  +  ++    +V E    G LF    +  R+      +  K       
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF---- 131

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTK 172
              S + Y+H      I+H D+K  NILL   + +   K+ DF  S     + +      
Sbjct: 132 ---SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-- 183

Query: 173 EIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP 230
            I T  ++ PE L   + EK DV+S GV+L  LL+G                     P+ 
Sbjct: 184 -IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG-------------------TPPFY 223

Query: 231 IENNS--LRQIL----NFQVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            +N    L+++      F   D  +   I   AK L  K L    + R T  Q 
Sbjct: 224 GKNEYDILKRVETGKYAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------RI 58
             Y    LLG GGFG VY G+ + DN  VA+   K V+K  I++  +            +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI---KHVEKDRISDWGELPNGTRVPMEVVL 99

Query: 59  ISQINHK--NVVKILGVCLETKVPL-LVYEFV-PNGTLFQHVRYQSSQVLKTWKTCLRIA 114
           + +++     V+++L    E      L+ E   P   LF  +       L+  +      
Sbjct: 100 LKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFIT--ERGALQE-ELARSFF 155

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSHDQTATTTKE 173
            +   A+ + H+ G   ++H D+K  NIL+D N    K+ DF S  L+   D   T    
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD--- 207

Query: 174 IETVGWLD---PEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
               G      PE++ +       + V+S G++L +++ G  P
Sbjct: 208 --FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.0 bits (224), Expect = 4e-21
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 51/239 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMR------- 57
            Y  +  +G+G +G V       DNT  A+K   K K++ +         +         
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 58  ---------------IISQINHKNVVKILGVCLE--TKVPL-LVYEFVPNGTLFQHVRYQ 99
                          I+ +++H NVVK++ V L+   +  L +V+E V  G + +     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVME---VP 129

Query: 100 SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV 159
           + + L           +    ++YLH      IIH D+K +N+L+ ++   K+ADF  S 
Sbjct: 130 TLKPLSE-DQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 160 LISSHDQTATTTKEIETVG---WLDPEYLFWTEK------SDVYSFGVVLVELLTGKHP 209
                D   +      TVG   ++ PE L  T K       DV++ GV L   + G+ P
Sbjct: 186 EFKGSDALLSN-----TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.9 bits (226), Expect = 5e-21
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 48/223 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINH 64
            YD    +G G FG            LVAVK   +   +D+ +  E+  H+      + H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRS-----LRH 75

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA----- 118
            N+V+   V + T   L ++ E+   G L++ +               R + + A     
Sbjct: 76  PNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQ 123

Query: 119 ---SALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKE 173
              S + Y HS+    I H D+K  N LLD +     K+ DF  S     H Q  +T   
Sbjct: 124 QLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 177

Query: 174 IETVG---WLDPEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
              VG   ++ PE L   E     +DV+S GV L  +L G +P
Sbjct: 178 ---VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.2 bits (222), Expect = 9e-21
 Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 40/224 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINH 64
            Y    LLGEG +G V + +        AVK   K K+          + +++++ ++ H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 65  KNVVKILGV-CLETKVPL-LVYEFVPNGT--LFQHVRYQSSQVLKTWKTCLRIAAETASA 120
           KNV++++ V   E K  + +V E+   G   +   V     +     +       +    
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV---PEKRFPVCQAH-GYFCQLIDG 121

Query: 121 LDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           L+YLHS G   I+H D+K  N+LL    T K++    +  +                   
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD----------DTC 168

Query: 181 D----------PEYLFWTE-----KSDVYSFGVVLVELLTGKHP 209
                      PE     +     K D++S GV L  + TG +P
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 66/350 (18%), Positives = 122/350 (34%), Gaps = 83/350 (23%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILIN-EVFQHKMRIISQ 61
            K Y  +  +G+G +G V   +      + A+K   K K+      + E  + ++R++ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA--- 118
           ++H N+ ++  V  + +   LV E    G L   +              +          
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 119 ----------------------------------SALDYLHSLGSPPIIHGDVKSANILL 144
                                             SAL YLH+ G   I H D+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201

Query: 145 --DDNYTAKVADFASSVLISSHD--QTATTTKEIETVGWLDPEYLFW-----TEKSDVYS 195
             + ++  K+ DF  S      +  +    T +  T  ++ PE L         K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 196 FGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA-DENEMEEIE 254
            GV+L  LL G  P                 FP   + +++ Q+LN ++  +      + 
Sbjct: 262 AGVLLHLLLMGAVP-----------------FPGVNDADTISQVLNKKLCFENPNYNVLS 304

Query: 255 IVAK-LASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEETEQL 303
            +A+ L S  L  +  ER    +  +        H   W  + S++  ++
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQ--------HP--WISQFSDKIYKM 344

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 65/297 (21%), Positives = 99/297 (33%), Gaps = 59/297 (19%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMR----I 58
              Y     LG G  G V           VA+K   K K              +     I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 59  ISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIA 114
           + ++NH  ++KI     + +   +V E +  G LF     + R           TC    
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL-------KEATCKLYF 120

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTT 171
            +   A+ YLH  G   IIH D+K  N+LL   +++   K+ DF  S ++   + +   T
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 175

Query: 172 KEIETVGWLDPEYLFWTEKS------DVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
               T  +L PE L     +      D +S GV+L   L+G                   
Sbjct: 176 L-CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG------------------- 215

Query: 226 YFPYPIENNS---LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           Y P+           QI + +         E+   A  L  K L      R T  + 
Sbjct: 216 YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 34/222 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQ-----HKMRI 58
             Y    LLG+GGFG V+ G  L D   VA+K   + +++    +++          +  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 59  ISQI-NHKNVVKILGVCLETKVPL-LVYEF-VPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           +     H  V+++L    ET+    LV E  +P   LF ++       L           
Sbjct: 91  VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYIT--EKGPLGE-GPSRCFFG 146

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEI 174
           +  +A+ + HS G   ++H D+K  NIL+D     AK+ DF S  L+  HD+  T     
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD---- 197

Query: 175 ETVGWLD---PEYLFWTE----KSDVYSFGVVLVELLTGKHP 209
              G      PE++   +     + V+S G++L +++ G  P
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRII-SQINHKNVVKILGV 73
           LG G +G V K   +P   ++AVK+ +        +     + I    ++    V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 74  CL-ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCL-RIAAETASALDYLHSLGSPP 131
              E  V  +  E + + +L +  +    +     +  L +IA     AL++LHS  S  
Sbjct: 75  LFREGDV-WICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130

Query: 132 IIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDPE------- 183
           +IH DVK +N+L++     K+ DF  S  L+      A    +     ++ PE       
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDI-DAGCKPYMAPERINPELN 186

Query: 184 ---YLFWTEKSDVYSFGVVLVELLTGKHP 209
              Y   + KSD++S G+ ++EL   + P
Sbjct: 187 QKGY---SVKSDIWSLGITMIELAILRFP 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.3 bits (217), Expect = 4e-20
 Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 47/287 (16%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKI--LINEVFQHKMRIIS 60
              +  +  LG G FG V+            +K   K +    +  +  E+      ++ 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI-----EVLK 75

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIAAETA 118
            ++H N++KI  V  E    + +V E    G L + +    ++    +      +  +  
Sbjct: 76  SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 119 SALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +AL Y HS     ++H D+K  NIL      +   K+ DF  + L  S + +        
Sbjct: 135 NALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AG 188

Query: 176 TVGWLDPEYL--FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
           T  ++ PE      T K D++S GVV+  LLTG                     P+   +
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG-------------------CLPFTGTS 229

Query: 234 NS--LRQILNFQVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
                ++    +     E   +   A  L  + L      RP+  QV
Sbjct: 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.9 bits (216), Expect = 4e-20
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 42/221 (19%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINH 64
           +Y     LG G FG V  G        VAVK   + K+    ++ ++ + +++ +    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRH 70

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAETAS 119
            +++K+  V + T     +V E+V  G LF    +H R +  +  + ++  L       S
Sbjct: 71  PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL-------S 122

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETV 177
           A+DY H      ++H D+K  N+LLD +  AK+ADF  S ++S  +   T+  +      
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS------ 173

Query: 178 GWLDPEY---------LFWTEKSDVYSFGVVLVELLTGKHP 209
               P Y         L+   + D++S GV+L  LL G  P
Sbjct: 174 ----PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 87.4 bits (217), Expect = 5e-20
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 28/215 (13%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM-VDKILINEVFQHKMRIISQINHKNV 67
            +    +G G  G V+K        ++AVK+ +   +K     +      ++   +   +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 68  VKILGVCL-ETKVPLLVYEFVPNGTLFQHVRYQSS---QVLKTWKTCLRIAAETASALDY 123
           V+  G  +  T V  +  E +         R Q     ++L       ++      AL Y
Sbjct: 87  VQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILG------KMTVAIVKALYY 139

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDP 182
           L       +IH DVK +NILLD+    K+ DF  S  L+    +  +         ++ P
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYMAP 193

Query: 183 EYLFWTE--------KSDVYSFGVVLVELLTGKHP 209
           E +   +        ++DV+S G+ LVEL TG+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 6e-20
 Identities = 60/290 (20%), Positives = 101/290 (34%), Gaps = 57/290 (19%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-ILINEVFQHKMRIISQ 61
            + Y   + +G G +G V   V        A K   K  + D      E+      I+  
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI-----EIMKS 62

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAAE 116
           ++H N++++     E    + LV E    G LF        ++ S   +  K  L     
Sbjct: 63  LDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----- 116

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKE 173
             SA+ Y H L    + H D+K  N L      +   K+ DF  +          T    
Sbjct: 117 --SAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--- 168

Query: 174 IETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI 231
           + T  ++ P+ L   +  + D +S GV++  LL G                   Y P+  
Sbjct: 169 VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCG-------------------YPPFSA 209

Query: 232 ENNS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
             +S  + +I        E +   +   A+ L  + L  S  +R T  Q 
Sbjct: 210 PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 7e-20
 Identities = 68/294 (23%), Positives = 107/294 (36%), Gaps = 65/294 (22%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-ILINEVFQHKMRIISQ 61
            K +    +LG G F  V+         L A+K   K        L NE+      ++ +
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI-----AVLKK 62

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRY---QSSQVLKTWKTCLRI 113
           I H+N+V +  +  E+     LV + V  G LF    +   Y    +S V++        
Sbjct: 63  IKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------- 114

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATT 170
                SA+ YLH  G   I+H D+K  N+L    ++N    + DF     +S  +Q    
Sbjct: 115 ---VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG----LSKMEQNGIM 164

Query: 171 TKEIETVGWLDPEYLFWT---EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
           +    T G++ PE L      +  D +S GV+   LL G                   Y 
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG-------------------YP 205

Query: 228 PYPIENNS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           P+  E  S    +I       +    ++I   AK      L     ER T  + 
Sbjct: 206 PFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.8 bits (218), Expect = 9e-20
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 41/222 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMR------II 59
             +Y    ++G G FG VY+  L     LVA+KK           V Q K        I+
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----------VLQDKRFKNRELQIM 101

Query: 60  SQINHKNVVKILGVCLET-----KVPL-LVYEFVPNGTLFQHVRY--QSSQVLKTWKTCL 111
            +++H N+V++      +     +V L LV ++VP  T+++  R+  ++ Q L      L
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL 160

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATT 170
            +  +   +L Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +     
Sbjct: 161 YM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---N 213

Query: 171 TKEIETVGWL-DPEYLF-WTEKS---DVYSFGVVLVELLTGK 207
              I +  +   PE +F  T+ +   DV+S G VL ELL G+
Sbjct: 214 VSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 69/303 (22%), Positives = 114/303 (37%), Gaps = 52/303 (17%)

Query: 7   TKNYD-KRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK-ILINEVFQHKMRIIS 60
              Y  +  +LGEG    V   + L  +   AVK   K     +  +  EV      ++ 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV-----EMLY 65

Query: 61  QI-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS-------SQVLKTWKTCLR 112
           Q   H+NV++++    E     LV+E +  G++  H+  +        S V++       
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD------ 119

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTAT 169
                ASALD+LH+ G   I H D+K  NIL    +     K+ DF     I  +   + 
Sbjct: 120 ----VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172

Query: 170 TTKEI-------------ETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALA 216
            +                E V     E   + ++ D++S GV+L  LL+G  P  +V   
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGRC 230

Query: 217 SNEMTRMVPYFPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTM 274
            ++            +N     I   +    + +   I   AK L SK L     +R + 
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290

Query: 275 RQV 277
            QV
Sbjct: 291 AQV 293

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 32/211 (15%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           +LGEG F  V           +   A+K   K  ++ +   N+V  +      ++S+++H
Sbjct: 37  ILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKE---NKV-PYVTRERDVMSRLDH 89

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
              VK+     +    L     +  NG L +++R           T     AE  SAL+Y
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRF-YTAEIVSALEY 145

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LH  G   IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T  ++ PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 184 YLFWTEK-----SDVYSFGVVLVELLTGKHP 209
            L  TEK     SD+++ G ++ +L+ G  P
Sbjct: 203 LL--TEKSACKSSDLWALGCIIYQLVAGLPP 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 41/227 (18%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHK-------- 55
           K    +    + G+G FG V  G        VA+KK           V Q          
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-----------VIQDPRFRNRELQ 68

Query: 56  -MRIISQINHKNVVKILGVCLETKVP-------LLVYEFVPNGTLFQHVRY--QSSQVLK 105
            M+ ++ ++H N+V++                  +V E+VP+ TL +  R   +      
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP- 126

Query: 106 TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSH 164
                     +   ++  LH   S  + H D+K  N+L++  + T K+ DF S+  +S  
Sbjct: 127 PPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           +        I +  +  PE +F    +T   D++S G +  E++ G+
Sbjct: 186 E---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 19/216 (8%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILIN-EVFQHKMRIISQ 61
              Y+   ++G+G F  V + +        AVK     K      ++ E  + +  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 62  INHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQH-VRYQSSQVLKTWKTCLRIAAETAS 119
           + H ++V++L     +   L +V+EF+    L    V+   +  + +         +   
Sbjct: 83  LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 120 ALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIET 176
           AL Y H      IIH DVK   +LL   +++   K+  F  ++ +      A     + T
Sbjct: 142 ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGT 196

Query: 177 VGWLDPEYLFWT---EKSDVYSFGVVLVELLTGKHP 209
             ++ PE +      +  DV+  GV+L  LL+G  P
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG+GGFG V    +     + A KK +   +I   +     +   +I+ ++N + VV  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKQILEKVNSRFVVS- 248

Query: 71  LGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           L    ETK  L LV   +  G L  H+ +         +     AAE    L+ LH    
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YAAEICCGLEDLHRER- 306

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE 189
             I++ D+K  NILLDD+   +++D   +V +            + TVG++ PE +    
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNER 361

Query: 190 --KS-DVYSFGVVLVELLTGKHP 209
              S D ++ G +L E++ G+ P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSP 384

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 49/229 (21%), Positives = 94/229 (41%), Gaps = 42/229 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK-----KPKMVDKILINEVFQHKMR--- 57
            +NY+ + +LG G    V + +  P     AVK              + E+ +  ++   
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 58  IISQIN-HKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRY---QSSQVLKTWKT 109
           I+ +++ H N++++           LV++ +  G LF    + V     ++ ++++    
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA--- 132

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
                      +  LH L    I+H D+K  NILLDD+   K+ DF  S  +   ++   
Sbjct: 133 -------LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 170 TTKEIETVGWLDPEYLFW---------TEKSDVYSFGVVLVELLTGKHP 209
                 T  +L PE +            ++ D++S GV++  LL G  P
Sbjct: 183 V---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 15  LLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKM---RIISQINHKNVVKI 70
           +LG GGFG V+   +     L A KK     ++   + +Q  M   +I+++++ + +V  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNK-KRLKKRKGYQGAMVEKKILAKVHSRFIVS- 249

Query: 71  LGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALDYLHSLG 128
           L    ETK  L LV   +  G +  H+           +       A+  S L++LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWT 188
              II+ D+K  N+LLDD+   +++D   +V + +            T G++ PE L   
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGE 364

Query: 189 E--KS-DVYSFGVVLVELLTGKHP 209
           E   S D ++ GV L E++  + P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 59/293 (20%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVD---KILINEVFQHKMRII 59
           T+ Y     LG+G F  V + V +      A       K+     + L  E      RI 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA-----RIC 64

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRY---QSSQVLKTWKTCLR 112
             + H N+V++     E     L+++ V  G LF        Y    +S  ++       
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ------ 118

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTAT 169
                  A+ + H +G   ++H ++K  N+LL         K+ADF  ++ +    Q   
Sbjct: 119 ----ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171

Query: 170 TTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY 226
                 T G+L PE L    + +  D+++ GV+L  LL G                  P 
Sbjct: 172 GF--AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-----------------YPP 212

Query: 227 FPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           F    ++   +QI          E + +   AK L +K L  + ++R T  + 
Sbjct: 213 FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 43/226 (19%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMR----I 58
            + YD + ++G G    V + V        AVK              E  +   R    I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 59  ISQI-NHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRY---QSSQVLKTWKT 109
           + Q+  H +++ ++    E+   + LV++ +  G LF    + V     ++  ++++   
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS--- 208

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
                     A+ +LH+     I+H D+K  NILLDDN   +++DF  S  +   ++   
Sbjct: 209 -------LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 170 TTKEIETVGWLDPEYLFWT---------EKSDVYSFGVVLVELLTG 206
                 T G+L PE L  +         ++ D+++ GV+L  LL G
Sbjct: 259 L---CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 68/232 (29%)

Query: 10  YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMR------IISQIN 63
           Y    ++G G FG V++  L ++  VA+KK           V Q K        I+  + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKK-----------VLQDKRFKNRELQIMRIVK 90

Query: 64  HKNVVKILGVCLET-----KVPL-LVYEFVPNGTLFQ---------------HVRYQSSQ 102
           H NVV +            +V L LV E+VP  T+++                ++    Q
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASS-VL 160
           +L+              +L Y+HS+G   I H D+K  N+LLD  +   K+ DF S+ +L
Sbjct: 150 LLR--------------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

Query: 161 ISSHDQTATTTKEIETVGWL-DPEYLF-WTEKS---DVYSFGVVLVELLTGK 207
           I+           I +  +   PE +F  T  +   D++S G V+ EL+ G+
Sbjct: 193 IAGE----PNVSYICS-RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 48/224 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--------KPKMVDKILINEVFQHKMRII 59
           +Y     LG G FG V  G        VAVK           +V KI      + +++ +
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI------RREIQNL 70

Query: 60  SQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIA 114
               H +++K+  V + T   + +V E+V  G LF    ++ R    +  + ++  L   
Sbjct: 71  KLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL--- 126

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
               S +DY H      ++H D+K  N+LLD +  AK+ADF  S ++S  +   T     
Sbjct: 127 ----SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----- 174

Query: 175 ETVGWLDPEY---------LFWTEKSDVYSFGVVLVELLTGKHP 209
            + G   P Y         L+   + D++S GV+L  LL G  P
Sbjct: 175 -SCG--SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.8 bits (203), Expect = 3e-18
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 41/223 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK---ILINEVFQHKMRII 59
           + NYD +  LG+G F  V + V        A K     K+  +    L  E      RI 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA-----RIC 59

Query: 60  SQINHKNVVKILGVCLETKVPLLVYEFVPNGTLF----QHVRY---QSSQVLKTWKTCLR 112
            ++ H N+V++     E     LV++ V  G LF        Y    +S  ++       
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ 113

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTAT 169
                  ++ Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +    
Sbjct: 114 ----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166

Query: 170 TTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHP 209
                 T G+L PE L    +++  D+++ GV+L  LL G  P
Sbjct: 167 F---AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 55/227 (24%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVD--------KILINEVFQHKMR 57
             +Y     LG G +  V++ + + +N  V VK  K V         KIL N      +R
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN------LR 88

Query: 58  IISQINHKNVVKILGVCL--ETKVPLLVYEFVPNGTLFQ--------HVRYQSSQVLKTW 107
                   N++ +  +     ++ P LV+E V N    Q         +R+   ++LK  
Sbjct: 89  -----GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-- 141

Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQ 166
                       ALDY HS+G   I+H DVK  N+++D ++   ++ D+    L   +  
Sbjct: 142 ------------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHP 183

Query: 167 TATTTKEIETVGWLDPEYLF-WTEKS---DVYSFGVVLVELLTGKHP 209
                  + +  +  PE L  +       D++S G +L  ++  K P
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.4 bits (204), Expect = 5e-18
 Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 50/231 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKM--------- 56
              Y  +  +  G +G V  GV  +   VA+K+    V       +              
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEFV----------PNGTLF-QHVRYQS 100
           R+++  +H N++ +  + +  + P      LV E +              +  QH++Y  
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 101 SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL 160
             +L                L  LH  G   ++H D+   NILL DN    + DF    L
Sbjct: 141 YHILL--------------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN---L 180

Query: 161 ISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
                  A  T  +    +  PE +     +T+  D++S G V+ E+   K
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 81.6 bits (202), Expect = 9e-18
 Identities = 66/294 (22%), Positives = 110/294 (37%), Gaps = 62/294 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDK---ILINEVFQHKMRII 59
           + NYD +  LG+G F  V + V        A K     K+  +    L  E      RI 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA-----RIC 82

Query: 60  SQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRY---QSSQVLKTWKTCL 111
            ++ H N+V++     + +    LV++ V  G LF        Y    +S  ++      
Sbjct: 83  RKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ----- 136

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTA 168
                   ++ Y HS G   I+H ++K  N+LL         K+ADF  ++ ++  +   
Sbjct: 137 -----ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188

Query: 169 TTTKEIETVGWLDPEYL---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP 225
                  T G+L PE L    +++  D+++ GV+L  LL G                  P
Sbjct: 189 GF---AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG-----------------YP 228

Query: 226 YFPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            F    ++    QI          E + +   AK L    L  +  +R T  Q 
Sbjct: 229 PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 61/297 (20%)

Query: 7   TKNYD---KRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQ 61
            ++YD   K   LGEG F    K V    N   AVK   K ++     E+       +  
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI-----TALKL 61

Query: 62  I-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVR-------YQSSQVLKTWKTCLRI 113
              H N+VK+  V  +     LV E +  G LF+ ++        ++S +++        
Sbjct: 62  CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK------- 114

Query: 114 AAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATT 170
                SA+ ++H +G   ++H D+K  N+L    +DN   K+ DF  + L    +Q   T
Sbjct: 115 ---LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168

Query: 171 TKEIETVGWLDPEYLFWT---EKSDVYSFGVVLVELLTGKHP-----RSYVALASNEMTR 222
                T+ +  PE L      E  D++S GV+L  +L+G+ P     RS    ++ E+  
Sbjct: 169 P--CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-- 224

Query: 223 MVPYFPYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
                        +++I     + +    + +   AK L    L     +R  M  +
Sbjct: 225 -------------MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 63/293 (21%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDK-ILINEVFQHKMRIISQIN 63
           +  ++    LG G    VY+          A+K   K VDK I+  E+      ++ +++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI-----GVLLRLS 106

Query: 64  HKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRY---QSSQVLKTWKTCLRIAA 115
           H N++K+  +  ET   + LV E V  G LF    +   Y    ++  +K          
Sbjct: 107 HPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ--------- 156

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTK 172
               A+ YLH  G   I+H D+K  N+L      +   K+ADF  S ++  H     T  
Sbjct: 157 -ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTV- 210

Query: 173 EIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
              T G+  PE L    +  + D++S G++   LL G                   + P+
Sbjct: 211 -CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG-------------------FEPF 250

Query: 230 PIENNS---LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
             E       R+ILN +        +E+ + AK L  K +     +R T  Q 
Sbjct: 251 YDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 23/213 (10%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQI 62
             +YD    LG G FG V++          A K    P   DK    E  + +++ +S +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVL 211

Query: 63  NHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
            H  +V +     E    + ++YEF+  G LF+ V  + +++  +    +    +    L
Sbjct: 212 RHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGL 268

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQTATTTKEIETVGW 179
            ++H       +H D+K  NI+     +   K+ DF  +  +        T     T  +
Sbjct: 269 CHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEF 322

Query: 180 LDPE---YLFWTEKSDVYSFGVVLVELLTGKHP 209
             PE          +D++S GV+   LL+G  P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 55/283 (19%), Positives = 107/283 (37%), Gaps = 42/283 (14%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQI 62
              YD    LG G FG V++ V      +   K    P  +DK       ++++ I++Q+
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK----YTVKNEISIMNQL 105

Query: 63  NHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           +H  ++ +     E K  + L+ EF+  G LF  +  +  ++  +    +    +    L
Sbjct: 106 HHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKM--SEAEVINYMRQACEGL 162

Query: 122 DYLHSLGSPPIIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            ++H      I+H D+K  NI+       + K+ DF  +  ++  +    T     T  +
Sbjct: 163 KHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEF 216

Query: 180 LDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
             PE          +D+++ GV+   LL+G  P                 F    +  +L
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----------------FAGEDDLETL 259

Query: 237 RQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           + +       DE+    +   AK      L+    +R T+   
Sbjct: 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 54/290 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
           T  Y+ +  +G G +    + +    N   AVK   ++DK    +  +    ++    H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKR-DPTEEIEILLRYGQHP 76

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQS-------SQVLKTWKTCLRIAAETA 118
           N++ +  V  + K   +V E +  G L   +  Q        S VL T            
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT----------IT 126

Query: 119 SALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEI 174
             ++YLH+ G   ++H D+K +NIL      +  + ++ DF  +  + + +    T    
Sbjct: 127 KTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--C 181

Query: 175 ETVGWLDPEYLFWT---EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI 231
            T  ++ PE L         D++S GV+L  +LTG                  P+   P 
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG----------------YTPFANGPD 225

Query: 232 ENNS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           +     L +I + + +        +   AK L SK L     +R T   V
Sbjct: 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 44/225 (19%)

Query: 8   KNYDKRHLLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---R 57
           ++Y+   ++G G FG V     K       + A+K   K +M+ +   ++          
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKR---SDS-AFFWEERD 121

Query: 58  IISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQ--SSQVLKTWKTCLRIA 114
           I++  N   VV+ L    +    L +V E++P G L   +       +  + +       
Sbjct: 122 IMAFANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY------T 174

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
           AE   ALD +HS+G    IH DVK  N+LLD +   K+ADF + + ++        T   
Sbjct: 175 AEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--- 228

Query: 175 ETVG---WLDPEYLFWTEKSDVY-------SFGVVLVELLTGKHP 209
             VG   ++ PE L        Y       S GV L E+L G  P
Sbjct: 229 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 51/252 (20%), Positives = 88/252 (34%), Gaps = 51/252 (20%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           ++G G F  V     K       + A+K   K  M+ +    EV         ++   + 
Sbjct: 68  VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKR---GEV-SCFREERDVLVNGDR 120

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AAETASALD 122
           + + + L    + +  L LV E+   G L   +     ++        R   AE   A+D
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMAID 176

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
            +H LG    +H D+K  NILLD     ++ADF S + + +     +       VG   P
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVG--TP 227

Query: 183 EYL--------FWTEKSDVY-------SFGVVLVELLTGKHP---RSYVALASNEMTRMV 224
           +YL             +  Y       + GV   E+  G+ P    S        +    
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287

Query: 225 PYFPYPIENNSL 236
                P+ +  +
Sbjct: 288 H-LSLPLVDEGV 298

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 15  LLGEGGFGFVYKGVLPDNTLV-AVK---KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
            +G+G FG V      D   + A+K   K K V++  +  VF+   +I+  + H  +V  
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL-QIMQGLEHPFLVN- 79

Query: 71  LGVCLETKVPL-LVYEFVPNGTLFQHVRYQ---SSQVLKTWKTCLRIAAETASALDYLHS 126
           L    + +  + +V + +  G L  H++       + +K +        E   ALDYL +
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF------ICELVMALDYLQN 133

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETVGWLDPEY 184
                IIH D+K  NILLD++    + DF  + ++    Q  T   TK      ++ PE 
Sbjct: 134 QR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP-----YMAPEM 185

Query: 185 LFWTEKS------DVYSFGVVLVELLTGKHP 209
               + +      D +S GV   ELL G+ P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 48/222 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
            Y+   L+GEG +G V K        +VA+KK         V KI + E+     +++ Q
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI-----KLLKQ 80

Query: 62  INHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
           + H+N+V +L VC + K   LV+EFV           PNG  +Q V+    Q++      
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN----- 135

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     + + HS     IIH D+K  NIL+  +   K+ DF  +  +++  +    
Sbjct: 136 ---------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183

Query: 171 TKEIETVGWL-DPEYLFWTEK----SDVYSFGVVLVELLTGK 207
             E+ T  W   PE L    K     DV++ G ++ E+  G+
Sbjct: 184 --EVATR-WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 55/228 (24%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
            K Y     +G G  G V        +  VA+KK        ++  FQ++          
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--------LSRPFQNQTHAKRAYREL 112

Query: 57  RIISQINHKNVVKILGVCLETKVPL------LVYEF--------VPNGTLFQHVRYQSSQ 102
            ++  +NHKN++ +L V    K         LV E         +      + + Y   Q
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 172

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS 162
           +L                + +LHS G   IIH D+K +NI++  + T K+ DF    L  
Sbjct: 173 MLC--------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LAR 212

Query: 163 SHDQTATTTKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGK 207
           +   +   T  + T  +  PE +      E  D++S G ++ E++  K
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.1 bits (196), Expect = 4e-17
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 48/222 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
            Y+K   +GEG +G V+K        +VA+KK         + KI + E+     R++ Q
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-----RMLKQ 58

Query: 62  INHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
           + H N+V +L V    +   LV+E+              G     V+  + Q L+     
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ----- 113

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                    A+++ H       IH DVK  NIL+  +   K+ DF  + L++    +   
Sbjct: 114 ---------AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYY 159

Query: 171 TKEIETVGWL-DPEYLFWTEK----SDVYSFGVVLVELLTGK 207
             E+ T  W   PE L    +     DV++ G V  ELL+G 
Sbjct: 160 DDEVATR-WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 15  LLGEGGFGFVYKGVLPDN-TLVAVKKPKMVDKILINEVFQHKM---RIISQINHKN---V 67
           ++G GGFG VY     D   + A+K      +I + +     +    ++S ++  +   +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           V  +     T   L  + + +  G L  H+      V          AAE    L+++H+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRF-YAAEIILGLEHMHN 310

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                +++ D+K ANILLD++   +++D   +    S  +   +   + T G++ PE L 
Sbjct: 311 RF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQ 363

Query: 187 WTE---KS-DVYSFGVVLVELLTGKHP-RSYVALASNEMTRMV 224
                  S D +S G +L +LL G  P R +     +E+ RM 
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 24/217 (11%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK-----KPKMVDKILINEVFQHKMRIIS 60
              YD    LG G F  V K          A K     + +   + +  E  + ++ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           Q+ H N++ +  V  E +  + L+ E V  G LF  +  + S    + +       +   
Sbjct: 71  QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILD 126

Query: 120 ALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEIE 175
            ++YLH+     I H D+K  NI+L          K+ DF  +  I    +         
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI---FG 180

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHP 209
           T  ++ PE   Y     ++D++S GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINH 64
            Y  R  LGEG FG V           VA+K   +  +    +   V + ++  +  + H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRH 68

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
            +++K+  V + T   + +V E+   G LF ++     + +       R   +   A++Y
Sbjct: 69  PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYI--VEKKRMTE-DEGRRFFQQIICAIEY 123

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIETVGWLD 181
            H      I+H D+K  N+LLDDN   K+ADF  S +++  +   T+  +          
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS---------- 170

Query: 182 PEY---------LFWTEKSDVYSFGVVLVELLTGKHP 209
           P Y         L+   + DV+S G+VL  +L G+ P
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 8   KNYDKRHLLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---R 57
           ++++   ++G G FG V     K     + + A+K   K +M+ +    E          
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKR---AET-ACFREERD 126

Query: 58  IISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRI-AA 115
           ++   + K +   L    +    L LV ++   G L   +     ++ +      R   A
Sbjct: 127 VLVNGDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLA 182

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           E   A+D +H L     +H D+K  NIL+D N   ++ADF S + +       ++     
Sbjct: 183 EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV---- 235

Query: 176 TVG---WLDPEYLFWTEKS--------DVYSFGVVLVELLTGKHP 209
            VG   ++ PE L   E          D +S GV + E+L G+ P
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 38/214 (17%)

Query: 15  LLGEGGFGFVY---KGVLPD-NTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           +LG+G FG V+   K    D   L A+K   K  +  +   + V         I+ ++NH
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRV--RTKMERDILVEVNH 85

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
             +VK L    +T+  L L+ +F+  G LF  +      +           AE A ALD+
Sbjct: 86  PFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKF-YLAELALALDH 141

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWL 180
           LHSLG   II+ D+K  NILLD+    K+ DF  S     H++ A +   T E     ++
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-----YM 193

Query: 181 DPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            PE +    +      D +SFGV++ E+LTG  P
Sbjct: 194 APEVV--NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 49/221 (22%), Positives = 97/221 (43%), Gaps = 45/221 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
           + Y K   +GEG +G VYK       +VA+K+ ++      +    I E+      ++ +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI-----SLLKE 75

Query: 62  INHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
           ++H N+V ++ V    +   LV+EF+             G     ++    Q+L+     
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR----- 130

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     + + H      I+H D+K  N+L++ +   K+ADF  +       +  + 
Sbjct: 131 ---------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SY 176

Query: 171 TKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
           T E+ T+ +  P+ L  ++K     D++S G +  E++TGK
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 58/292 (19%)

Query: 7   TKNYD--KRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIIS 60
              Y   K  +LG G FG V+K         +A K      M DK    E  ++++ +++
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK----EEVKNEISVMN 141

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           Q++H N++++     E+K  + LV E+V  G LF  +  +S  +  T    +    +   
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTILFMKQICE 198

Query: 120 ALDYLHSLGSPPIIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
            + ++H +    I+H D+K  NIL    D    K+ DF  +      ++           
Sbjct: 199 GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NF 249

Query: 178 GWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
           G   PE+L        F +  +D++S GV+   LL+G                     P+
Sbjct: 250 G--TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-------------------LSPF 288

Query: 230 PIENNS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
             +N++  L  IL  +   ++ E ++I   AK   SK L    + R +  + 
Sbjct: 289 LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 24/217 (11%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK-----KPKMVDKILINEVFQHKMRIIS 60
              YD    LG G F  V K          A K     + +   + +  E  + ++ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           Q+ H NV+ +  V  E +  + L+ E V  G LF  +  + S    + +       +   
Sbjct: 71  QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILD 126

Query: 120 ALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTTKEIE 175
            ++YLH+     I H D+K  NI+L          K+ DF  +  I    +         
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI---FG 180

Query: 176 TVGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHP 209
           T  ++ PE   Y     ++D++S GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 57/229 (24%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
            K Y     +G G  G V           VA+KK        ++  FQ++          
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--------LSRPFQNQTHAKRAYREL 75

Query: 57  RIISQINHKNVVKILGVCLETKVPL------LVYEFVPNGTLFQ---------HVRYQSS 101
            ++  +NHKN++ +L V    K         +V E +    L Q          + Y   
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY 134

Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
           Q+L                + +LHS G   IIH D+K +NI++  + T K+ DF    L 
Sbjct: 135 QMLC--------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LA 174

Query: 162 SSHDQTATTTKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGK 207
            +   +   T  + T  +  PE +      E  D++S G ++ E++ G 
Sbjct: 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 58/303 (19%), Positives = 97/303 (32%), Gaps = 93/303 (30%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
              Y+ RHL+G G +G V +     +  +VA+KK        I  VF+  +         
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--------ILRVFEDLIDCKRILREI 103

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEFVP---------NGTL-FQHVRYQSS 101
            I++++NH +VVK+L + +   V       +V E               L   H++    
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163

Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF------ 155
            +L                + Y+HS G   I+H D+K AN L++ + + KV DF      
Sbjct: 164 NLLV--------------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

Query: 156 --ASSVLISSHDQTATTTKEIETVGWLDPEYLFWTE--------------------KS-D 192
               +               + T           T                     ++ D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266

Query: 193 VYSFGVVLVELLTGKHP--------------RSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           V+S G +  ELL                    S   L+ ++       F      + L  
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326

Query: 239 ILN 241
           I N
Sbjct: 327 IFN 329

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           LLG+G FG V     K         A+K   K  +V K   +EV  H +   R++    H
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAK---DEV-AHTLTENRVLQNSRH 207

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
             +   L    +T   L  V E+   G LF H+     +V    +      AE  SALDY
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-YGAEIVSALDY 263

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWL 180
           LHS  +  +++ D+K  N++LD +   K+ DF           T  T   T E     +L
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----YL 316

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
            PE L    +    D +  GVV+ E++ G+ P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.8 bits (190), Expect = 3e-16
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 34/213 (15%)

Query: 15  LLGEGGFGFVY---KGVLPD-NTLVAVK---KPKMVDKILINEVFQHKM--RIISQINHK 65
           +LG+GG+G V+   K    +   + A+K   K  +V      +    K    I+ ++ H 
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHP 81

Query: 66  NVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            +V  L    +T   L L+ E++  G LF  +  +   +      C    AE + AL +L
Sbjct: 82  FIVD-LIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACF-YLAEISMALGHL 137

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLD 181
           H  G   II+ D+K  NI+L+     K+ DF              T   T E     ++ 
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE-----YMA 189

Query: 182 PEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           PE L           D +S G ++ ++LTG  P
Sbjct: 190 PEIL--MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 76/332 (22%), Positives = 116/332 (34%), Gaps = 67/332 (20%)

Query: 7   TKNYD-KRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQI 62
           T +Y   + +LG G  G V +          A+   K++        EV  H        
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCAL---KLLYDSPKARQEVDHHWQA----S 79

Query: 63  NHKNVVKILGVC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
              ++V IL V        +  L++ E +  G LF  ++ +  Q   T +    I  +  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-TEREAAEIMRDIG 138

Query: 119 SALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIE 175
           +A+ +LHS     I H DVK  N+L    + +   K+ DF  +           T     
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTP--CY 191

Query: 176 TVGWLDPEYLFWT---EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF----P 228
           T  ++ PE L      +  D++S GV++  LL G  P                 F     
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----------------FYSNTG 234

Query: 229 YPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV--------- 277
             I     R+I   Q      E  E+   AK L    L+T  TER T+ Q          
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

Query: 278 ----SEQLDSLRRLHE--NFWAQKNSEETEQL 303
                  L + R L E  + W +   E T  L
Sbjct: 295 MVVPQTPLHTARVLQEDKDHWDEVKEEMTSAL 326

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 40/214 (18%)

Query: 15  LLGEGGFGFV----YKGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           LLG+G FG V     K         A+K   K  ++ K   +EV  H +   R++    H
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAK---DEV-AHTVTESRVLQNTRH 64

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
             +   L    +T   L  V E+   G LF H+     +V    +      AE  SAL+Y
Sbjct: 65  PFLTA-LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARF-YGAEIVSALEY 120

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWL 180
           LHS     +++ D+K  N++LD +   K+ DF       S   T  T   T E     +L
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----YL 172

Query: 181 DPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
            PE L   +       D +  GVV+ E++ G+ P
Sbjct: 173 APEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 40/224 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
            Y+K   +G+G FG V+K         VA+KK  M           + E+     +I+  
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI-----KILQL 72

Query: 62  INHKNVVKILGVCLETKVPL--------LVYEFVPN--GTLFQH--VRYQSSQVLKTWKT 109
           + H+NVV ++ +C     P         LV++F  +    L  +  V++  S++    K 
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI----KR 128

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQT 167
            ++      + L Y+H      I+H D+K+AN+L+  +   K+ADF  A +  ++ + Q 
Sbjct: 129 VMQ---MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 168 ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
              T  + T+ +  PE L     +    D++  G ++ E+ T  
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 34/215 (15%)

Query: 15  LLGEGGFGFVY---KGVLPD-NTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
           +LG G +G V+   K    D   L A+K   K  +V K    +  +H     +++  I  
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK---AKTTEHTRTERQVLEHIRQ 117

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
              +  L    +T+  L L+ +++  G LF H+     +     +  +    E   AL++
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQI-YVGEIVLALEH 174

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATT---TKEIETVGW 179
           LH LG   II+ D+K  NILLD N    + DF  S   ++   + A     T E     +
Sbjct: 175 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE-----Y 226

Query: 180 LDPEYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           + P+ +   +       D +S GV++ ELLTG  P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 75.2 bits (186), Expect = 7e-16
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 46/224 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIIS 60
           + Y+K   +GEG +G V+K      + +VA+K+ ++      V    + E+      ++ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI-----CLLK 56

Query: 61  QINHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKT 109
           ++ HKN+V++  V    K   LV+EF                  + V+    Q+LK    
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK---- 112

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT 169
                      L + HS     ++H D+K  N+L++ N   K+A+F  +       +   
Sbjct: 113 ----------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY- 158

Query: 170 TTKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGKHP 209
            + E+ T+ +  P+ LF  +      D++S G +  EL     P
Sbjct: 159 -SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.3 bits (186), Expect = 9e-16
 Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 32/217 (14%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQIN 63
            + Y     LG G FG V++ V          K  K K  D+     + + ++ I++   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIAR 59

Query: 64  HKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           H+N++ +     E+   L +++EF+    +F+  R  +S      +  +    +   AL 
Sbjct: 60  HRNILHLHESF-ESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQ 116

Query: 123 YLHSLGSPPIIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
           +LHS     I H D++  NI+     + T K+ +F  +  +   D               
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL------LFT-- 165

Query: 181 DPEYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
            PEY           +  +D++S G ++  LL+G +P
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 55/226 (24%), Positives = 82/226 (36%), Gaps = 42/226 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILIN--EVFQHKMRIIS 60
              YD    LG G F  V K          A K   K +          E  + ++ I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAA 115
           +I H NV+ +  V  E K  + L+ E V  G LF    +       +  +  K  L    
Sbjct: 70  EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL---- 124

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTT 171
              + + YLHSL    I H D+K  NI+L          K+ DF  +  I          
Sbjct: 125 ---NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKN- 176

Query: 172 KEIETVGWLDPEYL--------FWTEKSDVYSFGVVLVELLTGKHP 209
                 G   PE++            ++D++S GV+   LL+G  P
Sbjct: 177 ----IFG--TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 42/223 (18%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILIN--EVFQHKMRIIS 60
             +Y+    LG G F  V K          A K   K ++         E  + ++ I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 61  QINHKNVVKILGVCLETKVPL-LVYEFVPNGTLF----QHVRYQSSQVLKTWKTCLRIAA 115
           +I H N++ +  +  E K  + L+ E V  G LF    +       +  +  K  L    
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL---- 118

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASSVLISSHDQTATTT 171
                + YLHS     I H D+K  NI+L      N   K+ DF  +  I + ++     
Sbjct: 119 ---DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170

Query: 172 KEIETVGWLDPEYL--------FWTEKSDVYSFGVVLVELLTG 206
                 G   PE++            ++D++S GV+   LL+G
Sbjct: 171 ----IFG--TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 45/221 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
           + Y     +GEG +G VYK         A+KK ++      +    I E+      I+ +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI-----SILKE 56

Query: 62  INHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
           + H N+VK+  V    K  +LV+E +             G      +    Q+L      
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN----- 111

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     + Y H      ++H D+K  N+L++     K+ADF  +       +    
Sbjct: 112 ---------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-- 157

Query: 171 TKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
           T EI T+ +  P+ L  ++K     D++S G +  E++ G 
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 70/322 (21%), Positives = 106/322 (32%), Gaps = 69/322 (21%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKN 66
                +LG G  G V +          A+   KM+        EV  H           +
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL---KMLQDCPKARREVELHWR----ASQCPH 116

Query: 67  VVKILGVCLETKVP----LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           +V+I+ V           L+V E +  G LF  ++ +  Q   T +    I      A+ 
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQ 175

Query: 123 YLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           YLHS+    I H DVK  N+L      N   K+ DF  +   +SH+   T          
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT------PCYT 226

Query: 180 LD---PEYLFWT---EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF----PY 229
                PE L      +  D++S GV++  LL G                  P F      
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-----------------YPPFYSNHGL 269

Query: 230 PIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV---------- 277
            I      +I   Q      E  E+    K L    L+T  T+R T+ +           
Sbjct: 270 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

Query: 278 ---SEQLDSLRRLHENFWAQKN 296
                 L + R L E+    ++
Sbjct: 330 KVPQTPLHTSRVLKEDKERWED 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 34/194 (17%)

Query: 106 TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD 165
           T +  +  + + A  +++L S      IH D+ + NILL +    K+ DF  +  I    
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR 222
                      + W+ PE +F   +T +SDV+SFGV+L E+ +         L ++    
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGAS---- 294

Query: 223 MVPYFPYP-IENNSLRQILNFQVADENEMEEIEI----VAKLASKCLRTSGTERPTMRQV 277
                PYP ++ +   +     + +   M   +     + +    C     ++RPT  ++
Sbjct: 295 -----PYPGVKIDE--EFCRR-LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 278 SEQLDSLRRLHENF 291
            E L +L  L  N 
Sbjct: 347 VEHLGNL--LQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 28/92 (30%), Positives = 40/92 (43%), Gaps = 8/92 (8%)

Query: 14  HLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKN 66
             LG G FG V +              VAVK  K       +     +++I+  I +H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 67  VVKILGVCLETKVPLLV-YEFVPNGTLFQHVR 97
           VV +LG C +   PL+V  EF   G L  ++R
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 42/226 (18%)

Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM-----VDKILINEVFQHKMR 57
           + ++  + +   LG G +  VYKG+       VA+K+ K+          I E+      
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI-----S 55

Query: 58  IISQINHKNVVKILGVCLETKVPLLVYEFVP--------NGTLFQHVRYQSSQVLKTWKT 109
           ++ ++ H+N+V++  V        LV+EF+         + T+    R     ++K +  
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF-- 113

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF----ASSVLISSHD 165
                 +    L + H      I+H D+K  N+L++     K+ DF    A  +      
Sbjct: 114 ----QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI------ 160

Query: 166 QTATTTKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
              T + E+ T+ +  P+ L  +       D++S G +L E++TGK
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 53/271 (19%), Positives = 93/271 (34%), Gaps = 80/271 (29%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
             NY  +HL+G G +G+VY          VA+KK        +N +F+  +         
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK--------VNRMFEDLIDCKRILREI 76

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEFVP---------NGTL-FQHVRYQSS 101
            I++++    ++++  + +   +       +V E               L  +H++    
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136

Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
            +L                 +++H  G   IIH D+K AN LL+ + + KV DF  +  I
Sbjct: 137 NLLL--------------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 162 SSHDQTATTTKEIETVGWLDP---------EY------------LFW---TEKSDVYSFG 197
           +S   T       E                 +            L     T+  D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 198 VVLVELLTGKHPRSYVALASNEMTRMVPYFP 228
            +  ELL             N+ T   P FP
Sbjct: 240 CIFAELLNMLQS------HINDPTNRFPLFP 264

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 52/266 (19%), Positives = 91/266 (34%), Gaps = 97/266 (36%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMR------II 59
           +K Y     LG G FG V +   +      A+KK           V Q          I+
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-----------VLQDPRYKNRELDIM 54

Query: 60  SQINHKNVVKILGVCLETKVPL-------------------------------------- 81
             ++H N++K++     T                                          
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 82  LVYEFVPNGTLFQ---------------HVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           ++ E+VP+ TL +                +     Q+ +              A+ ++HS
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR--------------AVGFIHS 159

Query: 127 LGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           LG   I H D+K  N+L++  + T K+ DF S+  +   +    +   I +  +  PE +
Sbjct: 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELM 213

Query: 186 F----WTEKSDVYSFGVVLVELLTGK 207
                +T   D++S G V  EL+ GK
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGK 239

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.4 bits (181), Expect = 5e-15
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 45/221 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKM-----VDKILINEVFQHKMRIISQ 61
           + Y K   LGEG +  VYKG     + LVA+K+ ++          I EV      ++  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV-----SLLKD 56

Query: 62  INHKNVVKILGVCLETKVPLLVYEFV-----------PNGTLFQHVRYQSSQVLKTWKTC 110
           + H N+V +  +    K   LV+E++            N     +V+    Q+L+     
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR----- 111

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                     L Y H      ++H D+K  N+L+++    K+ADF  +   S   +T   
Sbjct: 112 ---------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

Query: 171 TKEIETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
             E+ T+ +  P+ L  +       D++  G +  E+ TG+
Sbjct: 160 --EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.1 bits (180), Expect = 7e-15
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 58/229 (25%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
            K Y     +G G +G V   +       VA+KK        ++  FQ ++         
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--------LSRPFQSEIFAKRAYREL 74

Query: 57  RIISQINHKNVVKILGVCLETKVPL------LVYEF--------VPNGTLFQHVRYQSSQ 102
            ++  + H+NV+ +L V              LV  F        +      + ++Y   Q
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ 134

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS 162
           +LK               L Y+HS G   ++H D+K  N+ ++++   K+ DF  +    
Sbjct: 135 MLK--------------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177

Query: 163 SHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           +       T  + T  +  PE +     + +  D++S G ++ E+LTGK
Sbjct: 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 37/213 (17%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQ-IN 63
           ++G+G FG V     K    +    AVK   K  ++ K    E  +H M    ++ + + 
Sbjct: 45  VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKK---KEE-KHIMSERNVLLKNVK 97

Query: 64  HKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           H  +V  L    +T   L  V +++  G LF H+  Q  +     +     AAE ASAL 
Sbjct: 98  HPFLVG-LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALG 153

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGW 179
           YLHSL    I++ D+K  NILLD      + DF        H+ T +T   T E     +
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-----Y 205

Query: 180 LDPEYLFWTE--KS-DVYSFGVVLVELLTGKHP 209
           L PE L      ++ D +  G VL E+L G  P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM------VDKILINEVFQHKMRIISQ 61
            Y +   LGEG +G VYK +    N  VA+K+ ++      V    I EV      ++ +
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV-----SLLKE 89

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPN---GTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           + H+N++++  V        L++E+  N     + ++       +    K+ L    +  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVI----KSFLY---QLI 142

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTA-----KVADFASSVLISSHDQTATTTKE 173
           + +++ HS      +H D+K  N+LL  +  +     K+ DF  +       +    T E
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THE 197

Query: 174 IETVGWLDPEYLFWTEK----SDVYSFGVVLVELLTGK 207
           I T+ +  PE L  +       D++S   +  E+L   
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 63/230 (27%)

Query: 9   NYDKRHLLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RI 58
            +D+   LG G FG V     K         A+K   K K+V      ++ +H +   RI
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKL---KQI-EHTLNEKRI 94

Query: 59  ISQINHKNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAET 117
           +  +N   +VK+     +    L +V E+V  G +F H+R                AA+ 
Sbjct: 95  LQAVNFPFLVKLEF-SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARF-YAAQI 150

Query: 118 ASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV 177
               +YLHSL    +I+ D+K  N+L+D     +V DF  +             K ++  
Sbjct: 151 VLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA-------------KRVKGR 194

Query: 178 GWL---DPEYL---------------FWTEKSDVYSFGVVLVELLTGKHP 209
            W     PE L               +W       + GV++ E+  G  P
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWW-------ALGVLIYEMAAGYPP 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 74/248 (29%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI 62
            + Y+    LG+G +G V+K +      +VAVKK        I + FQ+     R   +I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK--------IFDAFQNSTDAQRTFREI 59

Query: 63  -------NHKNVVKILGVCL--ETKVPLLVYEFVPNGT-LFQ----------HVRYQSSQ 102
                   H+N+V +L V      +   LV++++   T L            H +Y   Q
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVL 160
           ++K               + YLHS G   ++H D+K +NILL+     KVADF  + S +
Sbjct: 118 LIK--------------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160

Query: 161 ISSHDQTATTTKEIETVGWLDPEYLFWTE---------------------KSDVYSFGVV 199
                         E     D +    T+                       D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220

Query: 200 LVELLTGK 207
           L E+L GK
Sbjct: 221 LGEILCGK 228

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQIN-HKN 66
           +LG+G FG V     KG    + L AVK  K  D ++ ++  +  M   R+++       
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVKILKK-DVVIQDDDVECTMVEKRVLALPGKPPF 403

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           + + L  C +T   L  V E+V  G L  H+  Q     K        AAE A  L +L 
Sbjct: 404 LTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVF-YAAEIAIGLFFLQ 459

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
           S G   II+ D+K  N++LD     K+ADF           T  T   T +     ++ P
Sbjct: 460 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----YIAP 511

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E +    +      D ++FGV+L E+L G+ P
Sbjct: 512 EII--AYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 49/237 (20%), Positives = 88/237 (37%), Gaps = 62/237 (26%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
           + ++  + LLGEG +G V      P   +VA+KK        I   F   +         
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IE-PFDKPLFALRTLREI 60

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEFVP--------NGTL-FQHVRYQSSQ 102
           +I+    H+N++ I  +             ++ E +            L   H++Y   Q
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF------- 155
            L+              A+  LH      +IH D+K +N+L++ N   KV DF       
Sbjct: 121 TLR--------------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 156 -ASSVLISSHDQTATTTKEIETVGWLDPEYLFW----TEKSDVYSFGVVLVELLTGK 207
            +++       Q +   + + T  +  PE +      +   DV+S G +L EL   +
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 63/224 (28%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVK---KPKMVDKILINEVFQHKM---RIISQINH 64
            LG G FG V+    +    +    A+K   K  +V      +V +H      ++S + H
Sbjct: 13  TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRL---KQV-EHTNDERLMLSIVTH 65

Query: 65  KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
             ++++ G   +    + ++ +++  G LF  +R   SQ           AAE   AL+Y
Sbjct: 66  PFIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKF-YAAEVCLALEY 121

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWL--- 180
           LHS     II+ D+K  NILLD N   K+ DF  +             K +  V +    
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFA-------------KYVPDVTYTLCG 165

Query: 181 DPEYL---------------FWTEKSDVYSFGVVLVELLTGKHP 209
            P+Y+               +W       SFG+++ E+L G  P
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWW-------SFGILIYEMLAGYTP 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 45/223 (20%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVF-QHKMRIIS---QI 62
           K Y+K   LGEG F  VYK      N +VA+KK K+  +    +   +  +R I    ++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVP---------NGTLF--QHVRYQSSQVLKTWKTCL 111
           +H N++ +L          LV++F+          N  +    H++      L+      
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ------ 123

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF--ASSVLISSHDQTAT 169
                    L+YLH      I+H D+K  N+LLD+N   K+ADF  A S    +      
Sbjct: 124 --------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----A 168

Query: 170 TTKEIETVGWL-DPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            T ++ T  W   PE LF    +    D+++ G +L ELL   
Sbjct: 169 YTHQVVTR-WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI-NHKN 66
           +LG+G FG V     K       L AVK  K  D IL ++  +  M   RI+S   NH  
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPF 85

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           + + L  C +T   L  V EFV  G L  H+  Q S+     +     AAE  SAL +LH
Sbjct: 86  LTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEIISALMFLH 141

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
             G   II+ D+K  N+LLD     K+ADF        +  T  T   T +     ++ P
Sbjct: 142 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-----YIAP 193

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E L   E       D ++ GV+L E+L G  P
Sbjct: 194 EIL--QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 56/288 (19%), Positives = 97/288 (33%), Gaps = 46/288 (15%)

Query: 7   TKNYD-KRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQ 61
              Y      LG G F  V + +        A K   K +            H++ ++  
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR--AEILHEIAVLEL 84

Query: 62  INH-KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
                 V+ +  V  E    + L+ E+   G +F     + ++++ +    +R+  +   
Sbjct: 85  AKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMV-SENDVIRLIKQILE 142

Query: 120 ALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            + YLH      I+H D+K  NILL         K+ DF  S  I    +       + T
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---MGT 196

Query: 177 VGWLDPE---YLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
             +L PE   Y   T  +D+++ G++   LLT                      P+  E+
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTH-------------------TSPFVGED 237

Query: 234 NS--LRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           N      I    V   E     +  +A       L  +  +RPT    
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 59/230 (25%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
              Y     +G G +G V   V       VA+KK        +   FQ ++         
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--------LYRPFQSELFAKRAYREL 75

Query: 57  RIISQINHKNVVKILGVCLETKVPL------LVYEF--------VPNGTLF-QHVRYQSS 101
           R++  + H+NV+ +L V    +         LV  F        + +  L    +++   
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 135

Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
           Q+LK               L Y+H+ G   IIH D+K  N+ ++++   K+ DF  +   
Sbjct: 136 QMLK--------------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178

Query: 162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            S       T  + T  +  PE +     +T+  D++S G ++ E++TGK
Sbjct: 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQ-INHKN 66
           +LG+G FG V    +K     N   A+K  K  D +L+++  +  M   R++S    H  
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +   +    +TK  L  V E++  G L  H+  QS       +     AAE    L +LH
Sbjct: 80  LTH-MFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF-YAAEIILGLQFLH 135

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
           S G   I++ D+K  NILLD +   K+ADF         D    T   T +     ++ P
Sbjct: 136 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-----YIAP 187

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E L    +      D +SFGV+L E+L G+ P
Sbjct: 188 EIL--LGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 48/227 (21%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKM-VDKILINEVFQHKMRIIS------ 60
            Y+    +G G +G VYK         VA+K  ++         +    +R ++      
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 61  QINHKNVVKILGVCLETKVPL-----LVYEFVP----------NGTLFQ--HVRYQSSQV 103
              H NVV+++ VC  ++        LV+E V                    ++    Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 104 LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS 163
           L+               LD+LH+     I+H D+K  NIL+    T K+ADF    L   
Sbjct: 130 LR--------------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG---LARI 169

Query: 164 HDQTATTTKEIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGK 207
           +      T  + T+ +  PE L  +  +   D++S G +  E+   K
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 60/223 (26%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHK---- 65
           ++G+G FG V K      +  VA+K    + +   +    E+     RI+  +  +    
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EI-----RILEHLRKQDKDN 157

Query: 66  --NVVKILG-------VCLETKVPLL---VYEFVPNGTL----FQHVRYQSSQVLKTWKT 109
             NV+ +L        +C+     LL   +YE +            VR  +  +L+    
Sbjct: 158 TMNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ---- 211

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLISSHDQT 167
                      LD LH      IIH D+K  NILL     +  KV DF SS       Q 
Sbjct: 212 ----------CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQR 255

Query: 168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
             T   I++  +  PE +    +    D++S G +L ELLTG 
Sbjct: 256 VYT--YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 47/230 (20%), Positives = 90/230 (39%), Gaps = 55/230 (23%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
              Y     +GEG +G V       +   VA+KK        I+  F+H+          
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------IS-PFEHQTYCQRTLREI 76

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEF--------VPNGTL-FQHVRYQSSQ 102
           +I+ +  H+N++ I  +     +       +V +         +    L   H+ Y   Q
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS 162
           +L+               L Y+HS     ++H D+K +N+LL+     K+ DF  + +  
Sbjct: 137 ILR--------------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

Query: 163 SHDQTATT-TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
                    T+ + T  +  PE +     +T+  D++S G +L E+L+ +
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.3 bits (173), Expect = 5e-14
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI-NHKN 66
           ++G G +  V     K     + + A+K  K  + +  +E          +  Q  NH  
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +V  L  C +T+  L  V E+V  G L  H+  Q  + L         +AE + AL+YLH
Sbjct: 72  LVG-LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARF-YSAEISLALNYLH 127

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
             G   II+ D+K  N+LLD     K+ D+           T +T   T       ++ P
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----YIAP 179

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E L    +      D ++ GV++ E++ G+ P
Sbjct: 180 EIL--RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.3 bits (173), Expect = 5e-14
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 50/231 (21%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGVLPDNT--LVAVKKPKM------VDKILINEVFQHKM 56
           +A + Y+    +GEG +G V+K     N    VA+K+ ++      +    I EV    +
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--AVL 65

Query: 57  RIISQINHKNVVKILGVCLETKVPL-----LVYEFV-----------PNGTL-FQHVRYQ 99
           R +    H NVV++  VC  ++        LV+E V           P   +  + ++  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 100 SSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV 159
             Q+L+               LD+LHS     ++H D+K  NIL+  +   K+ADF    
Sbjct: 126 MFQLLR--------------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG--- 165

Query: 160 LISSHDQTATTTKEIETVGWLDPEYLFWTEKS---DVYSFGVVLVELLTGK 207
           L   +      T  + T+ +  PE L  +  +   D++S G +  E+   K
Sbjct: 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 66/240 (27%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
              Y     LG GG G V+  V    +  VA+KK        I  V              
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--------I--VLTDPQSVKHALREI 59

Query: 57  RIISQINHKNVVKILGVCLETKVPL--------------LVYEFVP--------NGTLF- 93
           +II +++H N+VK+  +   +   L              +V E++          G L  
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 94  QHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKV 152
           +H R    Q+L+               L Y+HS     ++H D+K AN+ ++ ++   K+
Sbjct: 120 EHARLFMYQLLR--------------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162

Query: 153 ADFA-SSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            DF  + ++   +      ++ + T  +  P  L     +T+  D+++ G +  E+LTGK
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFVY----KGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI-NHKN 66
           ++G G +  V     K     + + A++  K  + +  +E          +  Q  NH  
Sbjct: 59  VIGRGSYAKVLLVRLKK---TDRIYAMRVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPF 114

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           +V  L  C +T+  L  V E+V  G L  H+  Q  + L         +AE + AL+YLH
Sbjct: 115 LVG-LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARF-YSAEISLALNYLH 170

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
             G   II+ D+K  N+LLD     K+ D+           T +T   T       ++ P
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----YIAP 222

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E L    +      D ++ GV++ E++ G+ P
Sbjct: 223 EIL--RGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 15  LLGEGGFGFV----YKGVLPDNTLVAVKKPKMVDKILINEVFQHKM---RIISQI-NHKN 66
           +LG+G FG V     KG    + L AVK  K  D ++ ++  +  M   R+++       
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKILKK-DVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 67  VVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           + + L  C +T   L  V E+V  G L  H+  Q     K        AAE A  L +L 
Sbjct: 83  LTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVF-YAAEIAIGLFFLQ 138

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT---TKEIETVGWLDP 182
           S G   II+ D+K  N++LD     K+ADF           T  T   T +     ++ P
Sbjct: 139 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----YIAP 190

Query: 183 EYLFWTEKS-----DVYSFGVVLVELLTGKHP 209
           E +    +      D ++FGV+L E+L G+ P
Sbjct: 191 EII--AYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 59/230 (25%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKM--------- 56
            + Y     +G G +G V           VAVKK        ++  FQ  +         
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--------LSRPFQSIIHAKRTYREL 79

Query: 57  RIISQINHKNVVKILGVCLETKVPL------LVYEFVP---------NGTLFQHVRYQSS 101
           R++  + H+NV+ +L V    +         LV   +                HV++   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139

Query: 102 QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
           Q+L+               L Y+HS     IIH D+K +N+ ++++   K+ DF  +   
Sbjct: 140 QILR--------------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182

Query: 162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
           +        T  + T  +  PE +     + +  D++S G ++ ELLTG+
Sbjct: 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 68/331 (20%), Positives = 106/331 (32%), Gaps = 102/331 (30%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKN 66
                +LG G  G V +          A+   KM+        EV        SQ    +
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL---KMLQDCPKARREV--ELHWRASQ--CPH 72

Query: 67  VVKILGVCLETKVP-----LLVYEFVPNGTLFQ------HVRY---QSSQVLKTWKTCLR 112
           +V+I+ V  E         L+V E +  G LF          +   ++S+++K+      
Sbjct: 73  IVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS------ 125

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADF--ASSVLISSHDQT 167
                  A+ YLHS+    I H DVK  N+L      N   K+ DF  A       +D  
Sbjct: 126 ----IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD-- 176

Query: 168 ATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
                                +  D++S GV++  LL G  P                 F
Sbjct: 177 ---------------------KSCDMWSLGVIMYILLCGYPP-----------------F 198

Query: 228 ----PYPIENNSLRQILNFQVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV---- 277
                  I      +I   Q      E  E+    K L    L+T  T+R T+ +     
Sbjct: 199 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

Query: 278 ---------SEQLDSLRRLHENFWAQKNSEE 299
                       L + R L E+    ++ +E
Sbjct: 259 WIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 54/228 (23%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK----KPKMVD------KIL--INEVFQHKMRIISQ 61
            LG G F  V+    + +NT VA+K         +      K+L  +N+    K      
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE---DS 82

Query: 62  INHKNVVKILG-----------VCLETKVPLLVYEFV-PNGTLFQHVRYQSSQVLKTWKT 109
           +   +++K+L            V +       V+E +  N  L   ++    + +     
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVM-------VFEVLGEN--LLALIKKYEHRGIPL-IY 132

Query: 110 CLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD------NYTAKVADFASSVLISS 163
             +I+ +    LDY+H      IIH D+K  N+L++           K+AD  ++     
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190

Query: 164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKH 208
           H      T  I+T  +  PE L    W   +D++S   ++ EL+TG  
Sbjct: 191 H-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 58/228 (25%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINH 64
           Y+   L+G+G FG V K     +   VA+K    K   +++  I EV     R++  +N 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EV-----RLLELMNK 109

Query: 65  ------KNVVKILG-------VCLETKVPLL---VYEFV----PNGTLFQHVRYQSSQVL 104
                   +V +         +CL     +L   +Y+ +      G      R  + Q+ 
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVF--EMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 105 KTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA--KVADFASSVLIS 162
                          AL +L +     IIH D+K  NILL +   +  K+ DF SS  + 
Sbjct: 168 T--------------ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212

Query: 163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK 207
                    + I++  +  PE L    +    D++S G +LVE+ TG+
Sbjct: 213 QR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 49/236 (20%), Positives = 82/236 (34%), Gaps = 68/236 (28%)

Query: 15  LLGEGGFGFVYKGV--LPDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHK--- 65
            LGEG FG V + +      + VA+K      K  +   + E+      ++ +I  K   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EI-----NVLKKIKEKDKE 79

Query: 66  ---NVVKILG-------VCLETKVPLL---VYEFVPN----GTLFQHVRYQSSQVLKTWK 108
                V +         +C+     LL    +EF+           HVR+ + Q+     
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAF--ELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH--- 134

Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTA 168
                      AL +LH      + H D+K  NIL  ++    + +   S    S   T+
Sbjct: 135 -----------ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 169 -------TTTKEIETVGWLD-------PEYLF---WTEKSDVYSFGVVLVELLTGK 207
                  + T + E    +        PE +    W +  DV+S G +L E   G 
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 40/234 (17%)

Query: 1   SELVKATKNYDK-RHLLGEGGFGFVYKGV---LPDNTLVAVKKPKMVDKILINEVFQHKM 56
           SE  +    ++     +G G +G VYK       D+   A+K+ +      I+     ++
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREI 69

Query: 57  RIISQINHKNVVKILGVCLETKVPL--LVYEFV------------PNGTLFQHVRYQSSQ 102
            ++ ++ H NV+ +  V L        L++++              +    + V+     
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129

Query: 103 VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA----KVADFASS 158
           V    K+ L    +    + YLH+     ++H D+K ANIL+          K+AD   +
Sbjct: 130 V----KSLLY---QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179

Query: 159 VLISSHDQTATT-TKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGK 207
            L +S  +        + T  +  PE L     +T+  D+++ G +  ELLT +
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 52/249 (20%), Positives = 84/249 (33%), Gaps = 94/249 (37%)

Query: 15  LLGEGGFGFVYKGV--LPDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINHK--- 65
            LGEG FG V + +        VAVK      +  +     E+     +++  +N     
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EI-----QVLEHLNTTDPN 74

Query: 66  ---NVVKILG-------VCLETKVPLL---VYEFVPN----GTLFQHVRYQSSQVLKTWK 108
                V++L        +C+     LL    Y+F+           H+R  + Q+ K   
Sbjct: 75  STFRCVQMLEWFEHHGHICIVF--ELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK--- 129

Query: 109 TCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA------------------ 150
                      ++++LHS     + H D+K  NIL   +                     
Sbjct: 130 -----------SVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 151 -KVADFASSVL----ISSHDQT----ATTTKEIETVGWLDPE---YLFWTEKSDVYSFGV 198
            KV DF S+       S+   T    A             PE    L W++  DV+S G 
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRA-------------PEVILALGWSQPCDVWSIGC 222

Query: 199 VLVELLTGK 207
           +L+E   G 
Sbjct: 223 ILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 58/240 (24%), Positives = 84/240 (35%), Gaps = 72/240 (30%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVK----KPKMVDKILINEVFQHKMRIISQINH----- 64
            +G+G FG V     + +    AVK      K      I E       I+ +I +     
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-EA-----DILKKIQNDDINN 95

Query: 65  KNVVKILG-------VCLETKVPLL---VYEFVPN----GTLFQHVRYQSSQVLKTWKTC 110
            N+VK  G       +CL      L   +YE +      G   + ++    ++LK     
Sbjct: 96  NNIVKYHGKFMYYDHMCLIF--EPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK----- 148

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
                    AL+YL  +    + H D+K  NILLDD Y  K       V      Q   T
Sbjct: 149 ---------ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 171 TK-------------EIETVGWL-------DPEYLF---WTEKSDVYSFGVVLVELLTGK 207
                          + +  G +        PE +    W   SD++SFG VL EL TG 
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 1e-10
 Identities = 48/292 (16%), Positives = 87/292 (29%), Gaps = 69/292 (23%)

Query: 6   ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQ------------ 53
            T+   +   +GEG FG V++ +  D+T VA+K   +    L+N   Q            
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 54  ----HKMRIISQINHKNVVKILGVCL------------------------------ETKV 79
                 +        +  + +  V                                +   
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 80  PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKS 139
             +V EF   G   + +R +    L +  T   I  +  ++L    +  S    H D+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 140 ANILLDDNYTAKVADFA---------SSVLISSHDQTATTTKEIETVGWLD---PEYLFW 187
            N+LL      K+               + +S  D T +  +    V + D    E LF 
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250

Query: 188 ---TEKSDVYSF-GVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS 235
                + D+Y              HP S V        +M+    +  + N+
Sbjct: 251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 6e-10
 Identities = 55/335 (16%), Positives = 100/335 (29%), Gaps = 102/335 (30%)

Query: 17  GEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE 76
           G  G G   K  +    L      K+  K +  ++F         +N       L  C  
Sbjct: 157 GVLGSG---KTWV---ALDVCLSYKVQCK-MDFKIFW--------LN-------LKNCNS 194

Query: 77  TKVPL-----LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
            +  L     L+Y+  PN T            + + +  LR       +  Y + L    
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR---RLLKSKPYENCL---- 247

Query: 132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT------ATTTKEI----------- 174
           ++  +V++A             + +  +L+++  +       A TT  I           
Sbjct: 248 LVLLNVQNAKAW-------NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300

Query: 175 -ETVG----WLD------PE----------YLFWTEKSDVYS----FGVVLVELLTGKHP 209
            E       +LD      P            +      D  +    +  V  + LT    
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 210 RSYVALASNEMTRMVPY-----FPY--PIENNSLRQILNFQVADENEMEEIEIVAKLASK 262
            S   L   E  +M  +     FP    I    L  ++ F V   + M    +V KL   
Sbjct: 361 SSLNVLEPAEYRKM--FDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMV---VVNKLHKY 414

Query: 263 CLRTSGTERPTMR------QVSEQLDSLRRLHENF 291
            L     +  T+       ++  +L++   LH + 
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 3e-07
 Identities = 48/317 (15%), Positives = 92/317 (29%), Gaps = 64/317 (20%)

Query: 25  YKGVLPDNTLVAVKK-------PKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET 77
           YK +L      A            M   IL  E   H   II   +  +    L   L +
Sbjct: 18  YKDILSVF-EDAFVDNFDCKDVQDMPKSILSKEEIDH---IIMSKDAVSGTLRLFWTLLS 73

Query: 78  KVPLLVYEFV-----PN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPP 131
           K   +V +FV      N   L   ++ +  Q   +  T + I        D L++  +  
Sbjct: 74  KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ--PSMMTRMYI-----EQRDRLYN-DNQV 125

Query: 132 IIHGDVKSA-------NILLDDNYTAKV-----ADFASSVLISSHDQTATTTKEIETVGW 179
               +V            LL+      V          + +          + +++    
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD----VCLSYKVQCK-- 179

Query: 180 LDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
                +FW    +  S   VL  L           +  N  +R        +  +S++  
Sbjct: 180 -MDFKIFWLNLKNCNSPETVLEMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233

Query: 240 LNFQVADEN---------EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH-- 288
           L   +  +           ++  +        C +   T R   +QV++ L +    H  
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-KILLTTRF--KQVTDFLSAATTTHIS 290

Query: 289 -ENFWAQKNSEETEQLL 304
            ++       +E + LL
Sbjct: 291 LDHHSMTLTPDEVKSLL 307

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 7e-08
 Identities = 26/163 (15%), Positives = 55/163 (33%), Gaps = 30/163 (18%)

Query: 16  LGEGGFGFVYKGV---------LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-K 65
                 G +Y+            P     ++K      ++   + F  +     Q+N  K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 66  NVVKILGVCLETKVPLLVYEFVPNG-------TLF----QHVRYQSSQVLKTWKTCLRIA 114
            +     +     +P  +   V                 Q     S + + + ++ L++A
Sbjct: 110 KLYSTPLLA----IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV--ADF 155
                AL++LH       +HG+V + NI +D    ++V  A +
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY 205

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 52/278 (18%), Positives = 91/278 (32%), Gaps = 102/278 (36%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILIN-----EVFQHKMRIISQI- 62
           Y     LG G F  V+    +     VA+K       ++ +     E    ++R++  + 
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-------VVKSAEHYTETALDEIRLLKSVR 91

Query: 63  -------NHKNVVKILG-----------VCLETKVPLLVYEFVPNG-TLFQHVRYQSSQV 103
                  N + VV++L            +C+       V+E    G  L + +   + Q 
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWIIKSNYQG 142

Query: 104 LKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL------------------- 144
           L       +I  +    LDYLH+     IIH D+K  NILL                   
Sbjct: 143 L-PLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199

Query: 145 ------------------------------DDNYTAKVADFASSVLISSHDQTATTTKEI 174
                                          +    K+AD  ++  +  H      T++I
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDI 254

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           +T  +   E L    +   +D++S   +  EL TG + 
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 32/165 (19%), Positives = 61/165 (36%), Gaps = 30/165 (18%)

Query: 14  HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI-------LINEVFQHKMRIISQINHKN 66
             +G+GGFG +Y   +  +  V    P +V K+       L  E      +  ++     
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVV-KVEPSDNGPLFTE--LKFYQRAAKPEQIQ 97

Query: 67  VVKILGVCLETKVPLLVY--EFVPNGTLF------------QHVRYQSSQVLKTWKTCLR 112
                       VP          NG  +            Q +   +++   + KT L+
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF-SRKTVLQ 156

Query: 113 IAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV--ADF 155
           ++      L+Y+H       +HGD+K++N+LL+     +V   D+
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDY 198

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 22/160 (13%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHK 65
           +Y     +GEG FG +++G  L +N  VA+K    +     L +E   +K+         
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL----AGCT 66

Query: 66  NVVKILGVCLETKVPLLVYEFV-PN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
            +  +     E    +LV + + P+   L      + S      KT    A +  + +  
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQS 121

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAK-----VADFASS 158
           +H      +++ D+K  N L+    +       V DF   
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 20/151 (13%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINH-KNVVKIL 71
           +G G FG +Y G  +     VA+K   +  K   L  E      +I   +     +  I 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGVGIPTIR 71

Query: 72  GVCLETKVPLLVYEFV-PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
               E    ++V E + P+  L     + S +   + KT L +A +  S ++Y+HS    
Sbjct: 72  WCGAEGDYNVMVMELLGPS--LEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKN-- 125

Query: 131 PIIHGDVKSANILLDDNYTAK---VADFASS 158
             IH DVK  N L+          + DF  +
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 34/163 (20%), Positives = 58/163 (35%), Gaps = 31/163 (19%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI---LINE--VFQ--HKMRIISQINHKN 66
            +G GGFG +Y           A    K+  +    L +E   +Q   K   I +   + 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 67  VVKILGV-----CLETKVPLLVYEFV------PN-GTLFQHVRYQSSQVLKTWKTCLRIA 114
            +  LG+        T+     Y F+       +   +                T L++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK------STVLQLG 157

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV--ADF 155
                 L+Y+H       +HGD+K+AN+LL      +V  AD+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADY 197

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 37/141 (26%), Positives = 56/141 (39%), Gaps = 17/141 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHK 65
           N+     +G G FG +  G  L  N  VA+K    K     L  E   +K       +  
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG----SGD 65

Query: 66  NVVKILGVCLETKVPLLVYEFV-PN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
            + ++       K   +V E + P+   LF       S      KT L IA +  S ++Y
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEY 120

Query: 124 LHSLGSPPIIHGDVKSANILL 144
           +HS     +I+ DVK  N L+
Sbjct: 121 VHSKN---LIYRDVKPENFLI 138

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 35/152 (23%), Positives = 63/152 (41%), Gaps = 22/152 (14%)

Query: 16  LGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQIN-HKNVVKIL 71
           +G G FG +Y G  +  N  VA+K   +  K   L+ E      +I   +     +  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES-----KIYRILQGGTGIPNVR 69

Query: 72  GVCLETKVPLLVYEFV-PN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
              +E    +LV + + P+   LF     + S      KT L +A +  + ++++HS   
Sbjct: 70  WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL-----KTVLMLADQMINRVEFVHSKS- 123

Query: 130 PPIIHGDVKSANILLDDNYTAK---VADFASS 158
              +H D+K  N L+     A    + DF  +
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	309
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.5
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.02
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.17
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.81
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.7
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.36
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	84.48
3eps_A	578	Isocitrate dehydrogenase kinase/phosphatase; ATP-b	83.11

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-56  Score=384.20  Aligned_cols=259  Identities=23%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ..++++.+.||+|+||.||+|.+.      +++.||+|.+.........+.|.+|+.++++++|||||++++++.+.+.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            356788999999999999999852      46899999987655555567899999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      +||||||++|+|.+++.....             ...+++..+..++.||+.||.|||+++   ++||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence            999999999999999965432             234678899999999999999999999   9999999999999999


Q ss_pred             CCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhc
Q 040698          148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRM  223 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~  223 (309)
                      +.+||+|||+++.....+.........|++.|+|||.+.   ++.++|||||||++|||++ |..||.......  .   
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~---  256 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--V---  256 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--H---
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--H---
Confidence            999999999998764444444455667899999999987   8999999999999999998 899986543211  1   


Q ss_pred             ccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                                  ...+. .....+.+..+++.+.+||.+||+.||++|||+.+|++.|+++..
T Consensus       257 ------------~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          257 ------------VEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             ------------HHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             ------------HHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence                        11111 111222344566779999999999999999999999999987543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-56  Score=382.80  Aligned_cols=261  Identities=27%  Similarity=0.424  Sum_probs=211.9

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|.+.+.||+|+||.||+|.+.      ++..||+|.+..... ...+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            468999999999999999999853      478899999876543 3457799999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           81 LLVYEFVPNGTLFQHVRYQS----------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      +||||||++|+|.+++....          ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            99999999999999997643          2235688999999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccC
Q 040698          151 KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      ||+|||+++.....+.........|++.|+|||.+.   ++.++|||||||++|||++ |..||...+...         
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---------  238 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---------  238 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            999999997654433333344456899999999987   8999999999999999998 899986543211         


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                              ....+.. ....+.+..+++.+.+||.+||+.||++|||+.++++.|+.+....+
T Consensus       239 --------~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          239 --------VIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             --------HHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             --------HHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence                    1111111 11122334556779999999999999999999999999988765443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-56  Score=383.37  Aligned_cols=261  Identities=27%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|.+.+.||+|+||.||+|.++      ++..||+|.+..... ...+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357888999999999999999853      478999999876543 3457799999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                      +||||||++|+|.+++.....            ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            999999999999999975432            234688999999999999999999999   99999999999999999


Q ss_pred             CeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcc
Q 040698          149 TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMV  224 (309)
Q Consensus       149 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~  224 (309)
                      .+||+|||+++.....+.........|++.|+|||.+.   ++.++|||||||++|||++ |..||........      
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~------  269 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA------  269 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH------
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            99999999997654433333444567899999999987   8899999999999999998 8999865432211      


Q ss_pred             cCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                                 +..+.. ....+.+..+++.+.+||.+||+.||++|||+.+|+++|+.+....+
T Consensus       270 -----------~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          270 -----------IDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             -----------HHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             -----------HHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence                       111111 11122334556779999999999999999999999999998876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-55  Score=377.05  Aligned_cols=261  Identities=27%  Similarity=0.431  Sum_probs=201.9

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+++++.+.||+|+||.||+|.+++  .||+|.+.... .....+.|.+|+.++++++|||||++++++.+ +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3578899999999999999999753  58999876432 33445779999999999999999999998865 56899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ||+||+|.+++.....  .+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||++.......
T Consensus       112 y~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999975432  4588999999999999999999999   9999999999999999999999999997654433


Q ss_pred             ccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .........||+.|+|||++.      ++.++|||||||++|||++|..||...................+         
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---------  257 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---------  257 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---------
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---------
Confidence            334445568999999999884      67799999999999999999999865422211111111100000         


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                          .....+..+++.+.+||.+||+.||++|||+.+++++|+.++...
T Consensus       258 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 ----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             ----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                001123345577999999999999999999999999998887543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-55  Score=383.38  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|.+.... .....+.+.+|+.+|++++|||||++++++++++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            47899999999999999999995 569999999875432 2334567899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||+||+|.+++..... ...++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++......
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999975543 24477889999999999999999999   999999999999999999999999999765221


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        .......+||+.|+|||++.   |+.++|||||||++|+|++|..||...+.....                 ..+..
T Consensus       179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-----------------~~i~~  239 (350)
T 4b9d_A          179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-----------------LKIIS  239 (350)
T ss_dssp             --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----------------HHHHH
T ss_pred             --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------------HHHHc
Confidence              12233467999999999997   888999999999999999999998654222111                 11111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ... ...+...++++.+||.+||+.||++|||+.+++++
T Consensus       240 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          240 GSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111 11123345679999999999999999999999886

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-55  Score=376.55  Aligned_cols=249  Identities=22%  Similarity=0.309  Sum_probs=206.5

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+.+|+.++|||||++++++++++.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999995 569999999886542  233356789999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||||+||+|.+++...+   .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus       111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999997654   3588999999999999999999999   99999999999999999999999999987644


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..........+||+.|+|||++.   ++.++|||||||++|+|++|..||...+...                 ....+.
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----------------~~~~i~  247 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----------------IFAKII  247 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHH
Confidence            44444556678999999999997   8889999999999999999999986432211                 111111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  ..+...++.+.+||.+||+.||++|||+.|++.+
T Consensus       248 ~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          248 KLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             cCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            1111  1122334669999999999999999999987544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.7e-55  Score=377.49  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||+|.+...... ..+.+.+|+.+|+.++|||||++++++++++.+|||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35799999999999999999996 46999999988654332 24567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ||+||+|.+++...    .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+|||++...... 
T Consensus       152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  223 (346)
T 4fih_A          152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  223 (346)
T ss_dssp             CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence            99999999988642    3588999999999999999999999   999999999999999999999999999765322 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       .......+||+.|+|||++.   |+.++|||||||++|+|++|.+||.........                 ..+...
T Consensus       224 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----------------~~i~~~  285 (346)
T 4fih_A          224 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----------------KMIRDN  285 (346)
T ss_dssp             -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------------HHHHHS
T ss_pred             -CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------------HHHHcC
Confidence             22344568999999999987   899999999999999999999998643221110                 111110


Q ss_pred             -cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 -QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 -~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ......+...++.+.+||.+||+.||++|||+.++++|
T Consensus       286 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             01112223445779999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-54  Score=366.35  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             ccc-ccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCcc
Q 040698            8 KNY-DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE----TKVP   80 (309)
Q Consensus         8 ~~y-~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~   80 (309)
                      ++| ++.+.||+|+||.||+|.+ .++..||+|.+.... .....+.+.+|+.++++++|||||++++++.+    .+.+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 7788899999999999995 468999999875432 23345678999999999999999999999865    3567


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~  159 (309)
                      +||||||+||+|.+++....   .+++..+..++.|++.||+|||+++ ++++||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999999997553   4578899999999999999999975 4499999999999997 57999999999997


Q ss_pred             ccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ...    ........||+.|+|||.+.  ++.++|||||||++|+|++|..||........-......            
T Consensus       181 ~~~----~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~------------  244 (290)
T 3fpq_A          181 LKR----ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS------------  244 (290)
T ss_dssp             GCC----TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT------------
T ss_pred             eCC----CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc------------
Confidence            532    22334568999999999987  899999999999999999999998643222111111111            


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          ...+...+...++.+.+||.+||+.||++|||+.++++|
T Consensus       245 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          245 ----GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                001111112233569999999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-54  Score=377.89  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=210.6

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC-Cccceeeeeeec-CC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-KNVVKILGVCLE-TK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~-~~   78 (309)
                      .++|++.+.||+|+||.||+|.+.      .++.||+|.+.........+.+.+|+.+|.+++| ||||++++++.+ ++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            468999999999999999999843      2468999988765554556779999999999965 899999999865 46


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      .++||||||++|+|.+++.....             ...+++..+..++.||+.||.|||+++   ++||||||+||+++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence            78999999999999999976432             234688899999999999999999999   99999999999999


Q ss_pred             CCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhh
Q 040698          146 DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMT  221 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~  221 (309)
                      +++.+||+|||+++...............|++.|+|||.+.   ++.++|||||||++|||++ |..||........   
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---  296 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  296 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            99999999999998664433334445567899999999987   8999999999999999998 8999865321111   


Q ss_pred             hcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                                    +............+..+++.+.++|.+||+.||++|||+.+++++|+.+..
T Consensus       297 --------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          297 --------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence                          111111112222334455779999999999999999999999999987754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.9e-54  Score=370.86  Aligned_cols=251  Identities=20%  Similarity=0.241  Sum_probs=201.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||+|.+.....      ..+|+.+++.++|||||++++++.+++.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            45688899999999999999995 4699999998865322      2468899999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~~~~  164 (309)
                      ||+||+|.+++...+   .+++..+..++.|++.||+|||+++   ++||||||+|||++.+| .+||+|||++......
T Consensus       131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            999999999997654   3588999999999999999999999   99999999999999887 6999999999765332


Q ss_pred             ccc---ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQT---ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~---~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...   ......+||+.|+|||++.   ++.++|||||||++|+|++|..||.......                 ....
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------------~~~~  267 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----------------LCLK  267 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----------------CHHH
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----------------HHHH
Confidence            211   1223457999999999987   8899999999999999999999986432111                 1111


Q ss_pred             hhcccc-cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          239 ILNFQV-ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       239 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      +..... ....+..+++.+.+||.+||+.||.+|||+.|++++|.....
T Consensus       268 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          268 IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            111111 112234556779999999999999999999999999866553

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.6e-54  Score=361.93  Aligned_cols=244  Identities=22%  Similarity=0.315  Sum_probs=187.5

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|.+...  ......+.+.+|+.+++.++||||+++++++++.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999995 56999999987543  22334567899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+ +|+|.+++....   .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..... 
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence            999 679998887543   4588999999999999999999999   99999999999999999999999999976422 


Q ss_pred             cccccccccccccccCCCcccc---c-CCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---W-TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~-~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                        ........||+.|+|||++.   + +.++||||+||++|+|++|..||...+...  .               ...+.
T Consensus       165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~---------------~~~i~  225 (275)
T 3hyh_A          165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--L---------------FKNIS  225 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---------------HHHHH
T ss_pred             --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--H---------------HHHHH
Confidence              22334568999999999986   3 578999999999999999999986432111  1               11111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  ..+...++.+.+||.+||+.||++|||+.++++|
T Consensus       226 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          226 NGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1111  1122344669999999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.9e-54  Score=379.27  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=203.0

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++.+.||+|+||.||+|.+ .+|+.||+|.+...... ..+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            46799999999999999999995 46999999988654332 24568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ||+||+|.+++...    .+++..+..++.|++.||.|||+++   |+||||||+|||++.+|.|||+|||++...... 
T Consensus       229 y~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-  300 (423)
T 4fie_A          229 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  300 (423)
T ss_dssp             CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred             CCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence            99999999988643    3578999999999999999999999   999999999999999999999999999765322 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       .......+||+.|+|||++.   |+.++|||||||++|+|++|..||.........                 ..+...
T Consensus       301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----------------~~i~~~  362 (423)
T 4fie_A          301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----------------KMIRDN  362 (423)
T ss_dssp             -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------------HHHHHS
T ss_pred             -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------------HHHHcC
Confidence             22344568999999999987   899999999999999999999998643221111                 011100


Q ss_pred             -cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 -QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 -~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ......+...++.+.+||.+||+.||++|||+.++++|
T Consensus       363 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             00111222344679999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-53  Score=361.82  Aligned_cols=251  Identities=23%  Similarity=0.404  Sum_probs=190.1

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-------
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK-------   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------   78 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|.+.........+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            35799999999999999999995 4699999999876655555678899999999999999999999987644       


Q ss_pred             -----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           79 -----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        79 -----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                           .+|||||||+|++|.+++.........+...++.++.|++.||+|||+++   ++||||||+||+++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999987665545566778899999999999999999   9999999999999999999999


Q ss_pred             eeeccccccccccc----------ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh
Q 040698          154 DFASSVLISSHDQT----------ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM  220 (309)
Q Consensus       154 d~g~~~~~~~~~~~----------~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~  220 (309)
                      |||++.........          ......+||+.|+|||++.   ++.++|||||||++|+|++   ||......... 
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~-  236 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT-  236 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH-
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH-
Confidence            99999765332211          1123457999999999987   8999999999999999996   65422111000 


Q ss_pred             hhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                     +..+..... .+.....++.+.+||++||+.||++|||+.+++++
T Consensus       237 ---------------~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          237 ---------------LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ---------------HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------------HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                           000111000 11122333557899999999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.7e-54  Score=365.52  Aligned_cols=246  Identities=26%  Similarity=0.317  Sum_probs=193.1

Q ss_pred             cccccceeecccCceEEEEEEc----CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ++|++++.||+|+||.||+|+.    .+++.||+|.+.... .......+..|+.+|++++|||||++++++++++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999984    247899999875432 11123357889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |||||+||+|.+++....   .+++..+..++.|++.||+|||+++   ++||||||+|||++.+|.+||+|||++....
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999997654   4588999999999999999999999   9999999999999999999999999997542


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  .........||+.|+|||++.   ++.++|||||||++|+|++|..||...+....                 ...+
T Consensus       178 ~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i  238 (304)
T 3ubd_A          178 D--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----------------MTMI  238 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHH
T ss_pred             C--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-----------------HHHH
Confidence            2  223344568999999999986   89999999999999999999999864322211                 1111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      .....  ..+...++.+.+||++||+.||++|||+     +++++|
T Consensus       239 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            11111  1122345679999999999999999984     677654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-52  Score=359.87  Aligned_cols=268  Identities=23%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----ccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK----VPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~i   82 (309)
                      .++|.+.+.||+|+||.||+|.+ +|+.||+|++......  ......|+..+.+++|||||++++++.+.+    .++|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            57899999999999999999998 6899999988654322  223445667777889999999999998653    5789


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL--------GSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||++        +   ++||||||+|||++.++.+||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~---IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---EeeccCCcccEEECCCCCEEEEe
Confidence            99999999999999743    347788999999999999999987        6   99999999999999999999999


Q ss_pred             eeccccccccccc--ccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc
Q 040698          155 FASSVLISSHDQT--ATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM  223 (309)
Q Consensus       155 ~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~  223 (309)
                      ||++.........  .......||+.|+|||.+.         ++.++|||||||++|||++|.+||.............
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            9998765432221  1223457999999999874         4568999999999999999998876443222111111


Q ss_pred             ccCccccccccchhhhhccccc-----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVA-----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ....+  ...............     ......+++.+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       232 ~~~~~--~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          232 VPSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SCSSC--CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccc--hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            10000  000001111111111     11234566789999999999999999999999999987653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.6e-50  Score=351.78  Aligned_cols=267  Identities=17%  Similarity=0.216  Sum_probs=197.0

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      .+|...++|++.+.||+|+||.||+|.+    .+++.||+|.+.....   ...+.+|+.+|+.+ +||||+++++++.+
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            4677889999999999999999999984    2478999998765433   34577899999988 69999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADF  155 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~  155 (309)
                      .+.+|+||||++|++|.+++.      .+++..+..++.|++.||+|||+++   ++||||||+||+++.+ +.+||+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999999884      2477899999999999999999999   9999999999999866 79999999


Q ss_pred             ecccccccccc--------------------------cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHh
Q 040698          156 ASSVLISSHDQ--------------------------TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLT  205 (309)
Q Consensus       156 g~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~  205 (309)
                      |++........                          .......+||+.|+|||++.    ++.++||||+||++|+|++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99965422110                          11223457999999999885    7888999999999999999


Q ss_pred             CCCCCchhhhcchhhhhcc----------------------cCccccccccchhhhh--------------cccccCccc
Q 040698          206 GKHPRSYVALASNEMTRMV----------------------PYFPYPIENNSLRQIL--------------NFQVADENE  249 (309)
Q Consensus       206 g~~p~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~--------------~~~~~~~~~  249 (309)
                      |..||.........+....                      ...+..........+.              ......+..
T Consensus       243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  322 (361)
T 4f9c_A          243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW  322 (361)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence            9999843221111110000                      0000000000000000              000011112


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...++.+.+||++||+.||++|||+.|+++|
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2344678999999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=352.38  Aligned_cols=267  Identities=18%  Similarity=0.241  Sum_probs=198.8

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE------TK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~   78 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++.... .....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36899999999999999999995 569999999886542 23334667899999999999999999998753      46


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      .+|||||||+ |+|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 6788888643   34688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccc--cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCcccc
Q 040698          159 VLISSH--DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYFPYP  230 (309)
Q Consensus       159 ~~~~~~--~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~~  230 (309)
                      ......  .........+||+.|+|||++.    ++.++||||+||++|+|++|.+||...+....-.....  ...+..
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            765332  1223345678999999999875    68899999999999999999999975432221111100  000000


Q ss_pred             c-c---ccchhhhhccccc-Cc-----cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 I-E---NNSLRQILNFQVA-DE-----NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ~-~---~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      . .   ............. ..     .....++.+.+||.+||+.||.+|||+.++++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0 0   0000000000000 00     011234668999999999999999999999886

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-48  Score=360.67  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=198.5

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHH---HHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQ---HKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++++.||+|+||.||+|.+ .+|+.||+|++.....  ......+.   .++.+++.++|||||+++++|++.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3468999999999999999999995 4699999998764321  11122233   3456777789999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      .+||||||++||+|.+++...+   .+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.|||+|||++
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence            9999999999999999997654   3588999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      .....    ......+||+.|+|||++.    |+.++|+|||||++|+|++|.+||.........              .
T Consensus       340 ~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--------------~  401 (689)
T 3v5w_A          340 CDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------E  401 (689)
T ss_dssp             EECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--------------H
T ss_pred             eecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--------------H
Confidence            76532    2334568999999999984    788999999999999999999998653221110              0


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      ....+....  ...+...++.+.+||.+||+.||.+|++     +.++++|
T Consensus       402 i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          402 IDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             HHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            001111111  1122334567999999999999999998     6888765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3e-48  Score=359.98  Aligned_cols=248  Identities=21%  Similarity=0.257  Sum_probs=202.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+...... ..+.+.+|+.+|+.++|||||++++++.+.+.++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            47899999999999999999995 46999999988654433 25678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEEeeeccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--NYTAKVADFASSVLISS  163 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~~~~  163 (309)
                      ||+||+|.+++....  ..+++..+..++.||+.||.|||+++   ++||||||+||+++.  .+.+||+|||++.....
T Consensus       235 ~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          235 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             ecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999886433  23578899999999999999999999   999999999999975  48999999999977532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                         ........|++.|+|||++.   ++.++|||||||++|+|++|..||.........                 ..+.
T Consensus       310 ---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-----------------~~i~  369 (573)
T 3uto_A          310 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-----------------RNVK  369 (573)
T ss_dssp             ---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------------HHHH
T ss_pred             ---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------------HHHH
Confidence               23334567999999999987   888999999999999999999998644222111                 1111


Q ss_pred             ccc--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQ--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  .........++.+.+||++||+.||.+|||+.++++|
T Consensus       370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  1111222345679999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-48  Score=336.02  Aligned_cols=279  Identities=36%  Similarity=0.578  Sum_probs=222.7

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ++..+.++|++.+.||+|+||.||+|..++|+.||+|.+...........+..|+.+++.++||||+++++++.+.+..+
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  103 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL  103 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence            46678899999999999999999999988899999998876544333446889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhc---CCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           82 LVYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSL---GSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      +||||+++++|.+++..... ...+++..+..++.|++.||.|||++   +   ++|+||+|+||+++.++.++|+|||+
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCcc
Confidence            99999999999999976543 33468889999999999999999999   8   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      +...... .........+++.|+|||.+.   ++.++||||||+++|+|++|..||...............+........
T Consensus       181 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 3uim_A          181 AKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK  259 (326)
T ss_dssp             CEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred             ccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence            8765322 222233455899999999885   788999999999999999999999754433322111111112222223


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ......+.......+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            33344444445556677888999999999999999999999999999763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-47  Score=332.19  Aligned_cols=281  Identities=37%  Similarity=0.553  Sum_probs=221.3

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      +....++|++.+.||+|+||.||+|.+++|+.||+|........ ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            44577999999999999999999999888999999987665432 35678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||+++++|.+++..... ....++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999988864432 224578899999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .............+++.|+|||.+.   ++.++||||||+++|+|++|..||.........  ....+............
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV--NLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC--CHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH--HHHHHhhhccccccHHH
Confidence            3333333334456788999999875   888999999999999999999998643221100  00000000001111222


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ..+.......+...+..+.+++.+||+.||++|||+.+++++|+.+..+.+
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            233333344566788889999999999999999999999999988876544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-46  Score=331.73  Aligned_cols=263  Identities=28%  Similarity=0.412  Sum_probs=211.9

Q ss_pred             hcccccceeecccCceEEEEEEc--------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL--------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~--------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      .++|++.+.||+|+||.||+|.+        .++..||+|.+.........+.+..|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            47899999999999999999984        235689999987665555566789999999999 899999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL  144 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv  144 (309)
                      +..++||||+++++|.+++.....             ....++..++.++.|++.||.|||+++   ++||||+|+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999986542             123577889999999999999999999   9999999999999


Q ss_pred             cCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhh
Q 040698          145 DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM  220 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~  220 (309)
                      +.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||......... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            999999999999997654333333334455678899999886   7889999999999999999 99998653221110 


Q ss_pred             hhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                                       ...........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....+
T Consensus       316 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          316 -----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             -----------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             -----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence                             00111111122334456799999999999999999999999999998876544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.8e-46  Score=332.99  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=207.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.++ +++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            578999999999999999999965 6899999988765444445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.....  .++...+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.......
T Consensus       193 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999975543  3477899999999999999999999   9999999999999999999999999986542221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .........++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                  ...
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~------------------~~~  329 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE------------------FVE  329 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH------------------HHH
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------------HHH
Confidence            111222233466799999986   7889999999999999998 999987543221110                  001


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      .......+..+++.+.+||.+||+.||++|||+.++++.|+.++.-
T Consensus       330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            1111112233446699999999999999999999999999888653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.4e-46  Score=320.44  Aligned_cols=263  Identities=28%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||+|+||.||+|.+ +|..||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3467999999999999999999987 68899999875543 233346788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++........+++..++.++.|++.||.|||+++ ++++||||+|+||+++.++.++|+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999999986654445688999999999999999999986 4489999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                        .........+++.|+|||.+.   ++.++||||||+++|+|++|..||...........                 ..
T Consensus       192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~-----------------~~  252 (309)
T 3p86_A          192 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA-----------------VG  252 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----------------HH
T ss_pred             --cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------HH
Confidence              112233456789999999987   78899999999999999999999875432211111                 00


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ........+...++.+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            011111222334466999999999999999999999999998776543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-45  Score=317.26  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            467899999999999999999995 569999999876544332 567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...    ..++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999998754    3477899999999999999999999   999999999999999999999999998665322


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                        ........+++.|+|||.+.   ++.++||||||+++|+|++|..||.............                ..
T Consensus       170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----------------~~  231 (297)
T 3fxz_A          170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------TN  231 (297)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------------HH
T ss_pred             --ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------hC
Confidence              12233457899999999986   7889999999999999999999986543221111100                00


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+...++.+.+||.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            011111223344669999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=320.95  Aligned_cols=262  Identities=26%  Similarity=0.389  Sum_probs=207.6

Q ss_pred             hhcccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3578999999999999999999963    345699999876545555678899999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus       127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999965432  3578899999999999999999999   999999999999999999999999999765


Q ss_pred             cccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...... .......+++.|+|||.+.   ++.++||||||+++|+|++ |..||............              
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------------  267 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------------  267 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------------
Confidence            332211 1222334566799999986   7889999999999999999 99998644322111100              


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                          ........+..+++.+.+||.+||+.||.+|||+.++++.|+.+....+.
T Consensus       268 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          268 ----EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             ----HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                00111112233456799999999999999999999999999988765443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-45  Score=320.87  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            457899999999999999999996 679999999875532 233456788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++....   .+++..+..++.|++.|+.|||+++   ++||||+|+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999997654   3578899999999999999999999   99999999999999999999999999865522


Q ss_pred             ccccccccccccccccCCCcccc---c-CCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---W-TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~-~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                         ........|++.|+|||.+.   + +.++||||||+++|+|++|..||..........                 .+
T Consensus       167 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----------------~i  226 (328)
T 3fe3_A          167 ---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE-----------------RV  226 (328)
T ss_dssp             ---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------------HH
T ss_pred             ---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------------HH
Confidence               22334567899999999986   3 468999999999999999999986543221111                 11


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....  ..+...++.+.+|+++||+.||.+|||+.+++++
T Consensus       227 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          227 LRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11110  1122234669999999999999999999999886

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=318.11  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||++.+ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            57999999999999999999995 4689999998755433 345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999976433  3578899999999999999999999   9999999999999999999999999987653222


Q ss_pred             ccc------------cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          166 QTA------------TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       166 ~~~------------~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ...            ......|++.|+|||.+.   ++.++||||||+++|+|++|..||..........          
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------  232 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------  232 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------
Confidence            111            111456889999999987   7889999999999999999999976432211110          


Q ss_pred             ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          231 IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                        ..........    ..+..+++.+.+++.+||+.||++|||+.++++.|+.++.....
T Consensus       233 --~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          233 --GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             --SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence              0000111110    01122334599999999999999999999999999998866543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-45  Score=319.14  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=210.8

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||+|+||.||++.+      .++..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            468999999999999999999984      34589999998765555556778999999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS---------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK  138 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~  138 (309)
                      .++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   ++|+||+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999976543                     123578899999999999999999999   9999999


Q ss_pred             CCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhh
Q 040698          139 SANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVA  214 (309)
Q Consensus       139 ~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~  214 (309)
                      |+||+++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987654433333334455678899999886   7889999999999999999 999986442


Q ss_pred             hcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          215 LASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....                  ...........+..+++.+.++|.+||+.||.+|||+.+++++|+++..
T Consensus       258 ~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          258 PERLF------------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GGGHH------------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH------------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            21111                  0011111112223345679999999999999999999999999987754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=327.92  Aligned_cols=267  Identities=28%  Similarity=0.377  Sum_probs=214.9

Q ss_pred             hhcccccceeecccCceEEEEEEc--------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL--------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~--------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      ..++|++.+.||+|+||.||+|.+        ..+..||+|.+.........+.+.+|+.+++.+ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            457999999999999999999984        234689999887665555567789999999999 89999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                      .+..++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+++   ++||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999986542             234688999999999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997654433333344456678899999886   7889999999999999999 99998654222111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWA  293 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~  293 (309)
                                        ...........+..+++.+.+||.+||+.||.+|||+.+++++|+.+.....+...
T Consensus       304 ------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          304 ------------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             ------------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             ------------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence                              00011111112223446699999999999999999999999999999876654443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.7e-46  Score=326.81  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=209.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      ...++|++.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.++.++ +||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            3568999999999999999999972      346899999987655544466789999999999 789999999998875


Q ss_pred             C-ccEEEEEcCCCCCHHHHHHhhcc-------------------------------------------------------
Q 040698           78 K-VPLLVYEFVPNGTLFQHVRYQSS-------------------------------------------------------  101 (309)
Q Consensus        78 ~-~~~iv~e~~~~~sL~~~l~~~~~-------------------------------------------------------  101 (309)
                      + ..++||||+++++|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            4 48999999999999999976543                                                       


Q ss_pred             --------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccccccc
Q 040698          102 --------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKE  173 (309)
Q Consensus       102 --------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~  173 (309)
                              ...+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...............
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                    112678899999999999999999999   999999999999999999999999999765443333344456


Q ss_pred             ccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccc
Q 040698          174 IETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENE  249 (309)
Q Consensus       174 ~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
                      .+++.|+|||.+.   ++.++||||||+++|+|++ |..||...........                 ..........+
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~  318 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-----------------RLKEGTRMRAP  318 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-----------------HHHHTCCCCCC
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-----------------HHHcCCCCCCC
Confidence            6788899999886   7889999999999999998 9999865422211111                 11111111122


Q ss_pred             hHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          250 MEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       250 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      ...++.+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            23446699999999999999999999999999887753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=315.77  Aligned_cols=272  Identities=19%  Similarity=0.266  Sum_probs=211.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--ccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK--VPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.........+.+.+|+.+++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4689999999999999999999964 599999999876554444667889999999999999999999987654  7799


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEEeeecc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASS  158 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv----~~~~~v~l~d~g~~  158 (309)
                      ||||+++++|.+++........+++..++.++.|++.||.|||+++   ++|+||+|+||++    +.++.++|+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999987665555788999999999999999999999   9999999999999    77788999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh---cc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR---MV  224 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~---~~  224 (309)
                      ......   .......+++.|+|||.+.           ++.++||||||+++|+|++|..||............   ..
T Consensus       164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            765322   2233456889999999762           778999999999999999999998643322211111   11


Q ss_pred             cCccccc-------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          225 PYFPYPI-------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       225 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      ...+...       .....................+..+.++|++||+.||++|||+.+++++..+
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            0000000       0000001011112223456778889999999999999999999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-45  Score=320.15  Aligned_cols=271  Identities=23%  Similarity=0.310  Sum_probs=206.0

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----ccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK----VPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~   81 (309)
                      ..++|++.+.||+|+||.||+|.+. ++.||+|.+......  ......|+.++++++||||+++++++.+..    .++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ--SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH--HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            4679999999999999999999874 799999988654332  344566888999999999999999998754    369


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCcEEEcCCCCeE
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL----------GSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      +||||+++++|.+++...    .+++..+..++.|++.||.|||+.          +   ++||||||+||+++.++.++
T Consensus        99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence            999999999999999653    257889999999999999999999          9   99999999999999999999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh-hh
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM-TR  222 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~-~~  222 (309)
                      |+|||++................+++.|+|||.+.        ++.++||||||+++|+|++|..||.......... ..
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            99999997664433333344467899999999875        3456799999999999999999986432111000 00


Q ss_pred             cccCccccccccchhhhhcccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          223 MVPYFPYPIENNSLRQILNFQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ...  ..+................     ......++.+.+||.+||+.||++|||+.++++.|+.++...
T Consensus       252 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          252 EIG--QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHC--SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhc--cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000  0000000000011111111     122355677999999999999999999999999999887653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.2e-45  Score=307.26  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=207.7

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      -..++|++.+.||+|+||.||++.++++..||+|.+......  .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            356899999999999999999999888889999988654322  456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++.....  .+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999976543  3578899999999999999999999   999999999999999999999999998755332


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      . ........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...............               
T Consensus       158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  221 (268)
T 3sxs_A          158 Q-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---------------  221 (268)
T ss_dssp             C-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---------------
T ss_pred             h-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC---------------
Confidence            1 12223344567799999986   7889999999999999998 99998654322211111100               


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                         .....+...++.+.+++.+||+.||.+|||+.+++++|+.++.
T Consensus       222 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          222 ---HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               0011111223569999999999999999999999999988865

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=322.51  Aligned_cols=264  Identities=24%  Similarity=0.404  Sum_probs=206.1

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+.........+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999984      246789999887654444456789999999999 8999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccc--------------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQ--------------------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVK  138 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~  138 (309)
                      ..++||||+++++|.+++......                    ..+++..++.++.|++.||.|||+++   ++|+||+
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999765431                    23577889999999999999999999   9999999


Q ss_pred             CCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhh
Q 040698          139 SANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVA  214 (309)
Q Consensus       139 ~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~  214 (309)
                      |+||+++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999997654433333334455677899999885   7889999999999999998 999986542


Q ss_pred             hcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          215 LASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ......                 ...........+...++.+.+||.+||+.||.+|||+.+++++|+.+....+
T Consensus       280 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          280 VDANFY-----------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CSHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cHHHHH-----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            211111                 1111111112222344669999999999999999999999999988765443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=326.01  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=209.2

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+...........+..|+.+++.++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            478999999999999999999842      46789999987654455566788999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccc----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEE
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQ----VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---TAKVA  153 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l~  153 (309)
                      ++||||+++++|.+++......    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++   .++|+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999865421    34577889999999999999999999   99999999999998554   59999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      |||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||..........         
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~---------  297 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE---------  297 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---------
Confidence            999987653333333444556788899999886   7889999999999999998 999986543221110         


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                              .+ ........+..++..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus       298 --------~i-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          298 --------FV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             --------HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --------HH-HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                    00 011111122334466999999999999999999999999998887543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.4e-46  Score=322.82  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=202.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4589999999999999999999954 799999998865544444567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999887543   23578999999999999999999999   999999999999999999999999999765433


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..........|++.|+|||.+.    .+.++||||||+++|+|++|..||...............               
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------------  223 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---------------  223 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT---------------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---------------
Confidence            3333344567899999999986    356799999999999999999998754332222111111               


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ...........++.+.+||.+||+.||.+|||+.+++++-
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          224 -KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             -TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             -ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence             1111111223346689999999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5e-44  Score=308.58  Aligned_cols=277  Identities=32%  Similarity=0.559  Sum_probs=216.3

Q ss_pred             hHHHhhcccccc------eeecccCceEEEEEEcCCCcEEEEEecccc---hhhhhHHHHHHHHHHHhhcCCCccceeee
Q 040698            2 ELVKATKNYDKR------HLLGEGGFGFVYKGVLPDNTLVAVKKPKMV---DKILINEVFQHKMRIISQINHKNVVKILG   72 (309)
Q Consensus         2 ~~~~~~~~y~i~------~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (309)
                      ++.+++++|...      +.||+|+||.||+|.. +++.|++|.+...   ......+.+.+|+.+++.++||||+++++
T Consensus        19 ~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   97 (307)
T 2nru_A           19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG   97 (307)
T ss_dssp             HHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            455666666655      8999999999999997 6889999987543   22344677899999999999999999999


Q ss_pred             eeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           73 VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        73 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                      ++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl  174 (307)
T 2nru_A           98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKI  174 (307)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred             EEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEE
Confidence            99999999999999999999999986655556788999999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      +|||++................+++.|+|||.+.  ++.++|+||||+++|+|++|..||........... .....  .
T Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~--~  251 (307)
T 2nru_A          175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD-IKEEI--E  251 (307)
T ss_dssp             CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH-HHHHH--H
T ss_pred             eecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH-HHHHh--h
Confidence            9999987654333333334456889999999887  78899999999999999999999875432211000 00000  0


Q ss_pred             ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          231 IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....+....+.. ....+...++.+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       252 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          252 DEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            0001111111111 123355677889999999999999999999999999988764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=322.16  Aligned_cols=263  Identities=27%  Similarity=0.386  Sum_probs=209.6

Q ss_pred             HhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||+|.+.      ++..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34689999999999999999999963      358999999876655555678999999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS---------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV  137 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl  137 (309)
                      ..++||||+++++|.+++.....                     ...+++..++.++.|++.||.|||+++   ++|+||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999976432                     135678899999999999999999999   999999


Q ss_pred             CCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchh
Q 040698          138 KSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYV  213 (309)
Q Consensus       138 ~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~  213 (309)
                      +|+||+++.++.++|+|||++................+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999987653333223334456678899999876   7889999999999999998 99998643


Q ss_pred             hhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          214 ALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ........                 +... .....+..++..+.++|.+||+.||.+|||+.+++++|+++..-.
T Consensus       281 ~~~~~~~~-----------------~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          281 AHEEVIYY-----------------VRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CHHHHHHH-----------------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             ChHHHHHH-----------------HhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            22211110                 0000 001112234466999999999999999999999999998876533

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-45  Score=316.42  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=211.7

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+.........+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457999999999999999999983      347899999887665545567889999999999 8999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccc---------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQ---------------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                      ..++||||+++++|.+++......               ..+++..++.++.|++.||.|||+++   ++|+||+|+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            999999999999999999765431               23688999999999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999987664433323333455677899999876   7889999999999999998 99998654221111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      .                 ...........+...+..+.++|.+||+.||.+|||+.+++++|+++....
T Consensus       258 ~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          258 Y-----------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             H-----------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H-----------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            1                 111111111112233466999999999999999999999999998776544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-45  Score=308.26  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=206.3

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||++.+.+++.||+|.+......  .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            35789999999999999999999888999999988754322  4568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.....  ..++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  159 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-  159 (269)
T ss_dssp             CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred             eCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-
Confidence            9999999999965433  3578899999999999999999999   999999999999999999999999998754221 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||..............                 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-----------------  222 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-----------------  222 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----------------
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-----------------
Confidence            112223344567899999986   7889999999999999999 9999865432221111000                 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                       ......+...++.+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          223 -GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence             00111112234569999999999999999999999999988764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.7e-45  Score=313.98  Aligned_cols=275  Identities=23%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--TK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   78 (309)
                      ..++|++.+.||+|+||.||++.+     .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..  .+
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999999999999983     36899999988765433 34678999999999999999999999865  45


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            68999999999999999976543  3577899999999999999999999   999999999999999999999999998


Q ss_pred             ccccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          159 VLISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ......... .......++..|+|||.+.   ++.++||||||+++|+|++|..||................  ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~  239 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ--GQMIVF  239 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC--THHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc--cchhHH
Confidence            765332211 1222344566799999886   7889999999999999999999976543221111000000  000000


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ..............+..+++.+.++|.+||+.||.+|||+.++++.|+.+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            111111112222334455677999999999999999999999999999887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.6e-45  Score=317.54  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=210.2

Q ss_pred             hhcccccceeecccCceEEEEEEc--------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL--------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~--------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      ..++|++.+.||+|+||.||+|.+        .++..||+|.+.........+.+..|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            468999999999999999999985        346789999987655555567789999999999 89999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                      .+..++||||+++++|.+++.....             ....++..++.++.|++.||.|||+++   ++|+||+|+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999976542             123577899999999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            9999999999999987654333223333445677899999885   7889999999999999999 99998643221100


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      .                 .+ ........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....+
T Consensus       270 ~-----------------~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          270 K-----------------LL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             H-----------------HH-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             H-----------------HH-hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            0                 00 00001112223446699999999999999999999999999998876554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.3e-45  Score=319.92  Aligned_cols=250  Identities=23%  Similarity=0.266  Sum_probs=201.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh-----hhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            35678999999999999999999954 6999999987654321     12467899999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVAD  154 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d  154 (309)
                      ..++||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++    .++|+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999986433   4588999999999999999999999   99999999999998776    799999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ||++.....   ........|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........            
T Consensus       163 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------------  227 (361)
T 2yab_A          163 FGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------  227 (361)
T ss_dssp             CSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------
T ss_pred             cCCceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------------
Confidence            999876532   22234557899999999986   788999999999999999999998643211111            


Q ss_pred             cccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ..+.......  ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       228 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          228 -----ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             -----HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 1111111111  0112234669999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.2e-45  Score=317.31  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK------   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   78 (309)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|.+.........+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999965 799999998876555555678999999999999999999999886543      


Q ss_pred             ---------------------------------------------------ccEEEEEcCCCCCHHHHHHhhccccccCH
Q 040698           79 ---------------------------------------------------VPLLVYEFVPNGTLFQHVRYQSSQVLKTW  107 (309)
Q Consensus        79 ---------------------------------------------------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~  107 (309)
                                                                         ..++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27899999999999999987766655666


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc----------cccccccccc
Q 040698          108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT----------ATTTKEIETV  177 (309)
Q Consensus       108 ~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~----------~~~~~~~~~~  177 (309)
                      ..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.........          .......+++
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            778999999999999999999   999999999999999999999999998766432211          1223456899


Q ss_pred             ccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHH
Q 040698          178 GWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIE  254 (309)
Q Consensus       178 ~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (309)
                      .|+|||.+.   ++.++||||||+++|+|++|..|+.........                   .... .........++
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~-------------------~~~~-~~~~~~~~~~~  300 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD-------------------VRNL-KFPLLFTQKYP  300 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHH-------------------HHTT-CCCHHHHHHCH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHH-------------------hhcc-CCCcccccCCh
Confidence            999999986   788999999999999999998874332111100                   0000 01111223446


Q ss_pred             HHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          255 IVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       255 ~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+.+||.+||+.||.+|||+.+++++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            68999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.3e-45  Score=315.25  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=210.6

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE   76 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (309)
                      .....++|++.+.||+|+||.||+|.+.      ++..|++|.+...........+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3456789999999999999999999853      3788999998765555556678899999999999999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccc-------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQ-------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      .+..++||||+++++|.+++......       ...++..++.++.|++.||.|||+++   ++||||+|+||+++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            99999999999999999998754321       34477899999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||...............
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            9999999987654333333334455678899999886   7889999999999999999 88997654322111110000


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                                        .....+..++..+.++|.+||+.||.+|||+.+++++|+.+..
T Consensus       257 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          257 ------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                              0011122344669999999999999999999999999976643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-45  Score=317.28  Aligned_cols=258  Identities=23%  Similarity=0.409  Sum_probs=198.9

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||+|+||.||+|.+. +|+    +|++|.+...........+.+|+.++++++||||+++++++.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            578999999999999999999953 444    458887766555555678899999999999999999999998755 68


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +|++|+.+++|.+++.....  .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999976443  3577889999999999999999999   999999999999999999999999999766


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............++..|+|||.+.   ++.++||||||+++|+|++ |..||........                  .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------------------~  229 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------------------S  229 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------------------H
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH------------------H
Confidence            4433333333445677899999986   7889999999999999999 9999865422211                  1


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ...........+..++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            111111111222334466999999999999999999999999998887543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-44  Score=310.02  Aligned_cols=264  Identities=24%  Similarity=0.333  Sum_probs=205.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.+ .++..||+|.+...  ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            457899999999999999999995 46899999986432  233445678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus        89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999997554   3578899999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .. .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||.................+..         
T Consensus       163 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------  232 (294)
T 4eqm_A          163 ET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV---------  232 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH---------
T ss_pred             cc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc---------
Confidence            21 112233456889999999886   78889999999999999999999875433222111111111100         


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~~~~~~  290 (309)
                           ....+...++.+.++|.+||+.||.+|| ++.++.+.|..+......
T Consensus       233 -----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          233 -----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             -----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             -----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence                 0011122346699999999999999999 999999988877654433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-44  Score=313.67  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=201.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|.+....  .....+.+..|..+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            357999999999999999999995 469999999886542  22234567889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|..++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus        83 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999887543   3478899999999999999999999   9999999999999999999999999986532


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+.....                 ..+
T Consensus       157 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------------~~i  217 (337)
T 1o6l_A          157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----------------ELI  217 (337)
T ss_dssp             C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------HHH
T ss_pred             c--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-----------------HHH
Confidence            2  122334567899999999986   788999999999999999999998643221110                 011


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      .....  ..+...++.+.+||.+||+.||.+||     ++.++++|
T Consensus       218 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            11110  11123346699999999999999999     89999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.9e-45  Score=315.28  Aligned_cols=263  Identities=26%  Similarity=0.349  Sum_probs=191.3

Q ss_pred             HHhhcccccceeecccCceEEEEEEcCC-Cc---EEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLPD-NT---LVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~---~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ....++|++.+.||+|+||.||+|.+.. +.   .||+|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3457889999999999999999999654 32   79999876542 2233567899999999999999999999998766


Q ss_pred             cc------EEEEEcCCCCCHHHHHHhhccc---cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           79 VP------LLVYEFVPNGTLFQHVRYQSSQ---VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        79 ~~------~iv~e~~~~~sL~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      ..      ++||||+++++|.+++......   ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      8999999999999998755422   14678899999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.............  
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--  253 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI--  253 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh--
Confidence            9999999987654333333333445677899999986   7889999999999999999 999987543222111100  


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                                      .......+...++.+.+|+.+||+.||.+|||+.++++.|+.+..-
T Consensus       254 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          254 ----------------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             ----------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----------------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                            0111112223446699999999999999999999999998877643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.7e-45  Score=317.26  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-C-----cEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-N-----TLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~-----~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||+|.+.. +     ..|++|.+.........+.+..|+.+++.+ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999999532 3     479999887665555567789999999999 8999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc-----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS-----------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      ..++||||+++++|.+++.....           ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999975532           234577899999999999999999999   9999999999999999


Q ss_pred             CCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhc
Q 040698          148 YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRM  223 (309)
Q Consensus       148 ~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~  223 (309)
                      +.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........    
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----  276 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF----  276 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH----
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH----
Confidence            999999999987654333323333455677899999875   7889999999999999998 89997643221111    


Q ss_pred             ccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                                   ............+...++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       277 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 -------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                         111111111111222346699999999999999999999999999877653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.1e-45  Score=321.43  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             hcccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|..+    ++..||+|.+.........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999854    5778999998765455556789999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus       124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999975432  3577899999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccc-cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          163 SHDQTA-TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       163 ~~~~~~-~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ...... ......++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                 
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~-----------------  261 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-----------------  261 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH-----------------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------
Confidence            321111 111223456799999986   7889999999999999998 999975432211100                 


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                       ..........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus       262 -~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          262 -AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             -HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             -HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence             001111111222344669999999999999999999999999998876543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.6e-44  Score=305.95  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||++.+.++..||+|.+......  .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            45789999999999999999999888889999988754322  4568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.....  ..++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999999975432  3578899999999999999999999   9999999999999999999999999987553221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...............                
T Consensus       175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----------------  237 (283)
T 3gen_A          175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----------------  237 (283)
T ss_dssp             -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----------------
T ss_pred             -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc----------------
Confidence             11222334567799999986   7889999999999999998 99998754322211111100                


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                        .....+...++.+.+++.+||+.||.+|||+.+++++|..+.+
T Consensus       238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence              0111112223569999999999999999999999999987764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-44  Score=312.99  Aligned_cols=267  Identities=20%  Similarity=0.240  Sum_probs=198.6

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+.+|+.||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            468999999999999999999998889999999876542 2233467889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++ +|.+.+....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI-  171 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence            99975 7877776443  23578899999999999999999999   99999999999999999999999999876522 


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh---cccCccccccccc-h
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR---MVPYFPYPIENNS-L  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~-~  236 (309)
                       .........+++.|+|||.+.    ++.++||||||+++|+|++|..||............   .....+....... .
T Consensus       172 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 -PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             -CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             -CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence             122233456788999999874    688999999999999999999998754332211110   0000000000000 0


Q ss_pred             hhhh-------cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQIL-------NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....       ............++.+.+||.+||+.||.+|||+.++++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0000       0000000112234568999999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=314.55  Aligned_cols=249  Identities=18%  Similarity=0.249  Sum_probs=201.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.+|+|.+.....  ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            468999999999999999999995 4689999998765432  2456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEEeeecccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--NYTAKVADFASSVLIS  162 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~~~  162 (309)
                      ||++|++|.+++....  ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.  ++.++|+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999886433  24578999999999999999999999   999999999999986  7899999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .   ........+++.|+|||.+.   ++.++||||||+++|+|++|..||........                 ...+
T Consensus       156 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------------~~~i  215 (321)
T 1tki_A          156 P---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------IENI  215 (321)
T ss_dssp             T---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHH
T ss_pred             C---CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----------------HHHH
Confidence            2   22233456789999999987   68899999999999999999999864322111                 1111


Q ss_pred             hcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          240 LNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       240 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ........  .....+..+.+||.+||+.||.+|||+.+++++-
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            11111111  1122346699999999999999999999999865

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-44  Score=310.22  Aligned_cols=271  Identities=25%  Similarity=0.310  Sum_probs=206.7

Q ss_pred             hcccccceeecccCceEEEEEE-----cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-----LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET--KV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~   79 (309)
                      .++|++.+.||+|+||.||+|.     ..+++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4679999999999999999998     3468999999987655544557789999999999999999999999876  66


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++.....  ..++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            8999999999999999965443  3578899999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........ .......++..|+|||.+.   ++.++|+||||+++|+|++|..|+.........   .............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~  251 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIGPTHGQMTVTR  251 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCGGGHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh---ccCCcccccCHHH
Confidence            65432221 2233455677899999886   778899999999999999999986543211111   0011111111111


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .............+..+++.+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11122222223334455677999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=315.86  Aligned_cols=264  Identities=23%  Similarity=0.407  Sum_probs=202.4

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcE----EEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~----v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||+|+||.||+|.+. +++.    |++|.+.........+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            578999999999999999999953 4543    57777655544445678899999999999999999999998755 78


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ++++|+.+++|.+++.....  .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999976543  3577889999999999999999999   999999999999999999999999999765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............+++.|+|||.+.   ++.++||||||+++|+|++ |..||........                  .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------------------~  229 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------------------S  229 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------------------H
Confidence            4333333333445677899999886   7889999999999999999 9999865422211                  1


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ  294 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~  294 (309)
                      ...........+..++..+.++|.+||+.||.+|||+.++++.|+.+..........
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  286 (327)
T 3lzb_A          230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI  286 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBCC
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEEe
Confidence            111111112222334466999999999999999999999999999988766555444

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-44  Score=305.92  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=195.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ...++|++.+.||+|+||.||+|.+..    +..|++|...........+.+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            456899999999999999999998532    45799998876655556678899999999999999999999985 4678


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999997543  23578899999999999999999999   99999999999999999999999999876


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ..... ........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||.........                 
T Consensus       166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-----------------  227 (281)
T 1mp8_A          166 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------------  227 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------
T ss_pred             cCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-----------------
Confidence            53221 11222334567899999886   7788999999999999996 99998654222111                 


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ..+... .....+..+++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       228 ~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          228 GRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            001000 0111223344679999999999999999999999999987754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-44  Score=312.03  Aligned_cols=262  Identities=25%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             HhhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLET   77 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   77 (309)
                      ...++|++.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.++..+ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3468999999999999999999973      357899999887655544556789999999999 689999999998765


Q ss_pred             -CccEEEEEcCCCCCHHHHHHhhccc-------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           78 -KVPLLVYEFVPNGTLFQHVRYQSSQ-------------VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                       ...++||||+++++|.+++......             ..+++..++.++.|++.||.|||+++   ++|+||+|+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence             4589999999999999999765431             12577899999999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.++|+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            9999999999999987654333333334456678899999886   7889999999999999998 99998653221111


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ....                 ........+...++.+.++|.+||+.||.+|||+.+++++|+.+..
T Consensus       261 ~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          261 CRRL-----------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             HHHH-----------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHh-----------------ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1000                 0001111122234569999999999999999999999999988764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.7e-44  Score=311.98  Aligned_cols=274  Identities=26%  Similarity=0.327  Sum_probs=210.4

Q ss_pred             hhccc-ccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--C
Q 040698            6 ATKNY-DKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--T   77 (309)
Q Consensus         6 ~~~~y-~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   77 (309)
                      ..++| ++++.||+|+||.||++.+     .+|+.||+|.+.........+.+.+|+.+++.++||||+++++++.+  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34566 9999999999999998863     26899999998776555556788999999999999999999999987  4


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      ...++||||+++++|.+++....    +++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            67789999999999999986443    577899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          158 SVLISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      +......... .......++..|+|||.+.   ++.++||||||+++|+|++|..||.............   .......
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~  257 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI---AQGQMTV  257 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS---CCHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc---cccchhH
Confidence            9765332211 1223345677799999986   7788999999999999999999987543221111100   0000011


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ...............+..++..+.+||.+||+.||.+|||+.++++.|+.+...+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            11112222222333344556779999999999999999999999999988876554

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-44  Score=312.57  Aligned_cols=279  Identities=24%  Similarity=0.306  Sum_probs=209.0

Q ss_pred             hcccccceeecccCceEEEEEEc-----CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-----PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL--ETKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~   79 (309)
                      .++|++.+.||+|+||.||++.+     .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.  +.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            47999999999999999999982     4689999998876543 33567899999999999999999999886  4567


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            8899999999999999976443  3578999999999999999999999   9999999999999999999999999997


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........ .......++..|+|||.+.   ++.++||||||+++|+|++|..||................  ... ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~-~~~  252 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VPA-LSR  252 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCH-HHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc--ccc-HHH
Confidence            65332221 1223445677899999886   6889999999999999999999976543321111110000  000 011


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQ  294 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~  294 (309)
                      .............+..+++.+.+||.+||+.||.+|||+.+++++|+.+..........
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence            11122222223334455677999999999999999999999999999887766555443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=315.70  Aligned_cols=248  Identities=27%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||++.+ .+|+.||+|.+....  .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            357899999999999999999995 468999999876532  223345677888999887 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|..++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999997654   3578899999999999999999999   999999999999999999999999998653


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+...                 ....
T Consensus       175 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~  235 (353)
T 3txo_A          175 IC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------LFEA  235 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHH
T ss_pred             cc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----------------HHHH
Confidence            21  122334567899999999987   8999999999999999999999986442221                 1111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      +......  .+...++.+.+||++||+.||.+||++      .++++|
T Consensus       236 i~~~~~~--~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          236 ILNDEVV--YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHcCCCC--CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            1111111  112234669999999999999999998      777764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-44  Score=313.18  Aligned_cols=253  Identities=20%  Similarity=0.266  Sum_probs=200.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh----hhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI----LINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+......    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457899999999999999999985 46999999987543221    1256789999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEEeee
Q 040698           81 LLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVADFA  156 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~---v~l~d~g  156 (309)
                      ++||||++|++|.+.+.... ....+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.   ++|+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988876543 2334578899999999999999999999   999999999999986554   9999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ++......  ........+++.|+|||.+.   ++.++||||||+++|+|++|..||.......  .             
T Consensus       179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~-------------  241 (351)
T 3c0i_A          179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--F-------------  241 (351)
T ss_dssp             TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH--H-------------
T ss_pred             ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH--H-------------
Confidence            98765332  12233457899999999986   7889999999999999999999986532110  0             


Q ss_pred             cchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 NSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                         ..+.......  ......++.+.+||.+||+.||++|||+.+++++-
T Consensus       242 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          242 ---EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             ---HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence               0000000000  00112346699999999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=311.75  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=200.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh-----hhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||++.++ +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35678999999999999999999964 6899999987553221     13567899999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVAD  154 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d  154 (309)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++    .++|+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            999999999999999998643   34578999999999999999999999   99999999999998877    799999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ||++......   .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||.................    
T Consensus       162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----  234 (326)
T 2y0a_A          162 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----  234 (326)
T ss_dssp             CTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC----
T ss_pred             CCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC----
Confidence            9998765321   2233456899999999986   78899999999999999999999854321111000000000    


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                 ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 -----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 -----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -----------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       00000111234568999999999999999999999885

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=322.00  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=201.2

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ....++|++.+.||+|+||.||+|.+ .+|+.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            35678999999999999999999985 568999999875432 2333567899999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeecc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASS  158 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~  158 (309)
                      +||||++|++|.+.+....   ..++..+..++.|++.||.|||+++   ++||||||+||+++   .++.++|+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            9999999999999887543   3578999999999999999999999   99999999999998   4678999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  ........|++.|+|||.+.   ++.++||||||+++|+|++|..||.........                
T Consensus       161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~----------------  222 (444)
T 3soa_A          161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY----------------  222 (444)
T ss_dssp             BCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------
T ss_pred             EEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH----------------
Confidence            665322  22233457899999999986   788999999999999999999998543221111                


Q ss_pred             hhhhhccccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ..+......  .+.....++.+.+||.+||+.||.+|||+.+++++
T Consensus       223 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          223 -QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             111111111  11112334669999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-44  Score=312.74  Aligned_cols=247  Identities=22%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            357899999999999999999995 679999999876432  22224578899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+ +++|.+++....   .+++..+..++.|++.|+.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus        87 v~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 678888886543   3578899999999999999999999   9999999999999999999999999987542


Q ss_pred             cccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .   ........|++.|+|||.+.    .+.++||||||+++|+|++|..||.......  ..               ..
T Consensus       160 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~---------------~~  219 (336)
T 3h4j_B          160 D---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LF---------------KK  219 (336)
T ss_dssp             T---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--CB---------------CC
T ss_pred             C---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--HH---------------HH
Confidence            2   22334457899999999987    3678999999999999999999986432111  00               00


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +...  ....+...++.+.+||++||+.||.+|||+.+++++-
T Consensus       220 i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          220 VNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             CCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             HHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            0000  0111223346699999999999999999999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=319.39  Aligned_cols=275  Identities=19%  Similarity=0.274  Sum_probs=212.7

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC--ccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK--VPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4689999999999999999999964 599999999876554444667789999999999999999999998654  6799


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEEeeecc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL----DDNYTAKVADFASS  158 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv----~~~~~v~l~d~g~~  158 (309)
                      ||||+++++|.+++........+++..++.++.|++.||.|||+++   ++||||+|+||++    +.++.++|+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999986655544788999999999999999999999   9999999999999    77778999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh---hhhcc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE---MTRMV  224 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~---~~~~~  224 (309)
                      .....   ........+++.|+|||.+.           ++.++||||||+++|+|++|..||.........   .....
T Consensus       164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            76532   22233456889999999863           567899999999999999999998643322111   11111


Q ss_pred             cCccccc-------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          225 PYFPYPI-------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       225 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ...+...       .................+...+..+.+++.+||+.||++|||+.++++.+..+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            1111000       0000111111112223346777889999999999999999999999999877654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-44  Score=305.40  Aligned_cols=253  Identities=23%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++.. .++..+|+|.+.........+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            467899999999999999999995 4689999998876554444677899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeecccc
Q 040698           85 EFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVL  160 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~~  160 (309)
                      ||+++++|.+.+.... ....+++..+..++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999886442 2345688899999999999999999999   9999999999999   4567899999999865


Q ss_pred             cccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...   ........+++.|+|||.+.  ++.++|+||||+++|+|++|..||...................         
T Consensus       177 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------  244 (285)
T 3is5_A          177 FKS---DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY---------  244 (285)
T ss_dssp             -------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             cCC---cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence            422   12233456788999999887  7788999999999999999999986543222111100000000         


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             .......++.+.+||.+||+.||.+|||+.+++++
T Consensus       245 -------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 -------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00001123568999999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=316.42  Aligned_cols=249  Identities=21%  Similarity=0.267  Sum_probs=199.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.+ .+|+.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            357899999999999999999995 458999999876532  22234567899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|..++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999987543   3578899999999999999999999   9999999999999999999999999997652


Q ss_pred             cccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .   ........|++.|+|||.+.      ++.++|+||||+++|+|++|..||..........              ..
T Consensus       167 ~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~--------------~~  229 (384)
T 4fr4_A          167 R---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE--------------IV  229 (384)
T ss_dssp             T---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH--------------HH
T ss_pred             C---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH--------------HH
Confidence            2   23344567899999999984      6889999999999999999999986432111100              00


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-HHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-MRQVSE  279 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~  279 (309)
                      ..+...  ....+...+..+.+||.+||+.||.+||+ +.++++
T Consensus       230 ~~~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          230 HTFETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            000000  11112233466999999999999999998 777665

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-44  Score=327.34  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||+|.++++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            4578999999999999999999988889999998875432  3567899999999999999999999987 567899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...... ..+...++.++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++.......
T Consensus       263 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999754322 3467889999999999999999999   9999999999999999999999999997653211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ........++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                 .+ .
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~-----------------~i-~  399 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-----------------AL-E  399 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-----------------HH-H
T ss_pred             -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HH-H
Confidence             11112234567799999986   7889999999999999999 999986543221110                 00 0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      .....+.+..+++.+.+||.+||+.||++|||+.++++.|+.+....+
T Consensus       400 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            111112223445679999999999999999999999999988765443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-44  Score=317.62  Aligned_cols=273  Identities=19%  Similarity=0.292  Sum_probs=203.3

Q ss_pred             HHhhcccccceeeccc--CceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            4 VKATKNYDKRHLLGEG--GFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g--~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ....++|++.+.||+|  +||.||++.++ +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3467899999999999  99999999964 69999999876542 23345678889999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++...... .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||.+.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence            99999999999999999765333 3578899999999999999999999   9999999999999999999999999875


Q ss_pred             ccccccc-----cccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          160 LISSHDQ-----TATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       160 ~~~~~~~-----~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      .......     ........+++.|+|||.+.     ++.++|||||||++|+|++|..||.................+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            4422111     11222346788899999875     6788999999999999999999987543332222111111110


Q ss_pred             cccccc------------------hhhhh---------cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 PIENNS------------------LRQIL---------NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 ~~~~~~------------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......                  .....         ........+...++.+.+||.+||+.||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000000                  00000         0000011223345679999999999999999999999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.8e-44  Score=303.98  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.|++|.+.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            5689999999999999999999964 689999998866544445677899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999998887533   24578899999999999999999999   999999999999999999999999998765333


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..........+++.|+|||.+.    .+.++|+||||+++|+|++|..||...............               
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------  223 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---------------  223 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence            2223334556788999999986    356799999999999999999998754322211111110               


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ...........++.+.+||.+||+.||.+|||+.+++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          224 -KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             000111112334669999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-44  Score=315.31  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467899999999999999999995 468999999875432 22334678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN---YTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~---~~v~l~d~g~~~  159 (309)
                      ||||++|++|.+.+....   ..++..+..++.|++.||.|||+++   ++||||+|+||+++.+   +.++|+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998886443   4578899999999999999999999   9999999999999754   459999999987


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....   ........|++.|+|||.+.   ++.++||||||+++|+|++|..||.........                 
T Consensus       180 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------  239 (362)
T 2bdw_A          180 EVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----------------  239 (362)
T ss_dssp             CCTT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------
T ss_pred             EecC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-----------------
Confidence            6532   22233457899999999986   788999999999999999999998643221110                 


Q ss_pred             hhhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..+.....  ........++.+.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            01111100  011112334669999999999999999999999886

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-44  Score=314.17  Aligned_cols=261  Identities=24%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch----hhhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD----KILINEVFQHKMRIISQINHKNVVKILGVCLE   76 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (309)
                      .+....++|++.+.||+|+||.||+|.+ .++..||+|.+....    .....+.+..|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            4667889999999999999999999995 568899999875432    22335678999999999999999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhcc-------------------------------------ccccCHHHHHHHHHHHHH
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSS-------------------------------------QVLKTWKTCLRIAAETAS  119 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~-------------------------------------~~~~~~~~~~~i~~~i~~  119 (309)
                      .+..++||||++|++|.+++.....                                     ....++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999998852110                                     112356778899999999


Q ss_pred             HHHHHHhcCCCCeEecCCCCCcEEEcCCC--CeEEEeeeccccccccccc--ccccccccccccCCCcccc-----cCCC
Q 040698          120 ALDYLHSLGSPPIIHGDVKSANILLDDNY--TAKVADFASSVLISSHDQT--ATTTKEIETVGWLDPEYLF-----WTEK  190 (309)
Q Consensus       120 ~l~~lh~~~~~~~~h~dl~~~nilv~~~~--~v~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~-----~~~~  190 (309)
                      ||.|||+++   ++|+||+|+||+++.++  .++|+|||++.........  .......+++.|+|||.+.     ++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998766  8999999998765332211  1234556889999999874     6789


Q ss_pred             cchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCC
Q 040698          191 SDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTE  270 (309)
Q Consensus       191 ~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  270 (309)
                      +||||||+++|+|++|..||..................               .........++.+.+||.+||+.||.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------FENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------TTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------cCCcccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999998654322211111111100               001111223466999999999999999


Q ss_pred             CCCHHHHHHH
Q 040698          271 RPTMRQVSEQ  280 (309)
Q Consensus       271 Rps~~~ll~~  280 (309)
                      |||+.+++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.7e-44  Score=317.14  Aligned_cols=253  Identities=22%  Similarity=0.297  Sum_probs=191.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            4579999999999999999999964 799999998865432  2356789999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eEEEeeecccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT--AKVADFASSVLIS  162 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~--v~l~d~g~~~~~~  162 (309)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.  ++|+|||++....
T Consensus        96 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           96 EYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999999987544   3578999999999999999999999   999999999999987665  9999999886431


Q ss_pred             cccccccccccccccccCCCcccc---cC-CCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WT-EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~-~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                         .........|++.|+|||.+.   +. .++||||||+++|+|++|..||...........             ....
T Consensus       170 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------------~~~~  233 (361)
T 3uc3_A          170 ---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK-------------TIQR  233 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH-------------HHHH
T ss_pred             ---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH-------------HHHH
Confidence               122233456899999999886   33 348999999999999999999875432211110             0111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      +.......+.....++.+.+||.+||+.||.+|||+.++++|-.
T Consensus       234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            11111111111223466999999999999999999999998743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-44  Score=315.43  Aligned_cols=259  Identities=25%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcE----EEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTL----VAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~----v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||+|+||.||+|.+. +++.    |++|.+...........+.+|+.+++.++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            468999999999999999999953 4544    77776644433222345678889999999999999999987 45688


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            9999999999999987543  24467889999999999999999999   999999999999999999999999999876


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .............++..|+|||.+.   ++.++||||||+++|+|++ |..||............               
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------------  230 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------------  230 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---------------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---------------
Confidence            4443333444556777899999986   7889999999999999999 99998754322111100               


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                         ........+..++..+.++|.+||+.||.+|||+.+++++|+.+....+
T Consensus       231 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          231 ---EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             ---HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             ---HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence               0000111111223448899999999999999999999999998875544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=307.95  Aligned_cols=244  Identities=25%  Similarity=0.313  Sum_probs=199.6

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||+|+||.||++.. .+|+.||+|.+.....  ....+.+..|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            57899999999999999999995 4699999998765421  22345678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999997543   3477889999999999999999999   99999999999999999999999999875422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                           ......|++.|+|||.+.   ++.++|+||||+++|+|++|..||........                 ...+.
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------------~~~i~  216 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----------------YEKIL  216 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHHH
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHH
Confidence                 223457899999999987   78899999999999999999999864322111                 11111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....  ..+...++.+.++|.+||+.||.+||     ++.++++|
T Consensus       217 ~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          217 NAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             hCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            1111  11122346699999999999999999     89999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-43  Score=299.74  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||++.+.+++.|++|.+......  .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            35789999999999999999999888899999988764332  4578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++.....  ..++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        84 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-  157 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-  157 (267)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred             CCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence            9999999999975432  3477899999999999999999999   999999999999999999999999998654221 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .........++..|+|||.+.   ++.++|+||||+++|+|++ |..||............ ...               
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~---------------  221 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STG---------------  221 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTT---------------
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcC---------------
Confidence            111222344567899999986   7788999999999999999 89998654322111000 000               


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                        .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       222 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 --FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              0011112233569999999999999999999999999988764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-44  Score=302.30  Aligned_cols=253  Identities=28%  Similarity=0.399  Sum_probs=192.3

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchh---hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. |+.+|+|.+.....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3578999999999999999999974 88999998765432   2224578899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--------CCCeEEEe
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--------NYTAKVAD  154 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--------~~~v~l~d  154 (309)
                      ||||+++++|.+++..    ...++..++.++.|++.|+.|||+++..+++|+||+|+||+++.        ++.++|+|
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999988852    24578899999999999999999987444779999999999985        77899999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ||++......    ......+++.|+|||.+.   ++.++|+||||+++|+|++|..||..............       
T Consensus       160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------  228 (271)
T 3dtc_A          160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-------  228 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-------
T ss_pred             CCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-------
Confidence            9998654221    222446788999999886   78899999999999999999999865432221111111       


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                                .......+..+++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus       229 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 ----------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                      1111112233446699999999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.3e-44  Score=307.08  Aligned_cols=265  Identities=23%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||+|+||.||+|.+.+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            6899999999999999999998789999999875442 222345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence            975 8888886543  23577889999999999999999999   999999999999999999999999998654221  


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccC----ccccccccc
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPY----FPYPIENNS  235 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~----~~~~~~~~~  235 (309)
                      ........+++.|+|||.+.    ++.++||||||+++|+|++|..||.............   ...    ++.......
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            12223446788999999874    6889999999999999999999987543222111100   000    000000000


Q ss_pred             hhhhh---cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQIL---NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....   ............++.+.+||.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000   0000001112344668999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8e-44  Score=316.60  Aligned_cols=257  Identities=23%  Similarity=0.260  Sum_probs=197.8

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++++.||+|+||.||++..+ +++.||+|++.....  ....+.+..|..++.++ +||||+++++++.+.+.++
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3578999999999999999999954 588999998765421  11223467888888876 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|..++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus       130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999887553   3578999999999999999999999   999999999999999999999999998653


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...........        .........
T Consensus       204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~~~  273 (396)
T 4dc2_A          204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQV  273 (396)
T ss_dssp             CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHH
T ss_pred             cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHHHH
Confidence            21  223344567899999999987   88899999999999999999999864321110000        000000111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      +....  ...+...+..+.+||++||+.||.+||++      .++++|
T Consensus       274 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          274 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             Hhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            11111  11223345669999999999999999985      566664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=306.21  Aligned_cols=254  Identities=25%  Similarity=0.435  Sum_probs=198.3

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .++|++.+.||+|+||.||++.+. ++.|++|.+....   ..+.+..|+.++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            578999999999999999999974 7889999886432   35678899999999999999999998874  47999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh---cCCCCeEecCCCCCcEEEcCCCC-eEEEeeecccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS---LGSPPIIHGDVKSANILLDDNYT-AKVADFASSVLIS  162 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~~~~h~dl~~~nilv~~~~~-v~l~d~g~~~~~~  162 (309)
                      +++++|.+++.........+...++.++.|++.||.|||+   ++   ++|+||+|+||+++.++. ++|+|||++....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            9999999999866554456778899999999999999999   78   999999999999988876 7999999986542


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||.............                
T Consensus       158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----------------  216 (307)
T 2eva_A          158 T-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----------------  216 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH----------------
T ss_pred             c-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH----------------
Confidence            2     122345788999999986   7889999999999999999999986432211110000                


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      .............+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       217 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            000011111223346699999999999999999999999999998766543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-43  Score=302.12  Aligned_cols=261  Identities=24%  Similarity=0.361  Sum_probs=203.6

Q ss_pred             HhhcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ...++|++.+.||+|+||.||+|.+.+    +..|++|.+.........+.+.+|+.+++.++||||+++++++.+ +..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            456899999999999999999998432    346999988766555556788999999999999999999999875 456


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||+++++|.+++.....  ..+...+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            899999999999999976543  3477889999999999999999999   99999999999999999999999999876


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ..... ........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...........               
T Consensus       163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---------------  226 (281)
T 3cc6_A          163 IEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---------------  226 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---------------
T ss_pred             ccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---------------
Confidence            53221 11222344567899999886   7888999999999999998 9999864322211100               


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                        + ........+..+++.+.++|.+||+.||.+|||+.+++++|+.+.....+
T Consensus       227 --~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          227 --L-EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             --H-HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --H-hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence              0 00001111222346699999999999999999999999999988765443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.9e-44  Score=302.42  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=202.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--CccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET--KVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. |+.+|+|.+.... .....+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            3578999999999999999999984 8899999876543 233456789999999999999999999999876  78899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++++|+||+|+||+++.++.++++|||..... 
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF-  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred             eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee-
Confidence            9999999999999975433 24588999999999999999999976 44899999999999999999999998876432 


Q ss_pred             cccccccccccccccccCCCcccc---cCC---CcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTE---KSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~---~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                            ......+++.|+|||.+.   ++.   ++||||||+++|+|++|..||...........               
T Consensus       164 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---------------  222 (271)
T 3kmu_A          164 ------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK---------------  222 (271)
T ss_dssp             ------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH---------------
T ss_pred             ------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH---------------
Confidence                  122346688999999986   233   69999999999999999999865432221111               


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                        ..........+...++.+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 --VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              111111112223344669999999999999999999999999988753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=308.44  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=191.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-------------------------hhHHHHHHHHHHH
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-------------------------LINEVFQHKMRII   59 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-------------------------~~~~~~~~e~~~l   59 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+......                         ...+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            457899999999999999999985 56899999987543211                         1124578999999


Q ss_pred             hhcCCCccceeeeeeec--CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040698           60 SQINHKNVVKILGVCLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV  137 (309)
Q Consensus        60 ~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl  137 (309)
                      +.++||||+++++++.+  .+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+++   ++|+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  163 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI  163 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence            99999999999999986  567899999999999876542    234688999999999999999999999   999999


Q ss_pred             CCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          138 KSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       138 ~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                      +|+||+++.++.++|+|||++......  ........+++.|+|||.+.      ++.++||||||+++|+|++|..||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999998765322  12233457889999999986      2557899999999999999999986


Q ss_pred             hhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          212 YVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........                 .+.......+.....++.+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          242 DERIMCLHS-----------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CSSHHHHHH-----------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CccHHHHHH-----------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            432211100                 0001111111112234669999999999999999999999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-43  Score=321.43  Aligned_cols=250  Identities=28%  Similarity=0.433  Sum_probs=201.8

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-ccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK-VPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+. |+.||+|.+....   ..+.+.+|+.++++++||||+++++++.+.+ ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3578999999999999999999974 7899999887643   2457899999999999999999999987654 789999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++..... ..++...+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus       267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  341 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  341 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence            99999999999986543 23477889999999999999999999   99999999999999999999999999865321 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                          ......++..|+|||.+.   ++.++||||||+++|+|++ |..||.........                 ..+ 
T Consensus       342 ----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~i-  399 (450)
T 1k9a_A          342 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----------------PRV-  399 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-----------------HHH-
T ss_pred             ----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HHH-
Confidence                112234567899999986   7889999999999999998 99998654221111                 111 


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ........+..+++.+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       400 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            1111122334455779999999999999999999999999987764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-43  Score=304.18  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=202.1

Q ss_pred             HhhcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeee-ecCCc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC-LETKV   79 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~   79 (309)
                      ....+|++.+.||+|+||.||+|...+    +..+++|.+.........+.+.+|+.++++++||||+++++++ ..++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            456789999999999999999998532    2358888877655555567789999999999999999999985 45678


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++....  ...+...++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999997533  23477889999999999999999999   9999999999999999999999999987


Q ss_pred             ccccccc--cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccc
Q 040698          160 LISSHDQ--TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       160 ~~~~~~~--~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      .......  ........+++.|+|||.+.   ++.++|+||||+++|+|++ |.+||............           
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-----------  245 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----------  245 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-----------
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----------
Confidence            6533221  11223345677899999886   7889999999999999999 56665443221111100           


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                            . .......+..+++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       246 ------~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          246 ------L-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ------H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ------h-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  0 001111122234569999999999999999999999999988876544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.4e-44  Score=309.69  Aligned_cols=262  Identities=26%  Similarity=0.348  Sum_probs=203.7

Q ss_pred             hhcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+...........+..|+.+++.++||||+++++++.+.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            468999999999999999999983      34779999998765444556678899999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccc----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQ----VLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKV  152 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l  152 (309)
                      .++||||+++++|.+++......    ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.   +..++|
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999865422    33577889999999999999999999   999999999999984   456999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      +|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |..||...........       
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-------  257 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-------
Confidence            9999986553333333334456678899999886   7889999999999999998 9999865422111100       


Q ss_pred             ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                                +.. ......+..++..+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus       258 ----------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          258 ----------VTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             ----------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             ----------Hhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                      000 0011112233466999999999999999999999999998876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=303.23  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=207.3

Q ss_pred             HHhhcccccce-eecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            4 VKATKNYDKRH-LLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         4 ~~~~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ....++|.+.+ .||+|+||.||+|.+.   ++..||+|.+.........+.+.+|+.+++.++||||+++++++. .+.
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   83 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA   83 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC
Confidence            34567888887 9999999999999843   578899999877555555677899999999999999999999994 566


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence            899999999999999986433  23578999999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ........ .......+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...........             
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------------  225 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------------  225 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------------
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------------
Confidence            65332221 1222344578899999886   7889999999999999998 9999865432111100             


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                          + ........+..+++.+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus       226 ----i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          226 ----I-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             ----H-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ----H-hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                0 0001111223345679999999999999999999999999988765443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-43  Score=310.85  Aligned_cols=245  Identities=23%  Similarity=0.266  Sum_probs=200.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++++.||+|+||.||++.++ +|+.||+|.+....  .....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3578999999999999999999964 69999999876542  22234567889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus       119 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            999999999999997654   3578899999999999999999999   9999999999999999999999999987642


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .     ......|++.|+|||.+.   ++.++|+||||+++|+|++|..||........                 ...+
T Consensus       193 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------------~~~i  250 (350)
T 1rdq_E          193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----------------YEKI  250 (350)
T ss_dssp             S-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHH
T ss_pred             C-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-----------------HHHH
Confidence            2     223457899999999986   78899999999999999999999864321111                 1111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      .....  ..+...+..+.+||.+||+.||.+||+     +.++++|
T Consensus       251 ~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          251 VSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            11111  111223466999999999999999998     8888775

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-43  Score=300.30  Aligned_cols=250  Identities=22%  Similarity=0.271  Sum_probs=201.2

Q ss_pred             HHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      -...++|++.+.||+|+||.||+|.+. ++..+++|.+....... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            346789999999999999999999954 57889999876543332 5678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~  159 (309)
                      ||||+++++|.+++....   .+++..+..++.|++.|+.|||+++   ++|+||+|+||++   +.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999887543   3578899999999999999999999   9999999999999   788899999999986


Q ss_pred             ccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ....   ........+++.|+|||.+.  ++.++|+||||+++|+|++|..||...........                
T Consensus       158 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----------------  218 (277)
T 3f3z_A          158 RFKP---GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----------------  218 (277)
T ss_dssp             ECCT---TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------
T ss_pred             eccC---ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----------------
Confidence            6532   22334456888999999887  88899999999999999999999865432211111                


Q ss_pred             hhhcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       +........  .....++.+.++|.+||+.||.+|||+.+++++
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          219 -IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111100000  001234669999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-43  Score=301.38  Aligned_cols=254  Identities=29%  Similarity=0.484  Sum_probs=199.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhh------HHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILI------NEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+........      .+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            457999999999999999999995 5799999998755432111      157889999999999999999999997654


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEE
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT-----AKVA  153 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~-----v~l~  153 (309)
                        ++||||+++++|.+.+.....  ..++..+..++.|++.|+.|||+++ ++++|+||+|+||+++.++.     ++|+
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              799999999999888865432  4578899999999999999999986 44899999999999987776     9999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      |||++....     .......+++.|+|||.+.     ++.++||||||+++|+|++|..||...........       
T Consensus       172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------  239 (287)
T 4f0f_A          172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-------  239 (287)
T ss_dssp             CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-------
T ss_pred             CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-------
Confidence            999886432     2233456789999999983     67789999999999999999999865432221100       


Q ss_pred             ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          229 YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                              ............+..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus       240 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 --------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                    111111111222233456799999999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.4e-44  Score=308.42  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=186.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            357899999999999999999995 4689999998765544333466789999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhcc---ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           85 EFVPNGTLFQHVRYQSS---QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||++ ++|.+++.....   ...+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 599988875432   123577889999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccC----cccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPY----FPYP  230 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~----~~~~  230 (309)
                      ...  ........+++.|+|||.+.    ++.++||||||+++|+|++|..||.............   ...    ++..
T Consensus       159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            221  12233456788999999874    6889999999999999999999997543222111000   000    0000


Q ss_pred             c------------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 I------------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .            ....+......    ......+..+.+||.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0            00000000000    0111234569999999999999999999999763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-43  Score=309.22  Aligned_cols=257  Identities=23%  Similarity=0.272  Sum_probs=199.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||++.+ .+|+.||+|.+....  .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            357899999999999999999995 468999999876542  223345678899999887 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        87 lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999987543   3578899999999999999999999   999999999999999999999999998653


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...........        .........
T Consensus       161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~  230 (345)
T 3a8x_A          161 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQV  230 (345)
T ss_dssp             CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHH
T ss_pred             cC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHH
Confidence            22  122334567899999999987   78899999999999999999999864321110000        000000111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH------HHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM------RQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~  280 (309)
                      +.....  ..+...+..+.+||.+||+.||.+||++      .++++|
T Consensus       231 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 ILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            111111  1222344669999999999999999995      677654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=313.90  Aligned_cols=255  Identities=17%  Similarity=0.257  Sum_probs=196.9

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCc
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINH--KNVVKILGVCLETKV   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~   79 (309)
                      +....++|++.+.||+|+||.||++...+++.||+|.+.... .....+.+.+|+.+++.++|  |||+++++++.+.+.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            445678899999999999999999998889999999875432 23334678899999999976  999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++|||+ .+++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++ ++.++|+|||++.
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEEEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence            9999995 5789999997543   3577889999999999999999999   99999999999997 6789999999997


Q ss_pred             ccccccccccccccccccccCCCcccc--------------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--------------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ...............|++.|+|||.+.              ++.++||||||+++|+|++|..||..........     
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----  230 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-----  230 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-----
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-----
Confidence            654333333334567899999999873              5678999999999999999999986432111111     


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                 ............+...+..+.+||.+||+.||.+|||+.+++++-
T Consensus       231 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          231 -----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                       111111111112222235689999999999999999999998874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-43  Score=307.02  Aligned_cols=267  Identities=28%  Similarity=0.398  Sum_probs=197.5

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC----CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      +....++|++.+.||+|+||.||+|...    ++..||+|.+.... .....+.+..|+.+++.++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3445689999999999999999999742    35589999876542 233346788999999999999999999999765


Q ss_pred             C-----ccEEEEEcCCCCCHHHHHHhhc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           78 K-----VPLLVYEFVPNGTLFQHVRYQS---SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        78 ~-----~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      +     ..++||||+++++|.+++....   ....+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            4     3589999999999999985432   2345688999999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++|+|||++................+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...........    
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY----  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----
Confidence            9999999987653332223333445677899999986   7788999999999999999 8889765432211110    


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                                   ... ......+..+++.+.++|.+||+.||.+|||+.+++++|+.+....++
T Consensus       262 -------------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          262 -------------LLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             -------------HHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             -------------HHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                         000 001111223446699999999999999999999999999988765543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-43  Score=325.32  Aligned_cols=254  Identities=29%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             hcccccceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.++. +..||+|.+.....  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4678999999999999999999654 89999998875432  25678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++...... .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999764432 3577889999999999999999999   9999999999999999999999999987653221


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ........++..|+|||.+.   ++.++||||||+++|+|++ |..||.........                  ....
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~------------------~~~~  433 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------------ELLE  433 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------------HHHH
T ss_pred             -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH------------------HHHH
Confidence             11222334467899999986   7889999999999999999 99998654322110                  1111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .......+..+++.+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11122223345577999999999999999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-43  Score=298.91  Aligned_cols=247  Identities=28%  Similarity=0.384  Sum_probs=197.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.+ .++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            568999999999999999999985 457899999875532  22335678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++....   .+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999987553   3477899999999999999999999   9999999999999999999999999875432


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .    .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||...........                 +
T Consensus       161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------------~  219 (279)
T 3fdn_A          161 S----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----------------I  219 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------------H
T ss_pred             c----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-----------------H
Confidence            2    2223456788999999886   77899999999999999999999864322111100                 0


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ..  .....+...++.+.+||.+||+.||.+|||+.+++++-
T Consensus       220 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          220 SR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             HH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             Hh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            00  00111222345699999999999999999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-43  Score=302.32  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||+|+||.||+|.++ ++..|++|.+.....  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            35688999999999999999999964 488999998865433  246788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++..... ..+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999976543 34577899999999999999999999   99999999999999999999999999876532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      . .........+++.|+|||.+.   ++.++|+||||+++|+|++ |..||.........                  ..
T Consensus       164 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~------------------~~  224 (288)
T 3kfa_A          164 D-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------------EL  224 (288)
T ss_dssp             S-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------------HH
T ss_pred             C-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------------HH
Confidence            2 112223344567899999886   7889999999999999999 99998654322111                  11


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      .........+..+++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            111111122233446699999999999999999999999999777653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.1e-43  Score=304.86  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=198.4

Q ss_pred             ccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      .|...+.||+|+||.||+|..+ +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            3788889999999999999965 7999999987654332 3566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++...    .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  .
T Consensus       125 ~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  195 (321)
T 2c30_A          125 QGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V  195 (321)
T ss_dssp             CSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC--c
Confidence            999999988632    3578999999999999999999999   999999999999999999999999998765322  1


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc-
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ-  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  243 (309)
                      .......|++.|+|||.+.   ++.++|+||||+++|+|++|..||..........                 .+.... 
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~-----------------~~~~~~~  258 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-----------------RLRDSPP  258 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----------------HHHHSSC
T ss_pred             cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------------HHhcCCC
Confidence            1223456889999999986   7889999999999999999999986432211100                 000000 


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .........++.+.++|.+||+.||++|||+.+++++-
T Consensus       259 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            00111223346699999999999999999999998864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=304.44  Aligned_cols=265  Identities=22%  Similarity=0.313  Sum_probs=198.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.. .+|..||+|.+...  ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            357899999999999999999995 57999999987642  223445678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999987533 2344678899999999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...  ........++..|+|||.+.   ++.++|+||||+++|+|++|..||.............               
T Consensus       187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------  249 (310)
T 2wqm_A          187 SSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---------------  249 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH---------------
T ss_pred             cCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH---------------
Confidence            321  11223346788899999886   7788999999999999999999986432111111000               


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      +.............++.+.++|.+||+.||.+|||+.++++.|+++++....
T Consensus       250 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            0000001111123346699999999999999999999999999998876554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.6e-44  Score=314.30  Aligned_cols=265  Identities=22%  Similarity=0.258  Sum_probs=204.1

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||++.+. +|..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            578999999999999999999964 6899999988766555556788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |+++++|.+++....   ..++..+..++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            999999999997654   347789999999999999999995 8   99999999999999999999999998865421 


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc--------------
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF--------------  227 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~--------------  227 (309)
                         .......+++.|+|||.+.   ++.++||||||+++|+|++|..||.................              
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               1223456788999999987   78889999999999999999999875432221111000000              


Q ss_pred             -----------cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 -----------PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                 +..........+.............+..+.+||.+||+.||.+|||+.++++|-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                       000000011111111111222223456799999999999999999999998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.1e-44  Score=323.44  Aligned_cols=260  Identities=27%  Similarity=0.403  Sum_probs=202.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||+|.++++..||+|.+.....  ..+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            3578999999999999999999988888899998875432  24678999999999999999999999876 67899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.......
T Consensus       259 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999999975432 23577899999999999999999999   9999999999999999999999999987653211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ........++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                 .+ .
T Consensus       335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-----------------~i-~  395 (452)
T 1fmk_A          335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-----------------QV-E  395 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----------------HH-H
T ss_pred             -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HH-H
Confidence             11122234567899999886   7889999999999999999 999986442211110                 00 0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                      .....+.+..+++.+.+||.+||+.||++|||+.++++.|+.+....++.
T Consensus       396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~  445 (452)
T 1fmk_A          396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  445 (452)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence            01111122344567999999999999999999999999998876554443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-43  Score=303.23  Aligned_cols=265  Identities=20%  Similarity=0.294  Sum_probs=195.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            6899999999999999999996 468999999875432 23334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++ ++.+.+....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI--  153 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS--
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC--
Confidence            9976 5555554332  34588999999999999999999999   99999999999999999999999999876422  


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc--cccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF--PYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  239 (309)
                      .........+++.|+|||.+.    ++.++||||||+++|+|++|..||-................  +...........
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            122334456788999999875    68899999999999999988887532211111111110000  000000000000


Q ss_pred             hcc---------cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNF---------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...         ..........++.+.+||.+||+.||++|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000         00001122344668999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=305.42  Aligned_cols=268  Identities=23%  Similarity=0.320  Sum_probs=195.3

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhh--cCCCccceeeeeeecC----Cc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--INHKNVVKILGVCLET----KV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~   79 (309)
                      ..++|++.+.||+|+||.||+|.+. |+.||+|.+.....    ..+..+..++..  ++||||+++++++.+.    ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            4679999999999999999999975 89999998754332    233444444444  4899999999999876    67


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCcEEEcCCCCeE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL--------GSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      .++||||+++++|.+++...    .+++..++.++.|++.||.|||++        +   ++||||||+||+++.++.++
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEE
T ss_pred             eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEE
Confidence            89999999999999999643    357789999999999999999998        8   99999999999999999999


Q ss_pred             EEeeeccccccccccc--ccccccccccccCCCcccc---cCCC------cchhhHHHHHHHHHhCCCCCchhhhcchhh
Q 040698          152 VADFASSVLISSHDQT--ATTTKEIETVGWLDPEYLF---WTEK------SDVYSFGVVLVELLTGKHPRSYVALASNEM  220 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~---~~~~------~DiwslG~ll~~~~~g~~p~~~~~~~~~~~  220 (309)
                      |+|||++.........  .......|++.|+|||.+.   ....      +||||||+++|+|++|..|+..........
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999998655332211  1123457889999999986   3333      899999999999999955443221111000


Q ss_pred             hhcccCccccccccchhhhhc-c--c---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          221 TRMVPYFPYPIENNSLRQILN-F--Q---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~-~--~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ....   +............. .  .   ........+++.+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus       263 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          263 HDLV---PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTS---CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhc---CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            0000   00000000111110 0  0   111123477888999999999999999999999999999887654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-43  Score=308.84  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEE--EEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLV--AVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v--~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.+. +|..+  ++|.+.........+.+..|+.+++.+ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            478999999999999999999953 56644  888776554444456788999999999 89999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           83 VYEFVPNGTLFQHVRYQS-------------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      ||||+++++|.+++....             ....+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999997553             2234688999999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ++|+|||++.....   ........+++.|+|||.+.   ++.++||||||+++|+|++ |..||........... .. 
T Consensus       181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~-  255 (327)
T 1fvr_A          181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LP-  255 (327)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GG-
T ss_pred             EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hh-
Confidence            99999998864311   12223344577899999886   7889999999999999998 9999865432211100 00 


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                                      .......+...++.+.+||.+||+.||.+|||+.+++++|..+.......
T Consensus       256 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          256 ----------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             ----------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             ----------------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence                            00111122233466999999999999999999999999998887655443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.7e-44  Score=304.66  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=191.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+..  .+++|.+.... .....+.+.+|+.++++++||||++++++. ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            46799999999999999999998643  58999775432 333456789999999999999999999965 456689999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....  ...++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999886443  33577899999999999999999999   999999999999999999999999998765433


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..........+++.|+|||.+.      ++.++||||||+++|+|++|..||....................        
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  245 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------  245 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--------
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--------
Confidence            3333344556889999999874      56689999999999999999999865422211111100000000        


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                           ........+++.+.+||.+||+.||.+|||+.++++.|+++.
T Consensus       246 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 -----DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -----CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                 000112234466999999999999999999999999998765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-43  Score=301.38  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=201.2

Q ss_pred             cccccceeecccCceEEEEEEcC-C---CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc-EE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-D---NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP-LL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~---~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~i   82 (309)
                      -.|++.+.||+|+||.||+|.+. +   +..+++|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45677799999999999999842 2   3379999887665555567889999999999999999999999876555 99


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      +|||+.+++|.+++....  ...++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus       101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999997533  34477889999999999999999999   9999999999999999999999999987553


Q ss_pred             ccc--ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCC-CchhhhcchhhhhcccCccccccccch
Q 040698          163 SHD--QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       163 ~~~--~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...  .........+++.|+|||.+.   ++.++|+||||+++|+|++|..| |.......                  .
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~------------------~  237 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------------------L  237 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG------------------H
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH------------------H
Confidence            222  112223445678899999987   67889999999999999995555 43221111                  0


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      ............+...++.+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11111111112223344669999999999999999999999999988876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=303.79  Aligned_cols=245  Identities=20%  Similarity=0.189  Sum_probs=188.5

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccc-hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV-DKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++... ...........++..+..+ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            378999999999999999999965 7999999976442 2222233444555555444 899999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+ +++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 6789888876543  4588999999999999999999999   99999999999999999999999999866522


Q ss_pred             ccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                         ........|++.|+|||.+.  ++.++||||||+++|+|++|..|+.........                    ..
T Consensus       210 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--------------------~~  266 (311)
T 3p1a_A          210 ---AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--------------------RQ  266 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH--------------------TT
T ss_pred             ---CCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--------------------hc
Confidence               22233456889999999887  888999999999999999996654322111100                    00


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+...++.+.+||.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            000011112234669999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=305.63  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=204.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee----cCCcc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL----ETKVP   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~   80 (309)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.    .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            457899999999999999999995 5799999998765433 33567889999999999999999999987    34577


Q ss_pred             EEEEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            89999999999999987542 2345688999999999999999999999   9999999999999999999999999876


Q ss_pred             cccccccc-------ccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC
Q 040698          160 LISSHDQT-------ATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       160 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      ........       .......+++.|+|||.+.      ++.++||||||+++|+|++|..||.............   
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---  259 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---  259 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---
Confidence            54211110       0112234688899999875      5789999999999999999999986542221111000   


Q ss_pred             ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                                   .........+...+..+.++|.+||+.||.+|||+.+++++|+.++.-.+.
T Consensus       260 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          260 -------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             -------------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             -------------hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                         000111111223346699999999999999999999999999888754443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-44  Score=320.47  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=201.0

Q ss_pred             HHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ....++|++.+.||+|+||.||+|.++ +++.||+|.+.....  ....+.+..|..+++.++||||+++++++.+.+.+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            345689999999999999999999964 589999998765321  11123477899999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||++|++|.+++...    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus       145 ~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999988643    3477889999999999999999999   99999999999999999999999999876


Q ss_pred             cccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      .... .........|++.|+|||.+.       ++.++|+||||+++|+|++|..||...+...                
T Consensus       218 ~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------  280 (410)
T 3v8s_A          218 MNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------------  280 (410)
T ss_dssp             CCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred             eccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh----------------
Confidence            5322 122334567899999999986       5678999999999999999999986432111                


Q ss_pred             cchhhhhccc--ccCccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHHH
Q 040698          234 NSLRQILNFQ--VADENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~l  281 (309)
                       ....+....  ...+.....+..+.+||++||+.+|.+  ||++.++++|-
T Consensus       281 -~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          281 -TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             -HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             -HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence             111111110  111111223466999999999999988  99999998863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.3e-43  Score=298.83  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.|++|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            3578999999999999999999995 458999999875542 23334678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~---v~l~d~g~~~  159 (309)
                      ||||+++++|.+.+....   ..++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.   ++|+|||++.
T Consensus        83 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999988887553   3578899999999999999999999   999999999999976655   9999999986


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....   ........+++.|+|||.+.   ++.++||||||+++|+|++|..||..................        
T Consensus       157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  225 (284)
T 3kk8_A          157 EVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------  225 (284)
T ss_dssp             ECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred             Eccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--------
Confidence            5532   22233456788999999987   788999999999999999999998543222111111000000        


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             .........++.+.+||.+||+.||.+|||+.+++++
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 -------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   0111112334669999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-43  Score=311.08  Aligned_cols=249  Identities=24%  Similarity=0.263  Sum_probs=197.6

Q ss_pred             HHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCc
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQI-NHKNVVKILGVCLETKV   79 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (309)
                      ....++|++.+.||+|+||.||+|.++ +|+.||+|.+.....  ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999964 689999998865421  22245567888888876 89999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999997543   3478899999999999999999999   9999999999999999999999999986


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+....                 .
T Consensus       167 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------------~  227 (345)
T 1xjd_A          167 ENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------F  227 (345)
T ss_dssp             CCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------H
T ss_pred             hccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-----------------H
Confidence            5322  122334567899999999986   78899999999999999999999864322111                 0


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHH-HHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMR-QVSE  279 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~  279 (309)
                      ..+.....  ..+...++.+.+||.+||+.||.+||++. ++++
T Consensus       228 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          228 HSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHhCCC--CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            11111111  11122346699999999999999999997 6654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-43  Score=299.41  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=204.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...++|++.+.||+|+||.||+|...++..|++|.+.....  ..+.+..|+.+++.++||||+++++++.+ +..++||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            34688999999999999999999988888999998765432  24678899999999999999999999874 5589999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++..... ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        87 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999865432 23577899999999999999999999   999999999999999999999999998765322


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      . ........++..|+|||.+.   ++.++|+||||+++|+|++ |..||............ .                
T Consensus       163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~----------------  224 (279)
T 1qpc_A          163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-E----------------  224 (279)
T ss_dssp             C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-H----------------
T ss_pred             c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-h----------------
Confidence            1 11222334567799999986   7889999999999999999 89998654322111000 0                


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                       .......+...++.+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       225 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          225 -RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence             000111122334669999999999999999999999999988765543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.7e-43  Score=300.20  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhh--cCCCccceeeeeeec----CC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--INHKNVVKILGVCLE----TK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~   78 (309)
                      ...++|++.+.||+|+||.||+|.+ +|+.||+|.+....    ...+..|..++..  ++||||+++++++..    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            4578999999999999999999988 68999999876543    2334555565555  799999999998654    35


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--------SLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      ..++||||+++++|.+++...    .+++..++.++.|++.||.|||        +.+   ++||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence            678999999999999999532    3578899999999999999999        888   9999999999999999999


Q ss_pred             EEEeeecccccccccccc--cccccccccccCCCccccc---------CCCcchhhHHHHHHHHHhC----------CCC
Q 040698          151 KVADFASSVLISSHDQTA--TTTKEIETVGWLDPEYLFW---------TEKSDVYSFGVVLVELLTG----------KHP  209 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~---------~~~~DiwslG~ll~~~~~g----------~~p  209 (309)
                      +|+|||++..........  ......+++.|+|||.+..         +.++||||||+++|+|++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999986653322211  1233478999999999862         2579999999999999999          666


Q ss_pred             CchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          210 RSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      |..................       .............+...+..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       233 f~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVC-------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHT-------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHh-------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            5432111100000000000       0000000011112345678899999999999999999999999999876

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-43  Score=314.83  Aligned_cols=251  Identities=17%  Similarity=0.260  Sum_probs=194.9

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcC--CCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQIN--HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||+|+||.||++...+++.||+|.+.... .....+.+.+|+.+++.++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            45699999999999999999998789999999875432 2334567899999999996  59999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      || +.+++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++ ++.++|+|||++.....
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 56889999987554   3467789999999999999999999   99999999999996 57999999999976543


Q ss_pred             ccccccccccccccccCCCcccc--------------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF--------------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      ...........|++.|+|||.+.              ++.++||||||+++|+|++|..||.........          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----------  276 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------  276 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----------
Confidence            32222334567899999999873              667899999999999999999998643211111          


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                            +..+.........+...+..+.+||.+||+.||.+|||+.+++++-
T Consensus       277 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          277 ------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                  1111111111111122235699999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=306.50  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=200.6

Q ss_pred             hcccccceeecccCceEEEEEEcCC-----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.+.||+|+||.||+|....     +..||+|.+...........+..|+.+++.++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678899999999999999998532     24699998876544445667899999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999975432  3577899999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccc-cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQTA-TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....... ......++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----------------  261 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----------------  261 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----------------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----------------
Confidence            3321111 112234467799999886   7788999999999999998 999986432211110                


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                       .+. .......+..++..+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus       262 -~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          262 -AIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             -HHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             -HHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence             000 0001111223446699999999999999999999999999888765544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=313.45  Aligned_cols=251  Identities=18%  Similarity=0.241  Sum_probs=199.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.. .+|+.+|+|.+....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh-HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            357899999999999999999995 468999999876543322 457889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEEeeecccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--NYTAKVADFASSVLIS  162 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~~~  162 (309)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.  ++.++|+|||++....
T Consensus       128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            9999999998886433  23578999999999999999999999   999999999999974  5779999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..   .......+++.|+|||.+.   ++.++||||||+++|+|++|..||................+.           
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  268 (387)
T 1kob_A          203 PD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  268 (387)
T ss_dssp             TT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             CC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            22   2223346789999999987   778899999999999999999998653221111000000000           


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          .........++.+.+||.+||+.||.+|||+.+++++
T Consensus       269 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 ----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                0111112334669999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.1e-44  Score=320.12  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||+|.++ +++.||+|.+......  .....+..|..++..++||||+++++++.+.+.++
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            45689999999999999999999965 5889999987653221  11233788999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus       151 lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            9999999999999997532  24588999999999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ... .........|++.|+|||.+.        ++.++|+||||+++|+|++|..||...+.....              
T Consensus       226 ~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--------------  290 (437)
T 4aw2_A          226 MED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--------------  290 (437)
T ss_dssp             CTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------------
T ss_pred             ccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH--------------
Confidence            322 222233467899999999874        788999999999999999999998643222111              


Q ss_pred             cchhhhhccc--ccC-ccchHHHHHHHHHHhHhhccCCCC--CCCHHHHHHH
Q 040698          234 NSLRQILNFQ--VAD-ENEMEEIEIVAKLASKCLRTSGTE--RPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~--~~~-~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~  280 (309)
                         ..+....  ... ......++.+.+||++||+.+|++  ||++.++++|
T Consensus       291 ---~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 ---GKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---HHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---HhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence               1111000  000 011123466999999999988888  9999999886

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.2e-43  Score=302.13  Aligned_cols=260  Identities=16%  Similarity=0.172  Sum_probs=204.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....   .+.+.+|+..++.+ +|+|++++++++.+....++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            467899999999999999999994 5799999998754432   23567888999988 799999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEEeeecc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT-----AKVADFASS  158 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~-----v~l~d~g~~  158 (309)
                      |||+ +++|.+++.....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.     ++|+|||++
T Consensus        85 ~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999 9999999976532  3578999999999999999999999   999999999999987766     999999999


Q ss_pred             ccccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          159 VLISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       159 ~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      .........     .......+++.|+|||.+.   ++.++||||||+++|+|++|..||.........           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----------  227 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----------  227 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----------
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----------
Confidence            765432221     1234456889999999986   688999999999999999999998753211110           


Q ss_pred             ccccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          231 IENNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       231 ~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                         .....+....   .....+..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          228 ---QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             ---HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence               0000000000   000111233467999999999999999999999999998876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-43  Score=305.05  Aligned_cols=250  Identities=23%  Similarity=0.267  Sum_probs=200.2

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhh-----hhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||++.++ +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35678999999999999999999954 6899999987554221     13567899999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVAD  154 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d  154 (309)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++    .++|+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            9999999999999999997533   3577899999999999999999999   99999999999999887    799999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ||++.....   ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||..........           
T Consensus       163 fg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----------  228 (321)
T 2a2a_A          163 FGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----------  228 (321)
T ss_dssp             CTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-----------
T ss_pred             CccceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH-----------
Confidence            999876532   12233456789999999886   7889999999999999999999986432211110           


Q ss_pred             cccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .+.......  ......++.+.+||.+||+.||.+|||+.+++++
T Consensus       229 ------~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          229 ------NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ------HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ------HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000000000  0011233569999999999999999999999885

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=317.33  Aligned_cols=253  Identities=19%  Similarity=0.252  Sum_probs=199.7

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      ....++|++.+.||+|+||.||++.. .+|+.||+|++.....  ....+.+..|..++..++||||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            34568999999999999999999996 4699999998865321  11223478899999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||++|++|.+++.....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence            999999999999999976532  3578889999999999999999999   99999999999999999999999999876


Q ss_pred             cccccccccccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      .... .........|++.|+|||.+.          ++.++|+|||||++|+|++|..||...+....            
T Consensus       212 ~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------------  278 (412)
T 2vd5_A          212 LRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------------  278 (412)
T ss_dssp             CCTT-SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------
T ss_pred             ccCC-CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------------
Confidence            5322 112233457899999999874          68899999999999999999999864322111            


Q ss_pred             ccccchhhhhccc--cc-CccchHHHHHHHHHHhHhhccCCCCC---CCHHHHHHH
Q 040698          231 IENNSLRQILNFQ--VA-DENEMEEIEIVAKLASKCLRTSGTER---PTMRQVSEQ  280 (309)
Q Consensus       231 ~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~  280 (309)
                           ...+....  .. ...+...++.+.+||++||+ +|.+|   |++.++++|
T Consensus       279 -----~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          279 -----YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             -----HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             -----HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                 01111100  00 00112234669999999999 99998   589999876

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=311.43  Aligned_cols=248  Identities=23%  Similarity=0.289  Sum_probs=185.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+....   ..+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            35678999999999999999999965 58899999876543   245678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~g~~~~  160 (309)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.   ++.++|+|||++..
T Consensus       127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999886443   3578899999999999999999999   999999999999975   88999999999875


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ...   ........+++.|+|||.+.   ++.++||||||+++|+|++|..||............               
T Consensus       201 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---------------  262 (349)
T 2w4o_A          201 VEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR---------------  262 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH---------------
T ss_pred             cCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH---------------
Confidence            422   12233456789999999986   788999999999999999999998543221111110               


Q ss_pred             hhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       +.....  ..+.....+..+.+||++||+.||++|||+.+++++
T Consensus       263 -i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          263 -ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -HHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -HHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             111000  011112334669999999999999999999999885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-43  Score=318.34  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3578999999999999999999964 79999999886542  22234678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....
T Consensus        94 v~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999988643   34588999999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .   ........|++.|+|||.+.    .+.++||||||+++|+|++|..||.........                 ..
T Consensus       168 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-----------------~~  227 (476)
T 2y94_A          168 D---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-----------------KK  227 (476)
T ss_dssp             T---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-----------------HH
T ss_pred             c---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-----------------HH
Confidence            2   22234457899999999986    356899999999999999999998643211110                 11


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +....  ...+...++.+.+||.+||+.||.+|||+.+++++-
T Consensus       228 i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          228 ICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             HHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             HhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence            11110  011122335699999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.2e-43  Score=306.77  Aligned_cols=258  Identities=19%  Similarity=0.191  Sum_probs=203.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....   .+.+..|+.+++.+ +||||+++++++.+.+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            467899999999999999999995 5799999998754432   23578899999999 999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEEeeecc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT-----AKVADFASS  158 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~-----v~l~d~g~~  158 (309)
                      |||+ +++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.     ++|+|||++
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            9999 999999997652  34588999999999999999999999   999999999999998877     999999999


Q ss_pred             cccccccccc-----cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          159 VLISSHDQTA-----TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       159 ~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ..........     ......|++.|+|||.+.   ++.++||||||+++|+|++|..||.........           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-----------  226 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-----------  226 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-----------
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-----------
Confidence            7653322211     123567899999999987   788999999999999999999998753211100           


Q ss_pred             ccccchhhhhcccccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          231 IENNSLRQILNFQVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       231 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                         .....+........   .+...+ .+.+++.+||+.||.+||++.++++.|+.+..-
T Consensus       227 ---~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          227 ---ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             ---HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence               00011100000000   011122 699999999999999999999999999877643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.8e-43  Score=304.73  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             hhcccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||++..    .+|+.||+|.+....   .......+..|+.+++.++||||+++++++.+.+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            357899999999999999999985    478999999876542   1223455788999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999987543   3477889999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  ........|++.|+|||.+.   ++.++|+||||+++|+|++|..||........                 
T Consensus       169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------------  229 (327)
T 3a62_A          169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----------------  229 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------
T ss_pred             cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-----------------
Confidence            653221  12233456889999999986   78899999999999999999999864322111                 


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ...+.....  ..+...+..+.+||.+||+.||.+||     ++.++++|
T Consensus       230 ~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          230 IDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             HHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            011111111  11122346699999999999999999     78888875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4e-43  Score=308.24  Aligned_cols=248  Identities=23%  Similarity=0.253  Sum_probs=198.7

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||++..+ +|+.||+|.+....  .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999965 48899999876542  122345677888999887 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997554   3578899999999999999999999   999999999999999999999999998653


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+...                 ....
T Consensus       172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~  232 (353)
T 2i0e_A          172 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----------------LFQS  232 (353)
T ss_dssp             CC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHH
T ss_pred             cc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----------------HHHH
Confidence            21  122334567899999999986   7889999999999999999999986432211                 1111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      +.....  ..+...+..+.+||.+||+.||.+||+     +.++++|
T Consensus       233 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          233 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111111  112234466999999999999999995     5777765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=303.74  Aligned_cols=266  Identities=25%  Similarity=0.325  Sum_probs=194.7

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+... ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            478999999999999999999964 5899999976543 23344567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|..++....   ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999988776443   3578899999999999999999999   999999999999999999999999998765321


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCccccc---ccc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYPI---ENN  234 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~---~~~  234 (309)
                        ........++..|+|||.+.    ++.++|+||||+++|+|++|..||..............   ...+...   ...
T Consensus       156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 --SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             --ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence              12223456788899999874    68899999999999999999999875433221111000   0000000   000


Q ss_pred             c-hhhhhccccc-----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 S-LRQILNFQVA-----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~-~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      . ..........     .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0 0000000000     00012344668999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=304.75  Aligned_cols=274  Identities=23%  Similarity=0.329  Sum_probs=206.3

Q ss_pred             hcccccceeecccCceEEEEEE-----cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC--Cc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGV-----LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET--KV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~   79 (309)
                      .++|++.+.||+|+||.||++.     ..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...  +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            4679999999999999999998     24689999998876433 3356789999999999999999999998764  37


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            8999999999999999976532  3577889999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........ .......++..|+|||.+.   ++.++||||||+++|+|++|..||..............  .........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~--~~~~~~~~~  271 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND--KQGQMIVFH  271 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT--CCTHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc--cchhhhHHH
Confidence            65332221 1122344566799999886   77899999999999999999998764321110000000  000000000


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      +............+..+++.+.++|.+||+.||.+|||+.++++.|+.++...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111111122233445577999999999999999999999999999887643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8e-43  Score=320.84  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=199.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh------------hhHHHHHHHHHHHhhcCCCccceeee
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI------------LINEVFQHKMRIISQINHKNVVKILG   72 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (309)
                      ..++|++++.||+|+||.||+|.. .+++.||+|.+......            ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            568899999999999999999995 45899999987654211            23467889999999999999999999


Q ss_pred             eeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---C
Q 040698           73 VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---T  149 (309)
Q Consensus        73 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~  149 (309)
                      ++.+.+..++||||++|++|.+.+....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999887543   3578999999999999999999999   99999999999998765   6


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ++|+|||++.....   ........|++.|+|||.+.  ++.++||||+|+++|+|++|..||........         
T Consensus       188 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---------  255 (504)
T 3q5i_A          188 IKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---------  255 (504)
T ss_dssp             EEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------
T ss_pred             EEEEECCCCEEcCC---CCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence            99999999876532   22334557899999999987  88999999999999999999999865432211         


Q ss_pred             cccccccchhhhhcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                              ...+........  .....++.+.+||++||+.||.+|||+.+++++-
T Consensus       256 --------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          256 --------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             --------HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence                    111111111111  1122346699999999999999999999998864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-43  Score=299.28  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=196.2

Q ss_pred             hhcccccceeecccCceEEEEEEcCC-C-------cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD-N-------TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~-------~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+.. +       ..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            46899999999999999999998543 3       4799998765443 3356789999999999999999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT--------  149 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~--------  149 (309)
                      +..++||||+++++|.+++.....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.        
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence            999999999999999999976543  2577889999999999999999999   999999999999988876        


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhhhcc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMTRMV  224 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~~~~  224 (309)
                      ++|+|||++.....      .....++..|+|||.+.    ++.++||||||+++|+|++| .+||......... ....
T Consensus       160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~  232 (289)
T 4fvq_A          160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE  232 (289)
T ss_dssp             EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH
T ss_pred             eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh
Confidence            99999998854321      12234677899999875    67889999999999999995 4454432211111 0000


Q ss_pred             cCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          225 PYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ....                   .+...++.+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       233 ~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 DRHQ-------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TTCC-------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ccCC-------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0000                   000112348999999999999999999999999987764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=295.36  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=183.9

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.|++|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3457899999999999999999995 5799999998764422  223467889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++....  ..+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+...
T Consensus        88 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999999987542  34578899999999999999999999   999999999999999999999999998764


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ....  .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||..........                 .
T Consensus       163 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------------~  223 (278)
T 3cok_A          163 KMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----------------K  223 (278)
T ss_dssp             C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------
T ss_pred             cCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----------------H
Confidence            3211  1222346788999999886   7889999999999999999999986432111000                 0


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus       224 ~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          224 VVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Hhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            0000  001122234569999999999999999999999763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-42  Score=296.43  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--------   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   76 (309)
                      ..++|++.+.||+|+||.||++.+. +|+.||+|.+....     +.+.+|+.+++.++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4678999999999999999999964 79999999876543     245688999999999999999998854        


Q ss_pred             --------CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           77 --------TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        77 --------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                              ....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    4557899999999999999976543 34577899999999999999999999   99999999999999999


Q ss_pred             CeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          149 TAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       149 ~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      .++|+|||++......   .......+++.|+|||.+.   ++.++|+||||+++|+|++|..|+...........    
T Consensus       160 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~----  232 (284)
T 2a19_B          160 QVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR----  232 (284)
T ss_dssp             EEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHH----
T ss_pred             CEEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhh----
Confidence            9999999998765322   2233456788999999886   78899999999999999999988653321111100    


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                                     ...    .+...+..+.++|.+||+.||.+|||+.+++++|+.++...+
T Consensus       233 ---------------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 ---------------DGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ---------------TTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ---------------ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                           000    011123558999999999999999999999999988775443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.8e-43  Score=306.24  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.|++.+.||+|+||.||+|.. .+|+.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            46699999999999999999995 579999999875432  233346788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||++ |+|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 57877775443  24578899999999999999999999   99999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                            .....+++.|+|||.+.      ++.++||||||+++|+|++|..||............               
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------------  265 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------  265 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---------------
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------
Confidence                  23456889999999872      788999999999999999999997643221111100               


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                        .........+...++.+.+||.+||+.||.+|||+.+++++..-
T Consensus       266 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          266 --AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             --HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             --HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence              00000111112234669999999999999999999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9e-43  Score=319.72  Aligned_cols=249  Identities=23%  Similarity=0.306  Sum_probs=196.2

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++++.||+|+||.||+|.++ ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999964 68999999876542 222346788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~g~~~~  160 (309)
                      |||+++++|.+.+....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.   ++.++|+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998887553   3477889999999999999999999   999999999999975   45599999999876


Q ss_pred             cccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...   ........|++.|+|||.+.  ++.++||||+|+++|+|++|..||.........                 ..
T Consensus       189 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------------~~  248 (494)
T 3lij_A          189 FEN---QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-----------------RK  248 (494)
T ss_dssp             CBT---TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------HH
T ss_pred             CCC---CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HH
Confidence            532   22334557899999999987  889999999999999999999998654322111                 11


Q ss_pred             hhccccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +......  .+.....++.+.+||++||+.||.+|||+.+++++
T Consensus       249 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          249 VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1111111  11112344669999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-42  Score=296.62  Aligned_cols=262  Identities=21%  Similarity=0.232  Sum_probs=197.6

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||++.+. +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34578999999999999999999954 68999999876542  2333567889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       111 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            9999999999999997553   3578899999999999999999999   999999999999999999999999998654


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .... ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||.......... ......+.         
T Consensus       185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~---------  253 (309)
T 2h34_A          185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPR---------  253 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCCCC---------
T ss_pred             cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCCCC---------
Confidence            3221 12223456788999999986   7889999999999999999999987543221100 00000000         


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~~~~~  289 (309)
                            ....+...+..+.++|.+||+.||++|| |+.++++.|+.......
T Consensus       254 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 ------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             ------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                  0011123335599999999999999999 99999999877655443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-42  Score=294.60  Aligned_cols=245  Identities=26%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||+|+||.||+|.+. ++..|++|.+....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            589999999999999999999954 58899999875542  222346788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++....   .+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999987654   3478899999999999999999999   99999999999999999999999998865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                          .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||...........                 +.
T Consensus       167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----------------~~  225 (284)
T 2vgo_A          167 ----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-----------------IV  225 (284)
T ss_dssp             ----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------------HH
T ss_pred             ----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-----------------Hh
Confidence                1223456788999999987   78899999999999999999999865432211110                 00


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  ...+...+..+.++|.+||+.||.+|||+.+++++
T Consensus       226 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          226 NVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             TTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            000  01112234669999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=306.06  Aligned_cols=273  Identities=24%  Similarity=0.281  Sum_probs=193.4

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeee-------
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCL-------   75 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-------   75 (309)
                      ....+|++.+.||+|+||.||++.+ .+|+.||+|.+..... ...+.+..|+.++..+. ||||+++++++.       
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            3456899999999999999999995 4689999998755433 33567889999999996 999999999983       


Q ss_pred             -cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           76 -ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        76 -~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                       .....+++|||++ ++|.+++........+++..++.++.|++.||.|||+++ ++++|+||+|+||+++.++.++|+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             3455789999996 689998876555556788999999999999999999975 3489999999999999999999999


Q ss_pred             eecccccccccccc----------cccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcch
Q 040698          155 FASSVLISSHDQTA----------TTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASN  218 (309)
Q Consensus       155 ~g~~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~  218 (309)
                      ||++..........          ......+++.|+|||.+.      ++.++||||||+++|+|++|..||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99987653321111          111345788899999873      67789999999999999999999864322110


Q ss_pred             hhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhhhhhhchh
Q 040698          219 EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSE  298 (309)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~  298 (309)
                      ..                     ...........+..+.+||.+||+.||.+|||+.+++++|..+.............+
T Consensus       262 ~~---------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~  320 (337)
T 3ll6_A          262 VN---------------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITE  320 (337)
T ss_dssp             -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHH
T ss_pred             hc---------------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHHH
Confidence            00                     000001111112338899999999999999999999999999887655444444444


Q ss_pred             Hhh
Q 040698          299 ETE  301 (309)
Q Consensus       299 ~~~  301 (309)
                      ..+
T Consensus       321 ~~~  323 (337)
T 3ll6_A          321 LLE  323 (337)
T ss_dssp             HHT
T ss_pred             HHH
Confidence            333

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=310.55  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             hcccccceeecccCceEEEEEEcC--C--CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee-cCCccE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP--D--NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL-ETKVPL   81 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~--~--~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   81 (309)
                      ...|++.+.||+|+||.||+|.+.  +  +..|++|.+.........+.+.+|+.++++++||||+++++++. .++..+
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            345788899999999999999853  2  24688998766544445677899999999999999999999865 456889


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  ..++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus       168 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999999975432  3477889999999999999999999   999999999999999999999999998755


Q ss_pred             cccccc--ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccc
Q 040698          162 SSHDQT--ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  .......+++.|+|||.+.   ++.++||||||+++|+|++ |.+||...........              
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------------  308 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------------  308 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------------
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------------
Confidence            322111  1122344567899999886   7889999999999999999 6777664422211110              


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                         +.. ......+..+++.+.++|.+||+.||++|||+.++++.|+.+.....
T Consensus       309 ---~~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          309 ---LLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ---HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ---HHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               000 01111122344669999999999999999999999999988875543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.8e-43  Score=298.65  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             Hhhcccccce-eecccCceEEEEEEc---CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            5 KATKNYDKRH-LLGEGGFGFVYKGVL---PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         5 ~~~~~y~i~~-~lg~g~~g~v~~~~~---~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ...++|++.+ .||+|+||.||+|.+   .++..|++|.+..... ....+.+..|+.+++.++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            4467899998 999999999999953   3478999998765432 33356789999999999999999999999 5567


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            899999999999999997543   3578899999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ........ .......+++.|+|||.+.   ++.++|+||||+++|+|++ |..||...........             
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------  232 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------------  232 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------------
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------------
Confidence            65332211 1122334567899999886   6789999999999999999 9999865432211100             


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                           .........+..+++.+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus       233 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          233 -----LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             -----HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             -----HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 00001111223344669999999999999999999999999987765443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-42  Score=318.57  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=200.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            568899999999999999999996 479999999875432 122356788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~~~  160 (309)
                      |||+++++|.+.+....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++   .++.++|+|||++..
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998887553   3578899999999999999999999   99999999999995   456799999999875


Q ss_pred             cccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...   ........|++.|+|||.+.  ++.++||||||+++|+|++|..||.........                 ..
T Consensus       174 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------------~~  233 (486)
T 3mwu_A          174 FQQ---NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------------KR  233 (486)
T ss_dssp             BCC---C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------HH
T ss_pred             CCC---CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HH
Confidence            422   22334457899999999987  788999999999999999999998643221111                 11


Q ss_pred             hhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          239 ILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       239 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      +.....  ..+.....++.+.+||.+||+.||.+|||+.+++++-
T Consensus       234 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            111111  1111223456799999999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6e-43  Score=309.06  Aligned_cols=269  Identities=16%  Similarity=0.199  Sum_probs=197.8

Q ss_pred             hhcccccceeecccCceEEEEEEcCC------CcEEEEEecccchhhhhH----------HHHHHHHHHHhhcCCCccce
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILIN----------EVFQHKMRIISQINHKNVVK   69 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~ik~~~~~~~~~~~----------~~~~~e~~~l~~l~h~~iv~   69 (309)
                      ..++|++.+.||+|+||.||+|.+++      ++.||+|.+.........          .....++..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998654      478999987554321111          12334455677788999999


Q ss_pred             eeeeeecC----CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           70 ILGVCLET----KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        70 ~~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      +++++...    ...++||||+ |++|.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998764    4579999999 999999997643  34588999999999999999999999   99999999999998


Q ss_pred             --CCCCeEEEeeecccccccccccc-----cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          146 --DNYTAKVADFASSVLISSHDQTA-----TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       146 --~~~~v~l~d~g~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                        .++.++|+|||++..........     ......|++.|+|||.+.   ++.++||||||+++|+|++|..||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999997653322111     113345899999999987   78899999999999999999999875322


Q ss_pred             cchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      .............     ..+....+....   ...+++.+.+++..||+.||.+|||+.++++.|+.+....
T Consensus       267 ~~~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          267 DPKYVRDSKIRYR-----ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             CHHHHHHHHHHHH-----HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHhh-----hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            2111100000000     001111111100   0122466999999999999999999999999998877543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.3e-43  Score=317.37  Aligned_cols=248  Identities=23%  Similarity=0.224  Sum_probs=191.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|.+....  .......+..|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            357899999999999999999995 569999999876532  22223456788999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+ .+   ++||||+|+||+++.++.++|+|||++...
T Consensus       226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999887543   35788999999999999999998 89   999999999999999999999999998653


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++||||||+++|+|++|..||...........                 
T Consensus       300 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----------------  360 (446)
T 4ejn_A          300 IK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----------------  360 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------------
T ss_pred             cC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-----------------
Confidence            22  222334567899999999986   88899999999999999999999864432211111                 


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      +.....  ..+...++.+.+||.+||+.||.+||     |+.++++|
T Consensus       361 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          361 ILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            111100  11122346699999999999999999     99999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-43  Score=297.02  Aligned_cols=251  Identities=26%  Similarity=0.404  Sum_probs=195.2

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++.+ .|+.|++|.+....   ..+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            457899999999999999999987 48899999887543   24678899999999999999999998754 45789999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++..... ..+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999975543 23477889999999999999999999   999999999999999999999999988654221


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                           .....++..|+|||.+.   ++.++|+||||+++|+|++ |..||........... ..                
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~----------------  228 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VE----------------  228 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HT----------------
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-Hh----------------
Confidence                 12234577899999986   7889999999999999998 9999865422111100 00                


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                       .......+..+++.+.++|.+||+.||.+|||+.++++.|+.++..
T Consensus       229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          229 -KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence             0011112223446699999999999999999999999999887653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=305.88  Aligned_cols=276  Identities=22%  Similarity=0.325  Sum_probs=194.8

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee-----cCCcc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL-----ETKVP   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   80 (309)
                      ..++|++.+.||+|+||.||+|.. +++.||+|.+.......  .....++..+..++||||+++++.+.     .....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN--FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh--HHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            457999999999999999999987 68999999886543221  12233444455689999999997543     23466


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCcEEEcCCCCeE
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL---------GSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                      ++||||+++++|.+++.....    ++..++.++.|++.||.|||+.         +   ++||||||+||+++.++.++
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCB----CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhccc----chhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999965432    6788899999999999999999         8   99999999999999999999


Q ss_pred             EEeeecccccccccc------cccccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          152 VADFASSVLISSHDQ------TATTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       152 l~d~g~~~~~~~~~~------~~~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                      |+|||++........      ........|++.|+|||.+.          ++.++||||||+++|+|++|..||-....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999976533211      12223456899999999875          34578999999999999999777532211


Q ss_pred             cchhhhhccc-Cccccccccchhhhhc-----c--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          216 ASNEMTRMVP-YFPYPIENNSLRQILN-----F--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       216 ~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      .......... ....+.. ........     .  ..........++.+.+||.+||+.||++|||+.++++.|+.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTF-EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCH-HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHhhhcccCCCchH-HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1110000000 0000000 00000000     0  001112335667899999999999999999999999999888765


Q ss_pred             hhhhh
Q 040698          288 HENFW  292 (309)
Q Consensus       288 ~~~~~  292 (309)
                      +....
T Consensus       320 ~~~~~  324 (336)
T 3g2f_A          320 WERNK  324 (336)
T ss_dssp             CCC--
T ss_pred             HHhcc
Confidence            55443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-42  Score=296.02  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=197.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE----TKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~   79 (309)
                      ..+.|++.+.||+|+||.||+|.+ .++..|++|.+.... .....+.+..|+.+++.++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345689999999999999999985 468899999875432 23345678999999999999999999998865    456


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeecc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASS  158 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~  158 (309)
                      .++||||+++++|.+++....   ..++..+..++.|++.||.|||+++ ++++|+||+|+||+++ .++.++|+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            899999999999999997543   3477899999999999999999985 3499999999999997 7899999999998


Q ss_pred             cccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .....    .......+++.|+|||.+.  ++.++|+||||+++|+|++|..||..................        
T Consensus       180 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  247 (290)
T 1t4h_A          180 TLKRA----SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--------  247 (290)
T ss_dssp             GGCCT----TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred             ccccc----cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence            65322    2223446788999999887  888999999999999999999998653322222111111100        


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              ....+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       248 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    011111222559999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-43  Score=305.85  Aligned_cols=260  Identities=25%  Similarity=0.277  Sum_probs=193.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc--
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVP--   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--   80 (309)
                      ..++|++.+.||+|+||.||++.+ .+++.||+|.+....  .......+.+|+.+++.++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            468899999999999999999995 679999999876542  233456788999999999999999999998876544  


Q ss_pred             --EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           81 --LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        81 --~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                        ++||||++|++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              99999999999999997554   3578899999999999999999999   999999999999999999999999998


Q ss_pred             ccccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          159 VLISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ......... .......|++.|+|||.+.   ++.++||||||+++|+|++|..||..................      
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC------
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC------
Confidence            765332211 2223356789999999986   778899999999999999999998654322211111100000      


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHH-HHHhhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS-EQLDSLRR  286 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll-~~l~~~~~  286 (309)
                               .........+..+.++|.+||+.||.+||++.+++ ..+.....
T Consensus       238 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 ---------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                     00001122346699999999999999999665554 44544443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-42  Score=305.05  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=199.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-------hhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-------KILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      ..++|++.+.||.|+||.||+|.++ +|+.||+|.+....       .....+.+..|+.+++.+ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            4578999999999999999999964 79999999865432       122345688899999999 79999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      .+..++||||++|++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999987543   3578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ++......   .......|++.|+|||.+.         ++.++||||||+++|+|++|..||..........       
T Consensus       246 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-------  315 (365)
T 2y7j_A          246 FSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR-------  315 (365)
T ss_dssp             TCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred             cccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH-------
Confidence            98765322   2234467889999999874         6779999999999999999999986432111100       


Q ss_pred             cccccccchhhhhcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                .+........  .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       316 ----------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 ----------MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             ----------HHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----------HHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                      0000000000  011223569999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=325.88  Aligned_cols=260  Identities=27%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+.....  ..+.+.+|+.+|+.++||||+++++++.+ +..+||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3578999999999999999999988888899998875432  24678999999999999999999999876 67899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.......
T Consensus       342 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999999999975432 23577899999999999999999999   9999999999999999999999999987653211


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                       ........++..|+|||.+.   ++.++||||||+++|+|++ |..||..........                 .+ .
T Consensus       418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-----------------~i-~  478 (535)
T 2h8h_A          418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-----------------QV-E  478 (535)
T ss_dssp             -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-----------------HH-H
T ss_pred             -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HH-H
Confidence             11112234567799999886   7889999999999999999 999986542221110                 00 0


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF  291 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~~  291 (309)
                      .......+..+++.+.+||.+||+.||++|||+.+|++.|+.+....++.
T Consensus       479 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence            01111122334567999999999999999999999999998876554443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-43  Score=321.38  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=203.0

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|.+....  .......+..|+.+++.++||||+++++++.+.+.++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            3567899999999999999999996 469999999876532  2223456788999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++..... ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999998875543 23578899999999999999999999   999999999999999999999999999765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...   .......|++.|+|||.+.   ++.++|+||||+++|+|++|..||.........             ......
T Consensus       337 ~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~~i~~~  400 (576)
T 2acx_A          337 PEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERL  400 (576)
T ss_dssp             CTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------HHHHHH
T ss_pred             ccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-------------HHHHHH
Confidence            321   2233457899999999987   788999999999999999999998653211000             000000


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      +...  ....+...++.+.+||.+||+.||.+||     ++.++++|
T Consensus       401 i~~~--~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          401 VKEV--PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             hhcc--cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0000  1111223446799999999999999999     78999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.7e-43  Score=308.36  Aligned_cols=244  Identities=23%  Similarity=0.257  Sum_probs=189.3

Q ss_pred             ceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCCCC
Q 040698           13 RHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      .+.||+|+||.||+|.. .+|..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            56899999999999985 56999999988765432 35678999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCCCeEEEeeeccccccccccccc
Q 040698           92 LFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv--~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      |.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||++  +.++.++|+|||++......   ..
T Consensus       173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~  244 (373)
T 2x4f_A          173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EK  244 (373)
T ss_dssp             EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CB
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cc
Confidence            998886543  23577889999999999999999999   9999999999999  56778999999998765322   22


Q ss_pred             ccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccC
Q 040698          170 TTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD  246 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (309)
                      .....+++.|+|||.+.   ++.++||||||+++|+|++|..||................+.               ...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------------~~~  309 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD---------------LED  309 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------SCS
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------CCh
Confidence            33456899999999886   677899999999999999999998644322111110000000               001


Q ss_pred             ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          247 ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       247 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......++.+.+||.+||+.||.+|||+.+++++
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1112334669999999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-42  Score=295.71  Aligned_cols=246  Identities=18%  Similarity=0.231  Sum_probs=194.5

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccc-hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMV-DKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+... ........+..|+..+..+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35689999999999999999999964 7999999987653 2223345678888888888 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-------------
Q 040698           82 LVYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-------------  147 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-------------  147 (309)
                      +||||+++++|.+++..... ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999976533 234588999999999999999999999   9999999999999844             


Q ss_pred             ------CCeEEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcc
Q 040698          148 ------YTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALAS  217 (309)
Q Consensus       148 ------~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~  217 (309)
                            ..++++|||.+......      ....+++.|+|||.+.    ++.++||||||+++|+|++|.+|+.......
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred             cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH
Confidence                  47999999988665321      2235788999999986    4468999999999999999987754322111


Q ss_pred             hhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          218 NEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......                     ...+...++.+.++|.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          239 EIRQGRL---------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHTTCC---------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHcCCC---------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1110000                     01112233569999999999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-42  Score=310.28  Aligned_cols=251  Identities=24%  Similarity=0.256  Sum_probs=187.4

Q ss_pred             hhcccccc-eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHh-hcCCCccceeeeeeec----CC
Q 040698            6 ATKNYDKR-HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIIS-QINHKNVVKILGVCLE----TK   78 (309)
Q Consensus         6 ~~~~y~i~-~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~   78 (309)
                      ..++|.+. +.||.|+||.||++.+ .+|+.||+|.+...      ..+.+|+.++. ..+||||+++++++..    .+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            34677776 6899999999999995 46899999987643      23556777664 4589999999999875    56


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~  155 (309)
                      .+++||||++|++|.+++..... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.   ++.++|+||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence            78999999999999999975433 24578999999999999999999999   999999999999987   789999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |++.....   ........+++.|+|||++.   ++.++||||||+++|+|++|..||.........             
T Consensus       209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------------  272 (400)
T 1nxk_A          209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------  272 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------------
T ss_pred             ccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------------
Confidence            99875422   22234556789999999986   888999999999999999999998643211100             


Q ss_pred             ccchhhhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          233 NNSLRQILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       233 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ......+.....  ........++.+.+||++||+.||.+|||+.+++++-.
T Consensus       273 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000001111111  11111234567999999999999999999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=302.57  Aligned_cols=267  Identities=22%  Similarity=0.256  Sum_probs=192.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh----hhhHHHHHHHHHHHhhc---CCCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK----ILINEVFQHKMRIISQI---NHKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....    ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            468999999999999999999995 5689999998754321    11123445566655555   599999999999765


Q ss_pred             C-----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           78 K-----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        78 ~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                      .     ..++||||++ ++|.+++...... .+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.++|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            4     4789999996 5999998765433 3578999999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCc
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYF  227 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~  227 (309)
                      +|||++.....   ........+++.|+|||.+.   ++.++||||||+++|+|++|..||..............  ...
T Consensus       162 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999875422   22334456789999999885   88899999999999999999999865432221111000  000


Q ss_pred             c-cccccc--chhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 P-YPIENN--SLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~-~~~~~~--~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      + ......  .........   .........++.+.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0 000000  000000000   0000112334669999999999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-42  Score=295.87  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..+.|++.+.||+|+||.||+|.+ .+++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            457799999999999999999985 5689999998866544444677899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus       100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999998863    24578899999999999999999999   999999999999999999999999998665322


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      .  .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||..............                 
T Consensus       173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------------  233 (303)
T 3a7i_A          173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-----------------  233 (303)
T ss_dssp             B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----------------
T ss_pred             c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-----------------
Confidence            1  2223456788899999986   78899999999999999999999865422211100000                 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                       ......+...+..+.+||.+||+.||.+|||+.+++++..
T Consensus       234 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          234 -NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             -SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             -CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence             0000111223356999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.4e-43  Score=302.48  Aligned_cols=266  Identities=23%  Similarity=0.259  Sum_probs=194.1

Q ss_pred             hhcccccc-eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKR-HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~-~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..+.|++. +.||+|+||.||+|.+ .+++.||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            35689885 7899999999999995 4699999998765432 2356788999999884 79999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~---v~l~d~g~~~  159 (309)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.   ++|+|||++.
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999997653   3477889999999999999999999   999999999999987765   9999999986


Q ss_pred             ccccccc-----cccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC
Q 040698          160 LISSHDQ-----TATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       160 ~~~~~~~-----~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      .......     ........+++.|+|||.+.        ++.++||||||+++|+|++|..||..............  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--  240 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE--  240 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc--
Confidence            5432111     11122345889999999874        68899999999999999999999865422110000000  


Q ss_pred             ccccccccchhhhhcccccCcc--chHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYPIENNSLRQILNFQVADEN--EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............+.........  ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000001111111111110  11234669999999999999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=308.67  Aligned_cols=265  Identities=20%  Similarity=0.250  Sum_probs=191.3

Q ss_pred             cccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            68999999999999999999964 68999999886544332222445789999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++ ++|.+++.....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  .
T Consensus        82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI--P  153 (324)
T ss_dssp             CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC--C
Confidence            97 588888875533  4577899999999999999999999   99999999999999999999999999865422  1


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccCccccccc----cc
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPYFPYPIEN----NS  235 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~----~~  235 (309)
                      ........+++.|+|||.+.    ++.++||||||+++|+|++|..||.............   ........+.    ..
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            22233456788999999875    6889999999999999999999987543322111100   0000000000    00


Q ss_pred             hhhhhccccc----CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVA----DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........    .......++.+.+||.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000    00112334668999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-43  Score=300.33  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=184.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||++.+ .+++.||+|.+.........+.+..|+.+++.++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            467899999999999999999995 4689999998876544444567888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhc-----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           85 EFVPNGTLFQHVRYQS-----SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ||+++++|.+++....     ....+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999987421     1234578999999999999999999999   9999999999999999999999999986


Q ss_pred             ccccccc---cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          160 LISSHDQ---TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       160 ~~~~~~~---~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      .......   ........+++.|+|||.+.    ++.++|+||||+++|+|++|..||.................+.. .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  248 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL-E  248 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT-T
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc-c
Confidence            5432211   11123346788899999874    78899999999999999999999875433222111111111100 0


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .    ..    .........+..+.++|.+||+.||.+|||+.+++++
T Consensus       249 ~----~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          249 T----GV----QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             C-------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c----cc----ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0    00    0001111233569999999999999999999999774

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=306.29  Aligned_cols=242  Identities=24%  Similarity=0.325  Sum_probs=196.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-------hhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-------LINEVFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+......       .....+..|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            467999999999999999999984 56899999987654211       1123467789999999999999999999999


Q ss_pred             CccEEEEEcCCCC-CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           78 KVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        78 ~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      +..++||||+.++ +|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999766 9998887543   3578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---c-CCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---W-TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~-~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      ++......   .......|++.|+|||.+.   + +.++||||||+++|+|++|..||.........      ..     
T Consensus       176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~-----  241 (335)
T 3dls_A          176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA------AI-----  241 (335)
T ss_dssp             TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT------CC-----
T ss_pred             cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh------cc-----
Confidence            98765322   2233456889999999986   3 66889999999999999999998643211000      00     


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                    ..+...++.+.+||.+||+.||.+|||+.+++++-
T Consensus       242 --------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          242 --------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             --------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                          00111235699999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=303.53  Aligned_cols=253  Identities=18%  Similarity=0.257  Sum_probs=200.1

Q ss_pred             HhhcccccceeecccCceEEEEEE------cCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC---CCccceeeeeee
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGV------LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN---HKNVVKILGVCL   75 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~   75 (309)
                      ...++|++.+.||+|+||.||+|.      ..+++.||+|.+....    ...+..|..+++.++   |+||+++++++.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            346789999999999999999994      4568999999886543    334566666666665   999999999999


Q ss_pred             cCCccEEEEEcCCCCCHHHHHHhhc--cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------
Q 040698           76 ETKVPLLVYEFVPNGTLFQHVRYQS--SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-------  146 (309)
Q Consensus        76 ~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-------  146 (309)
                      ..+..++||||+++++|.+++....  ....+++..+..++.|++.||.|||+++   ++||||||+||+++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            9999999999999999999997543  2345688999999999999999999999   999999999999988       


Q ss_pred             ----CCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh
Q 040698          147 ----NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE  219 (309)
Q Consensus       147 ----~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~  219 (309)
                          ++.++|+|||++................|++.|+|||.+.   ++.++||||||+++|+|++|..||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                8999999999997654333344445667899999999987   789999999999999999999997543221100


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLRRL  287 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~~~  287 (309)
                      ..   ..+..                    ...++.+.+++..||+.+|.+|+ ++.++.+.|+.+...
T Consensus       295 ~~---~~~~~--------------------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 PE---GLFRR--------------------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EC---SCCTT--------------------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ec---hhccc--------------------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            00   00000                    01135588999999999999985 788888777666544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-42  Score=298.36  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||+|+||.||++.. .+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            3568999999999999999999995 46999999988654332 245688999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~~  160 (309)
                      |||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++..
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           85 MQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999887543   3477899999999999999999999   9999999999999   7788999999998864


Q ss_pred             cccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ...    .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||..................         
T Consensus       159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------  225 (304)
T 2jam_A          159 EQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------  225 (304)
T ss_dssp             CCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred             cCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            321    1223345788999999987   677899999999999999999998643221111000000000         


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                            .........++.+.++|.+||+.||.+|||+.+++++-
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          226 ------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence                  00111123346699999999999999999999998853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-43  Score=310.65  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=188.1

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecC--Cc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQIN-HKNVVKILGVCLET--KV   79 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~   79 (309)
                      ...++|++++.||+|+||.||+|.+ .+|+.||+|.+... ........+.+|+.+++.+. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3568999999999999999999985 56999999987543 22333566788999999997 99999999999754  46


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++||||++ ++|..++...    .++...+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 5888888642    3477888999999999999999999   9999999999999999999999999987


Q ss_pred             cccccc-------------------ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhc
Q 040698          160 LISSHD-------------------QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALA  216 (309)
Q Consensus       160 ~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~  216 (309)
                      ......                   .........+++.|+|||.+.    ++.++|||||||++|+|++|.+||...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            542210                   111233457899999999875    788999999999999999999999754322


Q ss_pred             chhhhhcccCccccc-----------cccchhhhhcc----ccc--------------CccchHHHHHHHHHHhHhhccC
Q 040698          217 SNEMTRMVPYFPYPI-----------ENNSLRQILNF----QVA--------------DENEMEEIEIVAKLASKCLRTS  267 (309)
Q Consensus       217 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~----~~~--------------~~~~~~~~~~l~~li~~cl~~d  267 (309)
                      .... ........+.           .......+...    ...              ......+++.+.+||.+||+.|
T Consensus       238 ~~~~-~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          238 NQLE-RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHH-HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHH-HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            2111 1100000000           00000000000    000              0001123466999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 040698          268 GTERPTMRQVSEQ  280 (309)
Q Consensus       268 p~~Rps~~~ll~~  280 (309)
                      |.+|||+.++++|
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.4e-43  Score=303.11  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=179.3

Q ss_pred             hcccccc---eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccE
Q 040698            7 TKNYDKR---HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPL   81 (309)
Q Consensus         7 ~~~y~i~---~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   81 (309)
                      .++|++.   +.||+|+||.||+|.+ .+|+.||+|.+...    ....+..|+.+++.+. ||||+++++++.+.+..+
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            4567765   7899999999999996 46899999987643    2456678999999997 999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEEeeecc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY---TAKVADFASS  158 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~---~v~l~d~g~~  158 (309)
                      +||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++   .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a  156 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA  156 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred             EEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence            9999999999999997543   4588999999999999999999999   99999999999997665   7999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  ........+++.|+|||.+.   ++.++||||||+++|+|++|..||........          .......
T Consensus       157 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~  224 (325)
T 3kn6_A          157 RLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEI  224 (325)
T ss_dssp             EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHH
T ss_pred             eecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHH
Confidence            754221  22233456788999999986   78899999999999999999999875432100          0000011


Q ss_pred             hhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 LRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...+.......  +.....++.+.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            11111111111  1112345679999999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.2e-42  Score=292.06  Aligned_cols=247  Identities=24%  Similarity=0.293  Sum_probs=192.1

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.|++|.+....  .....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3578999999999999999999964 79999999876542  22334678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++....   ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999997653   3477899999999999999999999   9999999999999999999999999986642


Q ss_pred             cccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..   .......+++.|+|||.+.    .+.++|+||||+++|+|++|..||.........                 ..
T Consensus       163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----------------~~  222 (276)
T 2h6d_A          163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-----------------KK  222 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------HH
T ss_pred             CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-----------------HH
Confidence            21   2223446788899999987    256899999999999999999998643221110                 00


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +....  ...+...+..+.++|.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          223 IRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000  00112233569999999999999999999999885

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.7e-43  Score=320.41  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=202.2

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|.+....  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4578999999999999999999964 79999999875432  12335678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~  159 (309)
                      ||||+.+++|.+.+....   .+++..++.++.|++.||.|||+++   ++||||+|+||++   +.++.++|+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999887543   3578899999999999999999999   9999999999999   567899999999987


Q ss_pred             ccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      ....   ........|++.|+|||.+.  ++.++||||||+++|+|++|..||.........                 .
T Consensus       178 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------------~  237 (484)
T 3nyv_A          178 HFEA---SKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------------K  237 (484)
T ss_dssp             HBCC---CCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------H
T ss_pred             Eccc---ccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH-----------------H
Confidence            6522   22233456899999999887  888999999999999999999998654322111                 1


Q ss_pred             hhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          238 QILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       238 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .+.....  ..+.....++.+.+||.+||+.||.+|||+.++++|-
T Consensus       238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            1111111  1111223456799999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.4e-42  Score=302.99  Aligned_cols=197  Identities=26%  Similarity=0.364  Sum_probs=169.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-----CCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-----HKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|.+.....  ....+..|..+++.+.     ||||+++++++...+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH--HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh--hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            3568999999999999999999996 5689999998865332  2455677888888886     999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC------------
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD------------  146 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~------------  146 (309)
                      ..++||||+ +++|.+++...... .+++..+..++.|++.||.|||+++   ++||||||+||+++.            
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhc
Confidence            999999999 89999999765433 3577899999999999999999999   999999999999975            


Q ss_pred             -------------CCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCC
Q 040698          147 -------------NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPR  210 (309)
Q Consensus       147 -------------~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~  210 (309)
                                   ++.++|+|||++.....     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                         78999999999865322     223456788999999987   889999999999999999999998


Q ss_pred             chh
Q 040698          211 SYV  213 (309)
Q Consensus       211 ~~~  213 (309)
                      ...
T Consensus       260 ~~~  262 (360)
T 3llt_A          260 RTH  262 (360)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-42  Score=297.14  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=193.4

Q ss_pred             hhcccccceeecccCceEEEEEEc--CCCc--EEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL--PDNT--LVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~--~~~~--~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||+|+||.||+|.+  .++.  .|++|.+....  .....+.+.+|+.+++.++||||+++++++.+.+ 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            457899999999999999999984  2333  68999876542  2334567889999999999999999999998765 


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .++|+||+++++|.+++.....  ..++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            7999999999999999976532  3578899999999999999999999   9999999999999999999999999987


Q ss_pred             cccccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCcccccccc
Q 040698          160 LISSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       160 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ........ .......++..|+|||.+.   ++.++|+||||+++|+|++ |..||.........               
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---------------  234 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------------  234 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---------------
Confidence            65332221 1222344567799999986   7789999999999999999 99998654322111               


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                        ..+.........+..+++.+.++|.+||+.||.+|||+.++++.|.+++.
T Consensus       235 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          235 --HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence              11111111111222344669999999999999999999999999987764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.2e-42  Score=294.24  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||++.+. +++.+++|.+....  .....+.+..|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            35678999999999999999999964 58899999875432  2334567889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++....   .+++..+..++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            9999999999999887543   3478899999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ...  ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||................            
T Consensus       166 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------  231 (294)
T 2rku_A          166 EYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------  231 (294)
T ss_dssp             CST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------
T ss_pred             ccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc------------
Confidence            321  12223456788899999986   7889999999999999999999986543221111100000            


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                             ...+...+..+.++|.+||+.||++|||+.+++++-
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          232 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             -------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                   011122335699999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7e-43  Score=298.90  Aligned_cols=253  Identities=19%  Similarity=0.280  Sum_probs=187.1

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-hhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-LINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||++.+ .+|+.||+|.+...... ...+.+..+...++.++||||+++++++.+.+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            4568999999999999999999995 57999999988654332 223344455556788899999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           83 VYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ||||+++ +|.+++... .....+++..+..++.|++.|+.|||++ +   ++|+||+|+||+++.++.++|+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999974 887777542 2334568899999999999999999998 9   99999999999999999999999999865


Q ss_pred             cccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ....   .......+++.|+|||.+.       ++.++|+||||+++|+|++|..||.............          
T Consensus       160 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------  226 (290)
T 3fme_A          160 LVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV----------  226 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH----------
T ss_pred             cccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH----------
Confidence            4221   2223346788899999962       6778999999999999999999986432221111111          


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .............++.+.++|.+||+.||++|||+.+++++
T Consensus       227 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          227 ------VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ------HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ------hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                  11111111112334669999999999999999999999773

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=306.58  Aligned_cols=265  Identities=17%  Similarity=0.195  Sum_probs=193.6

Q ss_pred             hcccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhh----------hHHHHHHHHHHHhhcCCCccceeee
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKIL----------INEVFQHKMRIISQINHKNVVKILG   72 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~   72 (309)
                      .++|++.+.||+|+||.||+|.+.    ++..+|+|.........          ....+..|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999964    57889999876543211          1123567778889999999999999


Q ss_pred             eeec----CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 040698           73 VCLE----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY  148 (309)
Q Consensus        73 ~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~  148 (309)
                      ++..    ....++||||+ +++|.+++....   .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9887    67889999999 999999887544   4588999999999999999999999   99999999999998777


Q ss_pred             --CeEEEeeeccccccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcch
Q 040698          149 --TAKVADFASSVLISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN  218 (309)
Q Consensus       149 --~v~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~  218 (309)
                        .++|+|||++.........     .......+++.|+|||.+.   ++.++||||||+++|+|++|..||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999765332111     1123456889999999986   78899999999999999999999854221111


Q ss_pred             hhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          219 EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .............+......        .....+++.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKW--------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHH--------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHhhcccccHHHHhh--------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11110000000000000000        0001233569999999999999999999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=304.54  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=195.3

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....     ....|+.++.++ +||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            3567899999999999999999995 4689999998765432     234567777777 79999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CCeEEEeeecc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN----YTAKVADFASS  158 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~----~~v~l~d~g~~  158 (309)
                      ||||++|++|.+.+....   .+++..+..++.|++.||.|||+++   ++||||+|+||++.++    +.++|+|||++
T Consensus        94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999887543   4578999999999999999999999   9999999999998533    35999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......  ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||.........              ..
T Consensus       168 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--------------~~  231 (342)
T 2qr7_A          168 KQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--------------EI  231 (342)
T ss_dssp             EECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH--------------HH
T ss_pred             ccCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH--------------HH
Confidence            765322  12233456789999999986   788999999999999999999998642111100              00


Q ss_pred             hhhhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHh
Q 040698          236 LRQILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD  282 (309)
Q Consensus       236 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~  282 (309)
                      ...+.....  ....+...++.+.+||++||+.||++|||+.++++|-.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            011111110  11112234567999999999999999999999988643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-42  Score=294.16  Aligned_cols=251  Identities=23%  Similarity=0.278  Sum_probs=196.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-----hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-----ILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++.+.||+|+||.||++... +|+.+++|.+.....     ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            4578999999999999999999965 689999997654321     1135678999999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVADF  155 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d~  155 (309)
                      .++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++    .++|+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999997543   3578899999999999999999999   99999999999998776    7999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |++......   .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||..............  ....  
T Consensus       157 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--  229 (283)
T 3bhy_A          157 GIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA--VNYD--  229 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCC--
T ss_pred             ccceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh--cccC--
Confidence            998765221   2223446788999999886   77899999999999999999999864322111100000  0000  


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                 .........++.+.+++.+||+.||.+|||+.+++++
T Consensus       230 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          230 -----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                       0000111233569999999999999999999999884

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-42  Score=313.87  Aligned_cols=199  Identities=24%  Similarity=0.412  Sum_probs=164.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----C
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLET-----K   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|++... ......+.+.+|+.+++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999995 46899999988653 2333456788999999999999999999999765     5


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||++ ++|.+++...   ..+++..+..+++|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            7899999996 5999888643   34588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccccc--------------------ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          159 VLISSHDQT--------------------ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       159 ~~~~~~~~~--------------------~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                      .........                    .......+++.|+|||.+.    ++.++|||||||++|+|++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            765332211                    1235567899999999863    8889999999999999998766654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-42  Score=316.10  Aligned_cols=194  Identities=27%  Similarity=0.443  Sum_probs=150.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-----CC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLE-----TK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   78 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|++... ......+.+.+|+.+|+.++||||+++++++..     .+
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            357899999999999999999985 46899999987543 223335678899999999999999999999843     35


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      .+|+||||+ +++|.+++...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            789999998 56888888643   34588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccccc-------------------------ccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhC
Q 040698          159 VLISSHDQT-------------------------ATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTG  206 (309)
Q Consensus       159 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g  206 (309)
                      .........                         .......+++.|+|||++.    ++.++|||||||++|+|++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            765321110                         1233456789999999763    88899999999999999983

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-43  Score=305.74  Aligned_cols=268  Identities=24%  Similarity=0.370  Sum_probs=197.4

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            4678999999999999999999964 58999999864432 233456678999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|..+.....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus       103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999998887765333   3578999999999999999999999   99999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcccc------
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYP------  230 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~------  230 (309)
                      .  ........+++.|+|||.+.    ++.++||||||+++|+|++|..||..............   ...+..      
T Consensus       177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            1  12223456788899999875    67889999999999999999999875433221111100   000000      


Q ss_pred             ---ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          231 ---IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       231 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                         ......................++.+.+||.+||+.||.+|||+.+++++-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence               000000000000000011123456799999999999999999999998753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.5e-42  Score=305.10  Aligned_cols=269  Identities=19%  Similarity=0.257  Sum_probs=201.0

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----C
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET-----K   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (309)
                      ...++|++++.||+|+||.||++.+ .++..||+|.+.........+.+.+|+.+++.++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            4567999999999999999999995 468999999987655555567789999999999999999999998654     4


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||++ ++|.+++...    .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            6799999997 5888888643    3577899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc-
Q 040698          159 VLISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE-  232 (309)
Q Consensus       159 ~~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  232 (309)
                      ........ ........+++.|+|||.+.    ++.++||||||+++|+|++|..||...................... 
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            76533222 12234457899999999864    7889999999999999999999986543222111110000000000 


Q ss_pred             -----ccchhhhh-cc--ccc---CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 -----NNSLRQIL-NF--QVA---DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 -----~~~~~~~~-~~--~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                           ........ ..  ...   .......+..+.+||.+||+.||.+|||+.+++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                 00000000 00  000   000122346699999999999999999999998853

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.9e-42  Score=313.38  Aligned_cols=263  Identities=20%  Similarity=0.240  Sum_probs=191.3

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC------C
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLET------K   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~   78 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++... ........+.+|+.+++.++||||+++++++...      +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999985 46899999987653 2333456788999999999999999999999654      3


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||+++ +|.+.+..     .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            56999999976 45555532     2577889999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccCccc---
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPYFPY---  229 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~---  229 (309)
                      .....   ........+++.|+|||.+.   ++.++|||||||++|+|++|..||...+.........   ....+.   
T Consensus       212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            76422   22334567899999999987   8889999999999999999999997543221110000   000000   


Q ss_pred             --------------cccccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          230 --------------PIENNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       230 --------------~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                    ..............   .........++.+.+||.+||+.||.+|||+.++++|-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                          00000000000000   00011122356799999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=293.75  Aligned_cols=253  Identities=22%  Similarity=0.214  Sum_probs=195.8

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh---hhhHHHHHHHHHHHhhcCCCccceeeeee--ecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK---ILINEVFQHKMRIISQINHKNVVKILGVC--LETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~   78 (309)
                      ...++|++.+.||+|+||.||++.+ .++..+++|.+.....   ....+.+.+|+.+++.++||||+++++++  .+.+
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            3568999999999999999999996 4689999998765432   23356789999999999999999999998  4456


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||++++ |.+++..... ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence            889999999876 7677665433 34578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ................+++.|+|||.+.     ++.++||||||+++|+|++|..||..........             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------  223 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE-------------  223 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-------------
Confidence            7654333333344556889999999876     3568999999999999999999986432211100             


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                          .+....  ...+..+++.+.+||.+||+.||.+|||+.+++++-
T Consensus       224 ----~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          224 ----NIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             ----HHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             ----HHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                000000  011122345699999999999999999999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-42  Score=303.28  Aligned_cols=271  Identities=24%  Similarity=0.275  Sum_probs=192.6

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhh----hHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKIL----INEVFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      +....++|++.+.||+|+||.||+|.+. +|+.||+|.+.......    ....+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            4456789999999999999999999964 58999999886532211    123577899999999999999999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      +..++||||+++ +|..++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence            999999999976 8888776443  23466889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFPYP  230 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~  230 (309)
                      +......  ........+++.|+|||.+.    ++.++||||||+++|+|++|.+||..............   ......
T Consensus       159 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          159 AKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             GSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence            8765322  22233456788999999874    67789999999999999999999865432221111000   000000


Q ss_pred             cccc-chhhhhcccccCc-----cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          231 IENN-SLRQILNFQVADE-----NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       231 ~~~~-~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .... .............     .....++.+.+||.+||+.||.+|||+.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0000 0000000000000     0123346799999999999999999999998864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.9e-42  Score=299.85  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++.+. +++.+++|.+....  .....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4678999999999999999999964 58899999875432  23445678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999887543   3478899999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ..  ........++..|+|||.+.   ++.++||||||+++|+|++|..||...........                 +
T Consensus       193 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----------------~  253 (335)
T 2owb_A          193 YD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-----------------I  253 (335)
T ss_dssp             ST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------------H
T ss_pred             cC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-----------------H
Confidence            21  12223456788999999986   78899999999999999999999865322111100                 0


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ....  ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          254 KKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000  01111233568999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=294.71  Aligned_cols=250  Identities=23%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             ccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            9 NYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      +|.....||+|+||.||+|.+ .++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            344455999999999999995 5688999998765433 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEeeecccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++++|.+++.........++..+..++.|++.||.|||+++   ++|+||+|+||+++. ++.++|+|||.+......  
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--  176 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--  176 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence            99999999987654445567889999999999999999999   999999999999987 899999999998654321  


Q ss_pred             cccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          167 TATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ........+++.|+|||.+.     ++.++|+||||+++|+|++|..||.............                ..
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------------~~  240 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV----------------GM  240 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH----------------HH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh----------------cc
Confidence            11223456788999999875     5778999999999999999999986442221111000                00


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......+...++.+.++|.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001111122344669999999999999999999999763

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=296.93  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ...++|++.+.||.|+||.||+|.+. +|+.||+|.+.....   .+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34678999999999999999999964 589999998765432   34678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus       103 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999999987433  23578899999999999999999999   99999999999999999999999999865532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      .  ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||..............                
T Consensus       178 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------  239 (314)
T 3com_A          178 T--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT----------------  239 (314)
T ss_dssp             T--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----------------
T ss_pred             h--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----------------
Confidence            1  12223456788899999987   78899999999999999999999865432211110000                


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000111122234669999999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-42  Score=305.27  Aligned_cols=243  Identities=25%  Similarity=0.291  Sum_probs=186.6

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHH-HhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRI-ISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||++.++ ++..||+|.+.....  ......+..|..+ ++.++||||+++++++.+.+.+|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3578999999999999999999964 588999998765432  2223345556655 56789999999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.+|.++|+|||++...
T Consensus       116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999987543   3477888999999999999999999   999999999999999999999999998753


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||........                 ...
T Consensus       190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----------------~~~  250 (373)
T 2r5t_A          190 IE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----------------YDN  250 (373)
T ss_dssp             BC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-----------------HHH
T ss_pred             cc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----------------HHH
Confidence            22  122334567899999999987   78899999999999999999999864322111                 111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMR  275 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  275 (309)
                      +.....  ..+...+..+.+||.+||+.||.+||++.
T Consensus       251 i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          251 ILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             HHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence            111111  11122345699999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-43  Score=306.71  Aligned_cols=253  Identities=25%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             hcccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQI-NHKNVVKILGVCLETK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   78 (309)
                      .++|++.+.||+|+||.||++..    .+|+.||+|.+....   .....+.+..|+.+++.+ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47999999999999999999986    368999999876432   112234567788899988 6999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997553   3578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ...... .........+++.|+|||.+.     ++.++||||||+++|+|++|..||...........            
T Consensus       207 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~------------  273 (355)
T 1vzo_A          207 KEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE------------  273 (355)
T ss_dssp             EECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH------------
T ss_pred             eecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH------------
Confidence            754321 122233456899999999985     56789999999999999999999864321111000            


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~l  281 (309)
                       ........  ....+...+..+.+||.+||+.||.+||     |+.+++++.
T Consensus       274 -~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          274 -ISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -HHHHHhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             00001110  1112223446699999999999999999     999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.4e-42  Score=293.67  Aligned_cols=262  Identities=19%  Similarity=0.242  Sum_probs=197.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeee-ecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC-LETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|.......   .+.+..|+.+++.++|++++..+..+ .+.+..++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            4578999999999999999999995 5789999997544332   23477889999999888766655554 66778899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~  159 (309)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++.
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            99999 8999999875433  3578999999999999999999999   9999999999999   788999999999997


Q ss_pred             cccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          160 LISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ........     .......+++.|+|||.+.   ++.++||||||+++|+|++|..||........             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------  223 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------------  223 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-------------
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-------------
Confidence            65433221     1223456789999999987   77889999999999999999999865321110             


Q ss_pred             cccchhhhhcccccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          232 ENNSLRQILNFQVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                       ......+........   .+..+++.+.++|.+||+.||++|||+.++++.|+.+..-..
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          224 -RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -SSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -hhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence             001111111111111   112234669999999999999999999999999988876544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=303.07  Aligned_cols=262  Identities=21%  Similarity=0.280  Sum_probs=192.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK-----   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+... ......+.+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            457899999999999999999995 56999999987543 23344567889999999999999999999997653     


Q ss_pred             -ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           79 -VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        79 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                       ..++||||+ +++|.+++...    .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence             459999999 78999988752    3577889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYFPYPI  231 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  231 (309)
                      +.....     ......++..|+|||.+.    ++.++|+||+||++|+|++|..||...+..........  ...+...
T Consensus       175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            876422     233456788999999874    78899999999999999999999875432211110000  0000000


Q ss_pred             ----cccchhhhh----cc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ----ENNSLRQIL----NF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ----~~~~~~~~~----~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          .........    ..  ..........++.+.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                000000000    00  00001112334679999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.6e-43  Score=296.78  Aligned_cols=260  Identities=18%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             HHhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCc
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCL--ETKV   79 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~   79 (309)
                      +...++|++.+.||+|+||.||++.+. +|+.|++|.+.... .....+.+..|+.++++++||||+++++++.  ..+.
T Consensus         2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            556789999999999999999999964 68999999876532 2334567899999999999999999999874  4678


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLG--SPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      .++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++  ..+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            8999999999999999975432 234688999999999999999999975  1238999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      .+......  ........++..|+|||.+.   ++.++|+||||+++|+|++|..||..........             
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------  226 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------------  226 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-------------
Confidence            98654221  11122345788899999886   6788999999999999999999987543211100             


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                          .+.... ....+...++.+.++|.+||+.||.+|||+.++++++..
T Consensus       227 ----~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          227 ----KIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ----HHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----HHhhcc-cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                000000 001112334669999999999999999999999887643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=301.22  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=196.3

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec---
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE---   76 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---   76 (309)
                      ++....++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....  ..+.+..|+.+++.+ +||||+++++++..   
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            3556789999999999999999999995 5789999998765432  245678899999998 79999999999976   


Q ss_pred             ---CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           77 ---TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        77 ---~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                         .+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence               4678999999999999999976542 34577889999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      |||++......  ........+++.|+|||.+.        ++.++||||||+++|+|++|..||............   
T Consensus       172 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---  246 (326)
T 2x7f_A          172 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---  246 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---
T ss_pred             eCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---
Confidence            99998654221  11223446788999999874        678899999999999999999998643221111000   


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                    .............+..+.+||.+||+.||.+|||+.+++++
T Consensus       247 --------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          247 --------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             --------------HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --------------hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                          00000011112233569999999999999999999999885

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8e-42  Score=293.50  Aligned_cols=251  Identities=23%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--------hhhhHHHHHHHHHHHhhcC-CCccceeeeee
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--------KILINEVFQHKMRIISQIN-HKNVVKILGVC   74 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~   74 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+....        .....+.+..|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3468999999999999999999996 468999999875432        1233466888999999995 99999999999


Q ss_pred             ecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEe
Q 040698           75 LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVAD  154 (309)
Q Consensus        75 ~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d  154 (309)
                      .+.+..++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999997543   3578899999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVP  225 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~  225 (309)
                      ||++.....   ........+++.|+|||.+.         ++.++|+||||+++|+|++|..||...............
T Consensus       168 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          168 FGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             CTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            999876532   12233456788999999873         677899999999999999999998643221111000000


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHH
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSE  279 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~  279 (309)
                      ...               ...+.....+..+.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQ---------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCC---------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Ccc---------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            000               001111234466999999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=323.00  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             ccccce-eecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            9 NYDKRH-LLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         9 ~y~i~~-~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++.+.+ .||+|+||.||+|.++   ++..||+|.+.........+.+.+|+.+++.++||||+++++++.+ +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999753   4678999998765444446788999999999999999999999986 5689999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus       415 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999986442  34578899999999999999999999   999999999999999999999999999765322


Q ss_pred             ccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          165 DQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       165 ~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      ... .......+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........                 ..+
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----------------~~i  552 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------AFI  552 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----------------HHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HHH
Confidence            111 1112233457899999986   7889999999999999998 99998654222111                 111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                       ........+..+++.+.+||.+||+.||++|||+.++++.|+.+....
T Consensus       553 -~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          553 -EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             -HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             111112223345577999999999999999999999999998765443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.2e-41  Score=296.37  Aligned_cols=258  Identities=23%  Similarity=0.349  Sum_probs=199.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhh--cCCCccceeeeeeecCC----
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQ--INHKNVVKILGVCLETK----   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----   78 (309)
                      ...++|++.+.||+|+||.||++.+ +|+.||+|.+....    ...+..|..++..  ++||||+++++++...+    
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3568999999999999999999998 58999999876432    3456777788776  78999999999998765    


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCCCe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--------SLGSPPIIHGDVKSANILLDDNYTA  150 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~~~h~dl~~~nilv~~~~~v  150 (309)
                      ..++||||+++++|.+++...    ..++..++.++.|++.||.|||        +.+   ++|+||+|+||+++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence            789999999999999999643    3477899999999999999999        888   9999999999999999999


Q ss_pred             EEEeeecccccccccccc--cccccccccccCCCccccc---------CCCcchhhHHHHHHHHHhC----------CCC
Q 040698          151 KVADFASSVLISSHDQTA--TTTKEIETVGWLDPEYLFW---------TEKSDVYSFGVVLVELLTG----------KHP  209 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~---------~~~~DiwslG~ll~~~~~g----------~~p  209 (309)
                      +|+|||++..........  ......+++.|+|||.+..         +.++||||||+++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999987653322111  2344568899999999862         2579999999999999999          556


Q ss_pred             CchhhhcchhhhhcccCccccccccchhhhhcccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          210 RSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      |..........            ..............     .....+++.+.+||.+||+.||.+|||+.+++++|+.+
T Consensus       267 ~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          267 YYDLVPSDPSV------------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCcCcccH------------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            54321111000            00000010111111     11236667899999999999999999999999999887


Q ss_pred             hh
Q 040698          285 RR  286 (309)
Q Consensus       285 ~~  286 (309)
                      ..
T Consensus       335 ~~  336 (342)
T 1b6c_B          335 SQ  336 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-42  Score=308.01  Aligned_cols=242  Identities=16%  Similarity=0.174  Sum_probs=185.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc--hhhhhHHHHHHHH---HHHhhcCCCccceee-------e
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV--DKILINEVFQHKM---RIISQINHKNVVKIL-------G   72 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~--~~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~   72 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+...  ......+.+.+|+   ..++.++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999995 56999999987642  1223356788999   455566899999998       6


Q ss_pred             eeecCC-----------------ccEEEEEcCCCCCHHHHHHhhcccc----ccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 040698           73 VCLETK-----------------VPLLVYEFVPNGTLFQHVRYQSSQV----LKTWKTCLRIAAETASALDYLHSLGSPP  131 (309)
Q Consensus        73 ~~~~~~-----------------~~~iv~e~~~~~sL~~~l~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~~~  131 (309)
                      ++.+.+                 ..++||||+ +|+|.+++.......    .+++..++.++.|++.||.|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            655443                 378999999 579999997653221    1234778889999999999999999   


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc--------------cCCCcchhhHH
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF--------------WTEKSDVYSFG  197 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG  197 (309)
                      ++||||||+||+++.++.++|+|||++....     .......| +.|+|||.+.              ++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            9999999999999999999999999987531     12334456 8899999874              56789999999


Q ss_pred             HHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHH
Q 040698          198 VVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV  277 (309)
Q Consensus       198 ~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l  277 (309)
                      +++|+|++|..||.........                 ..+...      +...++.+.+||.+||+.||.+|||+.++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS-----------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS-----------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHHCCCCCcccccccch-----------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999998654321110                 000000      01223569999999999999999999999


Q ss_pred             HHH
Q 040698          278 SEQ  280 (309)
Q Consensus       278 l~~  280 (309)
                      +++
T Consensus       358 l~h  360 (377)
T 3byv_A          358 MET  360 (377)
T ss_dssp             HTS
T ss_pred             hhC
Confidence            873

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.8e-42  Score=315.55  Aligned_cols=255  Identities=19%  Similarity=0.237  Sum_probs=201.4

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||++..+ +|+.||+|.+.....  ......+..|..+++.++||||+++++++.+.+.+++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            4578999999999999999999964 699999998865422  2224567889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSS-QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||++|++|.+++..... ...+++..+..++.|++.||.|||+++   ++||||||+||+++.+|.++|+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999875432 334688899999999999999999999   999999999999999999999999999765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ....  .......|++.|+|||.+.   ++.++|+|||||++|+|++|..||.........             ......
T Consensus       340 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-------------~~~~~~  404 (543)
T 3c4z_A          340 KAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQR  404 (543)
T ss_dssp             CTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-------------HHHHHH
T ss_pred             cCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-------------HHHHHH
Confidence            3221  1223457899999999987   888999999999999999999998654211000             000011


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      +....  ...+...+..+.+||.+||+.||.+||++     .++++|
T Consensus       405 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          405 VLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             Hhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11111  11122344669999999999999999964     677654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=304.67  Aligned_cols=263  Identities=14%  Similarity=0.211  Sum_probs=198.8

Q ss_pred             hcccccceeecccCceEEEEEEcC---------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccce--------
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP---------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVK--------   69 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------   69 (309)
                      .++|++.+.||+|+||.||+|.+.         +++.||+|.+...      +.+.+|+.+++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            579999999999999999999965         3789999987643      35678899999999999987        


Q ss_pred             -------eeeeeec-CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040698           70 -------ILGVCLE-TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN  141 (309)
Q Consensus        70 -------~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~n  141 (309)
                             +++++.. .+..++||||+ +++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||+|+|
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N  189 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN  189 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence                   5666665 67889999999 9999999986532 34588999999999999999999999   9999999999


Q ss_pred             EEEcCCC--CeEEEeeeccccccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          142 ILLDDNY--TAKVADFASSVLISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       142 ilv~~~~--~v~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                      |+++.++  .++|+|||++.........     .......+++.|+|||.+.   ++.++||||||+++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999988  8999999999765432211     1123347888999999886   7789999999999999999999987


Q ss_pred             hhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          212 YVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ...............+......        ...........++.+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGP--------FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCC--------EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCcCHHHHHHHHHhccCChhh--------hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            6532221111111000000000        00000001122366999999999999999999999999998876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.6e-43  Score=305.75  Aligned_cols=265  Identities=20%  Similarity=0.290  Sum_probs=200.0

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhh----------------HHHHHHHHHHHhhcCCCcccee
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILI----------------NEVFQHKMRIISQINHKNVVKI   70 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~~iv~~   70 (309)
                      .++|++.+.||+|+||.||+|.. +|+.||+|.+........                .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 899999998765432211                1678999999999999999999


Q ss_pred             eeeeecCCccEEEEEcCCCCCHHHH------HHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEE
Q 040698           71 LGVCLETKVPLLVYEFVPNGTLFQH------VRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANIL  143 (309)
Q Consensus        71 ~~~~~~~~~~~iv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nil  143 (309)
                      ++++.+.+..++||||+++++|.++      +.... ...+++..+..++.|++.||.|||+ ++   ++|+||+|+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999887      43321 3456889999999999999999999 99   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc----cCC-CcchhhHHHHHHHHHhCCCCCchhhhcch
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTE-KSDVYSFGVVLVELLTGKHPRSYVALASN  218 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~-~~DiwslG~ll~~~~~g~~p~~~~~~~~~  218 (309)
                      ++.++.++|+|||.+......    ......++..|+|||.+.    ++. ++|+||||+++|+|++|..||........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999998764221    334456788999999987    223 89999999999999999999875433211


Q ss_pred             hhhhcccC-ccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          219 EMTRMVPY-FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       219 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........ ...+......................+..+.+||.+||+.||.+|||+.+++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111111 111110000000000000001112344669999999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-42  Score=302.38  Aligned_cols=267  Identities=18%  Similarity=0.242  Sum_probs=190.5

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999984 5799999998865432 2234567789999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-----CCCCeEEEeeec
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-----DNYTAKVADFAS  157 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-----~~~~v~l~d~g~  157 (309)
                      ||||+++ +|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++     .++.++|+|||+
T Consensus       111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999974 9998887554   3578899999999999999999999   99999999999994     455699999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-cccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-FPYPIE  232 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~  232 (309)
                      +......  ........+++.|+|||.+.    ++.++||||||+++|+|++|..||................ .+....
T Consensus       184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            8765221  22233456688999999875    6889999999999999999999987543322111110000 000000


Q ss_pred             ccchhhhh----------cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQIL----------NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........          ........+...++.+.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00000000          0000000011134668999999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.3e-42  Score=298.38  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=194.3

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeec--CCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLE--TKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+....    .+.+.+|+.+++.++ ||||+++++++.+  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            57899999999999999999984 579999999876543    356789999999997 9999999999987  667899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~  161 (309)
                      ||||+++++|.+++..      ++...+..++.|++.||.|||+++   ++||||+|+||+++.++ .++|+|||++...
T Consensus       111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999999887742      467889999999999999999999   99999999999999766 8999999998765


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc------
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI------  231 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  231 (309)
                      ..   ........++..|+|||.+.    ++.++||||||+++|+|++|..||.....................      
T Consensus       182 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            32   22234456788899999875    788999999999999999999998432111111110000000000      


Q ss_pred             -----cccchhh--------hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 -----ENNSLRQ--------ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 -----~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           .......        .+............++.+.+||.+||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 0000000        000001111122345679999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-42  Score=305.18  Aligned_cols=252  Identities=13%  Similarity=0.046  Sum_probs=177.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHH---HHHhhcCCCccceee-------ee
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKM---RIISQINHKNVVKIL-------GV   73 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~   73 (309)
                      ..+|++.+.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+   ..|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45699999999999999999995 479999999887643  333455677775   45555 699988755       44


Q ss_pred             eecC-----------------CccEEEEEcCCCCCHHHHHHhhccccccCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 040698           74 CLET-----------------KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTC------LRIAAETASALDYLHSLGSP  130 (309)
Q Consensus        74 ~~~~-----------------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~~  130 (309)
                      +...                 ...++||||++ ++|.+++.......  +...+      ..++.|++.||+|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~--~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY--VFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcccc--chhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            4322                 33799999998 89999998653322  33455      677799999999999999  


Q ss_pred             CeEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHh
Q 040698          131 PIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLT  205 (309)
Q Consensus       131 ~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~  205 (309)
                       ++||||||+||+++.++.++|+|||++.....     ......+++.|+|||.+.     ++.++||||||+++|+|++
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             99999999999999999999999999875422     111344568899999885     6889999999999999999


Q ss_pred             CCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          206 GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      |..||............          ................+...++.+.+||.+||+.||++|||+.+++++
T Consensus       289 g~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             SSCSTTBCCTTCTTCCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCCCcCcccccchh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99998755322111000          000000011111112222345679999999999999999999999763

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.8e-42  Score=292.62  Aligned_cols=262  Identities=19%  Similarity=0.243  Sum_probs=201.3

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeee-ecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC-LETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....   .+.+..|+.+++.++|++++..+..+ ...+..++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            3568999999999999999999995 6799999998755432   23578899999999988766555544 56778899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~  159 (309)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++.
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99999 8999999974432  3578999999999999999999999   9999999999999   488899999999987


Q ss_pred             ccccccccc-----cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          160 LISSHDQTA-----TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~~~-----~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      .........     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||.......              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------  222 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------------  222 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--------------
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh--------------
Confidence            654322211     123456888999999987   6789999999999999999999987532111              


Q ss_pred             cccchhhhhcccccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhh
Q 040698          232 ENNSLRQILNFQVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE  289 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~  289 (309)
                      .......+........   .+..+++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          223 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             SSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            0001111111110000   112334669999999999999999999999999988765443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.9e-42  Score=308.44  Aligned_cols=249  Identities=25%  Similarity=0.266  Sum_probs=186.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-------hhhHHHHHHHHHHHhhcCCCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-------ILINEVFQHKMRIISQINHKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+.....       ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            467899999999999999999985 5689999998754321       1112347889999999999999999999865 


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEEe
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN---YTAKVAD  154 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~---~~v~l~d  154 (309)
                      +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.+   +.++|+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            4579999999999998877533   34578999999999999999999999   9999999999999754   4599999


Q ss_pred             eecccccccccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP  228 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~  228 (309)
                      ||++.....   ........|++.|+|||.+.      ++.++||||||+++|+|++|..||..........        
T Consensus       286 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--------  354 (419)
T 3i6u_A          286 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--------  354 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--------
T ss_pred             cccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--------
Confidence            999976532   22233456899999999873      5678999999999999999999986432111100        


Q ss_pred             ccccccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          229 YPIENNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              ..+.......  ......++.+.+||.+||+.||.+|||+.++++|
T Consensus       355 --------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          355 --------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             --------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                    0011110000  0111234669999999999999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-42  Score=295.01  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=194.8

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+. +|..+++|.+...... ..+.+..|+.+++.++||||+++++++.+.+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            5688999999999999999999964 5899999987654332 3567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++.....  .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             ECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999998875433  3578899999999999999999999   999999999999999999999999987532111


Q ss_pred             cccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          165 DQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                        ........+++.|+|||.+.        ++.++|+||||+++|+|++|..||................          
T Consensus       171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------  238 (302)
T 2j7t_A          171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----------  238 (302)
T ss_dssp             --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------
T ss_pred             --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC----------
Confidence              11122346788899999872        6788999999999999999999987543221111000000          


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            ......+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       239 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 ------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  00011122334669999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-42  Score=309.20  Aligned_cols=263  Identities=22%  Similarity=0.282  Sum_probs=190.4

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC------cc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK------VP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~   80 (309)
                      ..+|++.+.||+|+||.||+|.+..+..+|+|++......     ..+|+.+++.++||||+++++++....      ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4679999999999999999999877677888876543221     236889999999999999999985433      37


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~  159 (309)
                      ++||||++++.+.............++..+..++.|++.||.|||+++   ++||||||+||+++ .++.++|+|||++.
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999987554444433333445688899999999999999999999   99999999999998 79999999999987


Q ss_pred             ccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc----
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI----  231 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  231 (309)
                      ....   ........+++.|+|||.+.    ++.++|||||||++|+|++|..||.....................    
T Consensus       191 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          191 ILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             ECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            6522   22233456788899999874    788999999999999999999998754322111110000000000    


Q ss_pred             ------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                            .................+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  0000000000000000112244679999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-42  Score=300.37  Aligned_cols=256  Identities=20%  Similarity=0.231  Sum_probs=198.3

Q ss_pred             HHhhcccccc-eeecccCceEEEEEEcC-CCcEEEEEecccch-hhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCc
Q 040698            4 VKATKNYDKR-HLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD-KILINEVFQHKMRIISQIN-HKNVVKILGVCLETKV   79 (309)
Q Consensus         4 ~~~~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (309)
                      ....++|.+. +.||+|+||.||+|... +|+.||+|.+.... .......+..|+.++..+. ||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            4567888988 89999999999999954 69999999876532 2233567888999999884 6999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEeee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADFA  156 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~g  156 (309)
                      .++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.   ++.++|+|||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999988754322 34578899999999999999999999   999999999999987   7899999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ++.....   ........+++.|+|||.+.   ++.++|+||||+++|+|++|..||................       
T Consensus       180 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------  249 (327)
T 3lm5_A          180 MSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-------  249 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------
T ss_pred             cccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc-------
Confidence            9876532   12223456889999999987   7889999999999999999999986543222111100000       


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                              ...........++.+.+||.+||+.||.+|||+.+++++-
T Consensus       250 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          250 --------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             --------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             --------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence                    0011111223346699999999999999999999998763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-42  Score=300.44  Aligned_cols=269  Identities=21%  Similarity=0.252  Sum_probs=196.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec-------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE-------   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------   76 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... .......+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            468999999999999999999996 579999999875432 22223467789999999999999999999876       


Q ss_pred             -CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           77 -TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        77 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                       .+..++||||+++ +|.+.+.....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence             3467899999975 77776654332  3578899999999999999999999   999999999999999999999999


Q ss_pred             eccccccccc--ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh--cccCc
Q 040698          156 ASSVLISSHD--QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR--MVPYF  227 (309)
Q Consensus       156 g~~~~~~~~~--~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~--~~~~~  227 (309)
                      |++.......  .........+++.|+|||.+.    ++.++||||||+++|+|++|..||............  .....
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9987653221  222334456789999999875    688999999999999999999998754322211100  00000


Q ss_pred             cc-cccc----cchhhhhcccccCcc-c-----hHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PY-PIEN----NSLRQILNFQVADEN-E-----MEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~-~~~~----~~~~~~~~~~~~~~~-~-----~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +. ....    ............... .     ...++.+.+||.+||+.||++|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00 0000    000000000000000 0     0113558999999999999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-41  Score=299.36  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=190.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK-----   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+... ........+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            357899999999999999999985 46899999987543 22334567889999999999999999999997654     


Q ss_pred             -ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           79 -VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        79 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                       ..++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence             67999999975 77777742     2477889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc-----
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY-----  229 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  229 (309)
                      +.....   ........+++.|+|||.+.   ++.++||||||+++|+|++|..||...+...............     
T Consensus       174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865422   12233456788999999987   7889999999999999999999997543322111110000000     


Q ss_pred             ---------------cccccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          230 ---------------PIENNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       230 ---------------~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                                     ..............   .........+..+.+||.+||+.||.+|||+.+++++-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                           00000000000000   00111223467799999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.8e-42  Score=302.01  Aligned_cols=270  Identities=21%  Similarity=0.253  Sum_probs=193.5

Q ss_pred             hHHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchh----------hhhHHHHHHHHHHHhhcCCCccceee
Q 040698            2 ELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK----------ILINEVFQHKMRIISQINHKNVVKIL   71 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~   71 (309)
                      ++....++|++.+.||+|+||.||+|.+.+|..||+|.+.....          ....+.+.+|+.+++.++||||++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            56778899999999999999999999988899999997754321          22246789999999999999999999


Q ss_pred             eeeec-----CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 040698           72 GVCLE-----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD  146 (309)
Q Consensus        72 ~~~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~  146 (309)
                      +++..     ....++||||++ ++|.+.+....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLAD  169 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcC
Confidence            99843     346799999997 58877776432  34578899999999999999999999   999999999999999


Q ss_pred             CCCeEEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh
Q 040698          147 NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR  222 (309)
Q Consensus       147 ~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~  222 (309)
                      ++.++|+|||++.....   ........+++.|+|||.+.    ++.++|+||||+++|+|++|..||............
T Consensus       170 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          170 NNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999864322   22233456788899999875    788899999999999999999998754322111000


Q ss_pred             cccCcccccc------ccchhhhh-cc------cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          223 MVPYFPYPIE------NNSLRQIL-NF------QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       223 ~~~~~~~~~~------~~~~~~~~-~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........      ........ ..      ..........++.+.+||.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            0000000000      00000000 00      00001112234669999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-42  Score=306.20  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=191.6

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-----
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-----   76 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   76 (309)
                      +....++|++.+.||+|+||.||+|.+ .+|+.||+|.+......     ..+|+.+++.++||||+++++++..     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            456788999999999999999999985 57999999987654322     2468899999999999999999843     


Q ss_pred             ---------------------------------CCccEEEEEcCCCCCHHHHHHhh-ccccccCHHHHHHHHHHHHHHHH
Q 040698           77 ---------------------------------TKVPLLVYEFVPNGTLFQHVRYQ-SSQVLKTWKTCLRIAAETASALD  122 (309)
Q Consensus        77 ---------------------------------~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~  122 (309)
                                                       ....++||||++ ++|.+.+... .....+++..+..++.|++.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             334789999997 5877777532 23345688999999999999999


Q ss_pred             HHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHH
Q 040698          123 YLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFG  197 (309)
Q Consensus       123 ~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG  197 (309)
                      |||+++   ++||||+|+||+++ .++.++|+|||++.....   ........++..|+|||.+.    ++.++||||+|
T Consensus       156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            999999   99999999999997 688999999999976522   22333456788899999874    78899999999


Q ss_pred             HHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc-----------chhhhhcccccCccchHHHHHHHHHHhHhhcc
Q 040698          198 VVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN-----------SLRQILNFQVADENEMEEIEIVAKLASKCLRT  266 (309)
Q Consensus       198 ~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  266 (309)
                      +++|+|++|..||............ ......+....           ..............+...++.+.+||.+||+.
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999998754322211110 00000000000           00000000000001223446699999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040698          267 SGTERPTMRQVSEQ  280 (309)
Q Consensus       267 dp~~Rps~~~ll~~  280 (309)
                      ||.+|||+.++++|
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.5e-42  Score=296.27  Aligned_cols=253  Identities=17%  Similarity=0.256  Sum_probs=192.6

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcC--CCccceeeeeeecCCccE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQIN--HKNVVKILGVCLETKVPL   81 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~   81 (309)
                      ...++|++.+.||+|+||.||++.+.+++.||+|.+.... .....+.+.+|+.+++.++  ||||+++++++.+.+..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4567899999999999999999998889999999875432 2334567889999999997  599999999999999999


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||| +.+++|.+++....   .+++..+..++.|++.||.|||+++   ++|+||+|+||+++ ++.++|+|||++...
T Consensus       105 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred             EEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccc
Confidence            9999 55789999997543   3477889999999999999999999   99999999999996 479999999998765


Q ss_pred             ccccccccccccccccccCCCcccc--------------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF--------------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~--------------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      .............+++.|+|||.+.              ++.++||||||+++|+|++|..||..........       
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-------  249 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-------  249 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-------
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH-------
Confidence            3332222333456789999999873              5568999999999999999999986432111111       


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                               ............+...+..+.++|.+||+.||.+|||+.+++++-
T Consensus       250 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          250 ---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             ---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                     111111111111112235699999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-41  Score=294.66  Aligned_cols=250  Identities=26%  Similarity=0.267  Sum_probs=191.8

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-------hhhHHHHHHHHHHHhhcCCCccceeeeeeec
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-------ILINEVFQHKMRIISQINHKNVVKILGVCLE   76 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (309)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|.+.....       ......+..|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            3568999999999999999999995 4689999998764321       1123357889999999999999999999876


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEE
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVA  153 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~---v~l~  153 (309)
                      .+ .++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.   ++|+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            55 79999999999999888643   24578899999999999999999999   999999999999986654   9999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      |||++.....   ........+++.|+|||.+.      ++.++||||||+++|+|++|..||...........      
T Consensus       160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------  230 (322)
T 2ycf_A          160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD------  230 (322)
T ss_dssp             CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH------
T ss_pred             cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH------
Confidence            9999876522   11223346788999999862      77899999999999999999999864322111000      


Q ss_pred             cccccccchhhhhcccccC--ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVAD--ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                .+.......  ..+...++.+.+||.+||+.||.+|||+.+++++
T Consensus       231 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          231 ----------QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             ----------HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----------HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                      000000000  0111234669999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-41  Score=289.82  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=198.8

Q ss_pred             HhhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|... +++.|++|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            35679999999999999999999964 689999998754322 2335678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN---YTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~---~~v~l~d~g~~~  159 (309)
                      ||||+++++|.+.+....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.+   +.++|+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999998887543   3578899999999999999999999   9999999999999753   479999999986


Q ss_pred             ccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .....   .......+++.|+|||.+.  ++.++|+||||+++|+|++|..||..........                 
T Consensus       173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----------------  232 (287)
T 2wei_A          173 CFQQN---TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-----------------  232 (287)
T ss_dssp             TBCCC---SSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------------
T ss_pred             eecCC---CccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH-----------------
Confidence            54221   2223345788899999887  7889999999999999999999986542221110                 


Q ss_pred             hhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+.....  ..+.....++.+.++|.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0000000  011112334669999999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.3e-41  Score=303.13  Aligned_cols=197  Identities=26%  Similarity=0.337  Sum_probs=166.6

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc------CCCccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI------NHKNVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~   78 (309)
                      ...+|++.+.||+|+||.||+|.+ .+++.||+|.+.....  ....+..|+.+++.+      +|+||+++++++...+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            356799999999999999999985 4589999999876432  244567777777766      5789999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eEEEeee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT--AKVADFA  156 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~--v~l~d~g  156 (309)
                      ..++||||++ ++|.+++...... .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.  ++|+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 6898888765443 3578899999999999999999999   999999999999998887  9999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhh
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVA  214 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~  214 (309)
                      ++....     .......+++.|+|||.+.   ++.++|||||||++|+|++|.+||....
T Consensus       248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            986532     2233457788999999986   8899999999999999999999987543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-41  Score=294.77  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=178.5

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHH-HHhhcCCCccceeeeeeecCCccEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMR-IISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+...........+..|.. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            57899999999999999999996 4699999998866533333444555554 777789999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhc--cccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           85 EFVPNGTLFQHVRYQS--SQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||+++ +|.+++....  .....++..+..++.|++.|+.|||++ +   ++|+||+|+||+++.++.++|+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 8877776422  234567889999999999999999998 9   999999999999999999999999998655


Q ss_pred             ccccccccccccccccccCCCcccc-------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF-------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~-------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ...   .......+++.|+|||.+.       ++.++||||||+++|+|++|..||.................+.     
T Consensus       177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  248 (327)
T 3aln_A          177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-----  248 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC-----
T ss_pred             ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC-----
Confidence            221   1222346788899999982       7889999999999999999999987532211111111110000     


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                              ..........++.+.+||.+||+.||.+|||+.+++++
T Consensus       249 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          249 --------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             --------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                    00011112234569999999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-41  Score=319.92  Aligned_cols=247  Identities=23%  Similarity=0.255  Sum_probs=199.2

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccch--hhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVD--KILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++++.||+|+||.||++.++ +++.||+|.+....  .....+.+..|..++..+ +||+|+++++++++.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999954 58899999876532  122235577888888877 69999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|..++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999997654   3578899999999999999999999   9999999999999999999999999987532


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  .........|++.|+|||.+.   ++.++|+||||+++|+|++|..||...+....                 ...+
T Consensus       494 ~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-----------------~~~i  554 (674)
T 3pfq_A          494 W--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----------------FQSI  554 (674)
T ss_dssp             C--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHH
T ss_pred             c--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-----------------HHHH
Confidence            2  122344567899999999987   88999999999999999999999865422211                 1111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCH-----HHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTM-----RQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~  280 (309)
                      .....  ..+...+..+.+||++||+.||.+||++     .++++|
T Consensus       555 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          555 MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111  1122344669999999999999999997     777654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.6e-41  Score=318.76  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             hhcccccceeecccCceEEEEEEcC----CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP----DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|++.+.||+|+||.||+|.+.    .+..|++|...........+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            4578999999999999999999853    2567999988766555556789999999999999999999999854 5689


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++++|.+++.....  .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999975432  3577889999999999999999999   999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .... ........+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........                 .
T Consensus       542 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-----------------~  603 (656)
T 2j0j_A          542 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------------G  603 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------------H
T ss_pred             CCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-----------------H
Confidence            3221 11222334567899999886   7889999999999999997 99998644222110                 0


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .+.. ......+..+++.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       604 ~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          604 RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             HHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            0000 00111223344669999999999999999999999999987753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-41  Score=299.32  Aligned_cols=268  Identities=21%  Similarity=0.295  Sum_probs=198.4

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----C
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLET-----K   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+...........+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            4578999999999999999999995 468999999987655555566788999999999999999999987653     6


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..++||||++ ++|.+++...    .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence            7899999997 5898888642    3578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccc--------cccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc--c
Q 040698          159 VLISSHDQTA--------TTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM--V  224 (309)
Q Consensus       159 ~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~--~  224 (309)
                      ..........        ......+++.|+|||.+.    ++.++|+||||+++|+|++|..||.............  .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            7653221111        122346788999999763    6778999999999999999999987543221110000  0


Q ss_pred             cCcccc-----ccccchhhhhccccc------CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          225 PYFPYP-----IENNSLRQILNFQVA------DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       225 ~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......     ...............      .......++.+.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000     000000000000000      00112345679999999999999999999999885

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.3e-41  Score=298.65  Aligned_cols=262  Identities=22%  Similarity=0.268  Sum_probs=195.7

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC--------CCccceeeeeee--
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN--------HKNVVKILGVCL--   75 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~--   75 (309)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+....  ...+.+.+|+.+++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            57899999999999999999985 568999999887543  23566788999998885        788999999987  


Q ss_pred             --cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCC----
Q 040698           76 --ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNY----  148 (309)
Q Consensus        76 --~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~----  148 (309)
                        +....++||||+ +++|.+.+..... ..+++..+..++.|++.||.|||++ +   ++||||||+||+++.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence              567889999999 5666666654432 2357889999999999999999998 9   99999999999998775    


Q ss_pred             ---------------------------------------------CeEEEeeecccccccccccccccccccccccCCCc
Q 040698          149 ---------------------------------------------TAKVADFASSVLISSHDQTATTTKEIETVGWLDPE  183 (309)
Q Consensus       149 ---------------------------------------------~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE  183 (309)
                                                                   .++|+|||++.....     ......+++.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCCh
Confidence                                                         799999999876422     233456789999999


Q ss_pred             ccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcch-----h---hhhcccCcccc------------ccccchhhhh
Q 040698          184 YLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN-----E---MTRMVPYFPYP------------IENNSLRQIL  240 (309)
Q Consensus       184 ~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~-----~---~~~~~~~~~~~------------~~~~~~~~~~  240 (309)
                      .+.   ++.++|||||||++|+|++|..||........     .   ........+..            ..........
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            986   78899999999999999999999864321110     0   00000000000            0000000000


Q ss_pred             c---------ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 N---------FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .         .......+...+..+.+||.+||+.||++|||+.++++|
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0         001123356677889999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-41  Score=294.43  Aligned_cols=270  Identities=22%  Similarity=0.261  Sum_probs=196.3

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc--CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhc---CCCccceeeeeee-
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL--PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQI---NHKNVVKILGVCL-   75 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~--~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-   75 (309)
                      +....++|++.+.||+|+||.||+|.+  .+|+.||+|.+..... ......+.+|+.+++.+   +||||+++++++. 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            455779999999999999999999996  4688999998754321 11112345666666655   8999999999987 


Q ss_pred             ----cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 040698           76 ----ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        76 ----~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                          .....++||||++ ++|.+++...... .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence                5677899999997 5999998765433 3578899999999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---cc
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VP  225 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~  225 (309)
                      |+|||++.....   ........++..|+|||.+.   ++.++||||||+++|+|++|..||.............   ..
T Consensus       161 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          161 LADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             ECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            999999865422   22334456788999999886   7889999999999999999999987543221110000   00


Q ss_pred             Cccccccc--cchhhhh---cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          226 YFPYPIEN--NSLRQIL---NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       226 ~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........  .......   ............++.+.+||.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000000  0000000   0000011122344669999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-41  Score=317.53  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             eeecccCceEEEEEEc---CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVL---PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~---~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|.+   ..+..||+|.+.... .....+.+..|+.+++.++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999963   347899999886543 23345778999999999999999999999975 457899999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc-cc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ-TA  168 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~-~~  168 (309)
                      ++|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........ ..
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999996443   3578899999999999999999999   99999999999999999999999999876533221 11


Q ss_pred             cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......+++.|+|||.+.   ++.++||||||+++|+|++ |..||.........                  .......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------------------~~i~~~~  589 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------------------AMLEKGE  589 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------------------HHHHTTC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------------HHHHcCC
Confidence            222334567899999986   7889999999999999998 99998654322111                  1111111


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      ....+..+++.+.+||.+||+.||++|||+.++++.|+.+..
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            122233455779999999999999999999999999987653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-40  Score=286.63  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=187.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec--------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE--------   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   76 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+....  ...+.+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            568999999999999999999995 479999999886532  234678899999999999999999998754        


Q ss_pred             -----CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 040698           77 -----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAK  151 (309)
Q Consensus        77 -----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~  151 (309)
                           .+..++||||+++++|.+++....  ...+...++.++.|++.||.|||+++   ++|+||+|+||+++.++.++
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                 456789999999999999997543  23467889999999999999999999   99999999999999999999


Q ss_pred             EEeeeccccccccc------------ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          152 VADFASSVLISSHD------------QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       152 l~d~g~~~~~~~~~------------~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                      |+|||++.......            .........+++.|+|||.+.    ++.++|+||||+++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999986543211            011223456788899999875    6789999999999999998   4332111


Q ss_pred             cchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......... .             ....+...+...+..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKKLRS-V-------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHHS-T-------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhccc-c-------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1100000000 0             0001111222334568999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-41  Score=299.89  Aligned_cols=262  Identities=22%  Similarity=0.275  Sum_probs=180.7

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecC------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLET------   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------   77 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+... ........+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            457899999999999999999984 56999999987543 2333456788999999999999999999998653      


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      ...++++|++ +++|.+++..    ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 6899888764    23578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc--ccCccc--
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM--VPYFPY--  229 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~--~~~~~~--  229 (309)
                      +.....     ......++..|+|||.+.    ++.++|||||||++|+|++|..||...+.........  ......  
T Consensus       179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            865422     233456788999999875    7889999999999999999999987543221110000  000000  


Q ss_pred             --cccccchhhhhccccc---C---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 --PIENNSLRQILNFQVA---D---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 --~~~~~~~~~~~~~~~~---~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ................   .   ......++.+.+||.+||+.||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence              0000000000000000   0   0011234668999999999999999999999886

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-41  Score=304.57  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=188.4

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE------TKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~   79 (309)
                      ..+|++.+.||+|+||.||+|.+. +|+.||+|.+.....     ...+|+.+++.++||||+++++++..      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            347999999999999999999964 699999998755322     23468899999999999999998853      224


Q ss_pred             cEEEEEcCCCCCHHHHHHh-hccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEEeeec
Q 040698           80 PLLVYEFVPNGTLFQHVRY-QSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-YTAKVADFAS  157 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-~~v~l~d~g~  157 (309)
                      +++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||+++   ++||||||+||+++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999975 56555543 223345688899999999999999999999   9999999999999955 5689999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      +......   .......+++.|+|||.+.    ++.++|||||||++|+|++|..||.......... ........+...
T Consensus       204 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~-~i~~~lg~p~~~  279 (420)
T 1j1b_A          204 AKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV-EIIKVLGTPTRE  279 (420)
T ss_dssp             CEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCSCCHH
T ss_pred             hhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHH
Confidence            9765221   2223456788999999874    7889999999999999999999987543221111 100000000000


Q ss_pred             c------chhhhhcccccC-----ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          234 N------SLRQILNFQVAD-----ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       234 ~------~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      .      ......-.....     ..+...++.+.+||.+||+.||.+|||+.++++|-
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            0      000000000000     01122346699999999999999999999998753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.4e-41  Score=297.20  Aligned_cols=269  Identities=21%  Similarity=0.234  Sum_probs=183.9

Q ss_pred             HHHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc--
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV--   79 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--   79 (309)
                      .....++|++.+.||+|+||.||+|.+ .+|+.||+|.+......  ......++..+..++||||+++++++.....  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            356678999999999999999999996 46899999987543222  2345677788888999999999999865333  


Q ss_pred             -----cEEEEEcCCCCCHHHHH-HhhccccccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEcC-CCCe
Q 040698           80 -----PLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASALDYLH--SLGSPPIIHGDVKSANILLDD-NYTA  150 (309)
Q Consensus        80 -----~~iv~e~~~~~sL~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~~~h~dl~~~nilv~~-~~~v  150 (309)
                           .++||||+++ +|...+ .........+...+..++.|++.|+.|||  +++   ++||||+|+||+++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 7899999986 444443 33334445678889999999999999999  999   999999999999996 8999


Q ss_pred             EEEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC
Q 040698          151 KVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY  226 (309)
Q Consensus       151 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~  226 (309)
                      +|+|||++......   .......+++.|+|||.+.    ++.++||||||+++|+|++|..||................
T Consensus       172 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999998765322   2233456788899999874    6889999999999999999999987543222111100000


Q ss_pred             ccccc----------cccc---hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYPI----------ENNS---LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~~----------~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....          ....   .................++.+.+||.+||+.||.+|||+.++++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000          0000   000000000011112245679999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-40  Score=289.62  Aligned_cols=263  Identities=23%  Similarity=0.331  Sum_probs=198.4

Q ss_pred             hhcccccceeecccCceEEEEEEc--CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC------ccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL--PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK------NVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||++.+  .+|+.||+|.+.....  ..+.+..|+.+++.++|+      +++++++++.+.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR--YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            357999999999999999999985  3689999998865432  345678888888888655      499999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-----------  146 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-----------  146 (309)
                      +..++||||+ +++|.+++..... ...++..+..++.|++.||.|||+++   ++||||+|+||+++.           
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            9999999999 8899998876543 23577899999999999999999999   999999999999986           


Q ss_pred             --------CCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          147 --------NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       147 --------~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                              ++.++|+|||++.....     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||...+.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                    66899999999865322     223456788999999986   78899999999999999999999875432


Q ss_pred             cchh--hhhcccCccccc-----------------cccc------hhhhhcccccCccchHHHHHHHHHHhHhhccCCCC
Q 040698          216 ASNE--MTRMVPYFPYPI-----------------ENNS------LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTE  270 (309)
Q Consensus       216 ~~~~--~~~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  270 (309)
                      ....  ........+...                 ....      .................++.+.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            2211  000001111000                 0000      00000000111223456678999999999999999


Q ss_pred             CCCHHHHHHH
Q 040698          271 RPTMRQVSEQ  280 (309)
Q Consensus       271 Rps~~~ll~~  280 (309)
                      |||+.+++++
T Consensus       320 Rpt~~ell~h  329 (339)
T 1z57_A          320 RITLREALKH  329 (339)
T ss_dssp             SCCHHHHTTS
T ss_pred             ccCHHHHhcC
Confidence            9999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=302.72  Aligned_cols=269  Identities=20%  Similarity=0.307  Sum_probs=181.2

Q ss_pred             hhccccc-ceeecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee--cCCc
Q 040698            6 ATKNYDK-RHLLGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL--ETKV   79 (309)
Q Consensus         6 ~~~~y~i-~~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~   79 (309)
                      ..+.|++ .++||+|+||.||+|.++   ++..||+|.+.....   ...+.+|+.+++.++||||+++++++.  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            3566887 458999999999999954   588999998865432   335788999999999999999999995  4678


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCC
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL----DDNYT  149 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv----~~~~~  149 (309)
                      .++||||++ ++|.+++.....      ...+++..+..++.|++.||.|||+++   ++||||+|+||++    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            899999996 578777754332      123678899999999999999999999   9999999999999    67789


Q ss_pred             eEEEeeecccccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcc-------
Q 040698          150 AKVADFASSVLISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALAS-------  217 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~-------  217 (309)
                      ++|+|||++........ ........+++.|+|||.+.    ++.++|||||||++|+|++|..||.......       
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            99999999976532211 12234457789999999875    6778999999999999999999986432210       


Q ss_pred             -hhhhhcccC--ccccccccchhh----------hhcccccCcc--------chHHHHHHHHHHhHhhccCCCCCCCHHH
Q 040698          218 -NEMTRMVPY--FPYPIENNSLRQ----------ILNFQVADEN--------EMEEIEIVAKLASKCLRTSGTERPTMRQ  276 (309)
Q Consensus       218 -~~~~~~~~~--~~~~~~~~~~~~----------~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~~  276 (309)
                       .........  .+.......+..          ..........        ....++.+.+||.+||+.||.+|||+.+
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             000000000  000000000000          0000000000        0011345889999999999999999999


Q ss_pred             HHHHH
Q 040698          277 VSEQL  281 (309)
Q Consensus       277 ll~~l  281 (309)
                      +++|-
T Consensus       331 ~L~hp  335 (405)
T 3rgf_A          331 AMQDP  335 (405)
T ss_dssp             HHTSG
T ss_pred             HhcCh
Confidence            99875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=297.84  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=193.2

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++.+.||+|+||.||+|.+.+  .+++|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35789999999999999999998744  488887754321 222345678889999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++ ++.++|+|||++......
T Consensus       109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999986543  23577899999999999999999999   99999999999998 679999999987654221


Q ss_pred             c---ccccccccccccccCCCcccc------------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccc
Q 040698          165 D---QTATTTKEIETVGWLDPEYLF------------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       165 ~---~~~~~~~~~~~~~~~~PE~~~------------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      .   .........+++.|+|||.+.            ++.++||||||+++|+|++|..||................   
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  259 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---  259 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC---
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC---
Confidence            1   112223345788899999875            4668999999999999999999986543221111100000   


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                                    .........+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       260 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          260 --------------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             --------------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             --------------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                          00000111224489999999999999999999999999888754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.4e-41  Score=303.95  Aligned_cols=261  Identities=18%  Similarity=0.241  Sum_probs=201.3

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCccEE
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-KNVVKILGVCLETKVPLL   82 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~i   82 (309)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.....   ...+..|+.+++.++| +++..+..++...+..++
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            3568999999999999999999995 5699999997654432   2346788999999987 566666677777888899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL---DDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv---~~~~~v~l~d~g~~~  159 (309)
                      ||||+ +++|.+++.....  .+++..++.++.||+.||.|||+++   ++||||||+||++   +.++.++|+|||++.
T Consensus        81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99999 8999999975433  3588999999999999999999999   9999999999999   588999999999997


Q ss_pred             cccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          160 LISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ........     .......+++.|+|||.+.   ++.++||||||+++|+|++|..||..........           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-----------  223 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-----------  223 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-----------
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-----------
Confidence            65432221     1122556899999999987   7888999999999999999999987532211100           


Q ss_pred             cccchhhhhccccc---CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          232 ENNSLRQILNFQVA---DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       232 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                         .+..+......   ...+..++..+.+||.+||+.||++||++.+|++.|+.+....
T Consensus       224 ---~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          224 ---KYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             ---HHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence               00000000000   0011223466999999999999999999999999998886543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-40  Score=290.97  Aligned_cols=253  Identities=23%  Similarity=0.244  Sum_probs=172.6

Q ss_pred             Hhhcccccce-eecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec----CC
Q 040698            5 KATKNYDKRH-LLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE----TK   78 (309)
Q Consensus         5 ~~~~~y~i~~-~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~   78 (309)
                      ...++|++.+ .||+|+||.||+|.++ +|+.||+|.+.....     ........++.+.||||+++++++..    .+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            3568899965 6999999999999964 699999998765322     11222334566789999999999876    45


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~  155 (309)
                      ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.   ++.++|+||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence            58999999999999999986543 34578999999999999999999999   999999999999975   455999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |++.....    .......+++.|+|||.+.   ++.++||||||+++|+|++|..||.............. ..     
T Consensus       176 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-----  245 (336)
T 3fhr_A          176 GFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RI-----  245 (336)
T ss_dssp             TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             ccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-hh-----
Confidence            99865422    2223456688899999986   77789999999999999999999865432211000000 00     


Q ss_pred             ccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          233 NNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                           ...............++.+.+||.+||+.||.+|||+.+++++-
T Consensus       246 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          246 -----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             -----hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                 00000011111123446699999999999999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-40  Score=295.51  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=192.3

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc---
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP---   80 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---   80 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+... ........+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            457999999999999999999985 46999999987653 2333456788999999999999999999999877655   


Q ss_pred             ---EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           81 ---LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        81 ---~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                         ++||||++ ++|.+.+..     .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 577766632     2578999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCccc--
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYFPY--  229 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~--  229 (309)
                      +....     .......+++.|+|||.+.    ++.++||||||+++|+|++|..||..............  ...+.  
T Consensus       191 a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          191 ARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            86542     2233456788999999875    78899999999999999999999875432211110000  00000  


Q ss_pred             --cccccchhhhhccc---ccC---ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 --PIENNSLRQILNFQ---VAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 --~~~~~~~~~~~~~~---~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ..............   ...   ......++.+.+||.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence              00000000000000   000   0012234679999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=289.48  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=186.0

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-----hhHHHHHHHHHHHhhc----CCCccceeeee
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQI----NHKNVVKILGV   73 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~~iv~~~~~   73 (309)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||+|.+......     .....+..|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34568899999999999999999985 56899999988654321     1123355688888888    89999999999


Q ss_pred             eecCCccEEEEEc-CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeE
Q 040698           74 CLETKVPLLVYEF-VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAK  151 (309)
Q Consensus        74 ~~~~~~~~iv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~  151 (309)
                      +.+.+..++|+|+ +.+++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++ .++.++
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999997643   3578999999999999999999999   99999999999998 889999


Q ss_pred             EEeeecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          152 VADFASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       152 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      |+|||++.....    .......++..|+|||.+.    .+.++||||||+++|+|++|..||.........    .   
T Consensus       181 l~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~---  249 (312)
T 2iwi_A          181 LIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA----E---  249 (312)
T ss_dssp             ECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT----C---
T ss_pred             EEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh----c---
Confidence            999999876532    2233456788899999876    244799999999999999999998644211100    0   


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                        ...+...+..+.++|.+||+.||++|||+.+++++
T Consensus       250 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          250 ------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              00111233569999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.1e-41  Score=312.31  Aligned_cols=267  Identities=22%  Similarity=0.246  Sum_probs=196.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE------TK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~   78 (309)
                      ..++|++.+.||.|+||.||+|.+ .+|+.||+|.+.........+.+..|+.+++.++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            458999999999999999999996 46899999988765555556778999999999999999999998765      67


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT---AKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~---v~l~d~  155 (309)
                      ..++||||++|++|.+++........+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.   ++|+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999987655445677899999999999999999999   999999999999987665   899999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-----c
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-----F  227 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-----~  227 (309)
                      |++......   .......+++.|+|||.+.   ++.++|+||||+++|+|++|..||........-.......     .
T Consensus       169 G~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          169 GYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            998765322   2234457889999999987   7889999999999999999999986432111000000000     0


Q ss_pred             cccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHH
Q 040698          228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS  278 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll  278 (309)
                      .........................++.+.++|.+||+.||++|||+.+++
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000000000000000111123345678899999999999999999998854

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-41  Score=292.58  Aligned_cols=241  Identities=22%  Similarity=0.324  Sum_probs=193.7

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-----hhHHHHHHHHHHHhhcC--CCccceeeeeeec
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQIN--HKNVVKILGVCLE   76 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~   76 (309)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+......     .....+..|+.+++.++  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            4578899999999999999999984 56899999987554221     11234567888999886  5999999999999


Q ss_pred             CCccEEEEEcCCC-CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEe
Q 040698           77 TKVPLLVYEFVPN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVAD  154 (309)
Q Consensus        77 ~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d  154 (309)
                      .+..++|+|++.+ ++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++ .++.++|+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999976 89999987643   3477899999999999999999999   99999999999998 788999999


Q ss_pred             eecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      ||++.....    .......+++.|+|||.+.    .+.++||||||+++|+|++|..||.........    ...    
T Consensus       194 fg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~----  261 (320)
T 3a99_A          194 FGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVF----  261 (320)
T ss_dssp             CTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC----CCC----
T ss_pred             Ccccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc----ccc----
Confidence            999876532    2223456788999999876    356789999999999999999998654211100    000    


Q ss_pred             ccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 IENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                       .+...++.+.+||.+||+.||++|||+.+++++
T Consensus       262 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          262 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             011123569999999999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=288.01  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=188.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeee---------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCL---------   75 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------   75 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            4679999999999999999999965 589999998765543 33567889999999999999999999873         


Q ss_pred             -----cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCC
Q 040698           76 -----ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYT  149 (309)
Q Consensus        76 -----~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~  149 (309)
                           +.+..++||||++ ++|.+++..    ...++..+..++.|++.||.|||+++   ++|+||+|+||+++ .++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence                 3467799999997 599888853    23577889999999999999999999   99999999999997 6779


Q ss_pred             eEEEeeeccccccccc-ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc
Q 040698          150 AKVADFASSVLISSHD-QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV  224 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~  224 (309)
                      ++|+|||++....... .........++..|+|||.+.    ++.++|+||||+++|+|++|..||......... ....
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~  238 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLIL  238 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence            9999999987653211 112223445678899999764    677899999999999999999998754322111 1111


Q ss_pred             cCccccccccchhhhh------------cc-cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          225 PYFPYPIENNSLRQIL------------NF-QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       225 ~~~~~~~~~~~~~~~~------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...+..... ......            .. ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEE-DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHH-HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchh-hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000000000 000000            00 00000112345679999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.7e-40  Score=291.21  Aligned_cols=260  Identities=21%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-----------CCccceeeeee
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-----------HKNVVKILGVC   74 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~   74 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+.....  ..+.+..|+.+++.++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            57899999999999999999995 5689999998875432  3456788888888776           89999999998


Q ss_pred             ecCC----ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEc----
Q 040698           75 LETK----VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLD----  145 (309)
Q Consensus        75 ~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~----  145 (309)
                      ...+    ..++|||++ +++|.+++...... ..++..+..++.|++.||.|||++ +   ++||||+|+||+++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            8654    788999999 88999998765433 357789999999999999999998 9   99999999999994    


Q ss_pred             --CCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcch--
Q 040698          146 --DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN--  218 (309)
Q Consensus       146 --~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~--  218 (309)
                        ..+.++|+|||++.....     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||........  
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              344799999999875422     233456789999999986   78899999999999999999999975431110  


Q ss_pred             ---h---hhhcccCccccc-----------------------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCC
Q 040698          219 ---E---MTRMVPYFPYPI-----------------------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGT  269 (309)
Q Consensus       219 ---~---~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  269 (309)
                         .   ........+...                       .........  ......+...+..+.+||.+||+.||.
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHHHHHHHHhccCcc
Confidence               0   000000000000                       000000000  011123456778899999999999999


Q ss_pred             CCCCHHHHHHH
Q 040698          270 ERPTMRQVSEQ  280 (309)
Q Consensus       270 ~Rps~~~ll~~  280 (309)
                      +|||+.+++++
T Consensus       324 ~Rpt~~ell~h  334 (373)
T 1q8y_A          324 KRADAGGLVNH  334 (373)
T ss_dssp             TCBCHHHHHTC
T ss_pred             ccCCHHHHhhC
Confidence            99999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=286.40  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=180.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|.+..... ....+.+..+..+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3578999999999999999999964 699999998865433 22234445555678888999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL-GSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |||+ ++.+..+.....  ..+++..+..++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 556655554332  3457889999999999999999995 9   9999999999999999999999999886542


Q ss_pred             cccccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ..   .......+++.|+|||.+.        ++.++||||||+++|+|++|..||.................+      
T Consensus       177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  247 (318)
T 2dyl_A          177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC------
T ss_pred             CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC------
Confidence            21   2223346788999999983        677899999999999999999998643211111111110000      


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                               .........+..+.++|.+||+.||.+|||+.+++++-
T Consensus       248 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          248 ---------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             ---------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ---------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence                     00011112335699999999999999999999998853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=290.37  Aligned_cols=260  Identities=19%  Similarity=0.260  Sum_probs=191.6

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc-----
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETKV-----   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----   79 (309)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||+|.+... ........+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            57899999999999999999995 46999999987553 233345678899999999999999999999987654     


Q ss_pred             -cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           80 -PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        80 -~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                       .++||||++ ++|.+++..     .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 587766532     2578899999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCccc---
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYFPY---  229 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~---  229 (309)
                      .....     ......+++.|+|||.+.    ++.++|+||||+++|+|++|..||..............  ...+.   
T Consensus       174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65422     223346788899999864    78899999999999999999999875432211100000  00000   


Q ss_pred             -cccccchhhhh----cc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          230 -PIENNSLRQIL----NF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       230 -~~~~~~~~~~~----~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                       ...........    ..  ..........++.+.+||.+||+.||.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             00000000000    00  00011122345679999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-39  Score=278.12  Aligned_cols=236  Identities=14%  Similarity=0.086  Sum_probs=184.0

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.....  ....+.+.+|+..+..++||||+++++++.+.+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3478999999999999999999964 589999998865432  3344678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++|++|.+++...    . ....+..++.|++.||.|||+++   ++||||||+||+++.++.++|++++.     
T Consensus       109 v~e~~~g~~L~~~l~~~----~-~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~-----  175 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS----P-SPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT-----  175 (286)
T ss_dssp             EEECCCEEEHHHHHTTC----C-CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHhcC----C-ChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc-----
Confidence            99999999999998532    2 34568889999999999999999   99999999999999999999985542     


Q ss_pred             cccccccccccccccccCCCcccccCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                                       ++|    ++.++||||||+++|+|++|..||............. .....           ..
T Consensus       176 -----------------~~~----~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~-----------~~  222 (286)
T 3uqc_A          176 -----------------MPD----ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAG-----------QP  222 (286)
T ss_dssp             -----------------CTT----CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-BCTTS-----------CB
T ss_pred             -----------------cCC----CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-HHhcc-----------CC
Confidence                             333    5678999999999999999999987543221000000 00000           00


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ..........++.+.++|.+||+.||.+| |+.++++.|..+....
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            00001112344669999999999999999 9999999998876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-39  Score=286.24  Aligned_cols=263  Identities=21%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CC-cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc------cceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DN-TLVAVKKPKMVDKILINEVFQHKMRIISQINHKN------VVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~-~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+. ++ ..||+|.+....  ...+.+..|+.+++.++|++      ++.+++++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            4579999999999999999999953 34 789999886543  23566788888888887655      89999999999


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-------------
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL-------------  144 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv-------------  144 (309)
                      +..++||||+ ++++.+.+..... ..+++..+..++.|++.||.|||+++   ++||||+|+||++             
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            9999999999 5677777765432 23578899999999999999999999   9999999999999             


Q ss_pred             ------cCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhh
Q 040698          145 ------DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVAL  215 (309)
Q Consensus       145 ------~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~  215 (309)
                            +.++.++|+|||++.....     ......+++.|+|||.+.   ++.++||||||+++|+|++|..||.....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                  5678999999999865322     223456789999999986   78899999999999999999999875432


Q ss_pred             cchhh--hhcccCccccc-----------------cccc------hhhhhcccccCccchHHHHHHHHHHhHhhccCCCC
Q 040698          216 ASNEM--TRMVPYFPYPI-----------------ENNS------LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTE  270 (309)
Q Consensus       216 ~~~~~--~~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  270 (309)
                      .....  .......+...                 ....      .................+..+.+||.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            21110  00000000000                 0000      00000000111123344567999999999999999


Q ss_pred             CCCHHHHHHH
Q 040698          271 RPTMRQVSEQ  280 (309)
Q Consensus       271 Rps~~~ll~~  280 (309)
                      |||+.+++++
T Consensus       325 Rpt~~e~l~h  334 (355)
T 2eu9_A          325 RITLAEALLH  334 (355)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHhcC
Confidence            9999999763

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5e-40  Score=296.64  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=184.1

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|.+.+.||+|+||.||.+...+|+.||+|.+....    .+.+..|+.+++.+ +||||+++++++.+.+..++|||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            45566778999999999987766689999999875432    34567899999876 89999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccc----cCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-------------C
Q 040698           86 FVPNGTLFQHVRYQSSQVL----KTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN-------------Y  148 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~-------------~  148 (309)
                      |++ ++|.+++........    ..+..++.++.|++.||.|||+++   ++||||+|+||+++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            996 599999975543211    122345679999999999999999   9999999999999754             4


Q ss_pred             CeEEEeeeccccccccccc--ccccccccccccCCCcccc----------cCCCcchhhHHHHHHHHHh-CCCCCchhhh
Q 040698          149 TAKVADFASSVLISSHDQT--ATTTKEIETVGWLDPEYLF----------WTEKSDVYSFGVVLVELLT-GKHPRSYVAL  215 (309)
Q Consensus       149 ~v~l~d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~----------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~  215 (309)
                      .++|+|||++.........  .......|++.|+|||.+.          ++.++|||||||++|+|++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            7999999999765332211  1223456899999999873          6778999999999999998 9999864322


Q ss_pred             cchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          216 ASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .........  ...            ...........++.+.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~~~i~~~~--~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          246 RESNIIRGI--FSL------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHHHHTC--CCC------------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hHHHHhcCC--CCc------------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            111110000  000            001111234566789999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-39  Score=288.80  Aligned_cols=197  Identities=27%  Similarity=0.368  Sum_probs=163.9

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CC-----ccceeeeeeecCC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HK-----NVVKILGVCLETK   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+.....  ....+..|+.+++.++ |+     +++++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            467899999999999999999995 4689999998875432  2445677788877774 44     4999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEc--CCCCeEEEe
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH--SLGSPPIIHGDVKSANILLD--DNYTAKVAD  154 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~~~h~dl~~~nilv~--~~~~v~l~d  154 (309)
                      ..++||||++ ++|.+++...... .+++..+..++.|++.||.|||  +.+   ++||||||+||+++  .++.++|+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999996 5999998765433 3578899999999999999999  467   99999999999995  477899999


Q ss_pred             eecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhh
Q 040698          155 FASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVA  214 (309)
Q Consensus       155 ~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~  214 (309)
                      ||++.....     ......+++.|+|||.+.   ++.++|||||||++|+|++|..||....
T Consensus       205 FG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          205 FGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999876522     233456788999999987   7889999999999999999999997543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=293.58  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=184.5

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ...+|++.+.||+|+||.|+.....+|+.||+|.+......    .+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            45679999999999999976555568999999987653322    246788999988 7999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---C--CCeEEEeeeccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---N--YTAKVADFASSV  159 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~--~~v~l~d~g~~~  159 (309)
                      ||++ ++|.+++......  .....+..++.|++.||.|||+++   ++||||||+||+++.   +  ..++|+|||++.
T Consensus        98 E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             ECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9996 5999998755432  233456789999999999999999   999999999999953   2  357899999987


Q ss_pred             ccccccc-cccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccc
Q 040698          160 LISSHDQ-TATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      ....... ........|++.|+|||.+.      ++.++|||||||++|+|++ |..||..........  .......  
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~~--  247 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSL--  247 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCCC--
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCCc--
Confidence            6532211 12233456899999999985      4668999999999999999 999986432211111  0000000  


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                  .........+..+.+||.+||+.||.+|||+.++++|
T Consensus       248 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 ------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                        0011122345668999999999999999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-39  Score=305.95  Aligned_cols=239  Identities=21%  Similarity=0.321  Sum_probs=191.3

Q ss_pred             hcccccceeecccCceEEEEEEcC--CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc-----
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP--DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKV-----   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----   79 (309)
                      .++|++.+.||+|+||.||++.+.  +|+.|++|.+...........+..|+.+++.++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            479999999999999999999964  6899999988665445556778999999999999999999999987665     


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .|+||||++|++|.+++..     .+++..+..++.|++.||.|||+++   ++||||||+||+++.+ .++|+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999887643     3578999999999999999999999   9999999999999875 89999999987


Q ss_pred             ccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                      .....      ....|++.|+|||.+.  ++.++||||||+++|+|++|..||......         ..+         
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~---------  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP---------  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC---------
T ss_pred             hcccC------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc---------
Confidence            54221      4456899999999887  677899999999999999998886532100         000         


Q ss_pred             hhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhh
Q 040698          238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLR  285 (309)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~  285 (309)
                             ........++.+.++|.+||+.||.+|| ++.++.+.|..+.
T Consensus       286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   0011122345699999999999999999 5666666665543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-38  Score=273.22  Aligned_cols=232  Identities=24%  Similarity=0.251  Sum_probs=177.6

Q ss_pred             hhcccccc-eeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHH-hhcCCCccceeeeeeec----CC
Q 040698            6 ATKNYDKR-HLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRII-SQINHKNVVKILGVCLE----TK   78 (309)
Q Consensus         6 ~~~~y~i~-~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~   78 (309)
                      ..++|.+. +.||+|+||.||++.+ .+|+.||+|.+...      ..+..|+.++ +..+||||+++++++..    .+
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            45778887 7899999999999995 56899999987643      2356677776 55689999999999876    67


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~  155 (309)
                      ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.   ++.++|+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence            88999999999999999986543 24578999999999999999999999   999999999999987   788999999


Q ss_pred             ecccccccccccccccccccccccCCCcccccCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      |++.....                     ..++.++|+||||+++|+|++|..||.............            
T Consensus       165 g~a~~~~~---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~------------  211 (299)
T 3m2w_A          165 GFAKETTG---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------  211 (299)
T ss_dssp             TTCEECTT---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC------------
T ss_pred             cccccccc---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH------------
Confidence            98854311                     014678999999999999999999986442211100000            


Q ss_pred             hhhhhcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          236 LRQILNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       236 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                       ...........  .....++.+.+||.+||+.||.+|||+.+++++-
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          212 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             -CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence             00000000000  0122346799999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-39  Score=286.43  Aligned_cols=257  Identities=16%  Similarity=0.155  Sum_probs=184.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh--hhHHHHHHHHHHHhhcCC-Cccce---------eee
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI--LINEVFQHKMRIISQINH-KNVVK---------ILG   72 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h-~~iv~---------~~~   72 (309)
                      ...+|.+.+.||+|+||.||+|.+ .+|+.||+|++......  ...+.+.+|+.+++.++| +|...         ..+
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688999999999999999994 56999999987643222  224568889999988876 22211         111


Q ss_pred             ------------eeec-----CCccEEEEEcCCCCCHHHHHHhh----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 040698           73 ------------VCLE-----TKVPLLVYEFVPNGTLFQHVRYQ----SSQVLKTWKTCLRIAAETASALDYLHSLGSPP  131 (309)
Q Consensus        73 ------------~~~~-----~~~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  131 (309)
                                  ++..     ....+++|+.+ +++|.+++...    .....+++..+..++.|++.||.|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                        1111     12346777766 68999888532    12334566788899999999999999999   


Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCccc----------c---cCCCcchhhHHH
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL----------F---WTEKSDVYSFGV  198 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~---~~~~~DiwslG~  198 (309)
                      ++||||||+||+++.++.+||+|||++.....     ......| +.|+|||.+          .   ++.++||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            99999999999999999999999999865422     1344566 889999998          3   667999999999


Q ss_pred             HHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHH
Q 040698          199 VLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS  278 (309)
Q Consensus       199 ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll  278 (309)
                      ++|+|++|..||........                 ...+...      ....++.+.+||.+||+.||++|||+.+++
T Consensus       306 il~elltg~~Pf~~~~~~~~-----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG-----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC-----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHCCCCCCCcchhhh-----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999865432111                 0001110      011235699999999999999999999998


Q ss_pred             HH--Hhhhhhhhhhhhhhh
Q 040698          279 EQ--LDSLRRLHENFWAQK  295 (309)
Q Consensus       279 ~~--l~~~~~~~~~~~~~~  295 (309)
                      ++  +..+.........++
T Consensus       363 ~~~~~~~~~~~~~~~~~~~  381 (413)
T 3dzo_A          363 ETPEYEQLRTELSAALPLY  381 (413)
T ss_dssp             TSHHHHHHHHHHHHHGGGG
T ss_pred             hCHHHHHHHHHHHHHhhhh
Confidence            76  555555444444333

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.4e-38  Score=274.92  Aligned_cols=243  Identities=18%  Similarity=0.188  Sum_probs=179.4

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccch-------hhhhHHHHHHHHHHHhhcC---------CCc----
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-------KILINEVFQHKMRIISQIN---------HKN----   66 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~~----   66 (309)
                      .++|++.+.||+|+||.||+|.+ +|+.||+|.+....       .....+.+.+|+.+++.++         |||    
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            57899999999999999999998 78999999876542       1222356788888888775         544    


Q ss_pred             -------------cceeeeeeec-------------CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHH
Q 040698           67 -------------VVKILGVCLE-------------TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASA  120 (309)
Q Consensus        67 -------------iv~~~~~~~~-------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~  120 (309)
                                   |+++++++.+             .+..++||||+++|++.+.+..    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence                         4555555544             6789999999999976555532    345789999999999999


Q ss_pred             HHHHH-hcCCCCeEecCCCCCcEEEcCCC--------------------CeEEEeeeccccccccccccccccccccccc
Q 040698          121 LDYLH-SLGSPPIIHGDVKSANILLDDNY--------------------TAKVADFASSVLISSHDQTATTTKEIETVGW  179 (309)
Q Consensus       121 l~~lh-~~~~~~~~h~dl~~~nilv~~~~--------------------~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~  179 (309)
                      |.||| +++   ++||||||+||+++.++                    .+||+|||++.....       ....|++.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 999   99999999999999877                    899999999976532       234788999


Q ss_pred             CCCcccc--cCCCcchhhHHHH-HHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHH
Q 040698          180 LDPEYLF--WTEKSDVYSFGVV-LVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIV  256 (309)
Q Consensus       180 ~~PE~~~--~~~~~DiwslG~l-l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (309)
                      +|||.+.  .+.++||||+|++ .++++.|..||.................           ..........+...++.+
T Consensus       244 ~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-----------TFKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-----------CCSSCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-----------ccCcccchhhhhhcCHHH
Confidence            9999987  5678999998766 7789999999754211000000000000           000011112234677889


Q ss_pred             HHHHhHhhccCCCCCCCHHHHH-HH
Q 040698          257 AKLASKCLRTSGTERPTMRQVS-EQ  280 (309)
Q Consensus       257 ~~li~~cl~~dp~~Rps~~~ll-~~  280 (309)
                      .+||++||+.|     |+.+++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999977     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.8e-30  Score=236.20  Aligned_cols=181  Identities=15%  Similarity=0.053  Sum_probs=126.3

Q ss_pred             ccCceEEEEEE-cCCCcEEEEEecccc---------hhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEEEEEc
Q 040698           18 EGGFGFVYKGV-LPDNTLVAVKKPKMV---------DKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus        18 ~g~~g~v~~~~-~~~~~~v~ik~~~~~---------~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .|..|....++ .-.|+.+++|.+...         ......+.+.+|+++|+++ .|+||+++++++++++..||||||
T Consensus       244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy  323 (569)
T 4azs_A          244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK  323 (569)
T ss_dssp             --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred             cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence            34444443333 224788999976433         1233345699999999999 699999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      ++|++|.+.+.....   ++..   .|+.||+.||+|+|++|   |+||||||+|||++++|.|||+|||+++.....  
T Consensus       324 v~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--  392 (569)
T 4azs_A          324 LPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--  392 (569)
T ss_dssp             CCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             CCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence            999999999975542   3433   57899999999999999   999999999999999999999999998765322  


Q ss_pred             cccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCC
Q 040698          167 TATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHP  209 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p  209 (309)
                      ........|++.|+|||.+.  +..++|+|++|++++.+.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            12234467899999999987  67789999999999887766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.7e-26  Score=213.04  Aligned_cols=182  Identities=14%  Similarity=0.146  Sum_probs=138.6

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecccc-------hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMV-------DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..+.||+|+||.||++.. .+..+++|.....       ......+.+.+|+.++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            356899999999999965 5677788754221       11122456899999999999999996666666777889999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++|++|.+++..           +..++.|++.+|.|||+++   ++||||||+||+++.  .++|+|||++......
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999998864           4578999999999999999   999999999999998  9999999999776332


Q ss_pred             cccc-----cccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCC
Q 040698          165 DQTA-----TTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPR  210 (309)
Q Consensus       165 ~~~~-----~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~  210 (309)
                      ....     ......|++.|+|||.+.     |+...|+|+...-..+.+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1111     123457899999999997     677889999888888777766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.1e-23  Score=178.78  Aligned_cols=138  Identities=20%  Similarity=0.232  Sum_probs=110.9

Q ss_pred             HhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhh-----------------hhHHHHHHHHHHHhhcCCCcc
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKI-----------------LINEVFQHKMRIISQINHKNV   67 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~~i   67 (309)
                      .....|.+.+.||.|+||.||+|.+.+|+.||+|.+......                 .....+..|+.+++.++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            344556677999999999999999977999999987543211                 13456889999999998  4 


Q ss_pred             ceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           68 VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        68 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      +++.+++.. +..++||||++|++|.+ +..         .....++.|++.||.|||+++   ++||||+|+||+++ +
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence            666665543 56799999999999987 311         223468999999999999999   99999999999999 9


Q ss_pred             CCeEEEeeecccc
Q 040698          148 YTAKVADFASSVL  160 (309)
Q Consensus       148 ~~v~l~d~g~~~~  160 (309)
                      +.++|+|||++..
T Consensus       229 ~~vkl~DFG~a~~  241 (282)
T 1zar_A          229 EGIWIIDFPQSVE  241 (282)
T ss_dssp             TEEEECCCTTCEE
T ss_pred             CcEEEEECCCCeE
Confidence            9999999998853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=1.4e-19  Score=151.73  Aligned_cols=139  Identities=17%  Similarity=0.124  Sum_probs=106.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcE--EEEEecccchh-----------------------hhhHHHHHHHHHHHhh
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTL--VAVKKPKMVDK-----------------------ILINEVFQHKMRIISQ   61 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~--v~ik~~~~~~~-----------------------~~~~~~~~~e~~~l~~   61 (309)
                      .-|++.+.||+|+||.||+|.+ .+|+.  ||+|.......                       ......+..|+..+..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3478899999999999999997 67888  99997543211                       1122467889999999


Q ss_pred             cCCCcc--ceeeeeeecCCccEEEEEcCCC-C----CHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 040698           62 INHKNV--VKILGVCLETKVPLLVYEFVPN-G----TLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH-SLGSPPII  133 (309)
Q Consensus        62 l~h~~i--v~~~~~~~~~~~~~iv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~~~  133 (309)
                      +.|+++  ..+++.    +..++||||+++ |    +|.+.....      ++..+..++.|++.++.+|| +.+   ++
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~------~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL------KELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG------GGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc------ChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            988764  333332    467899999942 3    666543211      23456788999999999999 999   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698          134 HGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus       134 h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      ||||+|.||+++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999988  8999999998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=5.8e-18  Score=147.89  Aligned_cols=139  Identities=15%  Similarity=0.117  Sum_probs=98.0

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccchh-------------h--------hhHHHHHHHHHHHhhcCCCcc
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK-------------I--------LINEVFQHKMRIISQINHKNV   67 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~-------------~--------~~~~~~~~e~~~l~~l~h~~i   67 (309)
                      =|++.+.||.|.+|.||+|...+|+.||+|+++....             .        ..+-....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3999999999999999999998999999997542110             0        001112345556666544433


Q ss_pred             ceeeeeeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 040698           68 VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDN  147 (309)
Q Consensus        68 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~  147 (309)
                      ....-+.  .+..+|||||++|.+|..+..         ......++.|++.+|.+||+.|   ++||||||.|||++++
T Consensus       176 ~vp~p~~--~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIA--QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEE--EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeeee--ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence            2211111  123479999999988754321         1223567889999999999999   9999999999999877


Q ss_pred             C----------CeEEEeeeccccc
Q 040698          148 Y----------TAKVADFASSVLI  161 (309)
Q Consensus       148 ~----------~v~l~d~g~~~~~  161 (309)
                      +          .+.|+||+.+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=6e-13  Score=111.44  Aligned_cols=147  Identities=18%  Similarity=0.087  Sum_probs=110.8

Q ss_pred             HHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccE
Q 040698            3 LVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPL   81 (309)
Q Consensus         3 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   81 (309)
                      +......|++...++.|+.+.||++... +..+++|........ ....+..|..+++.+. +..+.++++++.+.+..|
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3445567999999999999999999864 688999987653211 1235788888888874 667888999998888899


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG---------------------------------  128 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------  128 (309)
                      +||||++|.+|.+.+.        +......++.+++.++..||+..                                 
T Consensus        87 lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999999876521        11122366778889999999810                                 


Q ss_pred             -----------------------CCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          129 -----------------------SPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       129 -----------------------~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                                             ...++|+|+++.||++++++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   0228999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=8.7e-12  Score=103.98  Aligned_cols=141  Identities=18%  Similarity=0.149  Sum_probs=98.7

Q ss_pred             HHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc--cceeeeeeecCCccE
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN--VVKILGVCLETKVPL   81 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~   81 (309)
                      ......|.+....+.|..+.||++...+|..+++|......    ...+..|..+++.+.+.+  +.+++++....+..+
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            33445566655555777799999987778889999865431    234677888888775434  556888888777889


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG---------------------------------  128 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------  128 (309)
                      +||||++|.+|.  ..   .   ..   ...++.+++..+..||+..                                 
T Consensus        92 ~v~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            999999998873  11   0   01   1234556666667766532                                 


Q ss_pred             ----------------------CCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          129 ----------------------SPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       129 ----------------------~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                                            ...++|+|++|.||++++++.+.++||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  0118999999999999877666799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=6.7e-11  Score=103.58  Aligned_cols=143  Identities=17%  Similarity=0.261  Sum_probs=101.3

Q ss_pred             cceeecccCceEEEEEEcCCCcEEEEEecc--cchhhhhHHHHHHHHHHHhhcC--CCccceeeeeeecC---CccEEEE
Q 040698           12 KRHLLGEGGFGFVYKGVLPDNTLVAVKKPK--MVDKILINEVFQHKMRIISQIN--HKNVVKILGVCLET---KVPLLVY   84 (309)
Q Consensus        12 i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~--~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~iv~   84 (309)
                      -++.|+.|.++.+|++...+ ..+++|...  ..........+..|+.+++.+.  +..+.+++.++.+.   ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            46788999999999998754 678888776  4332223456788999998886  34577888888766   4579999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG------------------------------------  128 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------------  128 (309)
                      ||++|..+.+..     ....+......++.+++.+|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999988764311     112345667778889999999999720                                    


Q ss_pred             -------------------CCCeEecCCCCCcEEEcCCCC--eEEEeeecccc
Q 040698          129 -------------------SPPIIHGDVKSANILLDDNYT--AKVADFASSVL  160 (309)
Q Consensus       129 -------------------~~~~~h~dl~~~nilv~~~~~--v~l~d~g~~~~  160 (309)
                                         ...++|||+++.||++++++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               123999999999999987653  68999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=6.7e-10  Score=94.89  Aligned_cols=187  Identities=18%  Similarity=0.211  Sum_probs=113.3

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCc--cceeeeeeecCC---ccEEEEEc
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKN--VVKILGVCLETK---VPLLVYEF   86 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~iv~e~   86 (309)
                      ++.++.|....+|++.    ..+++|.....   .....+..|..+++.+. +..  +.+++......+   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863    45888875543   23567888999988773 332  344555444333   45799999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG--------------------------------------  128 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------------------  128 (309)
                      ++|.++......     ..+......++.+++..++.||+..                                      
T Consensus        98 i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           98 IKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999887643221     1233445556666666666666411                                      


Q ss_pred             -----------------CCCeEecCCCCCcEEEcC--CCCeEEEeeeccccccccccccccccc---cc-------cccc
Q 040698          129 -----------------SPPIIHGDVKSANILLDD--NYTAKVADFASSVLISSHDQTATTTKE---IE-------TVGW  179 (309)
Q Consensus       129 -----------------~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~~~~~~~~~~~~~~---~~-------~~~~  179 (309)
                                       .+.++|+|+++.||++++  +..+.++||+.+...............   .+       ...|
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                             123799999999999987  556789999987553111000000000   00       0001


Q ss_pred             --CC-Ccccc-cCCCcchhhHHHHHHHHHhCCCCCc
Q 040698          180 --LD-PEYLF-WTEKSDVYSFGVVLVELLTGKHPRS  211 (309)
Q Consensus       180 --~~-PE~~~-~~~~~DiwslG~ll~~~~~g~~p~~  211 (309)
                        .. |+... .....+.|++|.++|.+.+|..+|-
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence              11 12111 1112578999999999999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=2.2e-07  Score=77.73  Aligned_cols=135  Identities=18%  Similarity=0.173  Sum_probs=92.1

Q ss_pred             eecccCce-EEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEEEEcCCCCC
Q 040698           15 LLGEGGFG-FVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        15 ~lg~g~~g-~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      .+..|..+ .||+.... ++..+++|.....    ....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            34445544 68988754 4677888875543    2456778888888774 2236678888888889999999999988


Q ss_pred             HHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 040698           92 LFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL--------------------------------------------  127 (309)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------------------------------------------  127 (309)
                      +.+......       .....+..++...+..||+.                                            
T Consensus       107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            876553221       11223445555566666641                                            


Q ss_pred             -----------CCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698          128 -----------GSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       128 -----------~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                                 ....++|+|+++.||++++++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       011269999999999999887778999997643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=6.9e-07  Score=76.19  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=54.5

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC---ccceeeeeee-cCCccEEEEEcCC
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK---NVVKILGVCL-ETKVPLLVYEFVP   88 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~iv~e~~~   88 (309)
                      ++.++.|....+|..    |..+++|....   ......+..|..+|+.+.+.   .+.+++.+.. ..+..+++|+|++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456788998999987    56788887533   22356788999999988642   3556666663 4556789999999


Q ss_pred             CCCHHH
Q 040698           89 NGTLFQ   94 (309)
Q Consensus        89 ~~sL~~   94 (309)
                      |.++..
T Consensus        97 G~~l~~  102 (306)
T 3tdw_A           97 GQILGE  102 (306)
T ss_dssp             SEECHH
T ss_pred             CeECch
Confidence            988765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=1.4e-06  Score=75.90  Aligned_cols=81  Identities=7%  Similarity=0.056  Sum_probs=53.3

Q ss_pred             ceee-cccCceEEEEEEcC-------CCcEEEEEecccchh--hhhHHHHHHHHHHHhhcC-C--CccceeeeeeecC--
Q 040698           13 RHLL-GEGGFGFVYKGVLP-------DNTLVAVKKPKMVDK--ILINEVFQHKMRIISQIN-H--KNVVKILGVCLET--   77 (309)
Q Consensus        13 ~~~l-g~g~~g~v~~~~~~-------~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--   77 (309)
                      .+.| +.|....+|+....       ++..+++|.......  ......+..|..+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88999999988753       267888997654320  001134567777777663 2  3466777776654  


Q ss_pred             -CccEEEEEcCCCCCHH
Q 040698           78 -KVPLLVYEFVPNGTLF   93 (309)
Q Consensus        78 -~~~~iv~e~~~~~sL~   93 (309)
                       ...++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999986643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.24  E-value=5.9e-06  Score=73.04  Aligned_cols=76  Identities=13%  Similarity=0.164  Sum_probs=47.9

Q ss_pred             ceeecccCceEEEEEEcC-CCcEEEEEecccchh------hhhHHHHHHHHHHHhhcCC--C-ccceeeeeeecCCccEE
Q 040698           13 RHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDK------ILINEVFQHKMRIISQINH--K-NVVKILGVCLETKVPLL   82 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~i   82 (309)
                      .+.+|.|..+.||++... ++..+++|.......      ......+..|..+++.+..  | .+.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            568999999999999753 468899996543211      1112345667777776632  3 34455543  3455689


Q ss_pred             EEEcCCCC
Q 040698           83 VYEFVPNG   90 (309)
Q Consensus        83 v~e~~~~~   90 (309)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=1.6e-05  Score=68.46  Aligned_cols=28  Identities=29%  Similarity=0.365  Sum_probs=25.6

Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ++|||+++.||+++.++.+.++||+.+.
T Consensus       224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          224 LCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            9999999999999878899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.02  E-value=5e-05  Score=64.66  Aligned_cols=75  Identities=15%  Similarity=0.130  Sum_probs=58.1

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC---CCccceeeeeeecCCccEEEEEcCCC
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN---HKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      .+.|+.|....+|+... ++..+++|.....    ....+..|...|+.+.   ...+.+++.+....+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            46789999999999986 4678888876543    2456788888887773   35677888888777889999999998


Q ss_pred             CCH
Q 040698           90 GTL   92 (309)
Q Consensus        90 ~sL   92 (309)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.00  E-value=4.2e-05  Score=60.70  Aligned_cols=101  Identities=13%  Similarity=0.028  Sum_probs=66.5

Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccccc
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTAT  169 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~  169 (309)
                      -||.+.|+..+.  +++++++|.+++|.+.+|.-+-....  -...=+.|..|++..+|.|.+.+-. +      .    
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~~~-s------~----   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAPAA-D------D----   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECCC--------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccccc-c------c----
Confidence            378888876554  56899999999999999877632110  1233456789999999999887411 1      0    


Q ss_pred             ccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCC
Q 040698          170 TTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHP  209 (309)
Q Consensus       170 ~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p  209 (309)
                          .....+.|||...  .+.+.-|||||+++|..+-...|
T Consensus        98 ----~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1122356888764  45677899999999999986665

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=0.0004  Score=61.72  Aligned_cols=74  Identities=14%  Similarity=0.219  Sum_probs=44.2

Q ss_pred             ceeecccCceEEEEEEcCCCcEEEEEecccc-----hh-h--hhHHHHHHHHHHHh-hcCCCccceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMV-----DK-I--LINEVFQHKMRIIS-QINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~-----~~-~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .+.||.|..+.+|++.. ++..+++|...+.     .. .  .....+..|+..+. ......+.+++.+.  ....++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            56789999999999975 5678999932111     00 0  01223333332222 22234556666655  4667999


Q ss_pred             EEcC-CC
Q 040698           84 YEFV-PN   89 (309)
Q Consensus        84 ~e~~-~~   89 (309)
                      |||+ +|
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 87

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.71  E-value=0.00037  Score=58.50  Aligned_cols=80  Identities=16%  Similarity=0.117  Sum_probs=56.8

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC---CccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH---KNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~iv~   84 (309)
                      .+..-++.+|.|..+.||+....+|+.+++|....... .....+..|...|+.+..   -.+.+++++.    ..++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            45666788999999999999988999999997654322 223457888888887742   1344555432    347999


Q ss_pred             EcCCCCCH
Q 040698           85 EFVPNGTL   92 (309)
Q Consensus        85 e~~~~~sL   92 (309)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=0.00016  Score=61.14  Aligned_cols=74  Identities=12%  Similarity=0.103  Sum_probs=43.9

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEcC-
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEFV-   87 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~-   87 (309)
                      +.-.+.|+.|....+|++     ..+++|.........  .....|..+++.+....+ .+++...  .+.-++++||+ 
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            444788999999999998     558888765432111  112446666665532222 3555443  33457999999 


Q ss_pred             CCCCH
Q 040698           88 PNGTL   92 (309)
Q Consensus        88 ~~~sL   92 (309)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            76554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.00017  Score=63.07  Aligned_cols=146  Identities=15%  Similarity=0.170  Sum_probs=80.9

Q ss_pred             cccccceeecccCceEEEEEEcC--------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP--------DNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETK   78 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   78 (309)
                      ++.+ ++.|..|-...+|++...        ++..+++|......  .......+|..+++.+. +.-..++++++.+  
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE--  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence            3344 457888889999999864        25789999863321  12344567888887764 3223566666654  


Q ss_pred             ccEEEEEcCCCCCHHH--------------HHH-hhcc----cccc--CHHHHHHHHHHHHH------------------
Q 040698           79 VPLLVYEFVPNGTLFQ--------------HVR-YQSS----QVLK--TWKTCLRIAAETAS------------------  119 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~--------------~l~-~~~~----~~~~--~~~~~~~i~~~i~~------------------  119 (309)
                        .+|+||++|..|..              .+. -+..    ....  .+..+..+..++-.                  
T Consensus       126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  203 (379)
T 3feg_A          126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK  203 (379)
T ss_dssp             --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred             --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence              28999999865421              111 1111    0011  12344445443321                  


Q ss_pred             -HHHHH----HhcC-CCCeEecCCCCCcEEEcCC----CCeEEEeeecccc
Q 040698          120 -ALDYL----HSLG-SPPIIHGDVKSANILLDDN----YTAKVADFASSVL  160 (309)
Q Consensus       120 -~l~~l----h~~~-~~~~~h~dl~~~nilv~~~----~~v~l~d~g~~~~  160 (309)
                       .+..|    ...+ ...++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             12222    2211 1228999999999999876    7899999997743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00027  Score=60.67  Aligned_cols=30  Identities=27%  Similarity=0.352  Sum_probs=26.0

Q ss_pred             eEecCCCCCcEEEcCC----CCeEEEeeeccccc
Q 040698          132 IIHGDVKSANILLDDN----YTAKVADFASSVLI  161 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~----~~v~l~d~g~~~~~  161 (309)
                      ++|||+++.||+++.+    +.+.++||+.+...
T Consensus       185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            9999999999999874    67899999987543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.0011  Score=56.60  Aligned_cols=75  Identities=13%  Similarity=-0.014  Sum_probs=46.1

Q ss_pred             eeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCC--ccceeeee-----eecCCccEEEEEc
Q 040698           14 HLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK--NVVKILGV-----CLETKVPLLVYEF   86 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~iv~e~   86 (309)
                      ..++ |....+|++...+|+.+++|.......  ....+..|..++..+...  .+.+++..     ....+..+++|++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 778899988776777899998753311  133455666666665321  23444433     1223455789999


Q ss_pred             CCCCC
Q 040698           87 VPNGT   91 (309)
Q Consensus        87 ~~~~s   91 (309)
                      ++|..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00034  Score=62.36  Aligned_cols=73  Identities=12%  Similarity=0.155  Sum_probs=47.5

Q ss_pred             ceeecccCceEEEEEEcCC--------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~--------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv   83 (309)
                      .+.|+.|....+|++...+        +..+++|+......   .+.+..|..+++.+...+ ..++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            4578889999999998643        57899998743211   123346777777764323 3566666543    389


Q ss_pred             EEcCCCCCH
Q 040698           84 YEFVPNGTL   92 (309)
Q Consensus        84 ~e~~~~~sL   92 (309)
                      ++|++|.++
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.36  E-value=0.0039  Score=52.98  Aligned_cols=153  Identities=14%  Similarity=0.134  Sum_probs=77.0

Q ss_pred             HHHhhccccc-----ceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc--cceeeee--
Q 040698            3 LVKATKNYDK-----RHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN--VVKILGV--   73 (309)
Q Consensus         3 ~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~--   73 (309)
                      +.....+|.+     .+.|+.|....+|+....+| .+++|.......   .+.+..|..++..+....  +.+++..  
T Consensus        12 l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~   87 (322)
T 2ppq_A           12 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKD   87 (322)
T ss_dssp             HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             HHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence            3344445655     34566788889999886555 678887665211   123445566555553111  2333321  


Q ss_pred             ----eecCCccEEEEEcCCCCCHHH-----------HH---Hhh-cccc-c----cC---HHHHHH------------HH
Q 040698           74 ----CLETKVPLLVYEFVPNGTLFQ-----------HV---RYQ-SSQV-L----KT---WKTCLR------------IA  114 (309)
Q Consensus        74 ----~~~~~~~~iv~e~~~~~sL~~-----------~l---~~~-~~~~-~----~~---~~~~~~------------i~  114 (309)
                          ....+..+++++|++|..+..           .+   ... .... .    ..   +...+.            +.
T Consensus        88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~  167 (322)
T 2ppq_A           88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  167 (322)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence                122355689999999865311           11   000 0000 0    00   111000            00


Q ss_pred             HHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          115 AETASALDYLHSL----GSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       115 ~~i~~~l~~lh~~----~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ..+...+..+.+.    ....++|+|+++.||++++++.+.++||+.+.
T Consensus       168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            1123344444421    01128999999999999877666899999764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.29  E-value=0.00086  Score=60.17  Aligned_cols=74  Identities=15%  Similarity=0.068  Sum_probs=46.0

Q ss_pred             ceeecccCceEEEEEEcCC-CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCcc-ceeeeeeecCCccEEEEEcCCCC
Q 040698           13 RHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV-VKILGVCLETKVPLLVYEFVPNG   90 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~~~~   90 (309)
                      .+.|+.|....+|++...+ +..+++|..........  .-..|..+++.+...++ .++++++..    .+|++|++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence            4578889999999998754 57888887643211111  11467777777754444 466666632    3599999875


Q ss_pred             CH
Q 040698           91 TL   92 (309)
Q Consensus        91 sL   92 (309)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.17  E-value=0.00075  Score=58.77  Aligned_cols=74  Identities=11%  Similarity=0.015  Sum_probs=42.4

Q ss_pred             ceeecccCceEEEEEEcCC---------CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD---------NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLL   82 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~---------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~i   82 (309)
                      .+.++.|....+|++...+         +..+++|..........  ....|..+++.+...+ +.++++...    -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~--~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELY--NTISEFEVYKTMSKYKIAPQLLNTFN----GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTS--CHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcccee--cHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence            4577888889999988643         26888887654322111  1245666666664223 345665442    378


Q ss_pred             EEEcCCCCCH
Q 040698           83 VYEFVPNGTL   92 (309)
Q Consensus        83 v~e~~~~~sL   92 (309)
                      |++|++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999998543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.92  E-value=0.0093  Score=51.20  Aligned_cols=29  Identities=21%  Similarity=0.534  Sum_probs=26.1

Q ss_pred             eEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698          132 IIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       132 ~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++|+|+.+.||++++++.+.++||+.+..
T Consensus       208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          208 LCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            89999999999999888899999987654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.91  E-value=0.023  Score=50.01  Aligned_cols=29  Identities=31%  Similarity=0.470  Sum_probs=24.7

Q ss_pred             eEecCCCCCcEEE------cCCCCeEEEeeecccc
Q 040698          132 IIHGDVKSANILL------DDNYTAKVADFASSVL  160 (309)
Q Consensus       132 ~~h~dl~~~nilv------~~~~~v~l~d~g~~~~  160 (309)
                      ++|+|+.+.||++      +++..+.++||.++..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5899999999999      4567799999998754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.81  E-value=0.071  Score=47.17  Aligned_cols=74  Identities=7%  Similarity=-0.026  Sum_probs=46.3

Q ss_pred             ceeecccCceEEEEEEcCC--------CcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~--------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ++.|..|-...+|++...+        +..+++|.........  -...+|..+++.+. +.-..++++.+.    -+.|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~--idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF--YDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC--CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh--cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            4567788999999998653        5789999864432111  11245666666663 222345555332    3789


Q ss_pred             EEcCCCCCH
Q 040698           84 YEFVPNGTL   92 (309)
Q Consensus        84 ~e~~~~~sL   92 (309)
                      ++|++|..|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.70  E-value=0.46  Score=37.50  Aligned_cols=117  Identities=6%  Similarity=0.022  Sum_probs=77.1

Q ss_pred             CCCccceeeeeeecCCccEEEEEcCC-CCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 040698           63 NHKNVVKILGVCLETKVPLLVYEFVP-NGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSAN  141 (309)
Q Consensus        63 ~h~~iv~~~~~~~~~~~~~iv~e~~~-~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~n  141 (309)
                      .+|+++.. .+-++++.+.+.++.-+ +.++.. +.      ..+....++++.+++....+++.     -.|--++|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            58888866 56666676556555543 222221 11      22557788888898887644433     4889999999


Q ss_pred             EEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccccCCCcc-hhhHHHHHHHHHhCCCCCchhh
Q 040698          142 ILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSD-VYSFGVVLVELLTGKHPRSYVA  214 (309)
Q Consensus       142 ilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~D-iwslG~ll~~~~~g~~p~~~~~  214 (309)
                      ++++.++.+++.-.|+...                   ++|..  . ...| .-.+=+++..++.+...|...-
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~~--~-~ee~fL~qyKAliiall~~K~~Fe~l~  161 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPLP--V-SEAEFLTRYKALVICAFNEKQSFDALV  161 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCCC--C-CHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCCC--C-CHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence            9999999999998886432                   23321  1 1123 3357788999999988877553

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.36  E-value=0.9  Score=35.99  Aligned_cols=115  Identities=11%  Similarity=0.052  Sum_probs=76.6

Q ss_pred             CCCccceeeeeeecCCccEEEEEcCCCC-CHHHHHHhhccccccCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 040698           63 NHKNVVKILGVCLETKVPLLVYEFVPNG-TLFQHVRYQSSQVLKTWKTCLRIAAETASALD-YLHSLGSPPIIHGDVKSA  140 (309)
Q Consensus        63 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~~~h~dl~~~  140 (309)
                      .||++  ...+-.+++.+.+.++.-+++ ++. .+.      ..+....++++.+++.... +++.     -.|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            68888  566667778777777765433 333 232      1255777888888877555 3333     588999999


Q ss_pred             cEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccccCCCcch-hhHHHHHHHHHhCCCCCchh
Q 040698          141 NILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFWTEKSDV-YSFGVVLVELLTGKHPRSYV  213 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~Di-wslG~ll~~~~~g~~p~~~~  213 (309)
                      |++++.++.+++.-.|+-..                   ++|...   ...|. -++=+++..++.+...|...
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~---~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW---DDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCSC---CHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCCC---CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999999998886432                   233221   11233 34778888899888776543

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=84.48  E-value=3.9  Score=34.52  Aligned_cols=141  Identities=16%  Similarity=0.128  Sum_probs=77.1

Q ss_pred             ccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeee-------------e
Q 040698            9 NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVC-------------L   75 (309)
Q Consensus         9 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-------------~   75 (309)
                      +++.++....|..|..+...  ++..+++|...    ....+.+..++...-.+..|+..-+....             .
T Consensus        70 ~v~~I~~s~~Gstgvff~~t--d~~~~VVK~s~----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~  143 (342)
T 1cja_A           70 QFKGIERSEKGTEGLFFVET--ESGVFIVKRST----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAID  143 (342)
T ss_dssp             GEEEEEECCSTTSCEEEEEE--SSCEEEEECCT----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHC
T ss_pred             CeeEEEeccCCCCCeEEEEe--CCCEEEEeCcH----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhh
Confidence            45666777778776666555  57889999542    33466677777666667777743333110             0


Q ss_pred             ---------cCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec----CCCCCcE
Q 040698           76 ---------ETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHG----DVKSANI  142 (309)
Q Consensus        76 ---------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~----dl~~~ni  142 (309)
                               ..+..+++|+|.+|..|...-...- ......+....+  .-+-+++.+..++-  -...    .=.+.||
T Consensus       144 ~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~-~~~f~~~~~k~L--G~Ii~FDi~InN~D--R~Pl~W~n~GN~~NI  218 (342)
T 1cja_A          144 KSFRVITTLANQANILLMELVRGITLNKLTTTSA-PEVLTKSTMQQL--GSLMALDVIVNNSD--RLPIAWTNEGNLDNI  218 (342)
T ss_dssp             SSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSH-HHHSCHHHHHHH--HHHHHHHHHHTCCS--SSCSSSCSCCCGGGE
T ss_pred             hhhHHHHHhhcccceehhhhcCCCccccchhhhh-hhhcCHHHHHhh--chhheehhhhcCCc--cCcccccCCCChhhe
Confidence                     1224569999998766543211000 000121221111  11334555555531  1211    2378899


Q ss_pred             EEcCCCC-eEEEeeecccc
Q 040698          143 LLDDNYT-AKVADFASSVL  160 (309)
Q Consensus       143 lv~~~~~-v~l~d~g~~~~  160 (309)
                      ++++++. +.++|-+.++.
T Consensus       219 L~~~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          219 MLSERGATVVPIDSKIIPL  237 (342)
T ss_dssp             EEESBTTCEEECSCCCCCC
T ss_pred             EEeCCCCeEEEEcCCcccc
Confidence            9976544 88888887754

>3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A*

Probab=83.11  E-value=15  Score=33.08  Aligned_cols=135  Identities=14%  Similarity=0.023  Sum_probs=91.6

Q ss_pred             ecccCceEEEEEEcCCCcEEEEEecccc---hhhhhHHHHHHHHHHHhhcCCCccceeeeeee-----------------
Q 040698           16 LGEGGFGFVYKGVLPDNTLVAVKKPKMV---DKILINEVFQHKMRIISQINHKNVVKILGVCL-----------------   75 (309)
Q Consensus        16 lg~g~~g~v~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----------------   75 (309)
                      +.-|--|.|..+..--+-.++.|+++-.   .+...++..+..+.+.++  |..+=++-+..+                 
T Consensus       314 ~APGikGmVM~VFTLPSf~~VFKvIKD~F~p~K~~tr~~Vk~KY~LVK~--hDRVGRMADT~Efsn~~fp~~Rfs~eLL~  391 (578)
T 3eps_A          314 EAPGIRGMVMLVFTLPGFDRVFKVIKDKFAPQKEMSAAHVRACYQLVKE--HDRVGRMADTQEFENFVLEKRHISPALME  391 (578)
T ss_dssp             ECSSCCCSSEEEEECTTCSEEEEEECSSCCTTCCCCHHHHHHHHHHHHT--SCCTTTBCCCEEEEEEEEEGGGBCHHHHH
T ss_pred             ECCCCCceEEEEEcCCCCceEEEEEccCCCCccccCHHHHHHHHHHHHh--hhhhhhhhhhhhhhcccCchhhCCHHHHH
Confidence            6678889999988545666777876443   455556777777776664  444433333211                 


Q ss_pred             ------------cCCccE---EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040698           76 ------------ETKVPL---LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSA  140 (309)
Q Consensus        76 ------------~~~~~~---iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~  140 (309)
                                  +++.+.   +.+|.- ...|--++.+.      +..++...+.+.-.|++.|-..+   |+-||+-..
T Consensus       392 EL~~~~ps~le~~gd~liIkHlYiERR-MtPLNLYL~~a------~~~~~~~av~eYG~AIKqLAaAN---IFPGDML~K  461 (578)
T 3eps_A          392 LLLQEAAEKITDLGEQIVIRHLYIERR-MVPLNIWLEQV------EGQQLRDAIEEYGNAIRQLAAAN---IFPGDMLFK  461 (578)
T ss_dssp             HHHHHSGGGEEEETTEEEEEEEEEEEC-CEEHHHHHHHC------CTHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred             HHHHhCCccEEEcCCeeEeeeeeeecc-ccchhHHHhhC------CHHHHHHHHHHHHHHHHHHHHhc---CCCcccccc
Confidence                        122221   112221 23555555433      33567778889999999999999   999999999


Q ss_pred             cEEEcCCCCeEEEeeecccccc
Q 040698          141 NILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      |+=|+..|+|...||.-.+.++
T Consensus       462 NFGVTRhgRVVFYDYDEI~ylT  483 (578)
T 3eps_A          462 NFGVTRHGRVVFYDYDEICYMT  483 (578)
T ss_dssp             GEEECTTCCEEECCGGGCEEST
T ss_pred             cCCccccceEEEecccceeeec
Confidence            9999999999999999776653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	309
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-46
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 1e-66
 Identities = 66/284 (23%), Positives = 128/284 (45%), Gaps = 26/284 (9%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
                  +G G FG VYKG    +  V +          +   F++++ ++ +  H N++
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNIL 67

Query: 69  KILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
             +G     ++  +V ++    +L+ H+    ++        + IA +TA  +DYLH+  
Sbjct: 68  LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA-- 122

Query: 129 SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF-- 186
              IIH D+KS NI L ++ T K+ DF  + + S    +    +   ++ W+ PE +   
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 187 ----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
               ++ +SDVY+FG+VL EL+TG+ P  Y  + + +    +      +    L   L  
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFM------VGRGYLSPDL-- 231

Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
               +      + + +L ++CL+    ERP   Q+   ++ L R
Sbjct: 232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 8e-60
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 43/290 (14%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           K       +G+G FG V  G       VAVK    +      + F  +  +++Q+ H N+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNL 62

Query: 68  VKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           V++LGV +E K  L +V E++  G+L  ++R +   VL      L+ + +   A++YL  
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEG 121

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                 +H D+ + N+L+ ++  AKV+DF  +   SS   T         V W  PE L 
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALR 173

Query: 187 W---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
               + KSDV+SFG++L E+ +                        P     L+ ++  +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV--------------------PYPRIPLKDVVP-R 212

Query: 244 VADENEMEEIEI----VAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
           V    +M+  +     V ++   C       RP+  Q+ EQL+ ++  HE
Sbjct: 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT-HE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-59
 Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 32/280 (11%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +       LG G FG V+ G    +T VAVK   +    +  + F  +  ++ Q+ H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V++  V  +  +  ++ E++ NG+L   ++  S   L T    L +AA+ A  + ++   
Sbjct: 71  VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEER 128

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
                IH D+++ANIL+ D  + K+ADF  + LI   ++          + W  PE +  
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINY 184

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ- 243
             +T KSDV+SFG++L E++T                     +P       ++ +     
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGR----------------IPYPGMTNPEVIQNLERGYR 228

Query: 244 -VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLD 282
            V  +N  EE   + +L   C +    +RPT   +   L+
Sbjct: 229 MVRPDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-58
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 34/284 (11%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
                   +G G FG V+ G   +   VA+K   + +  +  E F  +  ++ +++H  +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V++ GVCLE     LV+EF+ +G L  +   ++ + L   +T L +  +    + YL   
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               +IH D+ + N L+ +N   KV+DF  +  +     T++T      V W  PE    
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSF 176

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
             ++ KSDV+SFGV++ E+ +                        P EN S  +++    
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKI--------------------PYENRSNSEVVEDIS 216

Query: 245 ADENEMEEIEI---VAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                 +       V ++ + C +    +RP   ++  QL  + 
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-58
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 29/276 (10%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
           +++D    LGEG +G V   V       VAVK   M   +   E  + ++ I   +NH+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           VVK  G   E  +  L  E+   G LF  +      +        R   +  + + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL- 185
           +G   I H D+K  N+LLD+    K++DF  + +   +++     K   T+ ++ PE L 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
              F  E  DV+S G+VL  +L G+                   +  P ++         
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE-----------------LPWDQPSDSCQEYSDWKE 221

Query: 243 QVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           +    N  ++I+     L  K L  + + R T+  +
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 8e-58
 Identities = 65/302 (21%), Positives = 123/302 (40%), Gaps = 30/302 (9%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +    +  +G+G FG V++G       VAVK     ++   +   + ++     + H+N+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENI 59

Query: 68  VKILGVCLE----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           +  +    +         LV ++  +G+LF ++   +     T +  +++A  TAS L +
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAH 115

Query: 124 LHS-----LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT--ATTTKEIET 176
           LH       G P I H D+KS NIL+  N T  +AD   +V   S   T        + T
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 177 VGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
             ++ PE L            +++D+Y+ G+V  E+                   +VP  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 228 PYP--IENNSLRQILNFQVADE-NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
           P    +      Q L   + +     E + ++AK+  +C   +G  R T  ++ + L  L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

Query: 285 RR 286
            +
Sbjct: 296 SQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-57
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 28/280 (10%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           ++      LG+G FG V+ G     T VA+K   +    +  E F  + +++ ++ H+ +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V++  V  E  +  +V E++  G+L   ++ ++ +        + +AA+ AS + Y+  +
Sbjct: 75  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERM 132

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
                +H D+++ANIL+ +N   KVADF  + LI  ++ TA    +   + W  PE    
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALY 188

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
             +T KSDV+SFG++L EL T                     +P  +    L Q+     
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGR----------------VPYPGMVNREVLDQVERGYR 232

Query: 245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                 E  E +  L  +C R    ERPT   +   L+  
Sbjct: 233 MPCPP-ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-56
 Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 38/298 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +++K   LG G  G V+K    P   ++A K   +  K  I      +++++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V   G         +  E +  G+L Q ++          +   +++      L YL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGLTYLRE- 122

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               I+H DVK +NIL++     K+ DF  S  +            + T  ++ PE L  
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177

Query: 187 --WTEKSDVYSFGVVLVELLTGKHP-----RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
             ++ +SD++S G+ LVE+  G++P        + L              P      R +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 240 LNFQVADENEMEEIEIVAK--------------------LASKCLRTSGTERPTMRQV 277
            ++ +     M   E++                        +KCL  +  ER  ++Q+
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-55
 Identities = 61/279 (21%), Positives = 116/279 (41%), Gaps = 32/279 (11%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           K+      LG G FG V  G       VA+K   + +  +  + F  + +++  ++H+ +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V++ GVC + +   ++ E++ NG L  ++R    +     +  L +  +   A++YL   
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE-- 117

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
            S   +H D+ + N L++D    KV+DF  S  +   + T ++      V W  PE L  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY 175

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS--LRQILNF 242
             ++ KSD+++FGV++ E+ +                      PY    NS     I   
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKM------------------PYERFTNSETAEHIAQG 217

Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL 281
                  +   + V  +   C      ERPT + +   +
Sbjct: 218 LRLYRPHLASEK-VYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-55
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 31/292 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNT-----LVAVKKPKMVDKILINEVFQHKMRIISQIN 63
              ++ ++G G FG VYKG+L  ++      VA+K  K          F  +  I+ Q +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N++++ GV  + K  +++ E++ NG L + +R +  +   +    + +    A+ + Y
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKY 125

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWLDP 182
           L +      +H D+ + NIL++ N   KV+DF  S VL    + T TT+     + W  P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 183 EYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           E +    +T  SDV+SFG+V+ E++T                       + + N+ + + 
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------PYWELSNHEVMKA 225

Query: 240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENF 291
           +N        M+    + +L  +C +     RP    +   LD L R  ++ 
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (456), Expect = 2e-55
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 54/308 (17%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           N +    +GEG FG V++   P        T+VAVK  K      +   FQ +  ++++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK----------------- 105
           ++ N+VK+LGVC   K   L++E++  G L + +R  S   +                  
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 106 ----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
               +    L IA + A+ + YL        +H D+ + N L+ +N   K+ADF  S  I
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 162 SSHDQTATTTKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASN 218
            S D       +   + W+ PE +F+   T +SDV+++GVVL E+ +             
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--------- 241

Query: 219 EMTRMVPYFPYPIENNS--LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQ 276
                    PY    +   +  + +  +    E   +E +  L   C      +RP+   
Sbjct: 242 ---------PYYGMAHEEVIYYVRDGNILACPENCPLE-LYNLMRLCWSKLPADRPSFCS 291

Query: 277 VSEQLDSL 284
           +   L  +
Sbjct: 292 IHRILQRM 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (453), Expect = 5e-55
 Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 47/308 (15%)

Query: 1   SELVKATKNYDKR---------HLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKIL 47
            +  +A + + K           ++G G FG V  G L         VA+K  K      
Sbjct: 10  EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69

Query: 48  INEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTW 107
               F  +  I+ Q +H NV+ + GV  ++   +++ EF+ NG+L   +R    Q   T 
Sbjct: 70  QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--FTV 127

Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
              + +    A+ + YL  +     +H D+ + NIL++ N   KV+DF  S  +      
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 168 ATTTKEIE---TVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT 221
            T T  +     + W  PE + +   T  SDV+S+G+V+ E+++                
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------------ 232

Query: 222 RMVPYFPYPIENNSLRQILNFQVAD---ENEMEEIEIVAKLASKCLRTSGTERPTMRQVS 278
                   P  + + + ++N    D      M+    + +L   C +     RP   Q+ 
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 279 EQLDSLRR 286
             LD + R
Sbjct: 285 NTLDKMIR 292

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (452), Expect = 5e-55
 Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 30/284 (10%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN 66
            +   +H LG G +G VY+GV    +  VAVK  K  D + + E F  +  ++ +I H N
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEE-FLKEAAVMKEIKHPN 74

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +V++LGVC       ++ EF+  G L  ++R  + Q + +    L +A + +SA++YL  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEK 133

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
                 IH D+ + N L+ +N+  KVADF  S L++  D           + W  PE L 
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLA 189

Query: 187 W---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS-LRQILNF 242
           +   + KSDV++FGV+L E+ T                      PYP  + S + ++L  
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLSQVYELLEK 231

Query: 243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
               E      E V +L   C + + ++RP+  ++ +  +++ +
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-54
 Identities = 60/301 (19%), Positives = 109/301 (36%), Gaps = 44/301 (14%)

Query: 9   NYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
                  LG G FG V +              VAVK  K    +   E    +++++S +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 63  -NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK---------------T 106
            NH N+V +LG C      L++ E+   G L   +R +    +                 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            +  L  + + A  + +L S      IH D+ + NILL      K+ DF  +  I +   
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
                     V W+ PE +F   +T +SDV+S+G+ L EL +                  
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--------------- 245

Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
              +P    ++   +++       +       +  +   C      +RPT +Q+ + ++ 
Sbjct: 246 -SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 284 L 284
            
Sbjct: 305 Q 305

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-54
 Identities = 67/276 (24%), Positives = 121/276 (43%), Gaps = 35/276 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVK--KPKMVDKILINEVFQHKMRIISQINH 64
           ++++    LG+G FG VY         ++A+K      ++K  +    + ++ I S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            N++++ G   +     L+ E+ P GT+++ ++  S       +       E A+AL Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTATYITELANALSYC 122

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     +IH D+K  N+LL      K+ADF      S H  ++  T    T+ +L PE 
Sbjct: 123 HSKR---VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 175

Query: 185 LFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
           +      EK D++S GV+  E L GK P                 F       + ++I  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-----------------FEANTYQETYKRISR 218

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            +    + +   E    L S+ L+ + ++RP +R+V
Sbjct: 219 VEFTFPDFVT--EGARDLISRLLKHNPSQRPMLREV 252

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-54
 Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 15  LLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           ++G G FG VY G L DN       AVK    +  I     F  +  I+   +H NV+ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 71  LGVCLETK-VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           LG+CL ++  PL+V  ++ +G L   +R ++     T K  +    + A  + +L S   
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLI--SSHDQTATTTKEIETVGWLDPEYLF- 186
              +H D+ + N +LD+ +T KVADF  +  +     D     T     V W+  E L  
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 187 --WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV 244
             +T KSDV+SFGV+L EL+T   P                    P  + +   I  + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP--------------------PYPDVNTFDITVYLL 248

Query: 245 ADENEMEEIEI---VAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
                ++       + ++  KC       RP+  ++  ++ ++ 
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 8e-54
 Identities = 63/307 (20%), Positives = 124/307 (40%), Gaps = 34/307 (11%)

Query: 2   ELVKATKNYDKRHLLGEGGFGFVYKGVLPDN-----TLVAVKKPKMVDKILINEVFQHKM 56
            ++K T  + K  +LG G FG VYKG+           VA+K+ +       N+    + 
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 57  RIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAE 116
            +++ +++ +V ++LG+CL + V  L+ + +P G L  +   +  +     +  L    +
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQ 119

Query: 117 TASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIET 176
            A  ++YL       ++H D+ + N+L+      K+ DF  + L+ + ++          
Sbjct: 120 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 177 VGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN 233
           + W+  E +    +T +SDV+S+GV + EL+T                      PY    
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIP 218

Query: 234 NS-LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFW 292
            S +  IL               V  +  KC       RP  R++  +   + R  + + 
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278

Query: 293 AQKNSEE 299
             +  E 
Sbjct: 279 VIQGDER 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (442), Expect = 3e-53
 Identities = 59/280 (21%), Positives = 99/280 (35%), Gaps = 38/280 (13%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQIN 63
            K +     +G G FG VY    + ++ +VA+KK     K    +      ++R + ++ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H N ++  G  L      LV E+           ++             +       L Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 124 LHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           LHS     +IH DVK+ NILL +    K+ DF S+ +++           + T  W+ PE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181

Query: 184 YLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR 237
            +       +  K DV+S G+  +EL   K P                        ++L 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----------------LFNMNAMSALY 224

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            I   +          E        CL+    +RPT   +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-53
 Identities = 50/279 (17%), Positives = 113/279 (40%), Gaps = 30/279 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILIN-EVFQHKMRIISQINHKN 66
           +Y+  + +G G +G   K     D  ++  K+           ++   ++ ++ ++ H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 67  VVKILGVCLET--KVPLLVYEFVPNGTLFQHV-RYQSSQVLKTWKTCLRIAAETASALDY 123
           +V+     ++       +V E+   G L   + +    +     +  LR+  +   AL  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 124 LHSLG--SPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
            H        ++H D+K AN+ LD     K+ DF  + +++     A     + T  ++ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF--VGTPYYMS 182

Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           PE +    + EKSD++S G +L EL     P  + A +  E+   +    +         
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIREGKFR-------- 232

Query: 239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
            + ++ +DE        + ++ ++ L      RP++ ++
Sbjct: 233 RIPYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-53
 Identities = 56/276 (20%), Positives = 114/276 (41%), Gaps = 32/276 (11%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
            K Y +   +G+G  G VY  + +     VA+++  +  +    E+  +++ ++ +  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNP 77

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V  L   L      +V E++  G+L   V                +  E   AL++LH
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH 133

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           S     +IH D+KS NILL  + + K+ DF     I+      +T   + T  W+ PE +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVV 188

Query: 186 FW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
                  K D++S G++ +E++ G+ P                 +       +L  I   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATN 231

Query: 243 QVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
              +    E++  + +   ++CL     +R + +++
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 9e-53
 Identities = 63/305 (20%), Positives = 119/305 (39%), Gaps = 49/305 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPD------NTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           N +   +LG G FG V             +  VAVK  K        E    ++++++Q+
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 63  -NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK---------------- 105
            +H+N+V +LG C  +    L++E+   G L  ++R +  +  +                
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 106 ----TWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI 161
               T++  L  A + A  +++L        +H D+ + N+L+      K+ DF  +  I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASN 218
            S             V W+ PE LF   +T KSDV+S+G++L E+ +             
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--------- 265

Query: 219 EMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS 278
                 PY   P++ N   +++      +      E +  +   C      +RP+   ++
Sbjct: 266 ------PYPGIPVDAN-FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 279 EQLDS 283
             L  
Sbjct: 319 SFLGC 323

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-52
 Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 35/284 (12%)

Query: 4   VKATKNYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           +     ++    LG+G FG VYK    + + L A K      +  + + +  ++ I++  
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASC 66

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           +H N+VK+L          ++ EF   G +   +      +  T      +  +T  AL+
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL--TESQIQVVCKQTLDALN 124

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           YLH      IIH D+K+ NIL   +   K+ADF  S   +   Q   +   I T  W+ P
Sbjct: 125 YLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAP 179

Query: 183 EYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN 234
           E +         +  K+DV+S G+ L+E+   + P                         
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----------------HHELNPMR 222

Query: 235 SLRQILNFQVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            L +I   +     +        K    KCL  +   R T  Q+
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 4e-52
 Identities = 59/278 (21%), Positives = 113/278 (40%), Gaps = 34/278 (12%)

Query: 16  LGEGGFGFVYKGVL---PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           LG G FG V +GV         VA+K  K   +    E    + +I+ Q+++  +V+++G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 73  VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPI 132
           VC + +  +LV E    G L + +  +  ++         +  + +  + YL        
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN---F 130

Query: 133 IHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIE-TVGWLDPEYLF---WT 188
           +H D+ + N+LL + + AK++DF  S  + + D   T     +  + W  PE +    ++
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190

Query: 189 EKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS--LRQILNFQVAD 246
            +SDV+S+GV + E L+                      PY        +  I   +  +
Sbjct: 191 SRSDVWSYGVTMWEALSYGQK------------------PYKKMKGPEVMAFIEQGKRME 232

Query: 247 ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
               E    +  L S C      +RP    V +++ + 
Sbjct: 233 CPP-ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-51
 Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 35/272 (12%)

Query: 16  LGEGGFGFVYKGVLPD-NTLVAVKK--PKMVDKILINEVFQHKMRIISQINHKNVVKILG 72
           +G G F  VYKG+  +    VA  +   + + K      F+ +  ++  + H N+V+   
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFYD 75

Query: 73  VCLET----KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLG 128
               T    K  +LV E + +GTL  +++          K       +    L +LH+  
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM---KIKVLRSWCRQILKGLQFLHTRT 132

Query: 129 SPPIIHGDVKSANILLDD-NYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
            PPIIH D+K  NI +     + K+ D   + L  +          I T  ++ PE    
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 187

Query: 187 -WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA 245
            + E  DVY+FG+ ++E+ T ++                PY          R++ +    
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEY----------------PYSECQNAAQIYRRVTSGVKP 231

Query: 246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
              +   I  V ++   C+R +  ER +++ +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-51
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 43/294 (14%)

Query: 16  LGEGGFGFVYKGVLPD---NTLVAVK--KPKMVDKILINEVFQHKMRIISQINHKNVVKI 70
           LG G FG V KG          VAVK  K +  D  L +E    +  ++ Q+++  +V++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-LLAEANVMQQLDNPYIVRM 73

Query: 71  LGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSP 130
           +G+C E +  +LV E    G L ++++          K  + +  + +  + YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEESN-- 127

Query: 131 PIIHGDVKSANILLDDNYTAKVADFASSVLISS-HDQTATTTKEIETVGWLDPEYLF--- 186
             +H D+ + N+LL   + AK++DF  S  + +  +     T     V W  PE +    
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 187 WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA 245
           ++ KSDV+SFGV++ E  + G+ P  Y  +  +E+T M+            R        
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAML--------EKGERMGCPAGCP 236

Query: 246 DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHENFWAQKNSEE 299
            E        +  L + C       RP    V  +L        N++    +E 
Sbjct: 237 RE--------MYDLMNLCWTYDVENRPGFAAVELRL-------RNYYYDVVNEG 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-51
 Identities = 66/290 (22%), Positives = 110/290 (37%), Gaps = 36/290 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNT----LVAVK--KPKMVDKILINEVFQHKMRIISQ 61
           K+      LG+G FG V +G     +     VAVK  KP ++ +    + F  ++  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           ++H+N++++ GV L   +  +V E  P G+L   +R           T  R A + A  +
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHF--LLGTLSRYAVQVAEGM 124

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWL 180
            YL S      IH D+ + N+LL      K+ DF     L  + D             W 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 181 DPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS-- 235
            PE L    ++  SD + FGV L E+ T                      P+   N S  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE------------------PWIGLNGSQI 223

Query: 236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
           L +I           +  + +  +  +C      +RPT   + + L   +
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-50
 Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 43/304 (14%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVLPDNTL---VAVKKPKMVDKILINEVFQHKMRIISQI-N 63
            +   + ++GEG FG V K  +  + L    A+K+ K       +  F  ++ ++ ++ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------TWKTC 110
           H N++ +LG C       L  E+ P+G L   +R                     + +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 111 LRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT 170
           L  AA+ A  +DYL        IH D+ + NIL+ +NY AK+ADF  S     + +    
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 171 TKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF 227
                 V W+  E L    +T  SDV+S+GV+L E+++      Y  +   E+   +P  
Sbjct: 187 RL---PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-PYCGMTCAELYEKLPQG 242

Query: 228 PYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL 287
                              E  +   + V  L  +C R    ERP+  Q+   L+ +   
Sbjct: 243 YRL----------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

Query: 288 HENF 291
            + +
Sbjct: 287 RKTY 290

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-49
 Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 31/287 (10%)

Query: 5   KATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQ 61
           K  +++    +LGEG F  V     L  +   A+K  + + + K         +  ++S+
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           ++H   VK+     + +       +  NG L +++R   S             AE  SAL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLD 181
           +YLH      IIH D+K  NILL+++   ++ DF ++ ++S   + A     + T  ++ 
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 182 PEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ 238
           PE L      + SD+++ G ++ +L+ G  P                 F    E    ++
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP-----------------FRAGNEYLIFQK 221

Query: 239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR 285
           I+  +     +         L  K L    T+R    ++        
Sbjct: 222 IIKLEYDFPEKF--FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-49
 Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 31/285 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINH 64
             +    +GEG FG V++G+          VA+K  K      + E F  +   + Q +H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
            ++VK++GV  E  V  ++ E    G L   ++ +   +     + +  A + ++AL YL
Sbjct: 68  PHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYL 124

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
            S      +H D+ + N+L+  N   K+ DF  S  +        +  ++  + W+ PE 
Sbjct: 125 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPES 180

Query: 185 LFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
           + +   T  SDV+ FGV + E+L            ++ + R+      P+  N       
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN------- 233

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
                         +  L +KC     + RP   ++  QL ++  
Sbjct: 234 --CPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-49
 Identities = 70/313 (22%), Positives = 136/313 (43%), Gaps = 43/313 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ 61
           +       LG+G FG VY+GV          T VA+K       +     F ++  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 62  INHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------TWKTCLRIA 114
            N  +VV++LGV  + +  L++ E +  G L  ++R     +         +    +++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 115 AETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEI 174
            E A  + YL++      +H D+ + N ++ +++T K+ DF  +  I   D      K +
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI 231
             V W+ PE L    +T  SDV+SFGVVL E+ T                      PY  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------------------PYQG 238

Query: 232 ENNS--LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHE 289
            +N   LR ++   + D+ +    +++ +L   C + +   RP+  ++   + S++   E
Sbjct: 239 LSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI---ISSIKEEME 294

Query: 290 NFWAQKNSEETEQ 302
             + + +   +E+
Sbjct: 295 PGFREVSFYYSEE 307

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 3e-48
 Identities = 55/277 (19%), Positives = 102/277 (36%), Gaps = 34/277 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +YD    LG G FG V++          A K           E  + +++ +S + H  +
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-PHESDKETVRKEIQTMSVLRHPTL 85

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           V +     +    +++YEF+  G LF+ V  + +++  +    +    +    L ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHEN 143

Query: 128 GSPPIIHGDVKSANILL--DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
                +H D+K  NI+     +   K+ DF  +  +        TT    T  +  PE  
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197

Query: 186 FW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
                   +D++S GV+   LL+G  P                 F    ++ +LR + + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP-----------------FGGENDDETLRNVKSC 240

Query: 243 QVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
               D++    I    K    K L      R T+ Q 
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 9e-48
 Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 45/301 (14%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLP--------DNTLVAVKKPKMVDKILINEVFQHKMRIIS 60
                  LGEG FG V                T VAVK  K             +M ++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 61  QI-NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-------------T 106
            I  HKN++ +LG C +     ++ E+   G L ++++ +    L+             +
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 107 WKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ 166
            K  +  A + A  ++YL S      IH D+ + N+L+ ++   K+ADF  +  I   D 
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 167 TATTTKEIETVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM 223
              TT     V W+ PE LF    T +SDV+SFGV+L E+ T                  
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------------- 236

Query: 224 VPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS 283
            PY   P+E   L ++L      +        +  +   C     ++RPT +Q+ E LD 
Sbjct: 237 -PYPGVPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 284 L 284
           +
Sbjct: 294 I 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-47
 Identities = 51/274 (18%), Positives = 104/274 (37%), Gaps = 29/274 (10%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
            Y     LG G FG V++ V          K  K+  K     + + ++ I++   H+N+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNI 63

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           + +       +  ++++EF+    +F+ +   + ++    +  +    +   AL +LHS 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NEREIVSYVHQVCEALQFLHSH 121

Query: 128 GSPPIIHGDVKSANILLD--DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
               I H D++  NI+     + T K+ +F  +  +   D         E       ++ 
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 186 FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQVA 245
             +  +D++S G ++  LL+G +P                 F        +  I+N +  
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP-----------------FLAETNQQIIENIMNAEYT 221

Query: 246 -DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            DE   +EI I A     + L      R T  + 
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 7e-46
 Identities = 63/290 (21%), Positives = 115/290 (39%), Gaps = 47/290 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILIN--------EVFQHKMRII 59
           NY+ + +LG G    V + +  P     AVK   +      +        E    ++ I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 60  SQIN-HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
            +++ H N++++           LV++ +  G LF ++     +V  + K   +I     
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVG 178
             +  LH L    I+H D+K  NILLDD+   K+ DF  S  +   ++     +   T  
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174

Query: 179 WLDPEYL---------FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPY 229
           +L PE +          + ++ D++S GV++  LL G  P                 F +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----------------FWH 217

Query: 230 PIENNSLRQIL--NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
             +   LR I+  N+Q       +  + V  L S+ L     +R T  + 
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 8e-46
 Identities = 65/308 (21%), Positives = 116/308 (37%), Gaps = 51/308 (16%)

Query: 9   NYDKRHLLGEGGFGFVYKGV------LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
                  LG G FG V +              VAVK  K       +     +++I+  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 63  NH-KNVVKILGVCLETKVPL-LVYEFVPNGTLFQHVRYQSSQVLK-------------TW 107
            H  NVV +LG C +   PL ++ EF   G L  ++R + ++ +              T 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 108 KTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT 167
           +  +  + + A  +++L S      IH D+ + NILL +    K+ DF  +  I      
Sbjct: 134 EHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV 224
                    + W+ PE +F   +T +SDV+SFGV+L E+ +                   
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--------------- 235

Query: 225 PYFPYPIENNSLRQILNFQVADENEMEEIEIV----AKLASKCLRTSGTERPTMRQVSEQ 280
                P     + +    ++ +   M   +       +    C     ++RPT  ++ E 
Sbjct: 236 -----PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

Query: 281 LDSLRRLH 288
           L +L + +
Sbjct: 291 LGNLLQAN 298

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 9e-46
 Identities = 50/277 (18%), Positives = 104/277 (37%), Gaps = 34/277 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
            YD    LG G FG V++ V      +   K        L     ++++ I++Q++H  +
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKL 88

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           + +     +    +L+ EF+  G LF  +  +  ++  +    +    +    L ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM--SEAEVINYMRQACEGLKHMHEH 146

Query: 128 GSPPIIHGDVKSANILLD--DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
               I+H D+K  NI+ +     + K+ DF  +  ++  +          T  +  PE +
Sbjct: 147 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200

Query: 186 FW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
                   +D+++ GV+   LL+G  P                 F    +  +L+ +   
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP-----------------FAGEDDLETLQNVKRC 243

Query: 243 QVA-DENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
               DE+    +   AK      L+    +R T+   
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-45
 Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 32/312 (10%)

Query: 3   LVKATKNYDKRHLLGEGGFGFVYKG--VLPDNTLVAVKKPKM------VDKILINEVFQH 54
           L +A + Y+    +GEG +G V+K   +      VA+K+ ++      +    I EV   
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--A 59

Query: 55  KMRIISQINHKNVVKILGVCLETKVPLLVYEFVPNGTLFQ---HVRYQSSQVLKTWKTCL 111
            +R +    H NVV++  VC  ++        +    + Q       +  +     +T  
Sbjct: 60  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 112 RIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTT 171
            +  +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + S      +  
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 175

Query: 172 KEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVP 225
             + T+ +  PE L    +    D++S G +  E+   K      S V      +  +  
Sbjct: 176 --VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 226 YFPYPIENNSLRQILNFQVADENEMEEI-----EIVAKLASKCLRTSGTERPTMRQVSEQ 280
                   +       F       +E+      E+   L  KCL  +  +R +       
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

Query: 281 --LDSLRRLHEN 290
                L R  EN
Sbjct: 294 PYFQDLERCKEN 305

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (376), Expect = 7e-44
 Identities = 72/295 (24%), Positives = 112/295 (37%), Gaps = 38/295 (12%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQIN 63
           +  Y+   +LG GG   V+    L  +  VAVK  +  +         F+ + +  + +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 64  HKNVVKILGVCLET----KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           H  +V +            +P +V E+V   TL   V  +      T K  + + A+   
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF-ASSVLISSHDQTATTTKEIETVG 178
           AL++ H  G   IIH DVK ANI++      KV DF  +  +  S +    T   I T  
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 179 WLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS 235
           +L PE         +SDVYS G VL E+LTG+ P                 F      + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----------------FTGDSPVSV 222

Query: 236 LRQILNFQVADENEMEEI--EIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH 288
             Q +       +   E     +  +  K L  +   R      +E    L R+H
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRADLVRVH 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 7e-43
 Identities = 55/277 (19%), Positives = 95/277 (34%), Gaps = 29/277 (10%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
              YD R +LG G F  V          LVA+K              ++++ ++ +I H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V +  +        L+ + V  G LF  +     +   T +   R+  +   A+ YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLH 124

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
            LG               LD++    ++DF  S +       +T      T G++ PE L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYVAPEVL 181

Query: 186 FW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF 242
                ++  D +S GV+   LL G  P                 F    +     QIL  
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPP-----------------FYDENDAKLFEQILKA 224

Query: 243 QVADENEMEEI--EIVAKLASKCLRTSGTERPTMRQV 277
           +   ++   +   +         +     +R T  Q 
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 8e-42
 Identities = 54/283 (19%), Positives = 106/283 (37%), Gaps = 38/283 (13%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVK---KPKMVDKILINEVFQHK--MRIISQI 62
           ++    ++G GGFG VY     D   + A+K   K ++  K         +  + ++S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
           +   +V +            + + +  G L  H+       + +       AAE    L+
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 121

Query: 123 YLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDP 182
           ++H+     +++ D+K ANILLD++   +++D   +   S           + T G++ P
Sbjct: 122 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAP 174

Query: 183 EYLF----WTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMVPYFPYPIENNSLR 237
           E L     +   +D +S G +L +LL G  P R +     +E+ RM       + ++   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--- 231

Query: 238 QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ 280
                  + E        +  L    L+     R        Q
Sbjct: 232 ------FSPE--------LRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-41
 Identities = 62/275 (22%), Positives = 96/275 (34%), Gaps = 34/275 (12%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEVFQHKMRIISQINH 64
           ++    +LG+G FG V+       N   A+K   K  ++    +      K  +     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +  +       +    V E++  G L  H++   S            AAE    L +L
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS G   I++ D+K  NILLD +   K+ADF         D    T     T  ++ PE 
Sbjct: 120 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEI 174

Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
           L    +    D +SFGV+L E+L G+ P                 F    E      I  
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSP-----------------FHGQDEEELFHSIRM 217

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQ 276
                   +E  +    L  K       +R  +R 
Sbjct: 218 DNPFYPRWLE--KEAKDLLVKLFVREPEKRLGVRG 250

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 1e-41
 Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 36/277 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINH 64
           +++     LG G FG V+      +    A+K  K ++V ++   E    +  ++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             ++++ G   + +   ++ +++  G LF  +R                AAE   AL+YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     II+ D+K  NILLD N   K+ DF  +  +     T        T  ++ PE 
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEV 172

Query: 185 LF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
           +    + +  D +SFG+++ E+L G  P                 F       +  +ILN
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP-----------------FYDSNTMKTYEKILN 215

Query: 242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVS 278
            ++         E V  L S+ +    ++R    Q  
Sbjct: 216 AELRFPPFFN--EDVKDLLSRLITRDLSQRLGNLQNG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 6e-41
 Identities = 65/291 (22%), Positives = 107/291 (36%), Gaps = 33/291 (11%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNV 67
           +Y    ++G G FG VY+  L D   LVA+KK     +    E+     +I+ +++H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL-----QIMRKLDHCNI 75

Query: 68  VKILGVCLETKVP------LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           V++      +          LV ++VP         Y  ++             +   +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 122 DYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
            Y+HS G   I H D+K  N+LLD D    K+ DF S+  +   +   +    I +  + 
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189

Query: 181 DPEYLF----WTEKSDVYSFGVVLVELLTGKHP----------RSYVALASNEMTRMVPY 226
            PE +F    +T   DV+S G VL ELL G+               + +        +  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                      QI                   L S+ L  + T R T  + 
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 6e-41
 Identities = 65/281 (23%), Positives = 105/281 (37%), Gaps = 26/281 (9%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKIL----INEVFQHKMRIISQINHKNVVK 69
            LGEG F  VYK      N +VA+KK K+  +      IN     +++++ +++H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 70  ILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
           +L          LV++F+                  T          T   L+YLH    
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQ--- 118

Query: 130 PPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLFW-- 187
             I+H D+K  N+LLD+N   K+ADF  +    S ++  T    + T  +  PE LF   
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELLFGAR 176

Query: 188 --TEKSDVYSFGVVLVELLTGKHP----RSYVALASNEMTRMVPYFPYPIENNSLRQILN 241
                 D+++ G +L ELL              L     T   P      +  SL   + 
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 242 FQVADENEMEEI-----EIVAKLASKCLRTSGTERPTMRQV 277
           F+      +  I     + +  L       +   R T  Q 
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  138 bits (349), Expect = 1e-39
 Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 23/284 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGVLPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKNV 67
            Y     +GEG +G VYK         A+KK     +   I      ++ I+ ++ H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 68  VKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSL 127
           VK+  V    K  +LV+E +           +         T      +  + + Y H  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDR 119

Query: 128 GSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF- 186
               ++H D+K  N+L++     K+ADF  +       +  T    I T+ +  P+ L  
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLMG 174

Query: 187 ---WTEKSDVYSFGVVLVELLTGKHP---RSYVALASN--EMTRMVPYFPYPIENNSLRQ 238
              ++   D++S G +  E++ G       S          +        +P      + 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 239 ILNFQVADENEMEEI-----EIVAKLASKCLRTSGTERPTMRQV 277
             NF V +    E       E    L SK L+    +R T +Q 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-39
 Identities = 52/293 (17%), Positives = 115/293 (39%), Gaps = 29/293 (9%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHK 65
              Y     +GEG +G V       +   VA+KK    +     +    +++I+ +  H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 66  NVVKILGVC----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
           N++ I  +     +E    + +   +    L++ ++ Q      +         +    L
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGL 122

Query: 122 DYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA-SSVLISSHDQTATTTKEIETVGWL 180
            Y+HS     ++H D+K +N+LL+     K+ DF  + V    HD T   T+ + T  + 
Sbjct: 123 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 181 DPEYLF----WTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFPYPIEN 233
            PE +     +T+  D++S G +L E+L+ +     + Y+   ++ +  +       +  
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 234 NSLRQILNFQVADENEMEEI---------EIVAKLASKCLRTSGTERPTMRQV 277
               +  N+ ++  ++ +                L  K L  +  +R  + Q 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-39
 Identities = 68/274 (24%), Positives = 107/274 (39%), Gaps = 34/274 (12%)

Query: 15  LLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGV 73
           +LG G  G V +          A+K  +   K    EV  H           ++V+I+ V
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWR----ASQCPHIVRIVDV 73

Query: 74  C----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGS 129
                   K  L+V E +  G LF  ++ +  Q   T +    I      A+ YLHS+  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSIN- 131

Query: 130 PPIIHGDVKSANILLD---DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF 186
             I H DVK  N+L      N   K+ DF  +   +SH+   T      T  ++ PE L 
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLG 186

Query: 187 ---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ 243
              + +  D++S GV++  LL G  P       SN    + P     ++         F 
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISP----GMKTRIRMGQYEFP 237

Query: 244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
             + +E+   E V  L    L+T  T+R T+ + 
Sbjct: 238 NPEWSEVS--EEVKMLIRNLLKTEPTQRMTITEF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-38
 Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 47/281 (16%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVK---KPKMVDKILINEV--FQHKMRIISQIN 63
           Y    LLG GGFG VY G+ + DN  VA+K   K ++ D   +        ++ ++ +++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 64  --HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASAL 121
                V+++L         +L+ E             +   +    +       +   A+
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEAV 123

Query: 122 DYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWL 180
            + H+ G   ++H D+K  NIL+D +    K+ DF S  L+     T        T  + 
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG----TRVYS 176

Query: 181 DPEYL----FWTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
            PE++    +    + V+S G++L +++ G  P         E+ R   +F   + +   
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEIIRGQVFFRQRVSSE-- 230

Query: 237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQV 277
                                 L   CL    ++RPT  ++
Sbjct: 231 -------------------CQHLIRWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 9e-38
 Identities = 52/287 (18%), Positives = 117/287 (40%), Gaps = 25/287 (8%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHK 65
           + Y+K   +GEG +G V+K      + +VA+K+     D   +      ++ ++ ++ HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
           N+V++  V    K   LV+EF                     +       +    L + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           S     ++H D+K  N+L++ N   K+A+F  +       +    + E+ T+ +  P+ L
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVL 173

Query: 186 F----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM--VPYFPYPIENNSLRQI 239
           F    ++   D++S G +  EL     P        +++ R+  +   P   +  S+ ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 240 LNFQ--------VADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
            +++         +  N + ++    + L    L+ +  +R +  + 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (336), Expect = 1e-37
 Identities = 45/299 (15%), Positives = 88/299 (29%), Gaps = 43/299 (14%)

Query: 4   VKATKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQI 62
           ++    Y     +G G FG +Y G  +     VA+K   +  K   +     + +I   +
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMM 59

Query: 63  NHKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALD 122
                +  +  C       ++   +   +L     + S +   + KT L +A +  S ++
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIE 117

Query: 123 YLHSLGSPPIIHGDVKSANIL---LDDNYTAKVADFASSVLISS-----HDQTATTTKEI 174
           Y+HS      IH DVK  N L           + DF  +          H          
Sbjct: 118 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI 231
            T  +           + + D+ S G VL+    G                    +    
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-----------------LPWQGLK 217

Query: 232 ENNSLRQILNFQVADENEMEEI------EIVAKLASKCLRTSGTERPTMRQVSEQLDSL 284
                ++         +   E+         A   + C      ++P    + +   +L
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-37
 Identities = 54/285 (18%), Positives = 105/285 (36%), Gaps = 23/285 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHKN 66
           N+ K   +GEG +G VYK        +VA+KK     +   +      ++ ++ ++NH N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 67  VVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS 126
           +VK+L V        LV+EF+            S+              +    L + HS
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 127 LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL- 185
                ++H D+K  N+L++     K+ADF  +       +T T    + T+ +  PE L 
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILL 175

Query: 186 ---FWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
              +++   D++S G +  E++T +      S +         +           +    
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 240 LNFQVADENEMEEIEIVAK-------LASKCLRTSGTERPTMRQV 277
                      +  ++V         L S+ L     +R + +  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 9e-37
 Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 35/298 (11%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKN 66
            Y+K   +G+G FG V+K         VA+KK  M  +K         +++I+  + H+N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 67  VVKILGVCLETKVP--------LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETA 118
           VV ++ +C     P         LV++F  +                T     R+     
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQMLL 127

Query: 119 SALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATT--TKEIET 176
           + L Y+H      I+H D+K+AN+L+  +   K+ADF  +   S    +     T  + T
Sbjct: 128 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 177 VGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHP------RSYVALASNEMTRMVPY 226
           + +  PE L     +    D++  G ++ E+ T          +  +AL S     + P 
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 227 FPYPIENNSLRQILNFQVADENEMEEIEIVAK-------LASKCLRTSGTERPTMRQV 277
               ++N  L + L      + ++++             L  K L     +R      
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-36
 Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 41/283 (14%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMV-----DKILINEVFQHKMRIISQIN 63
           YD    LG G F  V K          A K  K        + +  E  + ++ I+ +I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 64  HKNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDY 123
           H NV+ +  V       +L+ E V  G LF  +  + S    T +       +  + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYY 128

Query: 124 LHSLGSPPIIHGDVKSANILLDDN----YTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           LH   S  I H D+K  NI+L D        K+ DF  +  I   ++         T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 182

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL 236
           + PE +       ++D++S GV+   LL+G  P                 F    +  +L
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----------------FLGDTKQETL 225

Query: 237 RQILNFQVADENEMEEI--EIVAKLASKCLRTSGTERPTMRQV 277
             +       E+E       +      + L     +R T++  
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  128 bits (322), Expect = 1e-35
 Identities = 41/295 (13%), Positives = 82/295 (27%), Gaps = 37/295 (12%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-K 65
            +Y     +GEG FG +++G  L +N  VA+K      +       + + R    +    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCT 61

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
            +  +     E    +LV + +                  + KT    A +  + +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 118

Query: 126 SLGSPPIIHGDVKSANILLDDNYT-----AKVADFASSVLI-----SSHDQTATTTKEIE 175
                 +++ D+K  N L+    +       V DF             H           
Sbjct: 119 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 176 TVGWLDPEYLFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASN-EMTRMVPYFPYPI 231
           T  ++          + + D+ + G V +  L G  P   +  A+N +    +       
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235

Query: 232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR 286
               L                 E   K        +    P    +      +  
Sbjct: 236 PLRELCAGFP------------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 8e-34
 Identities = 53/233 (22%), Positives = 88/233 (37%), Gaps = 16/233 (6%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEV--FQHKMRIISQINH 64
            ++D   LLG+G FG V            A+K  +    I  +EV     + R++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 65  KNVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
             +  +            V E+   G LF H+     + + T +      AE  SAL+YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           HS     +++ D+K  N++LD +   K+ DF       S     T      T  +L PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 185 LFW---TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN 234
           L         D +  GVV+ E++ G+ P  +       +  ++          
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIRFPRT 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-33
 Identities = 63/283 (22%), Positives = 102/283 (36%), Gaps = 37/283 (13%)

Query: 8   KNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVK---KPKMVDKILINEVFQHKMRIIS 60
           +N++   +LG G +G V+            L A+K   K  +V K    E  + + +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 61  QINHK-NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
            I     +V +           L+ +++  G LF H+     +   T         E   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 140

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
           AL++LH LG   II+ D+K  NILLD N    + DF  S    + +              
Sbjct: 141 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 180 LDPEYLFW----TEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNS 235
                        +  D +S GV++ ELLTG  P                 F    E NS
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEKNS 240

Query: 236 LRQILNFQVADENEM-EEIEIVAK-LASKCLRTSGTERPTMRQ 276
             +I    +  E    +E+  +AK L  + L     +R     
Sbjct: 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 2e-32
 Identities = 57/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKN 66
           +Y     LG G +  V++ + + +N  V VK  K V K    +  + +++I+  +    N
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPN 91

Query: 67  VVKILGVCLE--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYL 124
           ++ +  +  +  ++ P LV+E V N    Q  +        T         E   ALDY 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYC 145

Query: 125 HSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPE 183
           HS+G   I+H DVK  N+++D ++   ++ D+  +       +       + +  +  PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 184 YLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV-----PYFPYPIENN 234
            L     +    D++S G +L  ++  K P  +     +++ R+            I+  
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 235 SLRQILNF-------------QVADENEMEEIEIVAK-LASKCLRTSGTERPTMRQV 277
           ++     F             +         +   A     K LR     R T R+ 
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-32
 Identities = 53/288 (18%), Positives = 101/288 (35%), Gaps = 25/288 (8%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHK 65
             Y     +G G +G V   V       VA+KK  +     L  +    ++R++  + H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLK-TWKTCLRIAAETASALDYL 124
           NV+ +L V    +      +F            +  +  K        +  +    L Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 125 HSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEY 184
           H+ G   IIH D+K  N+ ++++   K+ DF  +    S      T   +          
Sbjct: 138 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 190

Query: 185 L---FWTEKSDVYSFGVVLVELLTGKHP--RSYVALASNEMTRMVPYFPYPIENNSLRQI 239
           L    +T+  D++S G ++ E++TGK     S       E+ ++    P           
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 240 LNFQVADENEMEEIEIVAK----------LASKCLRTSGTERPTMRQV 277
               +    E+E+ +  +           L  K L     +R T  + 
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 2e-31
 Identities = 52/232 (22%), Positives = 93/232 (40%), Gaps = 19/232 (8%)

Query: 9   NYDKRHLLGEGGFGFVYKGV-LPDNTLVAVK--KPKMVDKILINEVFQHKMRIISQINHK 65
            +D+   LG G FG V            A+K    + V K+   E   ++ RI+  +N  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
            +VK+     +     +V E+V  G +F H+R        +       AA+     +YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF---SEPHARFYAAQIVLTFEYLH 158

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYL 185
           SL    +I+ D+K  N+L+D     +V DF  +  +     T        T   L PE +
Sbjct: 159 SLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEII 210

Query: 186 F---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN 234
               + +  D ++ GV++ E+  G  P  + A    ++   +        ++
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIVSGKVRFPSH 260

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 5e-29
 Identities = 54/294 (18%), Positives = 102/294 (34%), Gaps = 35/294 (11%)

Query: 7   TKNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINH 64
            + Y     +G G +G V           VAVKK  +    I+  +    ++R++  + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 65  KNVVKILGVC-----LETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           +NV+ +L V      LE    + +   +    L   V+ Q             +  +   
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT----DDHVQFLIYQILR 132

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            L Y+HS     IIH D+K +N+ ++++   K+ DF  +            T        
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYR 185

Query: 180 LDPEYL---FWTEKSDVYSFGVVLVELLTGKHP---RSYVALASNEMTRMVPYFPYPIEN 233
                L    + +  D++S G ++ ELLTG+       ++      + R+V      +  
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL-ILRLVGTPGAELLK 244

Query: 234 NSLRQILNFQVADENEMEEIEIVAK----------LASKCLRTSGTERPTMRQV 277
               +     +    +M ++               L  K L     +R T  Q 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-28
 Identities = 56/304 (18%), Positives = 102/304 (33%), Gaps = 46/304 (15%)

Query: 8   KNYDKRHLLGEGGFGFVYKGV-LPDNTLVAVKK-PKMVDKILINEVFQHKMRIISQINHK 65
           K Y     +G G  G V        +  VA+KK  +        +    ++ ++  +NHK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 66  NVVKILGVCLETKV------PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETAS 119
           N++ +L V    K         LV E +                    +    +  +   
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130

Query: 120 ALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGW 179
            + +LH   S  IIH D+K +NI++  + T K+ DF    L  +   +   T  + T  +
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 184

Query: 180 LDPEYLF---WTEKSDVYSFGVVLVELLTGKHP--------------RSYVALASNEMTR 222
             PE +    + E  D++S G ++ E++  K                          M +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 223 MVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAK---------LASKCLRTSGTERPT 273
           + P     +EN      L F     + +   +             L SK L     +R +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 274 MRQV 277
           +   
Sbjct: 305 VDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (257), Expect = 5e-26
 Identities = 44/218 (20%), Positives = 85/218 (38%), Gaps = 22/218 (10%)

Query: 10  YDKRHLLGEGGFGFVYKGV-LPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVV 68
           Y     LG G F  V+    + +NT VA+K  +     +  E  + +++++ ++N  +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNT 72

Query: 69  KILGVCLETKVPLLVY-------------EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAA 115
           K   +     + LL +              F   G     +  +            +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 116 ETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASSVLISSHDQTATTTKEI 174
           +    LDY+H      IIH D+K  N+L++  +    +     + L ++       T  I
Sbjct: 133 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 175 ETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP 209
           +T  +  PE L    W   +D++S   ++ EL+TG   
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 2e-18
 Identities = 26/198 (13%), Positives = 61/198 (30%), Gaps = 23/198 (11%)

Query: 15  LLGEGGFGFVYKGVLPDNTLVAVKKPK---------MVDKILINEVFQHKMRIISQINHK 65
           L+GEG    V+           VK  K            +   +  F       ++   +
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 66  NVVKILGVCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLH 125
            + K+ G+ +        Y +  N  +   +           +    +       +   +
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNA-VLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 126 SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETV-GWLDPEY 184
                 I+HGD+   N+L+ +     + DF  SV +          +++  +  +    Y
Sbjct: 121 ---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176

Query: 185 LFWTEKSDVYSFGVVLVE 202
                + D+ S    +++
Sbjct: 177 ---RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	309
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.43
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.09
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.99

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=371.57  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|.+.........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            357899999999999999999996 4699999998866544444567899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++||+|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++......
T Consensus        83 Ey~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          83 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999988543   34588999999999999999999999   999999999999999999999999999876444


Q ss_pred             cccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      ..........||+.|+|||++.    ++.++|||||||++|+|++|..||..............                
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----------------  220 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----------------  220 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH----------------
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------
Confidence            4444455678999999999986    35679999999999999999999865432222111111                


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ............++.+.+||.+||+.||++|||+.++++|
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111111122334668999999999999999999999663

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=363.50  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=201.4

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.+++  .||+|++.... .....+.+.+|+.++++++||||+++++++.+ +.+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            5789999999999999999998643  59999876432 33345678999999999999999999998764 56899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++|+|.+++.....  .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus        84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999975443  3578899999999999999999999   9999999999999999999999999997664433


Q ss_pred             ccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .........|++.|+|||++.      ++.++|||||||++|+|++|..||...................+         
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---------  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---------  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---------
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---------
Confidence            333445567899999999985      57789999999999999999999865422211111111100000         


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                          .....+..+++.+.+||.+||+.||++|||+.+++++|+.++...
T Consensus       230 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 ----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             ----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence                001122344567999999999999999999999999999887543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=361.64  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+....... .+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            35899999999999999999995 569999999876543332 5678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++|++|.+++...    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-  169 (293)
T d1yhwa1          98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  169 (293)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence            99999999877542    3578899999999999999999999   999999999999999999999999999765322 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                       ........|++.|+|||.+.   ++.++|||||||++|+|++|..||.............                ...
T Consensus       170 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----------------~~~  232 (293)
T d1yhwa1         170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------TNG  232 (293)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------------HHC
T ss_pred             -cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH----------------hCC
Confidence             22334567899999999997   7889999999999999999999986432221111000                011


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122233445679999999999999999999999765

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=357.85  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=196.4

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      ++|++.+.||+|+||.||+|.+++++.||+|.+.....  ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            58999999999999999999988899999999875432  3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++|+|.+++....  ...++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... .
T Consensus        83 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  156 (263)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-c
Confidence            9999999886543  33577889999999999999999999   9999999999999999999999999987653322 1


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......|++.|+|||.+.   ++.++||||||+++|+|+++ .+||....... ...                .+ ...
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~----------------~i-~~~  218 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVE----------------DI-STG  218 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHH----------------HH-HHT
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HHH----------------HH-Hhc
Confidence            2223456788999999987   88899999999999999995 55554322111 000                00 001


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....+..+++.+.+||.+||+.||++|||+.+++++|++++.
T Consensus       219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1111223344669999999999999999999999999988754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=355.80  Aligned_cols=245  Identities=28%  Similarity=0.392  Sum_probs=202.5

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999996 468999999876432  233456788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 mEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999997554   3578999999999999999999999   99999999999999999999999999865422


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                          .......|++.|+|||++.   ++.++|||||||++|+|++|..||...+.....                 ..+.
T Consensus       159 ----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----------------~~i~  217 (263)
T d2j4za1         159 ----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-----------------KRIS  217 (263)
T ss_dssp             ----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------------HHHH
T ss_pred             ----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-----------------HHHH
Confidence                2234457899999999997   789999999999999999999998643221111                 1111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  ...+...++.+.+||.+||+.||++|||+.++++|
T Consensus       218 ~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         218 RVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             TTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            111  11122344679999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=368.12  Aligned_cols=265  Identities=22%  Similarity=0.265  Sum_probs=205.0

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|.+...........+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            478999999999999999999995 5699999998866544555678899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      ||++|++|.+++....   .+++..+..++.|++.||.|||+ ++   ++||||||+||+++.++.+||+|||++.....
T Consensus        84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999997554   35889999999999999999997 58   99999999999999999999999999876522


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcc------------
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFP------------  228 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------  228 (309)
                          .......|++.|+|||++.   ++.++||||+||++|+|++|+.||...+..............            
T Consensus       158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                2234568899999999997   899999999999999999999999654322111110000000            


Q ss_pred             ---------ccccc----cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          229 ---------YPIEN----NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       229 ---------~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                               .....    ...................+..+.+||.+||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                     00000    00011111111111112234669999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=365.73  Aligned_cols=256  Identities=24%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             cccccceeecccCceEEEEEEcCC-C-----cEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPD-N-----TLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~-~-----~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   80 (309)
                      ++|++.+.||+|+||.||+|.+.. +     ..||+|.+...........+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            689999999999999999998532 2     368899876554444456788999999988 899999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc--------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS--------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSA  140 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~  140 (309)
                      ++||||+++|+|.+++.....                    ...+++..++.++.|++.||+|||+++   ++||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999975532                    134678899999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhc
Q 040698          141 NILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALA  216 (309)
Q Consensus       141 nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~  216 (309)
                      ||+++.++.+||+|||++................+++.|+|||.+.   ++.++|||||||++|+|++ |..||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999997764444433444566789999999886   8889999999999999997 89998643221


Q ss_pred             chhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          217 SNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .                 .+..+.......+.+..+++.+.+||.+||+.||++|||+.+|+++|..
T Consensus       274 ~-----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 A-----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             H-----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H-----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            1                 1111122222223344456779999999999999999999999999853

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-53  Score=359.43  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=197.5

Q ss_pred             hcccccceeecccCceEEEEEEcCC-C---cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD-N---TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~-~---~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.++. |   ..||+|.+.........+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3678899999999999999999642 3   35888987765555556789999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++|+|.+++.....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999998875433  3578899999999999999999999   9999999999999999999999999997653


Q ss_pred             cccccc---cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccc
Q 040698          163 SHDQTA---TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       163 ~~~~~~---~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ......   ......+++.|+|||.+.   ++.++|||||||++|+|++ |..||.........                
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----------------  243 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI----------------  243 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----------------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH----------------
Confidence            322211   112245688899999886   7889999999999999998 89998654322111                


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                       ..+ ......+.+..+++.+.+||.+||+.||++|||+.++++.|+++...
T Consensus       244 -~~i-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         244 -NAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -HHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHH-HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence             000 11111222334557799999999999999999999999999877553

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-53  Score=357.37  Aligned_cols=255  Identities=28%  Similarity=0.396  Sum_probs=205.1

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|.+.....  ..+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            468999999999999999999964 589999998865432  24578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++|+|.+++..... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (287)
T d1opja_          94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-  168 (287)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred             cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence            9999999999875543 34578889999999999999999999   999999999999999999999999999765332 


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      .........+++.|+|||++.   ++.++||||||+++|+|++|..|+........                 +......
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-----------------~~~~i~~  231 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEK  231 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------------HHHHHHT
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-----------------HHHHHhc
Confidence            222233345788899999986   88899999999999999997666432111111                 1111111


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ....+.+..+++.+.+||.+||+.||++|||+.++++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2222333445577999999999999999999999999887653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=351.01  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             hccc-ccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec----CCc
Q 040698            7 TKNY-DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE----TKV   79 (309)
Q Consensus         7 ~~~y-~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~   79 (309)
                      +++| ++.+.||+|+||.||+|.+ .++..||+|.+.... .....+.+.+|+++|++++||||+++++++.+    ...
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            3445 7788999999999999995 468899999875542 23335678999999999999999999999865    356


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEEeeecc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD-DNYTAKVADFASS  158 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~-~~~~v~l~d~g~~  158 (309)
                      +++||||+++++|.+++....   .+++..+..++.|++.||+|||+++ ++++||||||+||+++ +++.+||+|||++
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            789999999999999997554   3478899999999999999999975 3499999999999996 5789999999999


Q ss_pred             cccccccccccccccccccccCCCcccc--cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF--WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ....    ........|++.|+|||++.  ++.++|||||||++|+|++|..||.................         
T Consensus       163 ~~~~----~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~---------  229 (270)
T d1t4ha_         163 TLKR----ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---------  229 (270)
T ss_dssp             GGCC----TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---------
T ss_pred             eecc----CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC---------
Confidence            6532    22234567899999999987  89999999999999999999999864332221111111110         


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             .+...+...++.+.+||.+||+.||++|||+.|+++|
T Consensus       230 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 -------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                   0111112233568999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=356.63  Aligned_cols=249  Identities=24%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .+.|++++.||+|+||.||+|.+ .+|..||+|.+...... ..+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            45799999999999999999995 46899999987654332 24567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |++||+|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        90 y~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-  163 (288)
T d2jfla1          90 FCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  163 (288)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred             cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence            999999999876543  24588899999999999999999999   999999999999999999999999998654221 


Q ss_pred             ccccccccccccccCCCcccc--------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchh
Q 040698          166 QTATTTKEIETVGWLDPEYLF--------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLR  237 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~--------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
                       ........|++.|+|||++.        ++.++|||||||++|+|++|..||........-                 .
T Consensus       164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----------------~  225 (288)
T d2jfla1         164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----------------L  225 (288)
T ss_dssp             -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----------------H
T ss_pred             -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-----------------H
Confidence             12234567899999999873        678899999999999999999998654222111                 1


Q ss_pred             hhhccc-ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQ-VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .+.... .....+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       226 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111 1112233445679999999999999999999999774

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=348.85  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=205.5

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcC
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFV   87 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~   87 (309)
                      ++|++++.||+|+||.||+|.+++++.||+|.+.....  ..+.+.+|+.++++++||||+++++++.+.+.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            68999999999999999999998899999998765433  3567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++|+|..++.....  ..++..++.++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++...... ..
T Consensus        82 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY  155 (258)
T ss_dssp             TTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SC
T ss_pred             CCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC-Cc
Confidence            99999988765543  3477889999999999999999999   999999999999999999999999999765332 22


Q ss_pred             ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          168 ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      .......+++.|+|||.+.   ++.++||||||+++|+|++ |..||......+...                 .+.. .
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-----------------~i~~-~  217 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-----------------HIAQ-G  217 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-----------------HHHT-T
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-----------------HHHh-C
Confidence            2333456788999999986   8889999999999999998 899987553322111                 1111 1


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      .....+..+++.+.+||.+||+.||++|||+.+++++|.+
T Consensus       218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1111222344669999999999999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=352.63  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .++|++.+.||+|+||.||+|.++++..||+|.+.....  ..+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            478999999999999999999998889999998865432  24578999999999999999999998865 567999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++|+|.+++...... .+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++...... .
T Consensus        89 ~~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~  163 (272)
T d1qpca_          89 MENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E  163 (272)
T ss_dssp             CTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred             CCCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-c
Confidence            9999999877644432 3578899999999999999999999   999999999999999999999999999765332 2


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCC-CchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHP-RSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                      ........+++.|+|||.+.   ++.++||||||+++|+|++|..| +...... ....                .+ ..
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----------------~i-~~  225 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----------------NL-ER  225 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----------------HH-HT
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----------------HH-Hh
Confidence            22333456788999999986   88899999999999999996554 3332111 1111                11 11


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ......+..+++.+.+||.+||+.||++|||+.++++.|+.+
T Consensus       226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            111122334456799999999999999999999999988764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-53  Score=354.77  Aligned_cols=254  Identities=19%  Similarity=0.305  Sum_probs=191.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec--CCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE--TKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            47899999999999999999985 569999999876543 23335678899999999999999999999865  466899


Q ss_pred             EEEcCCCCCHHHHHHhhc-cccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           83 VYEFVPNGTLFQHVRYQS-SQVLKTWKTCLRIAAETASALDYLHSLG--SPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      ||||++||+|.+++.... ....+++..++.++.|++.||.|||+.+  .++++||||||+||+++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999986543 3345688999999999999999999853  1239999999999999999999999999997


Q ss_pred             ccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccch
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      .....  ........|++.|+|||++.   ++.++|||||||++|+|++|..||...+....                 .
T Consensus       163 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-----------------~  223 (269)
T d2java1         163 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-----------------A  223 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------H
T ss_pred             ecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-----------------H
Confidence            65322  22234567899999999986   78899999999999999999999864322111                 0


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..+.... ....+..+++.+.+||.+||+.||++|||+.++++|
T Consensus       224 ~~i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         224 GKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1111111 011222345679999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=357.79  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=200.2

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|++....  .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999996 569999999876432  2333467899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      ||++||+|.+++...+   .+++..+..++.|++.||+|||+++   ++||||||+||++++++.++|+|||++......
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999887554   3578899999999999999999999   999999999999999999999999999876444


Q ss_pred             cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          165 DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                      ..........|++.|+|||++.   ++.++|||||||++|+|++|..||...+.....                 ..+..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-----------------~~i~~  224 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-----------------QKIIK  224 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------------HHHHT
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-----------------HHHHc
Confidence            3444445567999999999986   788999999999999999999998643221111                 11111


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQL  281 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l  281 (309)
                      ...  ..+...++.+.+||++||+.||.+|||+.|++++-
T Consensus       225 ~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         225 LEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             TCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             CCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            111  11123346699999999999999999999986653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-52  Score=358.97  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=188.5

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..+.|++.+.||+|+||.||+|.+ .+|+.||+|.+.........+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457799999999999999999996 4689999998866544444567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeeccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVLI  161 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~~~~  161 (309)
                      ||++|++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++   +++.+||+|||++...
T Consensus        87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999999753   34588999999999999999999999   99999999999994   5789999999998754


Q ss_pred             ccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..   ........|++.|+|||++.   ++.++|||||||++|+|++|..||..................          
T Consensus       161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----------  227 (307)
T d1a06a_         161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE----------  227 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC----------
T ss_pred             cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC----------
Confidence            22   22334567899999999987   889999999999999999999998654322211111111000          


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                           ...+.....++.+.+||.+||+.||++|||+.++++|
T Consensus       228 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 -----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 1111122344679999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-52  Score=358.60  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      +.|++++.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4599999999999999999995 568999999875442  2333466889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSH  164 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~  164 (309)
                      |||++++|..++...   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....  
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA--  166 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC--
Confidence            999999987666543   24588999999999999999999999   9999999999999999999999999986542  


Q ss_pred             cccccccccccccccCCCcccc------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          165 DQTATTTKEIETVGWLDPEYLF------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                          ......|++.|+|||++.      ++.++|||||||++|+|++|..||.........                 ..
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-----------------~~  225 (309)
T d1u5ra_         167 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------------YH  225 (309)
T ss_dssp             ----SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------------HH
T ss_pred             ----CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-----------------HH
Confidence                223457899999999874      778999999999999999999998643222111                 11


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      +.........+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       226 i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            111111111222344679999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=350.21  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=198.6

Q ss_pred             cccccceeecccCceEEEEEEcCC-C----cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPD-N----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~-~----~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ++|++.+.||+|+||.||+|.+++ +    ..||+|.+...........+.+|+.++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            579999999999999999998543 2    47999988665444445678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+.++++.+.+.....  .+++..+..++.|++.|+.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999888765433  3578899999999999999999999   9999999999999999999999999997653


Q ss_pred             ccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ..... .......|++.|+|||.+.   ++.++||||||+++|+|++|..|+.........                 ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-----------------~~  224 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----------------MK  224 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------HH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-----------------HH
Confidence            32221 1223345788999999886   888999999999999999965553322111111                 11


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLH  288 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~  288 (309)
                      ........+.+..++..+.+||.+||+.||++|||+.++++.|+.+....
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            11111222233445567999999999999999999999999998877643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=349.21  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=204.3

Q ss_pred             hhccccccee-ecccCceEEEEEEcC---CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccE
Q 040698            6 ATKNYDKRHL-LGEGGFGFVYKGVLP---DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPL   81 (309)
Q Consensus         6 ~~~~y~i~~~-lg~g~~g~v~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (309)
                      ..++|.+... ||+|+||.||+|.++   ++..||+|.+.........+.+.+|+.+|++++|||||++++++.+ +.++
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            3567888885 999999999999753   3557999988765545556788999999999999999999999875 4579


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccc
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLI  161 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~  161 (309)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999875433  24588899999999999999999999   999999999999999999999999999776


Q ss_pred             cccccc-ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccch
Q 040698          162 SSHDQT-ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSL  236 (309)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
                      ...... .......+++.|+|||.+.   ++.++|||||||++|+|++ |..||.......  ..               
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~---------------  222 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM---------------  222 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH---------------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH---------------
Confidence            443222 2223456788999999986   8889999999999999998 899986542211  11               


Q ss_pred             hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          237 RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      ..+ ......+.+..+++.+.+||.+||+.||++|||+.++++.|+.+.
T Consensus       223 ~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         223 AFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH-HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            011 111112233445677999999999999999999999998886553

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-51  Score=357.61  Aligned_cols=248  Identities=21%  Similarity=0.266  Sum_probs=202.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|.+...... ..+.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46899999999999999999995 56999999988665433 35678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEEeeeccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD--DNYTAKVADFASSVLISS  163 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~--~~~~v~l~d~g~~~~~~~  163 (309)
                      |++||+|.+++....  ..+++..+..++.||+.||.|||+++   ++||||||+||+++  .++.+||+|||++.....
T Consensus       104 ~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         104 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             cCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999885433  24588999999999999999999999   99999999999996  467899999999876532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                         ........|++.|+|||++.   ++.++|||||||++|+|++|..||...+....                 +..+.
T Consensus       179 ---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------------~~~i~  238 (350)
T d1koaa2         179 ---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LRNVK  238 (350)
T ss_dssp             ---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHH
T ss_pred             ---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHH
Confidence               22334467899999999987   78899999999999999999999864322111                 11111


Q ss_pred             ccc--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQ--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  .........++.+.+||.+||+.||++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  1111122344679999999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=348.53  Aligned_cols=249  Identities=23%  Similarity=0.279  Sum_probs=201.6

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-----hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCc
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-----KILINEVFQHKMRIISQINHKNVVKILGVCLETKV   79 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|++....     .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            457899999999999999999996 569999999875432     12235678999999999999999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEEee
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY----TAKVADF  155 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~----~v~l~d~  155 (309)
                      .+|||||++||+|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+|++||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            999999999999999997654   4588999999999999999999999   99999999999998766    4999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |++.....   ........+++.|+|||++.   ++.++||||+||++|+|++|..||...+.....             
T Consensus       162 G~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------------  225 (293)
T d1jksa_         162 GLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------------  225 (293)
T ss_dssp             TTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------
T ss_pred             hhhhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH-------------
Confidence            99876522   22334557788999999987   889999999999999999999998643221111             


Q ss_pred             ccchhhhhccccc--CccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQVA--DENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                          ..+......  ...+...++.+.+||++||+.||++|||+.++++|
T Consensus       226 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         226 ----ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                111111111  11112334669999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-51  Score=350.08  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=209.3

Q ss_pred             HhhcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK   78 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (309)
                      ...++|++.+.||+|+||.||+|+.+      +++.||+|++.........+.+.+|+.++++++||||+++++++.+.+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34678999999999999999999853      467899999877665556778999999999999999999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS---------------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDV  137 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl  137 (309)
                      ..+++|||+++++|.+++.....                     ...+++..+..++.|++.||+|||+++   ++||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence            99999999999999999864322                     123577889999999999999999999   999999


Q ss_pred             CCCcEEEcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCC-CCCchh
Q 040698          138 KSANILLDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK-HPRSYV  213 (309)
Q Consensus       138 ~~~nilv~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~-~p~~~~  213 (309)
                      ||+||+++.++.+||+|||++................+++.|+|||.+.   ++.++||||||+++|+|++|. +||...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999987654444444444566788899999997   888999999999999999985 566543


Q ss_pred             hhcchhhhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          214 ALASNEMTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      .....                 ...+... ...+.+..+++.+.+||.+||+.||++|||+.+|++.|+++.
T Consensus       247 ~~~e~-----------------~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEEV-----------------IYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHHH-----------------HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHHH-----------------HHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            22211                 1111111 111223344567999999999999999999999999998875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=351.33  Aligned_cols=256  Identities=23%  Similarity=0.416  Sum_probs=200.2

Q ss_pred             cccccceeecccCceEEEEEEcC-CCc----EEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLP-DNT----LVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~-~~~----~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .+|++++.||+|+||.||+|.+. +|+    +||+|.+.........+.+.+|+.++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            57999999999999999999854 444    68888877655555567899999999999999999999999865 4678


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      +++++.+++|.+.+....  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            899999999998877553  34578899999999999999999999   9999999999999999999999999998764


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      ............|++.|+|||.+.   ++.++||||||+++|+|++ |.+||.......                  +..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------------------~~~  224 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------------ISS  224 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------------------HHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------------------HHH
Confidence            444444444556789999999886   8889999999999999998 788876542211                  111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                      ........+.+..+++.+.+||.+||+.||.+|||+.+++++|..+...
T Consensus       225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            1111122223344557799999999999999999999999999887643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=346.32  Aligned_cols=259  Identities=26%  Similarity=0.394  Sum_probs=200.3

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      .++|++.+.||+|+||.||+|.++++..||+|.+.....  ..+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            478999999999999999999988888999999865432  24678999999999999999999999865 567999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +++|+|..++...... .+++..+..++.|++.||+|||+++   ++||||||+||+++.++++||+|||++...... .
T Consensus        93 ~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~  167 (285)
T d1fmka3          93 MSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-E  167 (285)
T ss_dssp             CTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC-C
Confidence            9999999888654433 3588999999999999999999999   999999999999999999999999999765322 2


Q ss_pred             cccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhccc
Q 040698          167 TATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQ  243 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
                      ........+++.|+|||.+.   ++.++||||||+++|+|++|..|+.............                 ...
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-----------------~~~  230 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----------------ERG  230 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----------------HTT
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-----------------Hhc
Confidence            22333456789999999996   8889999999999999999665543221111111111                 111


Q ss_pred             ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          244 VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       244 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                      ...+.+..+++.+.+||.+||+.||++|||+++|++.|+.......+
T Consensus       231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            11222334456799999999999999999999999988776544443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-51  Score=355.89  Aligned_cols=248  Identities=18%  Similarity=0.260  Sum_probs=202.2

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|.+....... ...+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46799999999999999999995 579999999886654332 5678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEEeeeccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD--DNYTAKVADFASSVLISS  163 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~--~~~~v~l~d~g~~~~~~~  163 (309)
                      ||+|++|.+.+....  ..+++..++.++.||+.||.|||+++   ++||||||+|||++  .++.+||+|||++.....
T Consensus       107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999988775433  23588999999999999999999999   99999999999997  678999999999976532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                         ........+++.|+|||++.   ++.++|||||||++|+|++|..||.........                 ..+.
T Consensus       182 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----------------~~i~  241 (352)
T d1koba_         182 ---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-----------------QNVK  241 (352)
T ss_dssp             ---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------------HHHH
T ss_pred             ---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHH
Confidence               22334457789999999987   888999999999999999999998643322111                 1111


Q ss_pred             ccc--ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQ--VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ...  .........++.+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  1111222344679999999999999999999999886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=342.40  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             hcccccceeecccCceEEEEEEcCC----CcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPD----NTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4689999999999999999998532    457889988766666667789999999999999999999999964 67899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999998876443  24578899999999999999999999   9999999999999999999999999987653


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQ  238 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
                      .. .........+++.|+|||.+.   ++.++||||||+++|+|++ |.+||........                 ...
T Consensus       160 ~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-----------------~~~  221 (273)
T d1mp8a_         160 DS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----------------IGR  221 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----------------HHH
T ss_pred             CC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-----------------HHH
Confidence            22 222333456788999999986   8889999999999999997 8999765432211                 111


Q ss_pred             hhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          239 ILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       239 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                      +.. ....+.+..+++.+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       222 i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         222 IEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111 1111223345577999999999999999999999999987764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=347.73  Aligned_cols=248  Identities=23%  Similarity=0.250  Sum_probs=203.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i   82 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+.+|+.++||||+++++++++.+.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            357899999999999999999995 579999999886542  22234667899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLIS  162 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~  162 (309)
                      ||||++||+|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.+|.+||+|||++....
T Consensus        83 v~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999987654   3477889999999999999999999   9999999999999999999999999997542


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .  .........|++.|+|||++.   ++.++|+|||||++|+|++|.+||...+....                 ...+
T Consensus       157 ~--~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----------------~~~i  217 (337)
T d1o6la_         157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----------------FELI  217 (337)
T ss_dssp             C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHH
T ss_pred             c--CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-----------------HHHH
Confidence            2  123344568999999999997   89999999999999999999999865432211                 1111


Q ss_pred             hcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          240 LNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                      .....  ..+...++.+.+||.+||+.||.+||+     +.++++|
T Consensus       218 ~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             hcCCC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11111  112234466999999999999999994     8888875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=342.56  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=192.2

Q ss_pred             eeecccCceEEEEEEcC---CCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEcCCC
Q 040698           14 HLLGEGGFGFVYKGVLP---DNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEFVPN   89 (309)
Q Consensus        14 ~~lg~g~~g~v~~~~~~---~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~   89 (309)
                      +.||+|+||.||+|.++   .++.||+|.+... ......+.+.+|+.+|++++|||||++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999843   3578999987653 233345679999999999999999999999975 456899999999


Q ss_pred             CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc-c
Q 040698           90 GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT-A  168 (309)
Q Consensus        90 ~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~-~  168 (309)
                      |+|.+++....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++|||++......... .
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999987543   3578999999999999999999999   999999999999999999999999999765433222 2


Q ss_pred             cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhcccc
Q 040698          169 TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNFQV  244 (309)
Q Consensus       169 ~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
                      ......|++.|+|||.+.   ++.++||||||+++|+|++ |..||........  ..                ......
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~----------------~i~~~~  227 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TA----------------MLEKGE  227 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----------------HHHTTC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HH----------------HHHcCC
Confidence            233456788999999986   7889999999999999997 8999875432211  10                011111


Q ss_pred             cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhh
Q 040698          245 ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDS  283 (309)
Q Consensus       245 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~  283 (309)
                      ..+.+..+++.+.+||.+||+.||++|||+.++++.|+.
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            122233455779999999999999999999999887754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-50  Score=340.77  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=202.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--------hhhhHHHHHHHHHHHhhcC-CCccceeeeeeec
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--------KILINEVFQHKMRIISQIN-HKNVVKILGVCLE   76 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   76 (309)
                      .++|++.+.||+|+||.||+|++ .+|+.||+|.+....        .....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999995 569999999875432        1223456889999999997 9999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeee
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFA  156 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g  156 (309)
                      ++..||||||++|++|.+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999997544   4588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc
Q 040698          157 SSVLISSHDQTATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF  227 (309)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~  227 (309)
                      ++.....   ........|++.|+|||.+.         ++.++||||+||++|+|++|..||.........        
T Consensus       156 ~a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~--------  224 (277)
T d1phka_         156 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--------  224 (277)
T ss_dssp             TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------
T ss_pred             heeEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH--------
Confidence            9976532   22334567899999999885         577899999999999999999998754322111        


Q ss_pred             cccccccchhhhhcc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIENNSLRQILNF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                               ..+...  ....+.....++.+.+||.+||+.||++|||+.++++|
T Consensus       225 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         225 ---------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---------HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                     111111  11122233455779999999999999999999999764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=344.68  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec-CC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE-TK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~   78 (309)
                      .++|++.+.||+|+||.||+|.+.      +++.||+|.+.........+.+..|...+.++ +|+||+.+++++.+ ++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            478999999999999999999842      35689999987655444456677788777776 68899999998765 45


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD  145 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~  145 (309)
                      .+++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+++   ++||||||+||+++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999975542             234678899999999999999999999   99999999999999


Q ss_pred             CCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhh
Q 040698          146 DNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMT  221 (309)
Q Consensus       146 ~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~  221 (309)
                      .++.+||+|||++................|++.|+|||.+.   ++.++|||||||++|+|++| .+||........   
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---  245 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  245 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            99999999999997664444444455667899999999987   88899999999999999986 456654321111   


Q ss_pred             hcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          222 RMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                                    .............+..+++.+.+||.+||+.||++|||+.+++++|+.+.
T Consensus       246 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         246 --------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                          11111111122223344567999999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=336.88  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=195.2

Q ss_pred             hcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCccEEEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPLLVYE   85 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e   85 (309)
                      .++|++.+.||+|+||.||+|.+ .|..||+|++....   ..+.+.+|++++++++||||+++++++.+ .+.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            46899999999999999999998 47899999986543   24678999999999999999999998855 466899999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+++|+|.+++...... .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++++|||++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--  155 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--  155 (262)
T ss_dssp             CCTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence            99999999999755432 3578899999999999999999999   99999999999999999999999999875422  


Q ss_pred             ccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccchhhhhc
Q 040698          166 QTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILN  241 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
                         ......++..|+|||.+.   ++.++||||||+++|+|++ |.+||........                 ...+. 
T Consensus       156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-----------------~~~i~-  214 (262)
T d1byga_         156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPRVE-  214 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------HHHHT-
T ss_pred             ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-----------------HHHHH-
Confidence               223345678899999886   8889999999999999998 7887664322211                 11111 


Q ss_pred             ccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          242 FQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       242 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....+.+..+++.+.+||++||+.||++|||+.+++++|+.++.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            111122233445679999999999999999999999999988753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-50  Score=343.58  Aligned_cols=244  Identities=25%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            46899999999999999999996 569999999876432  233356788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||++|++|..++.....   .++..+..++.|++.|+.|||+++   ++||||||+||+++.+|.+||+|||++.....
T Consensus        83 mE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999988875543   367788889999999999999999   99999999999999999999999999976522


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                           ......|++.|+|||++.   ++.++|||||||++|+|++|..||...+....                 ...+.
T Consensus       157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------------~~~i~  214 (316)
T d1fota_         157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----------------YEKIL  214 (316)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHHH
T ss_pred             -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----------------HHHHH
Confidence                 233467899999999987   88999999999999999999999864322211                 11111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....  ..+...++.+.++|.+||+.||.+|+     |++++++|
T Consensus       215 ~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         215 NAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1111  11223346699999999999999996     89999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=343.33  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=209.7

Q ss_pred             hcccccceeecccCceEEEEEEc------CCCcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL------PDNTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKV   79 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (309)
                      .++|++.+.||+|+||.||+|.+      .++..||+|.+...........+.+|+.+++.+ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            47899999999999999999974      346799999987655555566788999999998 69999999999999999


Q ss_pred             cEEEEEcCCCCCHHHHHHhhcc---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSS---------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILL  144 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv  144 (309)
                      .++||||+++++|.+++.....               ...+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            9999999999999999875432               234678899999999999999999999   9999999999999


Q ss_pred             cCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhh
Q 040698          145 DDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEM  220 (309)
Q Consensus       145 ~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~  220 (309)
                      +.++.++++|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |.+||......    
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence            999999999999998765444444445567899999999987   7889999999999999998 55554332111    


Q ss_pred             hhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          221 TRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                                   ..+..+.........+...++.+.+||.+||+.||++|||+.++++.|++..
T Consensus       255 -------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                         1112222222223333345577999999999999999999999999997654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.1e-50  Score=348.95  Aligned_cols=247  Identities=21%  Similarity=0.261  Sum_probs=196.1

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh--hhhHHHHHH---HHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK--ILINEVFQH---KMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~--~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++.....  ......+..   ++.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46899999999999999999996 4699999998754321  111223333   46677778899999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      |+||||++|++|.+++....   ..++..+..++.||+.||.|||+++   ++||||||+||+++.+|.+||+|||++..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999997654   3477899999999999999999999   99999999999999999999999999976


Q ss_pred             cccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh-hhhcccCccccccccc
Q 040698          161 ISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE-MTRMVPYFPYPIENNS  235 (309)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (309)
                      ...    .......|++.|+|||++.    ++.++|||||||++|+|++|..||......... .......         
T Consensus       157 ~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------  223 (364)
T d1omwa3         157 FSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------  223 (364)
T ss_dssp             CSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------
T ss_pred             cCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Confidence            532    2334567899999999885    788999999999999999999998654222111 0000000         


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                              .....+...++.+.+||.+||+.||.+|||     +.++++|
T Consensus       224 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 --------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                    111112234466999999999999999999     7899875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=344.65  Aligned_cols=248  Identities=18%  Similarity=0.254  Sum_probs=201.2

Q ss_pred             hhcccccceeecccCceEEEEEEcC-CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLP-DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVY   84 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~   84 (309)
                      ..++|++++.||+|+||.||+|.++ +|+.||+|.+......  ...+.+|+.+|+.++||||+++++++++.+.+|+||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            4578999999999999999999964 6899999988765332  456789999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEEeeecccccc
Q 040698           85 EFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD--NYTAKVADFASSVLIS  162 (309)
Q Consensus        85 e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~--~~~v~l~d~g~~~~~~  162 (309)
                      |||+|++|.+++...+  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.  .+.++++|||++....
T Consensus        81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence            9999999999986543  23588999999999999999999999   999999999999984  4579999999987652


Q ss_pred             cccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhh
Q 040698          163 SHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQI  239 (309)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
                      .   ........+++.|+|||...   ++.++||||+||++|+|++|..||.......                 ....+
T Consensus       156 ~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----------------~~~~i  215 (321)
T d1tkia_         156 P---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----------------IIENI  215 (321)
T ss_dssp             T---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HHHHH
T ss_pred             c---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHH
Confidence            2   22334456788999999886   8889999999999999999999986442211                 11111


Q ss_pred             hcccccCc--cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          240 LNFQVADE--NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       240 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ........  .....++.+.+||.+||+.||.+|||+.++++|
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11111111  111234669999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=343.65  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=200.0

Q ss_pred             hcccccceeecccCceEEEEEEcC-CCc--EEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeecCCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP-DNT--LVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLETKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~--~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~i   82 (309)
                      -++|++.+.||+|+||.||+|.++ +|.  .||+|.+.........+.+.+|+.+|+++ +||||+++++++.+++.+++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            468999999999999999999964 444  46777765554444466789999999998 79999999999999999999


Q ss_pred             EEEcCCCCCHHHHHHhhc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 040698           83 VYEFVPNGTLFQHVRYQS-------------SQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYT  149 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~  149 (309)
                      ||||+++|+|.+++....             ....+++..+..++.|++.||.|+|+++   ++||||+|+||+++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            999999999999986442             2345688999999999999999999999   999999999999999999


Q ss_pred             eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCC-CCCchhhhcchhhhhccc
Q 040698          150 AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGK-HPRSYVALASNEMTRMVP  225 (309)
Q Consensus       150 v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~-~p~~~~~~~~~~~~~~~~  225 (309)
                      +||+|||++.....   ........++..|+|||.+.   ++.++||||||+++|+|++|. +||.......  ..    
T Consensus       166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~----  236 (309)
T d1fvra_         166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY----  236 (309)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----
T ss_pred             eEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HH----
Confidence            99999999865422   12223445788899999997   888999999999999999965 5654332111  11    


Q ss_pred             CccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          226 YFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                                 ..+.. ....+.+..+++.+.+||.+||+.||++|||+.+++++|+++...
T Consensus       237 -----------~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         237 -----------EKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -----------HHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----------HHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       11111 111222334556799999999999999999999999999887643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=336.91  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=192.9

Q ss_pred             hcccccceeecccCceEEEEEEc--CCC--cEEEEEecccc--hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL--PDN--TLVAVKKPKMV--DKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~--~~~--~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      .++|++.+.||+|+||.||+|..  .++  ..||+|++...  ......+.+.+|+.++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            57899999999999999999984  223  36899987654  223334678999999999999999999999976 467


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ++||||++++++.+.+.....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+|++|||++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            899999999999988775543  3578999999999999999999999   99999999999999999999999999977


Q ss_pred             cccccccc-cccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchhhhhcccCccccccccc
Q 040698          161 ISSHDQTA-TTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNEMTRMVPYFPYPIENNS  235 (309)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
                      ........ ......++..|+|||.+.   ++.++||||||+++|+|++ |..||.......                 .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----------------~  223 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----------------I  223 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------H
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----------------H
Confidence            64332222 223345677899999987   7888999999999999997 899976432221                 1


Q ss_pred             hhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          236 LRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                      ...+.......+.+..+++.+.+||.+||+.||++|||+.+|++.|.+.
T Consensus       224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111111222223334456799999999999999999999999988764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=342.03  Aligned_cols=249  Identities=25%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             hhcccccce-eecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhh-cCCCccceeeeeeec----CC
Q 040698            6 ATKNYDKRH-LLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQ-INHKNVVKILGVCLE----TK   78 (309)
Q Consensus         6 ~~~~y~i~~-~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~   78 (309)
                      ..++|++.+ .||+|+||.||+|.+ .+|+.||+|.+...      ..+.+|+.++.+ .+||||+++++++++    .+
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            467899875 599999999999995 56999999987643      345678887654 489999999999875    46


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEEee
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD---NYTAKVADF  155 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~---~~~v~l~d~  155 (309)
                      .+|+|||||+||+|.+++...+. ..+++..+..++.|++.||.|||+++   ++||||||+||+++.   ++.+||+||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence            78999999999999999975543 34688999999999999999999999   999999999999974   567999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      |++.....   ........|++.|+|||.+.   ++.++|||||||++|+|++|..||........... .         
T Consensus       159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~---------  225 (335)
T d2ozaa1         159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M---------  225 (335)
T ss_dssp             TTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred             ceeeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-H---------
Confidence            99976532   23344567899999999987   88999999999999999999999865422111000 0         


Q ss_pred             ccchhhhhcccc--cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          233 NNSLRQILNFQV--ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       233 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ...+.....  +.......++.+.+||.+||+.||++|||+.++++|
T Consensus       226 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         226 ---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               000011111  111223455779999999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=338.19  Aligned_cols=261  Identities=28%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             hhcccccceeecccCceEEEEEEcCC--------CcEEEEEecccchhhhhHHHHHHHHHHHhhc-CCCccceeeeeeec
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILINEVFQHKMRIISQI-NHKNVVKILGVCLE   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   76 (309)
                      ..++|++++.||+|+||.||+|+...        +..||+|++...........+..|...+.++ +||||+++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            35799999999999999999998422        3479999987665555556788888888887 79999999999999


Q ss_pred             CCccEEEEEcCCCCCHHHHHHhhcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 040698           77 TKVPLLVYEFVPNGTLFQHVRYQSS-------------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANIL  143 (309)
Q Consensus        77 ~~~~~iv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nil  143 (309)
                      ++..++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+++   ++||||||+||+
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            9999999999999999999975542             234688999999999999999999999   999999999999


Q ss_pred             EcCCCCeEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHh-CCCCCchhhhcchh
Q 040698          144 LDDNYTAKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLT-GKHPRSYVALASNE  219 (309)
Q Consensus       144 v~~~~~v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~-g~~p~~~~~~~~~~  219 (309)
                      ++.++.+||+|||++................+++.|+|||.+.   ++.++||||||+++|+|++ |.+||........ 
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence            9999999999999997765444444445567888999999986   8999999999999999997 7888764322211 


Q ss_pred             hhhcccCccccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhh
Q 040698          220 MTRMVPYFPYPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRL  287 (309)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~  287 (309)
                                       ..........+.+...++.+.+||.+||+.||.+|||+.+|++.|+++.+.
T Consensus       247 -----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 -----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                             011111122222334456799999999999999999999999999888654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-49  Score=335.46  Aligned_cols=259  Identities=26%  Similarity=0.303  Sum_probs=197.8

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETK----   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   78 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+.+|+.+++.++||||+++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            467899999999999999999995 579999999876532  2344567899999999999999999999987644    


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      .+|+||||++|++|.+++...+   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            3789999999999998887554   3578999999999999999999999   999999999999999999999999987


Q ss_pred             cccccc-cccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccccc
Q 040698          159 VLISSH-DQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENN  234 (309)
Q Consensus       159 ~~~~~~-~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
                      ...... ..........|++.|+|||.+.   ++.++|||||||++|+|++|..||.............. ..+      
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-~~~------  231 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDP------  231 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-CCC------
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh-cCC------
Confidence            654322 2223344567899999999987   78899999999999999999999864322211110000 000      


Q ss_pred             chhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC-CHHHHHHHHhhhh
Q 040698          235 SLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP-TMRQVSEQLDSLR  285 (309)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~l~~~~  285 (309)
                              ..........++.+.+||++||+.||.+|| |++++++.|.+++
T Consensus       232 --------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 --------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                    000111223446699999999999999999 8999988887664

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-49  Score=343.99  Aligned_cols=244  Identities=23%  Similarity=0.267  Sum_probs=201.4

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++....  .....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            47899999999999999999996 569999999876432  223345688999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+.|++|...+....   .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus       120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999987654   3578999999999999999999999   99999999999999999999999999976522


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                           ......|++.|+|||++.   ++.++|||||||++|+|++|..||...+....                 ...+.
T Consensus       194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------------~~~i~  251 (350)
T d1rdqe_         194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----------------YEKIV  251 (350)
T ss_dssp             -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHH
T ss_pred             -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-----------------HHHHh
Confidence                 233467899999999987   88999999999999999999999864322111                 11111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCC-----CHHHHHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERP-----TMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~  280 (309)
                      ....  ..+...++.+.+||++||+.||.+|+     |+.++++|
T Consensus       252 ~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         252 SGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             cCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            1111  11223446699999999999999995     89999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=336.99  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=208.3

Q ss_pred             hcccccceeecccCceEEEEEEcC------CCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCcc
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVLP------DNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETKVP   80 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (309)
                      -++|++.+.||+|+||.||+|.++      +++.||+|++...........+.+|+.++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478999999999999999999853      36789999987665555566789999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHHHhhcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           81 LLVYEFVPNGTLFQHVRYQSS-------QVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                      ++||||+++|+|.+++.....       ....++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            999999999999998864421       223477889999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhC-CCCCchhhhcchhhhhcccCccc
Q 040698          154 DFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTG-KHPRSYVALASNEMTRMVPYFPY  229 (309)
Q Consensus       154 d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~  229 (309)
                      |||++................+++.|+|||.+.   ++.++||||||+++|+|++| .+||.........          
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----------  245 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----------  245 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence            999997765544444455567889999999987   78899999999999999998 4776543222111          


Q ss_pred             cccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhh
Q 040698          230 PIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSL  284 (309)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~  284 (309)
                             ..+.+. ...+.+..+++.+.++|.+||+.||.+|||+.+|+++|++.
T Consensus       246 -------~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         246 -------RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             -------HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -------HHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                   111111 11122233456799999999999999999999999988654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=340.43  Aligned_cols=245  Identities=24%  Similarity=0.279  Sum_probs=196.3

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch--hhhhHHHHHHHHHHHh-hcCCCccceeeeeeecCCccEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD--KILINEVFQHKMRIIS-QINHKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|.+....  .....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6899999999999999999995 469999999886532  1222344556666554 68999999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISS  163 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~  163 (309)
                      |||+++|+|.+++.....   .++..+..++.|++.||+|||+++   ++||||||+||++++++.++++|||++.....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999975543   477899999999999999999999   99999999999999999999999999976532


Q ss_pred             ccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhh
Q 040698          164 HDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQIL  240 (309)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
                      .  ........|++.|+|||++.   ++.++||||+||++|+|++|..||...+...                 ....+.
T Consensus       156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-----------------~~~~i~  216 (320)
T d1xjda_         156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----------------LFHSIR  216 (320)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHH
T ss_pred             c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-----------------HHHHHH
Confidence            2  23334467899999999997   8899999999999999999999986432211                 111111


Q ss_pred             cccccCccchHHHHHHHHHHhHhhccCCCCCCCHH-HHHH
Q 040698          241 NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMR-QVSE  279 (309)
Q Consensus       241 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~  279 (309)
                      ...+  ..+...++.+.+||.+||+.||.+|||+. ++++
T Consensus       217 ~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         217 MDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             cCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1111  11223446699999999999999999995 6765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=334.82  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=198.8

Q ss_pred             ceeecccCceEEEEEEcCCC----cEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec-CCccEEEEEcC
Q 040698           13 RHLLGEGGFGFVYKGVLPDN----TLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE-TKVPLLVYEFV   87 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~   87 (309)
                      .++||+|+||.||+|.+.++    ..||+|.+.........+.+.+|+++|++++||||+++++++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999985432    35889988765555556789999999999999999999999765 56789999999


Q ss_pred             CCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccccc
Q 040698           88 PNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQT  167 (309)
Q Consensus        88 ~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~~  167 (309)
                      ++++|.+++.....  ..++..++.++.|++.||.|+|+.+   ++||||||+||++++++.+||+|||++.........
T Consensus       112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998864433  3366788999999999999999999   999999999999999999999999999765432222


Q ss_pred             --ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccccchhhhhcc
Q 040698          168 --ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIENNSLRQILNF  242 (309)
Q Consensus       168 --~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
                        .......+++.|+|||.+.   ++.++||||||+++|+|++|..||.......+                ....+...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----------------~~~~i~~g  250 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------------ITVYLLQG  250 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHHHHTT
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcC
Confidence              1223356788999999886   88899999999999999997777543211111                11111111


Q ss_pred             cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhhhhhh
Q 040698          243 QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRRLHEN  290 (309)
Q Consensus       243 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~~~~~  290 (309)
                       .....+..+++.+.+||.+||+.||++|||+.+++++|+++..-+..
T Consensus       251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence             11112233456799999999999999999999999999888765443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=336.69  Aligned_cols=262  Identities=24%  Similarity=0.257  Sum_probs=190.1

Q ss_pred             ccceeecccCceEEEEEEc-CCCcEEEEEecccchhhh----hHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698           11 DKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKIL----INEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus        11 ~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      +.++.||+|+||.||+|.+ .+|+.||+|.+.......    ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3568999999999999996 469999999886543322    12457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+.++++.....   ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-  153 (299)
T d1ua2a_          81 FMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-  153 (299)
T ss_dssp             CCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred             hhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-
Confidence            998877655443   2234577889999999999999999999   999999999999999999999999998664322 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccCccccccc-cchh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPYFPYPIEN-NSLR  237 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~  237 (309)
                       ........+++.|+|||++.    ++.++||||+||++|+|++|.+||.............   .......... ....
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence             22333457899999999875    6789999999999999999999986543222110000   0000000000 0000


Q ss_pred             hhhcccccCc-----cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 QILNFQVADE-----NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ..........     .....++.+.+||.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000000000     011234669999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=333.56  Aligned_cols=269  Identities=23%  Similarity=0.301  Sum_probs=199.7

Q ss_pred             hhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----ccE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK----VPL   81 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~   81 (309)
                      ++++|.+.+.||+|+||.||+|+. +|+.||+|++......  ......|+..+.+++||||+++++++.+.+    .++
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            367899999999999999999997 6899999988654321  223344566666789999999999997643    578


Q ss_pred             EEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCcEEEcCCCCeEEE
Q 040698           82 LVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS--------LGSPPIIHGDVKSANILLDDNYTAKVA  153 (309)
Q Consensus        82 iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--------~~~~~~~h~dl~~~nilv~~~~~v~l~  153 (309)
                      +||||+++|+|.+++...    .+++..++.++.|++.||.|+|+        ++   ++||||||+||+++.++.+||+
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEE
Confidence            999999999999999753    34778999999999999999996        47   9999999999999999999999


Q ss_pred             eeeccccccccccc--ccccccccccccCCCcccc---------cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh
Q 040698          154 DFASSVLISSHDQT--ATTTKEIETVGWLDPEYLF---------WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR  222 (309)
Q Consensus       154 d~g~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~---------~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~  222 (309)
                      |||++.........  .......|++.|+|||.+.         ++.++|||||||++|+|++|..||............
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            99999766433222  2234567899999999875         455789999999999999999887644322211111


Q ss_pred             cccCccccccccchhhhhcccc-----cCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhhh
Q 040698          223 MVPYFPYPIENNSLRQILNFQV-----ADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLRR  286 (309)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~~  286 (309)
                      .....+  ..............     ........+..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       231 ~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         231 LVPSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TSCSSC--CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccc--hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            111100  00000111111111     112234566779999999999999999999999999987764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=335.00  Aligned_cols=266  Identities=21%  Similarity=0.276  Sum_probs=197.2

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999995 5799999998855432 2234578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      |+.+ ++.+++..... ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+.....  
T Consensus        82 ~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--  154 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--  154 (298)
T ss_dssp             CCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--
T ss_pred             ecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC--
Confidence            9975 44445543332 34588999999999999999999999   99999999999999999999999999976532  


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCc-cccccccchhhhh
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYF-PYPIENNSLRQIL  240 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  240 (309)
                      .........+++.|+|||.+.    ++.++|+||+||++|+|++|..||...+............. +............
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            223344567899999999876    57889999999999999999999965432211111000000 0000000000000


Q ss_pred             cccccC---------ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          241 NFQVAD---------ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       241 ~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      ......         ......++.+.+||++||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000         0112334668999999999999999999999886

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=333.34  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=192.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhh-----hhHHHHHHHHHHHhhcC--CCccceeeeeeecC
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKI-----LINEVFQHKMRIISQIN--HKNVVKILGVCLET   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~   77 (309)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||+|.+......     .....+.+|+.++++++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            367899999999999999999995 57999999987543211     11233567889999886  89999999999999


Q ss_pred             CccEEEEEcCCC-CCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEEee
Q 040698           78 KVPLLVYEFVPN-GTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-NYTAKVADF  155 (309)
Q Consensus        78 ~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-~~~v~l~d~  155 (309)
                      +..++||||+.+ +++.+++....   .+++..+..++.|++.||+|||+++   ++||||||+||+++. ++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            999999999976 57777776543   3578999999999999999999999   999999999999984 579999999


Q ss_pred             ecccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc
Q 040698          156 ASSVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI  231 (309)
Q Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (309)
                      |++....    ........|++.|+|||.+.    ++.++||||+||++|+|++|..||......    ......     
T Consensus       156 G~a~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----~~~~~~-----  222 (273)
T d1xwsa_         156 GSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----IRGQVF-----  222 (273)
T ss_dssp             TTCEECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----HHCCCC-----
T ss_pred             ccceecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----hhcccC-----
Confidence            9987642    22334567899999999986    356789999999999999999998653211    000000     


Q ss_pred             cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                      .+...++++.+||.+||+.||++|||+.++++|
T Consensus       223 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         223 ----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                            111223669999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-48  Score=331.82  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=197.4

Q ss_pred             cccccceeecccCceEEEEEEcCCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEEc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYEF   86 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~   86 (309)
                      ++|++++.||+|+||.||+|.+++|+.||+|.+.... .....+.+.+|+.+|+.++||||+++++++.+.+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999899999999875542 223346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccccccccc
Q 040698           87 VPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHDQ  166 (309)
Q Consensus        87 ~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~~  166 (309)
                      +.++.+..+....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|++|||.+......  
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence            9877666555422   34688999999999999999999999   999999999999999999999999998765322  


Q ss_pred             cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhc---ccC----ccccccccc
Q 040698          167 TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRM---VPY----FPYPIENNS  235 (309)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~---~~~----~~~~~~~~~  235 (309)
                      ........+++.|+|||.+.    ++.++|+|||||++|+|++|..||.............   ...    ++.......
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            22233446788899999985    6889999999999999999999996543222111000   000    000000000


Q ss_pred             h---hhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          236 L---RQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       236 ~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .   ................++.+.+||++||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   00001111111123344679999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=330.74  Aligned_cols=269  Identities=21%  Similarity=0.248  Sum_probs=193.4

Q ss_pred             HHhhcccccceeecccCceEEEEEEc-CC-CcEEEEEecccchh-hhhHHHHHHHHHHHhhc---CCCccceeeeeeec-
Q 040698            4 VKATKNYDKRHLLGEGGFGFVYKGVL-PD-NTLVAVKKPKMVDK-ILINEVFQHKMRIISQI---NHKNVVKILGVCLE-   76 (309)
Q Consensus         4 ~~~~~~y~i~~~lg~g~~g~v~~~~~-~~-~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-   76 (309)
                      +...++|++++.||+|+||.||+|.+ ++ ++.||+|.+..... ......+.+|+.+++.+   +||||+++++++.. 
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            45678999999999999999999995 44 67799998754321 11122345666666554   79999999999853 


Q ss_pred             ----CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           77 ----TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        77 ----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                          ....+++|||++++++......  .....++..+..++.|++.||+|||+++   ++||||||+||+++.++.+++
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeee
Confidence                3567899999988766544332  2334578889999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhh---hcccC
Q 040698          153 ADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMT---RMVPY  226 (309)
Q Consensus       153 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~---~~~~~  226 (309)
                      +|||++...   ..........||+.|+|||++.   ++.++||||+||++|+|++|..||...+.......   .....
T Consensus       158 ~dfg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            999998654   2233445678899999999886   89999999999999999999999975432211100   00000


Q ss_pred             ccccccc--cchhhhh---cccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 FPYPIEN--NSLRQIL---NFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .......  .......   ............++.+.+||++||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000  0000000   0001111122344668999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=327.65  Aligned_cols=269  Identities=18%  Similarity=0.240  Sum_probs=197.2

Q ss_pred             HhhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC----c
Q 040698            5 KATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLETK----V   79 (309)
Q Consensus         5 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~   79 (309)
                      ..+.+|++++.||+|+||.||+|.+ .+|+.||+|.+.........+.+.+|+.+|+.++||||+++++++....    .
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            3567899999999999999999985 5799999999876555555667899999999999999999999987643    2


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                      .+++++++.+++|.+++...    .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence            35556667799999998643    3578999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccccc-cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccc---
Q 040698          160 LISSHDQ-TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPI---  231 (309)
Q Consensus       160 ~~~~~~~-~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  231 (309)
                      ....... ........+++.|+|||.+.    ++.++||||+||++|+|++|..||.....................   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            6533222 22334567889999999885    678899999999999999999998654322111110000000000   


Q ss_pred             ---cccchhh-hhcc--cccCc---cchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          232 ---ENNSLRQ-ILNF--QVADE---NEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       232 ---~~~~~~~-~~~~--~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ....... ....  .....   .....++.+.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0000000 0000  00000   011223568999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=328.68  Aligned_cols=262  Identities=24%  Similarity=0.292  Sum_probs=191.1

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCccceeeeeeec------CCcc
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKNVVKILGVCLE------TKVP   80 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~   80 (309)
                      -+|+.+++||+|+||.||+|.+ .+|+.||+|.+.....     ...+|+.+|++++||||+++++++..      ...+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            4799999999999999999996 4699999998865432     23468999999999999999999853      2356


Q ss_pred             EEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccc
Q 040698           81 LLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSV  159 (309)
Q Consensus        81 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~  159 (309)
                      ++||||++++.+..+.........+++..+..++.|++.||.|||+++   ++||||||+||+++.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence            899999987655444444444556688999999999999999999999   99999999999998765 89999999987


Q ss_pred             ccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc---cCcc----
Q 040698          160 LISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV---PYFP----  228 (309)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~---~~~~----  228 (309)
                      ....   ........++..|+|||.+.    ++.++||||+||++|+|++|..||..............   ....    
T Consensus       172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            6522   22334467889999999764    78999999999999999999999865432211110000   0000    


Q ss_pred             ---ccccccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          229 ---YPIENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       229 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         ........................++.+.+||.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0000000000000000000112234669999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=323.98  Aligned_cols=266  Identities=21%  Similarity=0.284  Sum_probs=193.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccc-hhhhhHHHHHHHHHHHhhcCCCccceeeeeeecCC-----
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMV-DKILINEVFQHKMRIISQINHKNVVKILGVCLETK-----   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   78 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|++... ......+.+.+|+.+|+.++|||||++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            468999999999999999999995 56999999998653 23344567889999999999999999999997654     


Q ss_pred             -ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           79 -VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        79 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                       .+++||||+ +.+|..+...    ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             569999999 6677776643    23588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcc--cCcccc-
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMV--PYFPYP-  230 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~--~~~~~~-  230 (309)
                      +....     .......+++.|+|||.+.    ++.++||||+||++|+|++|..||...+..........  ...+.. 
T Consensus       168 a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            97642     2334567889999999874    68899999999999999999999875432221100000  000000 


Q ss_pred             ---cccc----chhhhhcc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH--Hhhh
Q 040698          231 ---IENN----SLRQILNF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ--LDSL  284 (309)
Q Consensus       231 ---~~~~----~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--l~~~  284 (309)
                         ....    ........  ..........++.+.+||.+||..||.+|||+.++++|  |..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence               0000    00000000  00001112334668999999999999999999999987  4443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-46  Score=315.19  Aligned_cols=265  Identities=19%  Similarity=0.262  Sum_probs=198.5

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecCCccEEEEE
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLETKVPLLVYE   85 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e   85 (309)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            6899999999999999999995 578999999875432 23345778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeeccccccccc
Q 040698           86 FVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASSVLISSHD  165 (309)
Q Consensus        86 ~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~~~~~~  165 (309)
                      ++.++++..++....   ..++..+..++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+...... 
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC-
Confidence            999988887775433   3477899999999999999999999   999999999999999999999999999765322 


Q ss_pred             ccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC--ccccccccchh--
Q 040698          166 QTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY--FPYPIENNSLR--  237 (309)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--  237 (309)
                       ........++..|+|||.+.    ++.++||||+||++|+|++|+.||-...............  .+.........  
T Consensus       155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence             22233345567799999876    5788999999999999999999963222111111110000  00000000000  


Q ss_pred             -------hhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          238 -------QILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       238 -------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                             ...............++.+.+||++||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0000011111223344668999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=319.69  Aligned_cols=269  Identities=21%  Similarity=0.262  Sum_probs=191.4

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchh-hhhHHHHHHHHHHHhhcCCCccceeeeeeec-------
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDK-ILINEVFQHKMRIISQINHKNVVKILGVCLE-------   76 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------   76 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|++..... ......+.+|+.+|+.++|||++++++++..       
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            458999999999999999999995 5799999998754422 2234567899999999999999999998854       


Q ss_pred             -CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEee
Q 040698           77 -TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADF  155 (309)
Q Consensus        77 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~  155 (309)
                       .+..++||||+.++.+.....   .....++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence             346789999998766554332   2234577889999999999999999999   999999999999999999999999


Q ss_pred             ecccccccccc--cccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhh--hhcccCc
Q 040698          156 ASSVLISSHDQ--TATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEM--TRMVPYF  227 (309)
Q Consensus       156 g~~~~~~~~~~--~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~--~~~~~~~  227 (309)
                      |++........  ........+++.|+|||++.    ++.++||||+||++|+|++|..||..........  .......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99966533221  22333456899999999875    7889999999999999999999986432221110  0001011


Q ss_pred             ccccc----ccchhhhhcccccCcc-------chHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          228 PYPIE----NNSLRQILNFQVADEN-------EMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       228 ~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                      .....    ................       ....++.+.+||.+||+.||++|||+.++++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000    0000000000000000       01123557899999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=318.12  Aligned_cols=258  Identities=23%  Similarity=0.317  Sum_probs=192.9

Q ss_pred             hcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeec--CCccEE
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLE--TKVPLL   82 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~i   82 (309)
                      .++|++++.||+|+||.||+|.+ .+|+.||+|++....    .+.+.+|+.+|+.++ ||||+++++++..  ....++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            46899999999999999999996 569999999876543    346788999999995 9999999999874  456899


Q ss_pred             EEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEEeeeccccc
Q 040698           83 VYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNY-TAKVADFASSVLI  161 (309)
Q Consensus        83 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~-~v~l~d~g~~~~~  161 (309)
                      ||||+++++|....      ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++ .++++|||++...
T Consensus       110 v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         110 VFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence            99999999987643      23578899999999999999999999   99999999999998654 6999999998765


Q ss_pred             ccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccC-----------
Q 040698          162 SSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPY-----------  226 (309)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~-----------  226 (309)
                      ..   ........+++.|+|||.+.    ++.++||||+||++|+|++|..||................           
T Consensus       181 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         181 HP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             CT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             cC---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            22   22344556788999999975    6888999999999999999999986432211110000000           


Q ss_pred             ---cc-ccc----cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          227 ---FP-YPI----ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       227 ---~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                         .. ...    .....................++++.+||++||+.||++|||++++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00 000    0000000001111111223345679999999999999999999999873

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=320.61  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=197.5

Q ss_pred             hcccccceeecccCceEEEEEEc----CCCcEEEEEecccch---hhhhHHHHHHHHHHHhhcCC-CccceeeeeeecCC
Q 040698            7 TKNYDKRHLLGEGGFGFVYKGVL----PDNTLVAVKKPKMVD---KILINEVFQHKMRIISQINH-KNVVKILGVCLETK   78 (309)
Q Consensus         7 ~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~   78 (309)
                      .++|++++.||+|+||.||+|..    .+|+.||+|.+....   .....+.+.+|+.++++++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47899999999999999999984    248999999875431   12224567889999999976 89999999999999


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..+++|||+.+++|.+++......   ++..+..++.|++.|+.|+|+++   ++||||||+||+++.++.++|+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~---~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHhcccc---cHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999998766543   66888899999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc-----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCccccccc
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF-----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIEN  233 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
                      ...... .........+++.|++||.+.     ++.++|||||||++|+|++|..||...........            
T Consensus       177 ~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~------------  243 (322)
T d1vzoa_         177 KEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE------------  243 (322)
T ss_dssp             EECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH------------
T ss_pred             hhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence            765332 223344567889999999985     67789999999999999999999864422211100            


Q ss_pred             cchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCCC-----HHHHHHH
Q 040698          234 NSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERPT-----MRQVSEQ  280 (309)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~  280 (309)
                       ........  ....+...++.+.+||.+||+.||.+|||     ++|+++|
T Consensus       244 -i~~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         244 -ISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -HHHhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence             00111111  11122344577999999999999999994     7888763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=315.96  Aligned_cols=263  Identities=19%  Similarity=0.227  Sum_probs=187.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeec------C
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLE------T   77 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~   77 (309)
                      +.++|++++.||+|+||+||+|.+ .+|+.||+|++.... .......+.+|+.++++++||||+++++++..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            347899999999999999999996 469999999886542 23334568899999999999999999999863      4


Q ss_pred             CccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeec
Q 040698           78 KVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFAS  157 (309)
Q Consensus        78 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~  157 (309)
                      +.+|+||||+.++.+. .+.     ..+++..++.++.|++.||.|||++|   ++||||||+||+++.++.++++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence            6789999999765443 332     23478999999999999999999999   99999999999999999999999998


Q ss_pred             ccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhh---cccCcc---
Q 040698          158 SVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTR---MVPYFP---  228 (309)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~---~~~~~~---  228 (309)
                      +.....   ........+++.|+|||++.   ++.++||||+||++|+|++|.+||...+........   .....+   
T Consensus       166 ~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            765422   23334556789999999987   888999999999999999999998543211110000   000000   


Q ss_pred             --------------ccccccchhhhh-cc--cccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          229 --------------YPIENNSLRQIL-NF--QVADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       229 --------------~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                                    ............ +.  ..........++.+.+||++||+.||++|||++++++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                          000000000000 00  11111234556789999999999999999999999887

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-44  Score=309.73  Aligned_cols=257  Identities=19%  Similarity=0.219  Sum_probs=193.1

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc-cceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN-VVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|.+.....   .+.+..|..+++.++|++ |+.+.+++.+.+..++|
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            346899999999999999999995 5689999998665432   234678999999998765 55556667778888999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEEeeecccc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLD---DNYTAKVADFASSVL  160 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~---~~~~v~l~d~g~~~~  160 (309)
                      |||+ ++++...+....  ..+++..+..++.|++.||+|||+++   ++||||||+||+++   .+..++++|||++..
T Consensus        82 me~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence            9999 556666655433  24578999999999999999999999   99999999999985   455799999999987


Q ss_pred             ccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccccc
Q 040698          161 ISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYPIE  232 (309)
Q Consensus       161 ~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
                      .......     .......|++.|+|||.+.   ++.++|||||||++|+|++|..||..........            
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~------------  223 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------  223 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------------------
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH------------
Confidence            6432221     2233457899999999987   7889999999999999999999986532221110            


Q ss_pred             ccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          233 NNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       233 ~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                        .........   .....+..+++.+.++|.+||+.||++||++.++.+.|+.+.
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         224 --KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ---HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             --HHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence              000000000   001112234567999999999999999999999988877653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-44  Score=307.94  Aligned_cols=257  Identities=16%  Similarity=0.174  Sum_probs=199.2

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC-CccceeeeeeecCCccEEE
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH-KNVVKILGVCLETKVPLLV   83 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~iv   83 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|.+.....   .+.+..|++.++.+.| +|++.+++++.+....++|
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            468999999999999999999995 4689999998654332   2346778888888865 8999999999999999999


Q ss_pred             EEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCCeEEEeeecc
Q 040698           84 YEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDD-----NYTAKVADFASS  158 (309)
Q Consensus        84 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~-----~~~v~l~d~g~~  158 (309)
                      |||+ +++|.+++.....  .++...+..++.|++.||+|||+++   ++||||||+||+++.     ++.++++|||++
T Consensus        80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence            9999 6899988865443  3577899999999999999999999   999999999999964     578999999999


Q ss_pred             ccccccccc-----ccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc
Q 040698          159 VLISSHDQT-----ATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP  230 (309)
Q Consensus       159 ~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (309)
                      .........     .......||+.|+|||.+.   ++.++||||||+++|+|++|..||..........          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~----------  223 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----------  223 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----------
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH----------
Confidence            775332211     1233457899999999997   7889999999999999999999986432221110          


Q ss_pred             ccccchhhhhccc---ccCccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHHHhhhh
Q 040698          231 IENNSLRQILNFQ---VADENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQLDSLR  285 (309)
Q Consensus       231 ~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~l~~~~  285 (309)
                          ....+...+   .....+..+++.+.+++..|++.+|++||++..+.+.|.++.
T Consensus       224 ----~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         224 ----KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             ----HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                000000000   001112234466999999999999999999999988886653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=313.46  Aligned_cols=263  Identities=21%  Similarity=0.249  Sum_probs=192.6

Q ss_pred             hhcccccceeecccCceEEEEEEc-CCCcEEEEEecccch-hhhhHHHHHHHHHHHhhcCCCccceeeeeeecC-----C
Q 040698            6 ATKNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVD-KILINEVFQHKMRIISQINHKNVVKILGVCLET-----K   78 (309)
Q Consensus         6 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   78 (309)
                      ..++|++++.||+|+||.||+|.+ .+|+.||+|++.... .....+.+.+|+.+|++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            457899999999999999999995 579999999886542 233345688999999999999999999998642     3


Q ss_pred             ccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEEeeecc
Q 040698           79 VPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKVADFASS  158 (309)
Q Consensus        79 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~  158 (309)
                      ..+++++++.|++|.+++...    .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            446777888899999988532    3588999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccccccccccCCCcccc----cCCCcchhhHHHHHHHHHhCCCCCchhhhcchhhhhcccCcccc----
Q 040698          159 VLISSHDQTATTTKEIETVGWLDPEYLF----WTEKSDVYSFGVVLVELLTGKHPRSYVALASNEMTRMVPYFPYP----  230 (309)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----  230 (309)
                      ...     ........++..|+|||...    ++.++|||||||++|+|++|..||...+................    
T Consensus       169 ~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            653     23334556788899999865    67899999999999999999999864432211111000000000    


Q ss_pred             --ccccchhhhhcccccC------ccchHHHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 040698          231 --IENNSLRQILNFQVAD------ENEMEEIEIVAKLASKCLRTSGTERPTMRQVSEQ  280 (309)
Q Consensus       231 --~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~  280 (309)
                        ................      ......++.+.+||.+||+.||++|||+.++++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence              0000000000000000      0011234668999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-39  Score=282.39  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=185.7

Q ss_pred             cccccceeecccCceEEEEEEc-CCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-----------CCccceeeeeee
Q 040698            8 KNYDKRHLLGEGGFGFVYKGVL-PDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-----------HKNVVKILGVCL   75 (309)
Q Consensus         8 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~   75 (309)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|++.....  ..+.+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            5699999999999999999995 5799999999876532  2356678888887765           578999998876


Q ss_pred             c--CCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCC---
Q 040698           76 E--TKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS-LGSPPIIHGDVKSANILLDDNYT---  149 (309)
Q Consensus        76 ~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~~~h~dl~~~nilv~~~~~---  149 (309)
                      .  ....+++++++..+...............++..+..++.|++.|++|||+ .+   ++||||||+||+++.++.   
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence            4  34556677766555444444444444556788999999999999999998 88   999999999999976553   


Q ss_pred             ---eEEEeeecccccccccccccccccccccccCCCcccc---cCCCcchhhHHHHHHHHHhCCCCCchhhhcchh----
Q 040698          150 ---AKVADFASSVLISSHDQTATTTKEIETVGWLDPEYLF---WTEKSDVYSFGVVLVELLTGKHPRSYVALASNE----  219 (309)
Q Consensus       150 ---v~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~DiwslG~ll~~~~~g~~p~~~~~~~~~~----  219 (309)
                         ++++|||.+...     ........+++.|+|||.+.   ++.++|+||+|+++++|++|..||.........    
T Consensus       168 ~~~~kl~dfg~s~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWY-----DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEET-----TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeeccccccc-----ccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               899999988643     22334567889999999887   788999999999999999999998643211100    


Q ss_pred             -hhh---cccCccccc-----------------------cccchhhhhcccccCccchHHHHHHHHHHhHhhccCCCCCC
Q 040698          220 -MTR---MVPYFPYPI-----------------------ENNSLRQILNFQVADENEMEEIEIVAKLASKCLRTSGTERP  272 (309)
Q Consensus       220 -~~~---~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  272 (309)
                       ...   .....+...                       .........  ......+...++.+.+||.+||+.||.+||
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhc--ccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             000   000000000                       000000000  011223456778899999999999999999


Q ss_pred             CHHHHHHH
Q 040698          273 TMRQVSEQ  280 (309)
Q Consensus       273 s~~~ll~~  280 (309)
                      |++++++|
T Consensus       321 ta~e~L~H  328 (362)
T d1q8ya_         321 DAGGLVNH  328 (362)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhcC
Confidence            99999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.5e-23  Score=166.07  Aligned_cols=134  Identities=19%  Similarity=0.232  Sum_probs=104.7

Q ss_pred             cccceeecccCceEEEEEEcCCCcEEEEEecccchh-----------------hhhHHHHHHHHHHHhhcCCCccceeee
Q 040698           10 YDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDK-----------------ILINEVFQHKMRIISQINHKNVVKILG   72 (309)
Q Consensus        10 y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (309)
                      +.+.+.||+|+||.||+|.+.+|+.||+|..+....                 .........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457899999999999999988899999997543211                 111233456788888999999988876


Q ss_pred             eeecCCccEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 040698           73 VCLETKVPLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHSLGSPPIIHGDVKSANILLDDNYTAKV  152 (309)
Q Consensus        73 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~~~h~dl~~~nilv~~~~~v~l  152 (309)
                      +.    ..+++|||+++..+.+          ++......++.|++.+++|||+++   ++||||||+||+++++ .+++
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    2479999998765432          123445678899999999999999   9999999999999966 4899


Q ss_pred             Eeeeccccc
Q 040698          153 ADFASSVLI  161 (309)
Q Consensus       153 ~d~g~~~~~  161 (309)
                      +|||.+...
T Consensus       144 iDFG~a~~~  152 (191)
T d1zara2         144 IDFPQSVEV  152 (191)
T ss_dssp             CCCTTCEET
T ss_pred             EECCCcccC
Confidence            999988655

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.92  E-value=2.4e-09  Score=87.26  Aligned_cols=149  Identities=18%  Similarity=0.093  Sum_probs=97.7

Q ss_pred             ChHHHhhcccccceeecccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCc
Q 040698            1 SELVKATKNYDKRHLLGEGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKV   79 (309)
Q Consensus         1 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (309)
                      ++|.+..++|++++..+.++.+.||+... +++.+++|......... ...+..|...+..+. +--+.+++.+..+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            36778889999998877777789999875 55667777655433221 224566777766653 3335677788888888


Q ss_pred             cEEEEEcCCCCCHHHHHHhhccccccCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 040698           80 PLLVYEFVPNGTLFQHVRYQSSQVLKTWKTCLRIAAETASALDYLHS---------------------------------  126 (309)
Q Consensus        80 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---------------------------------  126 (309)
                      .++||++++|.++.+.....        .....++.++...++.||+                                 
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             eEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            89999999998775432110        0111223334444444443                                 


Q ss_pred             --------------------c---CCCCeEecCCCCCcEEEcCCCCeEEEeeeccc
Q 040698          127 --------------------L---GSPPIIHGDVKSANILLDDNYTAKVADFASSV  159 (309)
Q Consensus       127 --------------------~---~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~  159 (309)
                                          .   ....++|+|+.+.||++++++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                0   11116899999999999977666799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.43  E-value=4.1e-07  Score=73.24  Aligned_cols=74  Identities=18%  Similarity=0.101  Sum_probs=51.8

Q ss_pred             eecccC-ceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCC--CccceeeeeeecCCccEEEEEcCCCCC
Q 040698           15 LLGEGG-FGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINH--KNVVKILGVCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        15 ~lg~g~-~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~iv~e~~~~~s   91 (309)
                      .+..|. .+.||+....++..+++|.......    ..+..|...++.+..  -.+.+++.+..+.+..+++|++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            444444 4678999987888899997655432    235566666665532  235677888888888899999999866


Q ss_pred             H
Q 040698           92 L   92 (309)
Q Consensus        92 L   92 (309)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.09  E-value=9.8e-06  Score=69.40  Aligned_cols=78  Identities=13%  Similarity=0.181  Sum_probs=47.3

Q ss_pred             ceeecccCceEEEEEEcCC-CcEEEEEecccc------hhhhhHHHHHHHHHHHhhcC-C-C-ccceeeeeeecCCccEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD-NTLVAVKKPKMV------DKILINEVFQHKMRIISQIN-H-K-NVVKILGVCLETKVPLL   82 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~-~~~v~ik~~~~~------~~~~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~i   82 (309)
                      .+.||.|....||++...+ ++.+++|...+.      .......+...|...|+.+. + | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568999999999998644 678888854321      11111233456777776552 2 2 34455543  4556689


Q ss_pred             EEEcCCCCCH
Q 040698           83 VYEFVPNGTL   92 (309)
Q Consensus        83 v~e~~~~~sL   92 (309)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=9e-05  Score=61.50  Aligned_cols=68  Identities=13%  Similarity=0.029  Sum_probs=44.0

Q ss_pred             eEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc--cceeee-----eeecCCccEEEEEcCCCCC
Q 040698           22 GFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN--VVKILG-----VCLETKVPLLVYEFVPNGT   91 (309)
Q Consensus        22 g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~-----~~~~~~~~~iv~e~~~~~s   91 (309)
                      -.||++...+|+.+++|..++....  .+.+..|...+..+....  ++....     .+..+...+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            5799999889999999987664332  345667777777664222  122211     2234566788999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.16  E-value=0.00068  Score=57.60  Aligned_cols=73  Identities=12%  Similarity=0.127  Sum_probs=48.0

Q ss_pred             ceeecccCceEEEEEEcCC--------CcEEEEEecccchhhhhHHHHHHHHHHHhhcC-CCccceeeeeeecCCccEEE
Q 040698           13 RHLLGEGGFGFVYKGVLPD--------NTLVAVKKPKMVDKILINEVFQHKMRIISQIN-HKNVVKILGVCLETKVPLLV   83 (309)
Q Consensus        13 ~~~lg~g~~g~v~~~~~~~--------~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv   83 (309)
                      ++.|+.|-.-.+|++..++        ++.++++..-....   .....+|..+++.+. +.-..++++++.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            4678889999999998543        35677776543222   223456777777764 3334577777653    689


Q ss_pred             EEcCCCCCH
Q 040698           84 YEFVPNGTL   92 (309)
Q Consensus        84 ~e~~~~~sL   92 (309)
                      ++|++|..+
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.99  E-value=0.0043  Score=50.57  Aligned_cols=152  Identities=14%  Similarity=0.078  Sum_probs=77.8

Q ss_pred             hHHHhhcccccceeec-----ccCceEEEEEEcCCCcEEEEEecccchhhhhHHHHHHHHHHHhhcCCCc--cceeee--
Q 040698            2 ELVKATKNYDKRHLLG-----EGGFGFVYKGVLPDNTLVAVKKPKMVDKILINEVFQHKMRIISQINHKN--VVKILG--   72 (309)
Q Consensus         2 ~~~~~~~~y~i~~~lg-----~g~~g~v~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~--   72 (309)
                      +|.....+|.+.+...     .|.--..|.....+| .+++|.......   .+.+..+++++..+...+  +..+..  
T Consensus         7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             HHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             HHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceec
Confidence            5677778898765443     565677899887555 588887654322   223445556666553222  111111  


Q ss_pred             ----eeecCCccEEEEEcCCCCCHHH-----------HH---Hhh------------------------ccccccCHHHH
Q 040698           73 ----VCLETKVPLLVYEFVPNGTLFQ-----------HV---RYQ------------------------SSQVLKTWKTC  110 (309)
Q Consensus        73 ----~~~~~~~~~iv~e~~~~~sL~~-----------~l---~~~------------------------~~~~~~~~~~~  110 (309)
                          +.........++.++.+.....           .+   ...                        ...........
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                1122344556666666542210           00   000                        00000011112


Q ss_pred             HHHHHHHHHHHHHHH----hcCCCCeEecCCCCCcEEEcCCCCeEEEeeecccc
Q 040698          111 LRIAAETASALDYLH----SLGSPPIIHGDVKSANILLDDNYTAKVADFASSVL  160 (309)
Q Consensus       111 ~~i~~~i~~~l~~lh----~~~~~~~~h~dl~~~nilv~~~~~v~l~d~g~~~~  160 (309)
                      ...+..+...+.-..    ..+   ++|+|+.++|++++.+...-+.||+.++.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~g---iIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAG---VIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEE---EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhccCccccccc---cccCCcchhhhhcccccceeEeccccccc
Confidence            222222333233222    245   89999999999999887778999997753